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SMALL ANIMAL – CARDIOLOGY**
9:00 am C-1 Paul Mo˜tsku¨la PROGNOSTIC VALUE OF 24-HOUR AMBULATORY ECG (HOLTER) MONITORING IN BOXER
DOGS
9:15 am C-2 Ryan Fries COMPARISON OF TRANSTHORACIC TWO-DIMENSIONAL ECHOCARDIOGRAPHY, THREE-
DIMENSIONAL ECHOCARDIOGRAPHY, TRANSESOPHAGEAL ECHOCARDIOGRAPHY,
COMPUTED TOMOGRAPHY ANGIOGRAPHY, AND GATED MAGNETIC RESONANCE IMAGING
IN NORMAL CANINE HEARTS
9:30 am C-3 Bryan Bottorﬀ USE OF COMPUTED TOMOGRAPHY IN THE ASSESSMENT OF DOGS WITH PERICARDIAL
EFFUSION
9:45 am C-4 Kristen Parker DIRECT ARTERIAL BLOOD PRESSURE MEASUREMENT USING A CAROTID CATHETER IN
COMPARISON TO OSCILLOMETRIC AND DOPPLER METHOD
BREAK
10:30 am C-5 Sara Johns CAN STRAIN RATE IMAGING DIFFERENTIATE PHYSIOLOGIC FROM PATHOLOGIC
HYPERTROPHY IN THE DOG?
10:45 am C-6 Carley Saelinger OPTIMIZATION OF IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) DEFIBRILLATION
THRESHOLDS IN DOGS
11:00 am C-7 SeungWoo Jung ATRIAL FIBRILLATION IS A NEGATIVE PROGNOSTIC INDICATOR IN LARGE BREED DOGS
WITH MYXOMATOUS MITRAL VALVE DEGENERATION AND CONGESTIVE HEART FAILURE
11:15 am C-8 Hannah
Stephenson
MALIGNANT VENTRICULAR ARRHYTHMIAS ARE ASSOCIATED WITH DILATED
CARDIOMYOPATHY IN GREAT DANES
11:30 am C-9 Ioannis Giatis UTILIZATION OF TRANSESOPHAGEAL ATRIAL PACING TO OBTAIN SINUS NODE
RECOVERY TIME IN DOGS
11:45 am C-10 Ashley Saunders LONG-TERM EVALUATION OF CARDIAC SIZE AND FUNCTION IN 71 DOGS FOLLOWING
PATENT DUCTUS ARTERIOSUS CLOSURE
12:00 pm C-11 Rebecca
Langhorn
CANINE CARDIAC TROPONIN I SIGNIFICANTLY COMPLEMENTS ESTABLISHED
PROGNOSTIC COMPOSITE SCORE IN DOGS WITH SYSTEMIC INFLAMMATION
12:15 pm C-12 Keith Blass CLINICAL EVALUATION OF THE 3MTM LITTMANN® MODEL 3200 ELECTRONIC
STETHOSCOPE IN CATS
**Also see Cardiology abstracts C-13 – C-26 (Thursday, May 31, 2:15 pm – 6:15 pm) Boldface type indicates ACVIM Resident Research Award eligibility.
Bold face type indicates ACVIM Resident Research Award eligibility.
J Vet Intern Med 2012;26:690–822
SMALL ANIMAL - ENDOCRINOLOGY
9:00 am EN-1 Tim Williams RESTORATION OF EUTHYROIDISM IN MEDICALLY TREATED HYPERTHYROID CATS WITH
IATROGENIC HYPOTHYROIDISM (IH) IMPROVES RENAL FUNCTION
9:15 am EN-2 Mark Peterson THYROID SCINTIGRAPHY FINDINGS IN 917 CATS WITH HYPERTHYROIDISM
9:30 am EN-3 Bethany Sabatino AMINO ACID, IODINE, SELENIUM, AND COAT COLOR STATUS AMONG HYPERTHYROID,
SIAMESE, AND AGE-MATCHED CONTROL CATS
9:45 am EN-4 Aline Vieira EFFECT OF THE STAGE OF CHRONIC KIDNEY DISEASE ON SERUM TOTAL THYROXINE IN
CATS
BREAK
10:30 am EN-5 Eric Walsh ASPART INSULIN CONSTANT RATE INFUSION FOR TREATMENT OF DOGS WITH DIABETIC
KETOACIDOSIS
10:45 am EN-6 Mia Reeve-
Johnson
DETERMINATION OF REFERENCE VALUES FOR CASUAL BLOOD GLUCOSE
CONCENTRATION IN CLINICALLY-HEALTHY, AGED CATS MEASURED WITH A PORTABLE
GLUCOSE METER FROM AN EAR OR PAW SAMPLE
11:00 am EN-7 Erin Mooney EARLY-ONSET HYPOADRENOCORTICISM IN A KINDRED OF POMERANIANS
11:15 am EN-8 Rebecca Haviland CLINICAL FEATURES OF HYPOADRENOCORTICISM IN SOFT-COATED WHEATEN TERRIERS:
72 CASES (1979–2011)
11:30 am EN-9 Emily Skovira THE EFFECT OF SURGERY ON THE PITUITARY-ADRENAL AXIS IN DOGS
11:45 am EN-10 Pascale Smets LONG-TERM FOLLOW-UP OF RENAL FUNCTION IN DOGS WITH ACTH-DEPENDENT
HYPERADRENOCORTICISM (ESVE Award Winner)
12:00 pm EN-11 Jessica Timian EVALUATION OF A LONG-ACTING SOMATOSTATIN RECEPTOR LIGAND FOR THE
TREATMENT OF FELINE ACROMEGALY
12:15 pm EN-12 Linda Martin BASAL ALDOSTERONE CONCENTRATIONS AND RESPONSE TO ACTH STIMULATION IN
HEALTHY AND CRITICALLY ILL DOGS
SMALL ANIMAL – NEPHROLOGY / UROLOGY
9:00 am NU-1 Meryl Littman PROTEIN-LOSING NEPHROPATHY ASSOCIATEDWITHMUTATIONS IN NPHS1 (NEPHRIN)
AND KIRREL2 (NEPH3/FILTRIN) IN SOFTCOATEDWHEATEN TERRIERS
9:15 am NU-2 Cara Horowitz PRE-OPERATIVE PREDICTORS OF OUTCOME FOR CATS WITH SUCCESSFUL MANAGEMENT
OF URETERAL OBSTRUCTIONS VIA URETERAL STENTING OR A SUBCUTANEOUS
URETERAL BYPASS DEVICE
9:30 am NU-3 Sarah Stewart EVALUATION OF WHITE COAT HYPERTENSION IN DOGS AND CATS USING THE petMAP
OSCILLOMETRIC BLOOD PRESSURE MONITOR
9:45 am NU-4 Danielle Weinstein THE EFFECT OF BODY POSITION ON INDIRECT SYSTOLIC BLOOD PRESSURE
MEASUREMENT IN DOGS
BREAK
10:30 am NU-5 Rebecca Geddes FEEDING A RENAL DIET IS ASSOCIATED WITH A REDUCTION IN PLASMA FIBROBLAST
GROWTH FACTOR 23 (FGF-23) IN CATS WITH STABLE CHRONIC KIDNEY DISEASE (CKD)
10:45 am NU-6 Adam Eatroﬀ ACUTE KIDNEY INJURY IN DOGS HOSPITALIZED IN THE INTENSIVE CARE UNIT: A
PROSPECTIVE STUDY (INTERIM ANALYSIS)
11:00 am NU-7 Thierry Francey LONG-TERM RENAL OUTCOME OF DOGS WITH ACUTE KIDNEY INJURY
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11:15 am NU-8 Amy Lomas ACUTE AND CHRONIC EFFECTS OF TEPOXALIN ON RENAL FUNCTION IN DOGS WITH
CHRONIC KIDNEY DISEASE AND OSTEOARTHRITIS
11:30 am NU-9 Todd Archer ULTRASOUND-GUIDED PLACEMENT OF URETHRAL STENTS IN DOGS
11:45 am NU-10 Carrie Palm URINARY NGAL: A BIOMARKER FOR EARLY IDENTIFICATION OF ACUTE KIDNEY
INJURY IN DOGS
12:00 pm NU-11 Winnie Ybarra ACCURACY OF URICULT® VET PADDLES FOR THE DIAGNOSIS AND IDENTIFICATION OF
BACTERIAL CYSTITIS IN DOGS AND CATS
12:15 pm NU-12 Mary Thompson ASYMPTOMATIC BACTERIURIA ESCHERICHIA COLI STRAIN 83972 IN COMPETITION WITH
EMERGING, HIGHLY VIRULENT MULTI-DRUG RESISTANT ESCHERICHIA COLI STRAINS IN
CANINE URINE
SMALL ANIMAL – INFECTIOUS DISEASE**
9:00 am ID-1 Megan Downey CYTAUXZOON FELIS CYTOCHROME B GENOTYPE IS ASSOCIATED WITH SURVIVAL IN
DOMESTIC CATS WITH CYTAUXZOONOSIS
9:15 am ID-2 Leah Cohn DIAMENAZINE DIACETURATE AT 3 MG/KG DOES NOT ELIMINATE PARASITEMIA IN CATS
WITH CHRONIC CYTAUXZOON FELIS INFECTION
9:30 am ID-3 Audra Fenimore DETECTION OF LEPTOSPIRURIA IN SHELTER CATS IN COLORADO
9:45 am ID-4 Matthew Krecic IDENTIFICATION OF RHOPTRY ASSOCIATED PROTEIN-1S (RAP-1S) WITH BABSESIA
GIBSONI ISOLATES OF INFECTED DOGS IN THE UNITED STATES
BREAK
10:30 am ID-5 Paolo Silvestrini IRON STATUS AND C-REACTIVE PROTEIN IN CANINE LEISHMANIASIS
10:45 am ID-6 Craig Ruaux PREVALENCE OF BLASTOCYSTIS SPP AND GIARDIA SPP IN DOGS AND CATS RESIDENT IN
A PACIFIC NORTHWEST SHELTER
11:00 am ID-7 Audra Fenimore TREATMENT OF CHRONIC RHINITIS IN SHELTER CATS WITH PARENTERAL ALPHA-
INTERFERON OR AN INTRANASAL FELINE HERPESVIRUS 1 AND FELINE CALICIVIRUS
VACCINE
11:15 am ID-8 Allison Bradley INTRANASAL ADMINISTRATION OF A MODIFIED LIVE FELINE HERPESVIRUS 1 AND FELINE
CALICIVIRUS VACCINE INDUCES CROSS PROTECTION AGAINST BORDETELLA
BRONCHISEPTICA
11:30 am ID-9 Christian
Leutenegger
FELINE HERPESVIRUS 1 VIRAL LOAD AS A TOOL TO DIFFERENTIATE LYTIC FROM
LATENT INFECTION
11:45 am ID-10 Annette Litster SERIAL FIV SEROLOGICAL RESULTS IN COHABITING FIV-POSITIVE AND FIV-NEGATIVE
CATS
12:00 pm ID-11 Robert Lavan U. S. PREVALENCE OF CANINE INFECTIOUS RESPIRATORY DISEASE PATHOGENS: A 3-
YEAR STUDY
12:15 pm ID-12 Linda Kidd ARTHROPOD-BORNE DISEASE IN SICK SOUTHERN CALIFORNIA DOGS
**Also see Infectious Disease abstracts ID-13 – ID-17 (Thursday, May 31, 2:45 pm – 4:00 pm)
EQUINE
9:00 am E-1 Colin
Schwarzwald
ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT VENTRICULAR SIZE AND SYSTOLIC
FUNCTION IN HORSES USING LINEAR MEASUREMENTS AND AREA-BASED VOLUME
ESTIMATES
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9:15 am E-2 Mark Bowen VALIDATION OF A POINT OF CARE ULTRASOUND DEVICE FOR THE ASSESSMENT OF
CARDIAC DISEASE IN THE HORSE
9:30 am E-3 Erin McConachie DOPPLER AND VOLUMETRIC ECHOCARDIOGRAPHIC METHODS FOR CARDIAC OUTPUT
MEASUREMENT IN STANDING ADULT HORSES
9:45 am E-4 Stacy Tinkler EFFECTS OF PRE-RACE FUROSEMIDE ADMINISTRATION ON PLASMA ELECTROLYTE
CONCENTRATIONS AND ACID-BASE BALANCE IN STANDARDBREDS UNDERGOING A
SIMULATED RACE PROTOCOL
BREAK
10:30 am E-5 Stacey Sullivan ASSOCIATION BETWEEN EXERCISE-INDUCED PULMONARY HAEMORRHAGE AND
DURATION OF RACING CAREER IN THOROUGHBRED RACE HORSES
10:45 am E-6 Maty Looijen HYPERBARIC OXYGEN THERAPY DOES NOT ALTER mRNA INFLAMMATORY GENES
EXPRESSION IN HEALTHY HORSES
11:00 am E-7 Krista Estell TEMPORAL VIRAL LOAD IN SEVEN HORSES WITH NATURALLY OCCURRING EQUINE
HERPESVIRUS-1 MYELOENCEPHALOPATHY
11:15 am E-8 Nicola Pusterla INVESTIGATION OF THE ROLE OF MULES DURING AN OUTBREAK OF EQUINE
HERPESVIRUS-1 MYELOENCEPHALOPATHY IN CALIFORNIA
11:30 am E-9 Nathan Slovis EQUINE SALMONELLOSIS. THE USE OF AN ENHANCED RAPID TEST SYSTEM (Reveal® 2.0
Salmonella Test System) FOR EARLY DETECTION OF SALMONELLA IN FECES AND
ENVIRONMENTAL SAMPLES
11:45 am E-10 Gillian Perkins ANTIMICROBIAL SUSCEPTIBILITY OF SALMONELLA ISOLATES OBTAINED FROM HORSES
IN THE NORTHEASTERN UNITED STATES
12:00 pm E-11 Florence Polle ROLE OF INTRAOCULAR BACTERIAL INFECTIONS IN HORSES WITH RECURRENT UVEITIS
IN LOUISIANA
12:15 pm E-12 Raﬀaella Teixeira GENETIC DETERMINANTS OF MELANOMA SUSCEPTIBILITY IN GRAY HORSES
SMALL ANIMAL – CARDIOLOGY**
2:15 pm C-13 Manuela Perego ANALYSIS OF ATRIAL REPOLARIZATION WAVE (Ta) IN DOGS WITH THIRD-DEGREE
ATRIOVENTRICULAR BLOCK
2:30 pm C-14 Jorge Vila STRUCTURAL AND MOLECULAR PATHOLOGY OF THE ATRIUM IN BOXER
ARRHYTHMOGENIC CARDIOMYOPATHY
2:45 pm C-15 Jordan Vitt INCIDENCE OF HEART DISEASE IN CATS WITH ELECTROCARDIOGRAPHIC EVIDENCE OF
LEFTWARD MEAN ELECTRICAL AXIS SHIFT
3:00 pm C-16 Jennifer Mulz NT-PROBNP AS A SCREENING TOOL TO DETECT CLINICALLY SIGNIFICANT HEART
DISEASE IN ASYMPTOMATIC CATS WITH HEART MURMURS AND/OR GALLOP RHYTHMS
3:15 pm C-17 Bethany Smouther HEART RATE AND ARRHYTHMIA FREQUENCY OF NORMAL CATS COMPARED TO CATS
WITH HYPERTROPHIC CARDIOMYOPATHY
3:30 pm C-18 Bethany Smouther EFFECT OF ATENOLOL ON HEART RATE, ARRHYTHMIAS, BLOOD PRESSURE, AND
DYNAMIC LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION IN CATS WITH
ASYMPTOMATIC HYPERTROPHIC CARDIOMYOPATHY
3:45 pm C-19 Andrea Lantis THE EFFECT OF ENALAPRIL ON FUROSEMIDE-ACTIVATED RENIN-ANGIOTENSIN-
ALDOSTERONE SYSTEM (RAAS) IN NORMAL DOGS
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4:30 pm C-20 Marisa Ames THE EFFECT OF HIGH DOSE PIMOBENDAN ON THE FUROSEMIDE-INDUCED RENIN-
ANGIOTENSIN-ALDOSTERONE-SYSTEM (RAAS)
4:45 pm C-21 Mari Waterman DURATION OF BETA-BLOCKADE ASSOCIATED WITH REPEATED ONCE-DAILY
ADMINISTRATION OF ATENOLOL IN HEALTHY DOGS.
5:00 pm C-22 Dennis Trafny EFFECT OF KETANSERIN, A SEROTONIN 2A-RECEPTOR ANTAGONIST, ON
ECHOCARDIOGRAPHIC INDICES OF MITRAL REGURGITATION IN DOGS WITH
DEGENERATIVE MITRAL VALVE DISEASE
5:15 pm C-23 Sonja Fonfara MYOCARDIAL ICAM1 mRNA IS INCREASED IN CANINE DILATED CARDIOMYOPATHY
5:30 pm C-24 Melanie Hezzell ASSOCIATIONS BETWEEN N-TERMINAL PROCOLLAGEN TYPE III (PIIINP), FIBROSIS AND
ECHOCARDIOGRAPHIC INDICES IN DOGS WITH MITRAL VALVE DISEASE
5:45 pm C-25 Kristen Parker NOT ALL ARTERIES ARE CREATED EQUAL: COMPARISON OF PRESSURES WITHIN THE
AORTIC ROOT AND THE DORSAL PEDAL ARTERY IN CATS
6:00 pm C-26 Brandon Pogue RETROGRADE CORONARY VENOUS STEM CELL DELIVERY: A PILOT STUDY EVALUATING
SAFETY AND FEASIBILITY
**Also see Cardiology abstracts C-1 – C-12 (Thursday, May 31, 9:00 am – 12:30 pm)
SMALL ANIMAL - HEMATOLOGY
2:15 pm HM-1 Anna Dengate THE OVERALL HAEMOSTASIS POTENTIAL; A NOVEL, COST EFFECTIVE, GLOBAL
COAGULATION ASSAY FOR USE IN CANINE PLASMA
2:30 pm HM-2 Reinhard Mischke MEASUREMENT OF THROMBIN GENERATION IN DOGS WITH DIFFERENT DISEASES
2:45 pm HM-3 Be´re´nice Conversy IN VITRO EVALUATION OF THE EFFECT OF RIVAROXABAN ON COAGULATION
PARAMETERS IN HEALTHY DOGS
3:00 pm HM-4 Fiona Park ASSESSMENT OF HYPERCOAGULABILITY IN CANINE PITUITARY-DEPENDENT
HYPERADRENOCORTICISM
3:15 pm HM-5 Anna Dengate DELAYED FIBRINOLYSIS IN DOGS WITH NATURALLY OCCURRING PITUITARY
DEPENDANT HYPERADRENOCORTICISM
3:30 pm HM-6 Craig Ruaux SYRINGE AND AGGREGATE FILTER ADMINISTRATION DOES NOT AFFECT SURVIVAL OF
TRANSFUSED AUTOLOGOUS FELINE RED BLOOD CELLS
3:45 pm HM-7 Jessica Schavone LEUKOREDUCTION OF FELINE WHOLE BLOOD USING A NEONATAL LEUKOCYTE
REDUCTION FILTER: A PILOT EVALUATION
BREAK
4:30 pm HM-8 Alex Lynch UTILITY OF SERIAL ANTI-XA MONITORING IN DOGS RECEIVING DALTEPARIN
4:45 pm HM-9 Reinhard Mischke PLATELET FUNCTION IN DOGS WITH INFLAMMATORY DISEASES
5:00 pm HM-10 Alice Defarges 15-GAUGE CORE BONE MARROW BIOPSY IN SMALL DOGS AND CATS WITH
HEMATOLOGIC DISORDERS – 16 CASES
5:15 pm HM-11 Stephanie Smith SERUM BIOMARKERS INDICATE HEMOLYSIS AND AN INFLAMMATORY RESPONSE TO
TRANSFUSION OF AUTOLOGOUS STORED ERYTHROCYTE CONCENTRATES
5:30 pm HM-12 Sean Majoy ASSESSMENT OF PLATELET ACTIVATION IN DOGS ADMITTED TO THE INTENSIVE CARE
UNIT (ICU) BY USE OF FLOW CYTOMETRY AND THROMBOELASTOGRAPHY
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5:45 pm HM-13 Melissa Bucknoﬀ EVALUATION OF THROMBOELASTOGRAPHY TO PREDICT CLINICAL BLEEDING IN
THROMBOCYTOPENIC DOGS AFTER TOTAL BODY IRRADIATION AND HEMATOPOIETIC
CELL TRANSPLANTATION
6:00 pm HM-14 Andrea Zoia IMMUNE-MEDIATED HEMOLYTIC ANEMIA IN CATS WITH PANCREATITIS
SMALL ANIMAL – NEUROLOGY / PHARMACOLOGY
2:15 pm N-1 Christopher Levine CEREBELLAR ABIOTROPHY IN FOUR RELATED POMERANIANS
2:30 pm N-2 Unity Jeﬀery DOES CEREBROSPINAL FLUID CYTOLOGY PREDICT CENTRAL NERVOUS SYSTEM
HISTOLOGY?
2:45 pm N-3 Katherine Crook THE PHARMACOKINETICS OF CYTARABINE IN DOGS WHEN ADMINISTERED VIA
SUBCUTANEOUS AND CONTINUOUS INTRAVENOUS INFUSION ROUTES
3:00 pm N-4 Intan Shaﬁe CEREBROSPINAL FLUID CLUSTERIN IS A POTENTIAL BIOMARKER OF CANINE
NEURODEGENERATIVE DISORDERS
3:15 pm N-5 Daniel Sanchez-
Masian
L-2-HYDROXYGLUTARIC ACIDURIA IN YORKSHIRE TERRIER DOGS: CHARACTERIZATION
OF THE MOLECULAR DEFECT
3:30 pm N-6 Kendra Mikoloski DIAGNOSTIC VALUE AND DISCRIMINATORY ABILITY OF PROTON MAGNETIC RESONANCE
SPECTROSCOPY FOR INTRACRANIAL NEOPLASIA IN DOGS
3:45 pm N-7 Cona Anwer MAGNETIC RESONANCE IMAGING FEATURES OF INTRACRANIAL GRANULAR CELL
TUMORS IN SEVEN DOGS
BREAK
4:30 pm N-8 Devon Hague SIGNALMENT, CLINICAL FINDINGS, MAGNETIC RESONANCE IMAGING FEATURES AND
SURGICAL OUTCOMES WITH HISTOPATHOLOGICALLY CONFIRMED EPIDURAL AND
SUBDURAL SPINAL CORD HEMATOMA IN DOGS
4:45 pm N-9 Jessica Barker MRI ASSESSMENT OF DOGS WITH DESCENDING TRANSTENTORIAL AND / OR FORAMEN
MAGNUM BRAIN HERNIATIONS
5:00 pm N-10 Kari Foss KINEMATIC GAIT ANALYSIS USING 3-D MOTION MOTION CAPTURE IN DOBERMAN
PINSCHERS WITH AND WITHOUT CERVICAL SPONDYLOMYELOPATHY
5:15 pm N-11 Thomas Flegel THE VACUUM PHENOMENON IN INTERVERTEBRAL DISC DISEASE OF DOGS BASED ON
COMPUTED TOMOGRAPHY IMAGES
5:30 pm N-12 E Beltran MUTATION ASSOCIATED WITH NEONATAL CEREBELLAR CORTICAL DEGENERATION IN
BEAGLE DOGS IDENTIFIED BY GENOME-WIDE MRNA SEQUENCING
5:45 pm N-13 Starr Cameron SURGICAL REMOVAL OF FELINE INTRACRANIAL MENINGIOMAS: CLINICAL FEATURES AND
OUTCOME IN 121 CASES (1994–2011)
6:00 pm P-1 Michaela Beasley THE PHARMACOKINETICS OF SINGLE DOSE EXTENDED RELEASE KEPPRA® WITH AND
WITHOUT FOOD IN HEALTHY ADULT DOGS
SMALL ANIMAL – RESPIRATORY / OTHER
2:15 pm R-1 Katharine Woods COMPARISON OF BRONCHOALVEOLAR LAVAGE ASPIRATION TECHNIQUES IN HEALTHY
DOGS: MANUAL ASPIRATION VIA POLYETHYLENE TUBING AND SUCTION PUMP
ASPIRATION
2:30 pm R-2 Richard Stone ENVIRONMENTAL AIR QUALITY, METEOROLOGICAL FACTORS, AND FELINE
RESPIRATORY DISEASE
2:45 pm R-3 Erinne Branter TRACHEAL MALFORMATIONS IN YORKSHIRE TERRIERS
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3:00 pm R-4 Chee-hoon Chang ORAL GLUCOCORTICOIDS MAY DIMINISH EFFICACY OF ALLERGEN-SPECIFIC
IMMUNOTHERAPY IN EXPERIMENTAL FELINE ASTHMA
3:15 pm R-5 Chee-hoon Chang FELINE T REGULATORY CELLS IN BRONCHOALVEOLAR LAVAGE FLUID AND WHOLE
BLOOD IN HEALTHY AND EXPERIMENTALLY ASTHMATIC CATS
3:30 pm R-6 A. Ray Dillon LUNG PATHOLOGY ASSOCIATED WITH TOXOCARA CATI INFECTION IN CATS IS
INDEPENDENT OF DEVELOPMENT OF ADULT INTESTIONAL PARASITES
3:45 pm R-7 Laura Nafe CERVICAL LUNG LOBE HERNIATION IN DOGS WITH COUGH AS IDENTIFIED BY
FLUOROSCOPY
BREAK
4:30 pm R-8 Yukihito
Shiroshita
ASSESSMENT OF ARTERIALIZATION OF PERIPHERAL VENOUS BLOOD IN WELL-
PERFUSED DOGS
4:45 pm OT-1 Withdrawn
5:00 pm OT-2 Alexandra Floras HOSPITAL VERSUS COMMUNITY ACQUIRED INTRA-ABDOMINAL INFECTION OF
GASTROINTESTINAL ORIGIN IN DOGS
5:15 pm OT-3 Medora
Pashmakova
MULTI-CENTER EVALUATION OF THE ADMINISTRATION OF CROTALID ANTIVENOM IN
CATS
5:30 pm OT-4 Stacy Burdick ENDOSCOPIC-GUIDED LASER ABLATION OF VESTIBULOVAGINAL DEFECTS IN 36 DOGS
5:45 pm OT-5 Joshua Rowe 18FLT-PET/CT FOR NON-INVASIVE FUNCTIONAL IMAGING OF CANINE BONE MARROW
6:00 pm OT-6 Kara Osterbur LIPOPOLYSACCHARIDE, TUMOR NECROSIS FACTOR, AND INTERLEUKIN-1b INDUCE NT-
PRO C-TYPE NATRIUETIC PEPTIDE SECRETION FROM CANINE VASCULAR ENDOTHELIAL
CELLS
SMALL ANIMAL - GASTROENTEROLOGY**
2:15 pm GI-1 Melissa Markel CHARACTERIZATION OF FECAL DYSBIOSIS IN DOGS WITH CHRONIC ENTEROPATHIES
AND ACUTE HEMORRHAGIC DIARRHEA
2:30 pm GI-2 Maria Volkmann FINAL DIAGNOSES IN 136 DOGS WITH CHRONIC DIARRHEA
2:45 pm GI-3 Niels Gru¨tzner SERUM HOMOCYSTEINE CONCENTRATIONS IN CHINESE SHAR PEIS AND DOGS OF SIX
OTHER BREEDS WITH COBALAMIN DEFICIENCY
3:00 pm GI-4 CarolineMansﬁeld CONFOCAL ENDOMICROSCOPY ENABLES IN VIVO IDENTIFICATION OF GASTRIC
HELICOBACTER-LIKE ORGANISMS IN DOGS
3:15 pm GI-5 Romy Heilmann FECAL S100A12 CONCENTRATIONS ARE INCREASED IN DOGS WITH INFLAMMATORY
BOWEL DISEASE
3:30 pm GI-6 Katie Stroda HISTOPATHOLOGICAL, CLINICAL, ENDOSCOPIC, AND ULTRASOUND FEATURES OF DOGS
WITH CHRONIC ENTEROPATHIES AND SMALL INTESTINAL CRYPT LESIONS
3:45 pm GI-7 Itamar Aroch SERUM PEPSINOGEN A AS A PROGNOSTIC MARKER IN CANINE GASTRIC DILATATION
AND VOLVULUS
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BREAK
4:45 pm GI-8 Caroline Goutal COMPARISON OF QUALITY AND DIAGNOSTIC ADEQUACY OF CANINE DUODENAL
MUCOSAL BIOPSY SPECIMENS OBTAINED WITH DIFFERENT ENDOSCOPIC FORCEPS IN 17
DOGS
5:00 pm GI-9 Cris Otoni SEROLOGIC AND FECAL MARKERS IN PREDICTION OF ACUTE DISEASE COURSE IN CANINE
CHRONIC ENTEROPATHIES
5:15 pm GI-10 Alexandra Galler FLOW CYTOMETRICAL ANALYSIS OF PERIPHERAL BLOOD MONONUCLEAR CELLS IN
DOGS WITH INFLAMMATORY BOWEL DISEASE
5:30 pm GI-11 Shingo Maeda DECREASED IMMUNOGLOBULIN A LEVELS IN FECES, DUODENUM, AND PERIPHERAL
BLOOD LYMPHOCYTES OF DOGS WITH INFLAMMATORY BOWEL DISEASE
5:45 pm GI-12 Panagiotis Xenoulis FELINE EXOCRINE PANCREATIC INSUFFICIENCY: 150 CASES
6:00 pm GI-13 Katie Tolbert EXOGENOUS SIALIC ACID AND CYSTEINE PROTEASE INHIBITION BLOCK ADHERENCE OF
TRITRICHOMONAS FOETUS TO THE INTESTINAL EPITHELIUM
**Also see Gastroenterology abstracts GI-14 – GI-16 (Friday, June 1, 9:15 am – 10:00 am).
SMALL ANIMAL – IMMUNOLOGY / INFECTIOUS DISEASE** / ONCOLOGY
2:15 pm IM-1 Andrea Wang EFFICACY OF MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF CANINE IMMUNE-
MEDIATED HEMOLYTIC ANEMIA: 31 CASES (2007-2011)
2:30 pm IM-2 Laura Nafe EX VIVO IMMUNOSUPPRESSION OF CANINE T LYMPHOCYTE-SPECIFIC PROLIFERATION
USING DEXAMETHASONE, CYCLOSPORINE, AND THE ACTIVE METABOLITES OF
AZATHIOPRINE AND LEFLUNOMIDE IN A FLOW CYTOMETRIC ASSAY
2:45 pm ID-13 Nahvid Etedali NT-pCNP AS A DIAGNOSTIC BIOMARKER FOR SEPSIS IN DOGS PRESENTING FOR
EMERGENCY CARE
3:00 pm ID-14 Monika Burns SERIAL NT-pCNP in HOSPITALIZED DOGS WITH SEPSIS
3:15 pm ID-15 Amy Davenport PHYLOGENETIC DIVERSITY OF BACTERIA ISOLATED FROM SICK DOGS USING THE BAPGM
ENRICHMENT CULTURE PLATFORM
3:30 pm ID-16 Kimberly Yore PREVALENCE OF BARTONELLA SPP. AND HEMOPLASMAS IN THE BLOOD OF DOGS AND
THEIR FLEAS IN FLORIDA
3:45 pm ID-17 Lindsay Tangeman CLINICOPATHOLOGIC FEATURES AND ATYPICAL PRESENTATIONS OF NATURALLY
OCCURRING CANINE LEPTOSPIROSIS: 51 CASES (2000-2010)
** Also see Infectious Disease abstracts ID-1 – ID-12 (Thursday, May 31, 9:00 am – 12:30 pm)
BREAK
4:30 pm O-1 Esther Chon CHARACTERIZATION OF BETA-CATENIN EXPRESSION IN CANINE ORAL MELANOMA
(VCS AWARD WINNER)
4:45 pm O-2 Lindsay Thalheim AGREEMENT BETWEEN FLOW CYTOMETRY, PCR FOR ANTIGEN RECEPTOR
REARRANGEMENT, AND IMMUNOHISTOCHEMISTRY IN CANINE LYMPHOMA
(VCS AWARD WINNER)
5:00 pm O-3 Deborah Knapp FIROCOXIB HAS ANTITUMOR ACTIVITY AS A SINGLE AGENT AND ENHANCES THE
ACTIVITY OF CISPLATIN IN DOGS WITH TRANSITIONAL CELL CARCINOMA OF THE
URINARY BLADDER
5:15 pm O-4 Mitchell Kaye PHASE II CLINICAL TRIAL OF VINORELBINE AND PIROXICAM FOR DOGS WITH
TRANSITIONAL CELL CARCINOMA OF THE URINARY BLADDER
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5:30 pm O-5 Krysta Deitz COMPUTED TOMOGRAPHIC APPEARANCE OF CANINE THYROID TUMORS
5:45 pm O-6 Cecilia Robat MULTI-INSTITUTION RETROSPECTIVE STUDY OF 85 CASES OF CANINE THYMOMA (1999-
2010)
6:00 pm O-7 Krysta Deitz EVALUATION OF SECRETED FRIZZLED-RELATED PROTEIN 2 EXPRESSION IN CANINE
THYROID TUMORS USING RT-PCR AND IMMUNOHISTOCHEMISTRY
EQUINE
2:15 pm E-13 Victoria Scott EFFECT OF BODY POSITION ON ABDOMINAL PRESSURES IN ADULT HORSES
2:30 pm E-14 Harold Schott II VOLUME OF DISTENDED SMALL INTESTINE AND IONIC COMPSITION OF GASTRIC
REFLUX AND SMALL INTESTINAL FLUID IN HORSES
2:45 pm E-15 Jocelyn
Habershon-Butcher
PREVALENCE AND RISK FACTORS FOR ULCERATION OF THE GASTRIC GLANDULAR
MUCOSA IN THOROUGHBRED RACEHORSES IN TRAINING IN THE UK AND AUSTRALIA
3:00 pm E-16 James Belknap REGULATION OF HYPOXIA INDUCIBLE FACTOR-1A AND RELATED GENES IN THE EQUINE
KERATINOCYTE AND DIGITAL LAMINAE IN EXPERIMENTAL MODELS OF EQUINE
LAMINITIS
3:15 pm E-17 Teresa Burns LAMINAR INFLAMMATORY EVENTS IN LEAN AND OBESE PONIES SUBJECTED TO HIGH
CARBOHYDRATE FEEDING: IMPLICATIONS FOR PASTURE-ASSOCIATED LAMINITIS
3:30 pm E-18 Heidi Banse ABSENCE OF OXIDATIVE STRESS IN THE SKELETAL MUSCLE OF OBESE HORSES
3:45 pm E-19 Kate McGovern THE EFFECTS OF EXPERIMENTALLY INDUCED HYPERGLYCEMIA AND ENDOTOXEMIA ON
COAGULATION PARAMETERS IN HEALTHY ADULT HORSES
BREAK
4:30 pm E-20 Jennifer Mahon EVALUATION OF HYPERCOAGULABILTY IN GERIATRIC HORSES WITH/WITHOUT
PITUITARY PARS INTERMEDIA DYSFUNCTION
4:45 pm E-21 Katarzyna
Dembek
RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (RAAS) RESPONSE AND ACTH/
ALDOSTERONE RATIO IN SEPTIC NEWBORN FOALS
5:00 pm E-22 Martin Furr EFFECTS OF BLOOD CONTAMINATION ON PARAMETERS OF CEREBROSPINAL FLUID
ANALYSIS
5:15 pm E-23 Alexandra Draper THE EPIDEMIOLOGY OF SHIVERS IN HORSES
5:30 pm E-24 Nora Nogradi PROGNOSTIC FACTORS ASSOCIATED WITH SHORT-TERM AND LONG-TERM OUTCOME IN
HORSES WITH CHRONIC RENAL FAILURE
5:45 pm E-25 Noah Cohen IN VIVO ADMINISTRATION OF CPG ENHANCES FOAL NEUTROPHIL FUNCTION
6:00 pm E-26 Alexandra Burton EFFECT OF AGE ON THE PHARMACOKINETICS OF A SINGLE DAILY DOSE OF
GENTAMICIN SULPHATE IN FOALS
FOOD ANIMAL
2:15 pm FA-1 Christopher Luby SKILLS REQUIRED OF ENTRY LEVEL VETERINARIANS: A SURVEY OF DAIRY
PRACTITIONERS
2:30 pm FA-2 Scott Weese METAGENOMIC EVALUATION OF THE INTESTINAL MICROBIOME IN VEAL CALVES AND
THE INFLUENCE OF ORAL TETRACYCLINE
2:45 pm FA-3 Scott Weese A PROSPECTIVE CONTROLLED STUDY ON PREVALENCE OF CLOSTRIDIUM DIFFICILE IN
VEAL CALVES RECEIVING AND NOT RECEIVING ORAL OXYTETRACYCLINE
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3:00 pm FA-4 Angelika Schoster INCREASED STRONG ION GAP IN DAIRY CALVES WITH DIARRHEA IS LIKELY DUE TO D-
LACTATE
3:15 pm FA-5 Gillian Perkins ANTIMICROBIAL RESISTANCE TRENDS AMONG SALMONELLA ISOLATES OBTAINED FROM
DAIRY CATTLE IN THE NORTHEASTERN USA, 2004-2010
3:30 pm FA-6 Gretchen Grissett EVALUATION OF ORALLY SUPPLEMENTED D, L-METHIONINE AS A URINE ACIDIFIER FOR
SMALL RUMINANTS
3:45 pm FA-7 Philippa Sprake THE EFFECT OF AMMONIUM CHLORIDE TREATMENT AS A LONG TERM PREVENTATIVE
APPROACH FOR UROLITHIASIS IN GOATS AND A COMPARISON OF CONTINUOUS AND
PULSE DOSING REGIMES
BREAK
4:30 pm FA-8 Se´bastien
Buczinski
ECHOCARDIOGRAPHIC MEASUREMENT OF VALVULAR THICKNESS IN HEALTHY COWS,
COWS WITH BACTERIAL ENDOCARDITIS AND COWS WITH CARDIORESPIRATORY
DISEASES
4:45 pm FA-9 Withdrawn
5:00 pm FA-10 Meera Heller UTERINE NEOPLASIA IN SMALL RUMINANTS: RETROSPECTIVE STUDY (1991-2011)
5:15 pm FA-11 Piper Norton CAMELID HEAT STRESS AS A SYNDROME: 15 CASES (2003–2011)
5:30 pm FA-12 Toby Pinn COMPARISON OF THREE IMMUNOGLOBULIN G (IgG) ASSAYS FOR DIAGNOSIS OF FAILURE
OF PASSIVE TRANSFER IN NEONATAL ALPACAS
5:45 pm FA-13 Amanda Kreuder BIOAVAILABILITY AND PHARMACOKINETICS OF ORAL MELOXICAM IN LLAMAS
6:00 pm FA-14 Kristen Thane FLORFENICOL PHARMACOKINETICS IN HEALTHY ADULT ALPACAS, EVALUATING TWO
COMMERCIALLY AVAILABLE DRUG FORMULATIONS
ORAL PRESENTATIONS – FRIDAY, JUNE 1
SMALL ANIMAL – NUTRITION / METABOLISM
8:00 am NM-1 Ebenezer Satyaraj NUTRITIONAL IMMUNOMODULATION: BOVINE COLOSTRUM FOR IMMUNE & GUT
HEALTH IN DOGS
8:15 am NM-2 AlexanderGerman EFFECTS OF WEIGHT LOSS IN OBESE DOGS ON A RANGE OF RENAL BIOMARKERS
8:30 am NM-3 Hannelore Van
de Velde
mRNA EXPRESSION RESPONSE OF ADIPOKINES TO FELINE OBESITY DEPENDS ON ADIPOSE
TISSUE LOCATION
8:45 am NM-4 Isabelle Jeusette COMPARISON OF TWO WEIGHT LOSS DIETS IN OVERWEIGHT CATS
9:00 am NM-5 Angela Witzel
(Lusby)
COMPARISION OF HIGH FIBER AND LOW CARBOHYDRATE DIETS ON OWNER-PERCEIVED
SATIETY OF CATS DURING WEIGHT LOSS
9:15 am NM-6 Samuel Serisier SEASON AND MONTH EFFECTS ON FOOD INTAKE IN ADULT COLONY CATS
9:30 am NM-7 Raphae¨l Goudez INFLUENCE OF DIFFERENT SOURCES OF CORN STARCH ON STOOLS CHARACTERISTICS IN
DOGS DIFFERING IN BODY SIZE
9:45 am NM-8 Samuel Serisier A 8.5-YEAR LONGITUDINAL STUDY TO IDENTIFY RISK FACTORS OF OBESITY IN COLONY
CATS
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SMALL ANIMAL – HEPATOLOGY / GASTROENTEROLOGY**
8:00 am HP-1 Cle´mence Peyron LIVER HISTOLOGICAL LESIONS IN 43 SCOTTISH TERRIERS (ST) WITH HYPERACTIVITY OF
ALKALINE PHOSPHATASES (AP)
8:15 am HP-2 Jonathan Lidbury CLINICAL FEATURES OF HEPATIC ENCEPHALOPATHY IN DOGS: 80 CASES (1991–2011)
8:30 am HP-3 Sharon Center LONG-TERM SURVIVAL OF DOGS (n=597) WITH CONGENITAL OR ACQUIRED
PORTOSYSTEMIC SHUNTING: 1980-2010
8:45:am HP-4 Manabu Sakai SERUM BRANCHED-CHAIN AMINO ACID/TYROSINE RATIO (BTR) IN DOGS WITH LIVER
DISEASES
9:00 am HP-5 Yumi Sakamoto PLASMA AND HEPATIC ENDOTHELIN-1 IN DOGS WITH CHRONIC LIVER DISEASES
9:15 am GI-14 Belgin Dogan COMPARISON OF E. COLI ASSOCIATED WITH GRANULOMATOUS COLITIS OF BOXER DOGS
AND E. COLI FROM HEALTHY CONROLS
9:30 am GI-15 Alison
Manchester
GRANULOMATOUS COLITIS IN FRENCH BULLDOGS IS ASSOCIATED WITH INVASIVE E.
COLI AND CLINICAL RESPONSE TO FLUOROQUINOLONE ANTIBIOTICS
9:45 am GI-16 Sabrina Hoehne FELINE ALIMENTARY LYMPHOMA IS ASSOCIATED WITH CHANGES IN THE SPATIAL
DISTRIBUTION OF MUCOSAL BACTERIA
**Also see Gastroenterology abstracts GI-1 – GI-13 (Thursday, May 31, 2:15 pm – 6:15 pm).
POSTER PRESENTATIONS
On Display: Thursday, May 31, 7:00 am – 7:00 pm
Friday, June 1, 7:00 am – 7:00 pm
Saturday, June 2, 7:00 am – 2:30 pm
Attended by Authors Eligible for ACVIM Resident Research Awards:
Thursday, May 31, 9:50 am – 10:30 am
Friday, June 1, 9:50 am – 10:30 am
Attended by all Authors – Wine & Cheese Reception:
Friday, June 1, 6:00 pm – 7:30 pm
# Presenting Author Abstract Title
SMALL ANIMAL - CARDIOLOGY
C-27 David McGahie THE NATURAL ANTIOXIDANTS POMEGRANATE EXTRACT AND SOY ISOFLAVONES FAVOURABLY
MODULATE CANINE ENDOTHELIAL CELL FUNCTION
C-28 David McGahie POMEGRANATE EXTRACT COMBINED WITH OTHER NATURAL ANTIOXIDANTS PROTECTS
CANINE ENDOTHELIAL CELLS FROM DEATH INDUCED BY OXIDATIVE STRESS




C-REACTIVE PROTEIN IS ELEVATED IN DOGS IN SEVERE HEART FAILURE
C-31 Hung-Yin Chen ASSESSMENT OF HYPERTROPHIC CARDIOMYOPATHY IN SMALL BREED DOGS AFFECTED WITH
HYPERADRENOCORTICISM USING 2D SPECKLE-TRACKING ECHOCARDIOGRAPHY
C-32 Guilherme Goldfeder ECHOCARDIOGRAPHIC EVALUATION OF LEFT ATRIAL SIZE IN HEALTH COCKER SPANIEL DOGS
AND WITH DILATED CARDIOMIOPATHY
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C-33 Antonio Camacho TIME-DOMAIN HEART RATE VARIABILITY IN HEALTHY DOGS




RADIOGRAPHIC VERTEBRAL HEART SIZE AND LEFT ATRIAL BISECTING LINE: INTEROBSERVER
VARIABILITY AND COMPARISON TO ECHOCARDIOGRAPHIC LEFT ATRIAL SIZE IN DOGS WITH
DEGENERATIVE MITRAL VALVE DISEASE
C-36 Osuga Tatsuyuki LEFT ATRIAL FUNCTION ANALYSIS BY LEFT ATRIAL TRACKING METHOD IN CANINE CHRONIC
MITRAL VALVULAR HEART DISEASE
C-37 Keisuke Sugimoto EARLY DETECTION OF LEFT VENTRICULAR DYSFUNCTION IN DOGS WITH DOXORUBICIN-
INDUCED CARDIOMYOPATHY BY 2D SPECKLE TRACKING ECHOCARDIOGRAPHY
C-38 Antonio Camacho DOXORUBICIN-INDUCED DILATED CARDIOMYOPATHY IN A RABBIT MODEL: AN UPDATE
C-39 Maria Helena Larsson ASSESSMENT OF SERUM ADIPONECTIN AND ITS CORRELATION WITH OBESITY AND MITRAL
VALVE ENDOCARDIOSIS IN DOGS
C-40 Antonio Camacho ARTERIAL BLOOD PRESSURE ASSESSMENT IN NORMAL AND OVERWEIGHT DOGS BY THREE
DIFFERENT METHODS
C-41 Denise Schwartz PLASMA LEVELS OF NT-PRO BNP AND VENTRICULAR DIASTOLIC FUNCTION ASSESSED BY
PULSED TISSUE DOPPLER ECHOCARDIOGRAPHY IN OBESE DOGS
C-42 Hung-Yin Chen EFFECT OF BODYWEIGHT ON ASSESSMENT OF LEFT VENTRICULAR FUNCTIONS USING TWO-
DIMENSIONAL SPECKLE-TRACKING ECHOCARDIOGRAPHY
C-43 Denise Schwartz ECHOCARDIOGRAPHIC FINDINGS IN OBESE DOGS
C-44 Emily Mehlman CHARACTERIZATION OF GROSS AND HISTOLOGIC MYOCARDIAL LESIONS IN OBESE DOGS
C-45 Denise Schwartz TRANSVENOUS PERMANENT PACEMAKER THERAPY IN DOGS: BRAZILIAN EXPERIENCE
C-46 Paula Itikawa ECHOCARDIOGRAPHIC EVALUATION OF LEFT ATRIAL SIZE IN MAINE COON CATS, FROM APICAL
FOUR CHAMBER VIEW
C-47 Gretchen Singletary SURVIVAL OF CATS WITH ISOLATED DISCRETE UPPER SEPTAL THICKENING (DUST) VS. CATS
WITH AND WITHOUT CARDIOMYOPATHY
C-48 Maggie Machen EFFECT OF ATENOLOL THERAPY ON ECHOCARDIOGRAPHIC PARAMETERS IN CATS WITH
HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
C-49 Rachel Cohen EFFECT OF A HEART MURMUR ON ADOPTABILITY OF CATS IN AN URBAN NO-KILL RESCUE
ORGANIZATION
C-50 Maggie Machen DETECTION OF OCCULT FELINE CARDIOMYOPATHY USING A PET-SIDE POINT-OF-CARE NT-
PROBNP ELISA ASSAY
C-51 Paula Itikawa TRICUSPID ANNULAR PLANE SYSTOLIC EXCURSION (TAPSE) MEASUREMENTS IN MAINE COON
CATS
C-52 Guilherme Goldfeder TRICUSPID ANNULAR PLANE SYSTOLIC EXCURSION (TAPSE) MEASUREMENTS IN DOGS
C-53 Mark Oyama SURVEY OF SIX POTENTIAL CARDIAC BIOMARKERS IN DOGS WITH HEART DISEASE:
CHROMOGRANIN-A, ENDOGLIN, GALECTIN-3, NT-PROBNP, ST2, and OSTEOPONTIN
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C-54 Ryan Birks BREED-SPECIFIC VERTEBRAL HEART SIZE FOR THE DACHSHUND
C-55 Anthony Carr IN-HOME BLOOD PRESSURE MONITORING IN DOGS: A PILOT STUDY
C-56 Damon Leeder LONG-TERM SURVIVAL IN DOGS WITH UNTREATED SEVERE SUBAORTIC STENOSIS
C-57 Andrea Vollmar COMPARISON OF PIMOBENDAN, BENAZEPRIL, OR METHYLDIGOXIN MONOTHERAPY IN IRISH
WOLFHOUNDS WITH OCCULT DCM: A 10-YEAR-STUDY
SMALL ANIMAL - ENDOCRINOLOGY
EN-13 Ah Young Kim EVALUATION OF ONCE-DAILY ADMINISTRATION OF INSULIN GLARGINE IN DOGS WITH
NATURALLY OCCURING DIABETES MELLITUS
EN-14 Marcia Jerico´ CHROMATOGRAPHIC ANALYSIS OF THE LIPID FRACTIONS IN OBESE CLIENT-OWNED DOGS
EN-15 Marcia Jerico´ CHROMATOGRAPHIC ANALYSIS OF THE LIPID FRACTIONS IN OBESE CLIENT-OWNED CATS
SMALL ANIMAL - GASTROENTEROLOGY
GI-17 Dianne Mawby NATURALLY-OCCURRING HYPERADRENOCORTICISM IS ASSOCIATED WITH INCREASED
PANCREATIC LIPASE IMMUNOREACTIVITY CONCENTRATIONS IN DOGS
GI-18 Jacqueline Whittemore ALPHA-ENOLASE ANTIBODIES ARE NOT ASSOCIATED WITH FELINE PANCREATIC LIPASE
IMMUNOREACTIVITY CONCENTRATIONS IN CLIENT-OWNED CAT
GI-19 Hiroki Okanishi MUCOSAL NUCLEOTIDE OLIGOMERIZATION DOMAIN TWO (NOD2) MRNA OVEREXPRESSION AND
NF-KAPPAB ACTIVATION IN DOGS WITH CHRONIC ENTEROPATHY
GI-20 Nora Berghoﬀ FECAL AND URINARY N-METHYLHISTAMINE CONCENTRATIONS IN DOGS WITH CHRONIC
GASTROINTESTINAL DISEASE
GI-21 Nora Berghoﬀ SERUM COBALAMIN AND METHYLMALONIC ACID CONCENTRATIONS IN DOGS WITH CHRONIC
GASTROINTESTINAL DISEASE
GI-22 Niels Gru¨tzner SERUM CONCENTRATIONS OF CANINE ALPHA1-PROTEINASE INHIBITOR IN YORKSHIRE
TERRIERS WITH AND WITHOUT COBALAMIN DEFICIENCY
GI-23 Maria Volkmann EFFECTIVITY OF AST-120 IN DOGS WITH CHRONIC INFLAMMATORY ENTEROPATHIES
GI-24 Hiroshi Ohta INTERLEUKIN-17A GENE EXPRESSION IN THE INTESTINAL MUCOSA IN DOGS WITH
LYMPHOCYTIC-PLASMACYTIC ENTERITIS AND INFLAMMATORY COLORECTAL POLYP
GI-25 Leda Barros C-REACTIVE PROTEIN CONCENTRATIONS IN DOGS WITH INFLAMMATORY BOWEL DISEASE AND
CORRELATION WITH A CLINICAL DISEASE ACTIVITY INDEX AND SERUM ALBUMIN
CONCENTRATIONS
GI-26 Craig Webb THE EFFECT OF A MULTI-STRAIN SYNBIOTIC ON THE MICROBIOTA OF CATS WITH CHRONIC
ENTERITIS
GI-27 Alexis Lecoindre REGIONAL GRANULOMATOUS ENTERITIS IN 14 DOGS.
GI-28 Yasushi Minamoto EVALUATION OF FECAL SHORT CHAIN FATTY ACID CONCENTRATIONS IN HEALTHY DOGS AND
DOGS WITH CHRONIC DIARRHEA
GI-29 Brittany Marvel THE EFFECT OF VARIOUS STORAGE CONDITIONS ON THE ABUNDANCE OF BACTERIAL GROUPS
IN CANINE FECES
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GI-30 Jose Garcia-Mazcorro DAY-TO-DAY VARIATION OF FECAL MICROBIOTA IN DOGS OF DIFFERENT AGES
GI-31 Kohtaro Hayashi PRESURGICAL EVALUATION OF RECTAL MASSES IN DOGS BY ENDOSCOPY AND ENDOSCOPIC
ULTRASOUND: 28 CASES
SMALL ANIMAL - HEMATOLOGY
HM-15 Craig Webb OSMOTIC FRAGILITY AND FLOW CYTOMETRIC DETERMINATION OF LIPID PEROXIDATION IN
FELINE ERYTHROCYTES
HM-16 Alice Defarges POWER-DRIVER ASSISTED 11-GAUGE HUMERAL CORE BONE MARROW BIOPSY IN LARGE BREED
DOGS WITH HEMATOLOGIC DISORDERS – 6 CASES
HM-17 Haruhiko Maruyama EVALUATION OF A HUMAN ELISA KIT FOR THE MEASUREMENT OF PLASMA ADAMTS13
ACTIVITY IN DOGS
SMALL ANIMAL – INFECTIOUS DISEASE
ID-18 Leah Cohn PARASITE BURDEN DOES NOT FLUCTUATE WITH TIME OF DAY IN CATS WITH CHRONIC
CYTAUXZOON FELIS INFECTION
ID-19 Megan Downey MITOCHONDRIAL GENOME SEQUENCES RESULT IN IMPROVED UNDERSTANDING OF THE
PHYLOGENETIC RELATIONSHIPS OF PIROPLASMIDA THAT INFECT COMPANION ANIMALS
ID-20 SukullayaAssarasakorn PREVALENCE OF BARTONELLA SPP. ASSOCIATED CANINE INFECTIOUS ENDOCARDITIS IN
BANGKOK, THAILAND
ID-21 Rosalind Carslake PREVALENCE OF SELECTED INFECTIOUS DISEASES IN SAMOAN DOGS
ID-22 Jane Sykes MOLECULAR EPIDEMIOLOGY AND ANTIFUNGAL SUSCEPTIBILITY AMONG CRYPTOCOCCUS
ISOLATES FROM NORTH AMERICAN DOGS AND CATS
ID-23 Michael Lappin DEVELOPMENT OF AN INDIRECT ENZYME-LINKED IMMUNOSORBENT ASSAY FOR THE
DETECTION OF FELINE ANTIBODIES AGAINST MYCOPLASMA FELIS
ID-24 Michael Lappin DETECTION OF FELINE ANTIBODIES AGAINST A NOVEL ANAPLASMA PHAGOCYTOPHILUM
PEPTIDE (AP-4) AFTER EXPOSURE TO WILD-CAUGHT ADULT IXODES SCAPULARIS
ID-25 Scott Moroﬀ DETECTION OF CANINE SERUM ANTIBODIES AGAINST A NOVEL MUTANT PEPTIDE OF
ANAPLASMA PHAGOCYTOPHILUM
ID-26 Michael Lappin VACCINE-ASSOCIATED LEPTOSPIRA ANTIBODY RESPONSES IN CLIENT-OWNED DOGS
ID-27 Jhoanna Rodriguez FELINE LEPTOSPIROSIS: A SEROLOGIC AND URINARY PCR SURVEY IN HEALTHY CATS AND IN
CATS WITH KIDNEY DISEASE
ID-28 Kuribayashi Hagiwara ISOLATION AND CHARACTERIZATION OF LEPTOSPIRA INTERROGANS SEROVAR COPENHAGENI
AND SEROVAR CANICOLA FROM DOGS WITH LEPTOSPIROSIS
ID-29 Emily Barker NON-RIBOSOMAL GENE PHYLOGENY OF HEMOPLASMAS AND OTHER MYCOPLASMA SPECIES
ID-30 Michael Lappin FAILURE TO AMPLIFY BARTONELLA KOEHLERAE DNA FROM BLOOD OF CATS AND THEIR FLEAS
IN THE UNITED STATES
ID-31 Michael Lappin A FLEA AND TICK COLLAR CONTAINING 10% IMIDACLOPRID AND 4.5% FLUMETHRIN PREVENTS
FLEA TRANSMISSION OF BARTONELLA HENSELAE IN CATS FOR 8 MONTHS
ID-32 Scott Moroﬀ CLASSIFICATION OF BORRELIA BURGDORFERI INFECTION USING RESULTS OF 5 ANTIBODY
TARGETS IN AN AUTOMATED SYSTEM
ID-33 Kenneth Harkin FELINE HISTOPLASMOSIS: FLUCONAZOLE THERAPY AND IDENTIFICATION OF POTENTIAL RISK
FACTORS
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ID-34 Audra Fenimore EVALUATION OF ENTEROCOCCUS FAECIUM SF68 SUPPLEMENTATION WITH METRONIDAZOLE
FOR THE TREATMENT OF NON-SPECIFIC DIARRHEA IN DOGS HOUSED IN ANIMAL SHELTERS
ID-35 Cindy Karsten PREVALENCE OF AGENTS ASSOCIATED WITH CANINE INFECTIOUS RESPIRATORY DISEASE
SYNDROME IN CLIENT-OWNED DOGS AND DOGS HOUSED IN SHELTERS
ID-36 Julia Veir COMPARISON OF ELISA, CONVENTIONAL PCR, AND QUANTITATIVE PCR FOR DETECTION OF
CANINE PARVOVIRUS
ID-37 Michael Lappin EVALUATION OF THE USE OF QUANTITATIVE PCR FOR RAPID DIFFERENTIATION OF RECENTLY
VACCINATED CATS AND THOSE WITH NATURALLY OCCURRING PANLEUKOPENIA
ID-38 Christian Leutenegger TOXIN QUANTIFICATION OF CLOSTRIDIUM PERFRINGENS IS A PREDICTOR FOR DIARRHEA IN
DOGS AND CATS
ID-39 Christian Leutenegger CANINE INFLUENZA VIRUS H3N8: A 4 YEAR REVIEW OF SEASONAL PATTERNS, GEOGRAPHICAL
FREQUENCY DIFFERENCES AND AGE DISTRIBUTION
ID-40 Jamie Lenberg THE EFFECTS OF MAROPITANT VERSUS ONDANSETRON ON THE CLINICAL RECOVERY OF DOGS
WITH PARVOVIRAL GASTROENTERITIS
ID-42 Paul Morley IDENTIFICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS OF ANIMAL ORIGIN
USING BACTERIOPHAGE AMPLIFICATION AND A LATERAL-FLOW IMMUNOASSAY
ID-43 Brett Stillman PERFORMANCE OF THE NEW IN-CLINIC SNAP® 4Dx® PLUS TEST FOR THE DETECTION OF
EHRLICHIA EWINGII (GRANULOCYTIC EHRLICHIOSIS) AND ANAPLASMA PLATYS
(THROMBOCYTOTROPIC ANAPLASMOSIS) ANTIBODIES IN DOGS
ID-44 Lorelei Clarke PREVALENCE OF SELECT VECTOR BORNE DISEASE AGENTS IN OWNED DOGS OF GHANA
ID-45 Scott Moroﬀ USE OF AN AUTOMATED SYSTEM FOR DETECTION OF CANINE SERUM ANTIBODIES AGAINST
GLYCOPROTEIN GP36
SMALL ANIMAL – NEPHROLOGY / UROLOGY
NU-13 Miki Nishida GLOMERULAR FILTRATION RATE ESTIMATION ON THE BASIS OF PLASMA CLEARANCE OF
INULIN IN DOGS
NU-14 Miki Nishida ESTIMATION OF GLOMERULAR FILTRATION RATE ON THE BASIS OF INULIN INFUSION
CLEARANCE IN DOGS WITH AND WITHOUT RENAL FAILURE
NU-15 Mark Dunning CLINICAL UTILITY OF PLASMA INULIN CLEARANCE AS A MEASURE OF GLOMERULAR
FILTRATION RATE IN DOGS
NU-16 Bernard Schmidt AST-120 ATTENUATES SERUM LEVELS OF THE UREMIC TOXIN, INDOXYL SULFATE, IN CATS WITH
DECREASED RENAL MASS
NU-17 Tea Gluhak EVALUATION OF 3 STRUVITE-OXALATE PREVENTATIVE DIETS IN HEALTHY CATS
NU-18 Leigh Perry EVALUATION OF CULTURE TECHNIQUES AND BACTERIAL CULTURES FROM CANINE AND FELINE
UROLITHS
NU-19 Jessica Markovich THE USE OF DARBEPOETIN ALFA IN CATS WITH CHRONIC KIDNEY DISEASE
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NU-20 Allison Bradley INTRAVESICALGLYCOSAMINOGLYCANSASANOVELTHERAPYFORFELINE IDIOPATHICCYSTITIS –A
PILOTSTUDY
SMALL ANIMAL - NEUROLOGY
N-14 Kensuke Orito EFFECT OF CHLORIDE IN INFUSION FLUID ON SERUM BROMIDE CONCENTRATION IN DOGS
N-15 Cassandra Williams DOES BODY CONDITION SCORE INCREASE RECOVERY TIME IN DOGS TREATED WITH
HEMILAMINECTOMY FOR ACUTE ONSET DISC RUPTURE?
N-16 Simon Platt IMMUNOHISTOCHEMICAL QUANTIFICATION OF INTERLEUKIN-6 AND INTERLEUKIN-8
EXPRESSION IN CANINE INTRACRANIAL MENINGIOMAS.
N-17 Peter Dickinson A NOVEL ANTI-CANINE CD133 ANTIBODY COLOCALIZES WITH GFAP IN NORMAL AND
NEOPLASTIC CANINE BRAIN TISSUE
N-18 Jeremy O’Neill CLINICOPATHOLOGIC AND MAGNETIC RESONANCE IMAGING CHARACTERISTICS OF
HYPERTENSIVE ENCEPHALOPATHY IN TWO CATS AND TWO DOGS
N-19 Ronaldo da Costa RELATIONSHIP BETWEEN SPINAL CORD SIGNAL CHANGES AND CLINICAL AND MRI FINDINGS
IN DOGS WITH CERVICAL SPONDYLOMYELOPATHY – 102 CASES
N-20 Kari Foss FORCE PLATE GAIT ANALYSIS IN DOBERMAN PINCHERS WITH AND WITHOUT CERVICAL
SPONDYLOMYELOPATHY
N-21 Peter Dickinson CHARACTERIZATION OF A NOVEL CANINE GBM-DERIVED CELL LINE (G06A) AND ORTHOTOPIC
TUMORS IN MICE
SMALL ANIMAL – NUTRITION / METABOLISM
NM-9 Anna Salas Mani BALL FEEDING INCREASES PHYSICAL ACTIVITY AND REDUCES BODY WEIGHT REGAIN AFTER A
WEIGHT LOSS DIET IN CATS
NM-10 Nora Berghoﬀ PLASMA ADIPOKINE CONCENTRATIONS IN LEAN AND OBESE DOGS
NM-11 Yasushi Minamoto EFFECT OF LOW LEVEL FRUCTAN SUPPLEMENTATION ON THE ABUNDANCE OF SPECIFIC
BACTERIAL GROUPS IN FECAL SAMPLES OF DOGS
NM-12 Yuanlong Pan SOY GERM ISOFLAVONES SUPPLEMENTATION REDUCED BODY FAT ACCUMULATION AND
ENHANCED ENERGY METABOLISM IN DOGS
SMALL ANIMAL - ONCOLOGY
O-8 Joanna Schmit INVESTIGATING IN VITRO ANTI-CANCER EFFECTS OF BENZIMIDAZOLES IN CANINE
OSTEOSARCOMA (VCS AWARD WINNER)
O-9 Timothy Stein MULTIDRUG RESISTANCE GENE EXPRESSION BY REAL TIME PCR IN CANINE OSTEOSARCOMA
CELL LINES FROM DOGS NORMAL AND INCREASED SERUM ALKALINE PHOSPATASE
CONCENTRATION
O-10 Paul Woods CONTINUOUS LOW-DOSE (METRONOMIC) ORAL CHEMOTHERAPY THERAPY OF CANINE
APPENDICULAR OSTEOSARCOMA
O-11 Silvia Lucas SERUM C-REACTIVE PROTEIN CONCENTRATIONS IN CATS WITH ALIMENTARY LYMPHOMA
UNDERGOING CHEMOTHERAPY
O-12 Valter Winkel SERUM AMYLOID A CONCENTRATIONS IN CATS WITH LYMPHOMA DURING CHEMOTHERAPY
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SMALL ANIMAL - OTHER
OT-7 Kristen Walker PENTOSAN POLYSULFATE AND N-ACETYL GLUCOSAMINE COMBINATION ENHANCES INHIBITION
OF INTERLEUKIN-8 PRODUCTION BY MELOXICAM IN CANINE CHONDROCYTES
OT-8 Romy Heilmann COMPARISON OF PCR- AND CULTURE-BASED METHODS TO EVALUATE BLOOD FROM DOGS WITH
SUSPECTED SEPSIS
OT-9 Scott Weese METAGENOMIC INVESTIGATION OF THE ORAL MICROBIOME OF HEALTHY DOGS




COMPULSIVE CAT ADOPTERS: EVALUATION OF OWNERS´ MENTAL HEALTH STATUS AND
ATTACHMENT TO PETS IN A POPULATION OF BRAZILIAN OWNERS OF MULTIPLE CATS
SMALL ANIMAL - PHARMACOLOGY
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SMALL ANIMAL - CARDIOLOGY
ABSTRACT C-1
PROGNOSTIC VALUE OF 24-HOUR AMBULATORY ECG
(HOLTER) MONITORING IN BOXER DOGS. PF Mo˜tsku¨la1,
C Linney2, DJ Connolly1, YM Chang1, C Pace1, J Dukes
McEwan2, V Luis Fuentes1. 1The Royal Veterinary College,
London, UK, 2School of Veterinary Sciences, University of
Liverpool, Neston, UK
Arrhythmogenic right ventricular cardiomyopathy (ARVC) in
Boxers is characterized by fatty/ﬁbrofatty inﬁltration of the right
ventricular myocardium, often leading to ventricular ectopia, syn-
cope and sudden cardiac death. Antemortem diagnosis depends
on identiﬁcation of arrhythmias on ambulatory ECG (Holter)
monitoring. The prognostic value of Holter monitoring in Boxer
dogs has not been clearly deﬁned.
We aimed to identify factors associated with cardiac death.
The medical records, initial Holter recordings and echocardiogra-
phy results were reviewed for all boxer dogs seen at 2 centres
between 2004-2011. Exclusion criteria were congenital heart dis-
ease, and a Holter recording <19h. Owners/veterinarians of
included dogs were contacted for survival data.
Outcome data was available for 108 dogs, with 63 deaths (41
cardiac). At presentation, 83 dogs had a history of syncope, 11
had congestive heart failure (CHF) and 24 had no clinical signs.
Log rank analysis showed reduced cardiac survival with presence
of CHF, ventricular bigeminy/trigeminy, ventricular couplets/
triplets, ventricular tachycardia (VT), and male sex, but not with
a history of syncope. Univariable Cox proportional hazards anal-
ysis of Holter variables showed that mean heart rate, presence of
polymorphic ventricular premature complexes (VPCs), VT, cou-
plets or triplets, bigeminy/trigeminy, or number of VPCs/hour
were positively associated with cardiac death. In a forwards step-
wise multivariable model, presence of polymorphic VPCs
(p=0.001, hazard ratio (HR) 3.2 [95% conﬁdence interval (CI)
1.7-6.3]), presence of VT (p=0.013, HR 2.2 [95%CI 1.2-4.1]) and
presence of SVT (p=0.007, HR 2.5 [95%CI 1.3-4.9]) indepen-
dently predicted outcome.
Holter monitoring in Boxer dogs with suspected ARVC pro-
vides valuable prognostic information.
ABSTRACT C-2
COMPARISON OF TRANSTHORACIC TWO-DIMEN-
SIONAL ECHOCARDIOGRAPHY, THREE-DIMENSIONAL
ECHOCARDIOGRAPHY, TRANSESOPHAGEAL ECHO-
CARDIOGRAPHY, COMPUTED TOMOGRAPHY ANGIOG-
RAPHY, AND GATED MAGNETIC RESONANCE IMAGING
IN NORMAL CANINE HEARTS. RC Fries1, SG Gordon1,
MW Miller1, AB Saunders1, CD Hariu1, M Bogess1, M Lennox2,
TW Fossum2. 1Texas A&M University College of Veterinary
Medicine, College Station, TX, 2The Texas A&M Institute for
Preclinical Studies, College Station, TX
The purpose of this study was to determine the accuracy of
two-dimensional echocardiography (2DE), three-dimensional
echocardiography (3DE), transesophageal echocardiography
(TEE), and computed tomography angiography (CTA) in com-
parison to gated cardiac magnetic resonance imaging (cMRI).
Echocardiography was performed using the GE Vivid E9 with
appropriate 2DE, 3DE, and adult TEE probes. CTA and cMRI
images were acquired utilizing a 128-slice positron emission
tomography (PET)/CT scanner and a prospective ECG-gated, 3
Tesla MRI respectively. CTA and cMRI image analysis was per-
formed oﬀ-line using a Siemens LEONARDO 3D workstation
and applicable software. Six, adult, female mixed breed dogs (18-
25 kg) were anesthetized and underwent transthoracic 2DE,
3DE, and TEE (all by a single observer) CTA, and cMRI. Left
ventricular internal dimension, area, and volume (in systole and
diastole), stroke volume (cardiac output), and ejection fraction
were assessed. Left atrial dimension, area, and volume were also
evaluated.
The mean and standard deviation of the diﬀerence between
cMRI and each measurement modality for the left ventricle, in
diastole and systole, and left atrial volumes were estimated via
maximum likelihood, with robust standard errors. For left ven-
tricular end-diastolic volume the right parasternal four chamber
view performed with 2DE (4Ch-2D) had the smallest standard
deviation, while TEE and CTA had means closest to zero. For
end-systolic volume the apical four chamber view performed with
3DE had the smallest standard deviation, while the mean of
4Ch-2D was closest to zero. Left atrial volume assessment with
3DE appears mildly superior to 2DE.
ABSTRACT C-3
USE OF COMPUTED TOMOGRAPHY IN THE ASSESS-
MENT OF DOGS WITH PERICARDIAL EFFUSION. B
Bottorﬀ, S Stieger-Vanegas, D Sisson. Oregon State University
College of Veterinary Medicine, Corvallis, OR
The goal of this study was to prospectively evaluate the clini-
cal utility of contrast-enhanced computed tomography (CT) in
dogs with pericardial eﬀusion (PE).
Eleven dogs with PE were evaluated via thoracic radiography,
transthoracic echocardiography (TTE), and contrast-enhanced
thoracic and abdominal CT. Two dogs had small volume PE and
9 had moderate to large volume PE with echocardiographic evi-
dence of cardiac tamponade. TTE was performed in 9/11 dogs
prior to pericardiocentesis (PCC), whereas CT was performed
after PCC in 10/11 dogs. A right atrial mass was identiﬁed in 5/
11 dogs via TTE and a heart base mass was identiﬁed in 1/11
dogs. One dog was diagnosed with PE due to right heart failure
via TTE. Mesothelioma was later diagnosed in this dog via ster-
nal lymph node cytology. CT detected ﬁndings consistent with
TTE in all dogs with right atrial (5/5) and heart base masses (1/
1). Localized pericardial hemorrhage and soft tissue changes at
the site of PCC suggested a mass lesion by CT in 3/11 dogs. In
all dogs mild to moderate sternal lymphadenopathy was noted
using CT, which was not noted on radiographs. CT identiﬁed
hepatic and splenic lesions in 5/11 and 6/11 dogs, respectively.
Pulmonary metastasis was identiﬁed in 1/11 dogs via thoracic
radiography and in 2/11 dogs via CT. Cardiac masses were con-
ﬁrmed by histopathology in 3/6 dogs.
In this population of dogs, CT and TTE had similar sensitivity
for the detection of cardiac masses in dogs with PE. The value of
CT resided primarily in the detection of pulmonary metastasis
and extra-cardiac lesions in the liver and spleen. Pericardiocente-
sis performed prior to CT evaluation may confound the interpre-
tation of CT in dogs with PE.
ABSTRACT C-4
DIRECT ARTERIAL BLOOD PRESSURE MEASUREMENT
USING A CAROTID CATHETER IN COMPARISON TO
OSCILLOMETRIC AND DOPPLER METHOD. K Parker,
A Carr, T Duke-Novakovski. Western College of Veterinary
Medicine, University of Saskatchewan, Saskatoon, SK
Blood pressure measurement is an important parameter when
assessing hemodynamic status in animals. Cats have always been
considered especially diﬃcult to measure indirectly. This study
was carried out in anesthetized cats to evaluate two newer oscil-
lometric devices. (High Deﬁnition Oscillometry, Memodiagnostic
S+B medvet, Babenhausen Germany; PC-VetGard+, DVM
Solutions, San Antonio, TX), as well as ultrasonic Doppler
(Parks Medical).
A total of six cats ranging from 2 to 13 years were included in
this study. The anesthetized cats had the carotid artery isolated
surgically and then a direct tip blood pressure transducer inserted
(Millar 3.5 Fr.), then advanced approximately to the level of the
aortic root. Blood pressure data were recorded continuously
(Powerlab 26T, Model ML856, LabChart 7.2 software AD
Instruments). The catheter was calibrated using a mercury sphyg-
momanometer prior to placement. The position of the cuﬀs of
the oscillometrics was rotated between forelimbs and tail to mea-
sure blood pressure, whereas the forelimb alone was used for
Doppler measurements. Blood pressure was adjusted using
various isoﬂurane concentrations, colloids and dobutamine to
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achieve hypo- (<80 mmHg), normo- (81-110 mmHg) and hyper-
tension (>110 mmHg). Bias (indirect method minus direct) and
precision (SD of the diﬀerences) were calculated
265 paired samples from the HDO and Aortic root were ana-
lyzed. Results for normotension using the HDO were Bias (-1.1)
SD 5.0 mmHg for mean arterial pressure (MAP), Systolic Arte-
rial Pressure (SAP) 3.7 (SD 10.7), and diastolic (-5.8) (SD 6.7).
In hypotension (99 data pairs) bias for Mean was (-6.5) (SD 9.9),
SAP 17.3 (SD 15.7) and diastolic (-0.93) (SD 14.3). In hyperten-
sion HDO underestimated SAP with a bias of (-15.0) (SD 12.8),
MAP (-9.6) (SD 15.90, and diastolic (-20.9) (SD 14.3).
The VG (236 data pairs) was slightly less accurate in hypo-,
normo-, and hypertensive states. In hypotension bias in MAP
was 8.0 (SD 12.8 mmHg), systolic (-1.1) (SD 13.4), and diastolic
(-12.3) (SD 13.4). In normotension the SAP bias was (-9.3) (SD
10.3), MAP (-12.6) (SD 7.1), and diastolic (-12.3) (SD 13.4). In
hypertension the SAP bias was (-23.9) (SD 16.0), MAP (-19.3)
(SD 11.3), and diastolic (-20.8)(SD 13.7).
In 66 paired samples the Doppler Technique, when using
Return to Sound as the pressure reading on the manometer, was
an accurate measurement of MAP [bias (-0.5) (SD 11.0)] but not
systolic arterial pressure (SAP) [bias (-25.3) [SD 16.5].
These data indicate that HDO and VetGard appear to be
accurate means of measuring blood pressure in all pressure
ranges, losing some accuracy as the patient approaches hyperten-
sion. Doppler, when used for a measurement of MAP, is accurate
but less so when used to assess SAP.
ABSTRACT C-5
CAN STRAIN RATE IMAGING DIFFERENTIATE PHYSIO-
LOGIC FROM PATHOLOGIC HYPERTROPHY IN THE
DOG? SM Johns, OL Nelson. Washington State University
College of Veterinary Medicine, Pullman WA
The appearance of hypertrophy of the athlete’s heart can be
similar to hypertrophy due to heart disease or systemic hyperten-
sion. Pathologic cardiac hypertrophy can lead to decreased car-
diac function and increased risk of potentially life-threatening
arrhythmias. However, athletic hypertrophy is a benign process
without clinical signiﬁcance. The ability to more accurately diﬀer-
entiate between these processes will be of beneﬁt in determining
prognosis, monitoring protocols and treatment decisions.
Standard echocardiography may not reliably detect subtle
changes in myocardial function. Studies in humans have shown
that strain and strain rate imaging are both sensitive and speciﬁc
in diﬀerentiating physiologic from pathologic (eccentric or con-
centric) cardiac hypertrophy. We hypothesized that strain and
strain rate imaging will diﬀerentiate physiologic from pathologic
hypertrophy in dogs.
We performed echocardiograms on 10 Silken Windhounds
prior to initiation of athletic training. Athletic training of 9 of
the dogs was instituted in the form of coursing for a gradually
increasing number of miles per week. Echocardiograms were
repeated 9 weeks later to evaluate changes in left ventricular
diameters, wall thickness, mitral inﬂow, tissue Doppler, strain,
and strain rate. In addition, 5 dogs with varying degrees of path-
ologic concentric left ventricular hypertrophy due to cardiac dis-
ease were also evaluated for comparison. Preliminary results
indicate no change in left ventricular diameter, wall thickness,
mitral inﬂow pattern, tissue Doppler pattern, strain, or strain rate
in Silken Windhounds before and after 9 weeks of athletic train-
ing; a longer period of training may be needed to detect diﬀer-
ences. There was no signiﬁcant diﬀerence between dogs with
pathologic hypertrophy and conditioned windhounds for stan-
dard echocardiography parameters of ejection fraction, fractional
shortening, mitral inﬂow E/A, mitral E deceleration time, or tis-
sue Doppler E’ or A’. When compared to conditioned wind-
hounds, dogs with pathologic hypertrophy had signiﬁcantly
increased mitral inﬂow E/E’ ratios (12.2 vs. 5.9, p=0.018), signif-
icantly decreased systolic longitudinal velocity (2.218 m/s vs.
4.718 m/s, p<0.01) and E wave longitudinal velocity (-2.034m/s
vs. -4.27m/s, p=0.028), and signiﬁcantly increased A wave longi-
tudinal strain rate (1 vs 0.41, p=0.039). These primarily diastolic
strain imaging indices may be useful to diﬀerentiate pathologic
concentric hypertrophy from changes that may be associated with
athletic training.
ABSTRACT C-6
OPTIMIZATION OF IMPLANTABLE CARDIOVERTER
DEFIBRILLATOR (ICD) DEFIBRILLATION THRESHOLDS
IN DOGS. C Saelinger, J Vila, P Queiroz-Williams, R Pariaut.
Dept. of Veterinary Clinical Sciences, Louisiana State University,
Baton Rouge, LA
In dogs, treatment of malignant ventricular arrhythmias is cen-
tered on the administration of antiarrhythmics. Despite a reduc-
tion of clinical signs, the risk for sudden death is not decreased.
In human patients, utilization of implantable cardioverter deﬁ-
brillators (ICDs) in conjunction with antiarrhythmics is standard
of care to reduce clinical signs and sudden death from ventricular
arrhythmias. As ICDs become more available for implantation in
dogs, optimization of placement and programming while consid-
ering the unique canine anatomy and physiology is crucial.
The objectives of this study were to: 1) implant ICDs in
healthy canines in an anatomical location that allows successful,
low energy deﬁbrillation (at least 10 J safety margin) and 2) iden-
tify the shock conﬁguration that achieves the lowest deﬁbrillation
thresholds (DFTs), i.e. the lowest energy that terminates ventric-
ular ﬁbrillation (VF). We hypothesized that a ﬁxed pulse dura-
tion shock conﬁguration, as determined by a surrogate of the
cardiac tissue time constant, results in a lower DFT compared to
a ﬁxed tilt shock conﬁguration.
Ten healthy mongrels (24.6 kg ± 3.86 kg) were included in this
study. Under ﬂuoroscopic guidance, a 65-cm, 2-coiled endocardial
lead was placed into the right ventricular apex through the left jug-
ular vein. The proximal portion of the lead was tunneled subcuta-
neously under the left shoulder and secured into the generator in a
subcutaneous pocket between the 4th and 6th left intercostal spaces,
above the left ventricle. Capture testing was performed. VF was
induced via the shock-on-T method and the upper limit of vulnera-
bility theory was used to reduce the number of VF inductions
needed to determine the DFT. DFT testing was performed with
both ﬁxed pulse and ﬁxed tilt shock conﬁgurations in random
order. Plasma Troponin I (TnI) levels were measured before induc-
tion of VF and after the ﬁrst and second DFT protocols. Paired t-
test was used to analyze DFT results and repeated measures ANO-
VA was used for TnI levels. All values are shown as mean ± SD. P
 0.05 was considered statistically signiﬁcant.
One subject died during the induction of anesthesia. Nine
remaining dogs underwent successful ICD implantation and DFT
testing. Overall mean DFT was 9.19 ± 3.88 J. DFTs for ﬁxed pulse
(9.06 ± 4.195 J) and ﬁxed tilt (9.33 ± 3.783 J) shock conﬁgurations
were not signiﬁcantly diﬀerent. There was a signiﬁcant diﬀerence in
the TnI levels between baseline (0.034 ± 0.028 ng/mL) and follow-
ing determination of the ﬁrst (0.124 ± 0.055 ng/mL, P  0.05) and
second (0.217 ± 0.104 ng/mL, P  0.0001) DFT values.
Important results of this study are: 1) The proposed ICD
placement consistently resulted in a very low and more than ade-
quate (more than 20 J below maximum energy of the device)
DFT in normal canines, 2) there was no diﬀerence between the
ﬁxed pulse and ﬁxed tilt shock conﬁgurations, and 3) the increase
in TnI was not considered to be clinically signiﬁcant.
ABSTRACT C-7
ATRIAL FIBRILLATION IS A NEGATIVE PROGNOSTIC
INDICATOR IN LARGE BREED DOGS WITH MYXOMA-
TOUS MITRAL VALVE DEGENERATION AND CONGES-
TIVE HEART FAILURE. SW Jung, LG Griﬃths,
MD Kittleson, WR Pritchard. Veterinary Medical Teaching
Hospital, University of California-Davis, Davis, CA
The outcome of congestive heart failure (CHF) due to myxo-
matous mitral valve degeneration (MMVD) in small breed dogs
has been well documented. MMVD also occurs in large breed
dogs (> 15 kg) but the disease characteristics in this cohort are
poorly documented and are somewhat diﬀerent from small breed
dogs. For example, large breed dogs with MMVD usually have
overt evidence of myocardial dysfunction when CHF develops
and appear to develop atrial ﬁbrillation (AF) more frequently
than small dogs. The aim of the present study was to evaluate
the prevalence and prognostic signiﬁcance of AF in large breed
dogs with MMVD and CHF.
Medical records between January 2005 and December 2010 were
reviewed retrospectively and 63 large breed dogs with MMVD and
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CHF that reached the primary endpoint (cardiac-related death)
were identiﬁed. CHF was deﬁned as pulmonary edema, ascites or
both due to severe cardiac disease. The onset of CHF was deﬁned
as the time when diuretic drug administration was initiated. The
median age and body weight were 11 years of age (range: 6-15
years) and 24 kg (range: 16-64 kg), respectively. The median ratio
of left atrial diameter to aortic root diameter on 2D short-axis view
was 2.5 (range: 1.7-3.7). The median shortening fraction was 36%
(range: 22-55%). The median survival time of all dogs from the
identiﬁcation of CHF by the referring veterinarian to cardiac death
was 172 days (range: 9-879 days). Thirty three dogs (52%) had sus-
tained atrial ﬁbrillation. Their median heart rate before and after
pharmacological rate control was 220 beats/min (range: 160-270
beats/min) and 177 beats/min (range: 84-240 beats/min), respec-
tively. Kaplan-Meier statistics revealed that dogs in atrial ﬁbrilla-
tion had a signiﬁcantly shorter median survival time (142 days;
range: 9-478 days) compared with dogs in sinus rhythm (234 days;
range: 13-879 days) (P = 0.006).
We conclude that the prevalence of AF in large breed dogs in
CHF due to MMVD is high and that AF adversely impacts sur-
vival time. A prospective clinical trial is warranted to conﬁrm or
refute the ﬁndings from this study.
ABSTRACT C-8
MALIGNANT VENTRICULAR ARRHYTHMIAS ARE ASSO-
CIATED WITH DILATED CARDIOMYOPATHY IN GREAT
DANES. H Stephenson1, S Fonfara1, J Lo´pez-Alvarez1,2,
J Dukes-McEwan1. 1University of Liverpool Small Animal
Teaching Hospital, Liverpool, UK, 2The Royal Veterinary
College, Hertfordshire, UK
The Great Dane (GD) is commonly aﬀected by dilated cardio-
myopathy (DCM) and has the shortest median survival time.
Unlike some breeds, ventricular arrhythmias (VA) and sudden
death (SD) are infrequently reported in GD, however recent pro-
spective screening in the UK identiﬁed a high prevalence of VA
in GDs. Furthermore SD is frequently reported by owners and
breeders. This study aimed to investigate the prevalence, signiﬁ-
cance and association of VA and DCM in GD.
As part of an ongoing longitudinal study, asymptomatic dogs
were screened by physical examination, blood samples, Doppler
echocardiography (ECHO) and ECG. Pedigree and historical
data were collected. 24 hour ECG (Holter) monitors were ﬁtted
to selected GDs. Dogs were monitored by telephone follow-up,
repeat screening and post-mortem (PM) if possible.
Over three years, 111 dogs were screened. 3 were excluded due
to other disease. 4 dogs had no ECHO or ECG performed. VA
were identiﬁed on ECG in 29.8% of dogs (31/104). Holter moni-
tors were ﬁtted in 24 dogs and 54% (13/24) had VA. 7/38 dogs
with VA on either ECG or Holter died suddenly. 19 dogs
belonged to one family with a high prevalence of SD. Both VA
(10/19) and preclinical DCM (5/19) were identiﬁed in these dogs.
PM in 2 dogs showed myocardial ﬁbrofatty inﬁltrate.
In conclusion, our data shows that VA occur commonly in
GD in the UK. Both VA and DCM occur within the same fam-
ily. The high prevalence of VA suggests that this may be an
important cause of SD in GDs.
ABSTRACT C-9
UTILZATION OF TRANSESOPHAGEAL ATRIAL PACING
TO OBTAIN SINUS NODE RECOVERY TIME IN DOGS.
IZ Giatis1, HW Green III1, E Chatel2, RA Sanders2. 1Purdue
University College of Veterinary Medicine, West Lafayette, IN,
2Michigan State University, College of Veterinary Medicine.
Sick sinus syndrome (SSS) is classiﬁed into two etiologic catego-
ries: extrinsic and intrinsic. Extrinsic SSS, a vagally inﬂuenced bra-
dycardia must be diﬀerentiated from intrinsic SSS, true sinoatrial
node dysfunction. The atropine response test (ART) has been uti-
lized to rule out extrinsic causes of SSS; however, there are variable
responses with intrinsic SSS to the ART. Thus sinus node recovery
time (SNRT) via intracardiac electrophysiology studies is often uti-
lized as a more reliable method to measure sinus node function in
humans. Similar methodology is particularly limited in veterinary
medicine due to the invasive nature of this test and the extremely
limited availability of expensive electrophysiological equipment to
veterinary cardiologists. Thus diagnosis of dogs with intrinsic SSS
has been restricted in veterinary medicine to ART. Transesopha-
geal atrial pacing (TEAP) is an easily obtainable and cost-eﬀective
means to temporarily pace the atrium in dogs. We sought to com-
pare SNRT results obtained by using TEAP to those obtained by
standard intracardiac atrial pacing (ICAP).
Seven juvenile beagle dogs underwent general anesthesia fol-
lowed by oral placement of a multipolar electrophysiology cathe-
ter into the esophagus to the level of the carina. Jugular venous
access was obtained via modiﬁed Seldinger technique utilizing a 6
Fr introducer system following which a steerable multipolar elec-
trode was ﬂuoroscopically guided to the level of the high right
atrium. The SNRT was obtained following atrial pacing for 30
seconds at 500ms, 400 ms, 300 ms, and 200ms cycle lengths
respectively with each technique. Dogs were randomly selected to
receive TEAP or ICAP ﬁrst. Corrected sinus node recovery times
(cSNRT) were also calculated.
Three male and four female dogs (10.9 ± 1.26 kgs) were evalu-
ated in this study. No statistical diﬀerences were noted in mean
SNRT and cSNRT values respectively with either technique (See
table 1). Data is demonstrated as the mean ± standard deviation
in milliseconds where applicable.
We conclude that TEAP pacing demonstrates similar SNRT
times compared to those utilizing standard intracardiac technique
normal dogs. As such TEAP may be used when standard studies
are not available. Further assessment utilizing dogs with sinus
node disease need to be validated.
ABSTRACT C-10
LONG-TERM EVALUATION OF CARDIAC SIZE AND
FUNCTION IN 71 DOGS FOLLOWING PATENT DUCTUS
ARTERIOSUS CLOSURE. AB Saunders, SG Gordon,
CD Hariu, RC Fries, JA Carlson, RL Winter, MW Miller. The
Michael E. DeBakey Institute, College of Veterinary Medicine and
Biomedical Sciences, Texas A&M University, College Station, TX
Herein we report cardiac size and function at baseline (B) and
>12 months follow-up (F) in a cohort of dogs with PDA. Between
July 1996-November 2009, 523 dogs presented to TAMU for PDA.
Baseline data including signalment, history, physical examination,
diagnostic imaging, type of closure were obtained from medical
records. Follow-up was available on 71 dogs.
All had characteristic murmurs of PDA; 55 were female. The
most common breed was Chihuahua (10). PDA closure methods
included ligation (28), coil (20), Amplatz® canine duct occluder
(18), Amplatzer® vascular plug (5). Concurrent congenital heart
disease was identiﬁed in 7. Chronic valve disease was present in 1
(B) and 16 (F). Residual ductal ﬂow was documented within 24-
hours in 9 and in 4 at F. Median time from closure to F was
48.9 months (range, 13.0-125.3). Results are reported as
mean±SD (range) at B and F. Age (months) was 16.6±21.2 (2.2-
97.9) and 69.6±29.9 (21.3-151.9). Weight (kg) was 8.1±7.9 (0.3-
37.2) and 13.4±10.6 (1.3-36.5). Vertebral heart size was 11.7±1.1
(9.2-14.1) and 10.5±0.6 (9.0-12.6). LVIDdN was 2.21±0.54 (1.31-
4.28) and 1.54±0.25 (1.10-2.20). LVIDsN was 1.37±0.41 (0.60-
2.60) and 1.03±0.26 (0.50-2.90). FS% was 36.6±8.2 (13.0-54.0)
and 29.7±10.3 (9.0-56.0). LA/Ao mmode was 1.43±0.28 (0.84-
2.02) and 1.21±0.15 (0.87-1.50). P-value was <0.0001 for all vari-
ables compared. VHS was >10.5 in 56/66 (B) and 18/70 (F). The
Cycle Length TEAP SNRT(ms) ICAP SNRT(ms) P value TEAP cSNRT(ms) ICAP cSNRT(ms) P value
500 ms 798.5 ± 103.7 744.3 ± 208.9 .608 149.5 ± 103 132.8 ± 103.7 .785
400 ms 824.3 ± 210.6 827.3 ± 202.8 .981 199.9 ± 124.8 208.3 ± 141.0 .915
300 ms 873.17 ± 261.8 889.8 ± 280.6 .918 246.5 ± 161.7 265.8 ± 198.3 .858
200 ms 1268.4±921.3 1307.8±1000.2 .860 680.7±855.5 718.3±958.3 .886
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number of dogs >95% CI for LVIDdN and LVIDsN was 53/66
(B), 36/66 (B) and 6/70 (F), 11/70 (F) respectively suggesting nor-
malization of cardiac size ranging from 69.4-88.7% at long-term
follow-up based on these values.
ABSTRACT C-11
CANINE CARDIAC TROPONIN I SIGNIFICANTLY COM-
PLEMENTS ESTABLISHED PROGNOSTIC COMPOSITE
SCORE IN DOGS WITH SYSTEMIC INFLAMMATION.
R Langhorn1, M Oyama2, L King2, M Machen2, D Trafny2,
V Thawley2, JL Willesen1, I Tarnow3, M Kjelgaard-Hansen1.
1Department of Small Animal Clinical Sciences, University of
Copenhagen, Frederiksberg, Denmark, 2School of Veterinary
Medicine, University of Pennsylvania, Philadelphia, PA, 3Chr.
Hansen A/S, Horsholm, Denmark
Composite scoring models based on clinical and paraclinical
observations are used in intensive care units (ICUs) for stratiﬁca-
tion of disease severity and early assessment of prognosis for sur-
vival. Main components of these models are markers of organ
dysfunction. However, the signiﬁcance of myocardial injury was
not included when the models, e.g. the Acute Patient Physiologic
and Laboratory Evaluation (APPLE) score in dogs, were devel-
oped. In non-cardiac critical disease, myocardial injury as detected
by cardiac troponin I (cTnI) has been linked to high ICU mortality
in several human studies. The purpose of this study was to examine
the prognostic value of cTnI in critically ill dogs with systemic
inﬂammation as an addition to the APPLE scoring system.
Dogs admitted to the ICU (University of Pennsylvania) were
prospectively included over a 3 month period. Echocardiography
was performed on all dogs, and dogs with evidence of primary
structural cardiac disease were excluded. Systemic inﬂammation at
ICU admission was deﬁned as a serum concentration of C-reactive
protein (CRP) > 35 mg/L within the ﬁrst 24 hours in a dog with
clinical evidence of inﬂammation. Samples for cTnI analysis were
obtained at ICU admission and for CRP analysis at admission and
12-24 hours later. The APPLE score was calculated for each dog
within the ﬁrst 24 hours of ICU admission. Outcome (death versus
survival) was determined 28 days after admission. Areas under
receiver operator characteristic curves (AUC-ROC) were used to
evaluate the performance of cTnI and the APPLE score as prog-
nostic markers of outcome. cTnI concentrations were logarithmi-
cally transformed to optimize distribution for multiple logistic
regression analysis (MLR), and MLR was performed to evaluate
whether cTnI made a signiﬁcant contribution to the APPLE score
(Likelihood ratio test). Level of signiﬁcance was set to P < 0.05.
Forty-two dogs were included, with a mortality rate of 26.2%
(n=11). cTnI concentrations were (median [range]) 0.416 [0.004-
141.5] ng/mL. 88.1% (n=37), including all non-survivors, had
cTnI concentrations above reference limit (0.07 ng/mL). AUC-
ROC [95 % CI] for cTnI and the APPLE score as predictors of
outcome were 0.801 [0.649;0.907] and 0.776 [0.621;0.889], respec-
tively, thus both were individually signiﬁcant prognosticators.
Graphing the cTnI concentration against the APPLE score sug-
gested that cTnI complemented the APPLE score in providing
additional prognostic speciﬁcity, improving the positive predictive
value of the model. This was conﬁrmed by the MLR, where cTnI
signiﬁcantly contributed in a model combining the APPLE score
and cTnI (coeﬃcient estimate: 0.44 [0.02;0.86], corresponding to
an odds ratio for 28-day mortality of 1.6 for each 10-fold
increase in cTnI).
We concluded that the inclusion of canine cTnI as a marker of
myocardial injury in critically ill dogs with systemic inﬂammation
signiﬁcantly complemented the established prognostic composite
score APPLE, apparently by improving prognostic speciﬁcity.
ABSTRACT C-12
CLINICAL EVALUATION OF THE 3MTM LITTMANN®
MODEL 3200 ELECTRONIC STETHOSCOPE IN CATS. KA
Blass, KE Schober, BA Scansen, LC Visser, J Lu, D Smith, J
Ward, JD Bonagura. The Ohio State University, Columbus, OH
Cardiac auscultation is of utmost importance in the physical
examination of cats. Determination of heart rate and identiﬁca-
tion of murmurs, gallops, and clicks may help in the identiﬁca-
tion of cats with heart disease. However, auscultatory ﬁndings
may be dynamic, temporary, aﬀected by ambient noise, and inﬂu-
enced by observer training and expertise, thus being subject to
relevant observer variation. The objective of this study was to
evaluate a fully electronic stethoscope in cats.
Consecutive cats undergoing echocardiography were enrolled.
Cats were ausculted with a traditional stethoscope (WA Tycos
HarveyTM Elite®) by 2 observers and heart sounds were recorded
using an electronic stethoscope (3MTM Littmann® stethoscope
Model 3200) for oﬀ-line analysis. Results were compared using
standard statistical analysis. In addition, digital recordings were
assessed by 8 independent observers with various levels of exper-
tise and compared using interclass correlation (IC) and Cohen’s
weighted kappa analyses.
Of a total of 150 cats, 93 (62%) had cardiac murmurs, 33
(22%) systolic clicks, 20 (13%) gallop sounds, and 10 (7%) car-
diac arrhythmias. There was good total agreement (86% to 95%)
between the 2 observers using the Tycos. There was signiﬁcant
agreement (P<0.001) between results from the Tycos and the
3MTM Littman® stethoscope. The Littman was more sensitive
compared to the Tycos with regard to gallop sounds and clicks.
IC among observers was good to excellent (ICC 0.75 to 0.96).
The 3MTM Littmann® stethoscope is useful for detecting
abnormal heart sounds and murmurs with high sensitivity and
speciﬁcity and can be recommended for use in feline practice.
ABSTRACT C-13
ANALYSIS OF ATRIAL REPOLARIZATION WAVE (Ta) IN
DOGS WITH THIRD DEGREE ATRIOVENTRICULAR
BLOCK. M Perego1, S Skert2, RA Santilli1. 1Clinica Veterinaria
Malpensa, Samarate, Italy, 2Ambulatorio Veterinario Salus,
Salsomaggiore Terme, Italy
Data on atrial repolarization in dogs are scarce since the QRS
complex deﬂections usually obscure Ta wave. Electrocardiographic
features of Ta wave can be better analyzed in patients with third
degree atrioventricular (AV) block since, in this condition, the
presence of AV dissociation makes the Ta wave and the QRS com-
plex uncoupled. Atrial repolarization wave varies according to the
autonomic status and the presence of atrial injuries. The aim of the
study was to describe the electrocardiographic characteristics of Ta
wave in dogs with third degree AV block, regular atrial cycle length
and normal cardiac chamber size. Clinical records of 52 dogs with
third degree AV block were retrospectively analyzed. Ten dogs
were excluded because of the presence of ventriculophasic sinus
arrhythmia and 6 dogs because of the presence of atrial enlarge-
ment. The sample group included 21 males and 15 females with a
mean age of 110.9 (conﬁdence interval 95% [CI 95%] 99.5-122.4)
months and mean weigh of 29.0 kg (CI 95% 23.5-34.4). Standard
12-lead electrocardiograms were acquired with a digital system for
a subsequent oﬀ-line processing. Each parameter was evaluated by
a single operator with three repeated measurements. Normalcy was
assessed by Shapiro Wilks test, correlation was calculated by Pear-
son, Sperman and Kendall tests, on variable that showed a Pearson
correlation a linear regression was performed. A multivariate anal-
ysis was conducted by generalized linear equation. Repeatability
was tested by intra-class coeﬃcient of correlation using Shrout-Fle-
iss reliability test. Ta wave was detectable in 80.6 % of the cases in
inferior leads (II,III and aVF), in 22.2 % in lead I, in 44.4% in lead
aVL, in 75 % in lead aVR and in 67.6 % in precordial leads. Ta
wave showed a negative polarity in lead I, II, III and aVF and a
positive polarity in lead aVL and aVR with a mean electrical axis
in the frontal plane of -114.3° (CI 95% -121.6 - -107.0). In all pre-
cordial leads Ta wave showed a negative polarity. The mean dura-
tion and the mean amplitude of the Ta wave in lead II were,
respectively, 140.2 msec (CI 95% 127.5-152.9) and -0.09 mV (CI
95% -0.1 - - 0.08) with a Ta/P duration ratio of 2.3 and a Ta/P
amplitude ratio of -0.35. A linear correlation between Ta wave
duration and P-Ta interval duration was found. Multivariate anal-
ysis showed signiﬁcant correlations between Ta wave amplitude
and examined lead, Ta wave duration and weight, P-Ta interval
duration and atrial rate, Ta wave amplitude and duration with
weight and Ta wave duration and P-Ta interval duration with
weight. Ta wave measurements were repeatable (Ta voltage K
0.759; Ta duration K 0.942). In agreement with previous studies,
we found opposite polarity of the P and the Ta waves regardless of
which lead was analyzed, and a positive correlation between atrial
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rate and P-Ta interval duration. In contrast with previous veteri-
nary study, we found no correlation between P wave and Ta wave
duration. This study provides a full description of electrocardio-
graphic features of the atrial repolarization phase in dogs with
third degree AV block with possible extension of the results to the
normal population. Further studies are needed to analyze the atrial
repolarization phase in relation to the atrial arrhythmic propensity,
as does QT interval analysis in the case of ventricular arrhythmias.
ABSTRACT C-14
STRUCTURAL AND MOLECULAR PATHOLOGY OF THE
ATRIUM IN BOXER ARRHYTHMOGENIC CARDIOMYOP-
ATHY. J Vila1, EM Oxford2, C Saelinger1, NS Moise2, PR Fox3,
R Pariaut1. 1Dept. of Veterinary Clinical Sciences, Louisiana
State University, Baton Rouge, LA, 2College of Veterinary
Medicine, Cornell University, Department of Clinical Sciences,
Ithaca, NY, 3The Animal Medical Center, 510 E 62nd St, New
York, NY
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
is an inherited myocardial disease characterized by fatty or ﬁbro-
fatty inﬁltration of the myocardium. While the speciﬁc mecha-
nism is still unknown, ARVC is recognized as a disease aﬀecting
the cardiac intercalated disc and more speciﬁcally the desmo-
somal proteins that compose it. ARVC is classically associated
with ventricular arrhythmias as it primarily aﬀects the ventricular
myocardium, although atrial arrhythmias and atrial histopatho-
logical changes characteristic of ARVC have occasionally been
reported in both Boxers and humans. However, the extent of
atrial involvement in ARVC has not been investigated.
The objective of the study was to apply histopathology, immu-
nochemical detection, immunolocalization and transmission elec-
tron microcopy (TEM) techniques to better characterize the
distribution of desmosomal and gap junction proteins at the
intercalated disc level in the atria of Boxers with ARVC. We
hypothesized that histological changes consistent with ARVC
and alterations of the proteins of the intercalated disc are present
in the atria of Boxer dogs with ARVC and may represent the
anatomic substrate for atrial arrhythmias.
The hearts from 14 healthy mongrel dogs and 14 Boxer dogs
with conﬁrmed ARVC were studied. Right and left atrial sections
from 10 Boxers were examined by immunoﬂuorescent micros-
copy. Frozen tissue samples from 8 Boxers were used for Western
blot (WB) analysis. The intercalated disc proteins investigated
were Connexin 43 (Cx43), Connexin 45, Connexin 40, Plakoglo-
bin, Plakophilin 2, Desmoplakin, and Cadherin. Electron micros-
copy was performed on the right and left atrial sections of 2
Boxers and 2 controls. Western blot band relative density was
calculated for all the protein tested using the NIH software Ima-
geJ. Student-t test was used to analyze the WB results. P 0.05
was considered statistically signiﬁcant.
Western blots indicated a signiﬁcant decrease of Cx43 in the
right atrium of ARVC aﬀected Boxers (relative density Cx43/
Actin 0.68 +/- 0.23 SD) compared to controls (relative density
Cx43/Actin 1.115 +/- 0.3 SD). There was no diﬀerence between
controls and Boxers for the other proteins investigated. Immuno-
ﬂuorescence analysis showed that the concentration of Cx43 was
decreased in the left and right atrium of ARVC aﬀected Boxers
compared to controls. However, the intensity of the Cx43
appeared to be the same in the two groups. TEM showed disrup-
tion of the intercalated disc in Boxers.
Our data suggests that the atrial myocardium is also aﬀected dur-
ing ARVC. The decrease in Connexin 43 in conjunction with the
fatty or ﬁbro-fatty inﬁltration of the myocardium could represent the
substrate for the atrial arrhythmias that can be seen with ARVC.
ABSTRACT C-15
INCIDENCE OF HEART DISEASE IN CATS WITH ELEC-
TROCARDIOGRAPHIC EVIDENCE OF LEFTWARD MEAN
ELECTRICAL AXIS SHIFT. J Vitt, MC Machen, MA Oyama.
University of Pennsylvania, Philadelphia, PA
Detection of feline heart disease is diﬃcult as physical exami-
nation, radiographic, and electrocardiographic ﬁndings can be
relatively non-speciﬁc. Previously, leftward mean electrical axis
shift (LAS), has been proposed as a risk factor for feline heart
disease. We sought to determine if presence of LAS was predic-
tive for echocardiographic heart disease in a retrospectively-iden-
tiﬁed population of cats referred to a teaching hospital for
cardiac evaluation.
The mean electrical axis (MEA) was calculated for 153 cats.
Cats were classiﬁed as normal (N), or equivocal (E), or having
isolated dynamic right ventricular outﬂow tract obstruction
(DRVOTO), or heart disease (HD) based on echocardiography.
The results were as follows: LAS (-1° to -89°) n=28 (N, 2;
HD, 18; DRVOTO, 1; E, 7); 64% LAS had HD. N MEA (0°-
160°) n=102 (N, 21; HD, 54; DRVOTO, 7; E, 20); 53% N MEA
had HD. Right MEA (161° to -91°) n=18 (N, 2; HD, 13; DRV-
OTO, 0; E, 3). Indeterminant MEA (-90°) n=18 (N, 0; HD, 5;
DRVOTO, 0; E/R, 0). Chi-square analysis revealed that the pro-
portion of HD vs. N in cats with N MEA vs. LAS was not sta-
tistically diﬀerent (P=0.14). No signiﬁcant diﬀerence was found
regardless of whether E were analyzed as N or HD.
In a referral population of cats, the presence of LAS was not pre-
dictive of HD on echo compared to cats with a normal MEA, indi-
cating that LAS was not a risk factor for presence of HD in the
population. Further studies are needed to identify other parameters.
ABSTRACT C-16
NT-PROBNP AS A SCREENING TOOL TO DETECT CLINI-
CALLY SIGNIFICANT HEART DISEASE IN ASYMPTOM-
ATIC CATS WITH HEART MURMURS AND/OR GALLOP
RHYTHMS. JM Mulz, DP Schrope. Oradell Animal Hospital,
Paramus, NJ
The purpose of this study was to determine whether NT-proB-
NP could be used as a screening tool to detect clinically signiﬁcant
disease in patients with an indication of underlying cardiac disease
based on physical exam abnormalities. Clinically signiﬁcant disease
was deﬁned as structural cardiac disease severe enough to warrant
follow-up within four months or recommend medications.
A total of 86 cats were enrolled in the study. The cats either pre-
sented for a routine wellness examination to the Oradell Animal
Hospital, or were examined at a local animal shelter. Each cat iden-
tiﬁed had an auscultable murmur or gallop rhythm detected by a
general practitioner and was otherwise asymptomatic. A complete
blood count, serum chemistry, T4 level, NT-proBNP level and
Doppler blood pressure were performed. Of the 86 cats, 9 cats were
excluded based on bloodwork or blood pressure abnormalities and
six cats were lost to follow-up, leaving a total of 71 cats in the study
population. The 71 cats had echocardiograms performed by a sin-
gle, experienced investigator (DPS) who performed echocardio-
grams for several studies concurrently, blinding the investigator as
to whether or not the cat had a murmur. Cats were classiﬁed as
normal (17) or having equivocal (13), mild (24), moderate (12) or
severe disease (5) based on the echocardiographic ﬁndings. Due to
the low numbers of cats with moderate and severe disease, these
groups were combined, as all cats in these groups were considered
to have clinically signiﬁcant disease.
When compared to the echocardiographic results, NT-proBNP
reliably diﬀerentiated mild disease from normal (p=0.0315) and
equivocal disease (p=0.0410), as well as diﬀerentiating moderate
and severe disease from normal (p=0.0071), equivocal
(p=0.0073) and mild disease (p=0.0157). NT-proBNP did not
diﬀerentiate between normal and equivocal disease (p=0.682).
This study suggests that NT-proBNP may be a reliable screening
tool to detect clinically signiﬁcant disease in asymptomatic cats
with auscultatory abnormalities.
ABSTRACT C-17
HEART RATE AND ARRHYTHMIA FREQUENCY OF NOR-
MAL CATS COMPARED TO CATS WITH HYPERTRO-
PHIC CARDIOMYOPATHY. B Smouther, L Lehmkuhl, D
Adin, T Nguyenba. MedVet Medical and Cancer Centers for
Pets, Worthington, OH
Hypertrophic cardiomyopathy (HCM) often has a long
asymptomatic period, but can result in congestive heart failure,
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thromoboembolism, or sudden cardiac death. Although sudden
death is often attributed to a fatal arrhythmia, there is little
information in the literature regarding arrhythmia frequency in
this population of cats. The purpose of this study was to describe
the heart rate, arrhythmia frequency, and arrhythmia severity in
a population of asymptomatic HCM cats compared to a normal
population. Additionally, we assessed the ability of in-clinic mea-
sures of heart rate and rhythm (auscultation (AUSC) and 2-min-
ute electrocardiogram (ECG)) to predict average heart rate
(24AVE) and arrhythmia frequency at home assessed by 24 hour
Holter monitor.
Seventeen cats with HCM and 15 normal cats were prospec-
tively evaluated by AUSC, echocardiogram, blood pressure,
ECG, and 24 hour Holter monitor.
All (17/17) HCM cats had ventricular arrhythmias (geometric
mean, 124 complexes) with 82% (14/17) exhibiting complex ar-
rhythmias (couplets, triplets, or ventricular tachycardia). Most
(14/15) normal cats had ventricular arrhythmias (geometric mean,
4 complexes), but only 20% (3/15) exhibited complexity. HCM
cats had signiﬁcantly more total ventricular complexes (TOT),
ventricular premature complexes (VPCs), and accelerated idioven-
tricular rhythm than normal cats (p <0.0001, p<0.0001, and
p=0.01, respectively). There was no signiﬁcant correlation
between left ventricular outﬂow tract velocity and frequency of
TOT or VPCs (p=0.6, p=0.4 respectively). Eighty eight percent
(15/17) of HCM cats had supraventricular arrhythmias (geometric
mean, 9 complexes) with 23% (4/17) exhibiting complexity. Sixty
percent (9/15) of normal cats had supraventricular arrhythmias
(geometric mean 1 beat) with 13% (2/15) exhibiting complexity.
HCM cats had signiﬁcantly more supraventricular complexes than
normal cats (p=0.0148). Additionally, 100% of HCM cats (17/17)
had arrhythmias on Holter monitor, while only 18% (3/17) had
arrhythmias on ECG. All normal cats (15/15) also had arrhyth-
mias on Holter monitor, and none had arrhythmias on ECG.
There was no diﬀerence in heart rate between HCM cats and
normal cats regardless of modality used (AUSC p=0.8, ECG
p=0.3, Holter 10% p=0.99, Ave p=0.97, 90% p=0.2. When
comparing 24AVE and ECG, bias was 30 bpm with limits of
agreement of +/- 49 bpm. When comparing 24AVE to AUSC,
bias was 21bpm with limits of agreement +/- 54 bpm.
HCM cats have more frequent and complex ventricular and
supraventricular arrhythmias than normal cats. Agreement
between 24 hr Holter and in-clinic AUSC or ECG for HR assess-
ment and arrhythmia detection was poor. Long term studies are
needed to determine if this increased arrhythmia frequency and
severity is related to sudden cardiac death or survival.
ABSTRACT C-18
EFFECT OF ATENOLOL ON HEART RATE, ARRHYTH-
MIAS, BLOOD PRESSURE, AND DYNAMIC LEFT VEN-
TRICULAR OUTFLOW TRACT OBSTRUCTION IN CATS
WITH ASYMPTOMATIC HYPERTROPHIC CARDIOMY-
OPATHY. B Smouther1, D Adin1, L Lehmkuhl1, T Nguyenba1,
K Meurs2, B Maran3. 1MedVet Medical and Cancer Centers for
Pets, Worthington, OH, 2North Carolina State University
College of Veterinary Medicine, Raleigh, NC, 3Washington State
University College of Veterinary Medicine, Pullman, WA
Atenolol is commonly prescribed to asymptomatic cats with
hypertrophic cardiomyopathy (HCM) for theoretical beneﬁts
including heart rate (HR) reduction, increased ventricular ﬁlling
time, decreased myocardial oxygen demand, arrhythmia reduc-
tion, and dynamic left ventricular outﬂow tract (LVOT) obstruc-
tion reduction. The purpose of this study was to describe the
HR, murmur grade, arrhythmias, blood pressure (BP), and
LVOT velocity in cats with HCM pre (PRE) and post (POST) at-
enolol administration.
Seventeen cats with HCM were prospectively evaluated by aus-
cultation (AUSC), echocardiogram, BP, 2-minute electrocardio-
gram (ECG), and 24 hour Holter monitor. Cats were re-evaluated
after 2-4 weeks of atenolol administration. All cats were negative
for known beta-1 adrenergic receptor polymorphisms.
The HR decreased after atenolol for all HR modalities mea-
sured: AUSC from 191 bpm to 153 bpm (p<0.0001), ECG from
206 bpm to 154 bpm (P <0.0001), and Holter 90%, average,
and 10% HR from 245 bpm to 196 bpm (p <0.0001), 170 bpm
to 135 bpm (p<0.01), and 133 bpm to 104 bpm (p<0.001)
respectively.
There was a decrease in total ventricular ectopic complexes
(TOT) and ventricular premature complexes (VPCs) after atenolol.
TOT decreased from a geometric mean of 123 to 22 per 24 hr
(82% reduction, p=0.004). VPCs decreased from a geometric
mean 61 to 15 per 24hr (75% reduction, p <0.0001). For TOT, 5
cats had > 85% reduction, 5 cats had 50-85% reduction, and 7
cats had < 50% reduction. For VPCs, 4 cats had > 85% reduc-
tion, 10 cats had 50-85% reduction, and 3 cats had < 50% reduc-
tion. There was no decrease in accelerated idioventricular rhythm
(geometric mean 6 to 3 per 24hr, p=0.6) or supraventricular pre-
mature complexes (geometric mean 4 to 2 per 24 hr, p = 0.13).
Murmur grade decreased post atenolol (p <0.0001), as did
LVOT velocity (mean 3.3m/s to 1.5 m/s, p<0.0001). There were
11 HCM cats with LVOT obstruction secondary to systolic ante-
rior motion of the anterior mitral valve leaﬂet (SAM). Seven cats
had complete resolution of obstruction and SAM, 3 cats had >
50% reduction in LVOT velocity, and 1 cat had no decrease in
LVOT velocity or resolution of SAM. BP did not change post at-
enolol (P = 0.2).
Atenolol decreases HR, murmur grade, ventricular arrhyth-
mias, and LVOT obstruction in cats with HCM without lowering
BP. Further studies are needed to determine if long-term out-
come is aﬀected by atenolol administration.
ABSTRACT C-19
THE EFFECT OF ENALAPRIL ON FUROSEMIDE-ACTI-
VATED RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
(RAAS) IN NORMAL DOGS. AC Lantis1, CE Atkins2,
M Ames2. 1Virginia-Maryland Regional College of Veterinary
Medicine, Blacksburg, VA, 2North Carolina State University
College of Veterinary Medicine, Raleigh NC
The purpose of this study was to evaluate the ability of the
ACE-inhibitor, enalapril, to suppress circulating RAAS activa-
tion in normal dogs treated with furosemide. We hypothesized
that enalapril would suppress plasma ACE activity and furose-
mide-induced RAAS activation, as evaluated by urinary aldoste-
rone:creatinine ratio.
Sixteen healthy hound dogs were used. Group1 (control)
received furosemide (2 mg/kg PO, BID) for 7 days. Group 2
received furosemide (2 mg/kg PO, BID) and enalapril (0.5 mg/kg
every 12 hours) for 7 days. To measure the response of the
RAAS to the medications, plasma ACE activity and urinary
aldosterone:creatinine ratio (A:Cr) were obtained on days -1, -2,
1, 4 and 7.
Urinary aldosterone secretion, as indicated by the A:Cr,
increased nearly 3-fold by furosemide monotherapy. This was
maintained for the 7 days of the study. The addition of enalapril
to group 2 dogs successfully suppressed plasma ACE activity but
did not signiﬁcantly reduce urinary aldosterone excretion.
We have shown that, while enalapril successfully blunted ACE
activity, it did not reduce urinary aldosterone excretion. The
absence of circulating RAAS suppression accompanied by ACE
activity inhibition deﬁnes aldosterone breakthrough. Studies in
clinical patients are warranted to determine if and when aldoste-
rone breakthough occurs in dogs receiving ACE-I for cardiac dis-
ease, glomerular disease, or hypertension.
ABSTRACT C-20
THE EFFECT OF HIGH DOSE PIMOBENDAN ON THE
FUROSEMIDE-INDUCED RENIN-ANGIOTENSIN-ALDO-
STERONE-SYSTEM (RAAS). MK Ames1, CE Atkins1,
AC Lantis2. 1College of Veterinary Medicine, North Carolina
State University, Raleigh, NC, 2Veterinary Emergency and
Referral Group, Brooklyn, NY
Pimobendan confers positive inotropic and vasodilatory
eﬀects, the latter known to activate the RAAS, which is harmful
in heart failure. Evaluation of 118 dogs (from 4/2007- 8/2011)
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receiving pimobendan >TID for refractory heart failure revealed
30.5% to be receiving >1.2mg/kg/day (mean 2.20mg/kg/day;
range 1.22-3.90mg/kg/day; recommended dosage 0.5-0.6mg/kg/
day), indicating the potential negative clinical impact of a stimu-
latory RAAS eﬀect of ‘high-dose’ pimobendan.
The purpose of this study was to determine if high-dose pi-
mobendan (0.6mg/kg PO q12h) potentiates furosemide-induced
RAAS activation. We hypothesized, based on a previous study,
that high-dose pimobendan, when used concurrently with moder-
ate-dose furosemide, would activate the RAAS more than furose-
mide alone at the same dose.
Twelve healthy dogs, randomized into groups of six, received
furosemide (2mg/kg PO q12h) for 10 days (Group 1) or furose-
mide (2mg/kg PO q12h) and pimobendan (0.6mg/kg PO q12h)
for 10 days (Group 2). Heart rate, body weight, blood pressure,
and urine aldosterone:creatinine (UA:C, a measure of circulatory
RAAS activation) were measured on days -2,-1,1,5 and 10.
Serum chemistry and CBC were measured on days -2,5 and 10.
Although there was a statistically signiﬁcant rise in UA:C in
Group 2 over the study period (p=0.0015), the increase diﬀered
signiﬁcantly only on day 1 (p=0.044). ‘High-dose’ pimobendan,
therefore, neither suppresses nor potentiates, to a clinically-signif-
icant degree, furosemide-induced RAAS in healthy dogs.
ABSTRACT C-21
DURATION OF BETA-BLOCKADE ASSOCIATED WITH
REPEATED ONCE-DAILY ADMINISTRATION OF ATENO-
LOL IN HEALTHY DOGS. MI Waterman, JA Abbott,
AC Lantis, JR Wilcke. Virginia-Maryland Regional College of
Veterinary Medicine, Virginia Tech, Blacksburg, VA
Atenolol is a b-adrenergic receptor antagonist used in the
management of cardiovascular disease. In dogs, dose intervals of
12 and 24 hours are used but the duration of b-blockade associ-
ated with oral administration of atenolol is unknown.
To test the hypothesis that repeated, once-daily oral adminis-
tration of atenolol attenuates the heart rate response to isoprote-
renol for 24 hours, we performed a double-blind, randomized,
placebo-controlled crossover experiment.
Twenty healthy dogs were randomly assigned to receive either
placebo (P) and then atenolol (A) [1 mg/kg PO QD] or, vice
versa. Treatment periods were 5-7 days; time between periods
was 7 days. Heart rates (bpm) at rest (HRr) and during constant
rate [0.2 lg/kg/min] infusion of isoproterenol (HRi) were electro-
cardiographically obtained 0, 0.25, 3, 6, 12, 18, and 24 hours
after ﬁnal administration of drug or placebo. Repeated measures
ANOVA was used to evaluate the eﬀects of treatment (Tr), time
after drug or placebo administration (t), interaction of treatment
and time (Tr*t) as well as period and sequence on HRr and HRi.
Sequence or period eﬀects were not detected. There was a signiﬁ-
cant eﬀect of Tr (p <0.0001) and Tr*t (p <0.0001) on HRi. Ateno-
lol signiﬁcantly attenuated HRi for 24 hours but did so maximally
at t=3 (least squares means ± SE, A: 146±5, P: 208±5); the eﬀect at
t=24 was small (A: 193±5, P: 206±5). Atenolol had a small but sig-
niﬁcant eﬀect (p <0.0001) on HRr. These data may be relevant to
the use of oral atenolol in canine cardiovascular disease.
ABSTRACT C-22
EFFECT OF KETANSERIN, A SEROTONIN 2A-RECEPTOR
ANTAGONIST, ON ECHOCARDIOGRAPHIC INDICES OF
MITRAL REGURGITATION IN DOGS WITH DEGENERA-
TIVE MITRAL VALVE DISEASE. DJ Trafny1, GE Singletary1,
RJ Levy2, MA Oyama1. 1University of Pennsylvania,
Philadelphia, PA, 2Children’s Hospital of Philadelphia,
Philadelphia, PA
Canine mitral valve interstitial cells can be activated by seroto-
nin. A role of serotonin in degenerative mitral valve disease
(DMVD) is suggested by various transcriptional, molecular, and
biochemical studies in dogs. We sought to determine the eﬀects
of ketanserin, an oral serotonin 2A-receptor blocker on echocar-
diographic severity of mitral regurgitation in dogs with DMVD.
Twenty-seven dogs with ISACHC class I or II DMVD were
enrolled. Eight dogs completed a phase I open-label 6-month tol-
erability and dose-escalation study, followed by recruitment of
dogs into a phase II randomized, placebo-controlled, double-
blinded, 12-month trial. The primary endpoint of the randomized
trial was mitral regurgitant fraction (RF) as measured by Dopp-
ler echocardiography. Secondary endpoints included 2D-echo
mitral valve length, thickness, area, and prolapse, left ventricular
and atrial diameter, and width of the color ﬂow regurgitant jet
vena contracta. Results of phase I indicated that ketanserin up to
doses of 1.0 mg/kg BID were tolerated. Nineteen dogs completed
Phase II. Over a median study duration of 392 days (range, 357-
419 days), RF increased relative to baseline by 50.8% and 13.8%
in dogs receiving 1.0mg/kg BID ketanserin and placebo respec-
tively, and this diﬀerence was not statistically signiﬁcant
(P=0.21). There were no signiﬁcant diﬀerences in any secondary
endpoint between groups. Chronic oral ketanserin administration
did not alter or slow echocardiographic severity of mitral regurgi-
tation in dogs with DMVD. Further studies are needed to deter-
mine the importance of the serotonin pathway in the
pathophysiology of canine DMVD.
ABSTRACT C-23
MYOCARDIAL ICAM1 MRNA IS INCREASED IN CANINE
DILATED CARDIOMYOPATHY. S Fonfara1, MA Oyama2,
P Cripps1,3, SR Tew1, PD Clegg1. 1Department of
Musculoskeletal Biology and School of Veterinary Sciences,
University of Liverpool, Neston, UK., 2Department of Clinical
Studies, University of Pennsylvania, Philadelphia, PA USA.,
3Department of Epidemiology & Population Health, University of
Liverpool, Neston, UK.
The role of intramyocardial inﬂammation in canine dilated
cardiomyopathy (DCM) is unknown. Presence of endothelial
intercellular cell adhesion molecule-1 (ICAM1) expression sug-
gests myocardial inﬂammation, pro-inﬂammatory cytokines, and
leukocyte inﬁltration. Previously, no association between ICAM1
and canine degenerative valvular disease was detected but the
potential role of ICAM1 in DCM is unknown.
ICAM1-gene expression in myocardial samples (right and left
atrium and ventricle) of eight healthy dogs, four DCM dogs, and
ﬁve dogs with other cardiac diseases was investigated by quanti-
tative RT-PCR. The association between ICAM1 with myocar-
dial cytokine expression (IL1, IL2, IL4, IL6, IL8, IL10, TNFa,
IFNc) was determined.
There was no diﬀerence in ICAM1 mRNA between cardiac
regions (p=0.08). However, a signiﬁcantly higher ICAM1
mRNA expression was present in dogs with DCM in comparison
to control dogs and dogs with other cardiac diseases (p=0.004).
Dogs with cardiac diseases and with and without congestive heart
failure (CHF) showed no signiﬁcant diﬀerence (p=0.16), suggest-
ing an increase of ICAM1 mRNA in DCM but not necessarily
other cardiac diseases causing CHF.
A positive correlation of ICAM1 with pro-inﬂammatory IL1,
IL6, TNFa and anti-inﬂammatory IL10 was present (p<0.001).
The cytokines were also elevated in dogs with DCM in compari-
son to dogs with cardiac diseases other than DCM (p<0.01).
These results suggest that activation of the inﬂammatory system
and increased ICAM1 expression might be associated with canine
DCM.
ABSTRACT C-24
ASSOCIATIONS BETWEEN N-TERMINAL PROCOLLA-
GEN TYPE III (PIIINP), FIBROSIS AND ECHOCARDIO-
GRAPHIC INDICES IN DOGS WITH MITRAL VALVE
DISEASE. MJ Hezzell1, T Falk2, LH Olsen2, A Boswood1,
J Elliott1. 1The Royal Veterinary College, London, UK,
2University of Copenhagen, Denmark.
PIIINP is a serum biomarker of collagen biosynthesis and is
described as a marker of myocardial ﬁbrosis in human patients.
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We hypothesised that PIIINP concentrations would increase with
increasing myocardial ﬁbrosis in dogs with MMVD.
Myocardial tissue samples were collected post mortem from
the following sites; upper and lower cranial and caudal papillary
muscle, upper, middle and lower left ventricular wall, inter-ven-
tricular septum and the right ventricular wall. Between four and
eight tissue sections from each myocardial site were examined
by a pathologist masked to the dog’s clinical history. Myocar-
dial ﬁbrosis was scored as follows: 0, none; 1, mild interstitial;
2, moderate interstitial; 3, small to moderate areas of conﬂuent
ﬁbrosis; 4, large areas of conﬂuent ﬁbrosis. The average ﬁbrosis
score for all sites in the heart (up to 72 sections) was designated
the global ﬁbrosis score (GFS). The average ﬁbrosis score for
all papillary muscle sites (up to 36 sections) was designated the
papillary ﬁbrosis score (PFS). Serum PIIINP concentrations
(µg/ml) were measured using a validated commercially-available
radioimmunoassay. Echocardiographic measurements and serum
PIIINP are reported for the last examination prior to death or
euthanasia in all cases. Non-normally distributed variables were
logarithmically transformed. Correlations were assessed using
Pearson’s correlation coeﬃcient. Univariate linear regression
analyses were used separately to evaluate associations between
GFS and PFS, respectively, and the following characteristics:
PIIINP, left atrial to aortic root ratio (LA/Ao), left ventricular
end diastolic diameter to left ventricular free wall thickness in
diastole ratio (LVEDD/LVFWd) and left ventricular end
diastolic diameter normalised for body weight (LVEDDN).
Variables signiﬁcant at the 20% level were entered into
multivariable linear regression analyses with GFS and PFS as
the dependent variable in turn.
Twenty-two dogs with MMVD were studied. In the univariate
analysis (dependent variable; GFS), PIIINP (P=0.074) and
LVEDDN (P=0.180) were associated with GFS. In the ﬁnal
multivariable model, LVEDDN (P=0.044, B =1.264) and PI-
IINP (P=0.020, B =0.061) were independently positively associ-
ated with GFS (R2=0.318). In the univariate analysis (dependent
variable; PFS), PIIINP (P=0.092), Log (LA/Ao) (P=0.076),
LVEDDN (P=0.097) and LVEDD/LVFWd ratio (P=0.175)
were associated with PFS. In the ﬁnal multivariable model,
LVEDDN (P=0.019, B=1.628) and PIIINP (P=0.018,
B=0.068) were independently positively associated with PFS
(R2=0.289).
In conclusion, both LVEDDN and serum PIIINP increase
with increasing ﬁbrosis score. The relationship between extracel-
lular matrix turnover, ﬁbrosis and left ventricular remodelling
appears to be complex in dogs with MMVD.
ABSTRACT C-25
NOT ALL ARTERIES ARE CREATED EQUAL: COMPARI-
SON OF PRESSURES WITHIN THE AORTIC ROOT AND
THE DORSAL PEDAL ARTERY IN CATS. K Parker, A Carr,
T Duke-Novakovski. Western College of Veterinary Medicine,
University of Saskatchewan, Saskatoon, SK.
Blood pressure measurement is important when assessing he-
modynamic stability in cats. Any accessible artery, including the
dorsal pedal (DP), has been considered an appropriate artery for
direct measurement of systemic blood pressure.
To examine measurement of blood pressure within the dorsal
pedal artery compared to within the aortic root.
Five anesthetized cats had a 24 gauge catheter with an external
pressure transducer (AD Instruments) placed in DP. A trans-
ducer tip catheter (3.5 Fr. Millar) was then placed in the carotid
artery and advanced to approximately the sixth intercostal space,
the level of the aortic root. These were used for continuous blood
pressure monitoring. Data were recorded using Powerlab (Power-
lab 26T, Model ML856) LabChart7.2 software (AD Instru-
ments). Topical prilocaine and lidocaine cream was applied prior
to surgical cut down to the DP artery to minimize vascular
spasm. The DP and aortic root catheters were calibrated using a
mercury sphygmomanometer prior to placement. Systolic blood
pressure was adjusted using various isoﬂurane concentrations,
colloids and dobutamine to achieve hypo- (<80 mmHg), normo-
(81-110 mmHg) and hypertension (>110 mmHg). Bias (DP
minus Aortic Root), precision (SD of the diﬀerences) and limits
of agreement (bias ± 2SD) were calculated.
551 matched pairs of data were compared to the aortic root in
hypo-, normo-, and hypertensive states for Systolic, Diastolic and
Mean values, DP was inaccurate with a bias of(-22.2) for hypo-
tensive systolic (SD 16.6, Correlation Coeﬃcient (CC) 0.74), (-
22.9) hypotensive diastolic (SD 12.7, CC 0.73), (-22.2) hypoten-
sive mean (SD 13.4, CC 0.75), (-30.4) normotensive systolic (SD
17.8, CC 0), (-28.0) normotensive diastolic (SD 12.8, CC .49), (-
28.4) normotensive mean (SD 12.8, CC 0.58), (-39.8) hypertensive
systolic (SD 14.1, CC 0.78), (-29.13) hypertensive diastolic (SD
16.3, CC 0.66), and (-31.6) hypertensive mean (SD 16.7, CC
0.66).
Using the dorsal pedal artery with a 24 GA catheter and exter-
nal pressure transducer is not an accurate method to measure
systemic arterial blood pressure in cats.
ABSTRACT C-26
RETROGRADE CORONARY VENOUS STEM CELL
DELIVERY: A PILOT STUDY EVALUATING SAFETY AND
FEASIBILITY. B Pogue, AH Estrada, HW Maisenbacher III, A
Shih, TJ Conlon.
In human medicine, cellular transplantation of allogenic adult
stem cells into failing heart muscle has been employed via numer-
ous delivery methods with success, causing reported improve-
ments in heart function and survival for patients with ischemic
heart disease. The purpose of this study was to develop a method
of stem cell delivery for Doberman Pinschers with Dilated Car-
diomyopathy (DCM) in order to determine the (acute) safety and
feasibility of delivery of a large number of cells to a large portion
of the left ventricular myocardium. Retrograde coronary venous
delivery of adipose-derived mesenchymal stem cells transduced
with tyrosine mutant Adeno-associated virus 2 (tmAAV2) to
express stromal derived factor-1 (SDF-1) was performed in ﬁfteen
Dobermans with DCM (12 pre-CHF and 3 with stablized CHF).
A balloon wedge pressure catheter was placed within the coro-
nary sinus from the right jugular vein under general anesthesia.
With the balloon tip inﬂated, saline was injected retrograde to
coronary venous ﬂow at a pressure of 300mmHg in order to dis-
rupt the vascular endothelium. Cellular implantation (10 million
cells within 20mL of saline) was performed in a similar fashion
and the balloon remained inﬂated for 10 minutes to retain cells
within the coronary venous system. Anesthesia time ranged from
33 to 95 minutes (median 45 minutes), and actual procedural
time ranged from 30 to 82 minutes (median 35 minutes). Four-
teen dogs were discharged 24 hours following the procedure with-
out complications. One dog developed worsening ventricular
arrhythmias and suﬀered cardiac arrest. 7/15 dogs did not return
for follow-up as scheduled and 4/8 dogs who did return for fol-
low up eventually succumbed to either sudden death or conges-
tive heart failure (1 at 24 hours as mentioned above, 2 at 8
months, and 1 at 11 months). Antibody titers against tm-AAV2
were measured in 3/15 dogs at baseline and at 1 month and
found to be negative at both time points. Echocardiograms were
performed at baseline and 24 hours (15/15), at 1 month (8/15), 3
months (5/15), 6 months (5/15), and 12 months (1/15) following
cellular implantation. Measurements of ejection fraction (EF),
fractional shortening (FS), end diastolic and systolic volume
indexes (EDVI, ESVI) were compared to baseline. Statistical
comparisons were made using a repeated measures ANOVA. Dif-
ferences between the means were considered signiﬁcant at P>
0.05. At 1 month, EDVI was decreased compared to baseline
(105.97 mL/m2 vs 111.59 mL/m2, P=0.017) and FS was
improved compared to baseline (18.67% vs 17.14%, P=0.05). At
3 months, ESVI was increased compared to baseline (79.60 mL/
m2 vs 73.76 mL/m2, P= 0.035). At 6 months, both ESVI and
EDVI had increased signiﬁcantly (131.2 mL/m2 and 90.02 mL/
m2, respectively, P<0.0001 for both).
In summary, retrograde venous delivery of tm-AAV2-SDF1
adipose-derived mesenchymal stem cells appears safe but long
term functional eﬀects and changes in expected outcomes for
aﬀected dogs were not observed in the few Dobermans in which
long term follow up was available.
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ABSTRACT C-27
THE NATURAL ANTIOXIDANTS POMEGRANATE
EXTRACT AND SOY ISOFLAVONES FAVOURABLY
MODULATE CANINE ENDOTHELIAL CELL FUNCTION.
SM Baumgartner-Parzer1, FR Waldenberger2, A Freudenthaler1,
A Ginouves-Guerdoux3, D McGahie3, H Gatto3. 1Dept. Internal
Med III, Clin. Div. of Endocrinology&Metabolism, Vienna,
Austria, 2Heart Center Hietzing, Vienna, Austria, 3Laboratoire
VIRBAC, Carros Cedex, France.
Cardiovascular disease, preceded by valvular and vascular
endothelial dysfunction, is a prominent cause of death in dogs.
Endothelial dysfunction is characterized by impairment of crucial
cell functions, e.g. accelerated apoptosis and increased prolifera-
tion of endothelial cells. This study aimed to identify and charac-
terize vasoprotective agents which may be able to prevent or
ameliorate the sequelae of endothelial dysfunction and subse-
quent cardiovascular disease in dogs.
Due to the lack of canine-speciﬁc data from in vitro models,
we established such a model on the basis of canine macrovascular
(aortic) endothelial cells (CnAoECs), and showed it to be well
suited to test both vasoprotective and detrimental agents. As test
substances, the natural antioxidants Pomegranate Extract, Soy
Isoﬂavones, Taurine and L-Carnitine were studied in the respec-
tive model in comparison to Glutathione (GSH), N-Acetylcystein
(NAc), free fatty acids and Pioglitazone (PIO), which were previ-
ously shown to modulate human endothelial cell apoptosis and
proliferation in vitro, mimicking the in vivo situation in humans.
CnAoECs were cultured on ﬁbronectin coated cell culture dishes
in CECGM at 37°C/5%CO2, and were used in passages 5-7.
After replating, cells were labeled with 3H-thymidine, exposed to
the above mentioned test or control agents for 48 h, and apopto-
sis and proliferation were measured according to standardized
protocols.
Pomegranate Extract and Soy Isoﬂavones, even at the concen-
tration of 50 µg/ml, markedly reduced proliferation of CnAoECs
by 90% and 25%, respectively. This eﬀect was dose-dependent.
Exposure of CnAoECs to 250 µg/ml of these two substances led
to an impressive inhibition of the cells’ proliferation to 3.75%
and 15.5% of control (set to 100%), whereas PIO and GSH
reduced proliferation to only 62.25% and 54.75% of control,
respectively.
Pomegranate Extract signiﬁcantly reduced apoptosis at all con-
centrations tested. Once again this was in a dose dependent fash-
ion, showing the most striking eﬀect at 250 µg/ml with a
reduction of 73% compared to control cells, whereas the anti-
apoptotic eﬀect of Soy Isoﬂavones was observed only for the
highest concentration tested (250 µg/ml).
In the course of the present study we established a canine
endothelial cell in vitro model, very well suited to the standard-
ized testing of potential vasoprotective agents. Our data clearly
demonstrate that Pomegranate Extract and Soy Isoﬂavones dra-
matically reduce proliferation and apoptosis of canine aortic
endothelial cells, which is consistent with a vasoprotective activity
for these natural antioxidants. A combination of these substances
in association with cardio protective agents acting on other
aspects of the cardiac disease process, could be an interesting
potential dietary strategy to reduce the progression of canine car-
diovascular diseases.
ABSTRACT C-28
POMEGRANATE EXTRACT COMBINED WITH OTHER
NATURAL ANTIOXIDANTS PROTECTS CANINE ENDO-
THELIAL CELLS FROM DEATH INDUCED BY OXIDA-
TIVE STRESS. C Ripoll1, A Coussaert1, FR Waldenberger2,
A Ginouves-Guerdoux3, D McGahie3H Gatto3. 1Naturalpha
SAS, Loos, France, 2Heart Center Hietzing, Vienna, Austria,
3Laboratoire VIRBAC, Carros Cedex, France
Oxidative stress induces damage to canine and human cardio-
vascular cell types, and is implicated in the initiation and pro-
gression of cardiac diseases. Alterations in antioxidant reactivity
in dogs’ blood can be related to the severity of cardiac insuﬃ-
ciency. Decreased cardiac eﬃciency contributes to further
increased oxygen demand and increased free radical production.
The resulting oxidative damage to the endothelium also reduces
nitric oxide availability, limiting the ability of the vascular wall
to relax and placing further strain on the failing heart. Several
natural antioxidant substances have been shown to be beneﬁcial
in humans. However their beneﬁt in canine cardiovascular cells
has never been addressed.
In order to evaluate this point, we initially developed a
canine aortic endothelial cell (CnAoEC)-based model of oxida-
tive stress-induced cytotoxicity. We ﬁrst validated the use of the
MTT assay to assess cell viability after a cytotoxic challenge.
We then established that a 24 hour oxidative challenge with
2mM H2O2 resulted in a reproducible and consistent decrease
of cell viability.
In the second part of the study, we used this model to assess
the ability of 4 natural substances (Pomegranate Extract, Soy
Isoﬂavones, Taurine and L-Carnitine), alone and in combination,
to protect the CnAoECs from oxidative stress. They were also
assessed, at 1, 50 and 250µg/ml, for their antioxidant properties
using two common acellular in vitro free radical scavenging
assays.
In both the free radical scavenging assays, Soy Isoﬂavones
and, in particular, Pomegranate Extract, alone or in combination
with the other substances, proved to be potent antioxidants.
Indeed, 50 µg/ml of Pomegranate Extract was suﬃcient to
quench over 97% of the radicals. Soy Isoﬂavones quenched 83%
and 92% of the radicals at 50 and 250µg/ml respectively. Taurine
and L-Carnitine provided only low quenching. However they did
not interfere with the action of the Pomegranate Extract and Soy
Isoﬂavones in the mix.
In the CnAoEC assay, Pomegranate Extract showed a strong
protective eﬀect and increased the CnAoEC viability by 35% and
82% at 50 and 250µg/ml respectively. In this assay the other sub-
stances were not eﬃcient at protecting the cells from such a
potent oxidative challenge on their own. However they did not
interfere with the beneﬁcial eﬀects of the Pomegranate Extract
and may even have had a positive impact on the cells when used
in combination (cell viability increased by 41% with the mix at
50µg/ml, which contains only 12.5µg/ml of Pomegranate
Extract).
This study has shown that potent natural antioxidant sub-
stances such as Pomegranate Extract are able to protect
CnAoECs from signiﬁcant oxidative challenge, representing a
potentially beneﬁcial dietary strategy to maintain endothelial cell
health during initiation and progression of canine cardiovascular
diseases.
ABSTRACT C-29
CHANGES OF SERUM CARDIAC TROPONIN I CONCEN-
TRATION IN 13 DOGS WITH INTRACRANIAL DISOR-
DERS. J Kim, R Song, D Lee, H Lee, J Park, C Park. College
of Veterinary Medicine, Chonbuk National University, Jeonju,
Jeonbuk, Korea.
Cardiac troponin I (cTnI) that is found within myoﬁbers and
is leaked from damaged myocardial cell is a sensitive and spe-
ciﬁc biomarker for myocardial injury in humans and animals.
The protein structure of cTnI is highly conserved between spe-
cies. cTnI has greater sensitivity and speciﬁcity for myocardial
damage than other test including CK-MB, cardiac troponin C
and T.
Seizures can result in myocardial damage through elevated
catecholamines causing increased heart rate, blood pressure, con-
tractility, and myocardial oxygen demand.
Serum cTnI concentration was measured by electrochemilumi-
nescence immunoassay (ECLIA) in 13 dogs with seizure caused
by intracranial lesions including granulomatous meningoencepha-
litis (GME), necrotizing meningoencephalitis (NME), glioma, idi-
opathic epilepsy, arachnoid cysts and head trauma. The serum
cTnI concentration was signiﬁcantly increased in 6 of 13 dogs
(reference range 0 to 0.026).
Measuring cTnI concentrations in dogs with seizure caused by
intracranial disorders may help to identify myocardial damage
and possibly lead to earlier therapeutic interventions.
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ABSTRACT C-30
C-REACTIVE PROTEIN IS ELEVATED IN DOGS IN
SEVERE HEART FAILURE. A Domanjko Petricˇ, T Lukman, B
Verk, A Nemec Svete. Clinic for Surgery and Small Animal
Medicine, University of Ljubljana, Slovenia.
C-reactive protein (CRP) is an acute phase protein and an
early marker of inﬂammation. Recent studies in human medicine
provide evidence that inﬂammation plays a role in the pathogene-
sis of cardiovascular disease. To our knowledge, studies that
investigate CRP concentration in heart failure in dogs have not
been reported. The authors aimed to investigate whether CRP is
elevated in patients with various cardiac diseases and heart fail-
ure. In addition we were interested whether there is an associa-
tion between ISACHC class and CRP concentration.
Thirty nine client-owned cardiac patients (31 males and 8
females; 0.8 - 16 years old) and 12 healthy controls (2 males and
10 females; 1 - 10 years old) were included in the study. The dogs
were judged to be healthy based upon normal history, clinical
examination, and results of hematological and biochemical analy-
sis. Various congenital and acquired cardiovascular diseases were
conﬁrmed on the basis of history, clinical examination, thoracic
radiographs, electrocardiogram and echocardiography and classi-
ﬁed into International Small Animal Cardiac Health Council
classes (ISACHC). Patients with other diseases were excluded
from the study. Serum CRP concentration was determined with
LifeAssays® Canine CRP Test Kit, which is a two-site heteroge-
neous immunoassay. Independent T-test was used to compare
serum CRP levels between controls and individual class of heart
disease. One-Way ANOVA was used to test for statistically sig-
niﬁcant diﬀerences in CRP concentration between ISACHC
groups. Pearson’s correlation coeﬃcient test was used to correlate
ISACHC class with CRP concentration, white blood cell count
(WBC) and neutrophil cell count (NEUTH). A value of P <0.05
was considered statistically signiﬁcant. Results of statistical anal-
ysis demonstrated signiﬁcantly higher CRP concentration in IS-
ACHC III group (range: <10 - 62 mg/L) versus controls (range:
<10 – 13 mg/L), while no signiﬁcant diﬀerences were found
between controls and ISACHC I and II. Serum CRP was signiﬁ-
cantly higher in ISACHC II (range: <10 -37 mg/L) and III ver-
sus ISACHC I (<10 mg/L) and signiﬁcantly higher in ISACHC
III comparing to ISACHC II. Signiﬁcant positive correlations
were found between ISACHC class and CRP (r=0.330;
P=0.040), WBC (r=0.459; P= 0.000) and NEUTH (r= 0.464;
P=0.000), as well as between CRP and WBC (r= 0.690;
P=0.000) and between CRP and NEUTH (r= 0.634; P=0.000).
In conclusion, CRP concentration is elevated in heart failure
patients and increases with severity of heart failure. The results
of this present study warrant further studies on CRP as a bio-
marker of eﬀectiveness of cardiac therapy.
ABSTRACT C-31
ASSESSMENT OF HYPERTROPHIC CARDIOMYOPATHY
IN SMALL BREED DOGS AFFECTED WITH HYPERAD-
RENOCORTICISM USING 2D SPECKLE-TRACKING
ECHOCARDIOGRAPHY. HY Chen, HP Huang. Institute of
Veterinary Clinical Science, School of Veterinary Medicine,
National Taiwan University, Taipei, Taiwan.
The aim of the study was to assess left ventricular systolic and
diastolic function using 2D speckle-tracking echocardiography
(2D-STE) in small breed dogs aﬀected with hypertrophic cardio-
myopathy (HCM) in pituitary- and adrenal-dependent hyperad-
renocorticism (PDH and ADH, respectively) and age-matched
control dogs.
Diagnosis of HCM was based upon ﬁndings of conventional
echocardiography. Diagnosis of hyperadrenocorticism (HAC)
was based on aﬃrmative results from adrenocorticotropic hor-
mone stimulation tests and ultrasonographic adrenal morphol-
ogy. In 2D-STE, peak systolic and diastolic radial/longitudinal
tissue velocity, circumferential/longitudinal strain rate and peak
systolic circumferential/longitudinal strain of 6 segments, and
septal and lateral corners of mitral annulus were assessed from
right parasternal short-axis/left apical views.
In conventional echocardiography, 7 dogs with PDH (preva-
lence: 7/13, 54%), 8 dogs with ADH (8/12, 67%) and 11 non-
HAC dogs (11/53, 21%) were diagnosed as HCM (P = 0.002).
In these dogs, either the systolic (fractional shortening, ejection
fraction) or diastolic parameters (E/A ratio, isovolumetric relaxa-
tion time) was not diﬀerent among dogs with PDH, ADH and
non-HAC dogs. In 2D-STE analysis, 23 of 98 (23%) 2D-STE
variables were signiﬁcantly diﬀerent among 3 groups. The dogs
with ADH exhibited signiﬁcantly decreased longitudinal peak
systolic and early diastolic strain rates (P = 0.046 and P =
0.002, respectively), and longitudinal peak systolic strain (P =
0.038) compared to PDH and non-HAC dogs.
HCM was prevalent in HAC comparing to age-matched non-
HAC small breed dogs. In dogs with HCM, 2D-STE revealed
signiﬁcant decreases in both diastolic and systolic functions those
were not detected using conventional echocardiography in ADH
comparing to PDH-aﬀecting and non-HAC dogs.
ABSTRACT C-32
ECHOCARDIOGRAPHIC EVALUATION OF LEFT ATRIAL
SIZE IN HEALTH COCKER SPANIEL DOGS AND WITH
DILATED CARDIOMIOPATHY. GT Goldfeder, PH Itikawa,
GG Pereira, JR Castro, VM Oliveira. MHMA Larsson School of
Veterinary Medicine and Animal Sciences, University of Sao
Paulo, SP, Brazil.
Left atrial (LA) size is considered an important prognostic fac-
tor in many cardiomyopathies. In humans, it is known that LA
remodeling can occur in diﬀerent planes, according to the cause.
The aim of this study was to evaluate left atrial size, by measur-
ing the apical-basilar (ABd), medio-lateral (MLd) and cranio-
caudal (CCd) axis.
Eleven healthy adult Cocker Spaniel dogs (control) and nine
adult Cocker Spaniel dogs with dilated cardiomiopathy (DC)
were included. Control animals were screened by physical exami-
nation, thoracic radiography, electrocardiography, systolic blood
pressure measurement, echocardiography and laboratory tests
(CBC, biochemical blood urea and creatinine). ABd and MLd
measurements were done from apical 4 chamber view (Ap4cv) of
the heart, in end-systole. ABd was obtained by drawing a line
from the mitral apposition point of mitral leaﬂets to middle point
of LA roof. MLd measurement was performed drawing a perpen-
dicular line to the ABd. CCd measurements were done anterior-
posterior diameter from the paraesternal long-axis view. Data
were tested for normality and expressed as mean and standard
deviation. Comparisons among the methods were performed by
One-way Analysis of Variance.
LA measurements in ABd were 2.63±0.21 cm to control and
4.34±0.83 cm to DC; in MLd were 2.31±0.18 cm to control and
3.57±0.65 cm to DC; in CCd were 2.44±0.21cm to control and
3.59±0.42cm to DC. LA diameters were signiﬁcantly diﬀerent
among methods. Posterior similar studies involving dogs with dif-
ferent heart disease are recommended.
ABSTRACT C-33
TIME-DOMAIN HEART RATE VARIABILITY IN HEALTHY
DOGS. E Zacche´, FN Gava, EMG Ortiz, FA Rosa,
R Camacho, FM Marinho, R Navarrete, AA Camacho. Sa˜o
Paulo State University – UNESP, Jaboticabal, Sa˜o Paulo, Brazil.
Heart rate variability (HRV) is one of the most valuable non-
invasive marker of autonomic nervous system and is a prominent
method to assess its modulation of cardiovascular system. It is
well known that, besides diﬀerent diseases, several physiologic
conditions can aﬀect HVF in human beings but it still being
studied in canine patients. Thus, the aim of the present work was
to evaluate the inﬂuence of diﬀerent characteristics in HRV in
healthy dogs.
Twenty client-owned healthy dogs of diﬀerent breeds were
enrolled in the study. Heart rate variability, determined from 24-
hour Holter recordings in home environment, was assessed by
SDNN, SDANN, SDNNindex, rMSSD and pNN50. Dogs were
grouped on the basis of diﬀerent criteria such as gender (male,
n=8 and female, n=12), age ( 3 years-old, n=7 and >3 years-
old, n=13), cranial conformation (brachycephalic, n=5 and
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non-brachycephalic, n=15) and body weight ( 15 Kg, n=11
and > 15 Kg, n=9). Data was submitted to a normality test and
then analysis between groups was performed by using unpaired
Student’s t-test.
There was no signiﬁcant diﬀerence (p>0,05) between groups
when SDNN, SDANN, SDNNIDX and rMSSD were evaluated
on the basis of any of the tested criteria. The general mean (±
standard deviation) of such parameters were 328 ± 85 ms, 164 ±
35 ms, 277± 85 ms and 130 ± 44 ms, respectively. However,
pNN50 was signiﬁcantly higher (p=0,02) in patients with body
weight  15 Kg (71,93 ± 8,22 %) comparing with patients with
body weight 15 Kg (62,66 ± 9,13 %).
Indexes based on the comparison between adjacent cycles
(rMSSD and pNN50) reﬂect, predominantly, vagal tonus. Thus,
presented data strongly suggest that parasympathetic nervous
system of healthy dogs is not inﬂuenced by age, gender or cranial
conformation but it is body weight dependent. For this reason,
the establishment of normal range values should be based espe-
cially on that last criteria.
ABSTRACT C-34
HEART RATE VARIABILITY IN BOXER DOGS WITH AR-
RHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOP-
ATHY. PPC Chamas, VMC Oliveira, FL Yamaki, MHMA
Larsson. School of Veterinary Medicine and Animal Science –
University of Sa˜o Paulo, SP, Brazil.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is
a familial disease that aﬀects mainly Boxer dogs, characterized
by frequent ventricular arrhythmias that lead to sudden death. In
human patients, studies suggest important role of sympathetic
overstimulation in the genesis of these ventricular arrhythmias
through observation of diminished heart rate variability (HRV)
indices.
Seventy-three Boxer dogs were screened and classiﬁed, accord-
ingly to results of ambulatory electrocardiography and echocardi-
ography, into four groups: CB - control Boxers (n= 28, less than
50 VPC/24 hours), SB – suspected Boxers (n= 8, 50 to 300
VPC/24 hours), ARVCB – aﬀected Boxers without systolic dys-
function (n= 19, more than 300 VPC/24 hours) and SDB –
aﬀected Boxers with systolic dysfunction (n= 18). Five time
domain HRV indices were analyzed: SDNN, SDANN, SDNNi,
rMSSD and pNN50. Statistical analyses comprised ANOVA test,
Pearson correlation and Cox proportional hazards regression.
Compared to CB group, there was no decrease in HRV indices
on SB or ARVCB groups, and no correlation was found between
HRV indices and number or degree of ventricular arrhythmias,
suggesting that ventricular arrhythmias in Boxer ARVC do not
seem to be caused by increased activity of sympathetic nervous
system, as observed in human patients. Otherwise, SDB group
had impairment of these indices, justiﬁed by sympathetic stimula-
tion that occurs in congestive heart failure (CHF) associated with
systolic dysfunction. No relation was found between HRV indices
and cardiac related death (sudden death or death due to CHF)
of dogs with ARVC, demonstrating that such indices are poor
prognostic indicators for this disease.
ABSTRACT C-35
RADIOGRAPHIC VERTEBRAL HEART SIZE AND LEFT
ATRIAL BISECTING LINE: INTEROBSERVER VARIABIL-
ITY AND COMPARISON TO ECHOCARDIOGRAPHIC
LEFT ATRIAL SIZE IN DOGS WITH DEGENERATIVE
MITRAL VALVE DISEASE. J Hernandez-Lopez, MC Machen,
MA Oyama. University of Pennsylvania, Philadelphia, PA
Radiographic assessment of left heart enlargement is an
important diagnostic component of canine degenerative mitral
valve disease (DMVD). Previously, investigators have proposed
the radiographic left atrial bisecting line LABL as a more speciﬁc
measure of left atrial enlargement than vertebral heart size
(VHS).
Radiographs from 23 dogs diagnosed with DMVD from 2009-
2011 were examined by three investigators and VHS and LABL
(deﬁned as the line from the 90 degree intersection of the short
and long axis VHS measurements to the dorsal border of the left
atrium) were measured in vertebral bodies. Interobserver variabil-
ity (coeﬃcient of variation, CV) and correlation to echocardio-
graphic LA:Ao were calculated.
CV of right and left lateral LABL (R-LABL, 15.3%±13.3%;
L-LABL, 25.1%±23.1%) were signiﬁcantly (P<0.0001) greater
than CV of VHS (R-VHS, 6.1%±4.4%; L-VHS, 4.2%±4.3%).
Linear regression revealed moderate correlation between R-VHS
(r2=0.406; P=0.006) or L-VHS (r2=0.551; P=0.004) and LA:
Ao and weak or non-signiﬁcant correlation between R-LABL
(r2=0.265, P=0.034) or L-LABL (r2=0.208; P=0.12) and LA:
Ao. Median R-or-L-LABL was not signiﬁcantly (P>0.05) greater
in dogs with CHF (n=12) vs. without CHF (n=11). Diﬃculty of
the LABL measurement was graded as easy, moderate, or hard
in 54%, 28%, and 18% of measurements, respectively.
Assessment of left atrial size using LABL is challenging due to
high interobserver variability and weak correlation with echocar-
diographic LA:Ao, which is likely due to diﬃculty in ascertaining
the dorsal radiographic border of the left atrium in dogs with
more advanced disease. Future studies evaluating modiﬁcations
of the LABL technique should be performed.
ABSTRACT C-36
LEFT ATRIAL FUNCTION ANALYSIS BY LEFT ATRIAL
TRACKING METHOD IN CANINE CHRONIC MITRAL
VALVULAR HEART DISEASE. K Nakamura, T Osuga,
M Yamasaki, H Ohta, M Takiguchi. Department of Veterinary
Clinical Sciences, Graduate School of Veterinary Medicine,
Hokkaido University, Sapporo, Hokkaido, Japan.
Left atrial tracking method is a novel echocardiographic
modality for evaluation of left atrial function. The purpose of
this study was to assess the value of this method for the evalua-
tion of canine chronic mitral valvular heart disease.
Firstly, the repeatability of variables of left atrial tracking
method was investigated with 6 normal beagles. The within-day and
between-day coeﬃcients of variation of %LASpass (conduit func-
tion index), %LASact (booster pump function index), %LAStotal
(reservoir function index) were all clinically acceptable (< 20%).
Secondly, 36 clinical dogs with chronic mitral valvular heart
disease (15 dogs in ACVIM stage B1, 9 dogs in stage B2, 6 dogs
in stage C, 6 dogs in stage D) were enrolled. Receiver operating
characteristic curve analysis revealed that LA/Ao, E, %LASact
were highly useful (area under the curve > 0.9) and E/A, E/E’,
E’/A’, %LAStotal were moderately useful (area under the curve
> 0.7) to distinguish asymptomatic dogs (stage B1 and B2) from
symptomatic dogs (stage C and D). On the other hand, only %
LASact was highly useful (area under the curve > 0.9) and E, E/
A, %LASpass, %LAStotal were moderately useful (area under
the curve > 0.7) to distinguish mild symptomatic dogs (stage C)
from severe symptomatic dogs (stage D). LA/Ao had no value to
distinguish mild from severe symptomatic dogs.
In conclusion, these results indicate that left atrial tracking
method has adequately high repeatability for routine clinical
usage in dogs. Moreover, this method is more valuable than con-
ventional echocardiographic method in assessing the severity of
canine chronic mitral valvular heart disease.
ABSTRACT C-37
EARLY DETECTION OF LEFT VENTRICULAR DYSFUNC-
TION IN DOGS WITH DOXORUBICIN-INDUCED
CARDIOMYOPATHY BY 2D SPECKLE TRACKING ECHO-
CARDIOGRAPHY. K Sugimoto, H Takano, H Sunahara,
T Aoki, G Sugahara, Y Une, Y Fujii. Azabu University, School
of Veterinary Medicine, Kanagawa, Japan.
Doxorubicin (DOX) is one of the most frequently used drugs
for chemotherapy in dogs, and well known to have cardiac toxicity.
Two-Dimensional Speckle Tracking Echocardiography (STE) is a
relatively novel method to assess regional myocardial function and
has been reported to be useful to detect early myocardial dysfunc-
tion in doxorubicin-induced cardiomyopathy of human and rats.
The purpose of the study is to evaluate the usefulness of STE to
detect early left ventricular (LV) myocardial dysfunction due to
DOX in dogs by comparing the changes of STE parameters with
histopathological ﬁndings of corresponding regions in LV.
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DOX (30 mg/m2, 3 weeks apart, 4 times, total 120 mg/m2) and
saline were administered to ﬁve (DOX group) and four clinically
healthy beagles (placebo group), respectively. Conventional echo-
cardiographic and STE parameters were measured and com-
pared. All dogs were euthanized and the histopathologic score
corresponding to echocardiographic regions in LV was measured.
Radial strain at the apical level and radial strain rate in early
diastole at chordae tendineae level decreased signiﬁcantly in the
DOX group without signiﬁcant changes in conventional parame-
ters. Three of 4 dogs in the DOX group appeared to have
decreased STE parameters corresponding to severity of histopath-
ological lesions. Histopathological lesions among segments were
almost homogeneous in LV, but, changes of segmental STE
parameters did not always agree with the histological score.
Because of complex arrays of myocardial ﬁber in some LV
regions, STE parameters may not accurately detect localized
myocardial lesions in some areas.
ABSTRACT C-38
DOXORUBICIN-INDUCED DILATED CARDIOMYOPATHY
IN A RABBIT MODEL: AN UPDATE. FN Gava, E Zacche´,
EMG Ortiz, T Champion, MB Bandarra, JC Barbosa, RO
Vasconcelos AA Camacho. Sa˜o Paulo State University –
UNESP, Jaboticabal, Sa˜o Paulo, Brazil.
Dilated cardiomyopathy (DCM) is characterized by chamber
dilation, important systolic dysfunction and poor prognosis.
Thus, studies with experimental models of DCM are always
important. The purpose of this study was to investigate the onset
of systolic dysfunction using echocardiography in rabbits receiv-
ing diﬀerent doses of doxorubicin (DOX) and to characterize by
histological analysis and scanning electron microscopy from three
diﬀerent areas of myocardium.
Thirty male New Zealand White rabbits were randomized in
three experimental groups with 10 rabbits each, named: G1: con-
trol group, receiving NaCl 0.9 %, G2: receiving DOX 1 mg/kg
twice a week and G3: receiving DOX 2 mg/kg once a week, for 6
weeks. Echocardiographic evaluations were performed in awaken
animals, before DOX administration (T0) and every ﬁfteen days
(T15, T30, T45 and T60). The statistical analysis was performed
by analysis of variance followed by Tukey´s test.
Vacuolisation, intracytoplasmic granulation, necrosis and
extensive interstitial ﬁbrosis characterized DCM through histol-
ogy and electron microscopy in left ventricle (LV), interventricu-
lar septum (IVS) and right ventricle (RV). The results showed a
high mortality rate (70%) for G3 and only 30% for G2. There
were signiﬁcant reductions (p<0.05) in fractional shortening for
G2 and G3 at T45 (G1 = 38.57 ± 2.22%, G2 = 20.71 ± 4.02%,
G3 = 22, 66 ± 3.78%) and T60 (G1 = 37.35 ± 4.83%, G2 =
22.66 ± 3.50%, G3 = 22.33 ± 4.04%). This was also detected for
the ejection fraction at T45 (G1 = 73.28 ± 3.03%, G2 = 45.78 ±
7.44%, G3 = 49.33 ± 6.80%) and T60 (G1 = 71.00 ± 5.83%,
G2 = 49.50 ± 6.25%, G3 = 48.33 ± 6.65%).
Echocardiograph was important to indicate the start of sys-
tolic dysfunction whereas the histology and electron microscopy
featured the mainly lesions of doxorrubicin-induced DCM. The
administration of 1 mg/kg twice a week for only 6 weeks is suﬃ-
cient to induce DCM in rabbits.
ABSTRACT C-39
ASSESSMENT OF SERUM ADIPONECTIN AND ITS
CORRELATION WITH OBESITY AND MITRAL VALVE
ENDOCARDIOSIS IN DOGS. MHMA Larsson1, FLAM
achado1, DS Schwartz1, G Goldfeder1, MM Jerico´2. 1School of
Veterinary Medicine and Animal Science – University of Sa˜o
Paulo, Sa˜o Paulo, SP, Brazil, 2School of Veterinary Medicine -
University Anhembi Morumbi, Sa˜o Paulo, SP, Brazil.
Adipose tissue is known as a site for energy storage and syn-
thesis of hormones. Among them, adiponectin, a protein
expressed exclusively in adipocytes, is responsible for the correla-
tion between obesity and the atherosclerosis associated with insu-
lin resistance. Its circulating levels are inversely proportional to
body fat increase. Studies have suggested that adiponectin has its
eﬀects as an anti-atherogenic and anti-inﬂammatory molecule.
However, human studies have shown that circulating adiponectin
values should be interpreted with caution, because high levels of
adiponectin have been associated with increase mortality rate in
patients with coronary artery disease and heart failure. This
study evaluated the serum concentration of adiponectin in dogs,
divided into three groups: control (n=8), with chronic mitral
valve disease-dvcm (n=11) and obese patients with chronic
mitral valve insuﬃciency concomitantly (n=9). Blood samples
were processed by means of laboratory techniques of radioimmu-
noassay (RIA) and ELISA, verifying the correlation between
serum adiponectin levels among the groups. The group of dogs
with chronic mitral valve disease was classiﬁed according to the
ACVIM Consensus Statements of 2009. The results showed no
statistical signiﬁcance (Mann-Whitney test) among the groups,
probably due to the small sample (RIE: control/dvcm (p=0.264),
control/dvcm and obese (p=0.112) and (ELISA: control/dvcm
(p=0.283); control/dvcm and obese (p=0.147)), however, we
observed a tendency for decrease in mean and median adiponec-
tin values in dogs with dvcm and obese group compared to the
control group, conﬁrming the paradox between adiponectin cir-
culating levels in obesity and heart failure.
ABSTRACT C-40
ARTERIAL BLOOD PRESSURE ASSESSMENT IN NOR-
MAL AND OVERWEIGHT DOGS BY THREE DIFFERENT
METHODS. BC Rodrigues, FN Gava, E Zacche´, EMG Ortiz,
RDM Junior, T Champion, AA Camacho. Sa˜o Paulo State
University – UNESP, Jaboticabal, Sa˜o Paulo, Brazil.
The measurement of arterial blood pressure (ABP) is an
important clinical parameter that should be performed with pre-
cision mainly on the investigation of arterial hypertension. The
purpose of this study was to compare ABP values obtained indi-
rectly by Doppler and two kinds of oscilometric methods in nor-
mal and overweight dogs.
Thirty health adult dogs were selected after physical examina-
tion, echocardiograph and laboratory tests. The study groups
comprised fourteen overweight dogs with mean body score index
(BSI) of 6.9 and sixteen dogs with ideal BSI (4.8). The systolic
blood pressure (SBP) was measured in all animals ﬁrst by Dopp-
ler method (A), followed by oscilometric Dixtal® (B) and after
by Pet-MAP® (C). The mean and diastolic blood pressure were
measured by B and C. The statistical analysis was performed by
analysis of variance followed by Tukey´s test.
There was no signiﬁcant diﬀerence between normal and over-
weight dogs for SBP, but the values were higher (p<0.05) for
Pet-MAP® (Overweight dogs: A= 136.21±5,94 mmHg,
B=141.57±2.80 mmHg, C= 160.92±6.34 mmHg; Ideal BSI dogs:
A= 136.00±5,04 mmHg, B= 136.56±3.96 mmHg,
C=163.68±6.31 mmHg). For mean blood pressure, there was no
diﬀerence between normal and overweight dogs, but signiﬁcant
diﬀerence between the methods (Overweight dogs: B=103.28
±4.71 mmHg, C= 114.00±4.97 mmHg; Ideal BSI dogs: B=
100.81±3.46 mmHg, C=112.37±3.37 mmHg). For diastolic blood
pressure there were no diﬀerence between normal and overweight
dogs and no diﬀerence between the methods (Overweight dogs:
B= 82.35= ±5.00 mmHg, C=87.00 ±3.63 mmHg; Ideal BSI
dogs: B= 81.68±3.54 mmHg, C=86.50±2.80 mmHg).
The results suggest that overweight dogs may have normal
arterial blood pressure but the method of measurement must be
chosen carefully, once that Pet-MAP® may overestimate the sys-
tolic and mean blood pressure in normal and overweight dogs.
ABSTRACT C-41
PLASMA LEVELS OF NT-PRO BNP AND VENTRICULAR
DIASTOLIC FUNCTION ASSESSED BY PULSED TISSUE
DOPPLER ECHOCARDIOGRAPHY IN OBESE DOGS.
PRR Melo, AM Mazini, VMC de Oliveira, GT Goldfeder, CN
Duarte, DS Schwartz. FMVZ-USP (School of Veterinary
Medicine and Animal Science, University of Sa˜o Paulo) Sa˜o
Paulo, SP, Brazil.
Considering the controversial results on Nt-proBNP in obese
humans, and the lack of studies in obese dogs, we sought to eval-
uate the possible role of Nt-proBNP as a preclinical marker of
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cardiac disease in obese dogs, and the relationship with diastolic
function parameters assessed by pulsed tissue Doppler echocardi-
ography (TDE).
Forty-eight obese dogs (BCS8/9 and BCS9/9), and 49 dogs
with ideal body condition score (BCS5/9) were selected, matched
for gender, breed/size and age. Plasma concentration of Nt-proB-
NP and left ventricular (LV) myocardial TDE derived systolic
(Sm), early (Em) and late (Am) diastolic velocities (apical four-
chamber view at the lateral mitral annular region) were assessed.
Obese dogs had higher Nt-proBNP levels compared to lean
dogs (P=0.043). Eighty percent of BCS5 and BCS9 dogs had
Nt-proBNP<900pmol/L and 42% of BCS8 dogs were between
900-1800pmol/L. Based on a ROC curve, obese dogs showed Nt-
proBNP >550pmol/L while the non-obese showed Nt-proB-
NP<550pmol/L, with 75% sensitivity and 53% speciﬁcity
(P=0.044). Em was decreased (P=0.006) in obese and Ef/Em
was increased in BCS8 (P=0.02) and BCS9 (P=0.009) compared
to lean dogs, suggesting relaxation change and increased ventric-
ular ﬁlling pressure. Increased Ef/Em ratio was associated to
higher Nt-proBNP levels (P=0.032). The similarity of Nt-proB-
NP between BCS9 and BCS5 dogs, despite the presence of pre-
clinical LV diastolic changes, strengthen the need for further
studies, especially when considering obese dogs with heart dis-
ease, not included herein, which may need lower Nt-proBNP cut-
oﬀ values in order to diﬀerentiate the presence of heart failure as
a cause of respiratory distress.
ABSTRACT C-42
EFFECT OF BODYWEIGHT ON ASSESSMENT OF LEFT
VENTRICULAR FUNCTIONS USING TWO-DIMENSIONAL
SPECKLE-TRACKING ECHOCARDIOGRAPHY. HY Chen,
HP Huang. Institute of Veterinary Clinical Science, School of
Veterinary Medicine, National Taiwan University, Taipei,
Taiwan.
The aim of the study was to investigate the eﬀect of body
weight on assessment of left ventricular (LV) functions using
two-dimensional speckle-tracking echocardiography (2 D-STE) in
70 clinically healthy dogs.
These 70 dogs were categorized into small (<7 kg, n=35), med-
ium (7 to 20 kg, n=23), and large (>20kg, n=12) dogs. A com-
plete physical examination, non-invasive blood pressure
measurements, electrocardiography, thoracic radiography, conven-
tional echocardiography were performed to exclude possible pre-
existing cardiopulmonary disease. All dogs underwent 2D-STE:
longitudinal peak systolic and diastolic tissue velocity (LTV),
strain rate (LSR) and peak systolic strain (LS) of 6 segments (basal,
middle, and apical segments of interventricular septum and left
ventricular free wall), and also septal and lateral corners of mitral
annulus were measured from left apical long-axis views. Peak sys-
tolic and diastolic radial tissue velocity (RTV), circumferential
strain rate (CSR) and peak systolic circumferential strain (CS) of 6
segments (cranioseptal, cranial, lateral, caudal, ventral, and septal)
were measured from right parasternal short-axis views.
Variables derived from strain rate and strain, peak systolic and
diastolic LSR/CSR and peak systolic LS/CS, were not aﬀected by
bodyweight among these 3 groups. Variables derived from LV
velocity, peak systolic LTV/RTV, peak early diastolic LTV/RTV
and peak late diastolic LTV/RTV, were signiﬁcantly aﬀected by
bodyweight (P < 0.001, P < 0.001, P < 0.001, P < 0.001, P =
0.004 and P = 0.001, respectively) and positively correlated with
bodyweight (P < 0.001, P < 0.001, P < 0.001, P < 0.001, P =
0.039 and P = 0.001, respectively).
Variables derived from strain rate and strain were not aﬀected
by bodyweight and could amend conventional echocardiographic
assessment on LV functions in dogs.
ABSTRACT C-43
ECHOCARDIOGRAPHIC FINDINGS IN OBESE DOGS. DS
Schwartz, PRR Melo, AM Mazini, VMC de Oliveira, GT
Goldfeder, CN Duarte. FMVZ-USP (School of Veterinary
Medicine and Animal Science, University of Sa˜o Paulo) Sa˜o
Paulo, SP, Brazil.
Obesity has an eﬀect on cardiac dimensions and function in
humans, and some changes are diﬃcult to be detected on a rou-
tine echocardiographic exam. We sought to evaluate several
echocardiographic ratios in order to assess cardiac changes in
obese dogs compared to non-obese.
Sixty dogs with ideal body condition score (BCS5/9; control)
and 60 dogs with BCS8/9 and BCS9/9 (obese) were included,
matched for gender, breed/size and age. All dogs were healthy
based on clinical-laboratorial evaluation. Echocardiographic vari-
ables [left ventricular wall thickness in diastole (LVWd), interven-
tricular septum thickness in diastole (IVSd), left ventricular
diastolic diameter (LVDd), and left atria dimension (LA)] were
assessed and indexed to aorta (Ao) diameter and/or LVDd. Dia-
stolic function was assessed by early to late mitral ﬂow velocity
(E/A). Left ventricular mass (LVM) indexed to Ao was estimated
as LVM (Troy)=1.05([LVDd+LVWd+IVSd]3-[LVDd]3)g. Sys-
tolic arterial pressure (SAP) was assessed by Doppler.
Diastolic function was decreased in obese relative to controls
(P=0.041). The ratios LVWd/LVDd (P=0.002), IVSd/LVDd
(P<0.001) and (LVWd+IVSd)/LVDd (P<0.001) were increased
in obese compared to controls. BCS8 dogs had these variables
increased in comparison to BCS5 and BCS9. Ratios IVSd/Ao
(P=0.014) and (LVWd+IVSd)/Ao (P=0.016) were greater for
obese compared to control dogs. Obese dogs had a trend
(0.05<P<0.10) to increased LVWd/Ao (P=0.052) and to
indexed LVM (P=0.083). Systolic arterial pressure, LA/Ao and
LVWd/IVSd were similar among groups.
Although the measurements may be within normal ranges,
these results show concentric increased LVW thickness as an
adaptation to overload caused by obesity in dogs, already con-
tributing to diastolic dysfunction.
ABSTRACT C-44
CHARACTERIZATION OF GROSS AND HISTOLOGIC
MYOCARDIAL LESIONS IN OBESE DOGS. E Mehlman,
J Boon, J Bright, K Jeckel, C Porsche, M Frye. Colorado State
University College of Veterinary Medicine, Fort Collins, CO.
Obesity is the most common nutritional disease in dogs, and it
is predicted that prevalence will increase as the number of obese
humans continues to rise. Human obesity is associated with left
ventricular hypertrophy (LVH), and this structural change
increases the risk for heart failure. Unpublished data suggest that
canine obesity, in the absence of hypertension, is also associated
with LVH; the etiology of this structural change is not known.
The objectives of this study were to echocardiographically char-
acterize myocardial structure and function in obese normotensive
dogs, and examine postmortem tissues from a separate popula-
tion for evidence of potential contributors to LVH; namely, tri-
glyceride (TG) accretion, collagen accumulation and myocyte
hypertrophy.
Obese (body condition score  7/9) and age-matched lean
dogs were recruited for echocardiographic examination using
electronic notiﬁcation of students and employees at the Colorado
State University Veterinary Medical Center (CSU-VMC). Only
normotensive dogs with unremarkable physical examination ﬁnd-
ings were subsequently included as subjects. The postmortem
study was conducted using myocardium from 4 obese and 12
lean dogs with no history of cardiac disease, submitted for nec-
ropsy at the CSU-VMC for reasons unrelated to the present
study. Samples of left and right ventricles and the interventricular
septum were examined for lipid (oil red O staining, TG quantita-
tion), collagen (Masson’s trichrome staining, hydroxyproline
quantitation) and myocyte cross sectional area (Image J analysis
of H&E stained sections).
Echocardiography revealed increased left ventricular free wall
thickness in obese dogs during diastole (obese 9.9 ± 0.4 mm, lean
8.7 ± 0.4 mm; p = 0.03) and systole (obese 15.2 ± 0.5 mm, lean
12.9 ± 0.5 mm; p < 0.01). Septal thickness and left ventricular
chamber diameter were similar between groups. Isovolumic relax-
ation time, a measure of diastolic function, was prolonged in
37% (7/19) of obese dogs. Fractional shortening, an indicator of
systolic function, was similar between groups. Tissue studies
revealed comparable lipid and collagen content, as well as myo-
cyte area, in lean and obese groups.
The ﬁndings of this study support the idea that canine obesity
is associated with a focal increase in left ventricular thickness
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and possibly diastolic dysfunction, similar to early changes
observed in obese humans. Though this study did not reveal a
key contributor to gross LVH, trends toward increased TG con-
tent and myocyte area observed concomitantly with high variabil-
ity within groups suggest that larger studies are warranted,
controlling for known confounders in humans such as diet, activ-
ity and chronicity.
ABSTRACT C-45
TRANSVENOUS PERMANENT PACEMAKER THERAPY IN
DOGS: BRAZILIAN EXPERIENCE. DS Schwartz,
DT Fantoni, GT Goldfeder, MHMA Larsson. FMVZ-USP
(School of Veterinary Medicine and Animal Science, University
of Sa˜o Paulo) Sa˜o Paulo, SP, Brazil.
The use of transvenous cardiac pacemaker therapy for brad-
yarrhythmias is well established in veterinary medicine mainly
in the United States and Europe, but it has been introduced
into Brazilian veterinary practice only ﬁve years ago. During
this period, 16 dogs (11 females; 5 males) were treated with
transvenous pacemaker. Most dogs (15/16) had syncope as the
main complaint, four had pre-syncopal episodes which pro-
gressed to syncope and one had seizures episodes and syncope.
The most common arrhythmia was complete atrioventricular
block (AVB) (62.5%), followed by sick sinus syndrome
(31.25%), and one had advanced second degree AVB. The
patients included: three Dachshunds, Pitbulls, and Schnauzers;
two Labradors; and one Boxer, Bull Terrier, Cocker, English
Bulldog and Yorkshire. Age ranged from 2 to 10 years
(7.5±2.5 years), with 56.25% over 7 years. Two dogs had the
implant as an emergency procedure. Two dogs had decreased
ventricular function before the implant. The complications
observed (25%) were lead dislodgement (1/16); electrode throm-
bus formation (1/16); increased impulse threshold after 10
months of implant with decrease in battery lifetime and need
for generator replacement (1/16); metastatic implant infection
and thrombus (1/16). Eight dogs died in this period
(18.14±10.24 months post implant). Causes of death were
related to neoplasia (3/8), renal failure (1/8), heart failure sec-
ondary to mitral valve disease (1/8), myocardial failure associ-
ated with ventricular arrhythmias (1/8), seizures (1/8) and
myocardial failure during procedure to change device due to
infection (1/8). The type and rate of complications are similar
to what is reported in the literature.
ABSTRACT C-46
ECHOCARDIOGRAPHIC EVALUATION OF LEFT ATRIAL
SIZE IN MAINE COON CATS, FROM APICAL FOUR
CHAMBER VIEW. PH Itikawa, VM Oliveira, GT Goldfeder,
MHMA Larsson. School of Veterinary Medicine and Animal
Sciences –University of Sao Paulo, SP, Brazil.
Left atrial (LA) size is considered an important prognostic fac-
tor in many cardiomyopathies. In humans, it is known that LA
remodeling can occur in diﬀerent planes, according to the cause.
The aim of this study was to evaluate left atrial size, by measur-
ing the apical-basilar (ABd) and medio-lateral (MLd) axis and to
compare with standard measurements in M-mode (MM) and in
bidimensional LA short axis (2Dsax).
Thirty eight healthy adults Maine Coon cats were included.
Animals were screened by physical examination, thoracic radi-
ography, electrocardiography, systolic blood pressure, echocardi-
ography and laboratory tests (CBC, biochemical blood urea,
creatinine and total T4). ABd and MLd measurements were
done from apical 4 chamber view (Ap4cv) of the heart, in end-
systole. ABd was obtained by drawing a line from the mitral
apposition point of mitral leaﬂets to middle point of LA roof.
MLd measurement was performed drawing a perpendicular line
to the ABd. Data were tested for normality and expressed as
mean and standard deviation (± SD). Comparisons among the
methods were performed by ANOVA with Repeated Measure-
ments.
LA measurements were: 1.34±0.13 cm in MM; 1.34±0.15 cm in
2Dsax; 1.67±0.18 cm in ABd and 1.49±0.15cm in MLd. LA
diameters were signiﬁcantly diﬀerent among methods, except
between MM and 2Dsax, with higher values obtained from
Ap4cv. Posterior similar studies involving cats with diﬀerent
heart disease are recommended.
ABSTRACT C-47
SURVIVAL OF CATS WITH ISOLATED DISCRETE UPPER
SEPTAL THICKENING (DUST) VS. CATS WITH AND
WITHOUT CARDIOMYOPATHY. GE Singletary, MA Oyama.
University of Pennsylvania, Philadelphia, PA.
Isolated echocardiographic discrete upper septal thickening
(DUST) or proximal interventricular septal hypertrophy is occa-
sionally detected in cats but has unknown clinical signiﬁcance. In
humans, isolated DUST does not aﬀect cardiac mortality. We
retrospectively evaluated survival in cats with DUST vs. cats with
and without cardiomyopathy. We hypothesized that DUST is
not associated with increased mortality.
Echocardiograms from cats evaluated during 2009 were segre-
gated into three echo groups, DUST (n=13), cardiomyopathy
(CM, n=94), or no cardiomyopathy (no CM; n=44). Median
age between groups was signiﬁcantly diﬀerent (11.8yrs, 10.4yrs,,
7.6yrs, respectively; p=0.004). Median survival time (MST)
between the groups was signiﬁcantly diﬀerent (DUST, 513d; CM,
442d; no CM >800d; p=0.046).
On univariate analysis, age (p=0.0001), CHF (p<0.0001),
thromboembolism (p=0.025), and echo group (p=0.036) were
signiﬁcant risk factors for mortality whereas gender was not
(p=0.06). Backwards multivariate regression using all variables
identiﬁed age (b=1.09, CI=1.04-1.15, p=0.0009), presence of
CHF (b=5.34, CI=3.26-8.72, p<0.0001) and thromboembolism
(b=2.71, CI=1.07-6.86, p=0.0361) as signiﬁcant risk factors for
mortality. Thus, after adjustment for covariates, echo group did
not signiﬁcantly aﬀect mortality.
CM cats were more likely to die of cardiac-related complica-
tions vs. cats with DUST or no CM (CM, 35% vs. DUST/no
CM, 0%; p=0.0006). Cats with NT-proBNP>500pmol/L had
shorter MST than cats with lower concentrations (>500pmol/L,
n=9, 314d vs. <500pmol/L, n=14, >786d; p=0.009), however
cats with available NT-proBNP results were few. These results
indicate that isolated DUST is not a risk factor for mortality and
that cats with DUST are unlikely to die from cardiac-related
causes.
ABSTRACT C-48
EFFECT OF ATENOLOL THERAPY ON ECHOCARDIO-
GRAPHIC PARAMETERS IN CATS WITH HYPERTRO-
PHIC OBSTRUCTIVE CARDIOMYOPATHY. MC Machen1,
MJ Hezzell2, MA Oyama1. 1University of Pennsylvania,
Philadelphia, PA, 2Royal Veterinary College, London, UK.
Hypertrophic obstructive cardiomyopathy (HOCM) is com-
monly diagnosed in cats, and consists of left ventricular (LV)
concentric hypertrophy and dynamic LV outﬂow tract obstruc-
tion (dLVOTO). Atenolol is commonly prescribed in asymptom-
atic HOCM, however its eﬀect on LV hypertrophy is largely
unknown. We sought to retrospectively evaluate the eﬀects of at-
enolol on echocardiographic measures of LV hypertrophy and
aortic pressure gradient (APG) in asymptomatic cats with
HOCM.
A search of medical records from 2005-2011 identiﬁed asymp-
tomatic HOCM cats having received atenolol and echocardio-
graphic examinations prior to and after starting atenolol (n=24).
Cats with a diagnosis of non-obstructive hypertrophic cardiomy-
opathy (HCM) not administered atenolol were identiﬁed as con-
trols (n=12).
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Median follow up time was 221d (range, 83-555d). In cats
with HOCM, median atenolol dose was 6.25mg/day (range,
6.25mg-18.75mg/day). Repeated measures linear modeling with
compound symmetry covariance structure was used to analyze
changes in echo variables over time (days). There was a signiﬁ-
cant diﬀerence in the rate of change of interventricular septum
in diastole (IVSd) thickness between HOCM+atenolol and
HCM cats (P=0.002), with IVSd signiﬁcantly decreasing in the
HOCM+atenolol group (B=-0.0003, [95% CI, -0.0004 to -
0.0001], P<0.001) but not changing in the HCM group
(B=0.0001[-0.0000 to 0.0004], P=0.171) (Raw IVSd values:
HOCM-pre, median=0.71cm [IQR, 0.61-0.78cm]; HOCM-post,
0.57cm [0.52-0.66cm] vs. HCM-pre, 0.61cm [0.58-0.63cm];
HCM-post, 0.63cm [0.60-0.70cm]). There was a signiﬁcant diﬀer-
ence in the rate of change of Log[APG] between HOCM+ate-
nolol and HCM cats (P=0.009), with Log[APG] signiﬁcantly
decreasing in the HOCM+atenolol group (B=-0.0018, [-0.0025
to -0.0012], P<0.001) but not changing in the HCM group
(B=0.0003[-0.0011 to 0.0017], P=0.682) (Raw APG values:
HOCM-pre, 76.5mmHg [34.4-95.6mmHg]; HOCM-post,
11.2mmHg [4.1-19.9mmHg] vs. HCM-pre, 3.6mmHg [2.6-
13.5mmHg]; HCM-post, 4.9mmHg [3.9-10.8mmHg]). There were
no signiﬁcant diﬀerences in the rates of change of left ventricu-
lar internal diameter in diastole (P=0.336), left ventricular
internal diameter in systole (P=0.304), left ventricular posterior
wall thickness in diastole (P=0.933), fractional shortening
(P=0.468), or left atrial to aortic root diameter ratio (P=0.081)
between groups.
Atenolol therapy appears to decrease dLVOTO and ventricu-
lar septal hypertrophy in cats with HOCM. Limitations of this
study include the lack of a true control group and an unknown
eﬀect on outcome. Future prospective placebo-controlled ran-
domized studies are needed.
ABSTRACT C-49
EFFECT OF A HEART MURMUR ON ADOPTABILITY OF
CATS IN AN URBAN NO-KILL RESCUE ORGANIZATION.
RL Cohen, GE Singletary, MC Machen, DJ Trafny,
MA Oyama. University of Pennsylvania, Philadelphia, PA.
There are approximately 70 million stray cats in the United
States. Many of these cats are rescued and oﬀered for adoption
by animal shelter and rehoming organizations, however relatively
little is known about the variables that aﬀect the likelihood for
successful adoption. Heart disease is an important health issue in
adult cats, and we sought to determine the eﬀect of heart mur-
murs or heart disease on adoptability of cats from a large urban
no-kill rescue and rehoming organization.
Adult cats that entered a Philadelphia shelter were enrolled
over a 60-day period. Cats <1 year of age or with serious con-
current medical conditions such as orthopedic injuries or cancer
were excluded. A cardiologist and cardiology resident indepen-
dently ausculted all cats and those found to have murmurs
underwent echocardiography. The knowledge of a murmur and
subsequent echocardiographic diagnosis were made available to
adoption staﬀ and potential adopters. We examined the eﬀect of
the presence of a murmur and/or heart disease on adoption out-
come (yes vs. no) 90-days after end of study enrollment using
logistic regression.
Ninety cats were enrolled, and 10 (11%) were found to have
murmurs. Of those, 2 were found to have signiﬁcant heart disease
on echocardiography, while 8 were found to have murmurs of
benign origin. At the end of the study, 80 cats had been adopted.
On univariate regression, presence of heart murmur (P=0.18),
heart disease (P=0.49), gender (P=0.50), and coat color (black
vs. other) (P=0.19) were not associated with adoption outcome.
On multivariate regression, no variable was associated with adop-
tion outcome.
Results of this study show that benign heart murmurs are rela-
tively common in shelter cats and the presence of a murmur does
not inﬂuence adoptability if echocardiographic study indicates
normal underlying heart structure. Limitations of the study
include relatively low numbers of cats with heart disease. Further
studies in larger populations as well as in shelters with diﬀerent
adoption and rehoming policies from those present in this study
are warranted.
ABSTRACT C-50
DETECTION OF OCCULT FELINE CARDIOMYOPATHY
USING A PET-SIDE POINT-OF-CARE NT-PROBNP ELISA
ASSAY. MC Machen1, SG Gordon2, JS Buch3, MJ Beall3,
MA Oyama1. 1University of Pennsylvania, Philadelphia, PA,
2Texas A&M University, College Station, TX, 3IDEXX
Laboratories Inc., Westbrook, ME
Detection of asymptomatic (occult) feline cardiomyopathy
(OCM) is challenging. Previous study indicates that NT-proBNP
identiﬁes cats with moderate to severe OCM. We sought to deter-
mine the ability of a pet-side point-of-care ELISA that utilizes
SNAP® technology and second generation antibodies to detect
moderate to severe OCM.
Asymptomatic cats suspected to be “at-risk” for or known to
have OCM were prospectively recruited based upon a prior diag-
nosis, the presence of a heart murmur, gallop, arrhythmia, and/
or being a predisposed breed. A group of 16 healthy cats were
recruited as controls. All cats underwent physical examination,
blood pressure measurement, and echocardiography by an opera-
tor blinded to SNAP results. Blood for chemistry proﬁle, T4, and
an experimental second generation Cardiopet® proBNP assay
was drawn. A SNAP assay was performed at time of echocardio-
gram and evaluated by both an automated SNAP reader (SNAP-
shot DX®) and by visual interpretation by a separate reader
blinded to the echo results. The SNAP assay result was based on
the color of the sample spot compared to the reference spot.
SNAP results were called either positive (color of sample spot
equal to or darker than the reference spot) or negative (color of
sample spot lighter than reference spot).
In addition to the 16 control cats, 48 at-risk cats were exam-
ined and classiﬁed as normal (n=14), mild OCM (n=19), mod-
erate OCM (n=10), and severe OCM (n=5). Diagnosis in cats
with OCM included HCM (n=9), HOCM (n=23), and RCM
(n=2). In the 34 cats with any degree of OCM, SNAPshot DX
and visual interpretation of the SNAP had a sensitivity/speciﬁcity
of 68.8%/91.7% and 68.8%/100%, respectively. In cats with
moderate or severe OCM, SNAPshot DX and visual interpreta-
tion of the SNAP had a sensitivity and speciﬁcity of 100% and
88.2%, and 93.3% and 100%, respectively.
Quantitative ELISA plate assay using second generation anti-
bodies indicated that median plasma NT-proBNP concentration
was signiﬁcantly higher in OCM vs. normal at-risk cats or
healthy controls (OCM, 306pmol/L [IQR, 82-690pmol/L]; normal
at-risk, 28pmol/L [15-51pmol/L]; control, 31pmol/L [19-58pmol/
L]; P<0.0001). Median NT-proBNP concentration was signiﬁ-
cantly greater in cats with moderate or severe OCM vs. mild
OCM (moderate/severe, 651pmol/L [348-919pmol/L] vs. mild,
115pmol/L [35-286pmol/L]; P=0.0002). Comparison of results
from the SNAPshot DX vs. ELISA plate indicated that a posi-
tive SNAP test result was associated with a quantitative NT-
proBNP concentration >110-130pmol/L. Results of this study
indicate that a point-of-care SNAP assay aligns with ELISA
plate assay and detects moderate to severe OCM with high sensi-
tivity and speciﬁcity.
ABSTRACT C-51
TRICUSPID ANNULAR PLANE SYSTOLIC EXCURSION
(TAPSE) MEASUREMENTS IN MAINE COON CATS.
PH Itikawa, GT Goldfeder, VM Oliveira, MHMA Larsson.
School of Veterinary Medicine and Animal Sciences –University
of Sao Paulo, SP, Brazil.
Assessment of right ventricular (RV) function remains chal-
lenging because of complex RV chamber geometry. Recently, in
human medicine, many studies have been considered the tricuspid
annular plane systolic excursion (TAPSE) a useful tool for RV
function evaluation. In that species a good correlation was found
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between VD function, obtained by right heart catheterization,
and values of TAPSE. RV studies are important for diseases such
as pulmonary hypertension and Arrhythmogenic Right Ventricu-
lar Cardiomyopathy in cats. The aim of this study was to evalu-
ate TAPSE and to present initial normal reference range for
Maine Coon cats.
Twenty eight healthy adults Maine Coon cats were included.
Animals were screened by physical examination, thoracic radiog-
raphy, electrocardiography, systolic blood pressure, echocardiog-
raphy and laboratory tests (CBC, biochemical blood urea,
creatinine and total T4). In face of normal results, TAPSE was
obtained by apical four-chamber view and an M-mode cursor
was placed through the lateral tricuspid annulus in real time.
TAPSE was measured as the total displacement of the tricuspid
annulus in (centimeters) from end-diastole to end-systole. Data
were tested for normality and expressed as mean, standard devia-
tion (± SD) and 95% conﬁdence interval.
TAPSE measurements obtained were: 0.97 ± 0.25 cm and
0.87 to 1.07 cm, respectively. Posterior similar studies involving
more animals, others breeds and cats with diﬀerent disease are
recommended.
ABSTRACT C-52
TRICUSPID ANNULAR PLANE SYSTOLIC EXCURSION
(TAPSE) MEASUREMENTS IN DOGS. GT Goldfeder, PH
Itikawa, JR Castro, VM Oliveira, MHMA Larsson. School of
Veterinary Medicine and Animal Sciences –University of Sao
Paulo, SP, Brazil.
Assessment of right ventricular (RV) function remains chal-
lenging because of complex RV chamber geometry. Recently, in
human medicine, many studies have been considered the tricus-
pid annular plane systolic excursion (TAPSE) an useful tool for
RV function evaluation. In that species a good correlation was
found between VD function, obtained by right heart catheteri-
zation, and values of TAPSE. RV studies are important for dis-
eases such as pulmonary hypertension and Arrhythmogenic
Right Ventricular Cardiomyopathy. The aim of this study was
to evaluate TAPSE and to present initial normal reference
range for dogs.
Sixteen healthy adult dogs with 1 to 20 kg (G1) and nineteen
dogs with 21 to 40 kg (G2) were included. Animals were
screened by physical examination, thoracic radiography, electro-
cardiography, systolic blood pressure measurement, echocardiog-
raphy and laboratory tests (CBC, biochemical blood urea and
creatinine). In face of normal results, TAPSE was obtained by
apical four-chamber view and an M-mode cursor was placed
through the lateral tricuspid annulus in real time. TAPSE was
measured as the total displacement of the tricuspid annulus in
(centimeters) from end-diastole to end-systole. Data were tested
for normality and expressed as mean and standard deviation.
Comparisons among the groups were performed by unpaired T
Test. TAPSE measurements obtained were: 1.22±0.30 cm for
G1 and 1.70±0.25 cm for G2. TAPSE measurements were sig-
niﬁcantly diﬀerent between groups. Posterior similar studies
involving more animals and dogs with diﬀerent disease are
recommended.
ABSTRACT C-53
SURVEY OF SIX POTENTIAL CARDIAC BIOMARKERS IN
DOGS WITH HEART DISEASE: CHROMOGRANIN-A, EN-
DOGLIN, GALECTIN-3, NT-PROBNP, ST2, AND OSTEO-
PONTIN. MA Oyama1, MC Machen1, DJ Trafny1,
GE Singletary1, RC Gupta2, R Sainger1, HN Sabbah2.
1University of Pennsylvania, Philadelphia, PA., 2Henry Ford
Health Systems, Detroit, MI.
Biomarkers are substances released into the circulation by the
injured heart, and have diagnostic and prognostic potential.
Other than NT-proBNP, relatively little is known about circulat-
ing biomarkers in dogs with spontaneous heart disease. We
examined ﬁve additional potential biomarkers in dogs with either
degenerative mitral valve disease (DMVD) or dilated cardiomy-
opathy (DCM), and compared results to those from NT-proBNP
assay.
EDTA plasma was obtained from 61 healthy dogs, 22 with
DCM, and 65 with DMVD (ISACHC classes 1a/b [n=53], 2
[n=16], and 3 [n=18]). Plasma was stored at -80C until batch
ELISA analysis. Not all assays were performed in each dog due
to the volume of blood required.
Plasma concentrations of chromogranin-A (n=70), a negative
inotrope and marker of sympathetic activation; endoglin (n=35),
a soluble TGF-beta receptor; galectin-3 (n=50), a marker of
ﬁbrosis and remodeling; ST2 (n=69), a marker of remodeling
and cardiac stress; and osteopontin (n=37), a marker of ﬁbrosis,
were not signiﬁcantly elevated in dogs with heart disease vs. con-
trols (P-values of 0.60, 0.15, 0.21, 0.25, and 0.45, respectively). In
contrast, median NT-proBNP concentration was signiﬁcantly
increased in heart disease (2,115pmol/L, n=87) vs. control
(369pmol/L, n=61; P<0.0001).
Identiﬁcation of novel biomarkers in dogs is challenging. Limi-
tations of the study include relatively small numbers of dogs with
advanced disease and use of ELISA systems that might not be
ideally suited for use in canine samples. Future studies might
beneﬁt from more eﬃcient high-throughput screening methods to
identify candidate markers for further study.
ABSTRACT C-54
BREED-SPECIFIC VERTEBRAL HEART SIZE FOR THE
DACHSHUND. RR Birks, SE Clay, LG Britt, SB Leach,
DM Fine. University of Missouri, Columbia, MO.
Heart disease (HD) is common in dachshunds, and is often
monitored with radiographs. The radiographic vertebral heart
size (VHS) was developed to objectively evaluate the size of the
canine cardiac silhouette. A VHS reference range of 9.7±0.5 ver-
tebrae was established using a mixed population of breeds. Sub-
sequent studies have demonstrated that some breeds fall outside
this reference range. The aim of this study was to determine a
breed-speciﬁc VHS for the dachshund and compare results to the
established range.
Twenty-four normal control (CON) dachshunds had thoracic
radiographs (TXR) and an echocardiogram (Echo) performed.
Medical records were reviewed for dachshunds with HD.
Twenty-four dogs with a heart murmur, TXR, and an Echo per-
formed on the same day were identiﬁed. Five observers of vary-
ing levels of clinical training (1 each: senior veterinary student,
specialty intern, 3rd year cardiology resident, boarded cardiolo-
gist, boarded radiologist) measured VHS for all 48 dachshunds
on right and left lateral TXR. Measurements were performed on
2 separate days, at least 1 week apart and were recorded to the
nearest 0.25 vertebra. The data was analyzed using Wilcoxon
Rank-Sum analysis. The right and left VHS were correlated with
Echo 2D long-axis and M-mode left atrial (LA) measurements
and M-mode LA to aortic ratio. The Kappa reliability test was
used to evaluate inter-observer and intra-observer variability.
P<0.05 was considered signiﬁcant.
The median (range) for the right lateral CON VHS was 9.75
(8.1–11.0). A small but signiﬁcant decrease in left lateral CON
VHS was seen: 9.5 (8.2–10.5). The median right lateral HD VHS
measurement was: 11.0 (9–13.5). There was no diﬀerence when
compared with left lateral HD VHS, 11 (9.2-13.5). The median
VHS of HD was signiﬁcantly greater than that of CON. A high
correlation was seen between the VHS and the 2D LA Echo
measurements (Right sided VHS, r=0.824; Left sided VHS,
r=0.817). The Kappa inter-observer and intra-observer variabil-
ity was 0.69±0.03 and 0.76±0.1 respectively.
Results of this study indicate normal dachshunds have a
median VHS within the previously published reference range. A
VHS > 11.0 vertebrae may be a reliable indicator for the pres-
ence of HD. A signiﬁcant diﬀerence was present between right
and left lateral VHS in CON dogs, but not in HD. Therefore,
serial VHS measurements should consistently be performed with
the dog in the same lateral recumbency to limit variability.
Although HD VHS was signiﬁcantly higher than CON VHS,
there was overlap between groups, indicating VHS should be
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interpreted in conjunction with clinical and Echo ﬁndings. VHS
demonstrated a strong correlation with the 2D LA echo mea-
surment. Inter-observer and intra-observer variability showed
substantial agreement for measurements of VHS, indicating
VHS can be reliably performed by observers with varying
degrees of experience.
ABSTRACT C-55
IN-HOME BLOOD PRESSURE MONITORING IN DOGS: A
PILOT STUDY. AP Carr. Western College of Veterinary
Medicine, Saskatoon, Canada.
In-home blood pressure (BP) monitoring is commonly used in
humans and has been found to be equivalent to 24 hour ambula-
tory blood pressure (ABP) monitoring. Both ABP and in-home
measurements generally eliminate “white-coat” eﬀects as well as
detect masked hypertension.
This retrospective study was carried out to see if owners could
reliably obtain blood pressure readings in dogs and compare
these readings to those obtained in clinic. All in-clinic readings
had been obtained in an exam room with the owners present to
minimize stress. The readings were obtained using an HDO oscil-
lometric blood pressure device (S+BmedVET, Babenhausen,
Germany) while monitoring the oscillometric trace using MDS
Analyse software. It was recommended that the owners obtain
approximately 5 readings with 3 diﬀerent BP sessions. All BP
traces from in-clinic and in-home sessions were evaluated and
readings that showed minimal artifact were used for analysis in
this study.
A total of 6 dogs were evaluated that suﬀered from a variety
of clinical problems. Systolic hypertension was present in all 6
dogs in clinic (2 moderate and 4 severe risk of target organ dam-
age or TOD) but only 3 at home (1 mild, 1 moderate and 1
severe risk of TOD). Diastolic hypertension was present in 3 dogs
(1 mild and 2 moderate risk of TOD) in clinic and in 1 dog at
home (moderate risk of TOD). One dog (CRF, PLN) had pres-
sures obtained twice in clinic and at home with very consistent
ﬁndings (in clinic: 183/85, HR 221 October 2009, 185/81, HR 207
September 2010; at home: 126/81, HR 109 November 2009, 123/
62, HR 108 September 2010). One dog (hyperadrenocorticism)
had evidence of masked hypertension (in clinic: 174/95 MAP 123
HR 150; at home: 197/110 MAP 140 HR 80).
In our pilot study all owners were able to obtain blood pres-
sure readings with minimal artifact. Hypertension was diagnosed
less frequently at home than in the clinic, though one case of
masked hypertension was diagnosed. It appears that in home
blood pressure measurement is a viable option for assessing
blood pressure in dogs.
ABSTRACT C-56
LONG-TERM SURVIVAL IN DOGS WITH UNTREATED
SEVERE SUBAORTIC STENOSIS. DB Leeder1, AH Tobias1,
CD Stauthammer1, SC Hansen1, TM Hart2, DM Fine3.
1University of Minnesota, St. Paul, MN, USA, 2SylvaniaVet,
Sylvania, Ohio, USA. 3University of Missouri, Columbia, MO,
USA.
Dogs with untreated severe subaortic stenosis (SAS) are
reported to have a poor prognosis. This is largely based on the
results of a single retrospective study involving a total of 15 dogs
from one institution, which reported median survival of 1.6 years
of age. Subsequent studies have evaluated the eﬃcacy of various
therapeutic interventions on survival in dogs with SAS; however,
none have included an untreated control group. The purpose of
this study was to evaluate survival in dogs with untreated severe
SAS. The hypothesis was that survival is longer than previously
reported. Medical records at the University of Minnesota Veteri-
nary Medical Center and University of Missouri Veterinary Med-
ical Teaching Hospital were reviewed. Dogs with severe SAS
conﬁrmed by two-dimensional and Doppler echocardiography
(DP > 80 mmHg) were identiﬁed. Dogs with concurrent hemo-
dynamically-signiﬁcant cardiac disease and those prescribed ß-
blockers or any other cardiac medications at the time of diagno-
sis were excluded. Between 2002 and 2011, 21 dogs with uncom-
plicated, untreated severe SAS were identiﬁed. Median (range)
age and DP at time of diagnosis were 1.4 years (0.2-11.6) and 120
mmHg (81-207), respectively. Kaplan-Meier analysis disclosed
that their median survival was 8.8 years of age (95% CI: 4.5-
11.8) for an all-cause mortality, with the same median survival
for cardiovascular mortality but with a slightly narrower 95% CI
(4.9-11.5). Based on these data, we conclude that dogs with
untreated severe SAS survive considerably longer than previously
reported.
ABSTRACT C-57
COMPARISON OF PIMOBENDAN, BENAZEPRIL, OR
METHYLDIGOXIN MONOTHERAPY IN IRISH WOLF-
HOUNDS WITH OCCULT DCM: A 10-YEAR-STUDY. AC
Vollmar1, N Mohren2, C Tro¨tschel3, PR Fox4. 1Small Animal
Veterinary Clinic, Bonn Germany, 2Boehringer Ingelheim
Vetmedica GmbH, Germany, 3Boehringer Ingelheim Italia S.p.
A., Milano, 4. Animal Medical Center, NY, USA.
We prospectively studied cardiac outcome in 66 asymptomatic
(ISACHC stage 1B) Irish wolfhound dogs with occult DCM
(n=46) or lone atrial ﬁbrillation (AF) (n=20). Cases were allo-
cated at random to receive monotherapy with either pimobendan
(0.25 mg/kg q12hr, n= 23), benazepril (0.25-0.33 mg/kg/day,
n=22), or methyldigoxin (0.01 mg/kg/day, n=21) in a single-
blinded manner. Concomitant diltiazem (slow release formula-
tion, 1-3 mg/kg q12hr; n=8) was given for AF HR control.
Diagnosis was made by physical examination, echocardiography,
chest radiography, and ECG. Dogs were monitored approxi-
mately every 6 months. Primary endpoint was CHF or sudden
cardiac death (SD). We assessed median time to CHF/SD (Kap-
lan-Meier analysis) and between-group comparisons (two-sided
log rank tests with Bonferroni-Holm multiple comparisons). Sig-
niﬁcance level was p < 0.05.
Median age was 4.0 years, range 1.4-8.0 years (37 male, 27
female. Median weight was 70.0 kg (range 47.6 – 90.0 kg). Med-
ian study duration was 52.5 months. Endpoint was reached in 5/
23 (21.7%) pimobendan; 11/22 (50%) benazepril; 9/21 (42.9%)
methyldigoxin cohorts. Median time to CHF/SD was longer for
pimobendan (66.4 months) vs. benazepril (33.2 months)
(p=0.007) or methyldigoxin (42.1 months) cohorts (p=0.031).
In this long-term study pimobendan monotherapy improved
cardiac outcome for Irish Wolfhounds with occult DCM or lone
AF vs either benazepril or methyldigoxin alone.
EQUINE
ABSTRACT E-1
ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT VEN-
TRICULAR SIZE AND SYSTOLIC FUNCTION IN HORSES
USING LINEAR MEASUREMENTS AND AREA-BASED
VOLUME ESTIMATES. CC Schwarzwald, D Berthoud.
Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
Echocardiographic assessment of left ventricular (LV) size and
systolic function in horses is commonly limited to subjective eval-
uation, measurement of LV diameter in short-axis at the chordal
level, and calculation of LV fractional shortening (FS). The goal
of this study was to compare the conventional unidimensional
indices of LV size and function to LV volume estimates that are
based on linear measurements and two-dimensional (area) mea-
surements of the LV.
39 healthy horses (11 (4-23) y; 554 (350-660) kg) [mean
(range)] and 96 horses with suspected or conﬁrmed cardiac dis-
ease (14 (3-32) y, 550 (315-720) kg) were included in the study.
Echo-cardiograms were recorded by a single observer following a
standard protocol (GE Vivid 7 Dimension). The LV internal
diameter was measured at end diastole (LVIDd) and at peak sys-
tole from a right-parasternal short-axis M-mode recording at the
chordal level. The LV volume was estimated at end-diastole
(LVIVd) and at peak systole using single-plane Simpson’s model
(S) and the area-length method (AL) from a right-parasternal
4-chamber view and using the bullet method (B) based on right-
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parasternal long-axis and short-axis recordings. LV fractional
shortening (FS) and ejection fraction (EF) were calculated. Trip-
licate measurements were performed blinded and in random
order. LV dimensions were corrected for diﬀerences in body
weight using aortic annular diameter (AAD) as an internal refer-
ence of body size. Normal reference ranges were calculated (5-
95% percentile). Method comparison was performed using linear
regression, Bland-Altman analyses, and weighted Kappa (j). The
level of signiﬁcance was 0.05.
LVIVd was signiﬁcantly related to LVIDd (p<0.0001; R2=0.75
[S], 0.75 [AL], 0.83 [B]). The % diﬀerence between volumetric
methods [mean bias (limits of agreement)] was -4.8 (-8.2 to -1.5)%
[S-AL], -2.9 (-23.4 to +17.5)% [S-B], and +1.9 (-18.9 to +22.7)%
[AL-B]. Method agreement for classiﬁcation in reduced, normal,
and enlarged LV dimensions was moderate for LVIDd/AAD vs.
LVIVd[S]/AAD3 (j=0.48) and LVIVd[AL]/AAD3 (j=0.51) and
good for LVIVd[B]/AAD3 (j=0.62). The relationship between EF
and FS was signiﬁcant but mostly weak (p<0.0001; R2=0.15 [S],
0.19 [AL], 0.63 [B]). The absolute diﬀerence in EF between volu-
metric methods was -1.1 (-2.9 to +0.7)% [S-AL], -4.7 (-14.7 to
+5.3)% [S-B], and -3.6 (-13.0 to +5.9) [AL-B]. Method agreement
for classiﬁcation in reduced, normal, and enhanced LV systolic
function was poor for FS vs. EF[S] (j =0.18) and EF[AL] (j
=0.08) and moderate for FS vs. EF[B] (j=0.53).
Volumetric methods may be used to complement subjective
evaluation and linear measurements. Best agreement was seen
between conventional indices of LV size and function and
volumetric estimates using the bullet method. However, further
studies will be required to identify the most accurate and reli-
able method for assessment of LV size and systolic function in
horses.
ABSTRACT E-2
VALIDATION OF A POINT OF CARE ULTRASOUND
DEVICE FOR THE ASSESSMENT OF CARDIAC DISEASE
IN THE HORSE. AG Bevan, GD Hallowell, IM Bowen. School
of Veterinary Medicine and Science. University of Nottingham.
UK
Point of care (POC) ultrasound devices oﬀer the potential
advantage of portability and increased availability in equine prac-
tice due to their low cost. This study will determine the reliability
of such a device (V-Scan; GE Healthcare) compared to a hospi-
tal-based (HB) device (MyLab30; Esaote) for the assessment of
cardiac size, cardiac function and valvular regurgitation. The
POC device lacks M-mode capability and has limited depth of
imaging (24cm) so the study will also validate an alternative
method for assessment of left ventricular (LV) dimensions.
Nine Thoroughbred racehorses underwent cardiac assessment
on three separate occasions by one operator and on one occasion
by two further operators using both the POC and HB devices.
2D images were obtained and dimensions of the aorta (Ao), pul-
monary artery (PA) and left atrium (LA) were determined. LV
dimensions were assessed using a standard M-mode image
obtained through the left ventricle using the HB device. These
measurements were also determined in systole and diastole from
2D long and short axis images of the left ventricle using the HB
and, where possible, the POC device. An apically orientated left-
parasternal long axis view of the LV was also used. Valvular
regurgitation was identiﬁed and semi-quantitatively assessed
using Color Flow Doppler. The repeatability of measurement
from each device was determined both within and between opera-
tors using ANOVA and intraclass correlation. LV dimensions
obtained between devices and between diﬀerent methods of
assessment were compared using linear regression and Bland-
Altman analysis. Image quality and the presence and severity of
valvular regurgitation were also compared using Fishers exact
tests and calculation of Cohen’s Kappa.
Although image quality was less good with the POC device,
images were always of a suitable quality to enable measurements
to be made. Two horses could not be manually restrained when
using the HB device and their data was excluded from further
analysis. Inter and intra-observer repeatability was good
(ICC>0.6) or excellent (ICC>0.8) for both devices. There was
good correlation between 2D measurements of the LA (r2=0.85),
PA (r2=0.9) and Ao (r2=0.89) using the two devices. There were
no diﬀerences in LV measurements using the diﬀerent techniques
(Bias 3.4mm). Mitral regurgitation was identiﬁed in all horses
using both devices, aortic and tricuspid regurgitation was identi-
ﬁed in 6 horses using both devices. The agreement between
grades of severity was good for both aortic and tricuspid regurgi-
tation (Kappa of 0.9 and 0.6 respectively) but poor for mitral
(Kappa = 0.04), although neither machine could be classed as
being superior.
The POC machine provides reliable measurements of cardiac
size and for the documentation of valvular regurgitation. The lim-
ited depth of imaging can be overcome allowing assessment of LV
dimensions. The reduced image quality did not limit its ability to
provide images that are suitable for assessment of cardiac size.
ABSTRACT E-3
DOPPLER AND VOLUMETRIC ECHOCARDIOGRAPHIC
METHODS FOR CARDIAC OUTPUT MEASUREMENT IN
STANDING ADULT HORSES. E McConachie, MH Barton,
G Rapoport, S Gigue`re. Departments of Large Animal Medicine
and Small Animal Medicine and Surgery, University of Georgia,
Athens, GA
The purpose of this study was to assess and validate various
echocardiographic methods of measuring cardiac output (CO) in
adult horses by comparing results to the lithium dilution method.
In eight healthy adult horses, CO was manipulated with con-
tinuous rate infusions of dobutamine and romiﬁdine to achieve
high and low CO, respectively. CO at each level (baseline, high,
and low) was measured by lithium dilution and various echocar-
diographic methods. Images were stored as video loops for
review by an individual blinded to the lithium dilution results.
Limits of agreement and bias between methods were determined
by Bland-Altman analysis. A two-way ANOVA was conducted
to assess the eﬀect of CO method and level of CO on bias. Sig-
niﬁcance was set at P < 0.05.
Lithium determinations of CO ranged between 16.6 and 63.0
L/min. There was a signiﬁcant eﬀect of method of CO measure-
ment (P < 0.001) but no signiﬁcant eﬀect of CO level (P =
0.089) or interaction between level and method (P = 0.607).
The absolute values of the bias of the 4 chamber area-length,
Simpson, Doppler from the right ventricular outﬂow tract
(RVOT), and bullet methods [6.5, 6.1, 5.5, 8.8 L/min, respec-
tively] were signiﬁcantly lower than that of Doppler of the left
ventricular outﬂow tract or cubic methods [14.8, 24.3 L/min,
respectively].
The 4 chamber area-length, Simpson, bullet and Doppler from
the RVOT have acceptable agreement with lithium dilution and
provide a non-invasive method for CO estimation in adult horses
in a clinical setting.
ABSTRACT E-4
EFFECTS OF PRE-RACE FUROSEMIDE ADMINISTRATION
ON PLASMA ELECTROLYTE CONCENTRATIONS AND
ACID-BASE BALANCE IN STANDARDBREDS UNDERGO-
ING A SIMULATED RACE PROTOCOL. S Tinkler, L Coue¨til,
PD Constable. Purdue University College of Veterinary Medicine,
West-Lafayette, IN
Furosemide induces a clinically signiﬁcant hypochloremic,
hypokalemic, hypocalcemic, metabolic alkalosis as well as
marked reduction in plasma volume in sedentary horses. We
hypothesized that the pre-race administration of furosemide
would either augment or mitigate the profound acid-base, elec-
trolyte, and free water changes that occur in horses during and
after a simulated race.
Seven Standardbreds (2 to 6 years of age; 4 females, 3 geld-
ings) were fed a typical training diet (DCAD  200 mEq/kg
DM) and trained 5 times a week for 6 weeks using a high-speed
treadmill. Furosemide was administered intravenously (IV) at 0,
250 mg, and 500 mg in a randomized cross-over design 4 hours
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before horses underwent a simulated race protocol (SRP) on a
high-speed treadmill. Jugular venous blood samples were col-
lected via an indwelling catheter immediately before treatment
and periodically up to 90 minutes after the SRP. Plasma Na, K,
and Cl concentrations were determined using a Nova-4 analyzer
(Nova Biomedical Waltham, MA), plasma protein concentrations
were measured using refractometry and blood pH and gas ten-
sions were determined using an ABL-5 blood gas analyzer (Radi-
ometer Copenhagen, Denmark). Data were analyzed using
repeated measures analysis of variance and P<0.05 was
signiﬁcant.
Furosemide administration induced hypochloremia, hypokale-
mia, metabolic alkalosis, and alkalemia as well as a marked
reduction in plasma volume by 4 hours. Pre-race furosemide
administration caused a small dose-dependent decrease in
plasma chloride concentrations up to 4.5 mEq/L at all time-
points from fatigue to 90 minutes post SRP, as well as a dose-
dependent increase in plasma total protein concentration of up
to 0.7 g/dL at all time-points from fatigue to 90 minutes post
SRP. Interestingly, although plasma potassium concentration
peaked at 7.1±0.2 mEq/L at fatigue and then rapidly decreased
to 2.8±0.2 mEq/L at 90 minutes post SRP in untreated controls,
neither dose of furosemide signiﬁcantly changed plasma potas-
sium concentration during or after the SRP, compared to con-
trol. However, at fatigue, plasma potassium concentration was
numerically lower in horses receiving 500 mg (6.6±0.6 mEq/L)
or 250 mg (6.5±0.5 mEq/L) of furosemide IV than in untreated
controls.
We conclude that the pre-race administration of furosemide
(500 or 250 mg, IV) does not markedly alter the profound acid-
base and electrolyte changes that occur in horses during and after
a simulated race, but does have a small additive eﬀect on the
plasma volume reduction that occurs during high intensity exer-
cise. Our results suggest that IV furosemide is unlikely to increase
the incidence of cardiac arrhythmias in exercising racehorses
induced by changes in plasma potassium concentration.
ABSTRACT E-5
ASSOCIATION BETWEEN EXERCISE-INDUCED PULMO-
NARY HAEMORRHAGE AND DURATION OF RACING
CAREER IN THOROUGHBRED RACE HORSES.
SL Sullivan, MA Jackson, GA Anderson, PS Morley#,
KW Hinchcliﬀ. University of Melbourne, Victoria, Australia,
#College of Veterinary Medicine, Colorado State University, Fort
Collins, Colorado, USA
Exercise-induced pulmonary hemorrhage is associated with
impaired performance but the long term consequences to the
health and well being of horses are unknown. We assessed the
association between severity of EIPH and duration of racing
career in Thoroughbred race horses. Tracheobronchoscopic
examinations were performed during 2003 on 744 Thoroughbred
horses within 2 hours after completing a race and the severity of
exercise-induced pulmonary hemorrhage recorded (Grades 0-4).
Race records of horses as of May 1st, 2011 were then reviewed
to determine the duration of the horse’s racing career. The asso-
ciation between duration of the racing career and age at enrol-
ment, sex (male or female), and severity of EIPH were evaluated
using survival analysis. All models included age and sex.
Median career durations were 18.7, 17.2, 16.3, 19.6 and 5.9
months for the 332, 273, 101, 25 and 13 horses with EIPH grades
0, 1, 2, 3 and 4 respectively. The hazard ratio for EIPH grade 
1 versus 0 was 1.07 (95%CI 0.9–1.2, P=0.37) and for EIPH
grade  2 versus  1 was 1.07 (0.9–1.3, P=0.45). Males had a
signiﬁcantly increased career duration (P<0.001) and increasing
age reduced the career duration (P<0.001). Hazard ratios for
EIPH 1, 2, 3, or 4 vs 0 were 1.05 (95%CI 0.9-1.2,P=0.53), 1.04
(0.8-1.3,P=0.74), 1.09 (0.7-1.6, P=0.67) and 2.06 (1.2-3.6,
P=0.011), respectively. Only the most severe EIPH was associ-
ated with reduced duration of racing career. This could be attrib-
utable to racing regulations which mandate a three month
withdrawal from racing for horses with EIPH and epistaxis and
disqualiﬁcation from racing after a second episode of EIPH with
epistaxis.
ABSTRACT E-6
HYPERBARIC OXYGEN THERAPY DOES NOT ALTER
mRNA INFLAMMATORY GENES EXPRESSION IN
HEALTHY HORSES. M Looijen1, R Dardari1, R Leguillette1,2.
1University of Calgary, Faculty of Veterinary Medicine, Calgary,
AB, Canada, 2Moore Equine Veterinary Centre, Calgary, AB,
Canada
Hyperbaric oxygen therapy (HBOT) induces an oxidative
stress over time that may alter the mRNA expression of inﬂam-
matory cytokines and housekeeping genes in lung cells of horses.
Identifying stable reference genes is necessary to obtain reliable
quantitative PCR (QPCR) results. Therefore, the objectives of
this study were 1) to identify the most stable reference genes in
the bronchoalveolar lavage ﬂuid (BALF) cells of horses treated
with HBOT and 2) to evaluate if Th1, Th2 or Th17 inﬂammatory
cytokines expression was increased in the BALF of the horses
treated with HBOT.
Eight horses were used in a randomized controlled cross-over
design. Treated horses were exposed to 100% oxygen at 3 ATA
for 20 minutes for 10 days whereas the chamber was not pressur-
ized for control horses. The mRNA expression of IL-1b, IL-4,
IL-5, IL-6, IL-8, IL-10, IL-12p35, IFN-c, TNF-a and Eotaxin-2
was measured by QPCR in BALF sampled pre- and post-HBOT
treatment. Genes’ expression was measured by QPCR after eﬃ-
ciency correction using REST software analysis. The expression
stability of four candidate reference genes (GAPDH, HPRT,
SDHA and RPL-32) was determined using Normﬁnder and Gen-
ormplus.
GAPDH was found to be the most stable reference gene using
both Genormplus and Normﬁnder. The number of reference genes
used for optimal normalisation included GAPDH and HPRT.
The mRNA expression of cytokines was not signiﬁcantly up- or
down- regulated with HBOT, however there was a signiﬁcant
down-regulation for Eotaxin-2 between the HBOT and the con-
trol group after HBOT.
ABSTRACT E-7
TEMPORAL VIRAL LOAD IN SEVEN HORSES WITH
NATURALLY OCCURRING EQUINE HERPESVIRUS-1
MYELOENCEPHALOPATHY. KE Estell, D Dawson,
KG Magdesian, S Mapes, E Swain, N Pusterla. School of
Veterinary Medicine, University of California, Davis, CA
The pathogenesis of equine herpesvirus-1 myeloencephalopa-
thy (EHM) is poorly understood and is likely a result of viral,
host, and environmental factors. It has been hypothesized that
the magnitude of viremia is a central factor in the development
and severity of EHM; however, temporal viral load has never
been reported in a naturally occurring cases. Additionally, prog-
nosis for grade 4/5 neurologic horses has not been reported. The
purpose of this case series is to report the clinical signs, treat-
ment, and temporal viral load in 7 horses with naturally occur-
ring EHM and examine these factors’ association with survival.
Seven horses with EHM presented to the UC Davis VMTH
between 5/13/11 and 9/20/11 and were associated with 3 separate
outbreaks. All horses were graded on presentation using the neu-
rologic grading scale. Out of 7 horses, 1 horse was grade 5/5, 3
horses were grade 4/5 and 3 horses were grade 3/5. All horses
received valacyclovir, ﬂunixin meglumine, DMSO, vitamin E,
and supportive care. Urinary incontinence was present in all
horses and was treated with bladder catheterization and antimi-
crobials for the duration of urinary catheterization. All horses
presenting with > grade 3/5 neurologic signs received dexameth-
asone and were maintained in the Anderson sling support device.
All 7 horses were infected with the D752 genotype of EHV-1.
Quantitative PCR was performed on nasal secretions and whole
blood collected at admission and every 24 hours until horses were
negative for >2 days, died, or were euthanized. Viral load was
quantiﬁed and expressed as glycoprotein B (gB) gene copies per
million cells. Peak viral load in nasal secretion of horses which
survived ranged from 6,187-281,102 gB gene copies per million
cells (median 5,179); peak viral load in blood was 143-4,338 gB
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gene copies per million cells (median 3,146). The 2 non-surviving
horses presented with grade 3/5 neurologic signs and progressed
rapidly to recumbency with signs of encephalopathy. Peak viral
load was considerably higher in non-survivors with levels in nasal
secretions of 192,019,861- 221,904,282 gB gene copies per million
cells (median 192,019,861) and levels in blood of 20,467-102,491
gB gene copies per million cells (median 47,359). All horses that
survived showed cessation of viral shedding in nasal secretions by
day 5 of hospitalization.
Overall mortality rate was 28.6% (2/7). All horses that did not
develop encephalopathy survived. We hypothesize that the mag-
nitude of viral load is associated with outcome. Non-survivors
had viral loads that were 1000-fold higher in nasal secretions and
10-fold higher in blood than non-survivors. There was no rela-
tionship between severity of clinical signs at presentation with
survival, emphasizing the value of supportive care including man-
agement in a sling if necessary.
ABSTRACT E-8
INVESTIGATION OF THE ROLE OF MULES DURING AN
OUTBREAK OF EQUINE HERPESVIRUS-1 MYELOENCE-
PHALOPATHY IN CALIFORNIA. N Pusterla, S Mapes,
C Wademan, A White, K Estell, E Swain. School of Veterinary
Medicine, University of California, Davis, CA
Although all breeds of horses are susceptible to the neuro-
logic form of EHV-1 infection, the authors are unaware of
reports of neurologic EHV-1 clinically aﬀecting donkeys and
mules. However, donkeys and mules have shown seroconversion
indicating infection with EHV-1 while in contact with aﬀected
horses during outbreaks. The goal of this study was to investi-
gate the role of mules as possible silent shedders during an out-
break of EHM.
In early September of 2011, an EHV-1 outbreak with several
neurologic horses occurred at a packing station located in the
eastern Sierra of California. The packing station was visited with
the goal to assess the clinical status and exposure rate of the resi-
dent horses and mules. Using appropriate biosecurity measures, a
physical evaluation was performed followed by the collection of
whole blood and nasal secretions for the quantitative PCR and
serological detection of EHV-1.
A total of 141 horses and mules were evaluated during the
visit. There were 82 horses and 59 mules ranging in age from 3
to 30 years (median 12 years). On the day of the visit a total of 5
additional horses showed neurological deﬁcits. Fifty-six horses or
mules (39.7%) tested PCR positive for the EHV-1 gB and the
ORF 30 (D752) gene in blood (13 animals), nasal secretions (24)
or both (19). The viral load determined by PCR in blood and
nasal secretions ranged from 27 to 8,542 gB gene copies/million
cells (median 443 gB gene copies/million cells) and from 66 to 3.5
x 106gB gene copies/million cells (median 2,485 gB gene copies/
million cells), respectively. In an attempt to determine statistical
diﬀerences in viral loads, the PCR positive horses and mules were
grouped into asymptomatic horses (27 animals), asymptomatic
mules (24) and horses with neurological signs (6). The viral loads
in blood were signiﬁcantly diﬀerent between the three groups
(Wilcoxon-Mann-Whitney tests; P < 0.05) with asymptomatic
horses having the lowest viral loads and neurologic horses show-
ing the highest viral loads. For nasal secretions, asymptomatic
mules had signiﬁcantly higher viral loads in nasal secretions (P
< 0.05) compared to asymptomatic horses. A total of 33/141
(23.4%) horses and mules tested seropositive for EHV-1. Based
on combined molecular and serological testing 48/82 (58.5%)
horses and 32/59 (54.2%) mules had evidence of EHV-1
exposure.
The results of this study showed that equal percentages of
horses and mules became exposed to EHV-1 during an EHM
outbreak; however, neurological disease was only reported in
horses. Mules seem to be protected from the development of neu-
rological signs by means yet to be determined. However, the
molecular and serological results support the role of mules as
silent shedders, highlighting the need to institute appropriate bio-
security protocols when horses and mules are comingled.
ABSTRACT E-9
EQUINE SALMONELLOSIS. THE USE OF AN ENHANCED
RAPID TEST SYSTEM (REVEAL®2.0 SALMONELLA TEST
SYSTEM) FOR EARLY DETECTION OF SALMONELLA IN
FECES AND ENVIRONMENTAL SAMPLES. N Slovis4,
J Elam. Hagyard Equine Medical Institute, Lexington, KY
In veterinary medicine, a rapid, inexpensive and accurate diag-
nosis of horses infected with Salmonella spp. is important, so
that necessary control and preventative measures can be imple-
mented to reduce the risk of disease transmission to other horses
or personnel. Conventional diagnosis of Salmonella spp. is con-
ducted by testing fecal samples using bacteriologic procedures in
the laboratory. However, it can take up to 3 to 5 days to obtain
laboratory results. Several studies have developed PCR tests for
detection of Salmonella spp. in fecal and environmental samples
but there is evidence of an increased frequency of Salmonella-
PCR positive results in horses without clinical signs of salmonel-
losis that test negative to Salmonella spp by culture on multiple
fecal samples, perhaps due to the use of primers targeting a non-
speciﬁc Salmonella spp gene fragment that may cross-react with
other enteric or non-enteric organisms. The objective of the study
is to assess the diagnostic accuracy of an enhanced rapid test sys-
tem (Reveal ® 2.0 Salmonella test system) for the detection of
Salmonella spp. in fecal and environmental samples, compared to
bacteriological culture identiﬁcation.
The samples were initially plated to a hektoen agar and inocu-
lated in a selenite broth. After 24 hours, the hektoen agar was exam-
ined for black or green colonies. The selenite broth was subbed to a
hektoen agar, incubated for 24 hours and then examined for black
or green colonies. The Reveal ®test would be performed on any
black or green colonies found on either hektoen agar.
Our lab has performed 810 Reveal® tests on suspicious cul-
tures from January 16, 2010 to December 31, 2011. There were
150 Reveal® positive samples and 660 negative samples. There
was 100% correlation (100% sensitivity and 100% speciﬁcity) of
the Reveal® test results to the BBL Crystal identiﬁcation results.
The Reveal ®test has been shown in our lab to save 24 hour
to 48 hours in notifying the veterinarian of a positive Salmonella
culture.
Further studies are warranted with the Reveal ® test system
on Selenite broths. If similar correlations are noted with the
broths then Salmonella results may be able to be obtained in a
24 hour turnaround time.
ABSTRACT E-10
ANTIMICROBIAL SUSCEPTIBILITY OF SALMONELLA
ISOLATES OBTAINED FROM HORSES IN THE NORTH-
EASTERN UNITED STATES (2001-2010). GA Perkins1,
KJ Cummings1,2, SM Khatibzadah1, J Stiler1, LD Warnick1,
C Altier1. 1Cornell University, Ithaca, NY, 2Texas A&M
University, College Station, TX
The objectives of this study were to describe the antimicrobial
resistance status of equine Salmonella isolates recently cultured in
the northeastern U.S. and to identify trends in resistance over time.
Data were collected retrospectively for all equine Salmonella
isolates with antimicrobial minimum inhibitory concentrations
(MICs) that were isolated at the Cornell University Animal
Health Diagnostic Center from January 1, 2001 to December 31,
2010. MICs of isolates were determined using the microbroth
dilution method (TREK Sensititre).
A total of 459 equine Salmonella isolates with antimicrobial
susceptibility testing were retrieved (median of 45 isolates per
year; range 20- 83). The majority of isolates were from clinical
submissions (feces) either from regional veterinarians or the Cor-
nell University Hospital for Animals. Most isolates (98.4-100%)
were susceptible to amikacin, enroﬂoxacin and imipenem. Indi-
vidual Cochran-Armitage tests showed a signiﬁcantly decreasing
trend over time (p  0.005) in prevalence of resistance to amoxi-
cillin/clavulanic acid (AUG), ampicillin (AMP), cefazolin, cefoxi-
tin (FOX), ceftiofur (TIO), chloramphenicol (CHL) and
tetracycline (TET). Increasing resistance was not found for any
of the 16 antimicrobials tested. There were 380 isolates that
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tested nine available National Antimicrobial Resistance Monitor-
ing System panel drugs. The most common resistance patterns
were pan-susceptible (38.2%), AUG-AMP-FOX-TIO-CHL-TET
(16.6%), AUG-AMP-FOX-TIO-CHL-TET-Timethoprim/sulfa-
methoxazole (SXT) (12.4%), AUG-AMP-FOX-TIO-CHL-TET-
SXT-Gentamicin (GEN) (11.3%), and AMP-TIO-CHL-TET-
SXT-GEN (7.6%).
Judicious use of ﬂuoroquinolones would be appropriate for
the treatment of severe salmonellosis in horses in the northeast-
ern U.S. These results suggest that the emergence and dissemina-
tion of resistant Salmonella isolates is complex and may not be
related to overall antimicrobial use.
ABSTRACT E-11
ROLE OF INTRAOCULAR BACTERIAL INFECTIONS IN
HORSES WITH RECURRENT UVEITIS IN LOUISIANA.
F Polle, RT Carter. School of Veterinary Medicine, Louisiana
State University, Baton Rouge, LA
To investigate the role of intraocular bacterial infections in
horses with Equine Recurrent Uveitis (ERU), eyes were harvested
from donated horses with a history and ocular ﬁndings consistent
with chronic ERU. Additionally, eyes were collected from horses
with normal ophthalmic examinations as a control group. Blood
samples were obtained for Leptospira serology using microscopic
agglutination test (MAT). Following euthanasia, aqueous and
vitreous humor samples were aseptically obtained and submitted
for aerobic culture and Leptospira culture, PCR and MAT.
Twenty-one control horses (41 eyes) and 15 ERU horses (27
eyes) were available for study. Serology results were available for
35/36 horses: 16/21 control and 13/14 aﬀected horses were posi-
tive for at least one serovar; Bratislava was the most common
serovar for both groups. Bacillus sp. was cultured from one con-
trol eye; Streptococcus sp. (n=1) and Leptospira (n=1) from two
eyes with ERU. PCR results were positive in 10/27 (37%) eyes
from horses diagnosed with uveitis; no control horses were posi-
tive by PCR. MAT was positive for 20/26 tested eyes (77%) with
uveitis and 1/41 (2.4%) of normal eyes. PCR and MAT results
were in agreement for 55/67 (83%) of eyes sampled. Horses with
ERU had a high prevalence of Leptospira infection based on
PCR and MAT results from intraocular ﬂuids compared to con-
trols. Leptospira infection should be considered as a cause of
ERU in Louisiana. The diagnosis of these intraocular infections
was not aided by serology and required speciﬁc, invasive sam-
pling of the ocular ﬂuids.
ABSTRACT E-12
GENETIC DETERMINANTS OF MELANOMA SUSCEPTI-
BILITY IN GRAY HORSES. R Teixeira1, M McCue1,
S Anderson2, D Sigler3, B Buchanan4, B Coleman5,
J Mickelson2. 1Veterinary Population Medicine, 2Veterinary
Biomedical Science, University of Minnesota. St Paul, MN,
3Department of Animal Science, Texas A & M University,
College Station, TX, 4Navasota, TX, 5Department of Animal
Science, University of Kentucky, Lexington, KY
A correlation between the gray coat color and melanoma
development has long been recognized with up to 80% of gray
horses older than 15 years developing melanoma. Both graying
and melanoma formation have been linked to a duplication in
the Syntaxin 17 (STX17) gene, with the STX17 genotype aﬀect-
ing melanoma grade and severity in the Lipizzaner breed. An
ASIP mutation, responsible for bay/black coat color modiﬁes
melanoma risk in gray horses, with increased melanoma severity
potentially due to an increase in MC1R pathway signaling. We
have identiﬁed a population of gray Quarter Horses (QH) that
appear to have a decreased melanoma risk. Dermal melanoma is
very low to non-existent is some pedigrees, suggesting there are
other genetic inﬂuences in addition to gray coat color that play a
role in melanoma development. The reason for the decreased
incidence of melanoma in these horses is unclear, however based
on the importance of increased MC1R signaling in melanoma
susceptibility with the ASIP mutation; we believe that the cellular
mechanism responsible for decreased melanoma susceptibility
may also involve this pathway. The objective of this study was to
determine if the decreased incidence of melanoma in gray QH
was related to decreased MC1R signaling resulting from the
MC1R chestnut coat color allele
318 gray QH (Age: 1 to 33 years old; Mean age: 9 years old)
were phenotyped for melanoma (scale 0 to 4; 0= no melanomas,
4= ulcerated/metastatic melanomas). In this cohort, mean mela-
noma grade was 0.38 and the incidence was 16.9%, compared to
incidences of 50% and 31.4% in the Lipizzaner and Camargue
breeds, respectively. Further, melanoma incidence in QH older
than 15 years was lower (55.8 %) than published incidences in
Lipizzaner (75%) or Camargue (68%) horses older than 15 years.
291 horses were genotyped for MC1R, ASIP and STX17. Uni-
variate and multivariate regression analyses were performed to
determine the relationships between genotype and age with mela-
noma incidence and grade. Age was associated with melanoma
incidence and severity in both univariate and multivariate analy-
ses (p=2.0 x 10-16). However, no eﬀect of MC1R, ASIP or
STX17 genotypes was found in either analysis. Prior studies have
demonstrated that STX17 genotype is the major determinant of
melanoma grade, with homozygous horses being at a greater risk
of developing melanomas. In our cohort, only 15 (5%) of gray
horses were homozygous, resulting in poor statistical power to
demonstrate the eﬀect of STX17 genotype. Previous studies have
also shown that the ASIP mutation increases melanoma risk.
ASIP allele frequency in our study was low (8.7%), resulting in
poor statistical power to detect an eﬀect of ASIP genotype. Our
ﬁndings conﬁrm a low incidence and severity of melanoma and a
high frequency of the MC1R mutation (58.7%) in our gray QH
population. Further work is needed to determine if the decreased
incidence and severity of melanoma in gray QHs is due to infre-
quent STX17 homozygosity and/or low ASIP frequency, or due
to other genetic factors.
ABSTRACT E-13
EFFECT OF BODY POSITION ON ABDOMINAL PRES-
SURES IN ADULT HORSES. VHL Scott, JL Williams,
MC Mudge, SDA Hurcombe. The Ohio State University,
Columbus, OH
Accurate interpretation of intra-abdominal pressure (IAP) is
essential in documenting intra-abdominal hypertension; a signiﬁ-
cant cause of morbidity in critically ill humans, which has also
been described in horses with colic. Body position is known to
alter intra-abdominal pressure (IAP) measurements in people,
leading to the development of standardized acquisition methodol-
ogies to minimize variability. To date, such information is lack-
ing in equine studies. The purpose of this study was to
investigate the eﬀect of body position on direct IAP (dIAP) and
abdominal perfusion pressure (APP) in normal adult horses.
Nine healthy adult horses were included and a standardized
total intravenous anesthetic protocol was used to facilitate
patient positioning. dIAP via abdominal cannulation and elec-
tronic sphygmomanometry was measured from the left ﬂank
(LFl), right ﬂank (RFl) and ventral (V) abdomen with horses
randomly positioned into left lateral (LLR), right lateral (RLR)
and dorsal recumbencies (DR). Direct mean arterial blood pres-
sure (MAP) was obtained concurrently to calculate APP (MAP -
IAP). Horses were placed in each recumbency twice, repeatability
assessed and mean values of IAP/MAP/APP measured in tripli-
cate were used for statistical analysis. Diﬀerences in IAP/MAP/
APP at speciﬁc sites for each body position were assessed by
paired t-tests or repeated measures ANOVA. P<0.05 was signiﬁ-
cant.
Ventrum dIAP was signiﬁcantly lower with horses in DR (-7
mmHg) compared to values obtained in LLR or RLR (11 mmHg
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and 13 mmHg respectively); P<0.0001. Ventrum APP was not
diﬀerent with horses in all 3 recumbencies (DR = 76 mmHg,
LLR = 80 mmHg, RLR = 72 mmHg). MAP was signiﬁcantly
lower when horses were positioned in DR (69 mmHg) compared
to LLR or RLR (83 mmHg and 94 mmHg respectively);
P<0.0001. LFl dIAP was signiﬁcantly lower (-5 mmHg) and
APP signiﬁcantly higher (100 mmHg) with horses in RLR com-
pared to DR (15 mmHg and 54 mmHg respectively); P<0.0001
for both dIAP and APP. RFl dIAP was signiﬁcantly lower (-8
mmHg; P<0.001) and APP signiﬁcantly higher (91 mmHg;
P=0.002) with horses in LLR compared to DR (15 mmHg and
55 mmHg respectively)
Body position directly aﬀects intra-abdominal and hemody-
namic pressures. These eﬀects should be considered when evalu-
ating abdominal pressure proﬁles and visceral perfusion in
horses.
ABSTRACT E-14
VOLUME OF DISTENDED SMALL INTESTINE AND
IONIC COMPSITION OF GASTRIC REFLUX AND SMALL
INTESTINAL FLUID IN HORSES. HC Schott II. Michigan
State University College of Veterinary Medicine, East Lansing,
MI
Distension of the small intestine (SI) is a common ﬁnding in
horses with obstructive disorders, duodenitis-jejunitis, and post-
operative ileus. Removal of ﬂuid accumulated in the stomach,
largely SI secretions, via a nasogastric tube is an essential part of
management of aﬀected horses and can result in substantial ﬂuid
and electrolyte losses. There is little published data on the quanti-
tative amount of water and electrolyte losses that may be lost
through nasogastric reﬂux or with surgical resection of devital-
ized and distended SI. The purpose of this study was to deter-
mine the volume of water that would cause distension of the
duodenum and various lengths of jejunum to 6-7 cm diameter as
well as the concentration of electrolytes in normal SI ingesta,
nasogastric reﬂux ﬂuid from horses with colic, or ﬂuid in dis-
tended SI collected from horses undergoing surgical resection of
devitalized SI. First, various lengths (7 to 45 feet) of healthy SI
were collected immediately following euthanasia from 15 horses
that did not have colic signs and warm (~30oC) water was slowly
infused to distend the SI to a diameter of 6-7 cm. Water was then
drained from the SI and volumes were measured (± 0.5 L) and
correlated to the length of the SI that was distended. Second,
Na+, K+, and Cl- concentrations were measured in 23 intestinal
ﬂuid samples (10 SI ingesta samples collected from healthy
horses, 11 initial spontaneous gastric reﬂux samples, and 2 SI
ﬂuid samples collected during surgery). Correlation analysis
revealed that healthy SI is able to hold 0.81 L/foot of warm
water (r=0.92, p<0.01, n=15). Concentrations of Na+, K+,

































Concentrations of Na+ were lower (p<0.01) and Cl- greater
(p<0.03) in nasogastric reﬂux ﬂuid than in normal SI ingesta or
ﬂuid collected from distended SI at surgery. These data can be
used to estimate the magnitude of water and electrolyte losses
that may occur with SI disorders in order to implement appropri-
ate ﬂuid therapy plans for aﬀected horses.
ABSTRACT E-15
PREVALENCE AND RISK FACTORS FOR ULCERATION
OF THE GASTRIC GLANDULAR MUCOSA IN THOR-
OUGHBRED RACEHORSES IN TRAINING IN THE UK
AND AUSTRALIA. JL Habershon-Butcher1, GD Hallowell1,
IM Bowen1, B Sykes2. 1School of Veterinary Medicine and
Science, University of Nottingham, UK, 2Upper Orara, NSW,
Australia
Equine gastric ulcer syndrome is a common clinical condition
which can cause poor performance in racing Thoroughbreds
worldwide. Although squamous gastric ulceration has been
widely studied, evaluation of the prevalence and risk factors for
glandular ulcers has not. The study was performed to determine
the prevalence of ulceration in the glandular and pyloric regions
in Thoroughbred racehorses in training in the UK and Australia
(AUS) and identify associated risk factors. 113 horses from 3
training yards in the UK and 5 training yards in AUS were stud-
ied. Gastroscopy was performed on each horse after a period of
starvation and under sedation. All squamous, glandular and
pyloric regions were assessed for evidence of ulcers. Ulcers were
scored 0 to 4 depending on severity (EGUS Council System). A
comprehensive questionnaire which included signalment, detailed
information regarding training, feeding, general management
practice, racing results, recent medication administration and any
previous veterinary history was completed by the trainer for each
horse. Univariable logistic regression analyses and then multivari-
able mixed eﬀect logistic regression models were built in a step-
wise fashion to identify risk factors for glandular and squamous
gastric ulceration. Signiﬁcance was assumed as p<0.05.
The overall prevalence of glandular ulceration was 50.4%,
squamous ulceration was 73.5% and horses with both squamous
and glandular ulceration was 39.8%. There was a signiﬁcant rela-
tionship between glandular and squamous scores (p<0.001).
Horses in AUS had a higher prevalence of glandular ulceration
than those in the UK (p<0.001). The prevalence of squamous
ulceration was not diﬀerent between the UK and AUS horses
(p=0.32). Risk factors for glandular ulceration were gender
(p<0.01; colts were less likely to have ulcers than mares or geld-
ings), trainer (p<0.001), no grass turnout (p<0.006), horses in
direct contact with each other (p<0.001), horses not fed haylage
(p<0.002), horses fed unprocessed grain (p<0.003), horses that
were infrequently fed a complete diet (p<0.001), horses that
underwent fast exercise on fewer days of the week (p<0.001) and
that went swimming (p<0.001). Fewer risk factors were identiﬁed
for squamous ulceration. Increased squamous ulcer prevalence
was noted in horses in work for a longer period of time (p<0.048;
this was not observed for glandular ulceration (p=0.54)). A lower
prevalence of squamous ulceration was also noted in horses
aggressive towards humans (p<0.01). In conclusion, many risk
factors were identiﬁed pertaining to glandular ulceration; these
were diﬀerent to those for squamous ulceration. The strong associ-
ation between the concurrent presence of squamous and glandular
ulcers has not previously been reported nor have any the regional
diﬀerences in glandular ulceration prevalence.
ABSTRACT E-16
REGULATION OF HYPOXIA INDUCIBLE FACTOR-
1A AND RELATED GENES IN THE EQUINE KERATINO-
CYTE AND DIGITAL LAMINAE IN EXPERIMENTAL
MODELS OF EQUINE LAMINITIS. EA Pawlak1, RJ Geor2,
PJ Johnson3, SJ Black1, TA Burns4, MR Watts4, JK Belknap4.
1University of Massachusetts, Amherst, MA, 2Michigan State
University, East Lansing, MI, 3University of Missouri,
Columbia, MO. 4. Ohio State University, Columbus, OH
Hypoxia inducible factor-1 alpha (HIF-1A) is a central protein
in the cellular response to both hypoxia and inﬂammatory signal-
ing (i.e. NF B activation via TLR4 signaling). Increased cellular
HIF-1A concentrations, occurring most commonly from either
increased transcription or decreased proteosomal degradation,
lead to the induction of HIF-1A-responsive genes. Hypoxia alone
can induce a HIF-1A-mediated increase in genes involved in
energy regulation (e.g. glucose transporter 1 [GLUT1], phospho-
glycerokinase-1[PGK1]) whereas NFkB activation is reported to
induce a HIF-1A-mediated increase in inﬂammatory genes (e.g.
nitric oxide synthase-2 [NOS2] and cyclooxygenase-2 [COX-2]).
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Because of the implication of hypoxic and inﬂammatory events
in the pathogenesis of equine laminitis and the speciﬁc impor-
tance of the basal epidermal keratinocyte in maintaining lamellar
function, this study sought to determine the regulation of HIF-
1A and HIF-1A-responsive genes in both equine keratinocytes
and the equine digital lamina as a whole. Immunochemistry
(HIF-1A), and real time-quantitative PCR (HIF-1A, GLUT1,
PGK1, NOS2, COX-2) were used to assess gene/protein regula-
tion in 1) cultured equine keratinocytes (skin) exposed to LPS at
either normoxic or hypoxic (3%O2) conditions and 2) laminar
sections from control animals (CON) and animals at develop-
mental (DEV) and Obel grade 1 lameness (OG1) time points in
the carbohydrate and black walnut extract models of laminitis.
The laminar keratinocyte was the primary cell type positive for
HIF-1A via tissue immunoﬂuorescence, indicating that, similar to
skin keratinocytes, the laminar keratinocyte exists in a hypoxic
environment. Hypoxic cultured keratinocytes underwent marked
increases in cellular concentrations of HIF-1A protein with no
change in mRNA concentration. Unlike that reported in many
cell types, LPS exposure did not result in increased HIF-1A con-
centrations in normoxic cultured keratinocytes. Hypoxia alone
resulted in increased mRNA concentrations (p<0.05) of GLUT1
only; however, exposure of hypoxic cells to LPS resulted in
increased mRNA concentrations (p<0.05) of COX-2 and NOS2.
Laminar HIF-1A protein concentrations were only increased in
the CHO model at the OG1 time point (vs CON, p<0.05);
increased laminar mRNA concentrations were present at DEV
and OG1 time points for COX-2 and NOS2 (p<0.05, no changes
occurred in HIF-1A, VEGF, PGK1, or GLUT1 mRNA concen-
trations). In conclusion, these results indicate that HIF-1A is nor-
mally present in the laminar keratinocyte due to the cell
constantly being in a slightly hypoxic state, and that increases in
HIF-1A and in NF B-responsive HIF-1A related genes (COX-2
and NOS2) in aﬀected laminae in models of laminitis are likely
due to a TLR-related induction of NF B signaling resulting in a
synergistic increase in inﬂammatory genes which are responsive
to both HIF-1A and NF B signaling.
ABSTRACT E-17
LAMINAR INFLAMMATORY EVENTS IN LEAN AND
OBESE PONIES SUBJECTED TO HIGH CARBOHYDRATE
FEEDING: IMPLICATIONS FOR PASTURE-ASSOCIATED
LAMINITIS. TA Burns1, MR Watts1, RJ Geor2,
LJ McCutcheon2, JK Belknap1. 1College of Veterinary Medicine,
The Ohio State University, Columbus, OH, 2College of Veterinary
Medicine, Michigan State University, East Lansing, MI
A robust laminar inﬂammatory response, including leukocyte
inﬁltration and inﬂammatory mediator expression, has been well-
characterized in laminitis induced by black walnut extract or ent-
eral carbohydrate overload. Although inﬂammation has been
proposed to also play a role in laminitis associated with equine
metabolic syndrome, it has not been critically evaluated. The pur-
pose of this study was to characterize the expression of inﬂam-
matory genes and leukocyte inﬁltration in digital laminar tissue
of ponies subjected to a dietary carbohydrate challenge designed
to mimic abrupt exposure to pasture rich in nonstructural carbo-
hydrate (NSC). Following 4 weeks of conditioning consisting of
a diet of hay chop (NSC ~6% on a DM basis), mixed-breed
ponies (body weight 270.9 +/- 74.4 kg) were assigned to groups
based on body condition scoring (lean vs. obese). Ponies either
remained on the conditioning diet (CON diet; n=5 obese, n=5
lean) or received the same diet supplemented with sweet feed and
oligofructose (CHO diet [~42% NSC]; n=6 obese, n=6 lean) for
a period of 7 days. At the end of the feeding protocol, dorsal dig-
ital laminar tissue samples were collected immediately following
euthanasia; samples were formalin-ﬁxed or snap frozen. Laminar
immunohistochemistry was performed for CD163 and MAC387/
calprotectin using commercially-available antibodies; the number
of immunopositive cells was quantiﬁed at 40x magniﬁcation (n
= 10 ﬁelds) for each section by a blinded observer. Real-time-
quantitative PCR was used to assess laminar mRNA concentra-
tions of pro-inﬂammatory cytokine/chemokine genes (TNFa, IL-
1b, IL-6, IL-8, MCP-1, MCP-2) and COX-2. There was no eﬀect
of diet or body condition on the number of laminar CD163(+)
or MAC387(+) cells (p >0.05); very few laminar MAC387+
cells were present in any group. There was no diﬀerence in the
laminar mRNA concentrations of TNFa (p = 0.92), IL-1b (p =
0.18), IL-6 (p = 0.28), IL-8 (p = 0.21), MCP-1 (p = 0.25), or
MCP-2 (p = 0.67); however, laminar mRNA concentrations of
COX-2 (p = 0.01) were increased in ponies fed a high-CHO diet
(vs. CON diet). These results suggest that the primary inﬂamma-
tory events occurring in the marked inﬂammatory response
reported in sepsis models of laminitis, leukocyte inﬁltration and
proinﬂammatory cytokine/chemokine expression, are not central
events in EMS-associated laminitis. As laminar COX-2 expres-
sion has been primarily localized to vascular wall components
(endothelium and smooth muscle) and laminar keratinocytes in
the normal and laminitic equid in previous reports, the increased
laminar mRNA concentrations of COX-2 in this study may
reﬂect laminar epithelial dysfunction and/or vascular pathology
in the aﬀected laminae. Ongoing immunolocalization studies
will further clarify the cellular origin of the increased COX-2
expression.
ABSTRACT E-18
ABSENCE OF OXIDATIVE STRESS IN THE SKELETAL
MUSCLE OF OBESE HORSES. HE Banse1, D McFarlane1,
N Frank2. 1Oklahoma State University Center for Veterinary
Health Sciences, Stillwater, OK, 2Tufts University School of
Veterinary Medicine, North Grafton, MA
Obesity in people is associated with insulin resistance. In
horses, obesity is associated with insulin resistance and the devel-
opment of laminitis. In people, obesity is associated with
increased cellular reactive oxygen species production and local
(tissue) and systemic oxidative stress. Increased ROS may inter-
fere with insulin signaling, resulting in insulin resistance. How-
ever, measurements of systemic markers of oxidative stress in
obese horses have not demonstrated alterations in redox status.
Our objective was to determine the relationship between obesity
and oxidative stress in skeletal muscle of horses. We hypothesized
that obese horses have increased oxidative stress in skeletal mus-
cle compared with non-obese horses, as demonstrated by an
increase in thiobarbituric acid reactive substances (TBARS) and
compensatory increase in antioxidant gene expression.
Thirteen light breed horses, 2-24 years of age with a body con-
dition score (BCS) ranging from 4-9 were included. Plasma insu-
lin concentrations were quantiﬁed via ELISA. RNA was isolated
from biopsy samples of the semi-membranosus muscle for analy-
sis of gene expression. Relative expression of the antioxidant
genes, catalase, glutathione synthase, glutathione reductase, glu-
tathione peroxidase, periredoxin, and manganese superoxide
dismutase was determined in skeletal muscle by quantitative poly-
merase chain reaction (qPCR). TBARS were quantiﬁed in plasma
and muscle using a commercially available kit. Non-normal data
was log transformed for analysis. A Pearson’s coeﬃcient of corre-
lation was calculated for body condition score, insulin concentra-
tion, gene expression and TBARS. Muscle TBARS were
decreased in obese (BCS>7; n=7) compared to non-obese
(BCS<5; n=6) horses (0.44±0.08 versus 1.41 ±0.26 nmol/mg).
Body condition score was negatively correlated with tissue
TBARS (r=-0.56) but not plasma TBARS (r=-0.07). Plasma
and muscle TBARS were not correlated (r=0.12). There was a
negative correlation between tissue TBARS and plasma insulin (-
0.56) which approached signiﬁcance (p=0.06). Antioxidant gene
expression was not correlated with body condition score or insu-
lin concentration.
Obese horses demonstrated a decrease in oxidative stress
within skeletal muscle, which was not in support of our hypothe-
sis. These ﬁndings indicate that obesity in horses, unlike in peo-
ple, is not associated with increased reactive oxygen species
production. Further investigation into the cellular mechanism of
insulin resistance in the horse is warranted.
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ABSTRACT E-19
THE EFFECTS OF EXPERIMENTALLY INDUCED HYPER-
GLYCEMIA AND ENDOTOXEMIA ON COAGULATION
PARAMETERS IN HEALTHY ADULT HORSES.
KF McGovern1, KM Lascola1, SA Smith2, PA Wilkins1,
SC Clark-Price1, JH Foreman1. 1College of Veterinary Medicine,
Urbana, IL, 2College of Medicine, Urbana, IL
Hyperglycemia and endotoxemia have been independently
associated with equine coagulation abnormalities. Experimental
studies suggest a greater impact of hyperglycemia on coagulation
abnormalities with concurrent induction of endotoxemia. The
study purpose was to compare coagulation parameters in healthy
adult horses administered LPS with and without concurrent
induction of hyperglycemia.
Hyperglycemia (180-240 mg/dL) was maintained for 6 hours
in 6 healthy adult horses (Group 1) using 140mg/kg IV bolus
followed by 20% dextrose constant rate infusion (CRI). A simi-
lar volume of saline was administered to a further 6 adult
horses (Group 2). LPS (20ng/kg) was administered to each
horse. TNFa, white blood cell count, platelet count, ﬁbrinogen
concentration, prothrombin time (PT), activated partial throm-
boplastin time (aPTT), and thrombin anti-thrombin complex
level (TAT) were determined at baseline, 1,1.5,2,3,4,6 and 22h.
Thromboelastometry (TEM) parameters were determined at
baseline, 3,6 and 22h. Repeated Measure ANOVA and the
Friedman Rank Sum test were used to determine signiﬁcant dif-
ferences over time.
TNFa increased (p<0.001) in both groups. PT increased at 6
hours in Group 1 (p<0.001). For TEM, alpha angle (In-TEM
p=0.02; Ex-TEM p=0.006) and maximal clot ﬁrmness (Ex-TEM
p=0.009) decreased, and clot formation time (In-TEM p=0.003;
Ex-TEM p=0.001) increased at 3 hours in group 2. Increases in
TAT were identiﬁed in both groups but were not signiﬁcant.
Alterations in coagulation parameters were identiﬁed for both
groups in this study. Identiﬁed changes in markers of coagulation
diﬀered between groups. These results suggest that hypocoagula-
tion induced by exogenous endotoxin is not worsened, but rather
ameliorated, by concurrent hyperglycemia.
ABSTRACT E-20
EVALUATION OF HYPERCOAGULABILTY IN GERIATRIC
HORSES WITH/WITHOUT PITUITARY PARS INTERME-
DIA DYSFUNCTION. J Mahon1, MRParadis1, DM cFarlane2,
A Sanchez3, LL Price4, E Rozanski1, D Meola1,
AM deLaforcade1. 1Tufts Cummings School of Veterinary
Medicine, North Grafton, MA, 2Oklahoma State University,
Stillwater, OK, 3Tufts University Ambulatory Clinic, Woodstock,
CT and 4-Tufts Medical School, Boston, MA
Pituitary Pars Intermedia Dysfunction (PPID) is the most
common endocrine disorder in geriatric horses, and shares the
characteristic of increased ACTH with human and canine pitui-
tary dependent hyperadrenocorticism (PDH). PDH and aging (in
humans) has been associated with evidence of systemic hyperco-
agulability. The goal of this study was to determine if coagula-
tion status diﬀered between normal healthy horses, and geriatric
horses with and without PPID.
Healthy young and geriatric horses (> 20 years of age) and
PPID geriatric horses were recruited between May 15th and June
15th in 2010 and 2011. Horses were categorized as PPID by the
presence of hirsuitism, and if ACTH > 50 pg/mL and a-MSH
>35 pmol/dL. Horses were classiﬁed as normal based upon phe-
notype and an ACTH <35 pg/ml and a-MSH of <20 pmol/dl.
Kaolin-activated thromboelastography (TEG), prothrombin time
(PT), activated partial thromboplastin time (aPTT) and ﬁbrino-
gen (Fib C) were performed on all horses. T-tests were used to
compare normally distributed data and Mann-Whitney for non-
normally distributed data, with a p < 0.05 considered signiﬁcant.
Forty-four horses were screened for hirsuitism, and ACTH
and MSH levels. 12 were categorized as normal young horses, 8
as normal geriatric horses, and 13 as geriatric PPID horses. Ele-
ven horses had equivocal results and were not further evaluated.
There were no signiﬁcant diﬀerences in any TEG variable, ﬁbrin-
ogen or aPTT between young and geriatric horses, or healthy
and PPID geriatric horses. The PT in PPID horses was longer
than healthy geriatrics (18 ± 1.6 seconds versus 16.7 ±0.7 seconds;
p=0.03) but not clinically signiﬁcant. By study design, ACTH
and a-MSH were diﬀerent between groups (p<0.001). PPID geri-
atrics were older (p=0.02) than healthy geriatric horses. Older
horses and horses with PPID do not appear to develop systemic
evidence of hypercoagulability as evaluated by laboratory testing.
ABSTRACT E-21
RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (RAAS)
RESPONSE AND ACTH/ALDOSTERONE RATIO IN
SEPTIC NEWBORN FOALS. KA Dembek1, K Onasch1,
SD Hurcombe1, CW Kohn1, NM Slovis2, SM Reed3,
RE Toribio1. 1The Ohio State University, College of Veterinary
Medicine; Columbus, OH, USA, 2Hagyard Equine Medical
Institute, Lexington, KY, USA, 3Rood and Riddle Equine
Hospital, Lexington, KY, USA
Sepsis is a major cause of mortality in newborn foals. Dys-
function of the hypothalamic-pituitary-adrenal axis (HPAA),
manifested as relative adrenal insuﬃciency (RAI), has been asso-
ciated with sepsis in foals. The HPAA and RAAS are interactive
systems, and a relationship between RAAS activation and RAI is
well documented in critically ill children, but limited information
exists in septic foals. We hypothesized that in septic foals the
RAAS will be activated by inﬂammation and hypoperfusion and
the degree of activation will be associated with severity of sepsis
and mortality. We also proposed that ACTH will be associated
with aldosterone concentrations.
Blood samples were collected on admission from 49 septic
(sepsis score >12), 59 sick non-septic (SNS), and 20 healthy foals
of <3 days of median age. Blood concentrations of cortisol,
aldosterone, angiotensin-II (ANG-II), ACTH and plasma renin
activity were determined by immunoassays.
Aldosterone, ACTH and cortisol concentrations were higher in
septic and SNS compared to healthy foals. Septic foals had
higher ACTH/aldosterone and ACTH/cortisol ratios than healthy
foals. Nonsurviving septic foals had a higher ACTH/cortisol
ratio than survivors. No diﬀerences in renin activity and ANG-II
concentrations were found, but nonsurviving septic foals had
lower renin activity. Hyperkalemia and hypochloremia were cor-
related with hyperaldosteronemia. Hyperlactatemia was associ-
ated with aldosterone, cortisol and ACTH concentrations in
septic foals.
RAAS activation in critically ill foals is characterized by
increased aldosterone concentrations. The high ACTH/cortisol
and ACTH/aldosterone ratios in septic foals suggest that RAI
is not restricted to the zona fasciculata but also to the zona
glomerulosa.
ABSTRACT E-22
EFFECTS OF BLOOD CONTAMINATION ON PARAME-
TERS OF CEREBROSPINAL FLUID ANALYSIS. M Furr.
Equine Medical Center, Virginia-Maryland Regional College of
Veterinary Medicine, Leesburg, VA
Evaluation of cerebrospinal ﬂuid is a key component of the
examination of horses with neurologic disease. Contamination of
the sample by peripheral blood during collection is a recognized
complication of the procedure, and can compromise the assay of
the CSF. To date, it is unclear how to evaluate CSF with blood
contamination as the magnitude of the eﬀects have not been
quantiﬁed. The purpose of the study was to determine the eﬀects
of blood contamination on selected CSF parameters, and sec-
ondly to test a common correction equation for peripheral blood
contamination (i.e. proportionality of RBC to WBC counts in
whole blood).
To perform the experiment, peripheral blood from a normal
horse was diluted 1:2,000-1:10,000 with PBS and used to spike
normal CSF (N=6) to result in mean RBC counts of 34 to 1,450
RBC/ l. Following this, CSF was evaluated using conventional
clinical laboratory methods. To test the correction calculation,
pooled normal CSF with a WBC count of “0” was used. Aliqu-
ots of CSF (500 l) were spiked with WBCs resulting in a concen-
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tration of either 100 or 500 WBC/ l. CSF was then again spiked
with whole blood from healthy horses (N=6); samples were pre-
pared in duplicate and analyzed using routine clinical methods.
Procedures were approved by the Virginia Tech Institutional Ani-
mal Care Committee.
Results demonstrated that between a range of 0 and 1,450
RBC/ml CSF there was no obvious eﬀect upon WBC counts or
CSF total protein- these values remained unchanged from nor-
mal, uncontaminated CSF. Mean total protein was 40.8 mg/dl in
uncontaminated CSF and 52.9 mg/dl in the sample with the high-
est blood contamination (1,450 RBC/ l). WBC counts were 0
cells/ l in uncontaminated and 0.6 cells/ l in the sample with the
greatest blood contamination (RBC count 1,450 cells/ l). CSF
samples prepared with high WBC counts, then spiked with
peripheral blood demonstrated good correlation between actual
cell counts observed and that predicted by the correction equa-
tion. However, observed values diﬀered between –10 and + 30%
from that expected and a Bland-Altman plot demonstrated limits
of agreement up to 150 cells/ l, which was considered to be poor
performance.
The conclusions were that RBC contamination of CSF up to a
value of 1,500 RBC/ l does not alter resultant WBC or total pro-
tein values. RBC counts greater than 10,000 RBC/ l, however are
highly correlated with increasing TP and WBC numbers. Further,
the standard correction equation for RBC contamination of CSF
does not appear to be accurate enough to recommend its routine
clinical use.
ABSTRACT E-23
THE EPIDEMIOLOGY OF SHIVERS IN HORSES.
A Draper1, J Bender1, AM Firshman1, JD Baird2, S Reed3,
IJ Mayhew4, SJ Valberg1. 1College of Veterinary Medicine,
University of Minnesota, St Paul MN, 2Ontario Veterinary
College, Guelph, ON, Canada, 3Rood and Riddle Equine
Hospital, Lexington KY. 4. Massey University, Massey, New
Zealand
Shivers is a poorly deﬁned, chronic equine movement disorder.
This study sought to characterize the epidemiology of Shivers.
A standardized web-based survey was used to collect data on
signalment, onset, clinical signs, precipitating factors, eﬀect of
management, diet and therapies. A standardized video was
requested from owners, where possible. Shivers was deﬁned as
hyper-ﬂexion or -extension of the pelvic limbs during backwards
walking and manual hoof lifting. Diagnosis was conﬁrmed either
by video submission [V+], or by reported clinical signs without
video [V-]. Two matched case-controls were obtained from V+
owners that were normal, > 4 years old and in close proximity.
Analysis was by Chi2 analyses, p<0.05.
Responses included; V+ n=32, V- n=62, controls n=47. V
+ had signiﬁcantly more WBs, TBs and Draft breeds, taller
horses (>17hh) and males compared to the controls. Signs fre-
quently began at <10 years of age (V+ and V-). Clinical signs
in V+/V- horses included farrier problems (88%/91%), muscle
twitching (88%/84%), muscle wasting (44%/33%), weakness
(31%/22%) and exercise intolerance (25%/14%). Both groups
reported an improvement with increased turnout, exercise and a
low carbohydrate diet whereas NSAIDs, muscle relaxants, chiro-
practic and acupuncture therapy had minimal eﬀect. 50% of V+
horses showed worsening of clinical signs over time, and with
stress compared to V- horses.
In conclusion, Shivers often begins before 10 years of age, is
more common in male horses over 17hh, shows progressive signs
in 50% of cases and is best managed by increased turnout, regu-
lar exercise and a low carbohydrate diet.
ABSTRACT E-24
PROGNOSTIC FACTORS ASSOCIATED WITH SHORT-
TERM AND LONG-TERM OUTCOME IN HORSES WITH
CHRONIC RENAL FAILURE. N Nogradi, B Toth, MB
Whitcomb, R Riley, N Pusterla. William R. Pritchard Veterinary
Medical Teaching Hospital, University of California, Davis, CA
Chronic renal failure (CRF) is considered a devastating clinical
syndrome in horses, however prognostic factors have not been
determined. The objective of the present study was to describe
the most common clinical, clinicopathologic and utrasonographic
ﬁndings in horses diagnosed with chronic renal failure and to
reveal prognostic factors associated with short-term (discharge
from hospital) and long-term (12 months) survival.
Medical records of 58 horses diagnosed with CRF were
reviewed. Information on signalment, history, clinical examina-
tion ﬁndings, laboratory testing, renal ultrasonography and out-
come were collected. Long-term outcome was determined by
telephone interviews with owners. Statistical analysis included the
formulation of multivariate logistic regression models.
Thirty-eight horses (65.5%) were discharged from the hospi-
tal after diagnosis and initial treatment. Long-term follow up
was available for 24 cases and 14 horses were alive at 12
months after discharge. Both short-term and long-term non-
survivors had a signiﬁcantly higher serum creatinine and blood
urea nitrogen concentration when compared to survivors
(P<0.01 in both cases) and they more commonly had
decreased kidney size detected by ultrasound examination
(P=0.01 and P=0.02 respectively). Based on the results of the
multivariate logistic regression model, the serum creatinine con-
centration, the presence of hyponatremia and a decreased kid-
ney size on admission were associated with a negative short-
term outcome, while no factors were found to be associated
with long-term outcome.
Both laboratory and ultrasound ﬁndings are important to
assess short-term prognosis in horses with CRF, but admission
ﬁndings do not determine long-term outcome once the horse is
discharged form the hospital.
ABSTRACT E-25
IN VIVO ADMINISTRATION OF CPG ENHANCES FOAL
NEUTROPHIL FUNCTION. ND Cohen1, JR Nerren1,
AI Bordin1, CC Love1, CE Brake1, M Liu1, KR Kuskie1,
MH Kogut2. 1College of Veterinary Medicine and Biomedical
Sciences, Texas A&M University, College Station, TX, 2USDA-
ARS-sparcﬀsru, College Station, TX
Neonates are particularly dependent on innate immune
responses for protection against infection during early life
because of deﬁciencies in adaptive immunity. Neutrophils are
primary eﬀector cells of the innate immune response; however,
deﬁciencies in functional responses of neonatal neutrophils exist.
Consequently, enhancing neutrophil function in neonates might
help protect newborns against infectious diseases. The goal of
this project was to determine whether ex vivo neutrophil func-
tion of neonatal foals could be stimulated by in vivo administra-
tion of unmethylated CpG oligodeoxynucleotides, agonists for
Toll-like receptor 9 (TLR9). CpGs were administered IM to 9
foals on days 1 and 7 of life; an equal volume of saline was
administered IM to 9 control foals on days 1 and 7. Neutroph-
ils were isolated from blood collected from foals on days 1, 3,
7, 9, 14, and 28. Neutrophil degranulation was signiﬁcantly
(P<0.05) lower on days 3, 9, and 14 for CpG-treated foals
than for control foals. Neutrophils from CpG-treated foals
stimulated with Rhodococcus equi expressed signiﬁcantly greater
interferon-gamma (IFN-c) mRNA on days 3, 9, and 14 than
neutrophils from control foals; at age 28 days, there were no
signiﬁcant diﬀerences between treatment groups in expression of
IFN-c. Reactive oxygen species generation was not aﬀected by
CpG administration. Collectively these results suggest that
administration of CpG to neonatal foals may enhance neutro-
phil function during the ﬁrst fortnight of life. The increased
expression of IFN-c in response to stimulation may be of
particular importance because neonatal foals have been shown
to be IFN-c-deﬁcient at birth.
ABSTRACT E-26
EFFECT OF AGE ON THE PHARMACOKINETICS OF A
SINGLE DAILY DOSE OF GENTAMICIN SULPHATE IN
FOALS. AJ Burton1, S Gigue`re1, Y Al Hamhoom1, L Warner1,
RD Arnold1. 1University of Georgia, Athens, GA
Therapeutic drug monitoring in a small number of foals indi-
cates that the standard adult dose of 6.6 mg/kg q 24 h for genta-
micin is too low and a dose of 12 mg/kg has been proposed. The
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pharmacokinetics of this dosage in foals and the ages at which
this higher dose should be applied have not been investigated.
The objective of this study was to determine the eﬀect of age on
the pharmacokinetics of a single 12 mg/kg dose of gentamicin in
foals.
Six healthy foals were given a single IV dose of gentamicin at
ages 1-3 days, 2, 4, 8 and 12 weeks of age. Plasma concentrations
of gentamicin were measured using HPLC-MS. Pharmacokinetic
data were analyzed using a noncompartmental approach. Eﬀect
of age on each pharmacokinetic parameter was assessed using a
one-way ANOVA for repeated measures.
Gentamicin concentrations (mean +/- SD) 1 hour after
administration were signiﬁcantly higher at 8 (68.78 +/- 13.45 µg/
mL) and 12 (65.05 +/- 22.81µg/mL) weeks of age compared to
1-3 days (20.52 +/- 2.07 µg/mL). Trough concentrations were
signiﬁcantly lower at 4, 8 and 12 weeks of age (all < 0.78 µg/
mL) than at 1-3 days (1.97 +/- 0.90 µg/mL), consistent with a
signiﬁcantly longer elimination half-life in 1-3 day-old foals com-
pared to other ages. Eﬀect of age on AUC and clearance was not
statistically signiﬁcant.
These data indicate that age has a profound eﬀect on the
pharmacokinetics of gentamicin in foals and support the need for
a 12 mg/kg dose in neonatal foals.
ABSTRACT E-27
DEMONSTRATION OF ENDOGENOUS INFLAMMATORY
CYTOKINE PRODUCTION BY EQUINE ADRENOCORTI-
CAL TISSUE IN AN EX VIVO MODEL. KA Hart,
MH Barton, NA Norton, ML Vandenplas. Department of Large
Animal Medicine, University of Georgia College of Veterinary
Medicine, Athens, GA
Transient adrenal dysfunction characterized by inadequate
cortisol responses occurs in 40-60% of septic people and foals.
The pathogenesis of this critical illness-related corticosteroid
insuﬃciency (CIRCI) is unknown, but adrenocortical suppres-
sion mediated by inﬂammatory cytokines is believed to be key.
Human and bovine adrenocortical cells directly release inﬂam-
matory cytokines in response to bacterial endotoxin; this local
cytokine production might potentiate adrenal suppression and
CIRCI in patients with gram-negative sepsis. The objective of
this study was to determine if equine adrenocortical cells
directly release inﬂammatory cytokines in response to bacterial
endotoxin. Adrenal tissue was collected from 6 healthy horses
after euthanasia and adrenocortical explants were prepared,
cultured for 24 hours, and exposed to E. coli endotoxin (0.1-
10 ng/ml). Supernatants were collected after 1, 2, 4, 8, and 20
hours and assayed for IL-6, IL-10, and TNF-a by ELISA.
Cytokine production was expressed as ng/ml/g explant weight.
Data was analyzed with analysis-of-variance, with signiﬁcance
at P<0.05. IL-6, IL-10, and TNF-a production was observed
in control and treated explants, but IL-10 and TNF-a concen-
trations (peak mean concentrations 834.1±809.5 ng/ml/g and
694.0±489.1 ng/ml/g respectively) were higher than IL-6 con-
centrations (peak mean concentration 62.82±147.4 ng/ml/g).
Cytokine production was not signiﬁcantly diﬀerent between
treated and control explants, though a trend toward increased
TNF-a production in treated explants was observed. These
data illustrate endogenous cytokine production from equine
adrenocortical tissue, and suggest that the equine adrenal may
act as a local and systemic inﬂammatory organ. Further study
is needed to elucidate links between inﬂammation and equine
adrenal function.
ABSTRACT E-28
PROPIONATE AND OTHER METABOLITES IN HORSES
PUT ON PASTURE. ML Katz, DT Lewis. Veterinary & Animal
Sciences, University Massachusetts, Amherst, MA
Exposure to readily available grass carbohydrates (NFC) is
thought to be a stimulus for laminitis. This experiment exposes
horses to higher grass NFC after ingestion of long-term low
NFC hay, then to lower grass NFC after long-term ingestion of
high NFC hay.
Three miniature horses were fed nothing but ad-libitum ﬁrst-
cut hay plus a vitamin supplement at all times from 2009 through
2011 other than 10 days when on pasture. The same hay lot was
fed for at least 4 months prior to each experimental period. The
horses were sampled hourly over 2 days in August and 2 days in
October 2010 via jugular catheters, eating hay the ﬁrst day and
mixed grass pasture the next. The same horses were sampled
twice for 3 days each in both August and October 2011. The
2010 pasture contained at least twice the NFC as in the hay; the
2011 pasture contained ½ to 2/3 the NFC as in the hay. In both
years, October pasture contained signiﬁcantly more water than
did August pasture. [NFC as % dry matter in hay: 2010 = 8;
2011 = 23.5 // in pasture: 8/10 = 18.9; 10/10 = 18.9; 8/11 =
11.6; 10/11 = 16.4. H2O % in pasture: 8/10 = 60; 10/10 = 78;
8/11 = 54, 10/11 = 77.]
Glucose concentrations (GLUC) on hay averaged about 90
mg/dl in 2010 and 80 mg/dl in 2011. In 2010, GLUC rose to
120 mg/dl after 5-6h on pasture before returning to baseline.
In 2011, GLUC rose by a statistically signiﬁcant amount only
in the October samplings (5-15 mg/dl within 2.5h, soon return-
ing to baseline). Insulin concentrations were constantly low on
hay (<7 uIU/ml, mean = 4). Insulin mean concentrations in
2010 gradually rose on pasture to a peak of about 70 uIU/ml
(after 6h in August, 9h in October), then gradually decreased.
Insulin rose signiﬁcantly within 2h in both August 2011 ses-
sions, (peak 15 uIU/ml after 4h), then subsided. A similar
rapid increase occurred in October 2011 (peak 160 uIU/ml 1st
run; 70, 2d run), then subsided. Mean 2010 propionate concen-
tration (MPC) on hay was .08 mM in August and .06mM in
October. This rose immediately in both months and remained
elevated as long as the horses were on pasture (12h). The 2011
MPC on hay was .05-.06 mM, rising after 5h on pasture. Peak
MPC was reached after 24–26h on pasture. [1st August run =
.105 mM; 2d = .085mM; 1st October run = .09mM; 2d =
.115mM.] MPC decreased after 28 hours in all but the 1st
August run. Lactate and pyruvate concentrations revealed no
statistically signiﬁcant changes. However, the mean lactate/
pyruvate ratio (L/P) signiﬁcantly increased on pasture in both
years. Basal mean L/P was about 20 in 2010, increasing to 40
within 1h on pasture, and peaking at 70 by the end of the
sampling period (12 h). The 2011 basal level was about 25, ris-
ing to 35 by the 1st sampling in all pasture sessions. L/P/peak
values (35–50) were reached by 2.5h in the 1st Aug session and
by 5h in the other sessions. L/P remained only moderately ele-
vated thereafter and returned to baseline by Day 3 in all 2011
sessions.
ABSTRACT E-29
EFFECT OF DIETARY CARBOHYDRATE CHALLENGE ON
ACTIVATION OF 5’-ADENOSINE MONOPHOSPHATE
ACTIVATED PROTEIN KINASE (AMPK) IN LIVER,
SKELETAL MUSCLE, AND DIGITAL LAMINAE OF LEAN
AND OBESE PONIES. TA Burns1, MR Watts1, RJ Geor2, LJ
McCutcheon2, JK Belknap1. 1College of Veterinary Medicine, The
Ohio State University, Columbus, OH, 2College of Veterinary
Medicine, Michigan State University, East Lansing, MI
Systemic insulin resistance and hyperinsulinemia are pro-
posed to be important risk factors for laminitis associated with
equine metabolic syndrome (EMS) in horses and ponies.
AMPK, a highly conserved enzymatic regulator of cellular
energy status, has become a therapeutic target for human MS
and EMS due to its reported ability to increase systemic insu-
lin sensitivity. For example, the AMPK agonist metformin has
recently been used clinically to treat EMS-aﬀected equids.
However, regulation of AMPK activity in both 1) tissues pri-
marily responsible for insulin-mediated glucose disposal (liver,
skeletal muscle) and 2) the target tissue for injury in EMS-
related laminitis, the digital laminae, is largely unknown. The
purpose of this study was to characterize the cellular localiza-
tion and activation state of AMPK in liver, skeletal muscle,
and digital laminae of ponies subjected to a dietary carbohy-
drate challenge meant to mimic abrupt exposure to pasture
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rich in nonstructural carbohydrate (NSC). Following 4 weeks
of conditioning consisting of a diet of hay chop (NSC ~6% on
a DM basis), mixed-breed ponies (body weight 270.9 +/- 74.4
kg) were assigned to groups based on body condition scoring
(lean vs. obese). Ponies either remained on the conditioning
diet (CON diet; n=5 obese, n=5 lean) or received the same
diet supplemented with sweet feed and oligofructose (CHO diet
[~42% NSC]; n=6 obese, n=6 lean) for a period of 7 days.
At the end of the feeding protocol, samples of dorsal digital
laminae, middle gluteal muscle, and liver were collected imme-
diately following euthanasia; samples were formalin-ﬁxed or
snap frozen. AMPK was primarily localized to keratinocytes
and vascular elements in the laminae and hepatocytes (vs. local
vascular elements) in the liver via total AMPK immunohisto-
chemistry. Western blot analysis for phospho(P)-AMPK (indi-
cating activated AMPK) demonstrated decreased laminar P-
AMPK concentrations upon challenge with a high-carbohy-
drate diet (p = 0.01). In contrast, P-AMPK concentrations
were unchanged in skeletal muscle (p = 0.33), and there was
a trend for increased AMPK activation in the liver in obese
ponies in response to dietary CHO challenge (p = 0.13).
Unchanged or increased P-AMPK concentrations in the setting
of increased caloric intake suggest insulin resistance in skeletal
muscle and liver; the decreased laminar P-AMPK concentra-
tions with CHO challenge indicate that laminar tissue remains
insulin sensitive. In conclusion, whereas skeletal muscle and
liver are likely contributory to systemic insulin resistance and
resulting hyperinsulinemia in EMS, laminar dysfunction/injury
in EMS is more likely due to the local eﬀects of hyperinsulin-
emia, and not due to local insulin resistance/energy failure.
ABSTRACT E-30
REPEATABILITY OF THE COMBINED GLUCOSE AND
INSULIN TEST IN HORSES. J Bro¨jer, K Alvarsson,
J Hedenskog, K Nostell. Faculty of Veterinary Medicine and
Animal Sciences, Swedish University of Agricultural Sciences,
Sweden
The combined glucose-insulin test (CGIT) has been applied as
a dynamic test for insulin sensitivity in horses. However, there is
limited information on the reproducibility of the test. The object
of the study was thus to evaluate the repeatability of calculated
variables derived from the CGIT glucose and insulin curves in
horses.
Eighteen healthy horses (9 Icelandic horses and 9 Standard-
bred horses; age 6 – 20 years) underwent the CGIT on two occa-
sions with 3 weeks between the tests. The area under the glucose
and insulin vs. time curves (AUC-glu and AUC-ins), the duration
of the positive phase of the glucose curve (DPP-glu), and the
time duration to reach the insulin concentration 100 mU/L (DIC-
100) were determined. There were no signiﬁcant diﬀerences between
the two tests (p<0.05). The interday variation expressed as the
coeﬃcient of variation (CV) and intraclass correlation coeﬃcient
(ICC) were calculated. The CV and ICC was 14.6 % and 0.64 for
the AUC-glu and 7.7 % and 0.88 for the AUC-ins. The DPP-glu
had CV and ICC values of 44.9 % and 0.61, whereas the corre-
sponding values for DIC-100 were 7.0 % and 0.88.
When the CGIT is used as a diagnostic test to evaluate insulin
resistance, the patient is considered to be insulin resistant when
the DPP-glu > 45 min or the insulin concentration > 100 mU/L
at 45 min. However, the large CV and low ICC for DPP-glu in
the present study suggests that normal or impaired insulin sensi-
tivity should not be deﬁned solely on this parameter.
ABSTRACT E-31
DOPAMINE AND TYROSINE HYDROXYLASE CONCEN-
TRATIONS IN PARS INTERMEDIA TISSUE OF HORSES
WITH PITUITARY PARS INTERMEDIA DYSFUNCTION
WITH AND WITHOUT PERGOLIDE TREATMENT.
HC Schott II1, JS Patterson2, EB Howey2, MJ Benskey3,
JL Goudreau3, KJ Lookingland3. 1Department of Large Animal
Clinical Sciences; and 2Department of Pathobiology and
Diagnostic Investigation, College of Veterinary Medicine; and
3Department of Pharmacology and Toxicology, Neuroscience
Program; Michigan State University, East Lansing, MI
Pituitary pars intermedia dysfunction (PPID) develops slowly
over a period of years as degeneration of hypothalamic dopami-
nergic neurons leads to proliferation of pars intermedia (PI)
melanotropes through hyperplasia and adenoma formation. Fur-
ther, concentrations of dopamine (DA) and DA metabolites, as
well as tyrosine hydroxylase (TH) immunoreactivity, are mark-
edly reduced in PI tissue of PPID-aﬀected equids. Treatment
with the DA receptor agonist pergolide results in notable clini-
cal improvement in PPID-aﬀected horses. Thus, we hypothe-
sized that treatment of PPID-aﬀected horses with pergolide
would result in greater DA and TH concentrations in PI tissue
collected from PPID-aﬀected horses treated with pergolide, as
compared to PI tissues collected from untreated PPID-aﬀected
horses. To test this hypothesis, pituitary glands were removed
within 30 min of euthanasia (Aug-Nov, 2009) from 18 horses:
four untreated PPID-aﬀected horses (28±4 [SD] years), four
aged (25±5 years) and four young (5±2 years) control horses
without signs of PPID, and six PPID-aﬀected horses (25±3
years) that had been treated with pergolide for 6 months. PPID
status was conﬁrmed by dexamethasone suppression test results.
Pituitary glands were sectioned in a midline sagittal plane with
one half rapidly frozen on dry ice and the other half placed in
formalin. Using histological ﬁndings to outline the PI, an 18 g
needle was used to collect core samples of PI tissue from the
opposing half of pituitary glands, after thawing. After tissue
soniﬁcation, supernatant fractions were analyzed for DA con-
centration by high performance liquid chromatography and
standardized to protein concentration in the remaining cell pel-
let (reported as ng DA/mg protein). TH protein concentration
(normalized to b-actin) was determined by Western blot analy-
sis. DA concentration was greatest (p<0.05) in PI tissue col-
lected from young control horses, as compared to tissues
collected from the three other groups of horses. In contrast, TH
concentration in PI tissue was not diﬀerent between PPID-
aﬀected horses treated with pergolide and both young and aged
control horse PI. However, PI TH concentration was lowest
(p<0.05) in untreated PPID-aﬀected horses.
In conclusion, pergolide treatment of PPID-aﬀected horses
appears to restore TH concentration in PI melanotropes. Further
study is needed to determine whether the persistently low DA
concentrations in PI tissue of pergolide treated horses is a real
ﬁnding or a potential artifact of tissue collection and processing.
ABSTRACT E-32
EFFICACY OF OMEPRAZOLE PASTE IN THE PREVEN-
TION OF GASTRIC ULCERS IN HIGH LEVEL ENDUR-
ANCE HORSES. Y Tamzalia, LM Desmaizieresb, C Marguetb,
M Biragueb, F Lyazrhic. aEquine Internal Medicine, INP-Ecole
Nationale Ve´te´rinaire, Toulouse, France, bLa Clinique du Cheval,
Grenade, France, cEducational unit of biostatistics, National
Veterinary School, Toulouse, France
A high EGUS prevalence was shown in elite endurance
horses in a recent study with 48% during interseason period
compared to 93% during the competition season with a signiﬁ-
cant inﬂuence of training and performance level on the gastric
score. According to these results it was hypothesized that omep-
razole preventative treatment may reduce the gastric scores in
endurance horses maintained in similar training and perfor-
mance conditions. 26 endurance horses competing at high level
were selected and submitted to two gastroscopic examinations.
The ﬁrst gastroscopy was performed during training period 4
weeks before a planned ride of 90 km minimum and up to 160
km. Subsequently horses received 1mg/kg bwt omeprazole paste
(Gastrogard) once daily, in the morning for 28 days. The sec-
ond gastroscopy was performed within two-three days following
the ride. Data related to housing, feeding, training system as
well as age, breed and gender were recorded for each horse.
The prevalence of squamous gastric ulcers was 76.9% during
the training period (mean score 1.038 ± 0.87 on a scale from 0
to 4) and 73% following the ride (mean score 0.884 ± 0.76)
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with no signiﬁcant diﬀerence (p = 0.749 for prevalence and
p=0.103 for gastric scores). There was no inﬂuence of ride dis-
tance on the gastric score (in a previous prevalence study in
non-treated horses it was shown that the distance of the ride
preceding the second gastroscopy had a signiﬁcant inﬂuence on
the gastric score). There was a signiﬁcant inﬂuence of housing
on the gastric score (p = 0.018) showing lower scores in the
horses housed in a mixed environment (stable + pasture) versus
horses kept totally on pasture. There was also a signiﬁcant
inﬂuence of age on the gastric scores (p=0.042). Breed or gen-
der had no inﬂuence on gastric scores. This study suggests that
omeprazole paste, 1 mg/kg bwt peros is eﬀective in preventing
worsening of gastric scores EGUS in endurance horses.
ABSTRACT E-33
A COMPARISION OF TWO DOSES OF OMEPRAZOLE IN
THE TREATMENT OF GASTRIC ULCERATION IN
THOROUGHBRED RACEHORSES. BW Sykes1, GD
Hallowell2. 1Upper Orara, NSW, 2University of Nottingham,
Sutton Bonington, UK.
Equine gastric ulcer syndrome (EGUS) is a well recognized
condition in Thoroughbred racehorses. The purposes of this
study were to compare the therapeutic eﬃcacy of two doses of
omeprazole, and to report the healing rate of glandular EGUS
with omeprazole therapy. Thoroughbred racehorses in training
with grade II-IV/IV glandular EGUS were identiﬁed on gastro-
scopic examination. Squamous EGUS score was also recorded.
Horses were randomised to receive either 2.0 gram (high dose)
or 0.8 gram (low dose) omeprazole PO SID, equivalent to 4.0
and 1.6 mg/kg PO SID respectively for a 500 kg horse. Repeat
gastroscopy was performed at 33± 7 days and squamous and
glandular scoring repeated. Twenty-four horses met the inclu-
sion criteria and were randomised into two equal groups. One
horse in the low dose group was lost to follow up for unrelated
reasons. All horses, except one in the high dose and one in the
low dose group, had grade II-IV/IV squamous ulceration at day
0. Data were analysed using McNemar’s Test, Mann Whitney
U and Wilcoxon Paired Tests. Signiﬁcance was assumed at
p<0.05. No diﬀerences between the groups at enrolment, or in
the duration of therapy, were present (p>0.38). Ulcer healing
(deﬁned as a return to grade 0-I/IV) occurred in 67% and 44%
of the squamous, and 50% and 11% of the glandular, ulcers in
the high and low dose groups respectively. A dose eﬀect for
healing was noted for both squamous and glandular ulcer heal-
ing (p=0.003 and p<0.0001 respectively) whereas a dose eﬀect
for improvement was only seen for squamous ulcers (p=0.03;
glandular p=0.13). A relationship between healing of squamous
and glandular ulcers, wherein glandular healing, or improve-
ment, was more likely to have occurred if squamous healing, or
improvement, had occurred, existed in the high dose, but not
low dose group (p=0.005 and p=0.10 for healing, and p=0.04
and p=0.12 for improvement, for high and low dose respec-
tively).
In conclusion, healing of EGUS is commonly incomplete at 33
days and a dose dependent response exists. Control gastroscopy
is indicated to ensure healing has occurred, even when a 28 day
course has been completed, and a reduction in the omeprazole
dose below 4 mg/kg PO SID prior to this is likely to result in
inadequate healing in a signiﬁcant number of patients. Healing of
glandular ulceration is inferior to healing of squamous ulceration
and the current recommendation of 28 days therapy is inade-
quate. Investigation of complimentary and/or alternative thera-
pies for glandular EGUS is warranted as the response to
omeprazole therapy alone is poor.
ABSTRACT E-34
EFFECT OF EGUSIN® 250 AND SLH ON GASTRIC ULCER
SCORES, GASTRIC FLUID PH AND TOTAL CARBON
DIOXIDE IN HORSES. MC Woodward1, NK Huﬀ1, F Garza
Jr1, ML Keowen1, MT Kearney2, FM Andrews*,1. 1Equine
Health Studies Program, Department of Veterinary Clinical
Sciences and, 2Department of Pathobiological Sciences, School of
Veterinary Medicine, Louisiana State University, Baton Rouge,
LA, USA
Gastric ulcers are common in horses, but current pharma-
ceutical treatments are expensive and require prescriptions.
EGUSIN® 250 (E-250) and EGUSIN® SLH (E-SLH) are
commercially available feed supplement for the treatment and
prevention of gastric ulcers, but data on their eﬀectiveness has
not been reported. The purpose of this study was to evaluate
these two formulations for the treatment and prevention of
gastric ulcers in stall-conﬁned horses undergoing feed-depriva-
tion.
This study was a blinded two-period partial cross-over study
using Nine Thoroughbred and Thoroughbred-cross horses (ﬁve
geldings and four mares). Treatments consisted of an untreated
control and two treatment groups (E-250 and E-SLH) mixed
with a sweet feed. Horses were conﬁned to a stall and treated
for three weeks, followed by a one-week alternating feed-depri-
vation period, and then for one week after the feed-deprivation
period (ﬁve total weeks of treatment). Gastroscopies were per-
formed on horses on day 0 and at the end of week 3, week 4
and week 5. Gastric juice was aspirated and pH was measured.
Gastric ulcer number and severity scores were assigned at each
gastroscopy. Venous blood gas samples were obtained to deter-
mine changes in total CO2 and due to bicarbonate in the sup-
plements. A repeated measures ANOVA using the mixed
procedure in SAS was used to analyze the data. When signiﬁ-
cant diﬀerences were found, post-hoc pairwise comparisons
were conducted with t tests of least-squares means for main
eﬀects and for interaction eﬀects. A P < 0.05 was considered
signiﬁcant.
Non-glandular gastric ulcer scores signiﬁcantly increased in all
horses from Week 3 to Week 4, as a result of feed-deprivation.
There was no signiﬁcant treatment eﬀect on non-glandular gastric
number or severity scores through four weeks of study. However,
E-SLH and E-250 treated horses had signiﬁcantly lower nonglan-
dular ulcer number and severity scores at week 5. There was no
signiﬁcant diﬀerence in gastric juice pH between treatment
groups at any time during the study. TCO2 was signiﬁcantly
increased in the E-250 and E-SLH treated horses at 24 hours
when compared to the 12 hour samples.
No signiﬁcant treatment eﬀects were seen in the ﬁrst four
weeks of the study. However, one week after feed-deprivation,
EGUSIN®-treated (E-SLH and E-250) horses had fewer and less
severe gastric ulcers. Supplementation with EGUSIN® products
may have eﬃcacy in improving gastric ulcers in stall-conﬁned
horses undergoing intermittent feeding.
ABSTRACT E-35
EVALUATING REPLACEMENT OF SUPPLEMENTAL
INORGANIC MINERALS WITH ZINPRO PERFORMANCE
MINERALS ON PREVENTION OF GASTRIC ULCERS IN
HORSES. P Loftin1, M Woodward1, W Bidot, J Cartmill1,
S Zoccarato, F GarzaJr1, M Keowen1, C Larson2,
FM Andrews1. 1Louisiana State University, Baton Rouge, LA,
2Zinpro Corporation, Eden Prairie, MN
Non-glandular (NG) gastric ulcers are common in the horse.
Zinc is an essential co-enzyme involved in healing of mucosal
surfaces and has been used to treat and prevent gastric ulcers in
other species. The purpose of this study was to test the eﬃcacy
of a feed supplement containing zinc-methionine and other
organic minerals (ZPM) to a supplement containing inorganic
zinc, as zinc sulfate (ZS), for prevention of gastric ulcers in
horses.
The study was a blinded 2-period non-crossover using adult
Thoroughbred horses (n=36). ZPM (400 mg) or ZS (400 mg)
milled into pellets was mixed with crimped oats and fed to the
horses twice daily for 56 days. Horses were stratiﬁed by NG ulcer
score, then by sex and assigned to two treatment groups (n=18).
There were two 56-day periods, where horses were stall-conﬁned
in ambient environmental conditions. Horses received omeprazole
paste (GastroGard®, 4 mg/kg, PO, Q24h) from days 1-14, were
subjected to alternating feed-deprivation from days 42-49 and
allowed to recover for 7 days. Gastroscopy was performed on
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days 0, 14, 42, 49, and 56. Gastric juice pH was measured and
gastric ulcer number and severity scores were assigned by a mask
clinician (FMA). Weather data were collected for the two peri-
ods. Gastric ulcer scores were expressed as mean (SD) and an
ANOVA for repeated measures was used to compare ulcer scores
between groups and over time. A post-hoc Tukey’s test was used
to determine diﬀerences (P<0.05).
Horses (n=34) were treated for all 56 days. There was no
treatment eﬀect in the study; however there was a period eﬀect.
Mean NG number and severity scores were signiﬁcantly lower in
the ZPM-treated horses, compared to ZS-treated horses, on days
42, 49 and 56, during period 2. Overall, for both periods, mean
NG gastric ulcer scores signiﬁcantly decreased in both treatment
groups by day 14, after omeprazole treatment, compared to days
-1, 42, 49 and 56. Mean NG gastric ulcer scores signiﬁcantly
increased on day 42, compared to day 14, but were still lower
than on day -1. Mean NG gastric ulcer scores increased signiﬁ-
cantly by day 49, due to alternating feed-deprivation, then
decreased to below pretreatment values by day 56. No signiﬁcant
diﬀerences were seen in glandular ulcer scores between groups.
Means environmental temperature (68ºF vs. 84ºF), heat index (82
vs. 90) and relative humidity (74% vs. 79%) were higher during
period 2 of the study and may have contributed to the eﬀective-
ness of the ZPM.
ZPM-treatment resulted in lower gastric ulcer scores in horses
participating in period 2 of this study, but when data were
pooled there was no treatment aﬀect. ZPM at levels fed in this
study may be beneﬁcial in preventing gastric ulcers after omepra-
zole treatment in horses housed in stalls and fed intermittently,
especially in hot and humid environmental conditions.
ABSTRACT E-36
EVALUATION OF THREE GASTROINTESTINAL PROTEC-
TANTS IN A RODENT MODEL OF EQUINE CANTHARI-
DIN TOXICOSIS. HJ Qualls1, TC Holbrook2, LL Gilliam2,
B Njaa2, R Panciera2, C Pope2, M Payton2. 1Washington State
University, Pullman, WA, 2Oklahoma State University,
Stillwater, OK
The objective of this study was to evaluate the eﬃcacy of three
gastrointestinal protectants utilizing rats in an experimental
model of equine cantharidin toxicosis.
Male Sprague-Dawley rats were surgically implanted with
telemetry devises to record heart rate, locomotor activity and
body temperature. Combinations of cantharidin and treatments
(mineral oil, activated charcoal, and smectite) were administered
via orogastric gavage. Data were recorded for 24 hours prior to
and after treatments, and urine was collected for cantharidin
analysis. Rats were sacriﬁced 24 hours after treatment and nec-
ropsy was performed. Data analysis included a one-way ANOVA
and Fischer Exact Tests.
Cantharidin intoxicated (CI) rats treated with mineral oil
had a signiﬁcantly lower survival rate than all treatment
groups. (cantharidin (p=0.018), charcoal (p=.001), smectite
(p=.001)). There was a signiﬁcant decrease in mean heart rate
(328bpm; control - 407bpm) and temperature (30.6°C; control -
36.5°C) in mineral oil treated CI rats during the ﬁrst 8 hours
of treatment (P <0.05). The mean temperatures of charcoal
treated rats were signiﬁcantly lower than the control groups
only at the 8-12 hour post-intoxication interval. Mineral oil
treated CI rats had the highest mean urine cantharidin concen-
tration. (P = <0.05).
These results suggest mineral oil increases cantharidin absorp-
tion resulting in higher morbidity and mortality in rats. Both
charcoal and smectite appear to reduce morbidity in this rat
model of cantharidin toxicosis.
ABSTRACT E-37
EFFECT OF N-BUTYLSCOPOLAMMONIUM BROMIDE
(BUSCOPANTM) ON EQUINE ILEAL SMOOTH MUSCLE
ACTIVITY EX VIVO. KA Hart, CE Sherlock, AJ Davern,
T Lewis, TP Robertson. Department of Large Animal Medicine,
University of Georgia College of Veterinary Medicine, Athens,
GA.
N-butylscopolammonium bromide (NBB) is an anticholinergic
agent used to treat spasmodic colic in horses. Intestinal smooth
muscle spasm also occurs in horses with intraluminal intestinal
obstructions such as ileal impactions, and may decrease lumen
diameter in such cases. The antispasmodic eﬀects of NBB may be
useful in managing ileal impactions, but the eﬀects of NBB on
equine ileal smooth muscle are unknown. The objective of this
study was to investigate eﬀects of NBB on equine ileal smooth
muscle activity using an ex vivo model. Ileal tissue was collected
from 6 healthy horses after euthanasia, and isolated circular and
longitudinal smooth muscle was mounted in quadruplicate in
organ baths connected to isometric force transducers. After equil-
ibration, the eﬀect of NBB (1nM-100lM) on spontaneous and
induced contraction was determined and compared to responses
in control tissue. At >30lM, NBB inhibited spontaneous con-
tractions in all tissue segments that exhibited spontaneous activ-
ity. NBB inhibited carbachol-induced contraction in circular
(NBB-treated EC50 1.7x10-6 vs. control EC50 1.5x10-7) and lon-
gitudinal smooth muscle (NBB-treated EC50 8.5x10-6 vs. control
EC50 2.0x10-8). Abolishment of carbachol-induced contraction
with NBB was observed at 4.5-fold lower concentrations in circu-
lar than longitudinal smooth muscle. Pretreatment with NBB
inhibited carbachol-induced contraction, as NBB-treated tissue
required 7.5-fold greater carbachol concentrations to produce
sustained contractions than control tissue. Histamine-evoked con-
traction was not aﬀected by NBB. NBB inhibits spontaneous and
cholinergically-mediated contraction in equine ileal smooth mus-
cle ex vivo, and may reduce intestinal spasm in equine ileal
impactions. Further study is needed to conﬁrm these eﬀects in
vivo.
ABSTRACT E-38
EFFECTS OF SEDATION WITH XYLAZINE OR ACEPRO-
MAZINE ON THROMBOELASTOMETRY AND ON STAN-
DARD EQUINE COAGULATION PARAMETERS. B Saas1, K
Lascola1, S Smith2, G Zyrkowski1. 1College of Veterinary
Medicine, Urbana, IL, 2College of Medicine, Urbana, IL
Acepromazine and xylazine are administered to horses to
reduce anxiety, provide analgesia and enable safe evaluation of
the animal. These medications may cause a decrease in hemato-
crit. Variation in hematocrit can interfere with thromboelastome-
try (TEM). The purpose of this study was to evaluate changes in
thromboelastometry (TEM) and standard coagulation assays in
horses after the administration of acepromazine and xylazine.
Using a randomized crossover design 7 healthy adult horses
were administered a single dose of xylazine (1.1 mg/kg IV) or
acepromazine (0.1 mg/kg IV) with a 3 week washout period
between treatments. Hematocrit, total protein (TP), platelet
count, prothrombin time (PT), activated partial thromboplastin
time (aPTT), TEM and thrombin-antithrombin complexes (TAT)
were measured at baseline, 30 minutes and two hours for both
medications and at 6 and 12 hours for acepromazine. Repeated
Measures ANOVA and Friedman Rank Sum tests were used to
evaluate changes in measured parameters with signiﬁcance set at
p<0.05.
At 30 minutes post xylazine administration hematocrit and
TP decreased by 20.2% (p=0.004) and 4.3% (p=0.013) respec-
tively. At 2 hours post acepromazine administration hematocrit
and TP decreased by 19.7% (p<0.001) and 4.3% (p=0.005)
respectively. Changes in TEM included decreased clotting time
(Ex-TEM p=0.034) and increased alpha angle (Ex-TEM
p=0.034, In-TEM p=0.016) at 30 minutes for horses adminis-
tered xylazine. No other changes in coagulation parameters were
identiﬁed.
Changes in TEM parameters after xylazine administration sug-
gest hypercoagulability. The changes in TEM may represent an
ex-vivo artifact due to reduced red cell mass rather than a true
alteration in coagulation.
ABSTRACT E-39
EFFECT OF SEDATION ON ABDOMINAL PRESSURES IN
NORMAL STANDING HORSES. VHL Scott, JL Williams,
MC Mudge, SDA Hurcombe. The Ohio State University,
Columbus, OH.
Sustained increases in intra-abdominal pressure (IAP) lead to
intra-abdominal hypertension (IAH), decreased abdominal perfu-
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sion pressure (APP) and abdominal compartment syndrome
(ACS); a condition associated with high morbidity and mortal-
ity in critically ill people. Horses with colic share similar risk
factors to those identiﬁed in humans with ACS, which may
contribute to unfavorable outcomes seen in some horses with
abdominal disease. Sedative administration is employed in peo-
ple to reduce elevated IAP and may oﬀer a similar therapeutic
target in horses with colic. The purpose of this study was to
investigate the eﬀect of sedation on direct IAP (dIAP) and
APP in standing horses.
Nine healthy adult horses were included in this study. dIAP
was measured via abdominal cannulation and electronic sphyg-
momanometry from the left ﬂank (LFl), right ﬂank (RFl) and
ventral (V) abdomen in unsedated horses (baseline), ﬁve minutes
after low dose xylazine (LD; 0.3 mg/kg IV), and 5 minutes after
high dose xylazine (HD, 0.7 mg/kg; total dose 1 mg/kg). Direct
mean arterial blood pressure (MAP) was obtained concurrently
to calculate APP (MAP-IAP). Mean values of IAP/MAP/APP
measured in triplicate were used for statistical analysis. Diﬀer-
ences in IAP/MAP/APP for each abdominal site and level of
sedation were compared by repeated measures ANOVA. P<0.05
was signiﬁcant.
LFl dIAP was signiﬁcantly higher at baseline (-3 mmHg) com-
pared to LD and HD (-5 mmHg for each); P=0.023. LFl APP
was not diﬀerent at any level of sedation (baseline and LD =
105 mmHg, HD=112 mmHg). RFl dIAP was -5 mmHg at base-
line, LD and HD. RFl APP was not diﬀerent at any level of
sedation (baseline=107 mmHg, LD=105 mmHg, HD=108
mmHg). Ventrum dIAP was 25 mmHg at baseline, LD and HD.
Ventrum APP was not diﬀerent at any level of sedation (base-
line=78 mmHg, LD and HD=77 mmHg). There was no diﬀer-
ence in MAP at baseline, LD or HD (102 mmHg, 101 mmHg
and 105 mmHg respectively).
Intravenous sedation with xylazine did not aﬀect MAP/APP in
normal standing horses, or dIAP when measured from the RFl
or V abdomen. Reasons for decreased LFl dIAP observed after
sedation are unknown but may be due to diﬀerences in abdomi-
nal organ topography. Further investigation is required to assess
the eﬀect of sedative drugs on dIAP in horses with documented
IAH.
ABSTRACT E-40
RACING PERFORMANCE AND EARNINGS IN THOR-
OUGHBREDS AFTER COLIC SURGERY: A RETROSPEC-
TIVE COHORT STUDY. JE Tomlinson1, RC Boston1,
T Brauer2. 1Department of Clinical Studies - New Bolton,
University of Pennsylvania, Kennett Square, PA, 2Chino Valley
Equine Hospital, Chino Hills, CA
Currently there is limited information regarding post-operative
performance after abdominal exploratory celiotomy in athletic
horses. The null hypothesis of this study was that undergoing
colic surgery with or without intestinal resection would not aﬀect
subsequent racing performance in Thoroughbred horses. This ret-
rospective cohort study included racing Thoroughbreds that sur-
vived to discharge following exploratory surgery for acute colic
at Chino Valley Equine Hospital between 1996 and 2010. For
each case, 2 matched controls were identiﬁed from the last race
before surgery. Race earnings, starts, and earnings per start were
compared by 6 month periods for up to 42 months following sur-
gery. Associations were explored using mixed eﬀects modeling
and regression analysis.
A total of 96 cases were identiﬁed; of these 36 (37.5%) had
primarily small intestinal lesions, of which 12 underwent resec-
tion; 60 (62.5%) had large intestinal lesions, of which 2 under-
went resection. In total, 62% of horses that underwent colic
surgery returned to racing in the subsequent 42 months. Controls
were more likely to race >6 months after surgery than cases
(74% versus 62%, respectively, P=0.02). In the 36 months fol-
lowing a 6 month post-surgery lay-up, control horses earned on
average $12631 more (P=0.18) and had a mean of 1.7 more
starts (P=0.15). This resulted in controls earning a mean of $160
per start more than cases (P=0.90). In conclusion, although
horses that underwent colic surgery were less likely to race, those
that raced did not show a signiﬁcant reduction in number of
starts or earnings compared to controls.
ABSTRACT E-41
PROGNOSIS IN EQUINE COLIC: A RETROSPECTIVE
STUDY OF 392 CASES: SHORT-TERM AND LONG-TERM
COMPLICATIONS. CM SchuhDVM, M Nolf DVM,
A Benamou-Smith DVM, PhD, Dipl. ACVIM / ECEIM. Equine
Center, VETAGROSUPLYON,Marcy L’Etoile, FRANCE.
The purpose of the study is to provide clear data on complica-
tions after a surgical or medical treatment of colic.
Three hundred and ninety-two horses admitted to the Equine
Clinic ( Clinequine) of the Lyon Vet School (France) for gastro-
intestinal colic were used in this retrospective study.
History, clinical ﬁndings, treatments, outcomes, and complica-
tions of 392 colic cases were reviewed. Long-term follow-up data
were collected. Complications were described and complication
rates were calculated.
The most frequent short-term complication was recurrent colic
in both medical and surgical cases ( respectively: 5.7% and
22.4%). Thrombophlebitis (21.7%), incisional infection (18.9%),
ileus ( 17.5%), diarrhea (14.7%) and pyrexia ( 14%) are fre-
quently recorded after laparotomy for colic. Diarrhea ( 5.7%)
and thrombophlebitis ( 5.1%) are the most common complica-
tions, second to recurrent colic, in horses treated medically for
colic.
In conclusion, there is still some uncertainties and discrepan-
cies between studies regarding long-term and also short-term
complications following colic. Although types of complications
are clearly described after a colic treatment, a clear consensus
needs to be reached on clinical deﬁnitions of each complication,
in order to be able to compare results and draw useful conclu-
sions for clinicians.
ABSTRACT E-42
PHYSICOCHEMICAL INTERPRETATION OF ACID-BASE
ABNORMALITIES IN 54 HORSES WITH ACUTE COLITIS
AND DIARRHEA. DE Gomez1, LG Arroyo2, HR Sta¨mpﬂi2,
LE Cruz3, OJ Oliver3. 1University of Prince Edward Island,
Charlottetown, Prince Edward Island, Canada, 2University of
Guelph, Guelph, Ontario, Canada, 3Universidad Nacional de
Colombia, Bogota´, Colombia
Horses with acute colitis often have electrolyte and plasma
protein abnormalities which result in signiﬁcant acid-base imbal-
ances. The quantitative physicochemical approach emphasizes the
importance of strong electrolytes (Na, K, Cl, L-lactate), pCO2,
and the plasma protein concentrations (Atot) in determining
plasma pH. The objective of this retrospective study was to dem-
onstrate physicochemical acid-base interpretation of horses with
acute diarrhea and to illustrate that diﬀerent metabolic acid-base
situations may occur simultaneously.
Fifty-four horses presented to the Ontario Veterinary College
Teaching Hospital during 2008-2010 for clinical colitis and acute
diarrhea were included. An admission venous blood sample was
collected into a Na-heparin blood gas syringe and analyzed for
pH, pCO2 and plasma concentrations of Na, K, Cl, L-lactate
and calculated HCO3
- and Base Excess (BE) using a Radiometer
800 Flex analyzer. Strong ion diﬀerence (SID) was calculated as
SID=(Na+K)-(Cl+L-lactate), and total protein (TP) was mea-
sured using refractometry. Anion gap (AG) and Strong Ion Gap
(SIG) were calculated as: AG= (Na+K)-(Cl+HCO3
-); SIG=
A--AG. A- is net negative charge of plasma proteins; A-=0.22x
[total protein, g/L]/(1+10{6.65-pH}). Electro-neutrality (EN)
EN=SID-HCO3
--A-. If BG machine measures accurately and if
no additional unmeasured anion is present EN should be zero.
Means values were (mean plasma/blood concentrations ± SD):
pH=7.38±0.05; Na=129±7.3 mEq/L; K=3.1±0.71 mEq/L;
Cl=94±6.8 mEq/L; HCO3
-=24±3.7 mEq/L; BE=-0.22±4.3mEq/
L; SID=35.3±4.4 mEq/L; and Atot=12.6±3.3 mEq/L; L-lactate
=2.84±2.75 mmol/L; AG=15.7±5.7 mmol/L; SIG was 2.8±4.8
mmol/L;) EN=-1.40±2 mEq/L. Calculated AG and SIG were
signiﬁcantly correlated with L-lactate concentration AG=10.4
+1.36x[L-lactate] (R2 = 0.44), SIG=1.90-1.17x[L-lactate] (R2
=0.48). The sensitivity and speciﬁcity of AG and SIG to predict
hyperlactatemia (L-lactate>5 mmol/L) was 100% (95% CI 66.4-
100) and 84.4% (95% CI 70.5-93.5). The area under the curve
(ROC) for the prediction of hyperlactatemia for AG and SIG
were 0.956 (95% CI 0.862-0.993) and 0.938 (95% CI 0.838-0.986)
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respectively. Physicochemical interpretation of acid base events
revealed that metabolic acidosis (strong ion acidosis) and meta-
bolic alkalosis (hypoproteinemic) was concomitantly present in
30% of cases.
These results emphasize the importance of strong ions and
proteins in the maintenance of the acid-base balance. AG and
SIG predict the presence or absence of clinically signiﬁcant hy-
perlactatemia. Acid-base and electrolytes abnormalities were not
correlated with the outcome of survival. Electroneutrality was
excellent indicating that the measuring system is accurate and
that other unmeasured strong anions are unlikely present in sig-
niﬁcant concentrations in horses with colitis.
ABSTRACT E-43
IN-VITRO GROWTH CHARACTERISTICS OF COMMER-
CIAL PROBIOTIC STRAINS AND THEIR POTENTIAL FOR
INHIBITION OF CLOSTRIDIUM DIFFICILE AND
CLOSTRDIDUM PERFRINGENS. A Schoster1, B Kokotovic2,
A Permin3, P Dedenroth4, L Guardabssi1. 1University of
Copenhagen, Copenhagen, Denmark, 2Technical University of
Denmark, Copenhagen, Denmark, 3The DHI group,
Copenhagen, Denmark, 4Clerici-Sacco Group, Cadorago, Italy
Probiotics have gained importance in human and veterinary
medicine to prevent enteric disease. Little information is available
on commercial probiotic strains regarding their growth character-
istics and inhibition of equine enteric pathogens such as Clostrid-
ium diﬃcile and Clostridium perfringens.
To study growth characteristics of 17 commercial probiotic
strains (Lactobacilli n=16, Biﬁdobacteria n=1) MRS broth was
adjusted to pH 2 or 4 or supplemented with 0.15% or 0.3% bile.
Growth was measured at 0 and 24h and compared spectrophoto-
metrically to control growth in standard MRS broth. Growth
under aerobic conditions was assessed. To evaluate inhibition of
C. diﬃcile and C. perfringens sterile supernatant of the probiotic
culture was added to BHI inoculated with a standard C. diﬃcile
or C. perfringens suspension. Growth was measured spectropho-
tometrically at 0 and 24h and compared to the control (C. diﬃ-
cile or C. perfringens suspension in BHI).
At pH 4 12% of strains showed >50% growth and 24% were
unable to grow, however did survive. At pH 2 none of the tested
strains grew or survived. Eighty eight percent showed >75%
growth in 0.15% bile, 60% showed >75% growth in 0.3% bile.
Ninety-four percent grew under aerobic conditions. Ninety-four
percent of strains were inhibitory (0-20% growth compared to
control) against C. diﬃcile and 76% were inhibitory against C.
perfringens.
Sixty percent of the tested strains showed favourable in-vitro
characteristics for use as potential equine probiotics and could be
further studied in placebo controlled clinical trials for prevention
or treatment of C. diﬃcile and C. perfringens associated disease.
ABSTRACT E-44
PLASMA HIGH MOBILITY GROUP BOX-1 LEVELS IN
HORSES WITH GASTROINTESTINAL DISEASE.
JR Bauquier, L Nath, G Forbes, SR Bailey. University of
Melbourne Faculty of Veterinary Science, Werribee, Victoria,
Australia.
High mobility group box-1 (HMGB-1) has been established as
a late-phase cytokine in the pathophysiology of sepsis in experi-
mental rodent models and clinical human patients. It typically
increases in these species approximately 18 hours after the onset
of disease, and shows potential as a therapeutic target. It has
been characterized in synovial ﬂuid of horses with joint injury,
however its presence has not been investigated in horses with
colic and endotoxemia. The aim of this study was to determine
whether HMGB-1 is increased in horses with colic, and speciﬁ-
cally those with lesions more likely to cause endotoxemia, such
as strangulating lesions or colitis. A commercial ELISA kit was
used to measure HMGB-1 levels in plasma samples taken at
admission from 32 horses presented for colic and 22 normal con-
trol horses. HMGB-1 was signiﬁcantly higher in horses with colic
(median 12.2 ng/ml, 95% CI 13.1-21.8 ng/ml) than controls
(median 3.5 ng/ml, 95% CI 2.6-5.6 ng/ml), P<0.0001. When
colic horses were divided into 3 groups based on lesion (strangu-
lating, non-strangulating and inﬂammatory) the diﬀerence
between these groups was not signiﬁcant (P>0.05). However, a
signiﬁcant diﬀerence was found when comparing the inﬂamma-
tory or strangulating groups to the control group (P<0.05), but
not when comparing the non-strangulating group to the control
group (P>0.05). This study shows HMGB-1 is increased in
horses with colic compared to normal controls. As HMGB-1 is a
late-phase cytokine, it may be that more signiﬁcant results will be
obtained from horses with gastrointestinal disease over the course
of hospitalization, rather than at admission only. Further studies
are needed to determine the potential of HMGB-1 as a therapeu-
tic target for endotoxemia in horses.
ABSTRACT E-45
IN VITRO SCREENING OF FOUR NOVEL ANTI-ENDO-
TOXIC AGENTS USING EQUINE WHOLE BLOOD
ASSAYS. JR Bauquier, SR Bailey. University of Melbourne
Faculty of Veterinary Science, Werribee, Victoria, Australia.
Endotoxemia is a common complication in horses, causing
stimulation of leukocytes to produce pro-inﬂammatory cytokines
which leads to substantial compromise to the equine patient. Due
to the lack of highly eﬀective treatments for endotoxemia in
horses, there remains a need for investigation of novel therapies.
The aim of this study was to determine the anti-inﬂammatory
eﬀect of four drugs – rolipram, azithromycin, metformin and
ethyl pyruvate in equine whole blood stimulated with lipopoly-
saccharide (LPS). Blood was collected from 4 healthy horses for
each drug tested. Drugs were added to aliquots of whole blood
over a range of concentrations, after which LPS was added (E.
Coli O55:B5; 1 µg/ml). Samples were then incubated at 37°C
(98.6°F) for 21 hours. The anti-inﬂammatory eﬀect was measured
by determining tumor necrosis factor-alpha (TNF-a) levels in
plasma extracted from the whole blood aliquots, using the mur-
ine L929 cell line bioassay. Inhibition of TNF-a production
occurred for all drugs, with rolipram being most eﬃcacious, hav-
ing an IC50 of 1.2 lM (95% CI 0.4-3.5 lM). The IC50 values
for azithromycin, metformin and ethyl pyruvate were 7.2 lM
(3.0-17.6 lM), 4.5 lM (0.7-27.8 lM), and 59.9 lM (5.6-636.9
lM) respectively. Rolipram and azithromycin produced the
greatest maximum inhibition at 97.2±9.0% and 98.5±10.5%
respectively. The maximum inhibition caused by metformin and
ethyl pyruvate were 40.9±7.5% and 26.9±7.5% respectively.
These results show that rolipram, a speciﬁc phosphodiesterase
inhibitor, was most eﬀective at inhibiting TNF-a production.
Further studies are needed in live horse models to determine the
potential of rolipram as a therapeutic agent for endotoxemia in
horses. Any potential for azithromycin as a treatment for endot-
oxaemia in adult horses would be limited by its contraindication
due to the risk of severe colitis.
ABSTRACT E-46
THE EFFECTS OF HYDROXYETHYL STARCH 6% 130/0.4
ON THROMBOELASTOGRAPHY IN HEALTHY HORSES.
A Viljoen1, MN Saulez1, PC Page1, G Fosgate2. 1Section of
Equine Medicine, Department of Companion Animal Clinical
Studies, 2Section of Epidemiology, Department of Production
Animal Studies, Faculty of Veterinary Science, University of
Pretoria, South Africa
Hydroxyethyl starch solutions (HES) restore and maintain
intravascular blood volume and plasma colloid osmotic pressure
(pCOP). Reported safe dosage requirements are extrapolated
from human literature. Thromboelastography (TEG) has been
validated for horses. The objective of the study was to determine
the hemostatic and oncotic eﬀects of HES 6% 130/0.4 (Volu-
ven®) administered in healthy horses.
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Six clinically-healthy Nooitgedacht mares were used in a
randomized crossover, prospective study. Mares were assigned
to 3 treatment groups and received 10, 20 and 40ml/kg Volu-
ven® infusions with a 2-week washout period. Kaolin-activated
TEG and pCOP measurements were performed before (base-
line), immediately after each infusion (0h), and at 1, 6, 12, 24,
48 and 96h. TEG values: reaction time (R), clot formation
time (K), maximum amplitude (MA), and angle (a) were evalu-
ated.
Overall mean ± SD values for 40 vs. 20 and 10ml/kg groups
were: R = 18.5 ± 5.84min vs. 16.3 ± 3.41 (P = .492) and 13.4 ±
2.91 (P = .041); K = 4.61 ± 1.85min vs. 3.65 ± 0.71 (P = .025)
and 3.13 ± 0.74 (P = .011); MA = 55.1 ± 7.43mm vs. 60.4 ± 4.94
(P = .158) and 58.1 ± 3.99 (P = .353); a = 39.8 ± 10.56°vs. 46.1
± 6.92 (P = .042) and 50.4 ± 6.60 (P = .016). Overall mean ± SD
pCOP values for 40 vs. 20 and 10ml/kg were: 24.1 ± 3.59mmHg
vs. 21.7 ± 2.01 (P = .001) and 21.0 ± 1.78 (P = .001).
Compared to lower dosages, the administration of Voluven®
at 40ml/kg is more likely to induce changes consistent with hypo-
coagulability as measured by TEG.
ABSTRACT E-47
OPERATOR-BASED VARIABILITY OF EQUINE THROM-
BOELASTOGRAPHY. K Thane, D Bedenice, D Meola, A
Pacheco. Cummings School of Veterinary Medicine at Tufts
University, North Grafton, MA.
This prospective cohort study evaluated the eﬀect of operator-
based variability on the results of thromboelastography (TEG)
performed on 20 adult horses with no evidence of systemic
inﬂammation.
Blood samples were obtained at a single time point using
vacuum collection. Evaluation of physical examination and
hematological parameters at the time of blood collection estab-
lished that horses were free from systemic inﬂammation. TEG
was performed in duplicate by 2 operators (2 groups of 10
horses evaluated by either O1/O2 or O1/O3) using discrete set-
ups. TEG variables recorded for each sample included clot ini-
tiation time (R), clot formation time (K), rate of clot
formation (a), clot strength (MA), and viscoelastic/shear
strength (G). All operators independently determined clinical
coagulation status (normal, hypo-, or hypercoagulable) of each
sample tested based on previously determined reference values
for each parameter established from a population of healthy
horses (range calculated as mean +/- 2 standard deviations for
each variable).
For the study population, the following vital and hematologi-
cal values were identiﬁed (reported as mean and range): age 8.6y
(2–22y); platelet count 177,000/µL (117,000–252,000/µL); packed
cell volume 35% (28–43%). Intra-operator (between duplicate
samples) and inter-operator (between operators) variabilities were
determined for each parameter and cohort (summarized in Table
1) using descriptive statistics and paired samples t-test (with
P<0.05 considered signiﬁcant).
Assessment of coagulation status was well correlated between
operators with agreement in 8/10 and 9/10 patient assessments
for O1/O2 and O1/O3, respectively. For all TEG variables, there
was no signiﬁcant diﬀerence in values obtained between O1/O3;
however, signiﬁcantly diﬀerent MA values (p=0.04) and G val-
ues (p=0.02) were obtained by the O1/O2 operator pair.
In conclusion, intra-operator variability of TEG ranged from
1.2-18% in this study, while inter-operator based variability mini-
mally increased total TEG variability. Clinical coagulation assess-
ment remained well correlated between operators.
ABSTRACT E-48
EQUINE DIARRHEA PANEL TEST RESULTS IN 308
HORSES (2007-2010). HC Schott II1, N Grosjean2, S Bolin2.
1Department of Large Animal Clinical Sciences; and, 2Diagnostic
Center for Population and Animal Health, College of Veterinary
Medicine; Michigan State University College of Veterinary
Medicine, East Lansing, MI
Establishing an etiologic diagnosis for enterocolitis in horses
remains challenging. In an attempt to increase the frequency of
an etiologic diagnosis in aﬀected equids, the Diagnostic Center
for Population and Animal Health at Michigan State University
introduced an “equine diarrhea panel” in 2007 for testing feces
and blood from horses with a clinical diagnosis of enterocolitis.
The panel included a fecal culture for Salmonella spp, ELISA
testing of feces for Clostridium diﬃcile toxins A and B and Clos-
tridium perfringens enterotoxin (TechLab, Blacksburg, VA), and
(seasonally) PCR testing of blood and feces for Neorickettsia ris-
ticii. From July, 2007 through December, 2011, 322 samples were
tested from 308 horses and included 166 samples submitted
through the Veterinary Teaching Hospital (VTH) and 156 sam-
ples submitted from outside sources (predominantly within the
upper Midwest). The most frequent positive result was for PCR
testing of feces (41/156 or 26%) and blood (34/152 or 22%) for
Neorickettsia risticii followed by positive ELISA results for Clos-
tridium diﬃcile toxins A and B (54/324 or 17%) and Clostridium
perfringens enterotoxin (48/324 or 15%). Only 29 horses had
positive fecal culture results for Salmonella spp during the sam-
pling period. There were no signiﬁcant diﬀerences in frequencies
of positive results from samples collected from horses in the
VTH as compared to those submitted from outside sources with
the exception of detection of Salmonella spp. Of interest, 16 of
the 54 samples with positive ELISA results for Clostridium diﬃ-
cile toxins A and B also had positive ELISA results for Clostrid-
ium perfringens enterotoxin. With regard to Potomac Horse
Fever (PHF), 19 horses had positive PCR results for Neorickett-
sia risticii on both blood and feces while 14 and 18 additional
horses only tested positive on blood or feces, respectively. All
positive PCR results for PHF were found in samples submitted
during the late spring through fall (May 13 to October 27); how-
ever, this ﬁnding is biased by the fact that testing for PHF was
less commonly requested in samples submitted during the winter
months. Although frequencies for positive ELISA results for
clostridial toxins tended to be numerically higher in horses that
also had positive PCR results for Neorickettsia risticii (33% for
PCR+ blood samples and 34% for PCR+ fecal samples as com-
pared to 26% for PCR- blood samples and 17% for PCR- fecal
samples), Chi-square analysis did not reveal any signiﬁcant diﬀer-
ences. In conclusion, PHF remains the most frequent etiologic
diagnosis for enterocolitis in horses in the upper Midwest. Fur-
ther, detection of clostridial toxins in feces of one-third of horses
that also had positive PCR results for PHF is a novel ﬁnding
and raises the question of whether disruption of intestinal ﬂora
by Neorickettsia risticii infection may allow concurrent induction
of toxin production by enteric Clostridium spp.
ABSTRACT E-49
OLFACTORY DETECTION OF SALMONELLA ENTERICA
SEROVAR NEWPORT IN HORSE FECAL SAMPLES
USING GIANT AFRICAN POUCHED RATS: A PROOF-OF-
PRINCIPLE STUDY. A Durgin1, RD Nolen-Walston2,
N Beyene1, A Mahoney1, C Cox1, B Weetjens1, A Poling1. 1Anti-
Persoonsmijnen Ontmijnende Product Ontwikkeling APOPO,
Abstract E-47:
Table 1. Intra- and inter-operator variability of TEG values grouped by operator or operator pair. All variability values reported as: mean (standard devi-
ation).
R K a MA G
Intra-operator: O1 9.0% (5.1%) 14% (13%) 9.0% (9.2%) 2.6% (2.4%) 6.6% (6.8%)
Intra-operator: O2 12% (9.5%) 13% (12%) 11% (14%) 2.8% (2.3%) 6.2% (4.7%)
Intra-operator: O3 13% (10%) 18% (20%) 10% (12%) 1.2% (0.8%) 2.9% (1.7%)
Inter-operator: O1&O2 13% (5.1%) 15% (7.0%) 12% (9.0%) 3.2% (2.0%) 7.3% (4.5%)
Inter-operator: O1&O3 17% (12%) 23% (17%) 11% (7.6%) 2.7% (1.2%) 6.9% (4.1%)
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Morogoro, TZ, Africa, 2Department of Clinical Studies - New
Bolton, University of Pennsylvania, Kennett Square, PA
Nosocomial infections are a major cause of morbidity and
mortality in human and veterinary patients worldwide. The rapid
identiﬁcation of such infections is critical in preventing such out-
breaks. The hypothesis of the present study was that giant Afri-
can pouched rats can distinguish rapidly and accurately between
Salmonella-free equine fecal samples and those inoculated with
Salmonella enterica serovar Newport. Three adult giant African
pouched rats (Cricetomys gambianus) were trained using operant
procedures to sniﬀ sample pots within a semi-automated circular
chamber containing horse fecal samples. Positive indications were
deﬁned as the rat keeping its nose in the sniﬃng hole for  3 sec-
onds. The rats were initially trained to detect Salmonella in cul-
ture medium, then Salmonella-inoculated dried horse feces, and
ﬁnally Salmonella-inoculated fresh horse feces. Rats were trained
over 25 sessions, each session consisting of 50 randomized sam-
ples, 9 Salmonella-positive (18%) and 41 Salmonella-negative.
All 3 rats were able to detect Salmonella accurately in all sam-
ple types. Across rats and sessions, sensitivity and speciﬁcity,
respectively, were 100% and 99% when polypropylene squares
served as samples; 100% and 96% when dried horse dung was
used, and 100% and 96% with fresh horse manure (table 1).
These results suggest that rats can discriminate between Salmo-
nella and the profusion of other microbes of equine fecal ﬂora.
The use of scent-detecting pouched rats shows potential to pro-
vide highly accurate, rapid, and high-throughput detection of
pathogens to screen for the presence of Salmonella in samples
obtained from veterinary hospitals and elsewhere.
ABSTRACT E-50
RISK FACTORS FOR ENVIRONMENTAL CONTAMINA-
TION WITH SALMONELLA ENTERICA IN A VETERI-
NARY TEACHING HOSPITAL. BA Burgess, PS Morley.
Department of Clinical Sciences, College of Veterinary Medicine
and Biomedical Sciences, Colorado State University, Fort
Collins, CO
Salmonella enterica is commonly recognized as a cause of nos-
ocomial infections as well as zoonotic infections in veterinary
teaching hospitals (VTHs). The objective of this study was to
determine risk factors associated with environmental contamina-
tion of a veterinary teaching hospital with S. enterica.
Environmental surveillance samples were collected from Feb-
ruary 2003 through June 2011, using a commercially available
electrostatic wipe, as part of the ongoing infection control pro-
gram. Sampling sites included both ﬂoor and hand contact sur-
faces throughout the VTH. Risk factors evaluated included
hospital case load, hospital use areas, severity of disease, presence
of culture positive inpatients and season. Data on risk factors of
interest were collected retrospectively from the VTH medical
records database. Multivariable logistic regression was used to
evaluate associations between hospital risk factors and veterinary
hospital environmental contamination with S. enterica.
During the study period, approximately 53 samples were col-
lected monthly, for a total of 5337 environmental samples. Of the
samples collected, a total of 7.9% (n=423) were culture positive
for S. enterica using standard culture techniques. In general, envi-
ronmental samples collected in the Food Animal Hospital and
ﬂoor samples were more likely to be positive.
Risk factors identiﬁed in this study will allow for the reﬁne-
ment of existing infection control programs as well as provide
guidance to those in program development. A better understand-
ing of the risk factors associated with environmental contamina-
tion will allow for more practical evidence based preventive
measures to be implemented in veterinary hospitals experiencing
epidemics of nosocomial infections with S. enterica.
ABSTRACT E-51
METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS
(MRSA) COLONIZATION IN HORSES AT A VETERINARY
TEACHING HOSPITAL. JW Stull, JS Weese. Ontario
Veterinary College, Guelph, Ontario, Canada
This study evaluated an active surveillance system for MRSA
in-place at a veterinary teaching hospital to better understand the
epidemiology of equine MRSA colonization and eﬀectiveness of
surveillance. MRSA screening of nasal swabs is performed in
horses admitted to the Ontario Veterinary College (OVC) on
admission, every 7 days in hospital, and on discharge. Data from
June 1, 2009 to April 30, 2011 were analysed. Cases were classi-
ﬁed as community-associated (CA), community onset-hospital
associated (CO-HA), hospital-associated (HA) or indeterminate
(IN) using standard deﬁnitions.
During the study period there were 2235 admissions (1705 dif-
ferent horses) and 2783 MRSA surveillance samples obtained.
For admissions with a duration of at least one day (n=1277),
728 horses (57%) were screened according to protocol, 511
(40%) were screened, but less frequently than protocol, and 38
(3%) were not screened. MRSA was isolated from 80 samples
during 50 visits by 40 horses (ﬁrst positive visits: CA–19; CO-HA
–3; HA–17; IN–1; range 0-7 per month). Overall, 3.0% of horses
were positive (monthly range 0-8.6%). The prevalence at admis-
sion (CA and CO-HA combined) was 1.7% (monthly range 0-
7.1%). Three horses had MRSA infections at admission and all
were also colonized. No HA clinical MRSA infections were iden-
tiﬁed. spa typing was available for 18 of the isolates from diﬀer-
ent horses; 16 were spa type t064, an ST8 strain commonly found
in horses. Results for ﬁrst-time positive animals were available
for only 7 (18%) prior to discharge. However 11 (28%) colonized
horses were later re-admitted, and 7 of these were still colonized.
Within 6 months of the ﬁrst positive result, 5 owners of MRSA-
positive horses brought 14 additional horses to the OVC (range
1-4). Three horses from one of these owners were also colonized.
Overall, compliance with MRSA surveillance sample submis-
sions was good. The prevalence of MRSA colonization varied
throughout the study period, however the 1.7% admission preva-
lence is similar to previous reports from this facility. The time
delay associated with sample processing hampers the eﬀectiveness
of screening as most horses have been discharged by the time
results are known. However, using screening results to identify
subsequent high risk cases can allow for use of enhanced infec-
tion control practices while awaiting test results as well as pro-
vide important information for assessment about the
epidemiology of MRSA in the facilty. Ultimately, rapid testing is
required to optimize MRSA screening in horses.
ABSTRACT E-51B
SEROPREVALENCE TO NEOSPORA HUGHESI IN
HORSES WITH SUSPECTED EQUINE PROTOZOAL MY-
ELOENCEPHALITIS. N Pusterla, E Tamez-Trevino, A White,
J VanGeem, AE Packham, PA Conrad. School of Veterinary
Medicine, University of California, Davis, CA
Neosporosis, due to Neospora hughesi, is one cause of
equine protozoal myeloencephalitis (EPM), a progressively
debilitating central nervous system disease in horses. There
have been several. The incidence of EPM due to N. hughesi is
unknown, so is its geographic occurrence. The goal of this
study was to describe cases of suspected EPM that tested sero-
positive for N. hughesi.
Table 1. Rate of false positive and false negative detections, and the
probability of random positive indication by the rats using binomial distri-
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Blood samples submitted to the Immunology Laboratory at
the William R. Pritchard Veterinary Medical Teaching Hospital,
University of California at Davis from 12/1/2009 to 11/30/2011
for the detection of speciﬁc antibodies to Sarcocystis neurona and
N. hughesi were reviewed. The samples were accompanied by a
submission form which contained information regarding the ori-
gin, signalment and neurological signs of the suspected EPM
cases. Case selection included horses with neurological deﬁcits,
which tested seropositive by the NeoFluor indirect ﬂuorescent
antibody test to N. hughesi (titer  320). Concurrent titers to S.
neurona were also evaluated.
Over the 24-month study period 7,250 submissions of sus-
pected EPM cases were processed for antibody detection to N.
hughesi and S. neurona. One-hundred and ﬁfteen samples tested
seropositive for N. hughesi with titers ranging from 320 to 10,240
(median 640). 54/115 (47%) N. hughesi seropositive horses also
had antibody against S. neurona with titer ranging from 80 to
5,120 (median 320). In 34 dually seropositive serum samples,
titers to N. hughesi were higher than titers to S. neurona. Seven
serum samples had similar titers for N. hughesi and S. neurona
and 13 serum samples had higher titers to S. neurona than to N.
hughesi. The number of N. hughesi seropositive horses ranged
from 1 to 12 per month and they originated from 29 diﬀerent
States (TX 24 index cases; CA 18; OK 8; NY/VA 7; FL/PA/MO
5; GA/NJ 4; TN/IL/WA/NC/CT/AL/AR/ID/MT 2; MA/AZ/
MN/OH/SC/IA/NV/NM/WY/WV 1). The age of seropositive
horses ranged from 1 to 33 years (median 10 years) and a variety
of breeds were represented including quarter horse, thorough-
bred, warmblood, Arabian, draft breeds and other breeds. Most
commonly reported clinical signs in N. hughesi seropositive index
cases were ataxia (62%), weakness (38%), lameness/gait abnor-
mality (34%) and muscle atrophy (29%).
The results of this retrospective study show that N. hughesi is,
alone or in combination with S. neurona, associated with EPM
cases. The wide geographic origin of N. hughesi seropositive
horses highlights the need to test for both apicomplexan proto-
zoal pathogens in neurologically aﬀected horses with suspected
EPM.
ABSTRACT E-52
A COMPARISON OF BACTERIAL COLONISATION
BETWEEN TEFLON AND POLYURETHANE SHORT TERM
INTRAVENOUS CATHETERS. CW Spelta1, RHH Tan2,
J Picard2, B Gummow2. 1Townville Vet Clinic, Townsville,
Australia, 2James Cook University, School of Veterinary Science,
Townsville, Australia
The eﬀect of catheter material on intravenous catheterisation
complications in horses are unknown. This study evaluated the
presence of bacterial colonisation on Teﬂon® and polyurethane
short term intravenous catheters in healthy adult horses undergo-
ing elective surgery.
Horses on admission for elective surgery were randomly allo-
cated according to catheter type. Sixteen horses received Teﬂon®
catheters and 19 received polyurethane. Aseptic catheter place-
ment and removal was standardised, however systemic antibiotic
treatment was case dependant and at the clinician’s discretion.
To simulate routine clinical practice, face masks were not worn
during placement nor were the catheters bandaged. Catheters
were maintained for 74 hours and assessed for clinical evidence
of catheter site reaction, phlebitis or thrombosis twice daily.
Bacteria were cultured from 69% of Teﬂon® and 89% of
polyurethane catheters. Multiple isolates were found in 31% of
Teﬂon® and 42% of polyurethane catheters The Fisher exact test
showed no diﬀerence between the proportion of catheters with
colonisation (P=0.28) or multiple isolates (P=0.76). The
microbes cultured were predominantly gram positive, similar to
other equine and human studies. Multiple-drug resistance was
seen regularly, regardless of antibiotic treatment. Despite this, no
clinical evidence of phlebitis or thrombosis occurred in any
horse.
It was concluded, that was no clear association between bacte-
rial colonisation of Teﬂon® or polyurethane catheters
(0.9<RR<1.87). The unexpected large proportion of bacterial
isolates in the absence of clinical signs was also evaluated and
suggests that the equine immune system plays a role in the devel-
opment of septic phlebitis or thrombosis.
ABSTRACT E-54
PREVALENCE OF SERUM NEUTRALIZING ANTIBODIES
TO EQUINE RHINITIS A AND EQUINE RHINITIS B
VIRUS (ERV 1 AND ERV 2) IN SELECT REGIONS OF THE
UNITED STATES. R Keene1, J Tuttle1, L Mittel2, J Morrow3,
F Andrews4. 1Boehringer-Ingelheim Vetmedica, Inc. St Joseph,
MO, 2Animal Health Diagnostic Center, Cornell University
Ithaca, NY, 3Equine Diagnostic Solutions, LLC, Lexington, KY,
4Equine Health Studies Program, Louisiana State University
School of Veterinary Medicine, Baton Rouge, LA
Equine rhinitis viruses (ERV1&2) have been associated with
respiratory disease outbreaks worldwide. ERV 1&2 infections
cause subclinical signs or respiratory signs including fever, nasal
discharge, coughing, anorexia, pharyngitis, laryngitis and
enlarged submandibular lymph nodes. Over the past decade,
serologic evidence of infection has been documented in Canada,
Australia, and Europe. However, recent serologic data does not
exist in US horse populations. The purpose of this study was to
determine seroprevalence of ERV 1&2 in diﬀerent regions of the
US.
Frozen serum samples were obtained from six US veterinary
laboratories, Animal Health Diagnostic Center (AHDC) at Cor-
nell University SVM, Ithaca, NY, Texas Veterinary Medical
Diagnostic Laboratory Amarillo, TX, Veterinary Diagnostic Lab-
oratory Lexington, KY, University of California at Davis Veteri-
nary Teaching Hospital, Davis CA, Louisiana Animal Disease
Diagnostic Laboratory, Equine Health Studies program, Baton
Rouge, LA, and Equine Diagnostic Solutions, LLC Lexington,
KY. Samples were selected from horses between 1 to 4 years of
age. All samples were shipped to AHDC. Serum neutralization
(SN) antibodies were determined using an established assay. SN
titers  1:96 for ERV1&2 were considered positive.
Serum samples were evaluated in 1021 horses from regions of
the US and 451 (44%) were found to have neutralizing antibod-
ies  1:96 to ERV 1 and 164 (16%) were positive for ERV 2.
Seroprevalence of ERV 1 was highest in samples submitted from
Louisiana (49%), whereas samples from Kentucky had the lowest
seroprevalence rate (34%). Seroprevalence of ERV 2 ranged from
29% in AHDC sample submissions to 15% in Louisiana sam-
ples. Speciﬁc ages were available for 554 of the samples and sero-
prevalence for exposure to ERV 1 appeared to increase with age,
as positive titers to ERV 1 were found in yearlings (11/126 [9%]),
in 2 year olds (44/116 [38%]), 3 year olds (50/163 [31%]), and 4
year olds (52/149 [35%]).
ERV has high seroprevalence in several regions of the US. SN
antibodies to ERV 1 are more common than ERV 2 in the popu-
lations studied and seroprevalence appears to be age dependent.
ERV 1&2 infections and their relationship to concurrent respira-
tory disease and respiratory pathogens in horse populations war-
rant further investigation.
ABSTRACT E-55
PREVALENCE, RECURRENCE, RISK FACTORS AND
EFFECTS ON PERFORMANCE OF EPISTAXIS IN RACING
THOROUGHBREDS IN THE UK: 914,849 STARTS (2001-
2010). AD Thomas1, MJ Green1, T Morris1,2, N Bowen2 GD
Hallowell1. 1School Of Veterinary Medicine and Science,
University of Nottingham, Sutton Bonington,UK, 2British
Horseracing Authority, London, UK
Epistaxis is a severe manifestation of exercise-induced pulmo-
nary haemorrhage, seen in racing Thoroughbreds and other exer-
cising horses worldwide. The objectives of this study were to
report prevalence, incidence and recurrence of epistaxis, identify
risk factors and report eﬀects of epistaxis upon performance.
Features of this study included the large data set, evaluation of
recurrence in jump and ﬂat racing, all in a country where race
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day medication is prohibited. Cases of epistaxis were identiﬁed
from all race starts (914,849) in the UK from 2001-2010 using
veterinary surveillance, with additional use of stewards reports in
2010. Univariable logistic regression analyses and then multivari-
able mixed eﬀect logistic regression models were built in step-wise
fashion for diﬀerent race types to identify risk factors. Signiﬁ-
cance was assumed as p<0.05. 2076 cases of epistaxis in 1776
horses were identiﬁed. The overall prevalence of epistaxis was
0.23% and 0.32% for 2010. Prevalence was 0.13% in ﬂat race-
horses, 0.34% in hurdlers and 0.54% in steeplechasers. Incidence
was 10.6 cases per 1000 horse cases per year with 2.3% of the
racing population aﬀected by epistaxis during the study period.
Prevalence and incidence increased over the decade studied.
Horses that raced over fences (p<0.001), were competing over
shorter distances (within race types; p<0.001) and on ﬁrmer
going (p<0.001) showed increased prevalence of epistaxis.
Increased risk of epistaxis was observed with age only for ﬂat
horses (p=0.004). Horses with epistaxis were likely to have raced
over more seasons (p<0.008), but had a lower number of starts
per season (p=0.03) and a longer period between races
(p<0.0001). The number of days since the last race was higher
for epistaxis performances (67 days; p<0.003) when compared
with controls (58 days). 13.5% of horses with epistaxis demon-
strated recurrence (15.9%, 10.1% and 17.7% for ﬂat racehorses,
hurdlers and steeplechasers respectively). 71% of the recurring
cases of epistaxis occurred within a year of a previous episode.
Recurrence within a year was lower in steeplechase (63.7%) races
when compared to ﬂat (75.6%; p<0.001) and hurdle races
(76.2%; p<0.001) All performance indicators which included
money won, percentage of the ﬁeld beaten, lengths ﬁnished
behind the winner, ﬁnishing position (either won or placed in the
top three) and non-completion of race demonstrated inferior race
performance in those horses with epistaxis. A high percentage of
horses with epistaxis did not ﬁnish (~10% ﬂat to ~60% over
jumps). These ﬁndings suggest it is the intensity of racing that
aﬀects the prevalence of epistaxis, and this supports either the
capillary stress failure or locomotory impact-induced trauma
theory.
ABSTRACT E-56
COMPARISON OF AIRWAY RESPONSE OF RECURRENT
AIRWAY OBSTRUCTION AFFECTED HORSES FED
STEAMED VERSUS NON-STEAMED HAY. CA Blumerich1,
VA Buechner-Maxwell1, WK Scarratt1, KE Wilson1, C Ricco2, I
Becvarova1, J Hodgson3, S Werre3. 1Department of Large
Animal Clinical Sciences, 2Department of Small Animal Clinical
Sciences, 3Department of Biomedical Sciences and Pathobiology,
Virginia-Maryland Regional College of Veterinary Medicine,
Blacksburg, VA
Recurrent Airway Obstruction (RAO)-aﬀected horses experi-
ence bronchoconstriction and airway inﬂammation in response to
inhalation of aerosolized irritants including hay molds. Steaming
hay reduces fungal content, but the eﬀect on the antigenic poten-
tial of hay has not been investigated. We tested the hypothesis
that RAO-aﬀected horses develop less clinical disease when fed
steamed versus non-steamed hay and this reduction coincides
with decreased hay fungal content.
Six RAO-aﬀected horses in clinical remission were divided into
two groups and fed steamed or non-steamed hay for 10 days
using a two-way cross-over design. Hay was steamed using a
commercial hay-steamer a. Clinical assessment was performed
daily. Full assessment, including upper airway endoscopy, assign-
ment of mucous scores and measurement of maximal change in
pleural pressure, was performed on days 1, 5, and 10. Bronchial
ﬂuid sampling and cytology were performed on days 1 and 10.
Hay core samples were collected pre- and post-steaming and cul-
tured to determine fungal and bacterial concentrations.
Statistical analysis was performed using SAS® and included
repeated measures ANOVA, mixed model ANOVA, Wilcoxon
rank-sum and Wilcoxon two sample tests. P-value <0.05 was
considered signiﬁcant.
Horses fed non-steamed hay experienced a signiﬁcant increase
in clinical score (p<0.0001) and a trend towards total airway
neutrophilia (p=.0834) during the feeding period, while parame-
ters were unchanged in horses fed steamed hay. Steaming also
signiﬁcantly decreased the number of fungal colony-forming-units
in hay.
These results indicate that steaming reduces the RAO-aﬀected
horse’s response to hay which coincides with a reduction in via-
ble fungal content of hay.
aModel HG-1000, HAYGAIN hay steamer, Jiﬀy Steamer
Equine
ABSTRACT E-57
COMPARISON OF AIRWAY RESPONSES IN HORSES FED
ROUND BALE VERSUS SQUARE BALE HAY. J Larson1,
Buechner-Maxwell VA1, J Dascanio1, S Witonsky1, I Becvarova1,
RS Pleasant1, F Elvinger1, J Hodgson2, C Cossaboom3, C Seal3,
S Werre2. 1DLACS, VMRCVM, Duckpond Drive, Blacksburg,
VA, 2DBSP, VMRCVM, Duckpond Drive, Blacksburg, VA,
3Veterinary students, VMRCVM, Duckpond Drive, Blacksburg,
VA
Feed is a major expense associated with horse ownership. Hay
packaged as round bales (RB) costs approximately half that of
similar square bales (SB). Recent studies indicate that feeding RB
increases the risk of horses developing airway inﬂammation, and
it is not known if this response is due to packaging, storage or
hay quality diﬀerences. In this study we tested the hypothesis
that there would be no diﬀerence in the respiratory health of
horses fed RB as compared to horses fed SB of similar quality.
Hay harvested in mid-August from the same ﬁeld and pack-
aged as either RB or SB was fed two months later to two groups
of 15 horses. RB hay was wrapped in nylon mesh, stacked and
stored in an open-faced shed. SB hay was stacked and stored in
an enclosed loft. At the beginning and end of a 6-week feeding
period, physical and re-breathing examination, upper-airway
endoscopy, trans-tracheal wash (TTW) and bronchoalveolar-
lavage cytology, and TTW bacterial/fungal cultures were per-
formed on all horses. Nutritional analysis and bacterial/fungal
cultures were concurrently conducted on hay samples. Statistical
analyses were completed using a mixed model ANOVA, Wilco-
xon Two-sample test, Friedman’s Chi-square and a Fisher’s
Exact T-test. Data was log transformed as needed. Analyses were
performed using SAS® with P<0.05 considered signiﬁcant.
Horses fed RB demonstrated an increase in pharyngeal lym-
phoid hyperplasia (p=0.0143) and percentage neutrophils
(p=0.0078) in the TTW samples post-feeding as compared to
pre-feeding values. No additional signiﬁcant diﬀerences were
detected in any other measured parameters. Nutritional analysis
of hay and measurements of bacterial/fungal load did not diﬀer
over time and/or between hay types.
Following a six-week exposure to RB, normal horses demon-
strate subclinical evidence of upper airway inﬂammation as com-
pared to horses fed SB of similar quality, suggesting that
packaging contributes to this response. When eating round bales,
horses bury their nostrils in hay. This behavior could result in an
increased exposure to respirable particles that induce inﬂamma-
tion, but further studies are required to conﬁrm this prediction.
ABSTRACT E-58
CARDIAC ECHOGRAPHIC EVALUATION OF EQUINE
ELITE ATHLETES PRE AND POST ENDURANCE RACE.
A Giraudet1, C Robert2, D Maso2, E Barrey2. 1Ecole Nationale
Ve´te´rinaire d’Alfort, Maisons-Alfort, France, 2INRA-UMR1313,
Inserm-U902, France.
Equine echocardiography is routinely used in diseased horses
or poor performers. Athletes evaluation pre and post an actual
competition is less commonly performed.
Ten horses, 6 females and 4 gelding were examined the day
before and immediately after an 90km endurance ride. All horses
but one were 6 years old, one gelding was 11. All examined
horses successfully completed the race. A partial echocardio-
graphic examination was undertaken on every horses using a
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Vivid I (GE, Healthcare). Gray scale 2 D images from right
parasternal view with concurrent ECG were collected and stored
in 3 full cardiac cycles cine loops for later analysis. Only long
axis 4 chambers view were obtained. End systolic volume (mea-
sured at T repolarisation) and end diastolic volume (measured at
Q onset) were measured and fractional ejection (FE) calculated.
During the endocardium contouring process, it was noted that
mitral valves closure seemed delayed in post race measurements.
Systematic measurements of mitral valves closing time com-
pared with Q onset were performed. To adjust to heart rate vari-
ation the mitral valves closing time (MVCT) was divided by the
electric systolic duration (NMVCT). Due a non parametric distri-
bution of the calculated values (EF and NMVCT), Wilcoxon
Mann Whitney Test was used to compare pre and post race mea-
surements (P 0.05). As previously described, FE was not aﬀected
by the endurance race. NMVCT was statistically delayed after
the race, conﬁrming a post eﬀort prolonged isovolumetric con-
traction.
ABSTRACT E-59
EFFECT OF EXERCISE ON PLASMA ENDOTHELIN-1
AND ANGIOTENSIN CONVERTING ENZYME IN HORSES
WITH EXERCISE-INDUCED PULMONARY HEMOR-
RHAGE. L Coue¨til1, JS Biava2, S Tinkler1, K Ivester1, PD
Constable1. 1Purdue University College of Veterinary Medicine,
West Lafayette, Indiana, 2Sao Paulo State University College of
Veterinary Medicine, Sa˜o Paulo, Brazil
Horses exercising strenuously exhibit marked increase in pul-
monary artery pressure, a mechanism that has been implicated in
the pathophysiology of exercise-induced pulmonary hemorrhage
(EIPH). Endothelin-1 (ET-1) and angiotensin converting enzyme
(ACE) may act either directly or indirectly to cause pulmonary
artery hypertension. Therefore, we hypothesized that horses with
EIPH would exhibit higher plasma ET-1 concentration and ACE
activity compared to horses without EIPH following a standard-
ized treadmill exercise test (SET).
Eight Standardbred race horses were trained for 8 weeks
before participating in a randomized, crossover, controlled trial
where each horse received 0, 0.5 or 1 g/kg of sodium bicarbonate
by nasogastric intubation 4 hours prior to SET performed until
fatigue. Venous blood was collected prior to training, prior to
SET and 15 min post-SET for ET-1 assay and measurement of
ACE activity. Tracheoscopy was performed 15, 30, 60, 90, and
120 min post-SET to grade EIPH severity. Data were analyzed
using analysis of variance for repeated measures. Signiﬁcance
level was set at P<0.05.
Three horses exhibited EIPH. Plasma ET-1 concentration and
ACE activity were not signiﬁcantly aﬀected by training or bicar-
bonate treatment. Plasma ET-1 concentration increased signiﬁ-
cantly 15 min after SET in horses without EIPH (0.99 ± 0.55 pg/
ml) at which point it was signiﬁcantly higher than in horses with
EIPH (0.64 ± 0.34 pg/ml). ACE activity in plasma was signiﬁ-
cantly higher 15 min post-SET (69.8 ± 16.3 U/L) than before
(53.8 ± 11.9 U/L) regardless of EIPH status. Blood was detected
at the carina as early as 15 min post-SET with maximum EIPH
score being reached at 30 min. EIPH score 120 min post-SET
was signiﬁcantly lower than at 30 min post-SET.
We concluded that EIPH is not associated with an elevation in
plasma ET-1 concentration or ACE activity but horses without
EIPH experienced an increase in plasma ET-1 15 min following
strenuous exercise. Trained human athletes exhibit an increase in
ET-1 that peaks 30 minutes following exercise consistent with
ﬁndings in horses of this study.
ABSTRACT E-60
EQUINE PULMONARY CYTOKINE ENVIRONMENT AND
MICROBICIDAL ACTIVITY OF MACROPHAGES IN
FOALS VERSUS ADULTS. JM Gilbertie, S.A Wiechert, SK
Clark, M Bhandari, B Sponseller, B Bellaire, D Jones, BA
Sponseller. Iowa State University, College of Veterinary
Medicine, Ames, IA
Pneumonia is the most common cause of morbidity and mor-
tality in foals less than 6 months of age; however, adult horses,
unless immunocompromised, are not as susceptible to such respi-
ratory infectious agents, including Rhodococcus equi. We specu-
late that the pulmonary cytokine environment diﬀers between the
neonate and adult thereby imparting diﬀering phenotypes to pul-
monary alveolar macrophages (PAMs). This could result in dif-
ferences of microbicidal activity between adult and foal
monocyte-derived macrophages (MDMs) from blood and pulmo-
nary-alveolar macrophages (PAMs) from bronchoalveolar lavage
ﬂuid (BALF). MDMs and PAMs were stimulated in vitro with
IFNc and subsequently infected with R. equi transformed with a
GFP/dsRed plasmid enabling enumeration by ﬂuorescence. Con-
sistent with our hypothesis, MDMs and PAMs derived from
foals yielded a higher bacterial load than in adults. Also, foals
exhibited lower levels of peryoxynitrite production as compared
to the adult. Cytokine proﬁles, including TNFa and IL-10 from
BALF, were characterized by ELISA and yielded relative diﬀer-
ences, particularly for TNFa. The ratio of the concentration of
TNFa to IL-10 in BALF was higher in adults than in foals.
Foals exhibited a lower TNFa to IL-10 ratio than adults convey-
ing a lower pro-inﬂammatory cytokine milieu. In addition, the
IL-10 concentration was higher in the supernatant of R. equi
infected MDMs and PAMs. Taken together, these critical diﬀer-
ences indicate that foal macrophages are more susceptible to
infection with Rhodococcus equi and support the notion that the
cytokine milieu impacts the microbicidal response of the macro-
phage.
ABSTRACT E-61
EQUINE MONOCYTE-DERIVED DENDRITIC CELLS
STIMULATE PROLIFERATION AND FOXP3 EXPRESSION
IN AUTOLOGOUS, REACTIVE T CELLS. DJ Cavatorta, MJ
Felippe. Cornell University College of Veterinary Medicine,
Ithaca, NY
Dendritic cells (DCs) represent a heterogeneous population of
innate immune cells specialized in immune surveillance, antigen
presentation, and initiation of the adaptive immune response.
DCs are uniquely capable of stimulating naı¨ve T cells and can
generate a variety of eﬀector responses, anergy, or even tolerance.
Therefore, DCs are an essential component of a successful
immune response, and a detailed understanding of the interac-
tions between DCs and T cells is relevant to many areas of
immunology. We have developed a method of isolating and co-
culturing relatively pure populations of equine monocyte-derived
DCs with autologous, CFSE-stained peripheral blood T cells.
The magnitude and nature of the DC-induced T cell response
was monitored using multi-color ﬂow cytometry to measure T
cell proliferation, surface marker expression, and cytokine pro-
duction.
We discovered that equine monocyte-derived DCs, but not
macrophages, are able to potently induce proliferation of autolo-
gous, reactive T cells in the absence of foreign antigen
(p<0.002). This process, termed the autologous mixed leukocyte
reaction (AMLR), is a deﬁning feature of DCs not yet described
in cells from a domestic animal species. The equine AMLR is
contact-dependent (p<0.005), MHC class II-dependent
(p<0.02), and primarily involves CD3+, CD4+, CD8- T cells.
A subset of the proliferating T cells expresses the regulatory T
Table I. Mean Pre and post race FE, normalized mitral valve closure










Mean 72.48% 77.64% -5.3% 6.91% 12.24%
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cell (Treg) transcription factor FoxP3. Many of these DC-stimu-
lated, FoxP3+ T cells can produce eﬀector cytokines, indicating
that FoxP3 expression in the horse, in contrast to the mouse, is
regulated similarly to FoxP3 expression in man. However, the
FoxP3+ population is enriched for IL-10-competent cells, which
suggests that equine monocyte-derived DCs promote the genera-
tion of Tregs in vitro.
Our study describes the stimulatory capacity of equine mono-
cyte-derived DCs and permits the analysis of autologous, reactive
T cells that may play an important role in immune regulation.
Furthermore, we anticipate that future antigen-speciﬁc analyses
of the interactions between DCs and T cells in this manner will
enhance our knowledge of the equine immune system and pro-
mote the development of improved immunotherapeutic strategies.
ABSTRACT E-62
ARE BLOOD EQUINE NEUTROPHILS INHERENTLY
RESISTANT TO GLUCOCORTICOIDS? G Hirsch, A Lavoie-
Lamoureux, J-P Lavoie. Universite´ de Montre´al, St-Hyacinthe,
QC/CA
Human neutrophils are considered poorly responsive to gluco-
corticoids (GC). The reported increase in survival caused by GC
on this cell population partly supports this assertion. In heaves-
aﬀected horses, the persistent airway neutrophilia after GC
administration may be explained by this process. However, it was
recently shown that dexamethasone exerts potent anti-inﬂamma-
tory eﬀects on equine peripheral blood neutrophils through both
genomic and non-genomic pathways.
…Because objective support for the corticoresistance of neu-
trophils is lacking, we assess the eﬀects of three glucocorticoids
on apoptosis of equine blood neutrophils and compare their
transrepression eﬀects on neutrophils and mononuclear cells. To
determine if these eﬀects are species speciﬁc, data obtained from
horses were compared with those of human neutrophils and
mononuclear cells.
Peripheral blood neutrophils and mononuclear cells were iso-
lated from 6 healthy horses. To assess apoptosis, neutrophils
were incubated 20h with hydrocortisone, prednisolone or dexa-
methasone (10-8M to 10-6M). Quantiﬁcation of Annexin V-APC,
and 7-AAD binding was performed by ﬂow cytometry. To evalu-
ate transrepression eﬀects, neutrophils and mononuclear cells
were incubated 5h with or without LPS (100ng/mL) alone or
combined with GC. IL-8, IL-1b and TNF-a mRNA expression
was quantiﬁed by qPCR. Transrepression eﬀects of dexametha-
sone on human neutrophils and mononuclear cells were also
studied.
Stimulation with all three GC resulted in a signiﬁcant increase
in equine neutrophil survival. They also signiﬁcantly down-regu-
lated the LPS-induced mRNA expression of the three genes of
both equine and human neutrophils and mononuclear cells.
These eﬀects operate in a dose-dependent manner and dexameth-
asone appears to be the most potent drug.
These results indicate that glucocorticoids increase survival in
equine neutrophils but that these cells appear at least as respon-
sive as mononuclear cells to glucocorticoids.
ABSTRACT E-63
HEMATOPOIESIS IN THE EQUINE FETAL LIVER SUG-
GESTS IMMUNE PREPAREDNESS. JM Battista, T Stokol,
MJB Felippe. College of Veterinary Medicine, Cornell
University, Ithaca, NY
Our laboratory studies the development of the immune system
of the horse. Though B lymphocyte development is one of the
best-studied hematopoietic pathways, little is known about its
origin in the equine fetus, although it can produce antigen-spe-
ciﬁc immunoglobulins around 200 days of gestation. Studies in
other species show that hematopoietic stem cells (HSC) generated
in the aorta-gonad-mesonephros region and yolk sac seed the
fetal liver, which becomes the main hematopoietic organ and sup-
ports the development of B lymphocytes during fetal life.




Fetal Liver 98.5 97.9 99.3 98.6
Adult Bone Marrow 88.4 94.7 88.0 93.6
The purpose of our study was to learn how B cell hematopoie-
sis and immunoglobulin production develop in the equine fetus
during gestation. Our hypothesis was that hematopoiesis occurs
in the liver at early gestation with the generation of B cells with
limited immunoglobulin diversity. Equine fetal liver cells were
harvested around 100 days of gestation, and the presence of
hematopoietic stem cells and leukocytes were investigated at the
molecular and cellular levels.
The mRNA expression of molecules and transcription factors
involved in early lineage-speciﬁc hematopoietic diﬀerentiation
including c-KIT, CD34, IL7R, CXCL12, IRF8, PU.1, PAX5,
NOTCH1, GATA1, CEBP/A were detected using RT-
PCR. Immunohistochemistry and ﬂow cytometric analysis indi-
cated that approximately 5% of the cells were positive for the
HSC marker CD34, whereas 1-5% of cells stained positive for T
lymphocyte markers (CD2, CD3, CD4, CD5, CD8) and B lym-
phocyte markers (CD19, IgM), and 3-15% of cells expressed
myeloid markers (CD11b, CD172a). To characterize the pre-
immune B cell repertoire, heavy and lambda immunoglobulin
light chain V(D)J segments were cloned, sequenced, and ana-
lyzed. The fetal liver sequences had similar V(D)J gene segment
usage and complementarity determining region 3 (CDR3) amino
acid length, but had a higher degree of nucleotide identity with
germline sequences compared to those isolated from adult horse
bone marrow.
Our study demonstrates, for the ﬁrst time, active B cell hema-
topoiesis in the equine fetal liver around 100 days of gestation,
with a diverse, albeit in lower magnitude, pre-immune immuno-
globulin repertoire in comparison to the adult horse. The immu-
noglobulin diversity develops in an essentially sterile
environment, appears more extensive than other reported species,
and may have implications in equine neonatal immune-compe-
tence and response to vaccines.
ABSTRACT E-64
VERTEBRAL OSTEOMYELITIS AND DISKOSPONDYLITIS
IN FOALS. MC Coleman1, MK Chaﬃn1, J Griﬃn1,
WV Corapi1, TE Norman1, NM Slovis2, AL Johnson3,
KG Magdesian4, CC Clark5. 1Texas A&M College of Veterinary
Medicine, College Station, TX, 2Hagyard Equine Medical
Center, Lexington, KY, 3University of Pennsylvania New Bolton
Center, Kennett Square, PA, 4University of California School of
Veterinary Medicine, Davis, CA, 5Peterson and Smith Equine
Hospital, Ocala, FL
There are several cases reports in the literature of vertebral
osteomyelitis and/or diskospondylitis in the foal; however, to the
authors’ knowledge there are no large studies evaluating the clini-
cal features and outcome of this disease in foals.
The objective of this study was to describe the signalment,
clinical signs, results of clinicopathologic testing, results of diag-
nostic imaging (radiography, CT, ultrasound) and necropsy
examination, results of microbiologic testing, location of lesions,
treatment, and outcome of foals less than 1 year of age aﬀected
with vertebral osteomyelitis and/or diskospondylitis.
Data from 15 foals, from 5 diﬀerent referral centers were ret-
rospectively evaluated. Foals less than 1 year of age with radio-
graphic and/or necropsy ﬁndings consistent with osteolysis were
included in the study. Foals ranged in age from 2 weeks to 4
months. There were 11 males and 4 females with a variety of
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breeds represented. The most common clinical signs included
fever, tachycardia, tachypnea, anorexia, and lethargy. Spinal
ataxia and recumbency were noted in 1/2 and 1/5 of foals,
respectively. Clinicopathologic features were variable, with an ele-
vated white blood cell count in half of the cases. Lesions in the
cervical vertebral body were most common. Evidence of a septic
process of another body system was noted in less than half of the
cases. Seven foals survived to discharge.
In conclusion, vertebral osteomyelitis and diskospondylitis are
uncommonly reported in foals. Clinical signs and clinicopatho-
logic features are variable. Prognosis is guarded for aﬀected
foals.
ABSTRACT E-65
VERTEBRAL OSTEOMYELITIS AND DISKOSPONDYLITIS
IN ADULT HORSES. MC Coleman1, MK Chaﬃn1, J Griﬃn1,
WV Corapi1, TE Norman1, AL Johnson2, KG Magdesian3.
1Texas A&M College of Veterinary Medicine, College Station,
TX, 2University of Pennsylvania New Bolton Center, Kennett
Square, PA, 3University of California School of Veterinary
Medicine, Davis, CA
Vertebral osteomyelitis is uncommonly reported in adult
horses. While there are several case reports of vertebral osteomy-
elitis and/or diskospondylitis in the literature, to the authors’
knowledge there are no large studies evaluating the clinical fea-
tures and outcome of this disease in adult horses.
The objective of this study was to describe the signalment,
clinical signs, results of clinicopathologic testing, results of diag-
nostic imaging (radiography, CT, ultrasound) and necropsy
examination, results of microbiologic testing, location of lesions,
treatment, and outcome of adult horses aﬀected with vertebral
osteomyelitis and/or diskospondylitis.
Data from 19 adult horses, from 3 diﬀerent referral centers
were retrospectively evaluated. Cases with radiographic and/or
necropsy ﬁndings consistent with osteolysis were included in the
study. Cases consisted of 11 males and 8 females, ranging in age
from 2-24 years. A variety of breeds were represented. The most
common clinical signs included stiﬀness and poor performance.
Neurologic deﬁcits were noted in 1/3 of cases, all characterized
by symmetric ataxia in all four limbs. Clinicopathologic features
were variable, with a normal white blood cell count in 80% of
the cases. Lesions in the cervical vertebral body were most com-
mon. Lysis of adjacent vertebral endplates were noted in 2/3 of
cases. Thirteen horses survived to discharge, with 7 returning to
the previous level of performance.
In conclusion, vertebral osteomyelitis and diskospondylitis are
uncommonly reported in horses. Clinical signs and clinicopatho-
logic features are variable. Prognosis is guarded to fair.
ABSTRACT E-66
CLASSIFICATION AND PREDICTIVE FACTORS OF SEI-
ZURES IN HORSES. VA Lacombe1,2, M Mayes2, S Mosseri3,
SM Reed4, TH Ou5. 1Department of Veterinary Clinical
Sciences, 2College of Pharmacy, The Ohio State University,
Columbus, OH, 3The Equine Clinic, Peyrolles, France, 4Rood &
Riddle Equine Hospital, Lexington, KY, 5The University of
Michigan College of Pharmacy, Ann Arbor, MI
Although many studies have been performed to classify sei-
zures in humans and small animals, similar epidemiologic study
is lacking in horses. The purpose of this study was to characterize
seizures based on their type in 104 horses presented for seizure
disorders at The Ohio State University Veterinary Medical Cen-
ter in a retrospective case series.
Seizures were classiﬁed based on ictal phenomenology and sei-
zure type, according to most recent accepted deﬁnitions in both
human and small animal epileptology. History, clinical and neu-
rological observations, diagnostic investigations (e.g., electroen-
cephalograms, cerebrospinal ﬂuid analysis and computed
tomography imaging of the head) and postmortem examinations,
when available, were recorded for univariate and multivariate
logistic regression analyses.
Seizures were categorized as primary generalized in 24% of
horses, simple and complex partial without secondary generaliza-
tion in 45% of cases, secondary generalized in 20% of cases and
unclassiﬁed in 11% of cases. Status epilepticus was recorded in
2% of cases. Seizure type was not associated with etiology. For a
horse with recurrent seizures (i.e., epilepsy), the odds of having
partial seizures was higher (P<0.05) compared to a similar horse
with generalized seizures in the multivariate logistic regression
analysis.
This study provided a comprehensive classiﬁcation of seizures
by type in a referral-based equine population. Similar to human
and small animal classiﬁcation, the majority of the seizures
described were partial seizures with or without secondary general-
ization. Predictive factors of epilepsy in horses were similar to
those reported in other species and may assist the clinician with
the early diagnosis of epilepsy.
ABSTRACT E-67
BRAINSTEM AUDITORY EVOKED RESPONSE IN FOALS
UP TO 6 MONTHS OLD: REFERENCE VALUES AND
EFFECT OF AGE, RATE OF ACOUSTIC STIMULATION
AND NEUROLOGICAL DEFICITS. L Lecoq, M Gains,
L Blond, J Parent. Faculte´ de me´decine ve´te´rinaire Universite´ de
Montre´al, Saint-Hyacinthe, QC, Canada
Age and rate of acoustic stimulation aﬀect peak latencies in
brainstem auditory evoked responses (BAER) in human. Those
eﬀects are unknown in foals. The goals of this study were to 1)
establish references values for BAER in foals using 3 diﬀerent
stimulation protocols, 2) evaluate the eﬀects of age and rate of
stimulation on BAER traces in foals up to 6 months old, and 3)
compare the data with BAER obtained from foals with CNS dis-
orders.
Thirty nine foals neurologically normal and 16 foals with neu-
rological diseases. BAER were recorded using 3 diﬀerent proto-
cols of stimulation (11.33 Hz/70 dBNHL; 11.33 Hz/90 dBNHL;
90 Hz/70 dBNHL).
No eﬀects of age were observed in normal foals (p> 0.005).
No signiﬁcant diﬀerences were observed for latencies and inter-
peak latencies (IPL) when neurological foals were compared to
normal foals (p> 0.05). Increasing the stimulation rate did not
improve detection of CNS disorders. All neurologically abnormal
foals had latencies and IPL within reference values but 78.6%
had an asymmetry in their traces, reﬂecting a diﬀerence in con-
duction time between the left and right size of the brainstem.
We provide reference values of BAER for foals up to 6
months using 3 diﬀerent protocols. Further investigations are
needed to conclude on the use of an increased rate of acoustic
stimulation in foals. Most importantly, most foals with neurolog-
ical deﬁcits had also an abnormal BAER. This proves BAER is
useful is the early diagnosis of neurological disorders in foals.
ABSTRACT E-68
VALIDATION AND RELIABILITY OF ORTHOGONAL
ULTRASONOGRAPHIC PROJECTION DIMENSIONS OF
THE KIDNEY IN THE HORSE. JL Habershon-Butcher,
IM Bowen, GD Hallowell. School Of Veterinary Medicine and
Science, University of Nottingham, Sutton Bonington,UK
The aims of this study were to evaluate a novel translumbar
(TL) ultrasonographic method for assessment of renal dimen-
sions, to establish a normal reference range and to assess reli-
ability of renal dimensions obtained using this new approach
when compared with a conventional transabdominal (TA) ultr-
asonographic technique and measurements obtained at post-
mortem. Six Thoroughbred or TB cross horses, weighing
513±49Kg, were examined prior to slaughter. Both kidneys were
imaged in short and long axis using the TL and conventional
TA projections. Both cranial and caudal poles of the right kid-
ney were assessed. A minimum of twelve ultrasonographic cinel-
oops were obtained and stored for later analysis from both the
left and right kidneys. The overall length, width and depth were
determined, as were the thickness of the cortex, medulla and
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pelvis. The measurements were repeated in cadaveric material.
All measurements were undertaken by two observers to assess
reproducibility and measured on three separate occasions by
one observer to evaluate measurement repeatability. Measure-
ments were compared using Student’s T-test, ANOVA and
post-hoc Bonferoni and coeﬃcient of variation and reliability
was assessed using repeated measures ANOVA and intra-class
correlation coeﬃcients (ICC’s).
Both kidneys were consistently identiﬁed by both methods in
the 15-17th intercostal spaces (ICS) and paralumbar fossa with
maximal dimensions obtained for the left kidney in the 16th ICS
and for the right kidney in the 15th ICS. Image quality was good
to excellent for both techniques. There was no diﬀerence between
dimensions obtained by TA or TL projections and good correla-
tion between ultrasound dimensions and post-mortem measure-
ments (Table 1; ICC>0.8). Excellent repeatability and
reproducibility (ICC>0.80) was obtained for all measurements.
Reliability was better for larger structures. The TL technique is
easily performed and produces reliable dimensions that may
assist with the diagnosis of renal disease in horses.
ABSTRACT E-69
EFFECTS OF ORAL SODIUM BICARBONATE ADMINIS-
TRATION ON URINE NET BASE EXCRETION AND
STRONG ION DIFFERENCE IN STANDARDBRED
HORSES. S Tinkler, L Coue¨til, PD Constable. Purdue
University College of Veterinary Medicine, West-Lafayette, IN
It is widely recognized within the horse-racing industry that
accurate tests for the pre-race administration of alkalinizing
agents need to be developed. Measurement of urinary net base
excretion (NBE) or net acid excretion (NAE, where NAE=-
NBE) provides a more sensitive and speciﬁc method for evaluat-
ing acid-base balance than venous blood pH, bicarbonate, base
excess or urinary pH. We hypothesized that urinary NBE and
strong ion diﬀerence (SID) have utility as conﬁrmatory tests for
the race day administration of bicarbonate or other alkalinizing
agents in trained Standardbreds.
Four female Standardbreds (2 to 6 years of age) were fed a
typical training diet (DCAD  200 mEq/kg DM) and trained 5
times a week for 6 weeks using a high-speed treadmill. Sodium
bicarbonate was administered by nasal intubation at 0, 0.5, and
1.0 g/kg BW in 3 L of distilled water in a randomized cross-
over design 4 hours before horses underwent a simulated race
protocol (SRP) on a high-speed treadmill. Urine samples were
collected via a Foley catheter immediately before treatment
(time=0), at 2, 4, and 8 hours after treatment, and at 30 min-
utes and 90 minutes after the end of the SRP. Urine NBE and
ammonium concentration ([NH4
+]) were determined using an
automatic titrator (Schott Instruments, Mainz Germany) and
urine pH was determined using a glass electrode. Urinary
[Na+], [K+], and [Cl-] were measured using appropriate dilu-
tions on a Nova 4 analyzer (Nova Biomedical, Waltham MA)
and urinary SID was calculated as SID=[Na+]+[K+]-[Cl-].
Data was analyzed using repeated measures analysis of vari-
ance and P<0.05 was signiﬁcant using Bonferroni corrected
post-tests.
Oral sodium bicarbonate administration induced marked,
dose-dependent, and statistically signiﬁcant changes in urine
NBE, pH, and SID. Urine NBE was increased in horses adminis-
tered sodium bicarbonate, relative to untreated controls, at all
time-points after time=2 hours except 90 minutes after the end
of the SRP in horses treated with 0.5 g/kg. Urine pH was
increased in both groups of horses administered sodium bicar-
bonate, relative to untreated controls, at 30 minutes after the end
of the SRP and at time=8 hours. Urine SID was increased in
horses administered sodium bicarbonate, relative to untreated
controls, at all time-points after time=2 hours except at time=4
hours in horses treated with 0.5 g/kg. Urine pH was related to
NBE and urine [NH4
+] such that: pH = a + log10(NBE +
[NH4
+]). We conclude that the pre-race administration of oral
sodium bicarbonate induced marked, persistent, and statistically
signiﬁcant changes in urine NBE, urine pH, and SID. Our ﬁnd-
ings suggest that urine NBE and SID may have value as conﬁr-
matory tests for the race day administration of alkalinizing
agents in trained Standardbreds.
ABSTRACT E-70
EFFECTS OF MELOXICAM AND PHENYLBUTAZONE ON
RENAL RESPONSES TO FUROSEMIDE, DOBUTAMINE
AND EXERCISE IN HEALTHY HORSES. SL Raidal,
KJ Hughes, AL Charman, S Nielson, GK Noble. School of
Animal and Veterinary Sciences, Charles Sturt University,
Wagga Wagga, NSW, Australia
Non-steroidal anti-inﬂammatory drugs are widely used in
equine practice, exerting their therapeutic eﬀect by decreasing cy-
clooxygenase (COX) activity and thereby limiting production of
pro-inﬂammatory prostaglandins. However, prostanoids mediate
a number of protective mechanisms which are particularly impor-
tant for gastrointestinal and renal homeostasis. It has been hy-
pothesised that drugs which selectively target COX-2, the
induced isoform of this enzyme, may be safer analgesic and anti-
inﬂammatory agents than non-selective COX inhibitors. The
present study was undertaken to compare the eﬀects of meloxi-
cam, a COX-2 selective non-steroidal anti-inﬂammatory drug
(NSAID), with those of the non-selective drug phenylbutazone
on renal responses of healthy adult horses to furosemide, dobuta-
mine and sub-maximal exercise.
Ureteral catheterisation was used to determine urine ﬂow and
to collect samples for determination of exogenous creatinine
clearance during three hours of conﬁnement following adminis-
tration of placebo, phenylbutazone (PBZ, 4.4 mg/kg PO) or me-
loxicam (MEL, 0.6 mg/kg PO) to nine lightbreed mares.
Treatment order was randomised and a Latin square design uti-
lised such that each horse received all treatments. Thereafter, the
eﬀect of NSAID treatment on responses of these horses to the
subsequent administration of furosemide (1 mg/kg IV), dobuta-
mine (5 µg/min/kg IV for 30 minutes) and submaximal exercise
were assessed over a similar time period in three consecutive
studies.
Consistent with previous studies, NSAID administration had
no signiﬁcant eﬀect on baseline renal function of horses. Prior
treatment with PBZ or MEL attenuated increases in urine ﬂow
Abstract E-68:
Table 1. demonstrating normal reference ranges (Ref ranges; mean±2SD) and mean±SD for maximal renal dimensions obtained in the harvested kidneys
(PME) and from ultrasonograms using the novel technique (Translumbar; TL) and from conventional transabdominal (TA) ultrasonography. Maximal left
renal dimensions were obtained in the 16th ICS and those for the right in the 15th ICS.
Parameter (cm)
PME Translumbar (TL) Transabdominal (TA)
Ref ranges Mean±SD Ref ranges Mean±SD Ref ranges Mean±SD
Left renal length 13.4-18.6 16.0±1.3 10.6-17.8 14.2±1.8 10.5-19.7 15.1±2.3
Left renal width 11.6-14 12.8±0.6 10.4-14 12.2±0.9 11.4-13.4 12.4±0.5
Left renal depth 4.2-8.2 6.2±1.0 6.0-9.2 7.6±0.8 4.6-8.6 6.6±1.0
Right renal length 13.1-19.1 16.1±1.5 14.7-19.9 17.3±1.3 13.9-18.7 16.3±1.2
Right renal width 11-15 13.0±1.0 13.0-17.8 15.4±1.2 11.3-16.9 14.1±1.4
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associated with the administration of furosemide or following
exercise. Dobutamine infusion was associated with transient
increases in mean arterial pressure and urine output in all treat-
ment groups. Although COX-2 expression has not been evaluated
in the equine kidney, the results of this study suggest that selec-
tive COX-2 inhibitors, such as MEL, are likely to have similar
eﬀects on renal prostaglandin synthesis as non-selective agents,
and so pose similar risks for renal adverse eﬀects in susceptible
animals.
ABSTRACT E-71
EFFECT OF BUTORPHANOL ON THERMAL NOCICEP-
TIVE THRESHOLD IN HEALTHY PONY FOALS.
KT McGowan1, JR Elfenbein1,2, SA Robertson1, LC Sanchez1.
1University of Florida College of Veterinary Medicine,
Gainesville, FL, 2Texas A&M University College of Veterinary
Medicine and Biomedical Sciences, College Station, TX
Analgesia is an important component of foal medical care,
and no objective data currently exist regarding the analgesic eﬃ-
cacy of opioids in foals. The study objective was to evaluate the
somatic anti-nociceptive eﬀects of butorphanol in healthy foals.
The hypothesis was that thermal nociceptive threshold would
increase following intravenous butorphanol but not intravenous
saline administration in neonatal and older pony foals.
Seven healthy neonatal pony foals, 1-2 weeks of age, and 11
healthy older pony foals, 4-8 weeks of age were evaluated. Some
foals were used during both age periods. Interventions, which
included saline (0.5 mL IV), butorphanol (0.05 mg/kg) and but-
orphanol (0.1mg/kg) were administered in a blinded, randomized
cross-over design with at least 2 days between interventions. Each
dose was adjusted with saline to a total volume of 0.5 mL.
Response variables included thermal (TT) nociceptive threshold,
skin temperature (ST) and behavior score. Each was recorded
prior to and 15, 30, 45, 60, 90, 120, 150, and 180 minutes follow-
ing treatment.
A signiﬁcant (P<0.05) increase in thermal threshold, relative
to time 0, was noted following butorphanol (0.01mg/kg) adminis-
tration at times 15-60 and 120-150 minutes in neonates and at
times 15-90 and 150 minutes in older foals. Signiﬁcant time
eﬀects were not noted within other treatments in either age
group. No signiﬁcant time or treatment eﬀects were apparent for
skin temperature. Signiﬁcant time, but not treatment, eﬀects were
evident for behavior score in both age periods.
Butorphanol shows analgesic potential in both neonatal and
weanling age foals.
ABSTRACT E-72
SYSTEMIC AND ANTI-NOCICEPTIVE EFFECTS OF
PROLONGED CONTINUOUS RATE INFUSIONS OF
ANALGESIC COMBINATIONS IN HEALTHY HORSES.
JR Elfenbein1,2, SA Robertson1, RJ MacKay1, LC Sanchez1.
1University of Florida College of Veterinary Medicine,
Gainesville, FL, 2Texas A&M University College of Veterinary
Medicine and Biomedical Sciences, College Station, TX
Analgesic combinations are used to treat horses with severe
signs of pain. The purpose of this study was to determine the
eﬀects of prolonged constant rate infusions (CRI) of lidocaine
(L), butorphanol (B), and ketamine (K) alone and in combina-
tion on gastrointestinal transit, behavior, and thermal nociceptive
threshold in healthy horses.
Eight healthy adult horses, each equipped with a gastric can-
nula for purposes of other studies were used. Interventions were
saline, L, K, B, LK, LB, BK, and LBK as an intravenous CRI
for 96 hours in a randomized cross-over design with investigators
blinded to treatment. Drugs were mixed or diluted in saline; CRI
rate was 0.15mL/kg/hr (Table). Two-hundred plastic beads were
administered intragastrically by nasogastric tube immediately
prior to the bolus. Feces were collected every 2 hours, weighed,
and beads manually retrieved. Behavior was scored every 2
hours, vital parameters every 6 hours, and wireless thermal
threshold every 12 hours for 96 hours.
Four of 64 trials (3 LBK, 1 BK) were discontinued early due
to mild colic. There were no apparent diﬀerences between groups
in vital parameters or thermal threshold. Transit time was
delayed for LB and LBK with a corresponding decrease in fecal
weight.
Analgesic combinations cause a delay in gastrointestinal transit
in healthy horses without substantially aﬀecting somatic nocicep-
tion at the doses studied.
Drug Bolus (15 minutes) CRI
Saline 60 mL 0.15 mL/kg/hr
Lidocaine 1.3 mg/kg 3 mg/kg/hr
Butorphanol 0.018 mg/kg 0.013 mg/kg/hr
Ketamine 0.55 mg/kg 0.5 mg/kg/hr
ABSTRACT E-73
FIROCOXIB LOADING DOSE TRIAL IN HORSES. S Cox, C
Sommardahl, J Yarbrough, A Amicucci, K Reed, D Breeding, T
Doherty. University of Tennessee, College of Veterinary
Medicine, Knoxville, TN
The objective of this study was to determine if a single loading
dose, three times the label dose of ﬁrocoxib oral paste, followed
by nine maintenance doses at the current label dose achieves and
maintains near steady state concentrations. Six healthy, adult
mares received 0.3 mg/kg of ﬁrocoxib on Day 0, followed by 0.1
mg/kg administered at 24 hours on Day 1, and at 24 hour inter-
vals Day 2 through Day 9, for a total of 10 doses. Blood samples
were collected at 0 (prior to treatment), 0.25, 0.5, 1, 2, 4, 6, and
12 hours post treatment on Day 0, prior to treatment on Day 1,
and at the same times as Day 0. Blood samples were also col-
lected prior to each treatment on Days 2-9 and at 0.25, 0.5, 1, 2,
4, 6, 12, 24, 48, 72, 96, 120, 144, and 168 hours post treatment
on Day 9. Samples were centrifuged and plasma stored frozen
until analyzed by a validated HPLC-MS method.
After the initial loading dose of 0.3 mg/kg (3X label dose), the
average maximum concentration was 199 ng/mL. After the ﬁrst
maintenance dose of 0.1 mg/kg the maximum average concentra-
tion was 171 ng/mL. At steady state (after the last dose) the max-
imum average concentration was 183 ng/mL. This indicates near
steady state concentrations are achieved after the ﬁrst dose. The
maximum and minimum plasma concentrations (Cmax and
Cmin) at steady state ranged from 110-243 ng/mL and 50-168
ng/mL, respectively. There was no indication of unexpected accu-
mulation. The average AUC (0-tau) was 150 ng/mL*days.
Plasma concentrations decreased in a monoexponential manner
after the last dose and the average half life was 1.74 days.
ABSTRACT E-74
SAFETY AND PHARMACOKINETICS OF TOPICAL 1%
DICLOFENAC SODIUM CREAM IN HEALTHY NEONA-
TAL FOALS. S Barnett1, D Sellon1, M Hines1, D Neelis1, R
Mealey1, H Knych2, R Keene3. 1Washington State University,
Pullman, WA, 2University of California-Davis, Davis, CA,
3Boehringer Ingelheim, St. Joseph, MO
This study evaluated the biochemical, renal, and gastrointesti-
nal eﬀects of topical 1% diclofenac sodium cream (Surpass®) in
healthy neonatal foals.
A randomized, blinded, controlled, clinical trial was performed
on 12 healthy Arabian or part-Arabian foals that were 2-14 days
of age and weighed 27-54 kilograms on day 1 of the study.
Cream (7.3 mg [1.3 cm strip] of diclofenac or equivalent volume
of Cetaphil® hand moisturizer) was applied to a clipped area
over the left tibiotarsal joint twice daily for 7 days. Serum chem-
istry, CBC, urinalysis, urine gamma-glutamyltransferase:urine
creatinine (uGGT:uCr), renal and right dorsal colon ultrasound,
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and gastric endoscopy were evaluated on the ﬁrst and last days
of study. Foals were monitored daily and showed no signs of sys-
temic illness during the study. Venous blood was obtained at spe-
ciﬁc time points for pharmacokinetic analysis. Data were
compared using 2-sample T-test or ANOVA as appropriate. No
adverse events related to diclofenac treatment occurred. No sta-
tistically signiﬁcant diﬀerences (p 0.05) between groups were
observed. Changes in uGGT:uCr ratios, which were considered
the most sensitive parameters, were not diﬀerent between groups
(p=0.93). Skin and hair growth were normal at the application
site throughout the study and at 2-6 months following the study.
Plasma concentrations of diclofenac were low but detectable in
treatment foals throughout the study.
Diclofenac sodium applied to clipped skin of healthy neonatal
foals at 7.3 mg twice daily for 7 days was a safe dosing regimen.
Evaluation of eﬃcacy in reducing pain and inﬂammation in the
equine neonate is warranted.
ABSTRACT E-75
PHARMACOKINETICS OF GALLIUM MALTOLATE IN
HEALTHY AND LAWSONIA INTRACELLULARIS-
INFECTED RABBITS. F Sampieri1, J Alcorn2, AL Allen1,
CR Clark1, FA Vannucci3, N Pusterla4, KR Ball1,
PM Dowling1, J Thompson5, LR Bernstein6, CJ Gebhart3, DL
Hamilton1. 1Western College of Veterinary Medicine, University
of Saskatchewan, Saskatoon, SK, Canada, 2College of Pharmacy
and Nutrition, University of Saskatchewan, Saskatoon, SK,
Canada, 3College of Veterinary Medicine, University of
Minnesota, Saint Paul, MN, 4School of Veterinary Medicine,
University of California, Davis, CA, 5Canadian Light Source,
Saskatoon, SK, Canada, 6Terrametrix, Menlo Park, CA, USA
We hypothesized that gallium maltolate (GaM) may prove
eﬀective as a novel antimicrobial agent for weanling foals aﬀected
by equine proliferative enteropathy (EPE), caused by Lawsonia
intracellularis (LI). This is one of a series of experiments where,
in a rabbit infection model of EPE, we addressed pharmacokinet-
ics (PK) and pharmacodynamics characterization of GaM. Since
gallium may interfere with iron uptake pathways, we compared
PK and intestinal tissue (IT) concentrations of elemental gallium
[Ga] and iron [Fe] after oral administration of GaM to LI-
infected and uninfected rabbits. The Animal Research Ethics
Board of the University of Saskatchewan approved these studies.
Twelve, 8 to 9 wk old pathogen-free New Zealand White does,
2 to 2.5 kg, were divided into 2 groups of 6 animals: uninfected
group (control) and LI-infected group (EPE). Both groups were
treated once intragastrically with 50 mg/kg GaM. EPE rabbits
were treated 7 days post infection. Serial blood samples were
taken from an indwelling auricular arterial catheter, from time 0
to 216h (9 days) post-treatment (PT). At 9 days PT, rabbits were
sacriﬁced and IT samples were collected from intestinal sections
where EPE lesions are characteristically identiﬁed. Tissues were
frozen at -20°C or ﬁxed in 10% phosphate buﬀered formalin.
Presence or absence of EPE in rabbits was conﬁrmed via detec-
tion of LI-speciﬁc antibodies using immuno-peroxidase mono-
layer assay, quantitative PCR on feces and immuno-
histochemistry on IT. Elemental [Ga] and [Fe] were determined
in IT and blood ([Ga] only) using inductively coupled plasma -
mass spectrometry. A non-compartmental approach was used for
PK parameter estimation. Statistical comparison (alpha always
set at 5%) of PK parameters in the 2 groups was performed with
Student t-test; and [Ga] and [Fe] comparison in IT with one-way
ANOVA.
The log-linear terminal phase rate constant for gallium was
lower (p= 0.03) in EPE-rabbits (0.0171 ± 0.0028 (SD) h-1 in con-
trols and 0.0116 ± 0.004 (SD) h-1 in EPE-rabbits, consistent with
the longer terminal gallium half-life (t½) observed in EPE-rabbits
(59.4 ± 24.0h vs 39.4 ± 10.8h in controls). No other PK parame-
ter estimates were signiﬁcantly diﬀerent between groups. In con-
trols and EPE-rabbits respectively, Cmax was 0.5± 0.214 vs 0.59±
0.416 ug/mL; tmax was 1.75 ± 0.41 vs 0.9 ± 0.37 h; oral clearance
was 2.5 ± 0.9 vs 3.04 ± 1.14 ul/h. At 9 days PT [Ga] and [Fe] in
IT were higher (p < 0.0001) in controls. Our results suggest that
administration of GaM every 48h, is an appropriate dosing inter-
val for multi-dose studies in rabbits, since EPE increases GaM
t½. Furthermore, GaM-dosed EPE rabbits not only have reduced
[Ga] in IT, but also reduced [Fe], despite its consistent availabil-
ity in the diet.
ABSTRACT E-76
EFFICACY OF GALLIUM MALTOLATE AGAINST LAWSO-
NIA INTRACELLULARIS INFECTION IN A RABBIT
MODEL. F Sampieri1, A.L Allen1, J Alcorn2, CR Clark1,
FA Vannucci3, N Pusterla4, KR Ball1, PM Dowling1,
J Thompson5, LR Bernstein6, CJ Gebhart3, D.L Hamilton1.
1Western College of Veterinary Medicine, University of
Saskatchewan, Saskatoon, SK, Canada, 2College of Pharmacy
and Nutrition, University of Saskatchewan, Saskatoon, SK,
Canada, 3College of Veterinary Medicine, University of
Minnesota, Saint Paul, MN, 4School of Veterinary Medicine,
University of California, Davis, CA, 5Canadian Light Source,
Saskatoon, SK, Canada; 6Terrametrix, Menlo Park CA, USA
Rabbits act as a time-compressed infection model for weanling
foals aﬀected by equine proliferative enteropathy (EPE), due to
Lawsonia intracellularis (LI). As gallium maltolate’s (GaM) anti-
microbial eﬃcacy against LI is diﬃcult to evaluate in vitro, we
administered GaM to LI-infected rabbits (GAL-LI). Also, we
compared GaM eﬃcacy with untreated LI-infected controls
(CON-LI) and doxycycline-treated LI-infected positive controls
(DOXY-LI), as doxycycline is the leading treatment in clinical
cases. The Animal Research Ethics Board of the University of
Saskatchewan approved this study.
Twenty-four, 5 to 6 wk old, pathogen-free New Zealand White
does, 1.2 to1.5 kg, were infected intragastrically with LI (approx.
2.5 x 108 LI/rabbit) and then assigned to 3 groups (8 animals
each): untreated (CON-LI), medium-only treatment, q 24h,
orally; GaM-treated (GAL-LI) 50 mg/kg q 48h orally; and doxy-
cycline-treated (DOXY-LI) 5 mg/kg q 24h, orally. Treatment
started 7 days post-infection for each group. Feces were collected
daily from each group and blood was collected from each doe
once weekly for serology. A week from the ﬁrst treatment, all
rabbits were sacriﬁced and gastrointestinal tissues (GIT) were
collected from intestinal tracts characteristically aﬀected by EPE.
Samples were frozen at -20°C, or immediately ﬁxed in 10% phos-
phate buﬀered formalin. In all groups, EPE was conﬁrmed via
detection of LI-speciﬁc antibodies using immuno-peroxidase
monolayer assay, quantitative PCR on feces and immuno-histo-
chemistry (IHC) on GIT. Inductively coupled plasma-mass spec-
trometry was used to quantify gallium [Ga] and iron [Fe]
concentrations in GIT and blood ([Ga] only). Statistical analysis
(alpha always set at 5%) was performed using a contingency
table and Chi-square test for the number of lesions detected via
IHC in each GIT section of the 3 groups; a one-way ANOVA
was used to compare [Ga] and [Fe] in GIT.
EPE lesions were typically stained via IHC in mid- and end-
jejunum and cecum, but no diﬀerence due to treatment was
detected in the said GIT (p values 0.35; 0.77; 0.74 respectively).
None of the treatments caused a signiﬁcant diﬀerence in fecal
shedding detected by qPCR (p=0.64). Also, multiple GaM treat-
ment led to higher [Ga] and [Fe] in the cecum (p = 0.0064 and
<0.0001, respectively), compared to other GIT. Multiple doses
of GaM did not cause any adverse eﬀect in rabbits; however, our
results show that GaM is not more eﬃcacious than the leading
clinical treatment (doxycycline) in the EPE rabbit infection
model.
ABSTRACT E-77
PHARMACOKINETICS OF INTRAVENOUS CONSTANT
RATE INFUIONS OF CEFTIOFUR SODIUM IN THE
ADULT HORSE. S Khalfan, S Edwards SL Raidal. School of
Animal and Veterinary Sciences, Charles Sturt University,
Wagga Wagga, NSW, Australia
Ceftiofur is a time dependent bacteriocidal antimicrobial. As
such, plasma concentrations should be maintained above the
mean inhibitory concentration (MIC) of target organism(s) for
greater than 80% of the inter-dosing interval. Many Gram nega-
tive pathogens have MICs approaching or exceeding 1 – 2 µg/
mL, concentrations which are unlikely to be maintained in vivo
by the use of intermittent dosing. In human patients, b-lactam
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antimicrobials are often administered as a continuous rate infu-
sion (CRI) to ensure that plasma concentrations are maintained
at high levels for the duration of treatment. For hospitalised
equine patients, a CRI is readily implemented and may oﬀer a
therapeutic and economic advantages over bolus treatments.
Ceftiofur sodium (285 µg/kg/h) was administered by CRI to
six healthy thoroughbred / standardbred mares (age 3 to 9 years,
body weight 488 to 630 kg) for 48 hours following a 3.2 mg/kg
IV loading dose. Plasma samples were collected for determination
of desfuroylceftiofur concentrations prior to loading and at 1, 5,
10, 15, 30 and 60 min following commencement of treatment,
and then at regular intervals throughout the duration of infusion.
Plasma samples were also collected after 48 hours of treatment
and at 1, 2, 3, 4, 8, 12 and 18 h following completion of CRI.
Synovial ﬂuid samples were collected from intercarpal and radio-
carpal joints after 48 h CRI, and at 2, 8 and 18h following com-
pletion of treatment.
CRIs were well tolerated by all horses. Appetite, demeanour,
faecal output and consistency were unaﬀected by treatment. No
changes were observed in haematological or serum chemistry
parameters post-infusion, when compared with values obtained
prior to infusion. Peak plasma defuroylceftiofur concentrations
(28.2 ± 8.3 µg/mL, mean ± sd; range 20.4 to 41.7 µg/mL) were
observed 1 min following administration of the loading dose.
Thereafter plasma concentrations plateaued by 3 to 4 hours after
commencement of CRI and remained constant at 6.3 ± 1.3 µg/
mL. Synovial ﬂuid concentrations at 48 h were 2.0 ± 0.8 µg/mL.
The total amount of ceftiofur administered to each horse was
approximately 46% of the total dose administered via bolus dos-
ing at 10 mg/kg q 12h.
ABSTRACT E-78
USE OF COMBINATION OF TAZAROTENE CREAM AND
IMIQUIMOD 5% CREAM IN THE TREATMENT OF
EQUINE SARCOIDS: A 20 CASE RETROSPECTIVE
STUDY. Y Tamzali, M Boidot. INP-Ecole Ve´te´rinaire de
Toulouse, Universite´ de Toulouse, France
Sarcoids are the most common cutaneous neoplasms of horses.
Despite the numerous types of treatments that have been devel-
oped, none is universally eﬀective, and the rate of recurrence of
surgical excision is usually high. Successful management has been
achieved with the use of radiotherapy and chemotherapy, and
more recently with the use of electrochemotherapy.
However biosafety constraints restrict their use to qualiﬁed
equine structures. Topical treatments which could be used in
ambulatory practice at the owners place could oﬀer a valuable
alternative to these treatments. Imiquimod, an imidazoquinol-
amine, is an immune response modiﬁer with antitumoral and an-
tiviral activity successfully used in humans in the treatment of
cutaneous tumours such as melanomas, carcinomas and actinic
keratosis. In equine medicine, a 5% imiquimod cream has been
tested successfully in the treatment of equine sarcoids and aural
plaque. Tazarotene normalizes the behaviour of the keratino-
cytes, which is used for its keratolytic activity on verrucous
(warty) form of equine sarcoids. The aim of this study was to
conﬁrm the eﬃcacy of 5% imiquimod in treatment of equine sar-
coid, and to evaluate the beneﬁt of a prior treatment with a
0.1% tazarotene cream. 24 cases were treated from June 2007 to
June 2010. 20 cases totalizing 83 tumours (T0 to T3 according to
Owen’s classiﬁcation) met the criteria for inclusion in the study.
The four remaining cases were excluded because of lack of treat-
ment compliance. Animals were also required to have complete
medical records and a minimum of 12 months follow-up. Two
large tumours (one T3 and one T4) were subjected to prior deb-
ulking. Tazarotene 0.1% cream was applied daily for two weeks
prior to imiquimod 5% cream which initial prescription duration
was every other day for 12 weeks and pursued until complete res-
olution of tumours if necessary. All tumours responded well with
a complete response rate of 63% at 12 weeks, 87% at 16 weeks
and up to 100% at 21 weeks. There was no inﬂuence of the
tumour size on the duration of treatment (p= 0.153). 35% of
lesions resulted in persistent alopecia after treatment but alopecia
was signiﬁcantly correlated (p=0.0001) with keratinization
(verrucous sarcoids) which resulted in pretreatment alopecia. In
53% of tumours hair regrowth was observed while leucotrichia
was observed in 12% of treated tumours. The major side eﬀect
was inﬂammation and pain at the treatment site especially in thin
skin regions. This was controlled in most cases with NSAIDs
administration but was also the cause of some treatments lack of
compliance. This study provides additional evidence of the eﬀec-
tiveness of imiquimod on superﬁcial sarcoids and suggests that
the combination of tazarotene and imiquimod topical treatments
may improve the results compared to previous studies.
ABSTRACT E-79
REDUCED CARDIAC OUTPUT IN HORSES ANESTHE-
TIZED AFTER DANTROLENE ADMINISTRATION.
E McKenzie1, S Di Concetto2, M Payton3, R Mandsager1,
M Arko4. 1Oregon State University, Corvallis, OR, 2St George’s
University, Grenada, West Indies, 3Oklahoma State University,
Stillwater, OK, 4University of Ljubljana, Ljubljana, Slovenia
Dantrolene may prevent post-anesthetic myopathy in horses.
This study examined the eﬀect of dantrolene on cardiac output
(CO) and other variables in healthy horses under general anesthe-
sia, and on the duration and quality of anesthetic recovery.
In a randomized cross-over trial, six horses were administered
dantrolene (6 mg/kg in 2L of water) or water (2L) via nasogastric
tube one hour before commencing 90 minutes of isoﬂurane anes-
thesia. CO was measured via lithium dilution technique seven
times during anesthesia concurrently with analysis of plasma
potassium concentration. Anesthetic recovery was scored by two
anesthesiologists blinded to treatment groups. Serum creatine
kinase (CK) was measured before and 4, 8 and 12 hours after
anesthesia. Data were analyzed by repeated measures ANOVA (p
< 0.05).
Dantrolene caused signiﬁcantly lower CO (L/min) at the 2nd
(30.5±2.8 vs. 24.4±2.1), 3rd (28.1±1.3 vs. 20.9±3.0) and 4th
(27.9±0.9 vs. 20.9±2.5) measurements after which time diﬃculty
obtaining valid measurements in dantrolene-treated horses sug-
gested further decline. Plasma potassium (mEq/L) was signiﬁ-
cantly higher after dantrolene at the 5th (4.5±0.3 vs. 5.2±0.3), 6th
(4.5±0.2 vs. 5.3±0.5), and 7th (4.5±0.2 vs. 5.9±0.7) measurements.
Cardiac arrhythmias necessitated premature recovery of two dan-
trolene-treated horses. Recovery time was not diﬀerent between
treatments but quality score was superior after dantrolene. Serum
CK (U/L) was signiﬁcantly lower 4 hours (2873±1721 vs. 325±79)
and 8 hours (3159±2073 vs. 351±88) after anesthesia with dantro-
lene.
In conclusion, dantrolene reduces muscle damage in horses
undergoing general anesthesia without inhibiting anesthetic
recovery, but decreases cardiac output and can precipitate hyper-
kalemia and arrhythmias.
ABSTRACT E-80
RESPONSE OF ACTIVATED EQUINE CHONDROCYTES
FROM CARPAL AND HOCK JOINTS TO AN AVOCADO/
SOYBEAN UNSAPONIFIABLES, GLUCOSAMINE, CHON-
DROITIN SULFATE, PENTOSAN POLYSULFATE, AND N-
ACETYL GLUCOSAMINE COMBINATION. SL Ownby1,
LF Heinecke1, AC Mrozinski1, MW Grzanna1, AY Au1,
AM Rashmir-Raven2, CG Frondoz a1,3,4. 1Nutramax
Laboratories, Inc., Edgewood, MD, 2Michigan State University,
East Lansing, MI, 3Johns Hopkins University, Baltimore, MD,
4Mississippi State University, Mississippi State, MS
The pathogenesis of osteoarthritis (OA) has been attributed to
up-regulation of pro-inﬂammatory molecule expression in chon-
drocytes and other joint tissues. These molecules include prosta-
glandin E2, cytokines, and chemokines. Expression of these genes
is regulated by the transcription factor nuclear factor-kappa B
(NF-B). Inhibition of their up-regulation is a major objective for
the management of OA. While OA aﬀects articular cartilage in
diﬀerent joints, little is known whether the inﬂammatory response
of chondrocytes vary from diﬀerent sites. In the present study,
we compared the response of chondrocytes isolated from carpal
and hock cartilage to cytokine stimulation. We also evaluated
whether these stimulated chondrocytes would display similar
responses to the mixture of avocado/soybean unsaponiﬁables
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(ASU), glucosamine (GLU), chondroitin sulfate (CS), pentosan
polysulfate (PPS), and N-acetyl glucosamine (NG). These com-
pounds have been shown to provide anti-inﬂammatory and chon-
droprotective eﬀects in vivo and in vitro. ASU, GLU, and CS are
also been used for the management of equine OA.
Chondrocytes (5x105 cells/well) were pre-incubated for 24
hours with: (i) control media alone or (ii) the combination of
ASU (NMX1000®, 8.3µg/mL)+GLU (FCHG49®, 11µg/mL)
+CS (TRH122®, 20µg/mL)+[PPS+NG] (AUPEN5000TM,
PPS: 125lg/mL, NG: 200lg/mL). Cells were activated with inter-
leukin-1b (IL-1b; 10ng/mL) for 1 hour. Total RNA was isolated
and real-time PCR used to quantify IL-1b, tumor necrosis fac-
tor-a (TNF-a), interleukin-6 (IL-6), cyclooxyengase-2 (COX-2),
and interleukin-8 (IL-8) gene expression. Intracellular localization
of NF-jB was determined by immunohistochemistry. Statistical
analysis was run using one-way ANOVA and the Tukey post-hoc
test with signiﬁcance set at P<0.05.
Carpal and hock chondrocytes showed similar responses to
cytokine activation resulting in increased pro-inﬂammatory gene
expression. Cytokine activation in carpal and hock-derived chon-
drocytes was signiﬁcantly (P<0.001) and similarly inhibited by
ASU+GLU+CS+[PPS+NG]. Inﬂammatory gene expression
suppression was accompanied by NF-jB translocation inhibition.
These ﬁndings support the utility of the ASU+GLU+CS
+[PPS+NG] combination for the management of fore- or hind-
joint inﬂammation in horses and other species. (Research sup-
ported by Nutramax Laboratories, Inc.)
ABSTRACT E-81
LAMINAR ANTIOXIDANT GENE EXPRESSION IN EXPER-
IMENTALLY-INDUCED EQUINE LAMINITIS: A COMPAR-
ISON OF TWO MODELS. TA Burns1, MR Watts1,
T Westerman2, JK Belknap1. 1College of Veterinary Medicine,
The Ohio State University, Columbus, OH, 2College of
Veterinary Medicine, Oregon State University, Corvallis OR
Oxidative stress reportedly plays an important role in sepsis-
induced organ dysfunction/failure in many species. While oxida-
tive events are also likely to occur in laminae in sepsis-associated
laminitis, we have recently reported minimal evidence of end-
stage oxidative tissue injury in models of sepsis-related laminitis.
A robust antioxidant response to oxidative events might underlie
the lack of oxidative tissue modiﬁcation observed in the digital
laminae of horses with experimentally-induced laminitis. The
laminar antioxidant response to experimentally-induced equine
laminitis has not been fully characterized, and this response has
not been directly compared between the black walnut extract
(BWE) and enteral carbohydrate overload (CHO) models of lam-
initis. Antioxidant enzymes likely to be present in laminar tissue
include superoxide dismutase 1 (SOD1)/cytosolic SOD, SOD2/
mitochondrial SOD, SOD3/extracellular SOD, glutathione perox-
idase 1 (GPX1, cytosolic), and GPX4 (membrane-associated). We
hypothesized that these genes would be expressed at higher con-
centrations in the laminae of laminitic animals compared with
that of control animals. Archived digital laminar tissue collected
at various time points from adult horses subjected to BWE- (n
= 15) and CHO- (n = 20) induced laminitis were used for this
study. Laminar antioxidant gene expression was evaluated at
both the transcript (RT-qPCR) and protein (Western immuno-
blot) levels. In the CHO model, no change in mRNA concentra-
tion of GPX1 (p = 0.91), GPX4 (p = 0.43), SOD1 (p = 0.56),
or SOD3 (p = 0.29) was detected at the developmental or OG1
time points when compared with controls. The concentration of
SOD2 mRNA, however, was signiﬁcantly elevated at the OG1
time point when compared with controls (p = 0.0019). In the
BWE model, laminar mRNA concentrations of GPX4 (p =
0.018) and SOD2 (p = 0.0004) were signiﬁcantly increased at the
OG1 time point when compared with samples from both control
and developmental time points. Concentrations of SOD1 and
SOD3 mRNA were signiﬁcantly lower at the OG1 time point
compared with the developmental time point in this model (p =
0.0075 and p = 0.021, respectively). The protein concentration
of SOD2 within digital laminar tissue was increased at the devel-
opmental and OG1 time points in both models; this was the only
gene evaluated that displayed regulation at the protein level. The
results of this study suggest that up-regulation of antioxidant
genes within the digital laminae may play a role in mitigating the
extent of oxidative tissue modiﬁcation that occurs in the setting
of experimentally-induced laminitis; future studies including
assessments of non-enzymatic antioxidants and total reductive
capacity of laminar tissue would further our understanding of
the laminar antioxidant response.
ABSTRACT E-82
PLASMA ATRIAL NATRIURETIC PEPTIDE CONCENTRA-
TIONS AT REST IN HORSES WITH VARIOUS HEART
DISEASES. DS Trachsel, B Grenacher, CC Schwarzwald.
Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
Atrial natriuretic peptide (ANP) is physiologically expressed in
the heart and mainly released from atrial tissue after myocardial
stretch. Moreover, the expression in ventricular myocytes can be
enhanced by cardiac diseases. We hypothesized that horses with
heart diseases aﬀecting left atrial (LA) dimensions and/or func-
tion or left ventricular (LV) dimensions and/or function have
higher plasma ANP concentrations (CANP) than healthy controls
and that CANP can be used diagnostically to identify horses with
cardiac disease associated with alterations in chamber size and
function.
Blood samples were collected from 61 horses with heart dis-
eases (age 14 ± 6 years, body weight 542 ± 102 kg [mean ± SD])
and from 15 healthy horses (10 ± 4 years, 589 ± 47 kg). The
horses were assigned to 4 groups based on history, physical
examination and echocardiographic examination: (1) healthy con-
trols, (2) horses with heart disease but normal chamber size and
function, (3) horses with heart disease, abnormal LA size and/or
function, and normal LV, and (4) horses with heart disease with
both abnormal LA and LV size and/or function. CANP was mea-
sured by a commercially available radio-immunoassay (ANP(1-
28) (human, bovine, porcine) RIA kit (S-2011), Peninsula Labo-
ratories, San Carlos CA, USA). Log (CANP) was compared (a)
between controls and all horses with disease using Student’s t-test
and (b) between all 4 groups using one-way ANOVA with Holm-
Sidak post-hoc test for multiple comparisons. ROC analyses were
used to describe test characteristics and to identify appropriate
cut-oﬀ values.
CANP was higher in horses with heart disease (103.0 [13.5-
488.0] pg/mL, median [range]) compared to healthy controls
(65.0 [22.0-92.0] pg/mL; p = 0.01). When considering all 4
groups, the diﬀerence was only signiﬁcant between control horses
and group 4 (137.0 [13.5-488.0] pg/mL). At a cut-oﬀ value of
95.5 pg/mL, CANP had a sensitivity of 57% (95% CI: 44-70%)
and a speciﬁcity of 100% (95% CI: 78-100%) for diagnosing
heart disease in horses. However, the test did not allow discrimi-
nation between groups 2, 3 and 4.
In conclusion, CANP increases with heart diseases aﬀecting
chamber dimensions and/or function. Using the RIA applied in
this study, CANP can be used as a biomarker to identify horses
with heart disease with high speciﬁcity but low sensitivity. The
diagnostic value of this biomarker is compromised by the large
overlap in CANP between healthy horses and horses with heart
disease.
E-82B
IMMUNOLOGIC AND PHYSIOLOGIC RESPONSE TO
VACCINATION AGAINST ANGIOTENSIN II IN ADULT
HORSES. RC Carmichael1, TC Holbrook1, G Jennings2, P
Maurer2. 1Oklahoma State University, Stillwater, OK., 2Cytos
Biotechnology, Schlieren, Zurich Switzerland.
Hypertension is documented in equine diseases including meta-
bolic syndrome, laminitis and chronic renal failure. Currently,
eﬀective treatments for hypertension in the horse are limited. The
purpose of this study was to investigate the immunologic
response of normotensive adult horses to vaccination with Ang-
Qb, a modiﬁed angiotensin II structure linked to virus-like parti-
cles, and determine its eﬀect on arterial blood pressure.
Six adult horses were vaccinated intramuscularly with 900 lg
of AngQb on three diﬀerent occasions, one month apart. Serum
samples for anti-angiotensin II antibody titer determination were
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collected prior to vaccination, and weekly through week 16, and
on week 20. Indirect blood pressure was measured prior to vacci-
nation, and every 2 weeks through week 16 and weeks 20 and 24.
Mean antibody titer was determined by ELISA and peaked at
21,400 ± 19,380 on week 6 and was 9,986 ± 10,792 at week 20.
Data were evaluated statistically by repeated measures ANOVA
with Dunnett’s multiple comparison post hoc analysis and Pear-
son correlation. Systolic arterial pressure increased at weeks 8
and 20 compared to baseline (P = 0.008). Neither diastolic nor
mean arterial pressure were signiﬁcantly changed over time, how-
ever there was a signiﬁcant negative correlation of mean antibody
titer with both mean (R = - 0.24; P = 0.03) and diastolic (R = -
0.22; P = 0.05) arterial pressure. While a robust immunologic
response to AngQb vaccination was demonstrated, additional
studies are warranted to evaluate arterial blood pressure
responses in hypertensive horses.
ABSTRACT E-83
HYPERTENSIVE CARDIOMYOPATHY IN HORSES.
C Navas de Solis1, J Slack1, V.B Reef1. 1New Bolton Center,
University of Pennsylvania, Kennett Square, Pennsylvania
The objective was to describe the clinical presentation, physical
examination, prognosis, echocardiographic and pathologic ﬁnd-
ings of horses with hypertensive cardiomyopathy. Records from
cases presented between 1995 and 2011 diagnosed with cardiac
hypertrophy and systemic hypertension (systolic and mean non
invasive blood pressure > 144 and 116 mmHg respectively) were
studied retrospectively.
Five horses met the inclusion criteria (0.26% of horses evalu-
ated for cardiac disease). There were 3 geldings and 2 mares of
multiple breeds with a mean±SD age of 18±4 years (range 13-24).
The main diagnoses were chronic laminitis in 3 cases and chronic
renal failure in two. Persistent tachycardia, hypertension, chronic
laminitis or a combination of these prompted the cardiac evalua-
tions. Non invasive blood pressure [systolic/diastolic (mean)] was
212±36 mmHg [range 183-261 mmHg] / 169±38 mmHg [range
100-190 mmHg] (171±41 mmHg [range 126-222 mmHg]). No ar-
rhythmias were reported. All horses had increased relative wall
thickness 0.94±0.29 [range 0.57-1.26]. The interventricular septum
was thickened in all horses at end diastole and in 4 horses at
peak systole. The left ventricular free wall was thickened and the
internal diameter reduced at end diastole and peak systole in
three horses. All horses were euthanized due to grave prognosis
of the primary disease. All three horses that underwent necropsy
had macroscopic cardiac hypertrophy and 2 had microscopic car-
diovascular changes.
Hypertensive cardiomyopathy is rare and was associated with
chronic pain or renal disease. Information about the reversibility,
the importance of early detection of cardiomyopathy in hyperten-
sive horses and its long-term sequelae is needed.
ABSTRACT E-84
OXIDATIVE METABOLISM AND IN VITRO IMMUNE
RESPONSE OF HORSES SUPPLEMENTED WITH
VITAMIN COMPLEX ADE. RW Weigel, M Mirian Souza,
FN Fernandes, WR Della Libera, AMMP SucupiraM.C.A..
University of Sa˜o Paulo, Brazil
Horses working at explosive exercise are subjected to oxidative
stress. Animals unable to balance the production of reactive oxy-
gen species (ROS) and antioxidant reaction can lose performance
and have longer recover time. The aim of this study was to eval-
uate oxidative metabolism and in vitro immune response of polo
players equines treated or not with parenteral ADE vitamin com-
plex.
Twenty horses, crossbred, 7.0 (± 1.7) yrs of age, trained for
equestrian polo matches were used. They were randomly distrib-
uted in two groups. Control group received 10 mL of physiologic
saline solution, IM, and the Treated group received 1ml/50kgBW
IM of the supplement containing vitamins A (27 000 000 UI /
100mL), D3 (8 000 000 UI/100mL) e E (8 000 mg/100mL). The
horses were at rest 60 days before the game. The research began
with an application 30 and 15 days before the start of training.
At the ﬁrst training blood samples were collected before the game
(M0), 15 minutes (M1), 90 minutes (M2) and 3 hours (M3) after
the only chukker. Plasma was assayed for malondialdehyde
(MDA). Superoxide dismutase (SOD) concentration was determi-
nate in red blood cells. Reduced glutathione (GSH) and burst-
phagocytosis were determined in total blood. The burst-phagocy-
tosis was performed by ﬂow cytometry. Treatments were com-
pared by ANOVA (Tukey test) and Pearson coeﬃcient was
determinated between variables using Statistical Software MINI-
TAB®.
There were no diﬀerences in the concentrations of MDA,
SOD, GSH and burst-phagocytosis between Control and Treated
groups (P>0.05). Only the SOD concentration and phagocytic
intensity were negatively correlationated (r = -0.302 and P =
0.1). In this study parenteral ADE supplementation didn’t make
a diﬀerence in the oxidative metabolism and in vitro immune
response in horses trained for polo matches.
ABSTRACT E-85
ASSESSMENT OF VITAMIN E LEVELS IN A POPULA-
TION OF HEALTHY ADULT HORSES. K Vander Werf,
EG Davis, C Blevins. Kansas State University, Manhattan, KS
Equine Motor Neuron Disease (EMND) is associated with
chronic vitamin E deﬁciency resulting in neuromuscular weak-
ness, hyperhidrosis, preferred recumbency, and muscle fascicula-
tion. Among 7 clinical cases presented within the past 3 years,
57% had adequate serum vitamin E levels (ref. range: 2.0-4.0 µg/
mL).
Serum tocopherol levels in 50 healthy, adult horses maintained
on dry lots and 50 horses maintained on pasture for at least 1
year were analyzed at a commercial laboratory. Variables exam-
ined included vital parameters, environment (dry lot vs pasture),
duration in environment, and concentrate supplementation.
Horses were excluded if in the current environment for less than
1 year.
Vitamin E levels of horses maintained on pasture (5.44 ± 2.26
µg/mL) and those maintained on dry lot (mean: 3.99 ± 2.84 µg/
mL) were signiﬁcantly diﬀerent (p = 0.0003). Additionally, there
was a signiﬁcant positive correlation between age and tocopherol
level (r = 0.30, p = 0.0026). Geldings maintained on dry lots
had signiﬁcantly lower tocopherol levels than mares maintained
in the same environment or geldings and mares on pasture (p =
0.03). There was no signiﬁcant correlation between breed, brand
of pelleted feed, or duration in current environment and serum
vitamin E levels.
Horses maintained on dry lots should be monitored for signs
of EMND and should have vitamin E levels measured on a regu-
lar basis. Geldings appear to be at risk of low vitamin E levels
when maintained in dry lot environments. Supplementation with
natural vitamin E is recommended for horses with levels less than
2.0 µg/mL.
SMALL ANIMAL – ENDOCRINOLOGY
ABSTRACT EN-1
RESTORATION OF EUTHYROIDISM IN MEDICALLY
TREATED HYPERTHYROID CATS WITH IATROGENIC
HYPOTHYROIDISM (IH) IMPROVES RENAL FUNCTION.
TL Williams, J Elliott, HM Syme. Royal Veterinary College,
London, UK
IH is reported to increase the incidence of azotemia in hyper-
thyroid cats following treatment. IH is also associated with a
decreased heart rate (HR), packed cell volume (PCV) and plasma
alkaline phosphatase activity (ALP). Hypothyroidism reduces
glomerular ﬁltration rate (GFR) in other species, and treatment
of hypothyroidism in dogs is reported to increase GFR. There-
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fore, it could be postulated that adjustment of anti-thyroid medi-
cation in cats with IH to achieve euthyroidism would also
improve GFR, and hence reduce plasma creatinine concentration
and the incidence of azotemia. This study aimed to compare
renal function in cats with IH before and after dose adjustment
of anti-thyroid medication (methimazole or carbimazole) to
achieve euthyroidism.
Medically treated hyperthyroid cats with documented IH
(plasma total thyroxine concentration (TT4) <10 nmol/l in com-
bination with plasma cTSH >0.15 ng/ml) were prospectively
recruited into the study between July 2009 and March 2011.
Dose adjustments were made to anti-thyroid medication every
four weeks until euthyroidism was restored (TT4 10-40 nmol/l).
If restoration of euthyroidism was achieved more than eight
months after documentation of IH, the cat was excluded from
further analysis. Body weight (BW), body condition score (BCS),
systolic blood pressure (SBP), PCV, HR and plasma concentra-
tions of urea, creatinine, cholesterol, total calcium and plasma
activities of alanine aminotransferase (ALT) and ALP were
recorded at baseline and once euthyroidism was achieved. Con-
tinuous data are presented as median [25th, 75th percentile]. Clini-
copathological parameters were compared at baseline and
following restoration of euthyroidism using the Wilcoxon signed
rank test. Statistical signiﬁcance was deﬁned as P<0.05.
Twelve cats were eligible for inclusion. Baseline TT4 and
cTSH of the cats were <4.0 [<4.0, 6.1] nmol/l and 3.45 [0.48,
5.93] ng/ml respectively. At baseline, 9/12 cats were azotemic
(plasma creatinine concentration >2 mg/dl). TT4 following dose
adjustment was 24.9 [15.4, 26.6] nmol/l. Restoration of euthy-
roidism resulted in a signiﬁcant decrease in plasma creatinine
concentration (2.50 [1.92, 3.16] mg/dl vs. 2.07 [1.42, 2.66] mg/dl;
P=0.005), and azotemia resolved in 3/9 cats. Restoration of eu-
thyroidism also resulted in a signiﬁcant increase in plasma ALP
(20.8 [15.8, 30.8] U/l vs. 31.5 [23.2, 45.7] U/l; P=0.004) and HR
(186 [174, 204] beats per minute (bpm) vs. 214 [182, 225] bpm;
P=0.034), and a signiﬁcant decrease in BW (3.91 [3.36, 4.15] kg
vs. 3.70 [3.23, 4.16] kg; P=0.026). No signiﬁcant changes in BCS
(P=0.603), SBP (P=0.875), PCV (P=0.329), plasma concentra-
tions of urea (P=0.239), cholesterol (P=0.530), total calcium
(P=0.182) or plasma ALT activity (P=0.388) were observed fol-
lowing restoration of euthyroidism.
Restoration of euthyroidism in cats with IH improves renal
function, evaluated using plasma creatinine concentration, and
decreases the incidence of azotemia, although changes in BW
could inﬂuence plasma creatinine concentrations. Measurement
of GFR in cats with IH before and after dose adjustment is war-
ranted.
ABSTRACT EN-2
THYROID SCINTIGRAPHY FINDINGS IN 917 CATS WITH
HYPERTHYROIDISM. ME Peterson1, MR Broome2. 1Animal
Endocrine Clinic, New York, NY, 2Advanced Veterinary
Medical Imaging, Tustin, CA
Thyroid scintigraphy provides valuable information regarding
both thyroid anatomy and physiology and plays an integral role
in the diagnosis, staging, and management of feline thyroid dis-
ease. Recently, Harvey et al (Scintigraphic ﬁndings in 120 hyper-
thyroid cats. JFMS 2009;11: 96) reported that nearly 1 of 5
hyperthyroid cats had multiple areas of increased radionuclide
uptake (IRU) visible on thyroid imaging, commonly with intra-
thoracic tissue that could not be palpated. Many of those cats,
however, were referred for persistent or recurrent hyperthyroidism
so this may not represent what is seen in general practice. In this
study, we performed thyroid imaging on 917 consecutive hyper-
thyroid cats that were referred for radioiodine therapy between
January and December 2009. Scintigraphy was performed as part
of our staging protocol in which thyroid volume is estimated for
131I dose estimation (Vet Radiol Ultrasound 1996;27:141).
Of the 917 cats, 594 (65%) had bilateral thyroid lobe uptake
in the “expected” neck location, whereas 279 (30%) had unilat-
eral thyroid uptake. The remaining 44 cats (4.8%) had multiple
areas of IRU or areas of ectopic tissue not in the neck area. Of
the 917 cats, areas of IRU ranged from 1-5 (median 2), with 39
(4.2%) cats having >3 (Table 1). Areas of IRU were located in
the neck in 906 (98.8%), thoracic inlet in 105 (11.5%), and in the
thorax in 44 (4.8%); 22 cats (2.4%) had IRU in all 3 locations
(neck, thoracic inlet, thorax). The estimated size of the thyroid
tumor(s) in the 917 cats were small (<2.5 cm3) in 517 (56%),
medium-sized (2.5-5 cm3) in 243 (26%), and large (>5 cm3) in
166 (18%). Cats with large thyroid tumors had a higher pretreat-
ment median serum T4 value (20.6 lg/dl) than did cats with med-
ium-sized (13 lg/dl) or small masses (6.4 lg/dl). Cats with large
tumor volumes had been hyperthyroid for longer (median, 12
mos) than were cats with small or medium-sized tumors (1 mo).
Of the 157 cats with large thyroid masses, 14 were suspected of
having thyroid carcinoma, with an overall incidence of 1.7%.
Ectopic thyroid tissue was diagnosed in 30 (3.3%) cats; of these,
large tumor size was found in only 6 cats (20%).
In conclusion, results of this study conﬁrm that multiple areas
of hyperfunctional thyroid tissue do develop in hyperthyroid cats,
but at an incidence much lower than previously reported. Ectopic
thyroid tissue occurs in ~3-4% of hyperthyroid cats, many with
only mild to moderate hyperthyroidism. Thyroid carcinoma
develops in ~1.5% of cats, but these cats characteristically have
huge goiters, very high serum T4 values, and long-standing
hyperthyroidism.
ABSTRACT EN-3
AMINO ACID, IODINE, SELENIUM, AND COAT COLOR
STATUS AMONG HYPERTHYROID, SIAMESE, AND AGE-
MATCHED CONTROL CATS. BR Sabatino1, CA Kirk1, BW
Rohrbach1, PJ Armstrong2. 1University of Tennessee College of
Veterinary Medicine, Knoxville, TN, 2University of Minnesota
College of Veterinary Medicine, St. Paul, MN
Hyperthyroidism is common among older cats, but its patho-
genesis remains poorly understood. Siamese and Himalayan cats
have a reduced risk of hyperthyroidism than other cat breeds.
Tyrosine is the amino acid precursor for thyroxine and melanin.
Earlier studies reported tyrosine as a limiting amino acid in some
cat foods resulting in poor coat melanin production in dark-
coated cats. Because Siamese and Himalayan cats have unique
tyrosine metabolism responsible for a pointed coat color, this
study evaluated the relationship between tyrosine status and coat
color in hyperthyroid cats. In addition, key cofactors in thyroid
hormone metabolism (iodine and selenium) were evaluated as co-
dependent variables. The objective of this study was to determine
if tyrosine, phenylalanine, iodine, or selenium levels are altered in
hyperthyroid cats compared to normal cats and if light or
pointed coat color is protective with greater tyrosine availability
due to lowered use for melanin production.
Table 1. Total number and locations of areas of increased radionuclide
uptake (IRU).
1 2 3 4 5
Total number of cats 286 592 28 7 4
No. of cats with areas of IRU in neck 276 534 28 6 4
No. of cats with areas of IRU in thoracic
inlet
27 58 12 5 3
No. of cats with areas of IRU in thorax 2 12 17 6 4
Table 1. Plasma tyrosine, plasma phenylalanine, serum iodine, and
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Twenty-seven client-owned cats with (n=12) and without
(n=15) hyperthyroidism were studied. Coat color (9 white or
pointed; 18 dark), breed, and diet history were recorded. Whole
blood was collected for CBC, serum chemistry, total thyroxine
(TT4), serum iodine, serum selenium, and plasma amino acid
determination in fasted cats. A mixed model ANOVA with cat
and group included as class variables was used to evaluate the
relationship between group study factors (signiﬁcance = P <
0.05).
Chemistry and CBC values were similar among groups except
for TT4 levels. Tyrosine, phenylalanine, iodine, and selenium lev-
els were not signiﬁcantly diﬀerent among light or dark cats or
cats with or without hyperthyroidism. Altered tyrosine metabo-
lism associated with coat color does not explain the reduced risk
of hyperthyroidism in pointed or light coat colored cats.
ABSTRACT EN-4
EFFECT OF THE STAGE OF CHRONIC KIDNEY DISEASE
ON SERUM TOTAL THYROXINE IN CATS. AB Vieira,
MCN Castro, M Saloma˜o, LC Gershony, AMB Soares, AMR
Ferreira. College of Veterinary Medicine, Universidade Federal
Fluminense, Rio de Janeiro, Brazil
Non-thyroidal illnesses, such as chronic kidney disease, are
one of the factors that can aﬀect total thyroxine and hinder the
diagnosis of hyperthyroidism in cats. Cats with chronic kidney
disease are currently staged according to the degree of azotemia
based on the IRIS (International Renal Interest Society) guide-
lines. The purpose of the present study was to determine the
inﬂuence of chronic kidney disease stage on serum total thyroxine
(TT4) in cats.
Total thyroxine was measured by chemiluminescent immuno-
metric assay in the serum of 32 healthy cats and 33 cats with var-
ious degrees of chronic kidney disease. Nineteen cats were
classiﬁed as IRIS stage 2, nine cats as IRIS stage 3 and four cats
as IRIS stage 4.
Cats with chronic kidney disease had signiﬁcantly lower
(p<0.0001) mean serum TT4 concentrations than clinically
healthy cats. Mean serum TT4 concentration decreased 34.73%
in the IRIS stage 2 group, 41.67% in the IRIS stage 3 group and
55.58% in the IRIS stage 4 group when compared to the control
group. Even though mean TT4 concentrations decreased with the
increase of azotemia in the CKD groups, values were only signiﬁ-
cantly diﬀerent when compared to cats in the control group.
Results obtained in the present study suggest that any stage of
chronic kidney disease can lead to the suppression of total thy-
roxine concentration in cats.
ABSTRACT EN-5
ASPART INSULIN CONSTANT RATE INFUSION FOR
TREATMENT OF DOGS WITH DIABETIC KETOACIDO-
SIS. ES Walsh, KJ Drobatz, RS Hess. University of
Pennsylvania School of Veterinary Medicine, Philadelphia, PA
The purpose of this study was to determine whether aspart
insulin is safe and eﬀective for treatment of diabetic ketoacidosis
(DKA) in dogs.
Twelve client-owned dogs with spontaneous DKA were
enrolled into this prospective randomized clinical trial if they had
blood glucose >250mg/dl, venous pH between 7.0-7.35, and a
blood beta-hydroxybutyrate concentration >2.0mmol/L. Dogs
were randomly assigned to receive an IV continuous rate infusion
(CRI) of either aspart or regular insulin at an initial dose of 0.09
U/kg/hr, which was adjusted as previously described. Mean time
intervals from the time the CRI of insulin was begun until resolu-
tion of marked hyperglycemia (blood glucose concentration
>250 mg/dl), acidosis (venous pH <7.35), or ketosis (beta-hy-
droxybutyrate concentration >2.0 mmol/L) were compared in
dogs that received aspart or regular insulin. The number of hypo-
glycemic events (blood glucose < 60 mg/dl) that occurred in the
two insulin treatment groups was also compared.
Mean time to resolution of hyperglycemia (p=0.29), acidosis
(p=0.26), and ketosis (p=0.20) were not signiﬁcantly diﬀerent
between the two treatment groups. No hypoglycemic events were
noted in either treatment group, and no other adverse eﬀects
were observed in association with IV aspart or regular insulin
administration.
Should regular insulin become unavailable, aspart insulin is a
safe and eﬀective alternative for treatment of DKA in dogs.
ABSTRACT EN-6
DETERMINATION OF REFERENCE VALUES FOR
CASUAL BLOOD GLUCOSE CONCENTRATION IN CLINI-
CALLY-HEALTHY, AGED CATS MEASURED WITH A
PORTABLE GLUCOSE METER FROM AN EAR OR PAW
SAMPLE. MK Reeve-Johnson1, JS Rand1, S Anderson3,
RD Marshall2, D Vankan1. 1Centre for Companion Animal
Health, School of Veterinary Science, University of Queensland,
Australia, 2The Cat Clinic, Brisbane, Australia, 3School of
Biomedical Science, University of Queensland, Australia
Pre-diabetes is used to describe an intermediate stage between
normal glucose homeostasis and type 2 diabetes. Pre-diabetes is
estimated to be 4 times more prevalent than diabetes in the
human population and pre-diabetic patients are at high risk of
developing diabetes. Criteria for diagnosis of human pre-diabetes
are either impaired fasting glucose (>6.1 to < 7 mmol/L; >110
to >126 mg/dL after an 8 hour fast) or impaired glucose toler-
ance (7.8  11.1 mmol/l; 140mg/dL two hours following an oral
glucose load). A casual—or non-fasted—blood glucose concen-
tration can be used as a screening test; scores >11.1 mmol/l
(200mg/dl) are considered abnormal. The incidence of pre-diabe-
tes in cats is unknown, and there is a need to develop diagnostic
criteria and screening tests for this in cats. Such criteria are espe-
cially important for aged cats because they are most at risk of
diabetes. As cats are susceptible to stress hyperglycemia and fast-
ing samples are often impractical to obtain, the diagnostic meth-
odology should minimize stress and be based on causal blood
glucose concentrations. Previous studies in cats have documented
no statistical diﬀerence in blood glucose concentrations in capil-
lary blood and venous blood.
The aim of this study was to determine reference values for
casual blood glucose concentration in samples obtained in
healthy cats > 8 years old from a paw or ear sample (study
method), and to compare these with values obtained from a jugu-
lar sample after a physical examination (traditional method).
Clinically healthy cats (n=74) aged > 8 years old were recruited
for the study; 8 cats were excluded due to concomitant medical
problems or owner withdrawal, and 66 cats were enrolled. A
casual blood sample was taken from the ear or paw at the begin-
ning of the consultation. Blood glucose was measured immedi-
ately after sample collection using a portable glucose meter
calibrated for feline blood (AlphaTRAK, Abbott Laboratories).
A physical examination was performed before a further blood
sample was taken from the jugular vein.
The inter- and intra-assay coeﬃcients of variation for the glu-
cose meter were 2% and 3.3% respectively. Mean blood glucose
was 5.6 mmol/l (100.8 mg/dl; range 3.5-10.3mmol/l) for the study
method and 6.4 mmol/l (115.2 mg/dl; range 4.2-10.7 mmol/l) for
the traditional method. The upper limit of the 90% conﬁdence
interval for blood glucose for the study method was 9.7 mmol/L
(174 mg/dl) for all breeds excluding Burmese, and 10.1 mmol/l
(182mg/dl) for Burmese cats. Blood glucose concentrations were
0.7 mmol/L(13 mg/dl) lower (95% conﬁdence interval 0.39 to 1.0
mmol/L; p<0.05) when measured by the study method compared
with the traditional method (72% of cats had a lower value). This
study is the ﬁrst to report the upper reference value for casual
blood glucose concentration in aged, healthy cats, and demon-
strates a simple method for screening for pre-diabetes in cats.
ABSTRACT EN-7
EARLY-ONSET HYPOADRENOCORTICISM IN A KIN-
DRED OF POMERANIANS. ET Mooney1,2, TN Hammond1,
OM Mahony2. 1Tufts Veterinary Emergency Treatment and
Specialties, Walpole MA, 2Cummings School of Veterinary
Medicine at Tufts University, North Grafton, MA
Hypoadrenocorticism (Addison’s disease) is an uncommon
endocrine disorder in dogs that typically aﬀects middle-aged
females. Familial hypoadrenocorticism has been demonstrated in
several breeds including leonbergers, standard poodles, Nova
Scotia duck tolling retrievers and Portuguese water dogs. The
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purpose of this report is to describe a family of pomeranians with
early-onset hypoadrenocorticism.
Three pomeranians, full siblings from two litters, were pre-
sented at 12 months, 17 months, and 26 months of age with clini-
cal signs and laboratory ﬁndings consistent with
hypoadrenocorticism including cardiovascular collapse and severe
hyponatremia (125mmol/L, 118mmol/L and 115mmol/L). One
dog was female and the others were male. ACTH stimulation test-
ing conﬁrmed hypoadrenocorticism in all dogs. Dogs were treated
with intravenous ﬂuid resuscitation and glucocorticoid and miner-
alocorticoid replacement and made a complete recovery.
Both parents and the other 4 siblings are currently healthy,
and have never exhibited signs of hypoadrenocorticism.
This is the ﬁrst report of an early-onset hypoadrenocorticism
in pomeranians. An inherited basis is proposed to be the cause
however further documentation will be required to conﬁrm a
breed predisposition.
ABSTRACT EN-8
CLINICAL FEATURES OF HYPOADRENOCORTICISM IN
SOFT-COATED WHEATEN TERRIERS: 72 CASES (1979-
2011). RL Haviland, RL Toaﬀ-Rosenstein, MP Reeves, MP
Littman. University of Pennsylvania School of Veterinary
Medicine, Philadelphia, PA
This retrospective study evaluated the clinical features of spon-
taneous hypoadrenocorticism in Soft-coated Wheaten Terriers
(SCWT), a breed with increased risk. Medical records of 98 cli-
ent-owned SCWT from North America diagnosed with hypo-
adrenocorticism were reviewed. Inclusion criteria were met in 72
cases (39 male, 33 female) including ACTH stimulation test
results consistent with hypoadrenocorticism (pre-, post-cortisol
<2.0 ug/dl), serum electrolyte values recorded at diagnosis, and
absence of exogenous corticosteroid administration >1 month
prior to diagnosis. Signalment, history, clinical signs, physical
examination (PE) ﬁndings, clinicopathologic data, survival time,
and concurrent disease were reviewed. Median age at diagnosis
was 4.6 years (range 0.5- 11.4 years). Common clinical signs were
lethargy (77%), anorexia (74%), vomiting (66%), and diarrhea
(30%). The PE was unremarkable in 41% of cases; common
abnormalities were dehydration (24%), depressed mentation
(17%), thin body condition (15%), and bradycardia (4%). Elec-
trolyte ﬁndings included Na/K ratio  30 (96%), Na/K ratio
 27 (85%), hyperkalemia (77%), hyponatremia (63%), or no
abnormalities (12%). The lymphocyte count was  2.0 x 10^3 in
49 of 58 patients (84%). Median survival time following diagno-
sis was 3.2 years (range 0-8.6 years). Cause of death was largely
unrelated to hypoadrenocorticism. The most common concurrent
disease was protein-losing nephropathy (19%). Compared with
prior studies concerning the general canine population with sponta-
neous hypoadrenocorticism, this study population showed no gen-
der predisposition, less likelihood of serum electrolyte abnormalities
at the time of diagnosis, and shorter median survival time.
ABSTRACT EN-9
THE EFFECT OF SURGERY ON THE PITUITARY-ADRE-
NAL AXIS IN DOGS. EJ Skovira, EN Behrend, L Palmer, LG
Martin, RJ Kemppainen, HP Lee, Y Ueda. Auburn University,
College of Veterinary Medicine, Auburn, AL
Pituitary-adrenal response to surgery has received limited
study in dogs. Studies in humans indicate surgery activates the
axis and may serve as a model for acute, moderate stress. In
addition, it is important to know the level of axis activation upon
post-operative entry into an intensive care unit in case testing of
the axis is performed. Thus, our objective was to assess and com-
pare the eﬀect of surgery on serum cortisol, aldosterone, and
ACTH concentrations in dogs.
Forty healthy dogs undergoing laparotomy for veterinary stu-
dent surgical laboratories were used. Blood samples were
obtained pre-operatively prior to administration of any medica-
tion and at the completion of the surgery with an average surgery
time of 3 hours. Baseline samples were collected at least 4 hours
prior to the start of surgery. Cortisol, aldosterone, and endoge-
nous ACTH concentrations were measured using previously vali-
dated radioimmunoassays. Delta concentrations (pre-operative
concentration subtracted from the post-operative) were calculated
for each hormone. Data were analyzed using the paired t-test,
Wilcoxon signed rank test, and Spearman correlation or linear
regression. Signiﬁcance was set at p 0.05.
Cortisol, aldosterone, and ACTH concentrations increased sig-
niﬁcantly during surgery (p<0.001 for all). However, while corti-
sol and aldosterone concentrations rose during surgery in all
dogs, ACTH concentrations decreased in 26%. All dogs had a
basal cortisol concentration within the reference range pre-opera-
tively, but 63% had cortisol concentrations above the reference
range post-operatively. A weak non-linear correlation was
detected between pre-operative cortisol and ACTH concentra-
tions; no correlation was evident post-operatively. A weak corre-
lation between post-operative cortisol and aldosterone
concentrations (linear regression, p<0.001, R2=0.27) and a
moderate correlation between the delta cortisol and aldosterone
values were detected (linear regression, p<0.001, R2=0.34). No
relationship was detected between changes in either cortisol and
aldosterone concentrations with ACTH.
In conclusion, laparotomy stimulates adrenocortical secretion
of cortisol and aldosterone in dogs. In the majority of dogs, pitu-
itary secretion of ACTH rises, but not in all. The lack of correla-
tion between cortisol and ACTH concentrations post-operatively
suggest the possibility that ACTH-independent mechanisms are
responsible for the increase in post-operative cortisol values, or
that an early increase in ACTH caused a sustained release of cor-
tisol. The same mechanism may be at play, however, in causing
increases in both cortisol and aldosterone secretion. Further
studies are indicated to evaluate the eﬀects of various anesthetic
protocols and minimally invasive surgical techniques on the stress
response.
ABSTRACT EN-10
LONG-TERM FOLLOW-UP OF RENAL FUNCTION IN
DOGS WITH ACTH-DEPENDENT HYPERADRENOCOR-
TICISM. PMY Smets1, HP Lefebvre2, BP Meij3, S Croubels1, E
Meyer1, I Van de Maele1, S Daminet1. 1Ghent University,
Ghent, Belgium,, 2Ecole Nationale Ve´te´rinaire, Toulouse,
France,, 3Utrecht University, Utrecht, The Netherlands
Systemic hypertension and proteinuria are frequent complica-
tions in dogs with Cushing’s syndrome and do not always resolve
after treatment of hypercortisolism. Therefore, these patients may
be at risk for renal dysfunction.
Objectives were to assess renal function in dogs with ACTH-
dependent hyperadrenocorticism (ADHAC) before and after
treatment. A total of 19 dogs with ADHAC were included. Renal
function was assessed before, and at 1, 3, 6, and 12 months after
treatment. Twelve dogs were treated with trilostane and 7 dogs
by transsphenoidal hypophysectomy. Routine renal markers were
measured and urinary albumin (uALB), immunoglobulin G
(uIgG), and retinol-binding protein (uRBP) were assessed by
ELISA. Urinary N-acetyl-b-D-glucosaminidase (uNAG) was
determined colorimetrically. All urinary markers were indexed to
urinary creatinine concentration (c). Plasma clearance of creati-
nine (Clcreat), exo-iohexol (Clexo), and endo-iohexol (Clendo) were
used tomeasure glomerular ﬁltration rate (GFR). Data were ana-
lyzed using a general linear model.
Serum creatinine and urea concentration increased post treat-
ment, but remained within reference ranges. Plasma Clcreat and
Clendo were signiﬁcantly lower post treatment, whereas Clexo was
not diﬀerent. Urinary protein-to-creatinine ratio, uALB/c, uIgG/
c, and uRBP/c were decreased post-treatment, but at 12 months
5/13 dogs remained proteinuric. Urinary NAG/c did not change
signiﬁcantly.
The decrease in GFR and persistent proteinuria post-treatment
underline that canine ADHAC is associated with renal glomeru-
lar and tubular changes which do not always reverse after ther-
apy. (ESVE Award Winner).
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ABSTRACT EN-11
EVALUATION OF A LONG-ACTING SOMATOSTATIN
RECEPTOR LIGAND FOR THE TREATMENT OF FELINE
ACROMEGALY. J Timian, KF Lunn. Department of Clinical
Sciences, Colorado State University, Fort Collins, CO
This study was designed to evaluate whether long-acting octre-
otide (Sandostatin LAR®) is an eﬀective medical therapy for cats
with acromegaly.
Seven cats were diagnosed with acromegaly, based on physical
changes, the presence of insulin-resistant diabetes mellitus (diabe-
tes poorly regulated on  5 units of insulin BID), elevated insu-
lin-like growth factor 1 (IGF-1) levels, and no evidence for other
causes of insulin resistance. Cats received monthly long-acting
octreotide IM at an escalating dose of 2 mg for 3 months, 3 mg
for 1 month, and 4 mg for 2 months. Body weight, insulin dose,
biochemistry proﬁle, IGF-1 level, and fructosamine were
obtained prior to each injection, and at one month after the last
injection of long-acting octreotide.
Four cats received medication for 6 months; 3 cats received
medication for 3 months (1 cat euthanized due to progressive
disease; 1 cat withdrawn by the owner; 1 cat still enrolled).
Mean serum IGF-1 levels, before and after the course of
therapy, were 334 nmol/l and 339 nmol/l respectively. Mean
serum fructosamine values before and after therapy were 426
umol/l and 435 umol/l respectively. Mean insulin doses before
and after therapy were 1.4 units/kg and 1.1 units/kg respec-
tively. A paired t-test showed no signiﬁcant diﬀerences
between any of these parameters before and after therapy
(p=0.94; p=0.77; p=0.14, respectively). One cat became non-
insulin-dependent, coinciding with marked obtundation; nec-
ropsy revealed hemorrhage within and around a pituitary
tumor. Six cats remained signiﬁcantly insulin resistant. Long-
acting octreotide does not appear to be an eﬀective treatment
for feline acromegaly.
ABSTRACT EN-12
BASAL ALDOSTERONE CONCENTRATIONS AND
RESPONSE TO ACTH STIMULATION IN HEALTHY AND
CRITICALLY ILL DOGS. LG Martin, EN Behrend,
RJ Kemppainen, HP Lee. Auburn University, College of
Veterinary Medicine, Auburn, AL
Critical illness-related corticosteroid insuﬃciency (CIRCI) has
been recognized in veterinary patients. In humans diagnosed with
CIRCI, it is generally accepted that aldosterone insuﬃciency is
not a part of the syndrome. The same is suspected to occur in
dogs with CIRCI, but has not been documented. Furthermore,
aldosterone concentrations and its response to ACTH are infre-
quently measured in ill dogs despite the life-threatening eﬀects of
aldosterone insuﬃciency. The purpose of this study was to deter-
mine basal aldosterone concentrations and their response to
ACTH in clinically healthy and critically ill dogs, and to deter-
mine the relationship between cortisol and aldosterone insuﬃ-
ciency in dogs with CIRCI.
Basal and post-ACTH aldosterone concentrations were deter-
mined in 10 healthy and 32 critically ill dogs diagnosed with
sepsis, trauma, or GDV. (Cortisol data reported in Martin LG
et al, JVIM, 2010.) Each dog was given cosyntropin (5 µg/kg
IV) and blood samples for assay of aldosterone and cortisol
concentrations were obtained before and 60 minutes after
administration. Serum sodium and potassium concentrations as
well as delta aldosterone and cortisol concentrations (the diﬀer-
ence between stimulated and basal concentrations) were also
determined. Data were analyzed using Kruskal-Wallis one-way
ANOVA, Mann-Whitney rank sum test, Wilcoxon signed rank
test, and Spearman rank order correlation. Signiﬁcance was set
at p  0.05.
Undetectable basal or post-ACTH aldosterone concentrations
were found in 18/32 (56%) critically ill dogs. Ten of the critically
ill dogs met biochemical criteria for the diagnosis of CIRCI
based on their cortisol concentrations. Only 2/10 had either a
low basal or post-ACTH aldosterone concentration. None of the
dogs diagnosed with CIRCI or aldosterone deﬁciency had hypo-
natremia or hyperkalemia. Median basal aldosterone concentra-
tions in dogs with GDV were signiﬁcantly lower when compared
to healthy and septic dogs. In septic and trauma dogs, no diﬀer-
ence was detected between median basal and post-ACTH aldoste-
rone concentrations. Median delta aldosterone concentrations in
the trauma dogs were lower than those of healthy dogs. No rela-
tionship was detected between basal, post-ACTH, and delta aldo-
sterone and cortisol concentrations or between basal aldosterone
and electrolyte concentrations.
In conclusion, low aldosterone concentrations were common
in this population of critically ill dogs. The majority of dogs with
CIRCI did not have decreased aldosterone concentrations; thus,
canine CIRCI may be similar to the human syndrome. The etiol-
ogies for low aldosterone concentrations in this population of
critically ill dogs are unknown at this time, but do not appear to
be due to abnormalities in sodium or potassium. Future studies
are needed to determine the eﬀects of critical illness on adreno-
cortical aldosterone secretion and the signiﬁcance of the aldoste-
rone deﬁciency.
ABSTRACT EN-13
EVALUATION OF ONCE-DAILY ADMINISTRATION OF
INSULIN GLARGINE IN DOGS WITH NATURALLY OC-
CURING DIABETES MELLITUS. AY Kim, K Cho, S Noh,
J Paek, M Lee, D Chang, MP Yang, JH Kang. Chungbuk
National University College of Veterinary Medicine, Cheongju,
Chungbuk, Republic of Korea
The objective of this study was to evaluate the eﬃcacy of
once-daily administration of insulin glargine in dogs with diabe-
tes mellitus (DM). Sixteen client-owned dogs with DM were
enrolled, all of which had been previously treated with neutral
protamine Hagedorn (NPH) insulin for at least 4 weeks following
diagnosis of DM. Nine of these dogs (Group A) had DM that
was well-regulated by twice-daily administration of NPH insulin.
In the other seven dogs (Group B) NPH showed short-duration
of action at the lowest dose. Dogs received insulin glargine (Lan-
tus®) every 24 hours and were fed the recommended prescription
diet. Evaluations were performed prior to treatment with insulin
glargine and 1, 2, 4, 6, and 10 weeks after the administration of
insulin glargine. Evaluations included clinical signs, blood glucose
curves and serum fructosamine concentrations. Adjustments in
dosage of insulin glargine were made as needed to control glyce-
mia.
The 24-hour mean blood glucose (MBG) and serum fructos-
amine concentrations in Group A were signiﬁcantly elevated 2
weeks and 4 weeks after initiating the treatment, respectively, as
compared to levels prior to the administration of insulin glargine.
In Group B, by 4 weeks after initiation of treatment there were
no signiﬁcant diﬀerences in MBG and serum fructosamine con-
centrations as compared to prior to treatment, and no recurrence
of polyuria/polydipsia. Maintenance of successful glycemic con-
trol was attained in only seven of all dogs (one dog in Group A
and six dogs in Group B). The once-daily administration of insu-
lin glargine is not generally eﬀective in diabetic dogs but may
possibly be used as an alternative treatment in diabetic dogs in
which insulin has only a short-duration of action at the lowest
dose.
ABSTRACT EN-14
CHROMATOGRAPHIC ANALYSIS OF THE LIPID FRAC-
TIONS IN OBESE CLIENT-OWNED DOGS. MM Jerico´1,
FC Chiquito1, F Fusco2, S Catanozi2, VS Nunes2,
ER Nakandakare2. 1Anhembi Morumbi University and Cruzeiro
do Sul University, SP, Brazil, 2Lipids Laboratory LIM 10 of
Faculty of Medical Sciences of the University of Sao Paulo, SP,
Brazil
Obesity, a metabolic disease of multifactorial origin, impairs
the health and longevity of individuals. Dyslipidemia, a common
condition in obese animals, is usually associated to a variety of
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clinical problems, which include gastrointestinal alterations, hepa-
tic lipidosis, atherosclerosis and metabolic syndrome. The aim of
the study was to characterize the lipid proﬁle and lipoprotein
fractions in obese dogs (n=20) and compare them with control
dogs (n=10), selected from a veterinary hospital environment.
Lipoproteins (LP) were isolated by fast protein liquid chromatog-
raphy (FPLC) system and plasma total cholesterol (TC) and tri-
glycerides (TG) concentrations were measured by enzymatic
methods. In control group, TC was 193±44 mg/dL (mean±SD)
(percentage distribution among LP fractions: VLDL-C 2.34%,
LDL-C 15.79%, HDL-C 81.86%); Plasma TG concentration was
50±15 mg/dL (LP fraction percentage distribution: VLDL-TG
39.17%, LDL-TG 35.9%, HDL-TG 24.94%). In obese dogs,
plasma TC was 227±73 mg/dL (VLDL-C 3,325%, LDL-C
21.64%, HDL-C 75.03%) whereas the TG values were 87.9±52
mg/dL (VLDL-TG 61.98%, LDL-TG 24.71%, HDL-TG
13.36%). When compared to the normal dogs, the animals with
obesity presented a signiﬁcant increase (p<0.01) in plasmaTG
and VLDL-TG levels as well as a lower HDL-TG concentra-
tion. There were not signiﬁcant alterations in cholesterol frac-
tions or TC between groups although they presented
proportionally higher levels of TC, and LDL-C as well as lower
HDL-C. It was concluded that obese dogs present a signiﬁcant
diﬀerence when compared to normal dogs in relation to triglyc-
eride metabolism and their VLDL and HDL fractions, which
has been previously shown in experimental model of obese
canine insulin resistance. These ﬁndings suggest a higher risk of
metabolic complications in obese client-owned dogs, like diabe-
tes, hepatobiliary diseases and of blood ﬂow disturbances, like
atherosclerosis.
Key words: dogs, obesity, lipoproteins, cholesterol, triglyce-
rides.
ABSTRACT EN-15
CHROMATOGRAPHIC ANALYSIS OF THE LIPID FRAC-
TIONS IN OBESE CLIENT-OWNED CATS. MM Jerico´1,
S Zbo´ril1, ER Nakandakare2, VS Nunes2, S Catanozi2,
CA Geraldo Jr3, ANL Wludarski4, R Soila5, P Furtado5.
1Anhembi Morumbi University, Cruzeiro do Sul University, SP,
Brazil, 2Lipids Laboratory LIM 10 of Faculty of Medical
Sciences of the University of Sao Paulo, SP, Brazil; , 3Vetmaster
Clinic and FMVZ-USP University, SP, Brazil;, 4Petcenter Clinic,
SP, Brazil; , 5PROVET Laboratory, SP, Brazil
Obesity, a metabolic disease of multifactorial origin, impairs
the health and longevity of individuals. Dyslipidemia, a com-
mon condition in obese animals, is usually associated to a vari-
ety of clinical problems, which include gastrointestinal
alterations, hepatic lipidosis, atherosclerosis and metabolic syn-
drome. The aim of the study was to characterize the lipid pro-
ﬁle and lipoprotein fractions in obese cats (n=9) and compare
them with control cats (n=10), both selected from a veterinary
hospital environment. Lipoproteins (LP) were isolated by fast
protein liquid chromatography (FPLC) system and plasma total
cholesterol (TC) and triglycerides (TG) concentrations were
measured by enzymatic methods. In control group, TC was
132±59 mg/dL (mean±SD) (LP fraction percentage distribution:
VLDL-C 4.9%, LDL-C 28.3%, HDL-C 66.9%); Plasma TG
concentration was 57±25 mg/dL (LP fraction percentage distri-
bution: VLDL-TG 32.8%, LDL-TG 35.5%, HDL-TG 31.2%).
In obese cats, plasma TC was 167±71 mg/dL (VLDL-C 5,3%,
LDL-C 31.3%, HDL-C 63.3%) whereas plasma TG concentra-
tion was 93.5±43 mg/dL (VLDL-TG 43.2%, LDL-TG 30.3%,
HDL-TG 26.5%). Total TG and VLDL-TG were higher in
obese cats as compared to control group (t Student test;
p<0.05). On the other hand, TC, VLDL-C, HDL-C, LDL-C,
HDL-TG, LDL-TG values were not diﬀerent between animal
groups, although they presented proportionally higher levels of
TC, LDL-C as well as higher HDL-C. Similar results have
been previously shown in experimental model of obese feline
insulin resistance These ﬁndings suggest a higher risk of meta-
bolic complications in obese client-owned cats, like diabetes
and hepatobiliary diseases.
Key words: cats, obesity, lipoproteins, cholesterol, triglycerides.
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ABSTRACT FA-1
SKILLS REQUIRED OF ENTRY LEVEL VETERINARIANS:
A SURVEY OF DAIRY PRACTITIONERS. C Luby,
K McIntyre, M Jelinski. Western College of Veterinary
Medicine, Saskatoon, SK
To provide the optimal training experience for veterinarians, it
is important to determine the skills expected at graduation. The
purpose of this study was to determine skills required of entry-
level veterinarians for dairy practice in Western Canada.
We performed a survey of Western Canadian veterinarians
involved in dairy practice. The survey included questions regard-
ing respondent’s clinical activity, demographics, skills performed
in practice, open ended questions and space for comments. All
work was approved by the University of Saskatchewan Behavio-
ural Research Ethics Board.
Response rate for the surveys was 39.3% (281/714 mailed
out). Of these, ﬁve were excluded due to inconsistencies in
answers. Of the respondents, 43.8% were involved in dairy prac-
tice with a median 15% (0.5 – 100%) of practice time involving
dairies. Respondents were classiﬁed as either mixed practitioners
(<25% time in dairy practice) or dairy practitioners (>75%
time in dairy practice). For both groups, individual animal medi-
cine and surgery skills were performed more commonly than pro-
duction medicine skills. The most important skills identiﬁed were
pregnancy diagnosis by rectal palpation or ultrasound, correction
of displaced abomasum, physical examination and treatment of
common disorders.
These results demonstrate the continued importance of individ-
ual animal skills in dairy practice. Training programs for veteri-
narians should provide high quality training in individual animal
medicine, showing that ACVIM diplomates can provide an
important role in preparing students for dairy medicine.
ABSTRACT FA-2
METAGENOMIC EVALUATION OF THE INTESTINAL MI-
CROBIOME IN VEAL CALVES AND THE INFLUENCE OF
ORAL TETRACYCLINE. MC Costa, HR Staempﬂi,
LG Arroyo, FLF Feitosa, JS Weese. University of Guelph,
Guelph, ON. Canada, Universidade Estadual Paulista,
Arac¸atuba. Brazil
The intestinal bacterial population (the microbiome) is a com-
plex polymicrobial community that has an important role in
many aspects of health and disease. While there has only been
superﬁcial study of the intestinal microbiome in most species,
recent advances in molecular technologies have allowed for com-
prehensive evaluation of the microbiome, including unculturable
bacteria not identiﬁed before, and detailed investigation of
changes in the microbiome in response to various factors, such as
antimicrobials. The objective of this study was to characterize the
intestinal microbiome of veal calves by high throughput sequenc-
ing technology, and to investigate the impact of oral tetracycline
on the intestinal microbiome.
Fecal samples were collected from 22 healthy Holstein male
calves (2-7 days of age) within 24h after arrival on a commercial
veal farm. 12 calves were then treated with oxytetracycline (6.6
mg/kg PO for 5d) and 10 control calves did not receive any anti-
microbials. A 2nd fecal sample was collected 2 days after treat-
ment was ﬁnished. DNA was extracted and PCR of the 16S
rRNA gene was performed. Amplicons were sequenced by high
throughput sequencing technology with the use of a 454 sequen-
cer. The MOTHUR package of algorithms was used to clean
data and align sequences with the SILVA 16S rRNA reference
database, with taxonomic classiﬁcations obtained from the Ribo-
somal Database Project. Sequences were assigned into opera-
tional taxonomic units (OTUs) using the average neighbor
algorithm.
From 133,943 sequences obtained, 110,274 high quality
sequences remained after data cleaning. For OTU classiﬁcation,
a minimum of 2,324 sequences per calf was used, which
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excluded 3 calves from the analysis. Bacteroidetes was the main
Phylum among control and treated calves before use of oxytet-
racycline (65.7 and 46.9%, respectively) with Firmicutes being
the second most prevalent (33 and 29%, respectively). There
was a profound decrease in abundance of Bacteroidetes in both
control (P=0.003) and treated (P=0.014) calves at the 2nd
sampling time, with post-treatment abundances of 0.6 and
1.6%) and a concurrent increase in Firmicutes in control
(P=0.012) and treated (P=0.035) calves to 60.8 and 92.4%,
respectively. Diﬀerent communities were found between 1st and
2nd sampling in both control (P<0.013) and treated calves
(P<0.001), as well as between the two groups at the 2nd sam-
pling (P<0.001).
While there was diﬀerence between treatment and control
groups, the fecal microbiome changed dramatically in the 7 day
period after farm arrival irrespective of tetracycline exposure.
Multiple factors may be involved in fecal microbiome alterations
and these must be considered when assessing the impacts of anti-
microbial therapy or other potential modifying factors.
ABSTRACT FA-3
A PROSPECTIVE CONTROLLED STUDY ON PREVA-
LENCE OF CLOSTRIDIUM DIFFICILE IN VEAL CALVES
RECEIVING AND NOT RECEIVING ORAL OXTETRACY-
CLINE. MC Costa, H Staempﬂi, LG Arroyo, FLF Feitosa,
JS Weese. University of Guelph, Guelph, ON. Canada,
Universidade Estadual Paulista, Arac¸atuba. Brazil
Clostridium diﬃcile is the major cause of antibiotic associated
diarrhea in humans. While the role of this bacterium in disease
in calves is still unclear, public health concerns have been
expressed because of its presence in food animals and food. Epi-
demiologic studies have shown an increase on the prevalence of
C. diﬃcile in veal calves after arrival on the farm, which coin-
cides with antimicrobial treatment. Whether this increase is phys-
iological or due to treatment remains uncertain. The objective of
this prospective trial was to compare the prevalence of C. diﬃcile
in veal calves treated with oral oxytetracycline compared to age
matched controls.
Twenty-two bull calves (2-7 days) arriving on a veal farm were
enrolled. They were clinically normal and housed in individual
pens. Twelve received oral oxytetracycline (6.6mg/kg PO for 5d)
starting at arrival, and ten calves were left untreated. Feces were
collected by rectal digital stimulation at arrival, 3 days into treat-
ment and 2, 10 and 27 days after treatment. Selective culture for
C. diﬃcile was performed. Fisher’s exact test was used to deter-
mine the relationship between treatment with oral oxytetracycline
and the shedding of C. diﬃcile.
The prevalence of C. diﬃcile in both groups at the diﬀerent
sampling times is presented on Table 1. No signiﬁcant statistical
diﬀerences were found between groups at any sampling times.
The prevalences found at the ﬁrst two samplings were consistent
with previous reports in the literature. Interestingly, an increase
occurred at the ﬁfth sampling, which coincided with the moving
of the calves to collective pens (groups of 10) in another room
and therefore submitted to stress.
Administration of oral oxytetracycline seems to have no
impact on the prevalence of C. diﬃcile in calves and the changes
in prevalence that have been noted may be due to other factors,
such as environmental exposure, external stressors and other fac-
tors that may aﬀect the intestinal microﬂora.
ABSTRACT FA-4
INCREASED STRONG ION GAP IN DAIRY CALVES WITH
DIARRHEA IS LIKELY DUE TO D-LACTATE. HR Staempﬂi1,
PD Constable2. 1Ontario Veterinary College, University of Guelph,
Guelph, Ontario, Canada hstaempf@uoguelph.ca, 2Purdue
University,West Lafayette, Indiana
Physicochemistry emphasizes the importance of strong elec-
trolytes (Na, K, Cl, L-lactate, D-lactate), pCO2, and plasma
protein concentrations in determining plasma pH. We recently
determined that the physicochemical approach provided a clini-
cally useful method to predict the dependent variables (pH,
HCO3) in critically ill horses by using a Radiometer 800 Flex
blood gas analyzer to measure the plasma concentration of
strong electrolytes and refractometry to measure total protein
concentration (TP) (J Vet Intern Med 25 2011 p674). The situa-
tion in calves with diarrhea might diﬀer from that in horses in
that calves frequently develop strong ion (metabolic) acidosis
due to elevation of unmeasured strong anions such as D-lac-
tate..
Eighty-three venous blood gas analysis samples obtained
anaerobically from 20 calves aged 2 days to one month presented
to the Veterinary Teaching Hospital for dehydration and acid
base abnormalities associated with diarrhea were analyzed. Na-
heparinized blood samples were analyzed for pH (pHm), pCO2
and concentrations of Na, K, Cl, and L-lactate using a Radiome-
ter 800 Flex blood gas analyzer; Strong Ion Diﬀerence
(SID4=Na+K-Cl- Lac) was calculated and TP was estimated
using refractometry. Plasma pH values (pHc) were calculated
using Constable’s 6 factor simpliﬁed equation ((J. Appl. Physiol.,
1997. 83. 297-311). Anion gap (AG) and Strong ion gap (SIG)
were deﬁned as: AG=(Na+K)-(Cl+HCO3
-); SIG=[(0.343xTP)/
(1+10{7.10-pH})]-AG. Linear regression analysis was used to com-
pare pHc to measured pHm, as well as AG and SIG to blood L-
lactate concentrations.
Measured pH ranged from 6.66 to 7.59 (7.27±0.16,
mean±SD); measured SID4 ranged from 22.1 to 56.3 mEq/L
(36.6±6.1 mEq/L); TP concentration ranged from 32-98
(53.5±13.3 g/L). pHc was poorly associated with pHm (r=0.10;
pHc=0.31+5.09). This result was probably due to the presence
of unmeasured strong anions not included in the SID4 esti-
mate, with the most likely unmeasured strong anion being D-
lactate. Anion gap (in mEq/L) was signiﬁcantly and positively
correlated with L-lactate concentration (mmol/L); AG=0.93x
[lactate]+8.3 (R2=0.39). SIG (mEq/L) was signiﬁcantly and
negatively correlated with L-lactate concentration SIG=-1.10x
[lactate]-4.4 (R2=0.25). The intercept estimate of -4.4 mEq/L
for the strong ion gap regression equation indicated that neo-
natal calves with diarrhea had a mean unmeasured strong
anion concentration of 4.4 mEq/L.
Our ﬁndings demonstrate that a clinically useful application of
strong ion diﬀerence theory is calculation of the SIG to quantify
the unmeasured strong anion concentration. It would be interest-
ing to prospectively determine that the unmeasured strong anion
was D-lactate. We also conclude that an accurate estimate for
strong ion diﬀerence is required if plasma pH is to be calculated
from plasma constituents.
ABSTRACT FA-5
ANTIMICROBIAL RESISTANCE TRENDS AMONG SAL-
MONELLA ISOLATES OBTAINED FROM DAIRY CATTLE
IN THE NORTHEASTERN USA, 2004-2010. KJ Cummings1,2,
GA Perkins2, SM Khatibzadeh2, JD Siler2, LD Warnick2,
C Altier2. 1Texas A&M University, College Station, TX, 2Cornell
University, Ithaca, NY
The objectives of this study were to describe the antimicrobial
resistance status of Salmonella isolates recently obtained from
dairy cattle in New York and other northeastern states and to
identify trends in resistance to various antimicrobial agents over
time.
Data were collected retrospectively for all bovine Salmonella
isolates that were obtained from samples submitted to the Cor-
Table 1. Prevalence of C. diﬃcile in veal calves and P values before and
after administration of oral oxytetracycline.
1st 2nd 3rd 4th 5th
Control (%) 5/10 5/10 8/10 1/10 4/10
Treatment (%) 1/12 6/12 7/12 3/12 7/12
P value 0.056 1.000 0.381 0.594 0.670
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nell University Animal Health Diagnostic Center between Jan-
uary 1, 2004 and December 31, 2010 and that were subse-
quently tested for antimicrobial susceptibility. Standard
bacteriologic culture methods were used to isolate Salmonella
from samples, and antimicrobial susceptibility of isolates was
determined by use of the microbroth dilution method. Tempo-
ral trends in the prevalence of resistant Salmonella were investi-
gated for each antimicrobial agent using the Cochran-Armitage
trend test.
Antimicrobial susceptibility testing was performed on 4,589
bovine Salmonella isolates during the study period. Resistance
to individual antimicrobial agents ranged from 0% (amikacin)
to 74.9% (sulfadimethoxine) of all isolates tested. The Coch-
ran-Armitage test showed evidence of an overall signiﬁcantly
decreasing trend in prevalence of resistance to most antimicro-
bial agents (AUG-amoxicillin/clavulanic acid, AMP-ampicillin,
FOX-cefoxitin, TIO-ceftiofur, AXO-ceftriaxone, CHL-chloram-
phenicol, FFN-ﬂorfenicol, CTET-chlortetracycline, OXY-oxy-
tetracycline, TET-tetracycline, KAN-kanamycin, NEO-
neomycin, SPE-spectinomycin, STR-streptomycin, and FIS-sul-
ﬁsoxazole). Among the 1,677 isolates that were tested using the
full National Antimicrobial Resistance Monitoring System





These results do not support the notion that there is an ongo-
ing increase in the emergence and dissemination of resistant Sal-
monella isolates among dairy cattle.
ABSTRACT FA-6
EVALUATION OF ORALLY SUPPLEMENTED D, L-
METHIONINE AS A URINE ACIDIFIER FOR SMALL
RUMINANTS. G Grissett, S Fleming, K Neizman. Mississippi
State University College of Veterinary Medicine, Mississippi
State, MS
Urolithiasis is the most economically signiﬁcant urinary dis-
ease of ruminants, speciﬁcally castrated male small ruminants.
Due to treatment expense and poor prognosis for full recovery,
focus is generally placed on prevention. Most prevention strate-
gies attempt to create an environment inhibiting urolith forma-
tion such as an acidic urine pH. Methionine, a limiting amino
acid for most livestock species, is well-documented in castrated
male felids as a urine acidiﬁer. This study investigated the abil-
ity of D, L-Methionine (Met) to acidify urine in small rumi-
nants without signiﬁcant clinically apparent side eﬀects. The
ﬁrst objective was to determine if oral administration of Met
would acidify urine and lower solute concentration. The second
objective was to determine if castrated male goats (wethers)
voluntarily would consume a suﬃcient quantity of Met added
to grain to acidify urine and lower solute concentration. Five
caprine wethers (4 Nubian, 1 Oberhasil) were administered Met
(Ammonil®) orally at a 200mg/kg dose daily. One urine sample
was collected pre-treatment and fourteen treatment samples
were collected via free catch. The urine samples were analyzed
for urine pH, speciﬁc gravity, and osmolality using an electric
pH meter, refractometer, and osmometer respectively. Wethers
were given a one week wash-out period between trials. Pre-
treatment urine samples were obtained before beginning the
second trial. The same dose of Met was added to the grain
ration of each wether and urine samples were collected for
fourteen treatment days and analyzed as previously described.
Orally administered Met caused a mean drop in pH across
individuals that ranged from 0.66-1.82. Within Trial 1 there
were variations in individual urinary pH both up and down. At
the end of Trial 1the urine pH change was 1.7 from pre-treat-
ment mean. Trial 2 with voluntary intake of Met resulted in a
signiﬁcant continuous drop in urine pH with mean being 7.8
on trial day 1 and 5.7 on trial day 14. The mean urine pH
change in trial 2 ranged from 0.51-1.59. Three wethers reliably
ate the dose of methionine while two increased their intake
during Trial 2 to eating the full dose by completion of the trial.
No other clinically apparent side eﬀects were noted. Fluctua-
tions in urine pH may suggest a renal compensatory mecha-
nism to the Met. Neither orally administered or feed added
Met reliably decreased urine solute concentration based on spe-
ciﬁc gravity and osmolality. Based on these results, Met has
potential promise as a more palatable alternative for urine
acidiﬁcation in small ruminants that is worthy of further inves-
tigation.
ABSTRACT FA-7
THE EFFECT OF AMMONIUM CHLORIDE TREATMENT
AS A LONG TERM PREVENTATIVE APPROACH FOR
UROLITHIASIS IN GOATS AND A COMPARISON OF
CONTINUOUS AND PULSE DOSING REGIMES. P Sprake,
AJ Roussel, R Stewart, WT Bissett. Texas A&M University,
College Station, Texas
Long-term oral treatment with ammonium chloride in goats to
acidify urine as a mechanism to prevent phosphatic urolithiasis
has been observed to lose clinical eﬀectiveness. Clinically, pulse
dosing has been utilized in order to prevent the failure to achieve
acidiﬁcation of urine as seen with continuous daily dosing.
We hypothesized that continuous daily dosing of ammonium
chloride would lose clinical eﬀectiveness, pH<6.5, within 7 days,
and that pulse therapy (3 days of treatment followed by 4 days
rest) would result in repeated attainment of target pH during the
3-day treatment periods.
10 wether goats fed a commercially available concentrate
feed containing 0.1% ammonium chloride and supplemented
with alfalfa hay, were treated with ammonium chloride as con-
tinuous daily dosing and pulse regimes in a cross over study
design. The dose of ammonium chloride was titrated for each
goat, starting at 200 mg/kg q 12 hours, and increasing to 250
mg/kg and/or 300 mg/kg q12 hours in order to determine a
dose that decreased the pH to below target within 3 days.
Urine was collected twice daily at each treatment time by use
of a cup collection system and pH was determined using a 3-
pad indicator strip and pH meter. Once an eﬀective dose had
been determined for each goat, continuous twice daily dosing
was administered for 10 days, and pulse dosing was continued
for 3 treatment cycles. Basic descriptive statistics were per-
formed for this data.
The median urine pH for all goats during the pre-treatment
period was 8.3. Twenty four hours after starting continuous twice
daily treatment, 88% (8/9) of the goats had urine pH below the
target, achieving a median pH nadir of 5.49 (range 4.32-7.61).
Following 4 days of continuous dosing, only 50% (4/8) goats
had urine <6.5. Mean urine pH remained above the target pH
for subsequent treatment days, until 8.5 days after starting treat-
ment when median urine pH returned to below the target pH. 60
hours after ammonium chloride treatment was discontinued, all
goats had urine pH of >6.5. During the pulse treatment regime,
target median urine pH was achieved in cycles 1 and 3, 30 hours
after initiating treatment each. 4/10 goats achieved urine pH
<6.5 for all treatment cycles. All received pulse dose as the ﬁrst
treatment regime suggesting that treatment order inﬂuenced urine
pH.
These results showed that ammonium chloride is an eﬀective
method of acidifying urine in goats if the dose is titrated for
each individual. The data demonstrated re-alkalinization does
occur in goats receiving continuous daily dosing of ammonium
chloride, as has been suggested by previous literature. In this
study, re-alkalinization occurred at day 4 of ammonium chlo-
ride treatment. For some goats pulse dosing repeatedly
achieved urine pH to below the target, and therefore pulse dos-
ing regimens may be eﬀective in prolonging the treatment eﬀect
of ammonium chloride in the prevention of phosphatic urolith-
iasis.
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ABSTRACT FA-8
ECHOCARDIOGRAPHIC MEASUREMENT OF VALVULAR
THICKNESS IN HEALTHY COWS, COWS WITH BACTE-
RIAL ENDOCARDITIS AND COWS WITH CARDIORESPI-
RATORY DISEASES. S Buczinski1, M Tolouei2, A Rezakhani3,
T Mohamed4. 1Faculte´ de Me´decine Ve´te´rinaire, Universite´ de
Montre´al, St-Hyacinthe, QC, Canada, 2Department of Clinical
Studies, School of Veterinary Medicine, University of Tabriz,
Iran, 3Department of Clinical Studies, School of Veterinary
Medicine, Shiraz University, Shiraz, Iran, 4Faculty of Veterinary
Medicine, Zagazig University, Egypt
Ante-mortem diagnosis of bacterial endocarditis (BE) is based
on diﬀerent signs including the echocardiographic observation of
valvular thickening. This ﬁnding is a subjective criterion espe-
cially for operator not used to echocardiography. Our objective
was to determine the valvular thickness in healthy cows, cows
with a diagnosis of BE and cows with various cardiorespiratory
diseases.
Forty healthy Holstein adult cows (CONTROL), 12 adult
cows with BE (BE) and 10 cows with other cardiorespiratory
disorders (NONBE).The valvular thicknesses were assessed in 4
diﬀerent locations for all the cardiac valves and the maximal
value was used for further analysis.Results: The mean (±SD)
maximal thicknesses of the tricuspid, mitral, aortic and pulmo-
nary valves in CONTROL were 0.69±0.10 cm, 0.85±0.21 cm,
0.72±0.17 cm, and 0,58±0.12 cm, respectively. The maximal val-
vular thicknesses of the tricuspid and pulmonary valves were
less than 1 cm and for mitral and aortic valves were less than
1.28 cm. The mean (±SD) maximal thicknesses of the aﬀected
valves in BE group were 4.50±1.25 cm; 4.04±1.32 cm, 5.16 cm,
2.80 ±1.24 cm for the tricuspid (n=6), mitral (n=3), aortic
(n=1) and pulmonary (n=2) valves, respectively. This was dif-
ferent from CONTROL group as well as the normal valves in
BE group for tricuspid valve (P=0.0006) but not for the mitral
(P=0.055) or pulmonary valve (P=0.25). The maximal valvular
thickness of NONBE as well as non aﬀected valves in BE
group were not diﬀerent from the CONTROL group. The max-
imal valvular thickness in healthy dairy cows is generally less
than 1cm when assessed by right transthoracic echocardiogra-
phy using low frequency phased array probe. Thicker valvular
measurement should therefore raise the possibility of valvular
endocarditis.
ABSTRACT FA-10
UTERINE NEOPLASIA IN SMALL RUMINANTS: RETRO-
SPECTIVE STUDY (1991-2011). M Heller. University of
Missouri College of Veterinary Medicine, Columbia, MO
Literature concerning uterine neoplasia in small ruminants is
limited. The goal of this retrospective study is to add to our
understanding and aid in the diagnosis of uterine neoplasia in
sheep and goats by identifying common presentations, physical
exam ﬁndings, and diagnostic results. Medical records of sheep
and goats diagnosed with uterine neoplasia from 1991 to 2011
were reviewed. A total of 19 cases were reviewed for presenting
complaints, history, physical exam ﬁndings, clinical pathology
ﬁndings, diagnostic imaging results and histopathologic diagno-
sis. Cases lacking a deﬁnitive diagnosis were excluded. Age at
presentation ranged from 4-14 years old with a mean of 9.16
years and a median of 10 years. All cases except one were
goats, with the most common breed being Pygmy goats (74%).
The most common presenting complaints were anorexia (63%)
and vaginal discharge (70%), followed by straining (47%). On
physical examination 46% of cases had palpable masses in the
caudal ventral abdomen with 2 cases also being palpable in the
paralumbar fossa area as well. Concurrent udder enlargement
or inappropriate lactation was observed in 56% of cases. No
distinct trends were noted upon analysis of CBC or serum bio-
chemistry results, however for the subset of patients who had
urinalysis performed 8 out of 9 had proteinuria and/or hemo-
proteinuria ranging from trace to 3+. Diagnostic imaging
results were also analyzed, uterine abnormalities were visualized
in 14 out of 15 cases undergoing abdominal ultrasonagraphic
exam. Four of the 7 cases for which abdominal radiographs
were taken had evidence of caudal abdominal mass. The most
common histopathologic diagnosis was uterine adenocarcinoma
(56%), other tumor types diagnosed were leiomyoma, leiomyo-
sarcoma and leiomyoﬁbroma. Interestingly, several of the ade-
nocarcinoma cases had concurrent cystic endometrial
hyperplasia as well as two cases who had previously undergone
ovariohysterectomy for chronic cystic endometrial hyperplasia
and were both diagnosed with adenocarcinoma of their uterine
stumps. Thus endometrial hyperplasia may represent a pre-can-
cerous condition in goats. Uterine neoplasia should be a diﬀer-
ential diagnosis for goats presenting with straining and vulvar
discharge, particularly those with a history of udder enlarge-
ment not associated with pregnancy. Abdominal ultrasonagra-
phy is a useful diagnostic tool for evaluating reproductive tract
of small ruminants.
ABSTRACT FA-11
CAMELID HEAT STRESS AS A SYNDROME: 15 CASES
(2003-2011). PL Norton1, JR Gold2, KL Schulz1, BF Porter1.
1Texas A&M College of Veterinary Medicine, College Station,
TX., 2Dubai Equine Hospital, Dubai, UAE.
Heat stress is a well recognized condition in the southern Uni-
ted States bourgeoning camelid population. Camelids’ limited
thermal cooling window can be compromised by dense ﬁber
when unshorn during periods of elevated environmental tempera-
tures combined with high humidity. There is currently a paucity
of peer reviewed literature available regarding clinical outcomes
of camelids diagnosed with heat stress.
Medical records of camelids admitted to TAMU VMTH
between 2003 and 2011 were reviewed. Criteria for inclusion
included medical diagnosis, laboratory values and body tempera-
ture. Subject details, clinicopathologic ﬁndings, survival to time
of discharge, treatments, and non-survivor necropsy ﬁndings were
recorded. A heat stress index was calculated based on the
recorded ambient temperature and humidity.
Fifteen camelids ﬁt the inclusion criteria. Clinicopathologic
ﬁndings included decreased mean albumin, packed cell volume
and serum sodium were noted in addition to an increased mean
serum creatine kinase at time of admission. Seven camelids
(46.7%) survived to time of discharge. Eight cases received post-
mortem examinations, and the most signiﬁcant ﬁndings were mild
to severe skeletal muscle necrosis and minimal to mild spinal
axonal degeneration.
Camelid heat stress should be considered as a primary or sec-
ondary disease process in a recumbent camelid with a history of
suspected hyperthermia. Further research is needed to determine
risk factors and response to treatments.
ABSTRACT FA-12
COMPARISON OF THREE IMMUNOGLOBULIN G (IgG)
ASSAYS FOR DIAGNOSIS OF FAILURE OF PASSIVE
TRANSFER IN NEONATAL ALPACAS. T Pinn1, T Stokol1,
LF Gagliardo2, SR Purdy3, JA Appleton2. 1Cornell University
College of Veterinary Medicine, Ithaca, NY, 2James A. Baker
Institute for Animal Health, Cornell University, Ithaca, NY,
3University of Massachusetts Amherst, Hadley, MA
Measurement of serum IgG is used for assessment of passive
transfer of immunity in neonatal crias. While an IgG concentra-
tion below 1000 mg/dL is suggestive of failure of passive transfer
(FPT) in Peruvian herds, this cut-oﬀ remains undeﬁned in United
States herds. The purpose of this study was to determine whether
three commercially available assays yielded comparable results
for IgG in crias. Serum samples from 91 crias submitted to Clini-
cal Pathology for routine IgG measurement were used. Samples
were stored frozen until batch analysis on the same day with the
three assays. IgG was measured by radial immunodiﬀusion (assay
A) and 2 immunoturbidimetric methods - one is conﬁgured for
automated chemistry analyzers (assay B) and the other is a farm-
side test (assay C). Median IgG concentrations were signiﬁcantly
diﬀerent between the three assays. Assays A and B, which used
the same standard, yielded higher IgG values than assay C,
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resulting in a lack of concordance in 7-18% of samples at 1000
mg/dL IgG. Protein electrophoresis revealed that assay A and B
standards contained mostly albumin (>60%), whereas assay C
standard consisted of beta and gamma globulins. Median results
from assay B after calibration with the assay C standard were
not signiﬁcantly diﬀerent from those of assay C and diagnostic
concordance between these 2 assays improved. Our results indi-
cate that camelid IgG results are highly dependent on the assay
standard and are not directly comparable between assays, poten-
tially resulting in under-diagnosis of FPT in some crias.
ABSTRACT FA-13
BIOAVAILABILITY AND PHARMACOKINETICS OF ORAL
MELOXICAM IN LLAMAS. AJ Kreuder1, PJ Plummer1, LW
Wulf1, JA Schleining1, B KuKanich2, LL Layman1, JF Coetzee1.
1Iowa State University College of Veterinary Medicine, Ames,
IA, 2Kansas State University College of Veterinary Medicine,
Manhattan, KS
South American camelids in the United States have rapidly
developed into an important agricultural industry in need of vet-
erinary services. Pain management is challenging in camelids
because there are no drugs currently approved by the Food and
Drug Administration for use in these species. Dosage regimens
used for many therapeutic drugs have been extrapolated from
other ruminants; however, the pharmacokinetics in camelids may
diﬀer from those of other species. Studies investigating the phar-
macokinetics, in camelids, of non-steroidal anti-inﬂammatory
drugs considered to be cyclooxygenase-2 (COX-2) selective are
deﬁcient in the published literature.
The aim of this study was to evaluate the oral bioavailability
and pharmacokinetics of meloxicam in llamas in comparison to
intravenous (IV) meloxicam. Six adult llamas (121- 168kg) were
administered either a 1mg/kg dose of oral or a 0.5mg/kg dose of
IV meloxicam in a randomized cross-over design with an 11 day
washout period between treatments. Plasma samples collected up
to 96 hours post-administration were analyzed by high pressure
liquid chromatography and mass spectrometry detection (HPLC-
MS) followed by noncompartmental pharmacokinetic analysis
(results summarized in Table 1 below). No adverse aﬀects in the
llamas were associated with either treatment modality.
The mean bioavailability (F) of oral meloxicam was 76% indi-
cating excellent gastrointestinal absorption. Plasma meloxicam
concentrations >0.2 lg/mL were maintained for up to 72 h after
oral administration; >0.2 lg/mL is considered to be the concen-
tration of meloxicam required for analgesic eﬀects in other spe-
cies such as the horse. These data suggest that a single dosage of
oral meloxicam at 1mg/kg could potentially maintain therapeutic
concentrations in plasma for up to 3 days in adult llamas.
ABSTRACT FA-14
FLORFENICOL PHARMACOKINETICS IN HEALTHY
ADULT ALPACAS, EVALUATING TWO COMMERCIALLY
AVAILABLE DRUG FORMULATIONS. D Bedenice1,
MG Papich2, K Thane1, K Holmes1. 1Cummings School of
Veterinary Medicine at Tufts University, North Grafton, MA,
2North Carolina State University, Raleigh, NC
Single-dose ﬂorfenicol pharmacokinetics were compared using
2 commercially available drug formulations (Nuﬂor®, Nuﬂor-
Gold®, Schering-Plough) in 6 healthy adult alpacas, administered
at 40 mg/kg subcutaneously (s.c.) using a randomized, cross-over
design. Subsequently, each formulation of ﬂorfenicol was injected
s.c. every 48 hours for 10 doses (40 mg/kg) to evaluate long-term
eﬀects. Clinical parameters were monitored daily in addition to
weekly hematological analyses. Plasma drug concentrations were
obtained via high-performance liquid chromatography at 0, 0.5,
1, 2, 3, 4, 5, 6, 8, 12, 18, 24, 36, 48, 60, 72, 96 and 120 h post-
injection for single-dose studies, and at 0, 2, 4, and 8 h after the
last dose for multi-dose studies. The ﬂorfenicol plasma concentra-
tions vs. time plots were analyzed using a non-compartmental
analysis (Nuﬂor®) or 2 compartment model (NuﬂorGold®), and
commercial software (Phoenix WinNonlin 6.0). All data are pre-
sented as mean ± standard deviation; hematological parameters
were compared between time points using repeated measures
ANOVA and paired samples t-test post hoc.
Maximum plasma ﬂorfenicol concentrations (Cmax) were
achieved rapidly following single dose injections. Comparative
pharmacokinetic parameters are listed in Table 1 below:
Maximum plasma concentrations of 4.48±1.28 and 7.62±1.65
µg/mL were achieved at steady state for Nuﬂor® and Nuﬂor-
Gold®, respectively, after 10 doses. The following hematological
parameters decreased signiﬁcantly between weeks 0 and 3, follow-
ing repeated Nuﬂor® injection: total protein [TP] (6.38 vs. 5.61
g/dL, P<0.0001), globulin (2.76 vs. 2.16g/dL, P<0.0003), albu-
min (3.61 vs. 3.48g/dL, P=0.0038), white blood cell count
[WBC] (11.89 vs. 9.66910^3/lL, P<0.044), and hematocrit
(27.25 vs. 24.88%, P<0.0349). Signiﬁcant clinical illness was
observed in one alpaca. Similarly, the following parameters sig-
niﬁcantly decreased after 10 doses of 40mg/kg NuﬂorGold®: TP
(6.65 vs. 5.98 g/dL, P=0.009), globulin (2.82 vs. 2.28g/dL,
P=0.004), WBC (14.75 vs. 9.27910^3/lL, P=0.001). No clinical
illness was observed in the latter group.
In conclusion, both Nuﬂor® and NuﬂorGold® may be errati-
cally absorbed following s.c. administration in adult alpacas,
based on the observed variability in most measured pharmacoki-
netic parameters. Plasma concentrations of NuﬂorGold® reached
higher therapeutic concentrations, yet were associated with fewer
systemic complications following long term use.
ABSTRACT FA-15
EVALUATION OF POINT OF CARE GLUCOSE METERS
IN ALPACAS. O Beemer, S Byers, A Bohn. Colorado State
University, College of Veterinary Medicine and Biomedical
Sciences, Fort Collins, CO
Hospitalized alpacas are often hyperglycemic requiring
repeated blood sampling to monitor glucose levels and response
Table 1. Pharmacokinetic parameters. Mean (minimum - maximum).
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40mg/kg s.c. Cmax (lg/mL) Time to Cmax (h) AUC (h*µg/mL) T1/2 (h) T1/2 a (h) T1/2 b (h)
Nuﬂor® 1.95±0.94 2.50±1.07 99.78±23.58 99.7±59.9 - -
NuﬂorGold® 7.54±3.62 2.81±1.21 125.19±38.17 - 3.4±1.6 41.6±21.9
AUC – Area under the curve; T1/2 (1 compartment) – half life; T1/2 a and b (2 compartment)
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to insulin therapy. Point-of-care (POC) glucometers are com-
monly used to measure whole blood glucose concentrations due
to the rapid results and low expense. There is one POC glucome-
ter currently marketed for use in animals; however this meter has
not been validated for use in alpacas. Therefore human meters
are used but also have not been validated or compared to clinical
pathology laboratory glucose values for alpacas. Potential
sources of variation include meter accuracy, hematological varia-
tions, and drug interactions. The purpose of this study was to
compare 3 commercial glucometers to laboratory glucose read-
ings.
Four alpacas were used in this randomized cross-over study.
The alpacas were given either 0.4 U/kg of regular insulin intrave-
nously or 500 mg/kg of dextrose IV with a 1 week washout
between crossover periods. Blood samples were obtained from a
jugular catheter at speciﬁc time periods starting at 10 minutes
before drug administration until 6 hours post administration.
Whole blood and plasma samples were measured on 3 glucome-
ters, and serum glucose was measured on a laboratory chemistry
analyzer.
The POC meters had variable results compared to the serum
glucose and results also varied based on testing plasma or whole
blood. All 3 meters had either proportional or constant bias but
the variations were not considered clinically relevant. The POC
meters can be used for alpacas but if more accurate blood glu-
cose values are desired, reference intervals should be established.
ABSTRACT FA-16
RISK FACTORS AND PROGNOSTIC VARIABLES FOR
SURVIVAL IN 61 SICK NEONATAL NEW WORLD CAME-
LIDS. FR Bertin, JM Squire, JE Sojka-Kritchevsky, SD Taylor.
Purdue University, West Lafayette, IN
Neonatal New World Camelids (NWC) are more common
among large animal patients, but information pertaining to clini-
cal presentation and outcome is limited. The objective of this ret-
rospective study was to describe the signalment, clinical signs,
clinicopathologic values, antimicrobial use, and survival status in
neonatal NWC presented to Purdue University Veterinary Teach-
ing Hospital, and to identify variables for prediction of survival.
Inclusion criteria were NWC less than 30 days of age with com-
plete medical records that presented between 2000 and 2010.
Cases were categorized by outcome, and groups were compared.
Sixty-one patients met the inclusion criteria (36 alpacas and 25
llamas). The median age at presentation was 1 day. There was a
signiﬁcant overrepresentation of females (69%, P<0.01). The
most common clinical ﬁndings included clinical sepsis (49%), fail-
ure of transfer of passive immunity (41%), and congenital defects
(41%). Ophthalmologic (21%), gastrointestinal (15%), musculo-
skeletal (11%), respiratory (10%) and neurologic (10%) abnor-
malities were also reported. The most commonly administered
antimicrobials were penicillin G (39%), trimethoprim-sulfadiazine
(26%), amikacin (21%) and ceftiofur (10%).
Sixty-four percent of NWC survived to discharge. Clinicopath-
ologic ﬁndings on admission were variable and nonspeciﬁc but
albumin and TCO2 were signiﬁcantly lower in nonsurvivors
(P<0.05). The only independent factors associated with survival
were absence of congenital disorders (P<0.01), administration of
hyperimmune plasma (P<0.05), and antimicrobial treatment with
penicillin G (P<0.05) or trimethoprim-sulfadiazine (P<0.05).
We conclude that congenital disorders are common in NWC,
and that hypoalbuminemia and congenital disorders were predic-
tors of nonsurvival. Plasma administration and antimicrobial
treatment were associated with survival.
ABSTRACT FA-17
EVALUATION OF THE USE OF INFRARED THERMOGRA-
PHY IN THE NASAL CANTHUS OF THE EYES OF HOL-
STEIN CALVES WITH OR WITHOUT CLINICAL SIGNS
OF ENTERITIS. FCG Morelli, TS Polo´, LG A´vila, B Gerardi,
FLF Feitosa, LCN Mendes, JR Peiro´. FMVA – Univ Estadual
Paulista (UNESP), Arac¸atuba, SP, Brazil
The purposes of this study were to establish the pattern of
infrared temperature in the nasal canthus of the eyes of Holstein
calves with or without clinical signs of enteritis between 0 and 7
days old; observe whether calves with clinical signs of enteritis
have elevated temperature in the nasal canthus compared with
the healthy calves, and determine the correlation between the
temperature of nasal canthus of the eye and rectum temperature
of calves with or without signs of enteritis. Twenty Holstein
calves, from two dairy farms were divided into two groups: with-
out (control group) and with clinical signs of enteritis (experi-
mental group). The animals were subjected to measurement of
temperature in the nasal canthus of both eyes by infrared ther-
mography, and rectum temperature by a digital thermometer.
The animals were evaluated at birth and 1, 3, 5 and 7 days after
birth. The reference values for the nasal canthus of the left (LE)
and right (RE) eye were established for each group. There was
no diﬀerence in rectal temperature between groups (P = 0.6190).
The temperature in the nasal canthus did not signiﬁcantly change
in the LE (P = 0.3892) or RE (P = 0.2491) of calves in the con-
trol or experimental groups over 7 days of evaluation. The corre-
lation between the temperature of the nasal canthus of calves the
rectal temperature was 0.0007. We conclude that the reference
values for IRT in the nasal canthus of eyes of calves with or
without clinical signs of enteritis were generated. The use of the
nasal canthus of eyes of calves has a signiﬁcant correlation with
the rectal temperature. Thus, the temperature of the nasal can-
thus of eyes of calves might be used to evaluate the body temper-
ature of Holstein calves.
ABSTRACT FA-18
DEVELOPMENT, SAFETY, AND EFFICACY OF AN
AUTOGENOUS VACCINE FOR MYCOPLASMA OVIPNE-
MONIAE IN DOMESTIC SHEEP. JC Ziegler, TE Besser,
KK Lahmers, GM Barrington. Washington State University
College of Veterinary Medicine, Pullman, WA
Epizootic pneumonia is a major rate limiting factor in the re-
establishment of bighorn sheep (BHS) populations in western
North America. Mycoplasma ovipneumoniae (Movi), which is car-
ried by domestic sheep (DS) as a normal upper respiratory tract
commensal ﬂora, is the primary epizootic agent that triggers epi-
zootic pneumonia of bighorn sheep.
Our hypothesis is that interventions to reduce/eliminate Movi
in DS will reduce transmission to BHS. The objective of this pre-
liminary study was to evaluate the safety and immunogenicity of
two subcutaneous Movi vaccine formulations in DS: 1) live Movi
without adjuvant at 0 and 30 days, and 2) Movi in oil adjuvant
at 0 and 30 days. Injection sites were monitored and samples
were collected periodically for complete blood count, PCR, bEL-
ISA, and peripheral blood mononuclear cell lymphocyte stimula-
tion assay. Biopsies of the injection sites were performed 14 days
post-inoculation. Vaccination with live Movi without adjuvant
yielded no adverse reactions locally or systemically. Vaccination
with live Movi and oil adjuvant showed mild local inﬂammation
and ﬁbrosis, but no adverse reactions were noted systemically.
Neither vaccine formulation showed evidence of immunogenicity.
The vaccine formulations examined in this study were demon-
strated to be safe for use in DS, but didn’t exhibit immunogenic-
ity or protection in the sheep inoculated. Alternative approaches
toward improving immunogenicity must be explored, such as uti-
lizing a diﬀerent adjuvant. Another safety study would need to
be performed before eﬃcacy testing in a larger population.
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ABSTRACT FA-19
TEMPERATURE EVALUATION OF SHEEP SUBMITTED
TO EXPERIMENTAL ENDOTOXEMIA. EM Panelli,
B Gerardi, LG Avila, RF Araujo, MG Carvalho, JR Peiro, SHV
Perri, LCN Mendes. DCCRA – FMVA – unesp – Univ Estadual
Paulista, Brazil
The present study aimed to assess by thermometry and ther-
mography, changes in temperature aﬀected by endotoxemia in
sheep experimentally induced by inoculation of LPS from E. coli
(400 ng / kg body weight). For this, eight sheep were used, with
two years of age, obtained from commercial Arac¸atuba region.
Of the eight animals used, four (group 1) were inoculated with
LPS (Escherichia coli 055: B5, Sigma, St. Louis, MO) at a dose
of 400 ng / kg and four (group 2) were inoculated with 2 ml of
saline 0.9% Sodium Chloride (NaCl). We conducted a physical
examination of animals at the time of admission and data
recorded on individual sheets. After the physical examination
was performed thermographic examination on admission of ani-
mals and the 2, 4, 6, 12, 24, 36, 48 and 60 hours after administra-
tion of LPS or saline. We analyzed the following regions:
Temperature Front (TF), temperature of the dorsum (TD), axil-
lary temperature (AT), temperature of the external face of the
thigh (FEC), temperature of the inner thigh (FIC) and tempera-
ture of the perineum (TP). We can conclude that thermography
can be used to analyze the temperatures of sheep with endotox-
emia, better results were obtained by the analysis of the regions:
(TF) at times M6 and M60, (TD), M6, M12, M60, (TA), M12;
(FEC), and M12 (TFIC), M12. While the non-contact thermome-
try was not eﬀective in observing the temperature rise caused by
endotoxin administration.
ABSTRACT FA-20
ARSENIC TOXICOSIS IN A HERD OF CATTLE. FR Bertin1,
LJ Baseler2, SD Lenz2, CR Wilson2, JE Sojka-Kritchevsky1, SD
Taylor1. 1Department of Veterinary Clinical Sciences Purdue
University, West Lafayette, IN, 2Comparative Pathobiology,
Purdue University, West Lafayette, IN
Arsenic toxicosis is uncommon in cattle, and successful treat-
ment has not been previously reported. The objective of this
study was to describe the clinical signs, clinicopathologic indices,
treatment, and survival status of six cows intoxicated with
arsenic.
Cows ranged from 1 to 4 years of age. Cattle were exposed to
burned wood previously treated with arsenic. The ashes con-
tained more than 2,400ppm of arsenic by a colorimetric qualita-
tive test. The most common clinical signs included ataxia and
weakness (5/6; 83%), dehydration (4/6; 67%), diarrhea (4/6;
67%), respiratory distress (3/6; 50%) and sudden death (1/6;
17%). Clinicopathologic values on presentation revealed hemo-
concentration, azotemia, hypocalcemia, hyperbilirubinemia and
increased liver enzyme activity in all animals. A diagnosis of
arsenic toxicosis was made based on detection of elevated arsenic
concentrations in whole blood, urine or tissues using inductively
coupled plasma mass spectroscopy. The median blood arsenic
concentration for presenting cows was 677ppb [276-747ppb] (ref-
erence range: <50ppb). Supportive treatment included intrave-
nous and oral ﬂuids, oral mineral oil and oral activated charcoal.
Oral and intravenous sodium thiosulfate was used as a speciﬁc
antidote. After treatment, the median blood arsenic concentra-
tion was 463ppb [48-514ppb].
There was no association between severity of clinical signs,
blood arsenic concentration and outcome. Thirty-three percent of
cows survived and were healthy for up to two months after dis-
charge. Necropsy of nonsurvivors revealed abomasal erosions
and submucosal edema, segmental jejunal mucosal congestion,
and urinary bladder mucosal petechiae. Sodium thiosulfate may
be of limited use in aﬀected cattle.
ABSTRACT FA-22
ANALYTICAL VALIDATION OF A COMMERCIALLY
AVAILABLE IMMUNOASSAY FOR THE MEASUREMENT
OF SERUM FOLATE CONCENTRATIONS IN PIGS.
N Gru¨tzner1, D Knabe2, BD Lawhorn3, B Dominguez3,
J Kauﬀold4, JS Suchodolski1, JM Steiner1. 1Gastrointestinal
Laboratory, Texas A&M University, College Station, TX,,
2Department of Animal Science, Texas A&M University, College
Station, TX, 3Veterinary Large Animal Clinical Sciences, Texas
A&M University, College Station, TX, 4New Bolton Center,
University of Pennsylvania, School of Veterinary Medicine,
Kennett Square, PA
Folate (vitamin B9) plays an important role in amino acid
metabolism, and in RNA and DNA synthesis. Based on litera-
ture from human and veterinary medicine the majority of folate
is absorbed in the proximal small intestine. In humans, cats,
and dogs it has been shown that chronic and severe proximal
small intestinal disease can cause folate deﬁciency and that
small intestinal dysbiosis can lead to increased serum folate con-
centrations. An immunoassay labeled for the measurement of
serum folate concentration in humans is routinely used in dogs
and cats. In pigs, the role of serum folate has not yet been
extensively investigated. The aim of this study was to analyti-
cally validate said immunoassay, labeled for use in humans, for
the measurement of folate concentrations in serum samples
from pigs and to determine serum folate concentrations in
weaned pigs.
For the analytical validation of the assay (IMMULITE® 2000
folate immunoassay; Siemens, Deerﬁeld, IL), 20 surplus porcine
serum samples were used. Validation of the assay consisted of
determination of dilutional parallelism, spiking recovery, and
intra- and inter-assay variability. Additional surplus serum sam-
ples from 21 piglets from four litters owned by and housed at a
Texas A&M University farm were obtained. Each piglet had
been bled twice, the ﬁrst time at weaning (21 days of age) and
the second time 12 days later. To investigate results in compari-
son between age groups (time of weaning and post weaning),
serum folate concentrations were compared using a Wilcoxon
matched pairs test. Signiﬁcance was set at p<0.05.
Observed to expected ratios (O/E) for serial dilutions ranged
from 78.4 to 98.3% (mean ±SD: 85.2 ±6.9%) for ﬁve diﬀerent
serum samples for dilutions of 1:4, 1:8, 1:16, and 1:32. O/E for
spiking recovery ranged from 84.9 to 115.2% (mean ±SD: 98.5
±8.6%) for ﬁve diﬀerent serum samples that had been spiked
with each other. Intra-assay coeﬃcients of variation (%CV) for
ﬁve diﬀerent serum samples were 5.5, 6.5, 7.2, 7.4, and 8.7%,
respectively. Inter-assay %CVs for ﬁve diﬀerent serum samples
were 5.0, 6.7, 9.6, 10.4, and 12.5%, respectively. Serum folate
concentrations were signiﬁcantly higher in piglets post weaning
(median [range]: 45.0 [21.0–90.5] lg/L) compared to those at the
time of weaning (median [range]: 17.2 [8.5–50.7] lg/L;
p<0.0001).
The IMMULITE® 2000 folate immunoassay labeled for use in
humans is linear, accurate, precise, and reproducible for measure-
ment of serum folate concentrations in pigs. This study also
shows that piglets that diﬀer in age by only 12 days have signiﬁ-
cantly diﬀerent serum folate concentrations. Further investiga-
tions of the implications of diﬀering serum folate concentrations
in pigs at diﬀerent stages of life are warranted.
SMALLANIMAL –GASTROENTEROLOGY
GI-4
CONFOCAL ENDOMICROSCOPY ENABLES IN VIVO
IDENTIFICATION OF GASTRIC HELICOBACTER-LIKE
ORGANISMS IN DOGS. M J Sharman1, B Bacci1, P Sutton2, T
Whittem1, P Delaney3, C S Mansﬁeld1. 1School of Veterinary
Medicine, The University of Melbourne, Werribee, VIC,
Australia, 2Centre for Animal Biotechnology, The University of
Melbourne, Parkville, VIC, Australia, 3Optiscan, Nottinghill,
VIC, Australia
Confocal endomicroscopy (CEM) is an emerging technology
allowing for in vivo cellular imaging of the gastrointestinal
mucosa and is capable of achieving subcellular resolution. In
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people CEM has been successfully used to identify and diagnose
clinical Helicobacter pylori infections and associated gastritis.
CEM has also been used to characterise various other gastroin-
testinal conditions including dynamic morphologic changes in the
mucosa in response to provocative challenges. The objective of
this study was to determine whether CEM could be used to iden-
tify Helicobacter-like organisms in dogs.
Six clinically healthy colony dogs underwent standard upper
gastroduodenoscopy followed by CEM. CEM-guided pinch biop-
sies were obtained for comparison. Two ﬂuorophores previously
evaluated clinically in people, and shown to be eﬀective and safe
in dogs in a previous study, were used to provide contrast. Fluo-
rescein (10% solution, 15mg/kg) was ﬁrst administered intrave-
nously followed by topical acriﬂavine (0.05% solution) via an
endoscopy spray catheter.
CEM provided high quality in vivo cellular and subcellular
histologically-equivalent images for evaluation during gastrodu-
odenoscopy. Application of topical acriﬂavine allowed identiﬁ-
cation of Helicobacter-like organisms in all six dogs.
Organisms were most commonly identiﬁed within the gastric
mucus layer, but were frequently present deeper within gastric
pits. Distribution throughout the stomach was scattered and
multi-focal. CEM ﬁndings were correlated with standard histo-
pathologic evaluation, along with polymerase chain reaction
(PCR), serum antibody concentration and culture. CEM pro-
vided an accurate semi-quantitative assessment of Helicobacter-
like organisms.
Confocal endomicroscopy provides in vivo histology images
and is capable of aiding identiﬁcation of Heliocbacter-like organ-
isms and interpretation of mucosal morphology by gastroenterol-
ogists during the procedure. This has implications for further
investigating the relationship between these organisms and
inﬂammatory change in dogs.
ABSTRACT GI-7
SERUM PEPSINOGEN A AS A PROGNOSTIC MARKER IN
CANINE GASTRIC DILATATION AND VOLVULUS. I
Aroch1, J Steiner2, I Israeli1, S Yudelevitch1, Y Bruchim1, G
Segev1. 1Koret School of Veterinary Medicine, Hebrew
University of Jerusalem, Rehovot, Israel, 2GI Laboratory, Texas
A&M University, College Station, Texas, USA
Pepsinogens are zymogens secreted mainly by gastric chief
cells. In humans, their serum concentration reﬂects gastric muco-
sal morphology and function. Our aims were to characterize
serum canine pepsinogen A (cPG-A) and lactate concentrations
at presentation in dogs with gatric dialtation and volvulus
(GDV), assess their relationship with surgical ﬁndings and mor-
tality, and compare their prognostic usefulness. Sixty-six dogs
conﬁrmed with GDV at surgery were included in the study
group. Blood samples collected prospectively at presentation were
used to measure cPG-A and lactate concentrations. The reference
interval (RI) for cPG-A was based on 79 healthy, fasted controls.
The gastric wall status was assessed and assigned a score
(GWDS) at surgery.
The cPG-A RI was set at 105-802 µg/L. The mortality rate
was 22.7%. cPG-A was higher in GDV dogs (median 397µg/L,
range 37-5410) compared to controls (median 304 µg/L, range
18-848) (P=0.07). In dogs with GDV, cPG-A level was higher in
non-survivors compared to survivors (median 746 µg/L, range
128-5409 versus median 346, range 36-1575, respectively;
P=0.003). There was a signiﬁcant (P=0.007) trend for increased
cPG-A with an increase in GWDS. Receiver operator characteris-
tics analysis of cPG-A as a predictor of death had an area under
the curve (AUC) of 0.756 and performed better compared to lac-
tate concentration (AUC 0.66).
cPG-A is often increased in canine GDV at presentation. Its
level is positively associated with GWDS, and is signiﬁcantly
higher in non-survivors compared to survivors. cPG-A performed
better as an outcome predictor compared to serum lactate.
ABSTRACT GI-12
FELINE EXOCRINE PANCREATIC INSUFFICIENCY: 150
CASES. PG Xenoulis1, P Wooﬀ2, DL Zoran2, LC Doyal1, K
Wooten1, WN Cutrone1, JS Suchodolski1, JM Steiner1.
1Gastrointestinal Laboratory and, 2Department of Small Animal
Clinical Sciences, Texas A&M University, College Station, TX
Exocrine pancreatic insuﬃciency (EPI) is considered to be a
rare condition in cats. However, with the introduction of the
feline TLI (fTLI) assay, which is considered to be the gold stan-
dard test for the diagnosis of feline EPI, this condition is diag-
nosed with increasing frequency. Due to the small number of
reported cases, the clinical presentation and response to therapy
of cats with EPI have been poorly described. The purpose of the
present study was to describe the signalment, clinical signs, con-
current diseases, and response to treatment of a large number of
cats with EPI.
The Gastrointestinal Laboratory’s database was searched over
a 15-month period for cats with a serum fTLI concentration  8
µg/L, which is the currently recommended cut-oﬀ value for a
diagnosis of feline EPI. The veterinarians who had submitted the
samples were contacted and asked to ﬁll out a questionnaire for
each aﬀected cat. Information gathered involved signalment,
medical history, clinical signs, concurrent conditions, and treat-
ment.
Questionnaires for 150 cats with EPI were completed. Breeds
included DSH (94 cats), DLH (15), DMH (11), Maine Coon
(7), British shorthair (6), Siamese (6), Ragdoll (3), Abyssinian
(1), Balinese (1), Himalayan (1), and Savannah (1), while 4
cats were of mixed breed. The mean age of the cats was 8.1
years (SD: 4 years). Sixty-one cats were female (all neutered)
and 89 were male (86 neutered). The median body condition
score was 3/9 (range: 1/9 to 7/9). Ninety-two of 119 cats
(77%) had hypocobalaminemia (median: 149 ng/L; range: 149-
1,001 ng/L), and 83 of those cats (70%) had undetectable
serum cobalamin concentrations (<149 ng/L). Fifty-six of 119
cats (47%) had increased and 6 cats (5%) had decreased serum
folate concentrations (median: 21.1 µg/L; range: 3.9-121 µg/L).
The median serum Spec fPL concentration was 0.9 µg/L
(range: 0.2-4.8 µg/L). The most common clinical sign was
weight loss (median weight loss: 1.41 kg; range: 40 grams to
6.82 kg), and was reported in 91% of cases. Other clinical
signs included loose stools (62%), poor haircoat (50%), anor-
exia (45%), increased appetite (42%), depression (40%), watery
diarrhea (28%), and vomiting (19%). Eighty-seven cats (58%)
were reported to have concurrent diseases, the most common
of which were inﬂammatory bowel disease (21%), diabetes
mellitus (14%), pancreatitis (11%), and hepatic lipidosis (6%).
One hundred and two cats were treated with enzyme replace-
ment therapy using appropriate products and the treatment
response was reported to be good in 66%, partial in 24%, and
poor in 10% of cases.
In the present study, the most common clinical sign in cats
with EPI was weight loss. A relatively large percentage of cats
did not have diarrhea. The majority of cats evaluated had hy-
pocobalaminemia. Also, the majority of cats responded well to
enzyme replacement therapy.
ABSTRACT GI-1
CHARACTERIZATION OF FECAL DYSBIOSIS IN DOGS
WITH CHRONIC ENTEROPATHIES AND ACUTE HEMOR-
RHAGIC DIARRHEA. ME Markel1, N Berghoﬀ1, S Unterer2,
LM Oliveira-Barros3, A Grellet4, K Allenspach5, L Toresson6,
J Barr1, RM Heilmann1, JF Garcia-Mazcorro1, JM Steiner1,
N Luckschander-Zeller7, JS Suchodolski1. 1GI Laboratory, Texas
A&M University, College Station, TX, USA; 2Ludwig-
Maximilians University, Munich, Germany; 3University of Sa˜o
Paulo, Sa˜o Paulo, Brazil; 4Royal Canin France, Alfort, France;
5Royal Veterinary College, London, United Kingdom;
6Helsingborg Referral Animal Hospital, Helsingborg, Sweden;
7University of Veterinary Medicine, Vienna, Austria
Recent 16S rRNA gene sequencing studies of the duodenal
and fecal microbiota have revealed alterations in the abundance
of speciﬁc bacterial groups in dogs with various gastrointestinal
disorders (e.g., decreases in Clostridium clusters IV and XIVa
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with concurrent increases in Proteobacteria). The aim of this
study was to validate the results of previous sequencing studies
by measuring the abundance of selected bacterial groups using
quantitative real-time polymerase chain reaction (qPCR) assays
in healthy dogs, dogs with chronic enteropathies (CE), and dogs
with acute hemorrhagic diarrhea (AHD).
Fecal samples were collected from healthy dogs (n=180), dogs
with CE (n=87), and dogs with AHD (n=48). A qPCR panel
targeting 11 bacterial groups was used for analysis of fecal micro-
biota at various phylogenetic levels (i.e., Faecalibacterium spp.,
Turicibacter spp., Biﬁdobacterium spp., Lactobacillus spp., Strep-
tococcus spp., Ruminococcaceae, C. perfringens, E. coli, c-Proteo-
bacteria, Bacteroidetes, and Firmicutes). Diﬀerences in bacterial
abundance among groups were evaluated using a Kruskal-Wallis
test followed by a Dunn’s post-test. Statistical signiﬁcance was
set at p<0.05.
Signiﬁcant diﬀerences in the abundance of the evaluated
bacterial groups were observed for the disease groups when
compared to the healthy dogs. Faecalibacterium spp., Turicib-
acter spp., and Ruminococcaceae were signiﬁcantly decreased
in CE and AHD (p<0.001 for all). Bacteroidetes were signiﬁ-
cantly decreased in CE (p<0.001), but not diﬀerent in AHD
(p>0.05). E. coli and C. perfringens were signiﬁcantly increased
in CE (p<0.05 and p<0.001, respectively) and AHD
(p<0.001 and p<0.01, respectively). Biﬁdobacterium spp. and
c-Proteobacteria were signiﬁcantly increased in CE (p<0.05 for
both), but not diﬀerent in dogs with AHD (p>0.05 for both).
Lactobacillus spp. and Streptococcus spp. were signiﬁcantly
increased in dogs with CE (p<0.01 for both) and decreased in
dogs with AHD (p<0.05 and p<0.01, respectively). There was
no signiﬁcant diﬀerence in the abundance of Firmicutes in
dogs with CE or AHD compared to the healthy dogs
(p>0.05).
In conclusion, the here employed qPCR panel revealed a fecal
dysbiosis in dogs with CE and AHD when compared to healthy
dogs. These results are similar to recently reported ﬁndings using
molecular sequencing approaches. Quantiﬁcation of these bacte-
rial groups by qPCR may be a useful adjunct for diagnosis or
monitoring of gastrointestinal disease in dogs.
ABSTRACT GI-2
FINAL DIAGNOSES IN 136 DOGS WITH CHRONIC DIAR-
RHEA. M Volkmann1, GT Fosgate2, JM Steiner3, B Kohn1.
1Clinic of Small Animals, Faculty of Veterinary Medicine, Freie
Universita¨t Berlin, Germany, 2Department of Production Animal
Studies, Faculty of Veterinary Science, University of Pretoria,
3Gastrointestinal Laboratory, Texas A&M University, College
Station, TX
Chronic persistent or intermittent diarrhea is common in dogs
and many diﬀerent underlying causes have to be considered. The
objective of this study was to evaluate the ﬁnal diagnoses of a
large number of dogs with chronic diarrhea.
Medical records of 209 dogs with chronic diarrhea (with or
without vomiting) presented to the Small Animal Clinic of the
Berlin University between September 2009 and July 2011 were
retrospectively reviewed. Dogs were included if a minimum work-
up including a CBC, plasma chemistry proﬁle, and fecal parasi-
tology (ﬂotation and Giardia ELISA) had been performed. Fur-
ther diagnostic tests included abdominal radiography and/or
ultrasonography, serum cTLI, cobalamin, folic acid, cortisol, or
cPLI concentrations, fecal microbiology, a therapeutic trial with
an exclusion diet and/or gastroduodenoscopy and/or colonos-
copy.
In 136/209 (65%) cases a ﬁnal diagnosis was recorded. A pri-
mary enteropathy was diagnosed in 123/136 dogs (90%): food
responsive enteropathy (64), idiopathic inﬂammatory bowel dis-
ease (15), antibiotic responsive enteropathy (11; 9 metronidazole,
2 tylosin), steroid responsive enteropathy (4; corticosteroid-
responsive without histopathologic conﬁrmation of intestinal
inﬂammation), gastrointestinal parasites (15), lymphoma (5), pro-
tein losing enteropathy of unknown etiology (3), protothecosis
(2), and leishmaniasis, colorectal adenocarcinoma, colonic intus-
susceptions and systemic vasculitis in one dog each. In 13 dogs a
secondary enteropathy was diagnosed (10%): exocrine pancreatic
insuﬃciency (4), pancreatitis (3), and in one dog each a pancre-
atic adenocarcinoma, hypoadrenocorticism, hypothyroidism, por-
tosystemic shunt, renal insuﬃciency, and heart failure. 57/123
dogs (43%) ﬁnally diagnosed with a primary enteropathy
received antibiotics (other than or in addition to metronidazole,
tylosin) without identifying an obligate enteropathogen.
In this study food responsive enteropathies (47%) were
the most important diﬀerential diagnoses in dogs with chronic
diarrhea.
ABSTRACT GI-3
SERUM HOMOCYSTEINE CONCENTRATIONS IN CHI-
NESE SHAR PEIS AND DOGS OF SIX OTHER BREEDS
WITH COBALAMIN DEFICIENCY. N Gru¨tzner, VR
Rangachari, RM Heilmann, K Weber, JS Suchodolski, JM
Steiner. Gastrointestinal Laboratory, Texas A&M University,
College Station, TX
Cobalamin deﬁciency in the Chinese Shar Pei (Shar Pei) is
suspected to be hereditary. In humans, various defects of intra-
cellular cobalamin metabolism have been reported in several
diﬀerent studies. All these defects result in deﬁcient function of
one of the two main cobalamin-dependent enzymes, methylmal-
onyl-CoA mutase and methionine synthase, which may lead to
methylmalonic aciduria and homocysteinuria. In humans, both
disorders have been characterized with increased serum meth-
ylmalonic acid concentrations and increased serum homocyste-
ine (HCT) concentrations, respectively. In dogs, a previous
study showed that cobalamin-deﬁcient Shar Peis have higher
serum methylmalonic acid concentrations compared to normo-
cobalaminemic Shar Peis and cobalamin-deﬁcient dogs of 6
other breeds. The aim of this study was to evaluate serum
HCT concentrations in Shar Peis and dogs of 6 other breeds
with cobalamin deﬁciency.
Serum samples from 40 Shar Peis with an undetectable
serum cobalamin concentration (<150 ng/L), 28 normocoba-
laminemic Shar Peis, and 279 dogs of 6 other breeds that were
tested at the Gastrointestinal Laboratory between 2008–2011
and had an undetectable serum cobalamin concentration were
included in this study. Serum cobalamin concentrations (refer-
ence interval: 251–908 ng/L) and serum HCT concentrations
were measured using an Immulite®2000 assay (Siemens, Deer-
ﬁeld, IL) and a gas chromatography-mass spectrometry
method, respectively. A control interval for serum HCT con-
centrations was established from 35 healthy pet dogs. Serum
HCT concentrations were compared among cobalamin-deﬁcient
dogs belonging to the 7 diﬀerent breeds using a Kruskal-Wallis
test with a Dunn’s post test. A Fisher’s exact test was used to
evaluate if cobalamin deﬁciency in Shar Peis is associated with
hyperhomocysteinemia (p<0.05).
Serum HCT concentrations ranged from 5.2–25.9 lmol/L
(median: 10.3 µmol/L) in healthy pet dogs and the control inter-
val for serum HCT was established as 5.022.1 µmol/L. Serum
HCT concentrations were signiﬁcantly higher in cobalamin-deﬁ-
cient Shar Peis (median: 25.4 µmol/L) than in cobalamin-deﬁcient
German Shepherd dogs (median: 9.4 µmol/L; n=96), Labrador
Retrievers (median: 10.7 µmol/L; n=83), Yorkshire Terriers
(median: 3.8 µmol/L; n=44), Boxers (median: 11.8 µmol/L;
n=21), Cocker Spaniels (median: 5.0 µmol/L; n=20), and Bea-
gles (median: 9.0 µmol/L; n=15; p<0.0001). Serum HCT con-
centrations in normocobalaminemic Shar Peis ranged from 8.6–
51.9 µmol/L (median: 13.7 µmol/L), and cobalamin deﬁciency in
Shar Peis was signiﬁcantly associated with hyperhomocysteinemia
(p=0.0009).
In conclusion, cobalamin-deﬁcient Shar Peis had higher serum
HCT concentrations compared to cobalamin-deﬁcient dogs of 6
other breeds and a higher frequency of hyperhomocysteinemia
than normocobalaminemic Shar Peis. These ﬁndings suggest that
the function of the cobalamin-dependent enzyme methionine syn-
thase is impaired in cobalamin-deﬁcient Shar Peis.
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ABSTRACT GI-14
COMPARISON OF E. COLI ASSOCIATED WITH GRANU-
LOMATOUS COLITIS OF BOXER DOGS AND E. COLI
FROM HEALTHY CONROLS. B Dogan, M Volkmann, J Oh,
A Schukken, S Klaessig, KW Simpson. College of Veterinary
Medicine, Cornell University, Ithaca, NY
Granulomatous colitis (GC) of Boxer dogs is a breed speciﬁc
inﬂammatory bowel disease associated with mucosally invasive E.
coli. Three of four E. coli strains isolated from 2 Boxers with GC
were similar to adherent and invasive E. coli (AIEC) linked to
Crohn’s disease, raising the possibility that AIEC are adapted to
exploit an IBD susceptible host. It is unclear if AIEC arise from
the resident microbiome or are transmissible bacteria that could
pose a zoonotic risk. Our objectives were to determine the preva-
lence, relatedness and virulence traits of AIEC associated with
GC and then to compare GC-associated E. coli with strains from
healthy dogs.
E. coli were isolated via colonic biopsies of 20 Boxers with GC
and rectal mucosal swabs of 17 clinically healthy dogs. 10 to 15
isolates from each dog were evaluated for diﬀerences in genotype
by RAPD-PCR with representative strains evaluated for phylo-
group (A, B1, B2, D), serotype, multi locus sequence type
(MLST-7), virulence genes, invasion of Caco-2 intestinal epithe-
lial cells and survival in J774 macrophage cells. Gentamicin resis-
tant, cnf- or stx-positive strains were excluded from cell culture
assays (and could therefore not be identiﬁed as invasive or persis-
tent).
We isolated 45 diﬀerent E. coli strains from GC (1-4 / dog,
median 2) and 34 from healthy dogs (1-3 /dog, median 2). 10/18
(55%) GC dogs harbored AIEC strains; 15/35 (42%) GC strains
were AIEC and showed no consistent association with phylo-
group or serotype, and were not clonal: 10/15 (68%) belonged to
either phylogroup B1 or D. GC AIEC strains commonly carried
gsp (73%), hcp (73%), virB (40%), lpfA154 (40%) and fyuA
(33%) genes.
13/18 (72%) GC dogs harbored non-AIEC strains; 20/35
(58%) strains isolated from GC dogs were non-AIEC strains. 15/
20 (75%) belonged to phylogroup A or B1, and no serotype pre-
dominated. GC-associated non-AIEC strains also commonly car-
ried gsp (80%), virB (80%), lpfA154 (50%), hcp (45%) and fyuA
(35%) genes.
10/17 (59%) healthy dogs harbored invasive strains; 16/18
(89%) gentamicin-susceptible strains were invasive (persistence in
J774 was not assessed). 13/16 (81%) invasive strains belonged to
phylogroup B1 or D. Invasive strains from healthy dogs com-
monly carried virB (100%), lpfA154 (63%), gsp (56%), hcp (50%),
ratA (44%), and kpsMII (38%) genes. The 2 non-invasive strains
carried hcp (100%) genes. 8/34 healthy dog strains (all phylo-
group B2) had an O4:H56 serotype.
Our results reveal that mucosal E. coli isolated from GC are
not always AIEC. GC dogs do not have a substantially diﬀerent
proportion of invasive E. coli strains than healthy dogs; these E.
coli share similar phylogroup compositions, virulence genes, and
have no predominant serotype. Non-AIEC E. coli from GC dogs
carry virulence genes commonly found in their AIEC counter-
parts. Therefore, GC-associated AIEC are likely resident ﬂora
that, when presented with an opportunity, invade and persist in
mucosa of susceptible dogs leading to the clinical syndrome
of GC.
ABSTRACT GI-5
FECAL S100A12 CONCENTRATIONS ARE INCREASED IN
DOGS WITH INFLAMMATORY BOWEL DISEASE. RM
Heilmann1, A Grellet2, K Allenspach3, P Lecoindre4, MJ Day5,
F Procoli3, N Gru¨tzner1, JS Suchodolski1, JM Steiner1.
1Gastrointestinal Laboratory, Texas A&M University, College
Station, TX, 2Royal Canin, Aimargues, France, 3Royal
Veterinary College, University of London, UK, 4Clinique
ve´te´rinaire des Ce´risioz, St Priest, France, 5Division of Veterinary
Pathology, University of Bristol, Langford, UK
Diagnosis and treatment of inﬂammatory bowel disease (IBD)
in dogs can be challenging. Serological or fecal markers of the
disease that correlate with clinical severity would be very useful
for the clinician. To date, only one serum marker, C-reactive pro-
tein, has been shown to correlate with clinical activity of disease
and has shown some clinical utility in monitoring treatment of
these patients. Surrogate inﬂammatory markers that can be mea-
sured in feces, such as the concentration of fecal S100A12, are
considered useful tools for the detection of active gastrointestinal
inﬂammation in humans but have not been evaluated in canine
IBD. The aim of this study was to measure fecal S100A12 con-
centrations in dogs with IBD and to correlate these concentra-
tions to clinical and histological markers of disease severity.
Spot fecal samples were collected from 29 dogs with IBD
(median age [range]: 4 [1-13] years, 17 [59%] males) and 70
healthy control dogs (median age [range]: 4 [0.8-15] years, 37
[53%] males). Fecal S100A12 concentrations were measured by
an in-house ELISA, and were compared between dogs with IBD
and healthy controls using a Wilcoxon rank sum test. A Spear-
man rank sum correlation coeﬃcient ρ with Bonferroni correc-
tion (p<0.0071) was used to assess the relationship of fecal
S100A12 concentrations with clinical activity (using the CCECAI
scoring system) and with endoscopic and histologic disease sever-
ity (using 4-point semi-quantitative grading systems with 0=inac-
tive, 1=mild, 2=moderate, and 3=severe changes).
Fecal S100A12 concentrations were signiﬁcantly higher in dogs
with IBD (median [range]: 273 [5-110,400] ng/g) compared to
healthy controls (median [range]: 9 [1-1,810] ng/g; p<0.0001) and
correlated with the severity of endoscopic disease in the duode-
num (ρ=0.503; p=0.0064) but not in the stomach (p=0.9501)
and had a trend to correlate with the endoscopic disease activity
in the colon (ρ=0.815; p=0.0136). Fecal S100A12 concentrations
were not associated with the severity of histological changes in
the stomach (p=0.7749), duodenum (p=0.5517), or colon
(p=0.0574), but tended to be higher (15,830 [19-110,400] ng/g vs.
187 [5-7,370] ng/g; p=0.0783) if histology revealed a neutrophilic
component of the inﬂammatory inﬁltrate (n=5). Fecal S100A12
concentrations showed a trend towards correlation with the
CCECAI score (ρ=0.384; p=0.0400).
This study showed that fecal canine S100A12 concentrations
are increased in dogs with IBD compared to healthy dogs and
correlate with endoscopic disease severity. Further studies are
under way to evaluate the mucosal expression of S100A12 in
dogs with IBD and to assess fecal S100A12 concentrations in
response to treatment.
ABSTRACT GI-6
HISTOPATHOLOGICAL, CLINICAL, ENDOSCOPIC, AND
ULTRASOUND FEATURES OF DOGS WITH CHRONIC
ENTEROPATHIES AND SMALL INTESTINAL CRYPT
LESIONS. K Stroda1,2, N Wakamatsu2, L Gaschen1, M
Kearney2, F Gaschen1. 1Department of Veterinary Clinical
Sciences, Louisiana State University School of Veterinary
Medicine, Baton Rouge, LA, 2Department of Pathobiological
Sciences, Louisiana State University School of Veterinary
Medicine, Baton Rouge, LA
This study was designed to retrospectively deﬁne the signiﬁ-
cance of small intestinal crypt lesions in dogs with chronic idio-
pathic enteropathies (CE). We hypothesized that crypt lesions are
associated with more severe clinical disease in canine CE.
Dogs were selected from the LSU SVM biopsy database over
a 5.5-year period. Histology slides were graded using the WSA-
VA system that ranks inﬂammatory and architectural mucosal
lesions in the intestine. They were subsequently divided into those
with (CL) and without crypt lesions (NC). CL were further dif-
ferentiated in crypt abscesses (CA) and dilated crypts containing
mucus (DC). Historical data, clinical signs and laboratory parame-
ters were retrieved from the medical records. Duodenoscopy
recordings were reviewed when available and graded using an
established endoscopic scoring system. Additionally, abdominal
ultrasound (AUS) exams were evaluated using a previously pub-
lished scoring system. Finally, survival data was collected for all
dogs. Data was statistically analyzed with ANOVA, Tukey’s post
hoc test, Kruskal-Wallis, and Wilcoxon Rank Sum as appropriate.
Survival data was analyzed with Kaplan-Meier statistics.
Fifty-eight cases with idiopathic CE were found to have histo-
pathologic duodenal lesions. They were divided as follows; 22 had
CA, 9 had DC, while 27 had NC. The following paragraph sum-
marizes the statistically signiﬁcant diﬀerences (p<0.05) detected
between the 3 groups. Yorkshire terriers were signiﬁcantly more
2012 ACVIM Forum Abstracts 767
likely to have CA than other breeds. Dogs with CA and DC pre-
sented more frequently with ascites. When compared to NC and
DC, dogs with CA were older (mean±SD, 96±35 months old vs.
59±40 and 51±33 months old) and had lower serum albumin
(1.9±0.7 g/dL vs. 3.0±0.7 and 2.9±0.5 resp.), globulin (2.2±0.7 g/dL
vs. 2.8±0.4 and 2.7±0.6 resp.) and total calcium (8.0±1.8 mg/dL vs.
9.6±0.6 and 9.5±0.8 resp.). Their small intestinal mucosal echogenic-
ity scores and total AUS scores were greater, and they had more
secondary AUS changes such as ascites. Additionally, mucosal
edema was more frequently observed during duodenoscopy.
Finally, histopathologic lacteal dilation and villous stunting were
more frequent and more severe in dogs with CA than in those of
other groups. Crypt necrosis and attenuation were more pro-
nounced in dogs with CA than in those with DC. However, the
severity and type of the inﬂammatory lamina propria inﬁltrates
were not diﬀerent between the three groups. The median survival
of dogs with CA was 489 days and was signiﬁcantly shorter than
that of dogs with NC and DC, which could not be calculated.
Overall, the presence of CA is associated with more severe
intestinal protein loss, AUS changes, mucosal architectural
lesions, clinical course, and shorter survival in dogs with CE.
ABSTRACT GI-16
FELINE ALIMENTARY LYMPHOMA IS ASSOCIATED
WITH CHANGES IN THE SPATIAL DISTRIBUTION OF
MUCOSAL BACTERIA. S Hoehne, SP McDonough,
KW Simpson. College of Veterinary Medicine, Cornell
University, Ithaca, NY
Persistent bacterial infections are causally linked to gastric car-
cinoma and MALT-lymphoma in people, and the concept that
mucosa-associated bacteria can promote gastrointestinal carcino-
genesis is well established. Perturbation of the intestinal microbi-
ome has been documented in cats with IBD and it seems
plausible it could serve as a trigger for the development of intesti-
nal lymphoma. It is against this background that we sought to
assess the spatial distribution of mucosal bacteria in intestinal
biopsies from cats with histologically normal small intestine, lym-
pho-plasmacytic enteritis (LPE), and alimentary lymphoma.
Endoscopic or surgical biopsies of normal (N) small intestine
(n=16), LPE (n= 25), and alimentary lymphoma (small cell
(SC), low grade, n=33; large cell (LC), high grade, n=16) were
identiﬁed in the histopathology database at Cornell. The spatial
distribution of mucosal bacteria (luminal cellular debris, villus-
associated mucus, adherence to epithelium and serosa, mural
invasion, intravascular presence) was determined by ﬂuorescence
in situ hybridization (FISH) with the eubacterial probe EUB338.
The results of FISH analysis are shown in the table below:
The spatial distribution of mucosal bacteria was similar in N
and LPE. Colonization of luminal cellular debris was more com-
mon in both SC and LC lymphoma than N and LPE. Bacterial
colonization of adherent mucus was more common in SC lym-
phoma than LPE. Invasive bacteria were most frequently associ-
ated with lymphoma, particularly sections from the LC group.
Bacterial invasion was not restricted to areas of eroded or ulcer-
ated mucosa, and in some sections bacteria were visualized in
vessels and/or the serosa.
Our results reveal that alimentary lymphoma is associated with
alterations in the spatial distribution of mucosa-associated bacte-
ria. Bacterial invasion was most frequent in LC lymphoma
(69%), with evidence of bacterial translocation in approximately
30% of cases. Our results support the need to speciate lymphoma
associated bacteria, and to evaluate cats with alimentary lym-
phoma for evidence of septicemia.
ABSTRACT GI-8
COMPARISON OF QUALITY AND DIAGNOSTIC ADE-
QUACY OF CANINE DUODENAL MUCOSAL BIOPSY
SPECIMENS OBTAINED WITH DIFFERENT ENDOSCOPIC
FORCEPS IN 17 DOGS. C Goutal1, J Mansell2, K Ryan1,
F Gaschen1. 1Dept. of Veterinary Clinical Sciences, Louisiana
State University, Baton Rouge, LA, 2Dept. of Pathobiology,
College of Veterinary Medicine, Texas A&M University
Limited published veterinary data exist regarding the inﬂuence
of diﬀerent ﬂexible endoscopic forceps on canine duodenal
mucosa biopsy quality and diagnostic adequacy.
With the hypothesis that larger forceps would procure superior
biopsy specimens, we prospectively evaluated the eﬀect of 6 dif-
ferent disposable biopsy forceps on duodenal biopsy weight,
depth, crush artifact and assessment of histologic adequacy in 17
healthy adult dogs. Two operators each obtained 4 duodenal
biopsy specimens from each dog with each forceps. The lightest
sample was discarded and the 3 other specimens were blindly
evaluated by one pathologist. A total of 612 specimens were eval-
uated. Results were analyzed by one-way ANOVA of forceps
eﬀects with dog as a blocking factor. Post hoc pairwise compari-
sons were examined with Tukey’s test when indicated.
The operator had no statistically signiﬁcant eﬀect on any of
the variables. Biopsies performed with the 2 Boston Scientiﬁc
(BoS) Radial Jaw Large Capacity forceps were signiﬁcantly hea-
vier and their diagnostic adequacy was signiﬁcantly superior to
the Olympus Standard Oval and ‘pediatric’ forceps. However, no
statistically signiﬁcant diﬀerence in depth scores was noted. The
BoS spike forceps was signiﬁcantly associated with less crush
artifact than the other forceps. The results also showed that the
presence of a spike had no eﬀect on crush artifact and diagnostic
adequacy.
Overall, the two BoS Radial Jaw Large Capacity forceps were
superior to the standard size forceps, demonstrating optimal
quality and diagnostic adequacy. Our study provides valuable ini-
tial data to guide the choice of endoscopic biopsy forceps for
duodenal samples.
ABSTRACT GI-9
SEROLOGIC AND FECAL MARKERS IN PREDICTION OF
ACUTE DISEASE COURSE IN CANINE CHRONIC ENTER-
OPATHIES. CC Otoni1, RM Heilmann2, M Garcı´a-Sancho3, JS
Suchodolski2, JM Steiner2, AE Jergens1. 1College of Veterinary
Medicine, Iowa State University, Ames, IA; 2GI Laboratory,
Texas A&M University, College Station, TX; 3College of
Veterinary Medicine, Complutense University of Madrid,
Madrid, Spain
Canine chronic enteropathies (CE) include a group of disor-
ders characterized by persistent or recurrent gastrointestinal signs
and histological intestinal inﬂammation. The search for biologic
markers that can detect disease activity and monitor the eﬀect of
therapy has become an important focus of human CE research.
Little information is available on pathologic markers that assess
the disease course in dogs with CE, especially in response to diet
and drug interventions. The purpose of this study was to evaluate
the relationships between disease activity and serum and fecal bi-
omarkers in dogs with CE.
Fifteen dogs with CE were prospectively enrolled. CE was
diagnosed on the basis of chronic GI signs, the exclusion of iden-
tiﬁable underlying disorders, histological inﬂammation, and
response to sequential therapy with an elimination diet, antibiot-
ics, or immunosuppressive drugs. The clinical scores (i.e., CIB-















N 16 7(44) 2(13) 3(19) 1(6) 1(6) 0(0)
LPE 25 13(52) 2(8) 6(24) 0(0) ND ND
SC 33 27(82)**, # 12(36)# 14(42) 6(18)# ND ND
LC 16 16(100)***, ### 3(19) 6(38) 11(69)***, ####,^^ 6(38) 5(31)*
Fisher’s Exact Test, vs. N, P<0.05= *, P<0.01= **, P<0.001= ***; vs. LPE, P<0.05= #, P<0.001= ###, P<0.0001= ####; vs. SC, P<0.01= ^^.
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ELISA), perinuclear antineutrophil cytoplasmic antibodies (p-
ANCA by IFA), and canine calprotectin (cCP by ELISA) and
fecal concentration of cCP were measured in each dog before
and after 21 days of medical therapy. The correlation between
CIBDAI with serum and fecal markers was estimated using the
Spearman rank correlation coeﬃcient. P-values <0.05 were con-
sidered signiﬁcant.
The ﬁnal diagnoses for CE dogs included PLE (n=7), idio-
pathic IBD (n=5), antibiotic-responsive enteropathy (ARE;
n=2) and exocrine pancreatic insuﬃciency (EPI) with lympho-
plasmacytic enteritis (n=1). Treatment for CE resulted in full or
partial remission in 14/15 dogs. Serum CRP (P<0.01), fecal cCP
(P<0.01), and CIBDAI scores (P<0.01) were signiﬁcantly
increased in CE dogs pre-treatment versus post-treatment values.
There were no signiﬁcant associations between the CIBDAI
scores and pre- or post-treatment serum concentrations of CRP
or p-ANCA. In contrast, there was a signiﬁcant association
(P=0.02) between pre-treatment fecal cCP and CIBDAI scores.
There was a trend toward higher pre-treatment serum CRP and
fecal cCP concentrations to be found in dogs with moderate-to-
severe disease activity (i.e., CIBDAI > 6).
Our data indicate that fecal cCP levels were related to the
extent of disease activity at diagnosis in dogs with CE. Serum
and fecal biomarker concentrations are not associated with clini-
cal disease activity in response to short-term medical treatment.
Overall, dogs with severe GI disease more often have abnormal
inﬂammatory markers, compared with dogs having low grade
inﬂammation.
ABSTRACT GI-10
FLOW CYTOMETRICAL ANALYSIS OF PERIPHERAL
BLOOD MONONUCLEAR CELLS IN DOGS WITH
INFLAMMATORY BOWEL DISEASE. A Galler1, BC
Ruetgen2, A Saalmueller3, RA Hirt1, W Gerner3,
I Schwendenwein2, JG Thalhammer1, N Luckschander1. 1Clinic
for Internal Medicine, Department for Companion Animals and
Horses, 2Central Laboratory and 3Institute of Immunology,
Department for Pathobiology, University of Veterinary
Medicine, Vienna, Austria
Inﬂammatory bowel disease (IBD) is a common cause of
chronic gastrointestinal signs in dogs. Although the importance of
intestinal intraepithelial lymphocytes (IEL) in the pathogenesis of
canine IBD is evident, little is known about the role of peripheral
blood mononuclear cells (PBMC) in this disease. Thus the purpose
of this study was 1) to analyze PBMCs in canine patients suﬀering
from IBD by ﬂow cytometry (FCM) and 2) to compare PBMC
sub-populations between patients and healthy controls.
Blood samples of 5 dogs suﬀering from IBD, which were clini-
cally scored based on the canine IBD activity index (CIBDAI)
and the canine chronic enteropathy clinical activity index (CCE-
CAI) were collected. Blood samples of 10 healthy dogs served as
controls.
PBMCs were isolated and stained with a panel of anti-canine
and cross-reactive monoclonal antibodies against T and B cell
diﬀerentiation antigens, including CD45, CD3, CD4, CD8a,
CD8b, TCRab, TCRcd, CD79 and CD21. All analyses were per-
formed with multi-colour FCM.
Data of healthy dogs and dogs with IBD were compared by a
Mann-Whitney U test. P values less than 0.05 were accepted as
statistically signiﬁcant.
Diseased dogs were suﬀering from moderate to severe IBD
(CIBDAI: 6-11, median 9; CCECAI: 6-16, median 10). In canine
IBD patients PBMCs showed signiﬁcantly decreased percentages
of CD79+ B-lymphocytes (p=0.019), TCRcd+ bearing T-lym-
phocytes (p=0.03), including CD8a+ (p=0.04) and CD8b+
(p=0.02) T-cells, as compared to healthy dogs. The percentage
of CD4+TCRab+ lymphocytes (p=0.049) was signiﬁcantly
increased in dogs with IBD.
In summary, preliminary results demonstrate signiﬁcant diﬀer-
ences between PBMC populations in healthy and IBD dogs ana-
lyzed by FCM. These data suggest that canine IBD is associated
with an altered distribution in PBMC populations, indicating an
imbalance of lymphocytes with diﬀerent immunological functions
emphasizing the value of this examination technique in a larger
cohort of dogs.
ABSTRACT GI-11
DECREASED IMMUNOGLOBULIN A LEVELS IN FECES,
DUODENUM, AND PERIPHERAL BLOOD LYMPHO-
CYTES OF DOGS WITH INFLAMMATORY BOWEL DIS-
EASE. S Maeda, K Ohno, K Nakashima, K Fukushima, Y
Fujino, H Tsujimoto. The University of Tokyo, Tokyo, Japan
Decreased immunoglobulin A (IgA) levels in fecal and duode-
nal explants were reported in German shepherd dogs (GSDs).
This decrease in IgA levels was considered to be signiﬁcant in the
pathogenesis of inﬂammatory bowel disease (IBD). The aim of
this study was to determine IgA levels in dogs of other breeds
(non-GSDs) who had IBD.
Twenty healthy dogs and 21 dogs with IBD were used. IgA
and IgG concentrations in serum, fecal, and duodenal samples
were measured by ELISA. Duodenal lamina propria IgA+ cells
and CD21+ IgA+ cells in peripheral blood mononuclear cells
(PBMCs) were examined by immunohistochemistry and ﬂow
cytometry, respectively.
Compared to the healthy dogs, IgA levels in the fecal (P =
0.0053) and duodenal (P = 0.0233) samples obtained from dogs
with IBD were signiﬁcantly reduced; however, no signiﬁcant dif-
ference was observed in the IgG concentrations between the 2
groups. Furthermore, there was no signiﬁcant diﬀerence in the
serum IgA and IgG concentrations between the 2 groups. The
number of duodenal IgA+ cells was signiﬁcantly decreased in
dogs with IBD than in the healthy controls (P < 0.0001). More-
over, the proportions of CD21+ IgA+ cells in PBMCs were sig-
niﬁcantly decreased in dogs with IBD (P < 0.0001), and the
proportions were signiﬁcantly elevated in post-treatment com-
pared to pre-treatment (P = 0.0165). In conclusion, decreased
IgA levels in the feces, duodenum, and PBMCs were observed in
non-GSDs with IBD, suggesting that the decreased IgA may be
involved in the pathogenesis of canine IBD, regardless of the
dog’s breed.
ABSTRACT GI-15
GRANULOMATOUS COLITIS IN FRENCH BULLDOGS IS
ASSOCIATED WITH INVASIVE E. COLI AND CLINICAL
RESPONSE TO FLUOROQUINOLONE ANTIBIOTICS.
A Manchester1, S Hill2, B Sabatino3, R Armentano4, B Kessler1,
M Miller1, B Dogan1, SP McDonough1, KW Simpson1. 1College
of Veterinary Medicine, Cornell University, Ithaca, NY, 2Veterinary
Specialty Hospital, San Diego, CA, 3College of Veterinary
Medicine, University of Tennessee, Knoxville, TN, 4College of
Veterinary Medicine, University of Florida, Gainesville, FL
French bulldogs have been reported to develop a form of
inﬂammatory bowel disease that is histopathologically similar to
granulomatous colitis of Boxer dogs (GCB). GCB is associated
with mucosally invasive E. coli, whose eradication correlates with
clinical remission. We sought to determine the clinical features,
presence or absence of intramucosal bacteria and E. coli in colo-
nic biopsies, and response to ﬂuoroquinolone antibiotics in
French bulldogs with GC.
Five French bulldogs (4M, 1F; median age 10mo, range 5-
12mo) with a histological diagnosis of GC were studied. Bacterial
colonization was evaluated using eubacterial (EUB-338) and E.
coli-speciﬁc FISH probes. E. coli were isolated and antimicrobial
resistance was determined by broth microdilution MIC from
available fresh biopsies. Response to ﬂuoroquinolone antibiotics
was determined by monitoring clinical signs.
Dogs were presented with clinical signs of chronic hema-
tochezia (5/5), large bowel diarrhea (3/5), and tenesmus (1/5)
after failed therapeutic trials with metronidazole (5/5), various
other antimicrobials (3/5), and anthelmintics. Age at onset of
clinical signs was 1-7mo (median 3mo). Clinicopathologic ﬁnd-
ings and fecal analysis were unremarkable apart from mild ane-
mia (PCV=39%) in 1/5 dogs. Abdominal ultrasound revealed
patchy thickening of the colonic wall and regional lymphadenop-
athy in 3/4 dogs. Multiple hypoechoic foci within the colonic
submucosa were observed in 1/4 dogs. Colonoscopic ﬁndings
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included hyperemic and irregularly thickened mucosa (5/5), overt
bleeding (2/5) and mucosal ulceration (3/5). FISH revealed multi-
focal accumulations of intramucosal E. coli in colonic biopsies
from 5/5 dogs. E. coli (2-6 strains) isolated from 2/2 dogs were
susceptible to enroﬂoxacin, marboﬂoxacin and trimithoprim
sulfa. Treatment with ﬂuoroquinolones (enroﬂoxacin 4/5, marbo-
ﬂoxacin 1/5) at 4.4-10 mg/kg (median 10 mg/kg) PO SID for 6-
10 weeks was associated with clinical remission. Hematochezia
resolved in 3-14 days in 5/5 dogs, and 2 dogs had gained weight
within 1 month. All 5 dogs remained free of clinical signs over a
9-23 month follow up period.
We conclude that GC in young French bulldogs is associated
with the presence of invasive E. coli and closely parallels GCB.
Treatment with ﬂuoroquinolones was associated with lasting clin-
ical remission. Documented treatment failures in GCB caution
against empirical antimicrobial therapy in French bulldogs with
unconﬁrmed GC.
ABSTRACT GI-13
EXOGENOUS SIALIC ACID AND CYSTEINE PROTEASE
INHIBITION BLOCK ADHERENCE OF TRITRICHOMON-
AS FOETUS TO THE INTESTINAL EPITHELIUM.
K Tolbert, JL Gookin. North Carolina State University College
of Veterinary Medicine, Raleigh, NC
Tritrichomonas foetus (Tf) is a ﬂagellated protozoan that para-
sitizes the feline colon resulting in chronic foul-smelling diarrhea.
Up to 30% of young purebred cats are infected and this disease
is now recognized as pandemic. Only a single drug, with a nar-
row margin of safety, is eﬀective for treatment. While the vene-
real pathogenicity of bovine Tf is attributed to adherence to
uterovaginal epithelium, the pathogenesis of diarrhea in feline Tf
infection is unknown. Aims of this study were to establish an in
vitro model of Tf adhesion to intestinal epithelium and apply this
model towards investigating Tf cytopathogenicity and putative
pharmacological targets.
Conﬂuent monolayers of porcine intestinal epithelial cells
(IPEC-J2, TER 2,000O∙4.67cm2) were infected with axenic cul-
tures of feline Tf that were labeled with [3H]thymidine (4lCi/ml
for 48hrs) or CFSE (30lM for 20min) and harvested at log-
phase. The eﬀect on Tf cytoadhesion of multiplicity of infection,
duration of infection, viability of Tf, binding competition, sialic
acid (N-acetylneuraminic acid, 2-50µM), cytoskeletal (cytochala-
sin B, 10.5µM; colchicine, 250µM) and protease inhibitors (E64,
0.3-0.6mM; ethylenediaminetetraacetic acid, 0.5mM, 4-(2-amino-
ethyl) benzenesulfonyl ﬂuoride hydrochloride, 1-4mM, phen-
ylmethylsulfonylﬂuoride, 0.5-1.5mM, pepstatin A, 0.01-0.1mM)
were quantiﬁed by liquid scintillation counting and immunoﬂuo-
rescence of adherent Tf. A minimum of four replicates was per-
formed for each experiment. Data were analyzed using
commercially available statistical software.
3[H]thymidine and CFSE-labeled Tf cytoadhered to IPEC-J2
monolayers in a dose and time-dependent manner with reproduc-
ible adhesion achieved by infection with 209106 Tf for 6hrs.
Clinical isolates of feline Tf (n=5) demonstrated signiﬁcantly
greater adhesion to intestinal epithelium than feline Pentatricho-
monas hominis, the latter of which is a presumably nonpathogenic
trichomonad. Adhesion of Tf required viable trophozoites but
was independent of cytoskeletal activity. Based on competition
binding experiments, adhesion of Tf was receptor-ligand depen-
dent. Treatment of Tf with N-acetylneuraminic acid and cysteine
protease speciﬁc inhibitors, but not other classes of protease
inhibitors, signiﬁcantly blocked Tf adherence to the intestinal epi-
thelium.
Identiﬁcation of speciﬁc receptor-ligand dependent mechanisms
of Tf adherence that are ameliorated by exogenous sialic acid
and cysteine protease inhibitors suggests the presence of key
molecular targets for prevention of Tf adhesion and consequent
cytopathogenicity. The developed model provides a valuable
resource for investigating pathogenic mechanisms of feline Tf




IS ASSOCIATED WITH INCREASED PANCREATIC
LIPASE IMMUNOREACTIVITY CONCENTRATIONS IN
DOGS. DL Mawby1, JC Whittemore1, K Fecteau1, A Reed1, JM
Steiner2, JS Suchodolski2. 1University of Tennessee, Knoxville,
TN, 2Texas A&M Gastroenterology Lab, College Station, TX
Canine pancreatic speciﬁc lipase immunoreactivity concentra-
tions (cPLI) are used to diagnose pancreatitis. The eﬀect of natu-
rally-occurring hyperadrenocorticism (HAC) on cPLI
concentrations is unknown. The purpose of this study was to
determine whether dogs with HAC have diﬀerent cPLI concen-
trations by Spec cPL (SpeccPL) or SNAP cPL (SNAPcPL) assay
from dogs without HAC.
Healthy dogs based on clinical examination and laboratory
work (Group 1, n=20), dogs with signs of HAC but normal
ACTH stimulation tests (Group 2, n=12), and dogs with HAC
(Group 3, n=20) were enrolled between December 2009 and
November 2010. Dogs with signs compatible with pancreatitis
were excluded. Samples were batched and SpeccPL and SNAP-
cPL assays were performed. SNAPcPL results were categorized
as negative, low positive (LP), or high positive (HP). Associations
between Group and cPLI were assessed using the Fisher’s exact
test (SNAPcPL) or Kruskal-Wallis test (SpeccPL). P<0.05 was
signiﬁcant.
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SNAPcPL results diﬀered signiﬁcantly between groups
(p=0.005), with more HP results in Group 3 than Group 1.
SpeccPL concentrations were signiﬁcantly higher in Group 3 than
Group 1 or 2 (p<0.0001).
Dogs with HAC had signiﬁcantly higher SpeccPL concentra-
tions and more HP SNAPcPL results than dogs without HAC.
Further study is necessary to determine the clinical relevance of
this association.
ABSTRACT GI-18
ALPHA-ENOLASE ANTIBODIES ARE NOT ASSOCIATED
WITH FELINE PANCREATIC LIPASE IMMUNOREACTIV-
ITY CONCENTRATIONS IN CLIENT-OWNED CATS.
JC Whittemore1, JM Steiner2, JS Suchodolski2, S Radecki3,
MRLappin4. 1Department Small Animal Clinical Sciences,
University of Tennessee, Knoxille, TN, 2Gastrointestinal
Laboratory, Texas A&M University, College Station, TX,
3Private Statistical Consultant, MI, 4Department of Clinical
Sciences, Colorado State University, Ft. Collins, CO
Alpha-enolase antibodies are a biomarker for inﬂammatory
and autoimmune diseases in people. Pancreatitis is increasingly
diagnosed in cats based on increased feline pancreatic lipase
immunoreactivity (fPLI) concentrations. Histologically, it is char-
acterized by lymphocytic inﬁltration, suggesting a potential
underlying immune-mediated etiology. The purpose of this study
was to evaluate for an association between alpha-enolase anti-
bodies and fPLI concentrations in client-owned cats.
Residual sera were collected from 458 privately-owned cats fol-
lowing fPLI concentration measurement. Age was known for all
cases. fPLI concentrations were classiﬁed as normal (2.0-6.8mg/l),
questionable (6.9-12mg/l), or consistent with pancreatitis
(>12mg/l). Alpha-enolase antibody %ELISA values were deter-
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mined using a previously validated assay and designated as posi-
tive or negative using a positive cutoﬀ value of 80 based on
results from 20 adult unvaccinated cats. A Fisher’s exact test was
used to assess for a relationship between fPLI category and a-
enolase antibodies (%positive). Stepwise logistic regression analy-
sis was performed with dichotomized alpha-enolase %ELISA
results as the outcome variable. The ﬁnal model included fPLI
category, age, and the interaction between these factors. P<0.05
was considered signiﬁcant.
Antibodies against alpha-enolase were common. No signiﬁcant
associations were detected between alpha-enolase antibodies and
fPLI concentrations.
Alpha-enolase antibodies
fPLI category % positive (n) %ELISA mean (range)
Normal (n=192) 34.4 (66) 74.60 (0–359.14)
Questionable (n=108) 27.8 (30) 68.58 (0–317.35)
Positive (n=191) 24.1 (46) 67.29 (0–631.94)
The presence of alpha-enolase antibodies was not associated
with fPLI concentrations. Prospective evaluation in cats with and
without histologically conﬁrmed pancreatitis should be consid-
ered to further assess for associations.
ABSTRACT GI-19
MUCOSAL NUCLEOTIDE OLIGOMERIZATION DOMAIN
TWO (NOD2) MRNA OVEREXPRESSION AND NF-KAPPAB
ACTIVATION IN DOGS WITH CHRONIC ENTEROPATHY.
H Okanishi, K Hayashi, Y Sakamoto, T Watari. Nihon
University, Kanagawa, Japan
Nucleotide oligomerization domain two (NOD2) is an intracel-
lular receptor involved in the innate immune response against
muramyl dipeptide, a component of the bacterial cell wall.
Recently, NOD2 was reported to be overproduced in inﬂamed
mucosa in Crohn’s disease, and to be accompanied with a signiﬁ-
cant increase in NF-kappaB activity. However, few studies to
date have investigated intercellular signal molecules in Chronic
enteropathy dogs. The activities of NOD2 and NF-kappaB in
mucosal biopsies from CE dogs, as compared to healthy controls,
were investigated in the present study.
Endoscopic descending colon biopsies were obtained from 10
dogs referred for evaluation of chronic signs of large bowel dis-
ease. Biopsies from 5 healthy dogs were used as controls. Tissue
was collected and immersed in liquid nitrogen (RNA) or formalin
(histology). Expression of NOD2 mRNA was determined by RT-
PCR, and was normalized against GAPDH. Ampliﬁed products
were subjected to gel electrophoresis, followed by computer-
assisted densitometry analysis using Quantity One Software. NF-
kappaB binding activity was assessed by electrophoretic mobility
shift assay.
The histological diagnosis was lymphocytic-plasmocytic colitis
in CE dogs. NOD2 mRNA expression was signiﬁcantly higher in
CE dogs than in healthy controls (p=0.012). Moreover, NF-kap-
paB binding activity was signiﬁcantly upregulated in the inﬂamed
colon mucosa of CE dogs, as compared to healthy controls
(p=0.0047).
In conclusion, NOD2 mRNA is overproduced and NF-kap-
paB activity is upregulated in the inﬂamed colon of CE dogs.
Our data suggest that NOD2 and NF-kappaB play an important
role in the pathogenesis of CE.
ABSTRACT GI-20
FECAL AND URINARY N-METHYLHISTAMINE CONCEN-
TRATIONS IN DOGS WITH CHRONIC GASTROINTESTI-
NAL DISEASE. N Berghoﬀ, JS Suchodolski, JM Steiner.
Gastrointestinal Laboratory, Texas A&M University, College
Station, TX
The role of mast cells in dogs with chronic gastrointestinal
(GI) disease is not well understood. Mast cells are potentially
important in intestinal inﬂammation due to their ability to release
inﬂammatory mediators, such as histamine. Histamine is rapidly
metabolized upon its release, but one of its metabolites, N-meth-
ylhistamine (NMH), can be readily measured in both fecal and
urine samples. The purpose of this study was to measure NMH
in fecal and urine samples from dogs with chronic GI disease,
and to evaluate its utility as a potential inﬂammatory marker in
dogs.
Three consecutive fecal samples and one urine sample were
collected from 53 dogs with chronic GI disease. Fecal and uri-
nary NMH concentrations were measured by gas chromatogra-
phy/mass spectrometry. Fecal NMH concentrations were
reported as 3-day means and also as the maximum concentration
for the 3 days. Urinary NMH was normalized using urinary cre-
atinine concentrations and results were expressed as ng NMH/mg
creatinine. Fecal NMH concentrations were compared to those
in a group of 49 control dogs, and urinary NMH concentrations
were compared to a previously established control range. A cor-
relation between fecal and urinary NMH concentrations and the
clinical IBD activity index (CCECAI) in dogs with GI disease
was calculated using Spearman’s rank correlation. Statistical sig-
niﬁcance was set at p<0.05.
Mean 3-day fecal NMH concentrations were signiﬁcantly
higher in the dogs with GI disease (median: 97 ng/g, range: 0-
4,690 ng/g) than in the control dogs (median: 53 ng/g, range: 9-
252 ng/g; p<0.009). Similarly, 3-day maximum NMH concentra-
tions were signiﬁcantly higher in the dogs with GI disease (med-
ian: 160 ng/g, range: 0-7,059 ng/g) than in the control dogs
(median: 83 ng/g, range: 14-666.2 ng/g; p<0.01). Eleven dogs
(19%) had 3-day mean fecal NMH concentrations above the
upper limit of the reference interval (>191 ng/g), and 23 dogs
(36%) had maximum fecal NMH concentrations above the upper
limit of the reference interval (>334 ng/g). Sixteen dogs (30%)
had urinary NMH concentrations above the upper limit of the
control range (>136 ng/mg creatinine), 8 of which also had
simultaneously increased fecal NMH concentrations. There was
no correlation between fecal and urinary NMH concentrations,
or between these parameters and the clinical activity index.
These data show that fecal and/or urinary NMH concentra-
tions may be increased in a subset of dogs with chronic GI dis-
ease. The lack of correlation to the clinical IBD activity index
suggests that mast cell related inﬂammation may not be of clini-
cal importance in all dogs with GI disease. The lack of correla-
tion between fecal and urinary NMH concentrations may be due
to a diﬀerence in distribution of mast cells within the mucosa, or
may be due to potential uptake of NMH along the GI tract,
leading to subsequent urinary excretion. Further studies are
underway to evaluate the distribution of intramucosal mast cells
and the correlation between fecal and urinary NMH concentra-
tions and mucosal mast cell numbers in dogs with chronic GI
disease.
ABSTRACT GI-21
SERUM COBALAMIN AND METHYLMALONIC ACID
CONCENTRATIONS IN DOGS WITH CHRONIC GASTRO-
INTESTINAL DISEASE. N Berghoﬀ, JS Suchodolski,
JM Steiner. Gastrointestinal Laboratory, Texas A&M University,
College Station, TX
The prevalence of hypocobalaminemia in dogs with chronic
GI disease has been reported to range from 6-18%. A recent
study investigating cobalamin concentrations in canine serum
samples submitted to the GI Laboratory has shown that 46% of
dogs with hypocobalaminemia, and even dogs with low normal
serum cobalamin concentrations may have evidence of cellular
cobalamin deﬁciency, as evidenced by an increased serum meth-
ylmalonic acid (MMA) concentration. It is unknown how preva-
lent cobalamin deﬁciency on a cellular level is in dogs with
chronic GI disease. Thus, the aim of this study was to determine
the proportion of dogs with chronic GI disease that have hy-
pocobalaminemia and/or methylmalonic acidemia.
Serum samples were collected from 58 dogs with chronic GI
disease that had not previously been treated with cobalamin, and
in which exocrine pancreatic insuﬃciency (EPI) had been
excluded by measurement of serum trypsin-like immunoreactivity.
Serum cobalamin and MMA concentrations were measured in all
58 dogs and compared to a group of 43 healthy control dogs
using a Mann-Whitney U test. A correlation between serum
cobalamin and MMA concentrations and the clinical IBD activ-
ity index (CCECAI) in dogs with chronic GI disease was evalu-
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ated using Spearman’s rank correlation. Statistical signiﬁcance
was set at p<0.05.
Serum cobalamin concentrations were signiﬁcantly lower in
dogs with GI disease (median [range]: 334 [149-1,000] ng/L) than
in control dogs (median [range]: 515 [333-835] ng/L; p<0.001).
Twenty-one dogs with GI disease (36%) had hypocobalaminemia
(<251 ng/L), and 8 dogs (14%) had undetectable cobalamin con-
centrations (<150 ng/L). Serum MMA concentrations were sig-
niﬁcantly higher in dogs with GI disease (median [range]: 741
[442-205,399] nmol/L) than in control dogs (median [range]: 649
[228-1253] nmol/L; p<0.046). Five dogs with GI disease (9%)
had MMA concentrations above the reference interval (>1,192.5
nmol/L). There was a signiﬁcant negative correlation between
serum cobalamin and MMA concentrations in dogs with GI dis-
ease (Spearman r= -0.435, p<0.001). No correlation was found
between the clinical activity index and serum cobalamin or
MMA concentrations.
These data show a prevalence of 36% for hypocobalaminemia
in dogs with chronic GI disease. Only 9% of these dogs also had
increased serum MMA concentrations, suggesting cobalamin
deﬁciency on a cellular level. This number is lower than previ-
ously reported, where 46% of dogs with a serum cobalamin con-
centration <251 ng/L had increased MMA concentrations.
However, sample populations between the two studies were likely
diﬀerent, because no clinical data was available for the dogs in
the previous study, and dogs with neoplasia and EPI could not
be excluded from analysis. This may have led to the diﬀerence in
the results observed. In conclusion, serum cobalamin deﬁciency is
commonly seen in dogs with chronic GI disease, but does not
always appear to be associated with a deﬁciency of cobalamin on
the cellular level.
ABSTRACT GI-22
SERUM CONCENTRATIONS OF CANINE ALPHA1-PRO-
TEINASE INHIBITOR IN YORKSHIRE TERRIERS WITH
AND WITHOUT COBALAMIN DEFICIENCY. N Gru¨tzner,
RM Heilmann, JS Suchodolski, JM Steiner. Gastrointestinal
Laboratory, Texas A&M University, College Station, TX
Protein-losing enteropathy (PLE) is a condition associated
with an excessive loss of plasma proteins into the gastrointestinal
tract. Important causes of PLE are an altered lymphatic drainage
(e.g., intestinal lymphangiectasia) or an increased mucosal perme-
ability (e.g., inﬂammatory bowel disease). Fecal canine alpha1-
proteinase inhibitor (ca1-PI) concentration has been reported to
be increased in dogs with PLE due to its loss into the gastrointes-
tinal tract, and a chronic loss of ca1-PI may theoretically deplete
ca1-PI in serum, potentially altering the proteinase/-proteinase
inhibitor balance. Serum ca1-PI concentrations, which during
health are regulated within a narrow concentration range, have
been reported to be decreased in a small group of dogs with
PLE. PLE has been reported to occur frequently in certain dog
breeds, one of these breeds being the Yorkshire Terrier. Also, it
has been shown that inﬂammatory bowel disease and PLE in
dogs is often associated with low serum cobalamin concentra-
tions. The aim of this study was to compare serum concentra-
tions of ca1-PI in Yorkshire Terriers with and without cobalamin
deﬁciency.
Serum samples from 122 Yorkshire Terriers, which were sub-
mitted to the Gastrointestinal Laboratory between 2008 and
2011, were used retrospectively. Serum cobalamin concentrations
(reference interval: 251–908 ng/L) were measured using an auto-
mated chemiluminescence assay (Immulite®2000; Siemens, Deer-
ﬁeld, IL). Serum ca1-PI concentrations (reference interval: 749.9–
1,556.0 mg/L) were measured using an in-house radioimmunoas-
say. A Mann-Whitney U test was used to compare serum ca1-PI
concentrations between Yorkshire Terriers with and without
cobalamin deﬁciency. A v2-test was used to evaluate if cobalamin
deﬁciency in Yorkshire Terriers is associated with decreased
serum ca1-PI concentrations. Signiﬁcance was set at p<0.05.
Fifty-three Yorkshire Terriers with an undetectable serum
cobalamin concentration (<150 ng/L) and 69 Yorkshire Terriers
with a serum cobalamin concentration within the reference inter-
val (median [range]: 618 [394–956] ng/L) were included. Serum
concentrations of ca1-PI were signiﬁcantly lower in cobalamin-
deﬁcient Yorkshire Terriers (median [range]: 1,027.5 [315.0–
3,945.0] mg/L) compared to Yorkshire Terriers with a normal
serum cobalamin concentration (median [range]: 1,665.0 [900.0–
2,970.0] mg/L; p<0.0001). One fourth of the cobalamin-deﬁcient
Yorkshire Terriers had a serum ca1-PI concentration below the
lower limit of the reference interval (<749.9 mg/L), and cobala-
min deﬁciency was signiﬁcantly associated with a decreased
serum ca1-PI concentration (p<0.0001).
In this study, serum concentrations of ca1-PI were decreased
in cobalamin-deﬁcient Yorkshire Terriers compared to normo-
cobalaminemic Yorkshire Terriers. The functional and potentially
prognostic implications of this decrease in serum ca1-PI concen-
trations warrant further studies.
ABSTRACT GI-23
EFFECTIVITY OF AST-120 IN DOGS WITH CHRONIC
INFLAMMATORY ENTEROPATHIES. M Volkmann1,
NC Wirtherle2, GF Beddies2, B Kohn1. 1Clinic of Small Animals,
Faculty of Veterinary Medicine, Freie Universita¨t Berlin,
Germany, 2Bayer Animal Health GmbH, D-51368 Leverkusen
Canine chronic inﬂammatory enteropathies (CIE) are highly
complex diseases of unknown origin. Abnormal immunological
tolerance towards environmental and luminal bacterial antigens
might play an important role. AST-120 is a spherical carbon
adsorbent preparation with a highly adsorption ability for low
molecular substances.
The objective of this study was to evaluate the clinical eﬃcacy
of supplementary feeding of AST-120 in dogs with CIE.
Sixteen client-owned dogs with chronic diarrhea and no or
insuﬃcient response to an elimination diet were included into the
explorative, randomized, placebo-controlled, double blinded ﬁeld
study. The dogs received either AST-120 (n=8) or placebo
(n=8) for a duration of 21 days. The Canine Inﬂammatory
Bowel Disease Activity Index (CIBDAI) was used to assess dis-
ease severity and clinical outcome. Remission was deﬁned as
complete (75% or greater reduction in CIBDAI score) or partial
(<75% and >25% reduction).
A signiﬁcant reduction in the mean CIBDAI score was
observed in the AST-120 group (day 1: 4.6, day 21: 1.8;
p=0.016, Wilcoxon signed-rank test) but not in the placebo
group (day 1: 4.4, day 21: 3.6; p=0.656). After 21 days, 7/8 dogs
treated with AST-120 (3 complete, 4 partial) and 3/8 dogs treated
with placebo (2 complete, 1 partial) were in remission. An
increase of body condition score was observed in 5/8 dogs treated
with AST-120 but remained unchanged in the placebo group. No
side eﬀects of AST-120 were noted.
The data suggest that AST-120 may represent a safe and eﬀec-
tive alternative therapy for dogs with mild to moderate CIE.
ABSTRACT GI-24
INTERLEUKIN-17A GENE EXPRESSION IN THE INTESTI-
NAL MUCOSA IN DOGS WITH LYMPHOCYTIC-PLASMA-
CYTIC ENTERITIS AND INFLAMMATORY COLORECTAL
POLYP. H Ohta, K Takada, Y Tamura, K Nakamura,
M Yamasaki, M Takiguchi. Graduate School of Veterinary
Medicine, Hokkaido University, Sapporo, Hokkaido, Japan
Interleukin (IL)-17A is a proinﬂammatory cytokine produced
by T helper (Th)17 cells, and an increase in IL-17A expression in
the intestinal mucosa has been reported in human inﬂammatory
bowel disease (IBD). Lymphocytic-plasmacytic enteritis (LPE) is
the most common form of canine IBD, and IL-17A messenger
RNA (mRNA) expression has not been examined in dogs with
LPE. Inﬂammatory colorectal polyp (ICRP) in miniature dachs-
hunds is recently recognized in Japan as a major cause of large
bowel symptoms in this breed. ICRP is characterized by the for-
mation of multiple small polyps (small polyps) in the large bowel
mucosa, accompanied by a large space-occupying polyp (large
polyp) formation, and is thought to be a novel form of IBD. The
aim of the current study was to evaluate the mRNA expression
of IL-17A in the duodenal mucosa from dogs with LPE and
colorectal mucosa form dogs with ICRP.
Duodenal mucosae from 20 dogs with LPE were obtained by
endoscopic biopsy. Endoscopic or surgical colorectal biopsies
from 6 dogs with ICRP were obtained. Duodenal and colonic
mucosae were obtained from 8 control dogs. Total RNA was
extracted from intestinal mucosa and cDNA was synthesized. IL-
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17A mRNA expression was measured by a quantitative reverse
transcriptase polymerase chain reaction technique. In addition,
mRNA expression of IFN-gamma (Th1 cytokine), IL-4 (Th2
cytokine) and IL-10 (immunoregulatory cytokine) was measured.
Results were normalized using two housekeeper genes (GAPDH
and SDHA).
The mRNA expression of all cytokines in the duodenal
mucosa from dogs with LPE was not diﬀerent from those of the
control dogs. IL-17A, IFN-gamma, and IL-10 mRNA expression
in large polyps, but not in small polyps, was signiﬁcantly higher
than that in colonic mucosa form control dogs. IL-4 mRNA
expression was not diﬀerent among groups. IL-17A mRNA
expression in large polyps was negatively-correlate with IL-10
mRNA expression. In addition, IL-17A mRNA expression was
strongly-correlate with serum C-reactive protein (CRP) concen-
tration. Meanwhile, IL-10 mRNA expression was negatively-cor-
relate with serum CRP concentration.
These ﬁndings indicated that the IL-17A mRNA expression
was not increased in the duodenal mucosa in dogs with LPE. On
the other hand, IL-17A mRNA expression was increased in large
polyps in dogs with ICRP which composed mainly of neutroph-
ils. IL-17A may play an important role in the recruitment of neu-
trophils and the formation of large polyps in colorectal area in
dogs with ICRP, while IL-10 could oppose the proinﬂammatory
eﬀect of IL-17A.
ABSTRACT GI-25
C-REACTIVE PROTEIN CONCENTRATIONS IN DOGS
WITH INFLAMMATORY BOWEL DISEASE AND CORRE-
LATION WITH A CLINICAL DISEASE ACTIVITY INDEX
AND SERUM ALBUMIN CONCENTRATIONS. LM Oliveira-
Barros1, RM Heilmann2, JM Steiner2, JS Suchodolski2, LFM
Barros1, SRR Lucas1, JM Matera1. 1School of Veterinary
Medicine, University of Sa˜o Paulo, Sa˜o Paulo, Brazil,
2Gastrointestinal Laboratory, Texas A&M University, College
Station, TX, USA
C-reactive protein (CRP) is a positive acute-phase protein and
has been considered as a useful biological marker in dogs with
inﬂammatory bowel disease, particularly for monitoring the
response to treatment. The canine inﬂammatory bowel disease
activity index (CIBDAI) is used to assess clinical disease severity.
The purpose of this study was to compare serum CRP concentra-
tions between dogs diagnosed with inﬂammatory bowel disease
(IBD) and healthy dogs, and to correlate serum CRP concentra-
tions with CIBDAI scores and serum albumin concentrations in
aﬀected dogs.
Twenty dogs referred to the Small Animal Teaching Hospital
at the School of Veterinary Medicine, University of Sa˜o Paulo,
Brazil, with a diagnosis of IBD were included in this prospective
study. The severity of clinical disease was assessed using the CIB-
DAI scoring system. Blood samples were collected from these
animals and from healthy control dogs (n=20). Serum CRP con-
centrations were measured using a commercial ELISA kit (Tri-
Delta Phase CRP Canine kit, Tri-Delta Diagnostic, Boonton
Township, NJ). The data were statistically analyzed using Graph-
Pad InStat version 3.10 for Microsoft Windows. Data were
expressed as medians and range. The Mann-Whitney U test and
Spearman‘s rank order correlation test were used. Statistical sig-
niﬁcance was set at P<0,05 for all analyses.
Dogs in the IBD group had signiﬁcantly higher serum CRP
concentrations compared to dogs in the control group (medians
and range – IBD group: 1.85 mg/L versus control group: 0.10
mg/L; P= 0.0244; Mann-Whitney U test). Serum albumin con-
centration in the IBD group was 3.20±0.67g/dL (mean ± standard
deviation; reference interval: 2.5 – 4.5g/dL). Only one animal in
IBD group had serum albumin concentration below the reference
interval (<2.5 g/dL) and all other animals had normal serum
albumin concentration. No correlation was found between serum
CRP and albumin concentrations(r = -0.098; P= 0.7475; Spear-
man correlation coeﬃcient). The median CIBDAI score in
aﬀected dogs was 5 (range 0 to 9). A direct moderate positive
correlation was found between serum CRP concentration and
CIBDAI score (r= 0.613; P= 0.0040; Spearman correlation coef-
ﬁcient).
Hypoalbuminemia were not frequently observed in dogs with
IBD. Elevated serum CRP concentrations of aﬀected dogs
suggest that this protein can be useful as a biological disease
marker. Also, our ﬁndings indicate that CRP can reﬂect the
severity of clinical disease. Only one animal had serum albumin
concentration.
ABSTRACT GI-26
THE EFFECT OF A MULTI-STRAIN SYNBIOTIC ON THE
MICROBIOTA OF CATS WITH CHRONIC ENTERITIS.
CB Webb1, JF Garcia-Mazcorro2, JM Steiner2, JS Suchodolski2.
1Colorado State University, Fort Collins, CO, 2Gastrointestinal
Laboratory, Texas A&M University, College Station, TX
Alteration of the host microbiota is one proposed mechanism
for the potentially beneﬁcial eﬀect of pre- and probiotics in
patients with diarrhea. The purpose of this study was to test the
hypothesis that oral administration of a synbiotic (ProviableTM-
DC, Nutramax Laboratories) containing a total of 5x109 CFUs
of a mixture of multiple probiotic strains and a blend of prebiot-
ics would signiﬁcantly alter the microbiota of cats with chronic
diarrhea.
Adult cats (n=21) presenting for chronic diarrhea ( 3
months) without prior treatment were recruited and screened for
systemic disease and parasitism. The cats were then administered
the synbiotic once daily. Owners recorded stool quantity and
consistency before and after supplementation. After 21 days cats
underwent endoscopy for histopathology and characterization of
the mucosa-adherent microbiota. One cat was found to have GI
lymphoma and removed from the study. For analysis, cats were
grouped into responders (R; n=13) and non-responders (NR;
n=7) based on the subjective assessment of response to therapy
by the owner. Mucosal biopsies (n=13 and 7 for group R and
NR, respectively) and paired pre- and post-synbiotic fecal sam-
ples (n=5 each for groups R and NR) were used for microbiota
analysis by 16S rRNA gene 454-pyrosequencing and qPCR
assays. Diﬀerences in the abundance of bacterial groups and
baseline characteristics between R and NR were assessed by Wil-
coxon signed rank test or Kruskal-Wallis test. Diﬀerences in
microbial community structure between R and NR and
pre- post-synbiotic administration were assessed by the phyloge-
netic Unifrac distance method, followed by Analysis of similarity
(ANOSIM) of the distance matrix. Signiﬁcance was set as
p<0.05.
There were no signiﬁcant diﬀerences in age, body weight,
serum cobalamin or folate concentrations, duration of clinical
signs, or fecal scores between the 2 groups prior to supplementa-
tion (p=0.10). Histopathology revealed mild (n=8), moderate
(n=9), or severe (n=3) enteritis. No signiﬁcant diﬀerences in
microbiota composition of the mucosa-adherent microbiota were
observed between R and NR after synbiotic use. However, in
feces, the community structure at baseline diﬀered signiﬁcantly
between R and NR (p=0.04). The abundance of probiotic genera
in feces at baseline was signiﬁcantly higher in the NR than in R
(p=0.016). The NR displayed a signiﬁcantly lower bacterial
diversity (median Chao index: 130, range 86-169 vs. 306, range
186-313; p=0.03) in feces. No diﬀerences in fecal microbial com-
munity structure were observed between pre- and post-synbiotic
use samples.
In this study, synbiotic administration did not signiﬁcantly
alter the microbial community structure of cats regardless of their
clinical response. The lower diversity of the microbiota, as well
as the higher abundance of probiotic genera in the non-responder
cats at baseline, may help to explain the failure of their diarrhea
to improve with synbiotic use.
ABSTRACT GI-27
REGIONAL GRANULOMATOUS ENTERITIS IN 14 DOGS.
P Lecoindre1, A Lecoindre2, I Cattin2, M Chevallier3. 1Clinique
Ve´te´rinaire des Cerisioz, Lyon, France, 2Animal Health Trust,
Newmarket, UK, 3Laboratoire M. Me´rieux, Lyon, France
Regional granulomatous enteritis is a rare form of canine
inﬂammatory bowel disease (IBD) characterized by transmural
granulomatous inﬂammation primarily involving the distal ileum
and ileo-colic junction, and resulting in a stenosing, mass-like
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thickening of the aﬀected areas. The aim of this retrospective
study is to describe the clinical and morphological characteristics
of this condition, to describe and characterize the histological
lesions observed and to report the treatments used and long-term
follow-up.
Clinic data was reviewed to ﬁnd dogs with a histopathological
diagnosis of granulomatous enteritis.
Fourteen dogs were included in the study. All dogs were pure-
bred (5 French Bulldog, 4 Yorkshire Terrier, 2 West Highland
White Terrier, 2 Cavalier King Charles Spaniel, 1 English Cocker
Spaniel), with 7 males and 7 females and a mean age of 6.6 years
(range 2.5-13), body condition score was 3 to 4/9. All dogs pre-
sented with about 6 months history of chronic small intestinal
diarrhea and weight loss. Four dogs had concurrent tenesmus,
hematochezia, abdominal pain and vomiting. According to the
clinical index CIBDAI score (Jergens), all dogs were scored 10 or
more. In all dogs a ﬁrm, tubular soft mass was palpated in the
cranial abdomen. Mild to moderate hypoproteinemia was present
in 4 cases, and was severe in one case (total protein 3.3g/dl). On
abdominal ultrasonography a segmental, parietal thickening of
both the distal ileum and ileo-colic junction with loss of layering
was seen. In 3 dogs there was an obstructive pattern and in 1 an
intestinal intussusception was identiﬁed. Gastroduodenoscopy
and colonoscopy was performed in 12 dogs and inﬂammatory
lesions of the ascending colon were seen in 6 dogs. Exploratory
coeliotomy performed in 9 dogs revealed: severe thickening of
the ileum (n=9), serosal lipogranulomas (n=8), inﬂammation of
the caecum and ileo-colic junction (n=9) and inﬂammation of
the ascending colon (n=5). Histology of intestinal biopsies
revealed a transmural granulomatous inﬂammation with volumi-
nous lipogranulomas in the muscularis and serosa in all cases. In
9 dogs, an enterectomy was performed because of partial or total
intestinal obstruction. Medical treatment with antibiotics (enro-
ﬂoxacin and metronidazole) and immunosuppressive drugs (pred-
nisolone and/or cyclosporine) were used in all dogs. A long-term
(>6months) clinical improvement was seen in 7 cases, with a
complete remission in 6.
Regional granulomatous enteritis seems to be a speciﬁc entity
aﬀecting small breed dogs, characterized by profound parietal
changes in the intestine with preferential localization to the ileum
and the ileo-colic junction. Further evaluation to determine the
aetiology of the disease and classify it into the entity of inﬂam-
matory bowel disease is needed.
ABSTRACT GI-28
EVALUATION OF FECAL SHORT CHAIN FATTY ACID
CONCENTRATIONS IN HEALTHY DOGS AND DOGS
WITH CHRONIC DIARRHEA. Y Minamoto, N Berghoﬀ, VR
Rangachari, JM Steiner,, JS Suchodolski. Gastrointestinal
Laboratory, Texas A&M University, College Station, TX
Short-chain fatty acids (SCFA) are major end-products of bac-
terial carbohydrate fermentation in the gastrointestinal (GI) tract.
They constitute an important energy source for intestinal epithe-
lial cells and help maintain intestinal mucosal integrity. Several
studies have shown decreased fecal SCFA concentrations in
humans with inﬂammatory bowel disease. The role of SCFA in
dogs with GI disease has not yet been studied extensively. There-
fore, the aim of this study was to evaluate fecal concentrations of
SCFA in healthy dogs and dogs with chronic diarrhea.
Fresh fecal samples were collected from 10 healthy pet dogs
and 14 dogs with chronic diarrhea (>3 weeks duration). Fecal
concentrations of SCFA (acetate, propionate, butyrate, and total
SCFA) and branched chain fatty acids (BCFA; isobutyrate, is-
ovalerate, valerate, and total BCFA) were measured using gas
chromatography-mass spectrometry. The fecal SCFA concentra-
tions were compared between both groups using a Student’s t-test
or Wilcoxon rank-sum test where appropriate. Signiﬁcance was
set at p < 0.05.
Fecal concentrations of acetate, propionate, and total SCFA
were signiﬁcantly decreased in dogs with chronic diarrhea when
compared to the healthy dogs (Table 1). There were no signiﬁ-
cant diﬀerences in fecal concentrations of butyrate or any of the
BCFA between groups.
In this study, dogs with chronic diarrhea had decreased fecal
concentrations of total SCFA, acetate, and propionate. These
results warrant further studies with larger populations of dogs
and various GI diseases to further evaluate the role of SCFA in
gastrointestinal health and disease in dogs.
ABSTRACT GI-29
THE EFFECT OF VARIOUS STORAGE CONDITIONS ON
THE ABUNDANCE OF BACTERIAL GROUPS IN CANINE
FECES. BJ Marvel, NM Gossett, WE Geiger, JM Steiner,
JS Suchodolski. Gastrointestinal Laboratory, Texas A&M
University, College Station, TX
Quantitative polymerase chain reaction (qPCR) assays can be
used to quantify speciﬁc bacterial groups in fecal samples of
healthy dogs and dogs with clinical signs of gastrointestinal dis-
ease. The stability of fecal bacterial groups stored at various tem-
peratures and for various time periods is of critical concern,
because shifts in the fecal microbiota attributable to storage con-
ditions may inﬂuence the interpretation of ﬁndings. Limited
information is available about optimal storage conditions of fecal
samples for evaluation of the microbiota. It is often recom-
mended that samples be immediately frozen after collection. The
aim of this study was to evaluate the eﬀect of various storage
temperatures and time periods on the abundance of selected fecal
bacterial groups in dogs using qPCR.
Ten fresh fecal samples were collected from seven dogs. For
each sample, 9 aliquots were prepared. One aliquot of each sam-
ple immediately underwent DNA extraction using a modiﬁed
bead beating protocol (Zymo Fecal DNA extraction kit; Zymo-
Research, Orange, CA). The remaining aliquots were stored at -
80oC, -20oC, 4oC, and room temperature (RT). After 24 hours
and after 7 days, one aliquot of each sample was extracted and
analyzed. Previously established qPCR assays were utilized for
the evaluation of abundance of total bacteria, gram positive bac-
teria (Firmicutes, Faecalibacterium spp., and Clostridium perfrin-
gens), and gram negative bacteria (Bacteroidetes). The bacterial
abundance in all aliquots was compared using a repeated mea-
sures 2-Way ANOVA and a Bonferroni post-test with time and
temperature as independent variables. A p<0.05 was considered
statistically signiﬁcant.
Neither storage temperature nor storage time signiﬁcantly
inﬂuenced the abundance of total bacteria or gram positive bac-
teria. However, a lower abundance of Bacteroidetes was
observed across all time points and storage conditions as com-
pared to baseline abundance. Statistically signiﬁcant diﬀerences
were identiﬁed between the baseline samples (median=log 4.96
of DNA, range=log 4.02-5.43) and samples stored at -80oC for
24 hours (median=log 4.40, range=log 3.15-5.45 p<0.01),
those stored at -20oC for 24 hours (median= log 4.41, range=
log 3.69-5.12; p<0.01), those stored at -20oC for 7 days (med-
ian= log 4.49, range= log 3.00-5.35; p<0.05), and those stored
at RT for 7 days (median= log 4.46, range=log 3.67-5.43;
p<0.05).
In this study, neither temperature nor time had a signiﬁcant
inﬂuence on the abundance of Firmicutes, Faecalibacterium spp.,
or C. perfringens. However, a signiﬁcantly lower abundance of
Table 1. Culicoides midges caught in tent traps on 3 farms with 2 horses
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Bacteroidetes was observed within 24 hours of storage at -80oC
and -20oC, and after storage at RT for 7 days. Because there was
no signiﬁcant change observed at 4oC for any of the bacterial
groups analyzed, refrigeration may be recommended for short
term storage of fecal samples. Future studies are needed to estab-
lish the inﬂuence of storage conditions on other clinically relevant
bacterial groups.
ABSTRACT GI-30
DAY-TO-DAY VARIATION OF FECAL MICROBIOTA IN
DOGS OF DIFFERENT AGES. JF Garcia-Mazcorro1,
JM Steiner1, JS Suchodolski1. Gastrointestinal Laboratory, Texas
A&M University, College Station, TX
Despite increasing evidence suggesting age-related diﬀerences
in the composition and metabolic activity of the intestinal micro-
biota, the nature of this relationship remains unclear. Especially
young dogs appear to be at an increased risk for gastrointestinal
disease, which may or may not be related to changes of their
intestinal microbiota. Therefore, the aim of this study was to
investigate day-to-day variation of fecal microbiota in a popula-
tion of healthy dogs of diﬀerent ages.
A total of 22 dogs (median age: 6.2 years, range: 4 months -
12 years) were enrolled into this study. The dogs did not have
any clinical signs of gastrointestinal disease and did not receive
any medication within at least three months before enrolling
into the study. Fecal samples were collected daily from all dogs
during a period of ﬁve consecutive days. The abundance of
total bacteria, Enterococcus, Lactobacillus, and Streptococcus
spp. was estimated in feces using quantitative real-time PCR
targeting the 16S rRNA gene using published oligonucleotides.
The average, as well as day-to-day standard deviation and per-
centage coeﬃcient of variation (%CV) were calculated using
normalized 16S rRNA gene copies (16S rRNA gene copies from
the bacterial groups divided by the 16S rRNA gene copies for
total bacteria).
The day-to-day standard deviation for total bacteria ranged
from 0.1 to 1.7, and from 0.2-0.5 for the three bacterial groups
speciﬁcally analyzed (i.e., Enterococcus, Lactobacillus, and Strep-
tococcus spp.). The day-to-day %CV for all bacteria ranged from
2-41%, and from 3-323% for the three bacterial groups analyzed
separately. The bacterial group with the highest day-to-day vari-
ability was Streptococcus (median day-to-day %CV: 57%), fol-
lowed by Enterococcus (median %CV: 34%), and Lactobacillus
(median %CV: 6%). There was no signiﬁcant linear relationship
(R2<0.1, P>0.1) between age and either the average and day-to-
day standard deviation or %CV for any of the bacterial groups
analyzed, including total bacteria. Additionally, visual analysis of
day-to-day variability plots did not reveal any obvious patterns
associated with age. Instead, the pattern of day-to-day variability
seemed to be unique in each dog and dependent on the speciﬁc
bacterial group analyzed.
Our results suggest that short-term day-to-day variation of
fecal microbiota is not aﬀected by age in healthy dogs. Instead,
this variation seems to be unique in each dog and dependent on
the particular bacterial group analyzed. However, further studies
are warranted to evaluate more intestinal microbial groups in a
larger population of dogs to assess the relationship (if any)
between aging and over time variability of the intestinal
microbiota.
ABSTRACT GI-31
PRESURGICAL EVALUATION OF RECTAL MASSES IN
DOGS BY ENDOSCOPY AND ENDOSCOPIC ULTRA-
SOUND: 28 CASES. K Hayashi1, H Okanishi1, Y Sakamoto1, Y
Kagawa2, K Asano1, M Sakai1, T Watari1. 1Nihon University,
Kanagawa, Japan, 2North Lab, Hokkaido, Japan
Detailed evaluation of rectal masses is essential in selecting
endoscopic treatment and minimal access surgery. However,
because colorectal masses in dogs frequently occur in the distal
rectum, visualization by abdominal ultrasound is diﬃcult. The
purpose of this study was to assess the usefulness of preoperative
evaluation of rectal masses by endoscopy and endoscopic ultra-
sound (EUS).
This study targeted 28 cases in which rectal masses were
assessed by endoscopy and EUS, prior to undergoing surgery.
Abdominal ultrasound was performed in 10 cases, but was
unable to provide detailed evaluation data. Rectal tumors in all
cases could be evaluated in detail by EUS, and were classiﬁed by
T stage (Tis-T2) or as submucosal tumor (SMT). Endoscopic his-
topathology showed good correlation with surgical histopathol-
ogy in masses of Tis-T2 and accuracy was 92% (j=0.85).
However, endoscopic and surgical pathology results did not cor-
respond in SMT masses. Tis-T1 masses included 23 cases (inﬂam-
matory polyp: 15 cases; low-grade adenocarcinoma: 8 cases), T2
masses included 3 cases (high-grade adenocarcinoma: 2 cases;
low-grade adenocarcinoma: 1 case) and SMT masses included 2
cases (leiomyoma: 1 case; rectal cyst: 1 case). EUS showed good
correlation with surgical histopathology and accuracy was 86%
(j=0.72).
Endoscopic histopathology was useful for evaluating of Tis-T2
masses, but was not useful in evaluating SMT masses. Diagnosis
of SMT masses requires evaluation by both EUS and surgical
histopathology. Although abdominal ultrasound was ineﬀective
for evaluation of rectal masses, EUS was useful. Therefore, EUS
may be applicable in the selection of surgical procedure and esti-
mation of prognosis.
SMALL ANIMAL - HEMATOLOGY
ABSTRACT HM-1
THE OVERALL HAEMOSTASIS POTENTIAL; A NOVEL,
COST EFFECTIVE, GLOBAL COAGULATION ASSAY FOR
USE IN CANINE PLASMA. A Dengate1,2,3, MC Morel-Kopp1,
J Braddock3, R Churcher3, J Beatty2, V Barrs2, C Ward1.
1Northern Blood Research Centre, Kolling Institute, University
of Sydney, Australia, 2Faculty of Veterinary Science, University
of Sydney, Australia, 3North Shore Veterinary Specialist Centre,
Crows Nest, Australia
The overall haemostasis potential (OHP) is a novel global
coagulation assay, measuring both speed and extent of coagula-
tion as well as ﬁbrinolysis (Figure 1). Other global haemostasis
assays such as thromboelastography (TEG) and the calibrated
automated thrombogram (CAT) are gaining popularity in veteri-
nary medicine, though their application is limited by cost and the
requirement for specialised equipment. The OHP measures opti-
cal density (OD), directly related to ﬁbrin generation, with com-
mon absorbance spectrophotometry equipment. The purpose of
this study was to optimise the OHP assay for use with canine
platelet poor plasma, and correlate the outputs with those
obtained by TEG and CAT.
Citrated plasma was collected from 60 clinically healthy dogs.
The OHP assay and standard coagulation assays (prothrombin
time [PT], activated partial thromboplastin time [APTT], ﬁbrino-
gen [Fg], Factor VIII and von Willebrands factor [vWF]) were
performed for each sample. CAT was performed on 23 samples,
and TEG on seven.
Figure : Outputs generated by the OHP assay. The delay, max-
imum slope, and maximum optical density (OD Max) are
recorded. The overall ﬁbrinolytic potential is calculated by area
under OCP – OHP/OCP x 100.
Modiﬁcations to the published methodology for the OHP
assay were required, with less coagulation activator (thrombin)
and more ﬁbrinolysis activator (tPA) utilised in canine plasma.
Increasing Factor VIII activity was associated with a shortened
delay (P = 0.043). High ﬁbrinogen levels and decreased PT were
associated with increased OD Max, OCP, OHP and max slope
(P = <0.05). There was a strong correlation between the clot
stability (G) and maximum amplitude (MA) using TEG, and the
Delay, OCP, OD Max, OHP, and max slope obtained using the
OHP assay (P = <0.05). Comparing OHP assay with CAT,
there was a positive correlation for Peak with the OHP curve
(P = 0.019).
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These results support the use of the OHP assay as an accessi-
ble, cost-eﬀective alternative to TEG.
ABSTRACT HM-2
MEASUREMENT OF THROMBIN GENERATION IN DOGS
WITH DIFFERENT DISEASES. R Mischke1, C Witten1,
A Tiede2. 1Small Animal Clinic, University of Veterinary
Medicine Hannover, Hannover, Germany, 2Department of
Haematology, Haemostasis. Oncology and Stem Cell
Transplantation, Hannover Medical School, Hannover, Germany
The aim of the present study was to establish reference values
for the in vitro thrombin generation (TG) assay and to assess
possible changes in dogs suﬀering from diﬀerent diseases which
may be associated with hypo- and/or hypercoagulability.
Dogs with hemophilia A (5), hemophilia B (3), hyperadreno-
corticism (11), inﬂammatory diseases (11) and neoplastic diseases
(lymphoma [7], systemic histiocytic sarcoma [6], acute lympho-
blastic leukaemia [5]) were included. 62 healthy dogs served as a
control. TG was measured by use of the Calibrated automated
Thrombinography (CAT) method which revealed the following
parameters: lag time, peak, endogenous thrombin potential
(ETP), time to peak and reaction time. Measurements were car-
ried out with three diﬀerent TF concentrations (1, 5 and 20 pM)
using frozen platelet poor citrated plasma as sample material.
Dogs with hemophilia showed a signiﬁcantly lower peak and
prolonged lag time, time to peak and reaction time at low TF
concentrations when compared to healthy dogs,. Dogs with
hemophilia B showed evidence of a lower mean peak and ETP at
a TF concentration of 1 pM. There was a trend towards more
severe changes with decreasing residual factor activity. Dogs with
hyperadrenocorticism and inﬂammatory processes had signiﬁ-
cantly higher ETPs at all TF concentrations in comparison to
healthy dogs, whereas ETP in neoplastic diseases was mainly
unchanged. Dogs with histiocytic sarcoma had increased ETP
values at 1 pM TF.
TG, particularly when performed with 1 pM TF, seems to be
a valuable additional tool to verify hypo- and hypercoagulability
in dogs and may be a helpful indicator of severity of thrombo-
philia in hypercoagulable conditions and a predictor of the sever-
ity of hemorrhagic diathesis in dogs with hemophilia.
ABSTRACT HM-3
IN VITRO EVALUATION OF THE EFFECT OF RIVAROX-
ABAN ON COAGULATION PARAMETERS IN HEALTHY
DOGS. B Conversy, M-C Blais, C Gara-Boivin, JRE del
Castillo, L Carioto, M Dunn. Faculte´ de Me´decine Ve´te´rinaire,
Universite´ de Montre´al, Montreal, Canada
Rivaroxaban is a novel, direct factor Xa inhibitor used in peo-
ple for the prevention and treatment of thromboembolic disor-
ders at a ﬁxed-dose regime, without the need for laboratory
monitoring. Its per os administration makes it an attractive anti-
coagulant for dogs. The purpose of this study was to evaluate
the in vitro eﬀects of rivaroxaban on canine coagulation parame-
ters.
Aliquots of pooled citrated platelet poor plasma obtained
from 20 healthy adult beagles were fortiﬁed in vitro with
DMSO solutions of rivaroxaban (98% purity) to obtain 19 ﬁnal
concentrations ranging from 0 (solvent) to 1000 mg/L of drug.
Samples were immediately submitted for the following coagula-
tion assays: prothrombin time (PT), partial thromboplastin time
(PTT), tissue factor induced thrombin generation and anti-fac-
tor Xa activity. Concentration-eﬀect data were analyzed with
ADAPT v.5, using sigmoid stimulatory or inhibitory Emax
regression models.
Rivaroxaban caused a concentration-dependent prolongation
of all coagulation parameters. The half maximal inhibitory con-
centration (IC50) for the propagation phase (rate index) of
thrombin generation was 0.03 mg/L. The anti-Xa activity recom-
mended for thromboprophylaxis (0.5-1 U/mL) was reached at
rivaroxaban concentrations between 0.04 and 0.11 mg/L. At these
concentrations, PT and PTT remained within the reference range.
Two-fold prolongation from baseline of PT and PTT were
achieved with concentrations of 1.24 and 1.45 mg/L, respectively.
Thrombin generation was completely suppressed with concentra-
tions  0.8 mg/L.
In vitro concentration-eﬀect relationships of rivaroxaban on
canine plasma coagulation parameters were documented.
Thrombin generation and anti-Xa activity appear more sensi-
tive in detecting rivaroxaban’s anticoagulant eﬀect than PT and
PTT.
ABSTRACT HM-4
ASSESSMENT OF HYPERCOAGULABILITY IN CANINE
PITUITARY-DEPENDENT HYPERADRENOCORTICISM.
F Park, A Abrams-Ogg, D Wood, D Allen, S Blois. Ontario
Veterinary College, University of Guelph, Guelph, Ontario,
Canada
Dogs with pituitary-dependent hyperadrenocorticism (PDH)
are at increased risk of thromboembolic disease. Thromboelas-
tography (TEG®) provides a global assessment of coagulation,
and is more sensitive than conventional coagulation tests for
detecting hypercoagulability. TEG® with Platelet MappingTM
allows assessment of maximal amplitude (MA) in response to the
agonists arachidonic acid (MAAA) and adenosine diphosphate
(MAADP).
The purpose of this prospective clinical study was to evaluate
for, and quantify, hypercoagulability in dogs with PDH. Citrated
kaolin TEG® with Platelet MappingTM was performed in 19
dogs with PDH pre-treatment, in 16 of these dogs during treat-
ment with trilostane, and in 40 healthy control dogs. For citrated
kaolin TEG®, dogs with PDH had decreased k-time (p=0.002),
increased angle (p=0.007) and increased MA (MAthrombin)
(p<0.0001) compared to controls. The MAthrombin of dogs trea-
ted with trilostane decreased signiﬁcantly after 3 months
(p=0.02) and 6 months (p=0.04), but was still signiﬁcantly
higher than controls. MAAA was signiﬁcantly higher in dogs with
PDH (p=0.02) but did not change signiﬁcantly following treat-
ment. MAADP was not signiﬁcantly diﬀerent between PDH dogs
and controls.
In conclusion, dogs with PDH have evidence of increased clot
strength and rate of clot formation. Clot strength decreases sig-
niﬁcantly during trilostane treatment, but does not normalize.
Results also suggest that dogs with PDH may have higher plate-
let reactivity to arachidonic acid.
ABSTRACT HM-5
DELAYED FIBRINOLYSIS IN DOGS WITH NATURALLY
OCCURRING PITUITARY DEPENDANT HYPERADRENO-
CORTICISM. A Dengate1,2,3, MC Morel-Kopp1, J Braddock3,
R Churcher3, J Beatty2, V Barrs2, C Ward1. 1Northern Blood
Research Centre, Kolling Institute, University of Sydney,
Australia, 2Faculty of Veterinary Science, University of Sydney,
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Australia, 3North Shore Veterinary Specialist Centre, Crows
Nest, Australia
Canine hyperadrenocorticism has been associated with hyper-
coagulability due to increases in circulating procoagulant factors
II, V, VII, IX, X, XII, and ﬁbrinogen, and decreased anticoagu-
lant antithrombin (AT). In human hyperadrenocorticism,
increased plasminogen activator inhibitor (PAI-1) also contrib-
utes to impaired ﬁbrinolysis. The purpose of this study was to
identify hypercoagulability in dogs with pituitary-dependent hy-
peradrenocorticism (PDH), using a novel global coagulation
assay, the overall haemostasis potential (OHP).
Citrated plasma samples were collected from 11 client owned
dogs with PDH, and 11 age-matched, clinically healthy dogs. The
OHP assay was run on each sample, recording optical density
(related to ﬁbrin generation and lysis) over 1 hour (Figure 1).
The mean area under the OHP curve was signiﬁcantly
increased in the PDH group (8.9) compared with the normal
group (2.2), P = 0.038 (student’s t-test). The ﬁbrinolytic poten-
tial (area under OCP – OHP/OCP x 100) was signiﬁcantly
reduced in PDH group (51.45%) compared with the normal
group (84.68%), P = 0.017.
These results support the presence of a hypercoagulable state
associated with canine PDH, and that delayed ﬁbrinolysis con-
tributes to this state.
Figure : Overall haemostasis potential (OHP) and overall coag-
ulation potential (OCP) curves for canine PDH and pooled nor-
mal canine plasma (PNP). The OHP curve shows both
coagulation and ﬁbrinolysis, the OCP coagulation only.
ABSTRACT HM-6
SYRINGE AND AGGREGATE FILTER ADMINISTRATION
DOES NOT AFFECT SURVIVAL OF TRANSFUSED
AUTOLOGOUS FELINE RED BLOOD CELLS. B Heikes,
C Ruaux. Oregon State University College of Veterinary
Medicine, Corvallis, OR
The use of mechanical administration systems, such as ﬂuid
pumps and syringe+aggregate ﬁlters, are reportedly associated
with a risk of early loss of transfused autologous red blood cells
(RBC’s) in the dog. Of these two techniques, syringe+aggregate
ﬁlter is more commonly used in the cat. As cat RBC’s have dif-
fering ﬂexibility and size than canine RBC’s, the aim of this
study was to determine the eﬀect of syringe+aggregate ﬁlter
administration on RBC’s from domestic cats. Our hypotheses
were that administration of autologous feline RBC’s through a
syringe+aggregate ﬁlter would decrease the probability of short-
term survival of the transfused cells, and reduce the circulating
half-life of transfused cells, when compared to control RBC’s
administered via gravity ﬂow.
This was a prospective, blinded study. Six apparently healthy
cats (minimum 4.5 kg bodyweight) belonging to staﬀ and stu-
dents of the Oregon State College of Veterinary Medicine were
enrolled. Whole blood (40 ml/cat) was collected into 2x25ml
syringes containing CPDA-1 anticoagulant. Each aliquot of
blood was centrifuged, plasma was harvested and stored, and
then RBC’s were washed twice in PBS before suspension in
40ml of PBS+1%Dextrose. Washed cells were biotinylated at
one of two biotin densities. After biotinylation, cells were
washed twice in PBS, packed by centrifugation, and then sus-
pended in autologous plasma before transfer to a labeled sterile
syringe or 50ml blood bag. Each cat was then transfused with
both aliquots of autologous labeled blood, delivered at a rate
of 2 ml/kg/hr using either syringe pump+aggregate ﬁlter (AS-
50 Syringe Pump, Baxter & Hemo-Nate® Filter, Utah Medical
Products) or gravity ﬂow via a standard blood-giving set. After
transfusion, 1ml blood samples were collected into EDTA at 2-
hour intervals for 12 hours. Subsequent 1 ml samples were
obtained weekly for 7 weeks. Five µL aliquots of each whole
blood sample were washed in PBS, incubated with streptavidin-
phycoerythrin, and then analyzed by ﬂow cytometry. The pro-
portion of transfused cells remaining in each of the two popula-
tions was measured. Quantitative changes in the two
populations over time were assessed by two-way repeated mea-
sures ANOVA.
Biotinylated RBC’s were readily detected in all samples from
all cats over the 7-week sampling period. One cat showed early
loss of RBC’s delivered via gravity ﬂow. There was a signiﬁcant
decrease in both populations of labeled cells over the 7-week per-
iod (p<0.01), as expected. There was no signiﬁcant diﬀerence in
probability that the RBC’s would survive 12 hours immediately
following transfusion, and no signiﬁcant diﬀerence in survival
between the two groups over 7 weeks. The average half-life of all
labeled cells was approximately 42 days.
We conclude that the use of a syringe+aggregate ﬁlter method
to transfuse cats with autologous RBC’s is not associated with
decreased short-term RBC survival or decreased RBC half-life.
ABSTRACT HM-7
LEUKOREDUCTION OF FELINE WHOLE BLOOD USING
A NEONATAL LEUKOCYTE REDUCTION FILTER: A
PILOT EVALUATION. J Schavone1, E Rozanski1, J Schaeﬀer2,
L Monhait1, CR Sharp1. 1Section of Critical Care Tufts
Cummings School of Veterinary Medicine, North Grafton, MA,
2Pall Corporation, Port Washington, NY
Leukocytes (WBC) present in stored blood are associated with
a variety of potentially deleterious pro-inﬂammatory and immune
responses. Pre-storage leukocyte reduction (LR) has been advised
to reduce the WBCs in stored blood. While LR has been
described in human and canine transfusion medicine, due to siz-
ing of available ﬁlters, LR has not been previously evaluated in
cats. The purpose of this pilot study was to evaluate the eﬃcacy
of a human neonatal LR ﬁlter in leukoreducing feline fresh whole
blood (FWB) using diﬀerent techniques.
Sixty milliliters of FWB was obtained from 8 healthy donor
cats using standard techniques. LR was achieved using an in-
line LR ﬁlter. 3 diﬀerent techniques were assessed. Group 1)
Warm (room temperature) FWB ﬁltered immediately via slow
active push (n=2), Group 2) Warm FWB ﬁltered immediately
via gravity (n=3), and Group 3) FWB, chilled at 4°C for 60
min, ﬁltered via gravity. Eﬃcacy of ﬁltration was assessed by the
pre- to post-ﬁltration decrease in leukocyte count (WBCC) using
a Cell-Dyn Hematology Analyzer, with a level of detection of
500 cell/ul. LR of chilled blood ﬁltered by gravity was signiﬁ-
cantly more eﬀective (100% LR, p = 0.001) than warm FWB ﬁl-
tered actively (35%) or by gravity (59%).
Inadequate LR was achieved in room temperature blood with
active or gravity ﬁltration.
We conclude that chilled FWB can be successfully LR pre-
storage with gravity ﬂow through this in-line neonatal ﬁlter. The
main limitation of the technique is loss of blood volume, since
the residual ﬁlter volume is 8mL. Investigation of the potential
therapeutic beneﬁt of using LR blood in cats is warranted.
ABSTRACT HM-8
UTILITY OF SERIAL ANTI-XA MONITORING IN DOGS
RECEIVING DALTEPARIN. AM Lynch, AM DeLaforcade,
CR Sharp. Department of Clinical Sciences, Cummings School
of Veterinary Medicine, Tufts University, North Grafton,
Massachusetts
Dalteparin is commonly employed as an anticoagulant in criti-
cally ill dogs. The aim of this study was to describe the clinical
course of hospitalized dogs receiving dalteparin serially moni-
tored with a chromogenic anti-Xa assay.
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The medical records of 24 dogs were retrospectively
reviewed. Underlying diseases included immune mediated
hemolytic anemia, sepsis, neoplasia and protein losing diseases.
Five dogs had conﬁrmed thromboembolism prior to anticoagu-
lation. Nineteen dogs were hypercoagulable based on thrombo-
elastography. The median dalteparin starting dose was 150 IU/
kg SQ. Twice daily dosing was chosen for 14/24 dogs, three
times daily for 9/24 dogs and four times daily for the remaining
dog. Anti-Xa assays were performed 4 hours post-administra-
tion of dalteparin in 20 dogs and at trough for 4 dogs. From
the initial dalteparin dose 7 dogs achieved target anti-Xa levels
(0.5-1.0 units/mL), 10 dogs achieved levels above the target
range and 6 dogs were below range. Individual dose adjustment
was made in 19 dogs. Ultimately 20/24 dogs either achieved or
exceeded the target anti-Xa range. Minor bleeding complica-
tions (subcutaneous hemorrhage at the injection site) were
noted in 2 dogs. Nineteen dogs survived to discharge; 5 were
euthanized due to clinical deterioration. Three dogs had con-
ﬁrmed thromboemboli at necropsy.
Serial anti-Xa assays were useful to guide individual dose
adjustment of dalteparin in dogs in this study. Further studies
are warranted to understand the impact of individual dose
adjustment on outcome and cost eﬀectiveness of dalteparin treat-
ment in critically ill dogs at risk of thromboembolism.
ABSTRACT HM-9
PLATELET FUNCTION IN DOGS WITH INFLAMMATORY
DISEASES. R Mischke, M Abid, K Kalbantner. Small Animal
Clinic, University of Veterinary Medicine Hannover, Germany
The aim of this study was to examine the inﬂuence of inﬂam-
matory diseases on primary hemostasis in dogs.
Six diﬀerent parameters were used for testing platelet func-
tion in 25 dogs with bacterial or protozoal infections: capillary
bleeding time, automatic platelet function analysis (PFA 100,
collagen/ adenosine diphosphate [COL/ADP] and collagen/epi-
nephrine cartridges), turbidimetric platelet aggregation, imped-
ance aggregometry using a multiple electrode aggregometer,
platelet count and hematocrit. Results of the 25 dogs with
inﬂammatory diseases were compared to the control group and
additionally classiﬁed into two subgroups based on criteria of
systemic inﬂammatory response syndrome (SIRS) (groups
“SIRS” and “Non-SIRS”).
The following ﬁndings were observed in dogs with inﬂamma-
tory diseases when compared to the control group: a signiﬁcantly
prolonged closure time of the automatic platelet function analy-
ser measured with both cartridges (e.g. COL/ADP: 83 s [55–301
s] vs. 65 s [47–99 s]; median [minimum–maximum]; P < 0.0001),
a signiﬁcant decrease in maximal aggregation of the ADP-
induced turbidimetric aggregometry (e.g. 40 µmol/L: 45.2 ± 26.8
% vs. 67.3 ± 21.8 %; mean ± SD; P = 0.003) and collagen, a sig-
niﬁcant increase of impedance aggregometry induced with 5 µg/
mL collagen, and signiﬁcant suppression of arachidonic acid-
induced impedance aggregometry. A higher collagen-induced
impedance aggregation which was detected in dogs suﬀering from
“SIRS” was the only signiﬁcant diﬀerences between subgroups
“SIRS” and “Non-SIRS”.
Although individual tests indicate enhanced platelet aggrega-
tion, results of in vitro tests in the present study mainly reveal a
normal or minimally to moderately reduced functionality of
platelets. The reduced response to aggregation agonists in vitro
may partly attributed to the fact that platelets are already
activated under inﬂammatory conditions.
ABSTRACT HM-10
15-GAUGE CORE BONE MARROW BIOPSY IN SMALL
DOGS AND CATS WITH HEMATOLOGIC DISORDERS –
16 CASES. A Abrams-Ogg, A Defarges, D Bienzle. Ontario
Veterinary College, University of Guelph, Guelph, Ontario,
Canada
The diameter of 11-13ga Jamshidi-type needles makes bone
marrow (BM) core biopsy diﬃcult in small dogs and cats. We
previously reported the feasibility of 15ga BM biopsy in normal
small dogs (Vet Clin Pathol, in press) and cats (J Vet Intern Med
2011;25:703) using EZ-IO® (Vidacare) needles. In this study, 15-
25 mm EZ-IO needles were used by 5 operators with variable
procedural experience to obtain humeral head BM biopsies from
anesthetized small dogs and cats diagnosed with non-regenerative
anemia, neutropenia or pancytopenia between June 2009 and
October 2011. The EZ-IO cannulae were advanced and retracted
manually without a power driver. Specimens were placed into
Davidson’s ﬁxative for 20 min of rapid ﬁxation, and then trans-
ferred to formalin. Sternal or humeral BM aspirates were also
obtained. Animals were treated post-biopsy with opioid or
NSAID analgesics and assessed for pain and lameness. The tips
of the cannulae, which are crown-shaped, were inspected for
damage. Biopsies were reviewed by a pathologist. Biopsy length
on the slide was measured, and biopsy quality was scored from 0
(no hematopoietic tissue) to 5 ( 5 intertrabecular spaces free of
artifact). Results [Mean ± SD (range)] were:
Quality and length were not diﬀerent between dogs and cats
(P = 0.3-0.4). Biopsy quality and length were signiﬁcantly corre-
lated (rho = 0.74, P = 0.002). There were no correlations
between animal weight and biopsy quality or length. Six biopsies
had quality scores of 4-5; of these, 5 were obtained on the ﬁrst
attempt. For 4 biopsies, the cannulae tip were pinched closed;
these biopsies were of higher quality (4 – 5) and length (9 mm).
Although quality scores of 1-2 were given for 10 biopsies, even
these encompassed suﬃcient hematopoietic tissue to support a
diagnosis in conjunction with hemograms and BM cytology.
Diagnoses in dogs included myeloﬁbrosis (1), erythroid hypocell-
ularity (2), myeloid hypocellularity (1), trilineage hypocellularity
(1), myeloid hyperplasia (1), myeloid leukemia (1) and myelodys-
plasia (1). Diagnoses in cats included myeloﬁbrosis (1), erythroid
hypocellularity (3), bi- or trilineage hypocellularity (2), erythro-
leukemia (1), and lymphoid leukemia (1). For 5 dogs and 5 cats,
BM core biopsy was needed for diagnosis; for 3 dogs and 3 cats,
biopsy conﬁrmed the cytology diagnosis. In conclusion, 15ga core
BM biopsy is a well-tolerated procedure that may facilitate diag-
nosing hematopoietic disorders in small dogs and cats. Inten-
tional damage (pinching) of the cannula tip on the ﬁrst pass
through the BM may serve to facilitate specimen retention and
maximize quality.
ABSTRACT HM-11
SERUM BIOMARKERS INDICATE HEMOLYSIS AND AN
INFLAMMATORY RESPONSE TO TRANSFUSION OF
AUTOLOGOUS STORED ERYTHROCYTE CONCEN-
TRATES. SA Smith1, M McMichael2, JM Herring2,
A Galligan2, R Corsi2, T Ngwenyama2, AN Beloshapka3,
P Deng3, KS Swanson2,3. 1College of Medicine, 2College of
Veterinary Medicine, or 3Department of Animal Sciences,
University of Illinois, Urbana, IL
We previously reported that transfusion to normal dogs of
stored (21 days) autologous erythrocyte concentrates (pRBCs)
caused an inﬂammatory response as indicated by leucocytosis
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stored for 35 days elicited a degenerative left shift followed by a
regenerative left shift. We hypothesized that transfusion of fresh
pRBCs would elicit less profound increases in serum biomarkers
of inﬂammation than would stored pRBCs.
A whole blood unit was collected from healthy dogs (n=10)
for pRBCs on day 0, then again on day 32. On day 35 dogs
received an autologous transfusion of pRBCs stored for either 35
days (S, n=5) or 3 days (F, n=5). Serum free hemoglobin
(Hgb), CRP, interleukin-8 (IL-8), tumor necrosis factor a
(TNFa) were evaluated on serum samples collected at 0 (pre) and
5,9,24,48, and 72 hours after transfusion.
Fresh pRBCs did not elicit any change in serum Hgb, or
CRP. IL-8 and TNFa both increased approximately 2 fold, with
peaks at 5 hours and 24 hours respectively. Stored pRBCs elic-
ited a 60 fold increase in free serum Hgb (mean 0.21, SD 0.06 g/
dL) with a peak at 9 hours. CRP also profoundly increased up
to 90 fold with a peak at 24 hours (mean 91, SD 33 lg/mL). IL-
8 and TNFa both increased approximately 2 fold, with peaks at
5 hours and 9 hours respectively.
More signiﬁcant hemolysis occurs with transfusion of stored
erythrocytes. Transfusion of autologous stored pRBCs elicits a
markedly greater inﬂammatory response than fresh pRBCs.
ABSTRACT HM-12
ASSESSMENT OF PLATELET ACTIVATION IN DOGS
ADMITTED TO THE INTENSIVE CARE UNIT (ICU) BY
USE OF FLOW CYTOMETRY AND THROMBOELASTOG-
RAPHY. SB Majoy1, AM de Laforcade1, M Barnard2, A
Hoﬀman1, SP Shaw1. 1Cummings School of Veterinary Medicine
at Tufts University, North Grafton, MA, 2University of
Massachusetts Medical School, Worcester, MA
Thromboembolic disease is a potentially life-threatening com-
plication in critically ill dogs and may be related to excessive
platelet activation. We hypothesized that dogs admitted to the
ICU would exhibit increased platelet activation as measured by
ﬂow cytometry and thromboelastography compared to normal
dogs and that there would be a correlation between the degree of
platelet activation and severity of illness.
81 dogs hospitalized in the ICU and 24 normal control dogs
were enrolled. Blood was collected into 3.2% sodium citrate
tubes by jugular venipuncture and rested 30 minutes prior to
analysis. Platelet activation was determined by ﬂow cytometry
using monoclonal mouse anti-human CD61 and CD62 antibodies
in resting and ADP-activated samples. Thromboelastography was
performed using kaolin as an activator. SPI2 and APPLE scoring
systems were used to estimate severity of illness.
The degree of platelet activation at rest was not signiﬁcantly
diﬀerent between control dogs and sick dogs as measured by per-
cent positive platelets (%P; 1.34 vs 0.79, p = 0.23) or mean ﬂuo-
rescence intensity (MFI; 2314 vs. 798, p = 0.72). Compared to
control dogs, sick dogs had signiﬁcantly increased platelet activa-
tion in response to 2 uM ADP (23.5 vs. 2.9 %P, 2425 vs. 1235
MFI), 6 uM ADP (36.6 vs. 13.3%P, 2722 vs. 1783 MFI), and 10
uM ADP (3562 vs. 1306 MFI; p < 0.05). Sick dogs had a signiﬁ-
cantly increased MA (61.9 vs. 54.5), alpha (62.5 vs. 56.2), and G
(9723 vs. 5802), and a signiﬁcantly decreased K time (2.3 vs. 2.7)
compared to controls. MA was negatively correlated with %P
and MFI in sick dogs. No signiﬁcant association was found
between SPI2, APPLE, and degree of platelet activation.
There is evidence of increased platelet activation in dogs hospi-
talized in the ICU, but the SPI2 and APPLE scoring systems are
not predictive of the degree of activation.
ABSTRACT HM-13
EVALUATION OF THROMBOELASTOGRAPHY TO PRE-
DICT CLINICAL BLEEDING IN THROMBOCYTOPENIC
DOGS AFTER TOTAL BODY IRRADIATION AND HEMA-
TOPOIETIC CELL TRANSPLANTATION. MC Bucknoﬀ,
R Hanel, S Marks, A Motsinger-Reif, S Suter. North Carolina
State University College of Veterinary Medicine, Raleigh, NC
The objective of this prospective observational study was to
correlate results of clinical hemostatic assays to bleeding events
in a cohort of thrombocytopenic dogs. Ten client-owned dogs
with lymphoma undergoing total body irradiation and autolo-
gous hematopoietic cell transplantation were sequentially
enrolled. Bleeding events were separated into clinical bleeding
(CB), including melena, hematochezia, hematemesis, epistaxis
and hematuria, and minor surface bleeding (MSB), deﬁned as
new petechia or ecchymoses. Physical examinations, complete
blood counts, and serum chemistries were performed daily on all
patients and used to trigger data collection, which included kao-
lin activated thromboelastography [TEG, including reaction time,
clot formation time, angle, maximal amplitude (MA), and global
clot strength], buccal mucosal bleeding time, prothrombin time,
activated partial prothrombin time, d-dimers, and ﬁbrinogen.
Data was captured at hospital admission, when platelet counts
dropped below 30,000/ll, below 10,000/ll, or rebounded above
10,000/ll, and within 12 hours of a CB event.
Association analyses were performed for each assay variable
with Cox Proportional Hazards analysis, followed by a Bonfer-
roni correction. Groups compared included: 1) No bleeding or
MSB compared to CB; 2) MSB compared to no bleeding; 3) CB
compared to MSB; 4) CB compared to no bleeding. There was a
statistically signiﬁcant association of the TEG value MA for
groups 1, 3, and 4. No signiﬁcant association was found for any
other analyzed variable. In conclusion, MA was the only coagu-
lation parameter that was associated with signs of clinical
bleeding.
ABSTRACT HM-14
IMMUNE-MEDIATED HEMOLYTIC ANEMIA IN CATS
WITH PANCREATITIS. A Zoia. “San Marco” Veterinary
Clinic, Padua, Italy
Pancreatitis has been demonstrated in humans and experimen-
tally in rats as a complication of acute hemolysis. Following the
identiﬁcation of a cat with acute hemolysis due to IMHA and
concurrent pancreatitis, the aim of this study was to retrospec-
tively investigate if these two diseases are associated in cats.
For this retrospective, case-control study, the author’s resi-
dency case log of all cases seen at Glasgow University Small Ani-
mal Hospital between July 2004 and December 2007 (consisting
of 157 client owned feline patients and 674 canine patients), was
searched for cats diagnosed with pancreatitis. These cats were
included in group 1. A clinical diagnosis of pancreatitis was made
on a combination of: clinical signs, measurement of serum feline
pancreatic lipase (fPLI) or trypsin-like immunoreactivity (fTLI),
and abdominal ultrasonography. A control population sick cats
without pancreatitis (group 2) was created from the same data-
base. For each cat in group 1, three sick cats were included in
group 2. These cats were randomly selected after age-, sex-
(including neutered status) and breed-matching to the cats with
pancreatitis. IMHA was diagnosed as a hematocrit  15% and
the presence of a positive Coombs’ test. The prevalence of IMHA
between the two groups of cats was calculated and the diﬀerence
in prevalence was statistically evaluated with the Fisher exact
test. The level of signiﬁcance was set as p < 0.05.
Of the 157 cats included in the database, 9 were diagnosed at
presentation with pancreatitis and three of these cats (33%) had
a concurrent diagnosis of IMHA. Only 1 (3.4%) of the 27 cats in
group 2 (sick cats without pancreatitis) was diagnosed with
IMHA. The prevalence of IMHA was signiﬁcantly higher in
group 1 compared with groups 2 (p = 0.04).
Cats with pancreatitis have an higher prevalence of IMHA
compared to other sick cats. The hemolysis occurring during
IMHA may therefore be the etiological cause of this disorder in
these cats, as previously reported in humans and rats.
ABSTRACT HM-15
OSMOTIC FRAGILITY AND FLOW CYTOMETRIC DETER-
MINATION OF LIPID PEROXIDATION IN FELINE
ERYTHROCYTES. R Timmons, BF Goodrich, M Gillette,
CB Webb. Colorado State University, Fort Collins, CO
Vitamin E (vit E) antioxidant properties include reducing lipid
peroxidation. Antioxidant capacity in units of vit E is signiﬁ-
cantly decreased in cats with chronic kidney disease (CKD) com-
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pared to controls (56 ± 21 vs. 81 ± 13, p<0.005). With the goal
of allowing further assessment of the role of oxidative stress and
vit E in the anemia of CKD, we developed functional assays of
feline RBC health.
Osmotic fragility was measured in cats with a range of
packed cell volumes (PCV) using a standardized protocol. The
variance, eﬀect of sample dilution, and eﬀect of storage time
was determined. An r-squared of 0.45 described the ﬁt between
PCV and the NaCl concentration that produced 50% hemolysis
(n=15).
A protocol for the ﬂow cytometric determination of lipid per-
oxidation in feline RBCs was developed using the ﬂuorescence
attenuation of the DHPE ﬂuorophore, which is inversely propor-
tional to membrane lipid peroxidation. DHPE treated samples
(n=8) run in triplicate gave a mean ﬂuorescence of 1129 units,
with a mean standard deviation of 41.0 units (4%). DHPE trea-
ted samples (n=10) run before and after incubation with cumene
hydroperoxide to stimulate lipid peroxidation showed an average
decrease in ﬂuorescence of 18% (+/- 12%) after stimulation. An
r-squared of 0.75 described the ﬁt between PCV and DHPE ﬂuo-
rescence (n=10).
These assays can be used to determine the correlation
between RBC membrane health and vit E antioxidant capacity,
as well as the eﬀect of vit E supplementation, in anemic cats
with CKD.
ABSTRACT HM-16
POWER-DRIVER ASSISTED 11-GAUGE HUMERAL CORE
BONE MARROW BIOPSY IN LARGE BREED DOGS WITH
HEMATOLOGIC DISORDERS – 6 CASES. A Abrams-Ogg, A
Defarges, D Bienzle. Ontario Veterinary College, University of
Guelph, Guelph, Ontario, Canada
Bone marrow (BM) core biopsy is often performed using 11-
13ga Jamshidi-type tapered needles and manual power. Anecdot-
ally, some operators noted poor specimen retention. A newer
biopsy system (OnControl, Vidacare) consists of a trocar-tipped
stylet; a trephine with an internal marrow capture thread; and a
power driver. In this study, the OnControl system was used by 6
diﬀerent operators with variable procedural experience to obtain
humeral head BM biopsies from 6 anesthetized large-breed dogs
with hematologic disorders diagnosed between Nov 2010 and
2011. Specimens were placed in formalin, and concurrent sternal
or humeral BM aspirates were obtained. Biopsy length on the
slide was measured, and biopsies were reviewed and quality
scored from 0 (no hematopoietic tissue) to 5 ( 5 intertrabecular
spaces free of artifact) by a pathologist. Dogs were treated with
opioid or NSAID analgesics post-biopsy. Chronologic results
were:
For cases 2 and 5 there was diﬃculty orienting the biopsy nee-
dle and advancing through the cortex, and there was evidence of
mild necrosis at the proximal end of these biopsies. Once the cor-
tex was penetrated and the stylet removed, all operators reported
that the trephine was very easy to advance and retract, and this
phase of the biopsy was completed in <1 min. All biopsies cap-
tured specimens on the ﬁrst attempt. In the last dog the biopsy
was repeated as the specimen was grossly of lower quality than
in the previous dogs. One biopsy had a quality score of 1; this
was due to fragmentation, but the specimen was nevertheless ade-
quate for diagnosis. No dog showed signs of lameness attribut-
able to the procedure. In conclusion, the OnControl system
reliably captured humeral BM biopsies from large dogs with vari-
ous hematologic disorders. In 3 cases BM core biopsy was
needed for diagnosis; in 3 cases results were conﬁrmatory.
ABSTRACT HM-17
EVALUATION OF A HUMAN ELISA KIT FOR THE MEA-
SUREMENT OF PLASMA ADAMTS13 ACTIVITY IN DOGS.
H Maruyama, T Ohtake, M Kaneko, R Kano, Y Yamaya,
T Watari, H Kamata. Nihon University, School of Veterinary
Medicine, Kanagawa, Japan
A disintegrin-like and metalloprotease with thrombospondin
type 1 repeat motifs 13 (ADAMTS13) is a von Willebrand factor
(VWF)-cleaving protease. Deﬁciency in ADAMTS13 activity is
known to cause thrombotic diseases in humans. The minimal
substrate for ADAMTS13 in humans is VWF73, which contains
73 amino acid residues in the A2 domain of VWF. The aims of
this study were to clarify whether canine ADAMTS13 has the
ability to cleave human VWF73, and to test a human ADAM-
TS13 ELISA kit containing human VWF73 for the measurement
of plasma ADAMTS13 activity in dogs.
Human VWF73 fused with a GST-tag and a His-tag was
expressed in Escherichia coli and was puriﬁed (GST-VWF73-His).
The recombinant canine ADAMTS13 (rcADAMTS13) was
expressed in Hela cells, and the concentrated supernatant was
used. The GST-VWF73-His was incubated with serially diluted
rcADAMTS13, canine pooled plasma, or human pooled plasma.
The cleaved products were detected by Western blotting with
anti-GST antibody. In all samples, the signals of the cleaved
products increased with increasing ADAMTS13 activity.
An ADAMTS13 ELISA kit with human VWF73 (KAINOS
Lab., Tokyo) was used to measure canine plasma ADAMTS13
activity. Thirteen citrated plasma samples were obtained from 7
healthy dogs and 6 dogs with bacteremia. The ADAMTS13
activity was signiﬁcantly lower in dogs with bacteremia than in
healthy dogs (p = 0.019).
These results revealed that human VWF73 is cleaved eﬃciently
by canine ADAMTS13 and the ELISA kit with human VWF73
can be useful for measuring plasma ADAMTS13 activity in dogs
for the study of thrombotic disorders.
SMALL ANIMAL – HEPATOLOGY
ABSTRACT HP-1
LIVER HISTOLOGICAL LESIONS IN 43 SCOTTISH TER-
RIERS (ST) WITH HYPERACTIVITY OF ALKALINE PHO-
SPATESES (AP). M Chevallier, S Guerret, A Pagnon, P
Lecoindre, C Peyron, France
ST increased AP level was associated with development of a
vacuolar hepatopathy (VH) as shown in previous study on 13
dogs (Lecoindre 2009). To assess liver histological lesions in a
43ST with increased AP level (mean: 10N). 55 liver samples
obtained from 43 ST (16 wedge biopsies, 39 guided ﬁne-needle
biopsies), were analyzed including histological techniques: HES,
Trichrome, Picrosirius/PERLS stains, semi-quantitative assess-
















1-Giant Schnauzer 50 8 Nonregenera- tive anemia 2.7 5 Myelo-ﬁbrosis Non-diagnostic
2-Standard Poodle 29 8 Pancytopenia 2.6 5 Myelo-dysplasia Myelo-dysplasia
3-Lurcher 28 3 Nonregenera- tive anemia 3.5 5 Myelo-ﬁbrosis Non-diagnostic
4-Cane Corso X 51 3 Pancytopenia 2.4 5 Myelo-suppression Myelo-suppression
5-Mixed Breed 33 12 Thrombo-cytopenia 1.2 1 MGK hyperplasia MGK hypoplasia




Multiple myeloma Multiple myeloma
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(JAVMA 2006) necrotic-inﬂammatory activity (A0 to A3) and
ﬁbrosis (F0 to F4) according to METAVIR Score (1996). Cancer
or architectural changes were recorded. Ultrastructural study
(TEM) for two representative animals and a-smooth muscle actin
antibody (aSMA) immunohistochemistry (IHC) analysis for cells
involved in ﬁbrogenesis were undertaken.
Mean age was 8 years (2-13) and ratio M/F (21/22). Lesions
distribution was: vacuolar changes (G1=10, G2=15, G3=9, G4
=9), ﬁbrosis (F0=12, slight periportal F1-F2=17, extensive
periportal F3=8, cirrhotic stage F4=6); activity was absent or
weak (A0-A1) in 80% of cases. Advanced ﬁbrosis F3-F4 (14
cases) was correlated with vacuolar changeG3 (27%) and G4
(50%). Liver carcinoma was present in 9 biopsies: 4 with exten-
sive ﬁbrosis (F3 or F4) and 5 without signiﬁcant ﬁbrosis (F0=2,
F1=2, F2=1). Three cases had nodular regenerative hyperplasia
(NRH). TEM observation showed mitochondrial lesions and
absence of glycogen overload. IHC with aSMA revealed
increased number of stellate cells in perisinusoidal and perivacuo-
lar hepatocytes location.
Liver vacuolar change observed in 90% of ST with AP hyper-
activity correlated with ﬁbrosis stage (p= 0,051) and increased
stellate cells activation suggested cellular dysfunction probably
related to glucocorticoids metabolism. Cancer pathogeny
remained to be explained.
Bibliography: Lecoindre P. et al. ECVIM Abstract, 2009 ;
Center et al. JAVMA, 2006 ; METAVIR 1996.
ABSTRACT HP-2
CLINICAL FEATURES OF HEPATIC ENCEPHALOPATHY
IN DOGS: 80 CASES (1991-2011). JA Lidbury1, R Ivanek2, JS
Suchodolski1, JM Steiner1. 1Gastrointestinal Laboratory and,
2Veterinary Integrative Biosciences, Texas A&M University,
College Station, TX
Hepatic encephalopathy (HE) is common in dogs, but few
studies have speciﬁcally described this syndrome and the role of
potential predisposing factors. The objectives of this study were
to describe the clinical features of dogs with HE, to determine if
there is any relationship between plasma ammonia concentrations
and the severity of HE, and to determine what proportion of
dogs with HE have any of the predisposing factors recognized in
humans with HE, such as gastrointestinal hemorrhage, dehydra-
tion, or systemic inﬂammatory response syndrome (SIRS).
Medical records from all dogs with a recorded diagnosis of
HE between 1/10/91 and 1/10/11 (20 years) were reviewed. The
history, physical examination ﬁndings, results of diagnostic test-
ing, and diagnoses from each case were recorded. The severity of
HE was graded using a previously described system: grade I: apa-
thy, decreased alertness, staring, and/or unawareness of sur-
roundings; grade II: ataxia, circling, head pressing, blindness,
and/or salivation; grade III: stupor, severe salivation, and/or
completely inactive but arousable; and grade IV: coma and
totally unresponsive. Plasma ammonia concentrations were com-
pared amongst the groups of dogs with diﬀerent grades of HE
using a Kruskal-Wallis test. Signiﬁcance was set at p<0.05.
Eighty dogs met the inclusion criteria for the study. The most
common historical ﬁndings were: obtundation in 26 dogs (33%),
abnormal behavior in 23 (29%), head pressing in 22 (28%),
ataxia in 21 (26%), and apparent seizures in 19 (24%). On neu-
rological examination 46 dogs (58%) had abnormalities recorded.
These included obtundation in 25 dogs (31%), ataxia in 16
(20%), weakness in 8 (10%), decreased conscious proprioception
in 7 (9%), and seizures in 6 (8%). Twelve of 76 dogs (16%) for
which it was possible to grade HE had grade I, 60 (79%) had
grade II, 4 (5%) had grade III, and none had grade IV. Dogs
with HE grades I, II, and III had median (range) plasma ammo-
nia concentrations of 143 (50-356), 203 (15-617), and 361 (106-
1350) lg/dL, respectively (p=0.091). Forty-one of 65 dogs (63%)
for which a cause of HE had been recorded had congenital por-
tosystemic vascular anomalies, 16 (25%) had acquired portosys-
temic collaterals (APSC), 4 (6%) had hepatic parenchymal
disease but no APSC could be detected, and 3 (5%) had hepatic
parenchymal disease but were not evaluated for APSC. Forty-
three of 80 dogs (54%) had no potential predisposing factors
recorded, 9 (11%) had hypoglycemia, 7 (9%) had hypokalemia, 6
(8%) had SIRS, 5 (6%) had a clinically important coagulopathy
or DIC, 5 (6%) had hyponatremia, 4 (5%) had concurrent intra-
cranial disease, and 4 (5%) had azotemia.
Portosystemic shunting due to congenital portosystemic vascu-
lar anomalies or APSC was the cause of HE in at least 88% of
dogs evaluated. There was a non-signiﬁcant trend for the group
of dogs with HE severe enough to cause stupor to have higher
plasma ammonia concentrations than those with less severe HE.
Potential predisposing factors, such as hypoglycemia, hypokale-
mia, or SIRS were present in 46% of patients and thus should be
considered in dogs with HE.
ABSTRACT HP-3
LONG-TERM SURVIVAL OF DOGS (N=597) WITH CON-
GENITAL OR ACQUIRED PORTOSYSTEMIC SHUNTING:
1980-2010. SA Center, JF Randolph, KL Warner, KC Sapa, WE
Hornbuckle, AE Yeager, NL Dykes, HJ Harvey, JA Flanders.
College of Veterinary Medicine, Cornell University, Ithaca, NY
Surgical attenuation is preferred treatment for canine congeni-
tal portosystemic vascular anomalies (PSVA). However, success
of long-term medical management of large canine PSVA cohorts
and dogs with anicteric acquired portosystemic shunts (APSS) is
undetermined.
A retrospective survival study of dogs with PSVA (extrahe-
patic [EPSVA, n=378], intrahepatic [IPSVA, n=105]) and anic-
teric APSS (n=114) over 31 contiguous years at Cornell
University is described. Follow-up (91.5% cases) was derived
from medical records and contact with managing veterinarians
and clients. Medical management consisted of dietary protein-
restriction/modiﬁcation, ± lactulose, ± metronidazole. Surgical
PSVA attenuation was by suture ligation (n=225/239) to toler-
ance. Age at diagnosis, survival of EPSVA and IPSVA treated
surgically (n=189 and 50, respectively) and medically (n=166
and 46, respectively), and APSS survival were compared using
Wilcoxon rank sum test, Kaplan-Meier survival curves, and two-
sample survival tests (Gehran-Wilcoxon and Log Rank Tests),
respectively with alpha <0.05. Dogs dying without treatment
were censored. Survivals (years) at 50th (range:75th-25th) percen-
tiles are shown.
Median age (years) at diagnosis was signiﬁcantly younger for
PSVA (1[0.1-12]) vs APSS (4[0.12-12]), and IPSVA (0.5[0.1-5]) vs
EPSVA (1.5[0.12-12]); P<0.00001. EPSVA survival (all dogs:
n=334, 10[6.0-13]; Yorkshire Terriers: n=91; 12[6-13]) was sig-
niﬁcantly longer than IPSVA: n=104, 4.5(1.2-9); all P<0.00001.
There was no survival diﬀerence between surgically- or medi-
cally-treated EPSVA (all dogs; Yorkshire Terriers [n=41 and
n=43, respectively]), and surgically- or medically-treated IPSVA.
Of surgically treated dogs, 63 % EPSVA and 58% IPSVA also
received medical treatment. APSS survival (9.0[4.6-11]) was sig-
niﬁcantly shorter than medically-treated EPSVA (all dogs: 10 [6-
13]; Yorkshire Terriers:12.0 [6.0-13]), all P<0.04.
ABSTRACT HP-4
SERUM BRANCHED-CHAIN AMINO ACID/TYROSINE
RATIO (BTR) IN DOGS WITH LIVER DISEASES. M Sakai,
Y Ohori, M Nagamune, Y Sakamoto, T Watari, M Uechi.
Nihon University, Department of Veterinary Medicine,
Kanagawa, Japan
Branched-chain amino acids (BCAA; valine, leucine, isoleu-
cine) are decreased and aromatic amino acids (AAA; tyrosine,
phenylalanine) are increased in the blood of dogs with hepatic
disorders and hepatic encephalopathy. The degree of hepatic
parenchymal damage can be evaluated by calculating the Fischer
ratio, the molar ratio of BCAA to AAA by HPLC. The molar
ratio of BCAA to tyrosine ratio (BTR) can also be determined
using enzymatically quantiﬁed values in humans with chronic
liver disease.
We determined serum BTR for 92 dogs with chronic hepatitis
(CH, n=27), primary hyperplasia of the portal vein (PHPV,
n=15), congenital portosystemic shunts (CPSS, n=41), and
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hepatocellular carcinoma (HCC, n=9) using the Diacolor-BTR
kit. Acquired portosystemic collaterals (APSCs) were conﬁrmed
in 14 dogs with CH and in all dogs with PHPV. Plasma amino
acids were analyzed by HPLC in 24 healthy dogs included as
controls. The BTR closely correlated with the Fischer ratio in
controls (r=0.89, p<0.001). The BTR was signiﬁcantly lower in
dogs with PHPV (median, 3.28) and CPSS (2.95) than in controls
(10.62; p<0.001). In addition, BTR was signiﬁcantly decreased
in CH dogs with APSCs (3.65) compared with controls
(p<0.001). In contrast, BTR was not signiﬁcantly reduced in CH
dogs without APSCs (6.17) and HCC dogs (8.71) as compared to
controls.
The BTR is quite simple to determine by enzymatic methods
in dogs and it is considered a useful indicator of liver parenchy-
mal injury and for monitoring responses to nutritional therapy in
dogs with CPSS and APSCs.
ABSTRACT HP-5
PLASMA AND HEPATIC ENDOTHELIN-1 IN DOGS WITH
CHRONIC LIVER DISEASES. Y Sakamoto, M Sakai, T
Watari. Nihon University, Department of Veterinary Medicine,
Kanagawa, Japan
Elevated plasma endothelin-1 (ET-1) has been reported in
human chronic liver diseases, particularly cirrhosis accompanied
by esophageal varices. ET-1, which is a potently vasoactive, 21-
amino acid peptide, has been evaluated for associations with
respiratory and cardiac disorders, but not hepatic disorders, in
dogs.
In this study, blood samples were collected from 12 dogs with
chronic hepatitis/cirrhosis (CH). Liver biopsy samples were
obtained laproscopically using 5-mm biopsy forceps from 12 dogs
with CH and visually inspected for acquired portosystemic collat-
erals (APSCs). Plasma and hepatic ET-1 concentrations were
determined using an ELISA kit, and hepatic ET-1 mRNA
expression was evaluated using real-time PCR. Plasma (n=14)
and liver (n=3) samples were obtained from healthy dogs as con-
trols.
Plasma ET-1 concentration was higher in dogs with CH (med-
ian, 1.30 pg/mL; range, 0.68-2.65) than controls (median, 0.86
pg/mL; range, 0.41-1.41; p<0.05), and hepatic ET-1 concentra-
tion was higher in dogs with CH (median, 11.78 pg/mL; range,
3.55-23.90) than controls (median, 2.72 pg/mL; range, 1.70-3.34;
p<0.05). In dogs with CH, conﬁrmation of APSCs (n=8) was
associated with higher plasma ET-1 concentration. Hepatic ET-1
mRNA expression was signiﬁcantly greater in dogs with CH than
controls (p<0.05).
The ET-1 system was shown to be an important factor in
canine chronic liver disease. ET-1 may function as a potent vaso-
constrictor agonist in intrahepatic blood ﬂow regulation in CH
and play a role in the pathogenesis of portal hypertension.
SMALL ANIMAL - IMMUNOLOGY
ABSTRACT IM-1
EFFICACY OF MYCOPHENOLATE MOFETIL FOR THE
TREATMENT OF CANINE IMMUNE-MEDIATED HEMO-
LYTIC ANEMIA: 31 CASES (2007-2011). A Wang, JR Smith.
University of Georgia College of Veterinary Medicine, Athens,
GA
This retrospective case series evaluated the clinical use and
adverse eﬀects of mycophenolate mofetil (MMF) for treating
canine primary immune-mediated hemolytic anemia (IMHA).
Medical records (2007-2011) were searched for the diagnosis of
IMHA (n=93). Inclusion criteria included PCV<35%, with
either a positive slide agglutination test, spherocytosis, evidence
of hemolysis or positive Coombs’ test. Exclusion criteria included
IMHA secondary to infectious causes, drug toxicity, or neoplasia
(n=29). Data collected included presenting complaints, signal-
ment, vital parameters, body condition score, clinicopathologic
data, diagnostic imaging results, medications administered, dura-
tion of hospitalization, survival time, and adverse eﬀects.
Of 64 primary IMHA cases, 57 received steroids and a second-
ary immunosuppressive drug: 31 mycophenolate, 15 cyclosporine,
6 azathioprine, 1 human immunoglobulin. Seven dogs received
three immunosuppressives; 2 received only steroids; 2 were imme-
diately euthanized.
Data are presented as mean ± SD for dogs receiving myco-
phenolate mofetil. Initial PCV was 17 ± 5.2%. Initial MMF dose
was 20.5 ± 5.8 mg/kg PO or IV divided twice daily. Diarrhea was
the only adverse eﬀect noted (n=5), although one of these dogs
presented with diarrhea. Number of transfusions received was 1.9
± 1.6; hospitalization duration was 5.7 ± 4.5 days. Twenty-four
dogs (77.4%) survived to discharge, 2 were lost to follow-up, and
18 were alive at study conclusion. Mean survival time was 13
days in non-survivors.
In conclusion, oral and IV administration of mycophenolate
mofetil is a safe additional immunosuppressive for treating pri-
mary canine IMHA.
ABSTRACT IM-2
EX VIVO IMMUNOSUPPRESSION OF CANINE T LYM-
PHOCYTE-SPECIFIC PROLIFERATION USING DEXA-
METHASONE, CYCLOSPORINE, AND THE ACTIVE
METABOLITES OF AZATHIOPRINE AND LEFLUNOMIDE
IN A FLOW CYTOMETRIC ASSAY. LA Nafe, JR Dodam,
CR Reinero. University of Missouri College of Veterinary
Medicine, Columbia, MO
A high rate of mortality, expense and complications of
immunosuppressive therapy in dogs underscores the need for
optimization of drug dosing. While pharmacokinetics helps tar-
get therapeutic blood concentrations, pharmacodynamics mea-
sures the actual eﬀects of the drug on the immune system. To
date, no study has compared a panel of immunosuppressant
drugs on T lymphocyte proliferation using a ﬂow cytometric
assay in the dog. The purpose of this study was to determine
the 50% T cell inhibitory concentration (IC50) in dexametha-
sone, cyclosporine, and the active metabolites of azathioprine
(6-Mercaptopurine) and leﬂunomide (A77 1726) treated conca-
navalin A-stimulated canine lymphocytes. Whole blood was col-
lected from 7 privately owned, healthy dogs of various ages for
density gradient separation of peripheral blood mononuclear
cells (PBMCs). PBMCs were cultured for 72 hours with conca-
navalin A, a ﬂuorochrome-marked cell proliferation dye and
various concentrations of dexamethasone (-4, -5, -6 and -7 M),
cyclosporine (10, 20, 30 and 40 ng/mL), 6-mercaptopurine (50,
100, 250 and 500 nM) and A77 1726 (5, 10, 25 and 50 uM).
Following incubation, lymphocytes were labeled with propidium
iodide and an anti-CD5 antibody. Flow cytometry determined
the % live proliferating T lymphocytes with and without immu-
nosuppressants. Mean ( SEM) IC50 were: dexamethasone, -4.6
0.5M; cyclosporine 16 2ng/mL; 6-mercaptopurine 64 31nM;
and A77 1726, 24 3uM. Inhibition of T cell proliferation for
four immunosuppressants was demonstrated in a concentration-
dependant manner with marked variability between dogs. These
results represent the ﬁrst steps to tailor this assay for individual
immunosuppressant protocols for dogs with immune-mediated
disease.
SMALL ANIMAL - INFECTIOUS DISEASE
ABSTRACT ID-1
CYTAUXZOON FELIS CYTOCHROME B GENOTYPE IS
ASSOCIATED WITH SURVIVAL IN DOMESTIC CATS
WITH CYTAUXZOONOSIS. M Downey1, HS Marr1,
J Tarigo1, LA Cohn2, MG Levy1, AJ Birkenheuer1. 1North
Carolina State University College of Veterinary Medicine,
Raleigh, NC, 2University of Missouri College of Veterinary
Medicine, Columbia, MO
Cytauxzoon felis is a virulent tick-transmitted protozoan para-
site that infects felines. Without treatment, only 3% of infected
cats survive. Treatment combining atovaquone and azithromycin
(A&A) increased the survival rate to 60%1. In related parasites,
resistance to atovaquone has been attributed to mutations in its
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drug target, cytochrome b (cytb)2. We hypothesized that C. felis
cytb genotypes were associated with response (i.e. survival) to
A&A treatment. Cytauxzoon felis cytb genes were ampliﬁed by
PCR from samples collected from 45 cats with cytauxzoonosis
that received A&A treatment1. Amplicons were sequenced bi-
directionally, chromatograms were inspected for heterozygosity
and the sequences were edited accordingly3,4. The majority of
samples (30/45) had evidence of a single cytb genotype, while the
remaining samples (15/45) had two or more cytb genotypes pres-
ent. The most common single genotype was arbitrarily assigned
as the wild-type (WT). Two samples had missense mutations
compared to the WT, but there was no association with survival
or mortality. There was a signiﬁcant diﬀerence (p=0.001)
between survival rates of cats infected with C. felis that solely
contained the WT cytb (12/12 survived) compared to those
infected with C. felis of any other cytb genotype (16/33 survived).
However, the mere presence of the WT cytb (i.e. alone or concur-
rent with other genotypes) was not associated (p=0.35) with sur-
vival (15/21 survived) when compared to cats without the WT
cytb (13/24 survived). In conclusion, there is a high degree of
genetic variability in the C. felis cytb gene, and cytb genotypes
may be associated with survival.
ABSTRACT ID-2
DIAMENAZINE DIACETURATE AT 3 MG/KG DOES NOT
ELIMINATE PARASITEMIA IN CATS WITH CHRONIC
CYTAUXZOON FELIS INFECTION. KM Lewis1, LA Cohn1,
H Marr2, AJ Birkenheuer2. 1University of Missouri – College of
Veterinary Medicine, Columbia, MO, 2North Carolina State
University College of Veterinary Medicine, Raleigh, NC
Cytauxzoon felis is a hematoprotozoan parasite of cats that
causes substantial morbidity and mortality, but cats that survive
acute infection remain persistently parasitemic and may serve as
a source of infection for vector ticks. We tested the ability of the
antiprotozoal drug diminazene diaceturate to eliminate persistent
parasitemia from seven apparently healthy cats with naturally
acquired chronic C. felis infections.
Cats were administered either 3 mg/kg of drug or saline intra-
muscularly twice, one week apart. Cats that remained parasitemic
after 10 weeks were crossed over to the other treatment and fol-
lowed for an additional 10 weeks. Cats were observed for adverse
reactions via periodic examination, CBC, plasma biochemical
proﬁle, and urinalysis. At 0, 3, 6, and 10 weeks after treatment
pathogen number was assessed. Blood smears were prepared
immediately, stained with Wright-Giemsa and examined thor-
oughly for piroplasms. Blood collected in EDTA was used for
real time PCR for C. felis. Cycle threshold (Ct) was also used as
a semi-quantitative measure of parasite burden in peripheral
blood. Ct was compared between days using a two way repeated
measures ANOVA.
Hypersalivation after injection was the major adverse reaction
and was alleviated by atropine pre-treatment. Piroplasms were
observed at low numbers on all blood smears at all time points
and all blood samples were PCR positive for C. felis. Although 3
mg/kg diminazene was safely administered, it failed to eliminate
or reduce parasitemia in chronically infected carrier cats.
ABSTRACT ID-3
DETECTION OF LEPTOSPIRURIA IN SHELTER CATS IN
COLORADO. A Fenimore, K Carter, KF Lunn. Department of
Clinical Sciences, Colorado State University, Fort Collins, CO
Leptospirosis is an important zoonotic bacterial disease aﬀect-
ing many mammalian species worldwide, including livestock,
horses, dogs, and people. No studies have clearly documented
naturally occurring clinical leptospirosis in cats, but experimental
feline infections have been shown to result in leptospiruria. The
purpose of this study was to use a quantitative real-time PCR
(qPCR) assay to determine if pathogenic leptospires are shed in
the urine of shelter cats.
Stray and feral shelter cats in Colorado having spent time out-
doors were included in the study. Relinquished cats, indoor cats,
and cats receiving antibiotics were excluded. At least 5 mL of
voided urine was collected from each cat and DNA was isolated
using the QIAamp Viral RNA Mini Kit®. For the qPCR, prim-
ers were used to amplify an 87 base pair product from a region
of the Leptospira spp. 16S ribosomal DNA sequence. This assay
is speciﬁc for pathogenic leptospires and has been validated in
canine urine. To validate the qPCR for this study the assay was
used in normal feline urine to which live pathogenic leptospiral
serovars were added in serial 10-fold dilutions. The assay showed
linearity over a range of dilutions and the threshold (Ct) was set
at 36 cycles.
Urine samples were obtained from a total of 85 shelter cats;
10 cats were positive for leptospires in the urine based on the
qPCR assay (Ct<36).
Outdoor cats in Colorado can shed pathogenic leptospires in
the urine and may potentially be reservoir or incidental hosts in
the transmission of leptospirosis.
ABSTRACT ID-4
IDENTIFICATION OF RHOPTRY ASSOCIATED PROTEIN-
1S (RAP-1S) WITH BABSESIA GIBSONI ISOLATES OF
INFECTED DOGS IN THE UNITED STATES. MR Krecic1,
H Marr2, AJ Birkenheuer2. 1Orlando, FL, 2College of Veterinary
Medicine, North Carolina State University, Raleigh, NC
Babesia gibsoni organisms are obligate intraerythrocytic proto-
zoa that infect dogs, often American pit bull terriers and Ameri-
can Staﬀordshire terriers in the United States (US). Babesia
gibsoni infections are endemic in Asia, Africa, Europe, and por-
tions of the Americas. Infection may cause fever and progressive
anemia. Infected dogs that ﬁght with susceptible dogs and
infected ticks transmit B gibsoni sporozoites, leading to erythro-
cyte invasion. Rhoptry proteins are one of several believed to be
necessary for parasite attachment and invasion of host erythro-
cytes. Antibodies against rhoptry associated protein-1s (RAP-1s)
have been shown to protect cattle from infection by Babesia bige-
mina and Babesia bovis. Thus far, three RAP-1s; RAP-1 A, RAP-
1 B, and RAP-1 C; from B gibsoni have been identiﬁed and DNA
sequenced. North Carolina State University has identiﬁed two addi-
tional RAP-1s from B gibsoni that have not yet been reported and
DNA sequenced. Goal of this project is to determine the presence
of the three previously reported and the two new RAP-1s in iso-
lates of B gibsoni from naturally infected dogs from the US.
We used primers developed at North Carolina State University
for polymerase chain reaction (PCR) to conﬁrm the presence of
previously reported RAP-1 A, RAP-1 B, and RAP-1 C, and
newly identiﬁed RAP-1 D and RAP-1 rhoptry related antigen
(RRA) among B gibsoni isolates of ten naturally infected dogs
diagnosed with babesiosis. We optimized PCR conditions such
that the desired targets (i.e. RAP-1 A, RAP-1 B, etc) are ampli-
ﬁed rather than dog genomic DNA. Optimal PCR conditions
were 95°C for 20 seconds for DNA denaturing, 60°C for 30 sec-
onds for primer annealing, and 72°C for 2 minutes for Taq poly-
merization. Forty-ﬁve PCR cycles were run.
RAP-1 A, RAP-1 B, RAP-1 C, RAP-1 D, and RAP-1 RRA
were conﬁrmed among B gibsoni isolates from these ten naturally
infected dogs.
Next steps are to sequence the DNA for each RAP-1 identiﬁed
with these B gibsoni isolates and determine their degree of con-
servation. If the DNA of at least one RAP-1 variant is highly
conserved among isolates, they may be future targets for a diag-
nostic assay and a therapy.
ABSTRACT ID-5
IRON STATUS AND C-REACTIVE PROTEIN IN CANINE
LEISHMANIASIS. P Silvestrini1,2, A Zoia1, M Planellas2,
X Roura2, J Pastor2, JJ Cero´n3, M Caldin1. 1San Marco
Veterinary Clinic, Padua, Italy;, 2Autonomous University of
Barcelona, Spain;, 3University of Murcia, Spain
Previous studies demonstrated increased concentrations of
acute phase proteins in dogs with canine leishmaniasis (CL).
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The objective of the study was to investigate in dogs with CL
the iron status and its relation with c- reactive protein (CRP), as
sensitive marker of inﬂammation.
Iron, UIBC, TIBC, % of saturation, ferritin and CRP were
measured in 86 dogs (group 0) presented to the San Marco
Veterinary Clinic (November 2008-December 2011) and in
which CL was diagnosed based on presence of clinical signs,
high-titer anti-Leishmania antibodies and positive real-time
PCR on bone marrow sample. All dogs were classiﬁed as
stages C or D, according to the Canine Leishmaniasis Working
Group guidelines. Control groups consisted of age, sex and
breed-matched dogs from the same database. Group 1 (n=86)
were healthy patients and Group 2 (n=86) were non-CL sick
patients.
Dogs aﬀected by CL showed signiﬁcant lower (p < 0.0001)
iron and TIBC and signiﬁcant higher (p < 0.0001) CRP and fer-
ritin concentrations respect to both control groups. UIBC and %
of saturation of group 0 were signiﬁcantly lower (p = 0.02 and p
= 0.0005, respectively) only compared to group 1.
Within group 0 serum CRP was signiﬁcantly correlated (p <
0.0001, r = -0.46) with serum iron. In this group 6/86 (6.9%)
dogs died 28 days post-diagnosis. Their serum CRP was signiﬁ-
cantly higher than survival (p = 0.03)
To assess if plasma ferritin concentrations in dogs with CL
was aﬀected only by the degree of inﬂammation, the three groups
were stratiﬁed based on diﬀerent CRP concentrations. Plasma
ferritin was found still signiﬁcantly higher (p < 0.001) in group 0
compared to control groups.
Inﬂammation contributes to decrease plasma iron concentra-
tions. Degree of inﬂammation is a risk factor for outcome.
Increased ferritin is not only due to inﬂammation, but may reﬂect
other speciﬁc mechanisms implicated in intracellular infections as
demonstrated in human beings.
ABSTRACT ID-6
PREVALENCE OF BLASTOCYSTIS SPP AND GIARDIA
SPP IN DOGS AND CATS RESIDENT IN A PACIFIC
NORTHWEST SHELTER. B Stang, C Ruaux. Oregon State
University College of Veterinary Medicine, Corvallis, OR
Blastocystis spp and Giardia spp are protozoan parasites of
the gastrointestinal tracts of many mammalian species. Giardia
spp are well-recognized enteric pathogens in dogs, cats, and
humans, while there is limited data regarding the prevalence of
Blastocystis spp in companion animals. Blastocystis spp are,
however, the most commonly recognized enteric protozoan par-
asite in human patients with gastrointestinal disease within the
Paciﬁc Northwest region of the USA. The aim of this study
was to estimate the prevalence of these two organisms within a
population of shelter-resident dogs and cats in the Paciﬁc
Northwest.
Freshly voided stool samples were collected from 40 dogs and
40 cats resident at the Oregon Humane Society facility in Port-
land, Oregon. Giardia carriage was assessed using a commercially
available immunoﬂuoresence assay kit (Meriﬂuor® Cryptospori-
dium/Giardia), while Blastocystis spp were detected using a novel
nested PCR methodology, following extraction of DNA from
feces using routine methods. Ampliﬁed material from all samples
testing positive for Blastocystis in the PCR assay was isolated
and sequenced to conﬁrm results. Contingency table analysis was
used to compare the relative risk of carriage of Giardia spp and
Blastocystis spp between dogs and cats.
Giardia spp were detected in stool samples from 6/40 dogs and
0/40 cats. Dogs were signiﬁcantly more likely to test positive for
Giardia than cats (p<0.05, Fischer’s Exact Test). Blastocystis spp
were detected in stool samples from 9/40 dogs and 19/40 cats, with
cats being signiﬁcantly more likely to test positive for Blastocystis
than dogs (p<0.05, Fischer’s Exact Test). Coinfection with both
protozoa was noted in 2/40 dogs. Shelter resident animals overall
were signiﬁcantly more likely to test positive for Blastocystis spp
than Giardia spp. (p<0.01, Fischer’s Exact Test).
We conclude that both Giardia spp and Blastocystis spp are
common in shelter-resident animals in the Paciﬁc Northwest
region. Cats apparently have a higher carriage rate of Blastocystis
than dogs, however, in this population of cats at least, Giardia
spp were uncommon.
ABSTRACT ID-7
TREATMENT OF CHRONIC RHINITIS IN SHELTER CATS
WITH PARENTERAL ALPHA-INTERFERON OR AN
INTRANASAL FELINE HERPESVIRUS 1 AND FELINE
CALICIVIRUS VACCINE. A Fenimore, J Fankhauser, K
Carter, JR Hawley, MR Lappin. Department of Clinical
Sciences, Colorado State University, Ft. Collins, Colorado
Feline upper respiratory tract disease is a leading cause for
euthanasia in shelter cats and can be frustrating to treat. The
purpose of this study was to evaluate novel treatments for cats
from shelters with suspected chronic viral rhinitis that have failed
conventional therapy.
Cats from shelters that failed traditional therapy (lysine; anti-
biotics) for 2-3 weeks were transported to CSU and randomly
assigned to one of two treatment groups. Group A was adminis-
tered human interferon alpha (10,000 Units/kg SQ) once daily
for 14 days. Group B was administered an intranasal FHV-1/
FCV vaccine (HESKA Corporation, Loveland, CO) on Day 1 as
immunotherapy followed by 1 mL of saline SQ once daily for 14
days. A clinical score for each cat was determined daily by a
trained, blinded individual. Cats who improved (clinical score <
3) by day 14 were eligible for adoption. Cats with a score of  3
on Day 14 were entered into the crossover group. Cats who
failed both therapies and/or had severe ocular signs were admin-
istered famciclovir as a rescue drug for FHV-1. Total DNA and
RNA was extracted from nasal or pharyngeal swabs collected
prior to the ﬁrst treatment and evaluated for the presence of
FHV-1 DNA and FCV RNA using previously reported molecu-
lar assays.
A total of 47 cats were transferred from the shelters to the
research facility to enter the treatment study. Of these cats, 16
had clinical signs resolve spontaneously during the ﬁnal equilibra-
tion period before treatment, three cats required famciclovir
treatment immediately due to ocular ulcers, one cat had to be
euthanized prior to treatment because of severe stomatitis, and
one cat was euthanized early during the ﬁrst treatment period
because of severe stomatitis. One cat had a clinical score > 3
after both treatments and famciclovir rescue therapy and was
found on workup to have a severe proliferative rhinitis. All other
cats (n = 25) had a clinical score of < 3 during the ﬁrst treat-
ment period or soon after crossover. Response rates to primary
treatment with interferon alpha or intranasal vaccine administra-
tion were 66.7% (8 of 12 cats) and 100% (13 of 13 cats), respec-
tively (p = 0.039). All four cats with clinical scores > 3 after
alpha interferon therapy had clinical scores < 3 two to seven
days after the crossover to intranasal vaccine administration.
Mean time to response for those cats developing clinical scores
< 3 during the ﬁrst treatment was not signiﬁcantly diﬀerent
between groups. All six cats positive for nucleic acids of FHV-1,
FCV, or both responded to the primary treatment (2 cats-inter-
feron alpha; 4 cats-intranasal vaccine).
Administration of human interferon alpha or a topical FHV-1/
FCV vaccine as immunotherapy may be beneﬁcial in alleviating
chronic clinical signs of suspected feline viral URTD in some cats.
ABSTRACT ID-8
INTRANASAL ADMINISTRATION OF A MODIFIED LIVE
FELINE HERPESVIRUS 1 AND FELINE CALICIVIRUS
VACCINE INDUCES CROSS PROTECTION AGAINST
BORDETELLA BRONCHISEPTICA. A Bradley1, J Kinyon2,
T Frana2, D Bolte3, DRHyatt3, MRLappin1. 1Department of
Clinical Sciences, Colorado State University, Fort Collins, CO,
2Veterinary Diagnostic Laboratory, Iowa State University, Ames,
IA, 3Veterinary Diagnostic Laboratory, Colorado State
University, Fort Collins, CO
Vaccination against all feline upper respiratory pathogens is
not possible. Results of previous studies suggest that intranasal
vaccination may stimulate nonspeciﬁc immunity against agents
not contained within the vaccine, but no study has directly exam-
ined this in cats. The authors hypothesized that cats administered
a modiﬁed live feline herpesvirus-1 (FHV-1) and feline calicivirus
(FCV) intranasal vaccine would have fewer clinical signs after
challenge inoculation with Bordetella bronchiseptica than unvacci-
nated controls.
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Twenty speciﬁc pathogen free 12 week-old kittens were random-
ized into 2 groups of 10 cats each. The vaccinated group was
administered a single intranasal dose of a commercially available
vaccine containing modiﬁed live strains of FHV-1 and FCV, and
the control group remained unvaccinated. All 20 cats were admin-
istered B. bronchiseptica by nasal inoculation seven days later and
were observed daily for clinical signs of illness for 20 days.
In the ﬁrst 10 days after B. bronchiseptica challenge, vaccinated
cats were less likely to be clinically ill (indicated by lower cumula-
tive clinical scores) than control cats (p = 0.01). The most com-
monly observed clinical sign was sneezing. Overall, 9 of 10 control
cats and 2 of 10 vaccinated cats were noted to sneeze at least once
during days 1-10 after inoculation with B. bronchiseptica (p =
0.006). These diﬀerences were no longer apparent during days 11-
20. Finally, the percentage of observation points with sneezing
recorded was signiﬁcantly greater in control cats than in vaccinated
cats over days 1-10 (p < 0.0001) and days 1-20 (p = 0.02).
Intranasal vaccination against FHV-1 and FCV decreased signs
of illness due to an infectious agent not contained in the vaccine.
This nonspeciﬁc immunity could be beneﬁcial for protection
against organisms for which vaccines are not available and as early
protection while speciﬁc adaptive immunity is developing.
ABSTRACT ID-9
FELINE HERPESVIRUS 1 VIRAL LOAD AS A TOOL TO
DIFFERENTIATE LYTIC FROM LATENT INFECTION.
CM Leutenegger1, PA Pesavento2. 1IDEXX Laboratories, Inc.,
Sacramento CA, 2School of Veterinary Medicine, University of
California, Davis
Feline Herpesvirus 1 (FHV-1) detection by real-time polymer-
ase chain reaction (PCR) is considered the most sensitive diag-
nostic tool in feline upper respiratory infections (URI). It has
long been criticized that PCR overestimates FHV-1 prevalence
because of detecting latent virus not involved in causing respira-
tory disease manifestation. In this report we review three studies
that establish protocols to use FHV-1 DNA viral load to diﬀer-
entiate acute, lytic from latent infections.
In the ﬁrst study, FHV-1 experimentally infected cats were
monitored with clinical examination, quantitative virus isolation
and quantitative real-time PCR. Viral load by PCR correlated
with quantitative virus isolation during the clinical phase but
remained detectable at a lower level for a period of 8 weeks while
cats were free of clinical signs. A PCR cutoﬀ value was estab-
lished to diﬀerentiate virus loads associated with clinical signs
and positive virus isolation indicating lytic virus from later stages
in infection with negative virus isolation, absence of clinical signs
characterizing the chronic or latent stage of FHV-1 infection. In
a second study, immune induction and FHV-1 replication was
studied in shelter cats naturally infected with FHV-1. Cats with
conﬁrmed FHV-1 infection by virus isolation had a speciﬁc type
of immune induction, detectable FHV-1 replication and high
DNA viral loads measured by real-time PCR. In a third study, a
link was established between lytic FHV-1 infection in naturally
infected shelter cats, herpes speciﬁc inclusions, histological scores
in biopsies, and FHV-1 DNA load measured by real-time PCR.
This study was able to establish causality between the presence of
FHV-1 and disease manifestation and conﬁrmed that FHV-1
DNA viral load correlated with lytic FHV-1 infection.
In conclusion, these studies strongly indicate a link between
FHV-1 DNA viral load and clinical parameters, viral replication,
isolation in cell culture, immune reaction, pathognomonic inclu-
sions, and histological grades for tissue damage. Real-time PCR
therefore could be a key tool to diﬀerentiate between lytic and
latent FHV-1 infection in cats and could be used to determine if
FHV-1 is the cause of URI in individual cats.
ABSTRACT ID-10
SERIAL FIV SEROLOGICAL RESULTS IN COHABITING
FIV-POSITIVE AND FIV-NEGATIVE CATS. A Litster.
Purdue University College of Veterinary Medicine, West
Lafayette, IN
Horizontal transmission of feline immunodeﬁciency virus
(FIV) most commonly occurs via the inoculation of infected sal-
iva into bite wounds during territorial ﬁghts. Conﬂicting accounts
have been published in the veterinary literature regarding trans-
mission between cohabiting cats in stable closed households
and the mechanics of possible casual transmission, if it occurs,
are poorly understood. The aim of this study was to document
the FIV serological status of cats living long-term in a stable
multi-cat household containing FIV-positive and FIV-negative
cats.
Serological testing (IDEXX SNAP FIV/FeLV Combo) was
performed on 138 cats living in a stable multi-cat household. All
cats had unrestricted access to each other. Eight of the 138 cats
were FIV-positive (6 MN, 2 FS; median age 28 months; range 5-
129 months) and 130/138 cats were FIV-negative (71 MN, 59 FS;
median age 4 months; range 2-155 months). Some inter-cat ﬁght-
ing took place, mainly involving 2 cats known to be FIV-posi-
tive, but only scratches were observed rather than bite wounds.
All cats were kept indoors only, except for 1 FIV-positive cat,
which was housed indoor/outdoor. No cats were FeLV-positive
on the ﬁrst test.
Testing was repeated in 50/138 and the FIV/FeLV serological
status of each cat was unchanged, (FIV-positive n=5; FIV-nega-
tive n=45; median 28 months after the ﬁrst test; range 1-106
months), except for one of the FIV-negative cats, which was
FeLV-positive on the second test. That cat was transferred to
another household 6 days after the test and subsequently died 2
weeks later. A third test was performed on 5/138 cats (median 3
months after the second test; range 1-45 months) and FIV and
FeLV serological status remained unchanged (FIV-positive n=1;
FIV-negative n=4). Total cumulative exposure to FIV-positive
cats was calculated for each FIV-negative cat that had at least 2
test results and was exposed to FIV-positive cats (months of
exposure to each FIV-positive cat was calculated and the results
for the FIV-negative group were added; FIV-positive n=5; FIV-
negative n=44; median cumulative exposure duration of FIV-
negative cats to FIV-positive cats =140 months; range 14-167
months)
It is concluded that despite occasional minor ﬁghting between
FIV-positive and FIV-negative cats kept in a stable multi-cat
household, FIV transmission did not occur over years of cumula-
tive exposure to FIV-positive cats.
ABSTRACT ID-11
U. S. PREVALENCE OF CANINE INFECTIOUS RESPIRA-
TORY DISEASE PATHOGENS: A 3-YEAR STUDY.
R Lavan1, O Knesl1, S Podhayny1, S Shields1, B Dronson1, C
Leutenegger2. 1Pﬁzer Animal Health, Madison, NJ, 2IDEXX
Laboratories, West Sacramento, CA
The diagnosis of canine infectious respiratory disease (CIRD)
is complicated by the emergence of at least four canine respira-
tory pathogens since 2000: canine inﬂuenza virus (CIV), canine
respiratory coronavirus (CRCoV), Mycoplasma cynos, and Strep-
tococcus equi subspecies zooepidemicus.
Pﬁzer established an Immunization Support Guarantee (ISG)
program to diagnostically evaluate samples from dogs vaccinated
with a Pﬁzer Animal Health vaccine that subsequently developed
clinical signs of CIRD. Resulting data were combined with
CIRD diagnostic data from Idexx Laboratories to determine the
prevalence of nine common CIRD pathogens, including the four
newly emerging agents. The combined databases included diag-
nostic results from 2008-2011 for >13,000 dogs from all 50
states.
The three most frequently identiﬁed pathogens in the Idexx
database were M. cynos (36.5%, 682/1,867), Bordetella bronchi-
septica (Bb) (24.2%, 3,247/13,429), and canine distemper virus
(19.2%, 2,578/13,429). In the ISG database, the three most fre-
quent diagnoses were M. cynos (59.6%/65/109), CRCoV (15.3%,
50/327), and Bb (14.4%, 47/327). Divergence in prevalences
between the two databases can be partly explained by a high per-
centage of unvaccinated, at-risk shelter dogs in the Idexx data-
base.
Results indicated that newly emerging CIRD pathogens may
be the cause of CIRD in dogs that were vaccinated for conven-
tional agents, and that M. cynos should be a prime suspect in
clinical CIRD, especially in dogs that do not respond to antimi-
crobial therapy that targets other pathogens.
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ABSTRACT ID-12
ARTHROPOD-BORNE DISEASE IN SICK SOUTHERN
CALIFORNIA DOGS. L Kidd1, M Barr1, M Lappin2, E
Breitschwerdt3, C Osmond4, J Hart5, S Hill5, K Richter5.
1Western University of Health Sciences, Pomona, CA, 2Center
for Companion Animal Studies, Fort Collins, CO, 3Vector Borne
Disease Diagnostic Laboratory, Raleigh, NC, 4California
Veterinary Specialists, Carlsbad, CA, 5Veterinary Specialty
Hospital, San Diego, CA
The distribution of arthropod borne disease (ABD) is expand-
ing. Dogs are sentinels for ABD in people. Rocky Mountain
spotted fever is rare in southern California due to a lack of Der-
macentor ticks, the primary vector for Rickettsia rickettsii in
North America. Rhipicephalus sanguineus caused recent outbreaks
in Arizona and Mexicali, Mexico. This ubiquitous tick is also a
known or suspected vector for Ehrlichia, Babesia, and Bartonella
species. Ixodes paciﬁcus, which transmits Anaplasma phagocyto-
philum and Borrelia burgdorferi, is also present in southern Cali-
fornia. Studies investigating the prevalence of ABD in dogs in
the southernmost regions of California are very limited. The
objective of this study was to determine the prevalence of expo-
sure to, or active infection with, ABD agents in ill dogs present-
ing to specialty hospitals in San Diego County.
Dogs presenting to three specialty hospitals in San Diego
County with unexplained fever, anemia, thrombocytopenia, pol-
yarthritis, ocular inﬂammation, epistaxis, myalgia, proteinuria,
hyperesthesia, CNS signs, petechiae, vasculitis, cough, or GI
signs with one other clinical sign were eligible for inclusion. Dogs
receiving tetracycline antibiotics were excluded. DNA extracted
from whole blood was tested using PCR for spotted fever group
(SFG) Rickettsia, Bartonella, Babesia, Ehrlichia, Anaplasma and
haemotropic Mycoplasma. Serum was tested for antibodies to A.
phagocytophilum, E. canis and B. burgdorferi using ELISA
(SNAP®4Dx®), and for antibodies to R. rickettsii, E. canis, B.
henselae, B. vinsonii ssp. berkhoﬃ, and B. canis using immunoﬂo-
rescent assays (IFA). Convalescent serum was tested for R. rick-
ettsii antibodies (IFA).
Evidence of infection or exposure to one or more agents was
present in 8 of 49 dogs (16.3%). Ehrlichia canis antibodies (IFA)
and DNA were detected in 2 dogs; one of these dogs was also
seropositive by SNAP® 4Dx®. One dog was PCR positive but
seronegative for B. canis. One dog was PCR positive for B. con-
radae, M. haematoparvum and M. haemocanis, and seropositive
for B. vinsonii ssp. berkhoﬃ. Antibodies to A. phagocytophilum,
and B. burgdorferi were detected in one dog each. No dog tested
PCR or IFA positive for SFG Rickettsia acutely. Convalescent
titers of 1:64 to R. rickettsii were detected in 2 of the 31 dogs
tested. One had cephalosporin responsive discospondylitis. The
other had fever and arthralgia for 24 hours that resolved without
treatment.
This study documents that exposure to or infection with ABD
is relatively common in sick dogs presenting to specialty practices
in this region of the United States. The weakly positive convales-
cent titers to R. rickettsii may have been due to cross-reacting
antibodies rather than infection with SFG Rickettsia. However,
clinicians should remain vigilant given the presence of competent
vectors and proximity to outbreaks. This study also illustrates
that limiting testing to either PCR or serology may overlook
infection or exposure to ABD in some patients.
ABSTRACT ID-13
NT-PCNP AS A DIAGNOSTIC BIOMARKER FOR SEPSIS
IN DOGS PRESENTING FOR EMERGENCY CARE.
N Etedali, CR Sharp, M Burns, J Morlock. Tufts Cummings
School of Veterinary Medicine, North Grafton, MA
In a single center study, N-terminal pro-CNP (NT-pCNP) has
been shown to have high sensitivity and speciﬁcity (using a cut-
oﬀ value of 10.1pmol/L) for the diagnosis of nonperitoneal sepsis
and its diﬀerentiation from noninfectious causes of the systemic
inﬂammatory response syndrome (nSIRS) in dogs admitted to an
ICU. The purpose of this prospective serial admission study was
to evaluate the diagnostic utility of NT-pCNP in a larger, more
diverse, group of dogs presenting for emergency care. A second-
ary objective of the study was to further assess NT-pCNP in
dogs with septic peritonitis. Blood samples were collected from
dogs at the time of emergency room presentation for measure-
ment of NT-pCNP. NT-pCNP was measured on serum with a
previously validated ELISA. One hundred and eighty eight dogs
were enrolled. Based on the deLaforcade SIRS criteria, nine dogs
(5.05%) had conﬁrmed sepsis, 12 (6.7%) had suspected sepsis, 56
(31.5%) had nSIRS, 9 had infection (5.05%) and 92 (51.7%) had
no evidence of SIRS or infection. A high pCNP (above the cut-
oﬀ) had a high speciﬁcity (0.92) but low sensitivity (0.42) for the
diagnosis of sepsis in this population of dogs. Contrary to previ-
ous ﬁndings, NT-pCNP was a useful diagnostic biomarker for
septic peritonitis in this study. Further work is needed to improve
the diagnostic utility of NT-pCNP, notably to improve speciﬁc-
ity, across a broad population of dogs. This may involve reas-
sessment of the cut-oﬀ value and/or combination with other
biomarkers.
ABSTRACT ID-14
SERIAL NT-PCNP IN HOSPITALIZED DOGS WITH
SEPSIS. M Burns, CR Sharp, N Etedali, J Morlock. Tufts
Cummings School of Veterinary medicine, North Grafton, MA
N-terminal pro-CNP (NT-pCNP) has been shown to have high
sensitivity and speciﬁcity (using a cut-oﬀ value of 10.1pmol/L)
for the diagnosis of sepsis and its diﬀerentiation from noninfec-
tious causes of the systemic inﬂammatory response syndrome,
when excluding dogs with septic peritonitis. The purpose of this
prospective pilot study was to evaluate the utility of serial mea-
surement of NT-pCNP in assessing response to treatment and
assigning prognosis to hospitalized dogs with sepsis. A secondary
objective of the study was to further assess NT-pCNP in dogs
with septic peritonitis. Serial blood samples were collected from
dogs with sepsis at hospital admission, and then at 24-hour inter-
vals until hospital discharge for measurement of NT-pCNP.
Fourteen dogs with sepsis were enrolled. The origin of sepsis was
intra-abdominal (n=5), pneumonia (3), urosepsis (3), cutaneous
(2), and chemotherapy induced (1). Thirteen dogs had commu-
nity acquired (CA) sepsis, while two dogs had hospital acquired
(HA) sepsis. Thirteen dogs survived to discharge, and two were
euthanized. All but one dog had an NT-pCNP concentration
above the cut-oﬀ value. The two dogs with HA-sepsis had low
NT-pCNP concentrations initially, that subsequently increased
with the onset of sepsis. There was no predictable change in NT-
pCNP over time in dogs with CA-sepsis. Despite a clinical
response to treatment, NT-pCNP concentrations did not reliably
decrease. NT-pCNP may not be a useful standalone biomarker
to assess response to treatment in dogs with sepsis. Contrary to
previous ﬁndings, NT-pCNP was a useful diagnostic biomarker
for septic peritonitis in this study.
ABSTRACT ID-15
PHYLOGENETIC DIVERSITY OF BACTERIA ISOLATED
FROM SICK DOGS USING THE BAPGM ENRICHMENT
CULTURE PLATFORM. AC Davenport, PE Mascarelli,
RG Maggi, EB Breitschwerdt. North Carolina State University,
Raleigh, NC
It is estimated that fewer than 5% of bacterial organisms have
been isolated using contemporary bacteriologic methods; how-
ever, isolation remains the gold standard for the diagnosis of
bacterial infections. During the last decade, our laboratory devel-
oped and optimized a liquid growth medium, Bartonella alpha-
Proteobacteria growth medium (BAPGM), in an attempt to more
successfully isolate Bartonella spp. As BAPGM is not a selective
medium, non-Bartonella spp. isolated from canine blood, patho-
logical eﬀusions, and tissue samples were phylogenetically charac-
terized by 16S rDNA sequencing. The purpose of this study is to
describe the phylogenetic bacterial diversity and disease manifes-
tations in dogs infected with these isolates.
Non-Bartonella BAPGM subculture isolates were obtained from
70 of 513 dogs (14%) tested using the BAPGM platform. All iso-
lates (n=98) were members of 4 Phyla: 55 Proteobacteria, 26 Fir-
micutes, 14 Actinobacteria, and 3 Bacteroidetes. Members of the
class alpha-Proteobacteria were more frequently isolated (n=36)
than any other bacterial class. Fourteen dogs were co-infected with
a Bartonella spp. Retrospective review of the 26 dogs with NCSU-
786 2012 ACVIM Forum Abstracts
VTH medical records identiﬁed Sphingomonas spp. (n=7) and
Staphylococcus (n=5) as the most common isolates. These twenty-
six dogs had variable clinical presentations, including 7 dogs with
suspected immune-mediated disease, 4 with pathological eﬀusions,
and 4 with endocarditis. Direct comparison of conventional and
BAPGM blood culture was not performed in this population; how-
ever, review of blood cultures performed for NCSU-VTH patients
revealed the distribution of organisms isolated diﬀered substan-
tially: 58% Firmicutes, 24% Proteobacteria, 12% Actinobacteria,
and 6% fungi using conventional culture techniques versus 63%
Proteobacteria, 22% Firmicutes, 11% Actinobacteria, and 4%
Bacteroidetes using BAPGM.
BAPGM preferentially facilitates growth of alpha-Proteobac-
teria. Future studies are needed to elucidate the diagnostic util-
ity of BAPGM and other “non-conventional” growth media
for the isolation of fastidious organisms from patients with
immune-mediated, eﬀusive and other “sterile” diseases and to
determine if these organisms play a causal role in disease devel-
opment.
ABSTRACT ID-16
PREVALENCE OF BARTONELLA SPP. AND HEMOPLAS-
MAS IN THE BLOOD OF DOGS AND THEIR FLEAS IN
FLORIDA. K Yore1, BA DiGangi2, M Brewer1, MRLappin1.
1Department of Clinical Sciences, Colorado State University, Ft.
Collins, Colorado;, 2Department of Small Animal Clinical
Sciences, University of Florida, Gainesville, FL
Fleas are known to be the vector for a number of Bartonella
spp. and are believed to be associated with the transmission of
some hemoplasmas. While a number of studies have evaluated
dogs for these potential pathogens, little is known about preva-
lence rates in ﬂeas. The objective of this study was to deﬁne the
prevalence of these organisms in healthy shelter dogs and their
ﬂeas in Florida.
Blood (EDTA), serum, and ﬂeas of unknown genus and spe-
cies were collected from 37 healthy dogs on admittance to a shel-
ter in Florida as part of routine screening for Diroﬁlaria immitis
and tick borne diseases. The samples were stored at -20°C until
shipped to Colorado State University. Upon arrival, total DNA
was extracted from the blood and the ﬂeas and assayed in previ-
ously reported genus-speciﬁc, conventional PCR assays that
amplify the DNA of Bartonella spp. and hemoplasmas. An aver-
age of 4.8 ﬂeas were collected from each dog; for the 4 dogs with
> 5 ﬂeas, the ﬂeas were assayed in groups of 3 to 6. Positive
amplicons were sequenced to conﬁrm the species.
Bartonella spp. or hemoplasma DNA was ampliﬁed from 6 of
37 dogs (16.2%) and from at least one ﬂea group from 5 of the
dogs (13.5%) giving a total of 8 positive (dog, ﬂeas, or both)
sample pairs (Table 1). Bartonella vinsonii subsp. berkhoﬃi DNA
was ampliﬁed most frequently.
While B. vinsonii subsp. berkhoﬃi DNA has been ampliﬁed
from ﬂeas (predominately Pulex simulans) collected on gray
foxes, to our knowledge, this is the ﬁrst study to amplify DNA
of the organism from ﬂeas collected from domestic dogs. In
Florida, C. felis is the most prevalent ﬂea feeding on dogs. The
genus and species of the ﬂeas are being determined for all new
cases in this ongoing, prospective study. Results of this study
document that ﬂea-associated, potentially zoonotic, infectious
agents are common in dogs and ﬂeas in Florida and support
the recommendation that stringent ﬂea control be maintained
on dogs.
ABSTRACT ID-17
CLINICOPATHOLOGIC FEATURES AND ATYPICAL PRE-
SENTATIONS OF NATURALLY OCCURRING CANINE
LEPTOSPIROSIS: 51 CASES (2000-2010). LE Tangeman,
MP Littman. University of Pennsylvania, School of Veterinary
Medicine, Philadelphia, PA.
The purposes of this study were to retrospectively review the
clinicopathologic presentations of dogs infected with leptospiro-
sis, identify antibodies against Leptospira serovars based on acute
and convalescent microscopic agglutination test (MAT), identify
and describe the percentage of atypical abnormalities, and evalu-
ate the importance of convalescent MAT titers.
Medical records of 138 dogs with leptospirosis presented to
the Matthew J. Ryan Veterinary Hospital of the University of
Pennsylvania between January 1, 2000 and January 1, 2010 were
retrospectively reviewed. The MAT titers were considered posi-
tive when  1:1600 in vaccinated dogs,  1:800 in non-vacci-
nated dogs, or when demonstrating a  4-fold increase in
convalescent titer.
Fifty-one dogs met the criteria for inclusion. Clinical presenta-
tion, temporal distribution and signalment were similar to previ-
ous studies. Convalescent MAT titers were necessary for
diagnosis in 45% of cases. L. icterohemorrhagiae and L. grippo-
typhosa were the most commonly identiﬁed infectious serovars on
MAT. Atypical abnormalities included hepatic dysfunction alone
(22%), coagulopathy (29%), radiographic evidence of pulmonary
disease (43%), proteinuria (82%), glucosuria (18%), and hypoal-
buminemia (27%). Signiﬁcant associations were found between
L. grippotyphosa and renal involvement (p = 0.02), and L. ict-
erohemorrhagiae and hepatic involvement (p = 0.01).
Atypical presentations were common. Awareness of atypical
presentations may decrease misdiagnosis of leptospirosis for
other disease entities (e.g. Lyme nephritis, protein-losing disease,
tick-borne disease, pulmonary disease). Convalescent titers are
necessary to identify infection when acute titers are negative.
Further research is needed to determine the true association
between infecting serovars and clinical presentation.
ABSTRACT ID-18
PARASITE BURDEN DOES NOT FLUCTUATE WITH TIME
OF DAY IN CATS WITH CHRONIC CYTAUXZOON FELIS
INFECTION. LA Cohn1, KM Lewis1, JR Dodam1, H Marr2, AJ
Birkenheuer2. 1University of Missouri – College of Veterinary
Medicine, Columbia, MO, 2North Carolina State University
College of Veterinary Medicine, Raleigh, NC
Cytauxzoon felis is a hematoprotozoan parasite of cats that
causes substantial morbidity and mortality, but cats that survive
acute infection may remain persistently parasitemic and may serve
as a pathogen source for vector ticks. For many hematologic infec-
tions, parasite numbers in circulation vary markedly over periods
of time as brief as hours, and often parasite numbers vary with
time of day. If this were true for C. felis, it could impact a veteri-
narian’s ability to identify chronically infected carrier cats.
Parasite burden was estimated in the peripheral blood of ﬁve
apparently healthy cats with naturally acquired chronic C. felis
infections. Peripheral blood was obtained twice in a 24 hour per-
iod, 12 hours apart, from each cat via jugular venipuncture on 4
separate occasions. In total, 20 samples were obtained at approx-
imately 9 am and 20 samples obtained at approximately 9 pm
into EDTA containing Vacutainer tubes. Blood smears were pre-
pared immediately, and the reminder of the blood was used to
perform CBC in routine fashion and for real time PCR for C.
felis. Each slide was stained with Wright-Giemsa and examined
thoroughly for piroplasms, and the number of piroplasms per
1500 RBC was noted. Cycle threshold (Ct) was also used as a
semi-quantitative measure of parasite burden in peripheral blood.
Ct was compared between times of day using a two way repeated
measures ANOVA (two factor repetition).
Piroplasms were observed at low numbers on all blood smears
at all time points, and all blood samples were PCR positive for
C. felis. While at least a single RBC containing piroplasm was
seen on every slide, the number of piroplasm infected RBCs per
1,500 RBC ranged from 0 to 4, with no diﬀerence between sam-
ples obtained in the morning versus the evening. The mean Ct
for all cats on samples obtained in the morning was 24.1 ± 1.2
Table 1.
Sample Pair #
1 2 3 4 5 6 7 8
Blood BV NEG BV BV BV, MH BV NEG MHP
Fleas NEG BC NEG BV BV NEG BV BV
NEG = negative; MH = Mycoplasma haemocanis; MHP = ‘Candida-
tus M. haematoparvum’; BV = B. vinsonii; BC = B. clarridgeiae.
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and the mean in the evening was 24.7 ± 2.0. No signiﬁcant diﬀer-
ence was detected in the Ct between samples obtained in morning
versus the evening (p = 0.107). However, parasite burden was
observed to vary from day to day in a given cat (p = 0.041).
This suggests that timing of blood collection to detect the carrier
state is unimportant despite some variability in parasite burden
from day to day. PCR is a more sensitive method for detection
of the carrier state, but if blood smear analysis is used, the entire
smear must be carefully evaluated as piroplasms often occur in
extremely low numbers.
ABSTRACT ID-19
MITOCHONDRIAL GENOME SEQUENCES RESULT IN
IMPROVED UNDERSTANDING OF THE PHYLOGENETIC
RELATIONSHIPS OF PIROPLASMIDA THAT INFECT
COMPANION ANIMALS. M Downey1, HS Marr1, J Tarigo1,
LA Cohn2, DM Bird3, EH Scholl3, MG Levy1, AJ Birkenheuer1.
1North Carolina State University College of Veterinary
Medicine, Raleigh, NC, 2University of Missouri College of
Veterinary Medicine, Columbia, MO, 3North Carolina
State University College of Agriculture and Life Sciences,
Raleigh, NC
Based on phylogenetic analyses using 18S ribosomal ribonu-
cleic acid (rRNA) gene sequences, parasites in the order Piroplas-
mida have been sub-categorized into at least ﬁve distinct groups1.
Piroplasma from these groups infect common companion animal
species—dogs and cats. In this study, we characterized the mito-
chondrial genome sequence and structure from these piroplasma.
We hypothesized that use of mitochondrial gene sequences would
improve upon previous phylogenetic analyses that used 18S
rRNA genes alone. Blood was collected from dogs or cats
infected with species representing the proposed sub-groups: Babe-
sia microti-like sp. (AKA, Theileria annae), B. conradae, B. canis
canis, B. canis rossi, B. canis vogeli, an un-named Babesia sp.
(“Coco”), and Cytauxzoon felis. DNA was isolated and the entire
mitochondrial genome (5.6-5.9 kb) was PCR-ampliﬁed in over-
lapping fragments. Amplicons were sequenced bi-directionally,
and contigs were assembled using a commercially available soft-
ware package2. Mitochondrial genomes were annotated for cox1,
cox3, cytb and ribosomal subunit genes. Phylogenetic trees were
constructed using both mitochondrial genes and 18S rRNA gene
(Neighbor-joining, 1000 bootstrap replicates3). Utilization of
mitochondrial genes improved bootstrap support and resolved
uncertainties concerning the relationship between Cytauxzoon
species and Theileria species compared to trees based on 18S gene
sequence alone. Additionally, one sub-group characterized by its
tropism for ungulid hosts was shown to include a species (Babe-
sia sp. “Coco”) that parasitizes dogs. In conclusion, we demon-
strate the utility of the mitochondrial genome structure and
sequence for phylogenetic analyses, and propose that future stud-
ies include mitochondrial genes to further deﬁne evolutionary
relationships between Piroplasmida species.
ABSTRACT ID-20
PREVALENCE OF BARTONELLA SPP. ASSOCIATED
CANINE INFECTIOUS ENDOCARDITIS IN BANGKOK,
THAILAND. S Surachetpong1, S Assarasakorn1, AV Scorza2,
MM Brewer2, KW Simpson3, MRLappin2. 1Department of
Veterinary Medicine, Faculty of Veterinary Science,
Chulalongkorn University, Bangkok, Thailand, 2Department of
Clinical Sciences, Colorado State University, Fort Collins, CO,
3Department of Clinical Sciences, College of Veterinary
Medicine, Cornell University, Ithaca, NY
Infectious endocarditis (IF) is a heart valve or endocardial dis-
ease caused by bacterial infection. Bartonella spp. is considered
one of the major causes of IF. Stray dogs in Thailand were
found seropositive to Bartonella spp. The prevalence of Bartonella
spp. associated canine IF in Thailand has not been investigated.
The prevalence of IF was studied by the necropsy reports of
dogs, from January 1999 to December 2009. The cardiac paraﬃn
embedded tissue blocks were used to study the presence of Barto-
nella spp. by ﬂuorescence in situ hybridization (FISH) and con-
ventional polymerase chain reaction (PCR).
A review of 3545 dogs demonstrated 23 cases of IF, yielding a
prevalence rate of 0.65%. Paraﬃn blocks from 11 dogs were
retrieved. Two of 11 dogs were positive to eubacteria by FISH.
None of these dogs was positive for Bartonella spp. by FISH and
conventional PCR.
The prevalence of canine IF is low. Bartonella spp. was not
detected in the dogs tested in this study. Other types of bacteria
should be considered as the cause of IF in Thailand.
ABSTRACT ID-21
PREVALENCE OF SELECTED INFECTIOUS DISEASES IN
SAMOAN DOGS. RJ Carslake1, KE Hill1, K Sjo¨lander2,
D Prattley1, E Acke1. 1Institute of Veterinary and Biomedical
Sciences, Massey University, Palmerston North, New Zealand,
2Faculty of Veterinary and Animal Sciences, Swedish University
of Agricultural Sciences, Uppsala, Sweden
Samoa has a tropical island climate ideally suited to many
infectious diseases, and vectors for some infectious diseases are
known to be present. Dogs are very common pets in Samoa with
88% of households owning an average of two dogs, which live in
direct contact with their owners and the wider village community.
These dogs also come into close proximity to a substantial tourist
population visiting this holiday destination. Many canine infec-
tious diseases are zoonotic and there is limited preventative medi-
cine available for dogs in Samoa. There are very few studies into
the presence of zoonotic pathogens in Samoa or other South
Paciﬁc islands, and the role of dogs as a reservoir for zoonotic
diseases is unknown.
The prevalence of selected infectious diseases was evaluated in
242 dogs undergoing surgical sterilisation in Samoa in July 2010
and August 2011. Dogs were selected from both main Samoan
islands, in rural and urban areas. Data were obtained from dogs’
owners by interview, including age, environment and any previous
preventative medication. Serum and fecal samples were collected,
and the skin examined for external parasites. Seroprevalence of
ﬁve vector-borne diseases were assessed in 237 dogs using point of
care qualitative ELISA assays (SNAP Leishmania and SNAP
4Dx, IDEXX, Westbrook, ME) to detect antibodies against
Leishmania infantum, Anaplasma phagocytophilum, Ehrlichia canis
and Borrelia burgdorferi, and Diroﬁlaria immitis antigens. Fecal
analysis was performed by ﬂotation testing on fresh fecal samples
from 204 dogs to screen for intestinal parasites. Forty-eight fecal
samples were tested for Giardia and Cryptosporidium spp.
The median age of dogs enrolled was one year, with a range of
four months to eight years and 73.3% (176/240) were male. The
vast majority of dogs, 95% (230/242), were owned, the remaining
were stray animals. The seroprevalence of D. immitis was 46.8%
(111/237) and A. phagocytophilum prevalence was 8.4% (20/327).
All serum samples tested negative for E. canis, B. burgdorferi and
L. infantum. Prevalence of hookworm was 92.6% (185/204), Trichu-
ris vulpis 6.9% (14/204), Dipylidium caninum 4.4% (9/204), Toxo-
cara canis 3.4% (7/204) and Capillaria spp. 2.0% (4/204).
Prevalence of Giardia spp. was 14.6% (7/48) while no Cryptospori-
dium was detected. Examination for external parasites was com-
pleted in 221 dogs. Fleas were found on 83.7% of the dogs (185/
221), ticks on 42.1% (93/221) and lice on 8.1% (18/221). Identiﬁed
ticks were Rhipicephalus sanguineus, with no Ixodes spp. found.
The results indicate a very high prevalence of hookworm, D.
immitis, and external parasites in dogs in Samoa. This study pro-
vides valuable information on canine health and suggests dogs
could play a role in the spread of some zoonoses in Samoa. Fur-
ther studies are required to review the public health implications
of this study.
ABSTRACT ID-22
MOLECULAR EPIDEMIOLOGY AND ANTIFUNGAL SUS-
CEPTIBILITY AMONG CRYPTOCOCCUS ISOLATES
FROM NORTH AMERICAN DOGS AND CATS.. LM Singer1,
W Meyer2, GR Thompson3, E Samitz4, JE Sykes5. 1Small
Animal Clinical Sciences, Michigan State University College of
Veterinary Medicine, East Lansing, MI, 2Molecular Mycology
Research Laboratory, The University of Sydney at Westmead
Hospital, Westmead, NSW, Australia, 3Department of Medical
Microbiology, University of California, Davis, 4Veterinary
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Medical Teaching Hospital, University of California, Davis,
5Department of Medicine & Epidemiology, University of
California, Davis, CA
Cryptococcosis is caused by Cryptococcus neoformans and
Cryptococcus gattii. Eight molecular types have been described
(VNI-VNIV for C. neoformans and VGI-VGIV for C. gattii).
The objective of this study was to examine correlations between
species, molecular type and antifungal drug susceptibility among
canine and feline isolates from North America.
Cryptococcal isolates from dogs and cats from 2004 to 2011
were typed using restriction fragment polymorphism analysis
and/or multilocus sequence typing. Susceptibilities to amphoteri-
cin B, ﬂuconazole, itraconazole, 5-ﬂucytosine, voriconazole, and
posaconazole were determined using the Sensititre YeastOne®
microdilution susceptibility test. The unpaired t-test and F-test
were used to compare minimum inhibitory concentrations (MICs)
between groups.
Fifteen canine and 27 feline isolates were examined. Most
were from California (34); 3 were from Washington and Ore-
gon. Molecular types were VGI (3), VGIIa (3), VGIIb (1),
VGIIc (2), VGIII (16), VGIV (2), VNI (14) and VNII (1). All
VGIII isolates were from cats in CA, AZ, and NV. The most
common type in dogs was VNI (9 dogs). Flucytosine and
amphotericin MICs were lower among C. gattii than C. neofor-
mans isolates. For all drugs except itraconazole, C. gattii exhib-
ited wider variation in MICs than C. neoformans isolates.
VGIII MICs were not diﬀerent to non-VGIII MICs. VGIII iso-
lates exhibited wider variation in ﬂuconazole and ﬂucytosine
MICs than non-VGIII isolates.
In conclusion, diﬀerences in drug susceptibility exist between
C. gattii and C. neoformans isolates and molecular types from
dogs and cats in North America. The clinical signiﬁcance of these
ﬁndings requires further investigation.
ABSTRACT ID-23
DEVELOPMENT OF AN INDIRECT ENZYME-LINKED
IMMUNOSORBENT ASSAY FOR THE DETECTION OF
FELINE ANTIBODIES AGAINST MYCOPLASMA FELIS.
KT Wiggans, JR Hawley, MR Lappin. Department of Clinical
Sciences, Colorado State University, Fort Collins, CO
Mycoplasma spp. are normal commensal organisms of the
feline conjunctiva, genital tract and upper respiratory tract but
also have been implicated in upper respiratory tract disease
(URTD), lower respiratory tract disease, conjunctivitis and
arthritis. Current detection methods for Mycoplasma include cul-
ture and polymerase chain reaction (PCR), both of which require
specialized staﬀ and facilities. Serology can be performed with
minimal equipment and may be adapted for use at the point-of-
care. The purpose of this study was to develop an indirect
enzyme-linked immunosorbent assay (ELISA) for detection of
antibodies against M. felis.
A checkerboard titration was performed to determine the opti-
mal IgG ELISA conditions using M. felis antigen produced from
an isolate grown from a shelter cat with URTD. Sera from spe-
ciﬁc pathogen-free (SPF) cats (n = 6) prior to and after (10 days,
6 months and 12 months) exposure to M. felis and shelter cats (n
= 52) with and without signs of URTD were tested in the
ELISA. PCR assay for M. felis DNA was performed on conjunc-
tival cells collected on swabs from the shelter cats. Potential for
M. felis antibody cross-reactivity was tested by creating an IgG
ELISA using Ureaplasma sp. antigen produced from an isolate
grown from a shelter cat with URTD and used under the same
ELISA conditions as the M. felis assay.
The precision of the optimized M. felis ELISA was estimated
at approximately 5% by calculating the coeﬃcients of variation
for negative and positive absorbance values on 3 plates run on 3
separate days. When the same M. felis positive and negative sera
were evaluated parallel in the M. felis and Urealplasma sp. IgG
ELISAs, the percentage agreement was 92.3% suggesting a high
degree of cross-reactivity between the antigen preparations. In
the SPF cats, M. felis IgG absorbance values were signiﬁcantly
greater than pre-exposure absorbance values 10 days (P < 0.001)
and 6 months (P < 0.001) post-exposure, but not 12 months (P
= 0.098) suggesting that M. felis antibody titers may wane over
time. Shelter cats with signs of URTD had signiﬁcantly higher (P
< 0.001) M. felis IgG absorbance values than healthy cats, but
the percent agreement with PCR results was only 36.5%. Using
the PCR assay results as the gold standard for infection, the
speciﬁcity, sensitivity, positive predictive value and negative pre-
dictive value of the M. felis ELISA were 19.5%, 100%, 25% and
100%, respectively.
Cats experience a rapid and prolonged elevation in M. felis
IgG antibodies following exposure to M. felis. Detection of M.
felis IgG may prove to be a useful epidemiological tool for study
of cats with URTD but appear to cross-react with other Molli-
cute species. While negative test results in cats with URTD can
be used to exclude the diagnosis, positive test results do not accu-
rately predict current infection.
ABSTRACT ID-24
DETECTION OF FELINE ANTIBODIES AGAINST A
NOVEL ANAPLASMA PHAGOCYTOPHILUM PEPTIDE
(AP-4) AFTER EXPOSURE TO WILD-CAUGHT ADULT IX-
ODES SCAPULARIS. MR Lappin1, R Chandrashekar2, B
Stillman2, J Liu2. 1Department of Clinical Sciences, Colorado
State University, Ft. Collins, CO, 2IDEXX Laboratories,
Portland ME
Cats that are exposed to Anaplasma phagocytophilum (AP)
infected Ixodes scapularis ticks develop serum antibody responses
to an immunodominant peptide (P44) used in a commercially
available assay that is licensed for use with canine serum. The
purpose of this study was to evaluate feline antibody responses
to a novel AP peptide (AP-4) as a method for evaluating for
early evidence of AP infection in cats.
Young, adult, mixed sex research cats (n = 4) were used in
this pilot study with IACUC approval. Each of the cats was
shown to be negative for antibodies against AP using a commer-
cially available kit (SNAP® 4Dx®, IDEXX Laboratories) and
negative for AP DNA in blood by use of a commercially avail-
able conventional PCR assay (Veterinary Diagnostic Laboratory,
Colorado State University). Using the pre-inoculation samples,
an ELISA for detection of antibodies against the AP-4 was opti-
mized. Cats were infected with AP by exposure to wild-caught
Ixodes scapularis. Blood for AP PCR assay and for serum sepa-
ration for assessment for AP antibodies by SNAP® 4Dx® and
AP-4 ELISA were collected prior to tick attachment and then on
weeks 1 - 10 after tick attachment.
Each cat had AP DNA ampliﬁed from blood and each cat
developed detectable AP antibodies in serum by both assays.
Antibodies against AP were detected prior to those detected by
the commercially available kit for 3 of 4 cats.
Cat A. phagocytophilum DNA SNAP® 4Dx® AP-4 ELISA
1 Weeks 2 - 5; 8 – 10 Weeks 6 – 13 Weeks 6 - 10
2 Weeks 2 - 6, 8 - 10 Weeks 5 – 13 Weeks 2 – 10
3 Weeks 2 – 5 Weeks 5 – 13 Weeks 3 – 10
4 Weeks 2, 3, 6 Weeks 5 – 13 Weeks 3 - 10
The results suggest that antibodies against the AP-4 peptide
may be useful for the early detection of AP exposure in cats and
that further studies from samples collected from naturally
exposed cats should be performed.
ABSTRACT ID-25
DETECTION OF CANINE SERUM ANTIBODIES AGAINST
A NOVEL MUTANT PEPTIDE OF ANAPLASMA PHAGO-
CYTOPHILUM. S Moroﬀ1, I Sokolchik1, T Woodring1,
C Woodruﬀ1, B Atkinson1, M Lappin2. 1Antech Diagnostics,
Lake Success, NY, 2Department of Clinical Sciences, Colorado
State University, Ft. Collins, Colorado
Anaplasma phagocytophilum (AP) is the cause of granulocytic
anaplasmosis in a variety of species including dogs. The purpose
of this study was to validate a new automated system to detect
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antibodies against AP using a novel mutant peptide of the organ-
ism.
Mixed sex beagles were inoculated with culture derived AP IV
with serum and blood collected prior to inoculation, twice weekly
for 4 weeks, and then weekly for an additional 4 weeks to provide
samples for assay development. To assess the optimized assay using
ﬁeld-like conditions, adult Ixodes scapularis (average AP PCR posi-
tive rate = 15%) wild-caught in Rhode Island were allowed to feed
on 18 mixed sex beagles for 7 days (13 female and 12 male per
dog). Serum and blood in EDTA were collected prior to tick
attachment and then weekly for 16 weeks. The AP mutant peptide
was used as the capture reagent in a proprietary automated ﬂuores-
cence system that is based on a silicon wafer. Titrations were per-
formed to determine the optimal concentrations of the peptide,
buﬀers, serum dilutions, and secondary antibody concentrations
using samples from IV inoculated dogs. After the assay was opti-
mized, sera from the dogs exposed to wild caught I. scapularis were
assayed. The sera were also assayed for AP antibodies by IFA
(Prototek Reference Laboratory, Chandler AZ) and a commercially
available kit (SNAP®4DX; IDEXX Laboratories, Portland ME).
In addition, a proprietary PCR assay (Antech Diagnostics, Lake
Success, NY) was used to attempt to amplify AP DNA from blood
from the tick exposed dogs.
The precision of the AP mutant peptide based assay based on
determining the coeﬃcient of variation of 20 positive samples
assayed 4 times on diﬀerent days was approximately 13%. Over-
all, 10 I. scapularis exposed dogs became PCR or IFA positive
(Table 1). The time to ﬁrst positive result for these 10 dogs var-
ied by the assay but was statistically diﬀerent amongst groups on
week 3 when more samples were PCR positive than positive in
any of the antibody assays.
Results of the 3 AP antibody tests were similar. Performance
of AP PCR assays is indicated in dogs with suspected acute ana-
plasmosis if antibody assays are negative.
ABSTRACT ID-26
VACCINE-ASSOCIATED LEPTOSPIRA ANTIBODY
RESPONSES IN CLIENT-OWNED DOGS. KT Wiggans1,
LER Martin1, K Curtis2, R Chandrashekar2, MR Lappin1.
1Colorado State University, Fort Collins, CO;, 2IDEXX
Laboratories, Portland ME
Antibody testing by microscopic agglutination test (MAT) is
commonly used to aid in the diagnosis of canine leptospirosis.
Leptospira vaccines are commonly administered to lessen illness
associated with infection but induce antibodies that cannot be
distinguished from those induced by natural infection. In addi-
tion, while multiple 4 serovar vaccines are now available in the
United States, MAT responses after vaccination of client-owned
dogs have not been widely reported. The purpose of this study
was to determine the antibody responses of client-owned dogs
vaccinated with 1 of 4 commercially-available 4-serovar Lepto-
spira vaccines.
Healthy, client-owned dogs (n = 32) with no history of Lepto-
spira vaccination for at least 1 year were enrolled. Dogs were
randomly assigned to be administered 1 of 4 vaccines containing
the Canicola, Grippotyphosa, Icterohemorrhagiae, and Pomona
serovars with a booster vaccine 3 weeks later. Sera were collected
prior to vaccination, week 3, and week 7. MAT titers against ser-
ovars Bratislava (B), Canicola (C), Grippotyphosa (G), Hardjo
(H), Icterohemorrhagiae (I), and Pomona (P) were determined at
Colorado State University.
One dog was positive for one serovar (1:200; I) prior to vac-
cination. Percentages of dogs developing a MAT titer of >
1:100 varied between the weeks and amongst the vaccines
(Table 1).
MAT titers > 1:800 were detected for at least one serovar for
19 dogs (59.4%) on Week 3 and 20 dogs (62.5%) on Week 7.
MAT titers as high as 1:6,400 were detected and 28 of 32 dogs
developed at least one MAT titer >1:1,600. The most common
serovars with MAT titers > 1:800 after vaccination (Weeks 3
and 7 combined) varied amongst the vaccines, but were most
commonly associated with C (31 samples), G (14 samples), P (13
samples), and I (10 samples).
Leptospire MAT titers after vaccination vary amongst client-
owned dogs, the weeks after vaccination, and the vaccine prod-
uct. MAT titers > 1:800 will not always correlate to the pres-
ence of clinical leptospirosis if vaccines were recently
administered.
ABSTRACT ID-27
FELINE LEPTOSPIROSIS: A SEROLOGIC AND URINARY
PCR SURVEY IN HEALTHY CATS AND IN CATS WITH
KIDNEY DISEASE. J Rodriguez, M-C Blais, C Lapointe,
L Carioto, J Harel. Faculte´ de me´decine ve´te´rinaire, Universite´
de Montre´al, St-Hyacinthe, Que´bec, Canada
Leptospirosis is a globally widespread zoonosis, with preva-
lence in cats varying from 8.8% to 35% depending on geographi-
cal localization. Although serologic evidence of feline exposure
exists, clinical disease is rarely reported.
This study aimed to compare seropositivity and urinary PCR
status for Leptospira spp. between healthy (H) and cats with kid-
Table 1. % positive test results for 10 I. scapularis exposed dogs over time after tick placement.
Assay/
Week 0 1 2 3 4 5 6 7 8 10 12 14 16
PCR 0 20 60 70 70 80 50 40 50 30 40 30 30
AP Peptide 0 0 10 10 70 90 90 90 90 90 70 70 60
IFA 0 0 20 30 60 90 90 90 100 90 90 90 90
SNAP 0 0 0 10 50 60 100 100 100 90 90 90 90
Table 1. Vaccine.
% Positive MAT Results – Week 3 % Positive MAT Results – Week 7
Neg B C G H I P Neg B C G H I P
1 0 25 63 38 0 63 100 13 0 63 38 13 75 50
2 0 75 63 50 0 100 75 0 38 38 75 13 88 50
3 13 38 63 88 13 75 88 0 0 100 75 0 88 63
4 13 38 75 75 0 63 63 13 13 88 63 0 38 38
Vaccine 1 = Leptovax 4 (Boehringer-Ingelheim); Vaccine 2 = Nobivac Lepto4 (Intervet Schering-Plough); Vaccine 3 = Recombitek 4 (Merial); Vaccine
3 = Vanguard L4 (Pﬁzer Animal Health).
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ney disease (KD; acute and chronic KD IRIS stages II, III and
IV).
Cats (n=240) enrolled from January 2010 to December 2011
were aged-matched into two groups: H (n=121) and KD
(n=119). A complete blood count, biochemistry proﬁle, urinaly-
sis, Leptospira spp. serology (titers  1:100 considered positive)
and PCR were performed in all cats.
Seropositivity for Leptospira spp. was not statistically diﬀerent
between groups: 7.5% (n=9) and 13.2% (n=15) in the H and
KD, respectively (p=0.20). Serovars implicated were L. pomona
(n=14), L. bratislava (n=9) and L. grippotyphosa (n=1), with
titers signiﬁcantly higher for L. pomona (p=0.04). Of the 24 sero-
positive cats, only one (H) was PCR positive. Similarly, no statis-
tical diﬀerence was found in the PCR status between groups
(H=1, KD=5; (p=0.11)).
Sex did not inﬂuence serologic or PCR status. Seropositivity
was greater in older cats ( 10 years; p=0.008), during summer
(p =0.005), and was more prevalent in healthy outdoor cats
(p=0.01) living in urban areas (p=0.01) and in known hunters
(p=0.007).
No signiﬁcant diﬀerence was found in the serologic and PCR
leptospirosis status between H and KD cats, suggesting that they
are good sentinels for leptospirosis monitoring and that renal col-
onization occurs, thereby creating a renal carrier.
ABSTRACT ID-28
ISOLATION AND CHARACTERIZATION OF LEPTOSPIRA
INTERROGANS SEROVAR COPENHAGENI AND SER-
OVAR CANICOLA FROM DOGS WITH LEPTOSPIROSIS.
AMA Rodrigues1, MK Hagiwara1, ZM Moraes1, GO Souza1,
AP Gonc¸ales1, AQ Silva2, SA Vasconcellos2. 1School of
Veterinary Medicine and Zootechny – University of Sa˜o Paulo,
Sa˜o Paulo, SP, Brazil, 2CPQGM-FIOCRUZ, Salvador, Ba,
Brazil
Leptospira interrogans serovar icterohaemorrhagiae and ser-
ovar canicola are the most common serovars associated to lepto-
spiral infection in dogs worldwide. In Brazil, serovar
copenhageni is found more frequently as the etiological agent in
both human and canine infection. Aiming to conﬁrm the clinical
diagnosis of leptospirosis, serum samples of 29 dogs presented
with history and clinical syndromes associated to leptospiral
infection (contact to rats, jaundice and/or acute renal failure)
were submitted to microagglutination test (MAT) for anti-lepto-
spiral antibodies. Additionally, urine samples were obtained by
cystocentesis and cultured in Fletcher medium at 28-30°C for up
to two months, in an attempt to isolate the leptospira involved.
For antigenic and molecular characterization of the isolates,
MAT with policlonal and monoclonal antibodies and VNTR-
PCR were performed.
The serum MAT yielded negative results for six dogs; seven
dogs reacted to one serovar and sixteen dogs reacted to two or
more serovars, with antibody titers ranging from 100 to 3,200.
At presentation, only eight (27.5 %) dogs had antibody titer 
800. Paired serum samples obtained from 11 dogs revealed 4-fold
increasing titers or seroconversion in ﬁve dogs, supporting a
recent infection. Isolation attempts were successfully made in
four dogs. Two of the isolates were inoculated in hamsters and
re-isolated. Using speciﬁc anti-serum the isolates were identiﬁed
as serovar copenhageni (sample A, titer 51,200) and canicola
(samples B, C, titer 3,200). Sample A was identiﬁed as serogroup
icterohaemorrhagiae when submitted to VNTR-PCR and the
remaining samples as serovar canicola. Both serovar copenhageni
and serovar icterohaemorrhagiae belong to the same serogroup
icterohaemorrhagiae, and share the same molecular characteris-
tics, therefore they could not be identiﬁed based on VNTR-PCR.
The deﬁnitive identiﬁcation was made by cross-reaction with spe-
ciﬁc monoclonal antibodies for each serovar (F70 C24, F70 C14-
10, F12 C3-11 and F89 C12), which allowed the diﬀerentiation of
both representatives of serogroup icterohaemorrhagiae. The iso-
late A showed immunological identity to serovar copenhageni
(standard strain LI 130, FIOCRUZ – Bahia). Because of the
poor ability of MAT to predict the serogroup or serovar of le-
ptospira involved, the identiﬁcation of infecting serovar should
be based on the isolation of leptospiras from urine of dogs with
clinical suspicion of leptospirosis.
ABSTRACT ID-29
NON-RIBOSOMAL GENE PHYLOGENY OF HEMOPLAS-
MAS AND OTHER MYCOPLASMA SPECIES. EN Barker,
CA Hicks, IR Peters, CR Helps, S Tasker. School of Veterinary
Sciences, University of Bristol, Langford, UK
Hemoplasmas are blood-borne bacteria that have been
detected in many mammalian species, including cats and dogs.
Previous phylogenetic analyses of the hemoplasmas have been
based on 16S rDNA and ribonuclease P ribosomal gene (rnpB)
data, or limited to the heat shock protein 70 gene (dnaK) of a
couple of hemoplasma species. The aim of this study was to
amplify and sequence fragments of the glyceraldehyde-3-phos-
phate dehydrogenase gene (gapA) and dnaK of a large number of
hemoplasmas and Mycoplasma fastidiosum to use in phylogeny
for the ﬁrst time, and compare this to previously reported phy-
logeny.
DNA was puriﬁed from hemoplasma-positive blood and a
freeze-dried ampoule of type-speciﬁc M. fastidiosum. GapA and
dnaK sequences for available hemoplasmas, and selected other
Mycoplasma species, were obtained from GenBank. Primers were
designed to regions of hemoplasma gapA and dnaK using Pri-
mer3 and were used in polymerase chain reaction assays on the
puriﬁed DNA to amplify gene fragments, which then underwent
sequencing. Sequences were aligned using ClustalW run in Mac-
Vector v12. Phylogenetic trees were constructed for both gapA
and dnaK.
GapA fragments (length range; 551-902bp) from 7 hemoplasma
species (Mycoplasma haemocanis, Mycoplasma haemomuris, ‘Can-
didatus Mycoplasma haemohominis’, Mycoplasma coccoides,
‘Candidatus Mycoplasma haemolamae’, ‘Candidatus Mycoplasma
haematoparvum’ and ‘Candidatus Mycoplasma kahaneii’) and M.
fastidiosum were obtained. DnaK fragments (length range; 908-
1710bp) from 5 hemoplasma species (M. haemocanis, M. hae-
momuris, ‘Ca. M. haemolamae’, ‘Ca. M. haemohominis’, and
‘Ca. M. kahaneii’) were obtained. GapA and dnaK-based phylog-
eny showed that all hemoplasma species resided within a single
clade, and that the hemoplasmas were further subdivided into
two distinct groups, the haemofelis and haemominutum groups,
as found previously with 16S rDNA- and rnpB-based phylogeny.
Mycoplasma haemofelis and M. haemocanis, present within a sin-
gle clade on 16S rDNA-based phylogeny, were in separate clades
on both gapA- and dnaK-based phylogeny, conﬁrming the previ-
ous rnpB-based phylogeny. Additionally, the gapA-based phylog-
eny did not cluster the hemoplasmas with members of the
pneumoniae group of Mycoplasma species, including M. fastidio-
sum, which agrees with the rnpB phylogeny but contrasts to 16S
rDNA- and dnaK-based phylogeny.
These results support previous work documenting the position
of hemoplasma species within a single clade distinct from other
members of the genus Mycoplasma, but more work is necessary
to establish the relationships between the hemoplasma clade and
other members of the genus Mycoplasma. It also indicates that
gapA- and dnaK-based phylogeny may be useful in resolving rela-
tionships between highly related hemoplasmas.
ABSTRACT ID-30
FAILURE TO AMPLIFY BARTONELLA KOEHLERAE DNA
FROM BLOOD OF CATS AND THEIR FLEAS IN THE
UNITED STATES. MR Lappin1, R Maggi2, JR Hawley1,
EB Breitschwerdt2. 1Department of Clinical Sciences, Colorado
State University, Fort Collins, CO, 2Department of Clinical
Sciences, College of Veterinary Medicine, North Carolina State
University, Raleigh, NC
Bartonella koehlerae DNA has been ampliﬁed from approxi-
mately 1-3% of Ctenocephalides felis removed from cats in
France, Taiwan, and Thailand. In previous studies of cats and
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their ﬂeas in the United States, a PCR assay utilizing primers tar-
geting a portion of the 16S-23S rRNA intergenic region that
results in a diﬀerent amplicon size for each Bartonella spp. has
been used. Recently, it has been shown that in this PCR assay,
B. koehlerae and B. henselae DNA have the same amplicon size
which may lead to misidentiﬁcation of the species if genetic
sequencing is not performed.
Total DNA previously extracted from cats (n = 48 cats) and
their C. felis (n = 47 ﬂea groups [1 – 12 ﬂeas per group]) that
were positive for DNA of B. henselae, B. clarridgeiae, or both in
the 16S-23S intergenic region Bartonella spp. PCR assay were
selected. The DNA had been stored at - 80°C until used in this
study. A conventional PCR assay with primers designed to
amplify only the DNA of B. koehlerae was optimized (sensitivity
= 1.5-2 bacteria/µl DNA) and applied to the DNA extracts.
Forward primer 5’ CTTCTAAAATATCGCTTCTAAAAATT
GGCATGC 3’
Reverse primer 5’ GCCTTTTTTGGTGACAAGCACTTTTC
TTAAG 3’
Based on the 16S-23S intergenic region Bartonella spp. PCR
assay results, DNA of B. henselae (26 cat samples; 6 ﬂea groups),
B. clarridgeiae (15 cat samples; 16 ﬂea groups), or both (7 cat
samples; 25 ﬂea groups) were ampliﬁed from the samples. When
the B. koehlerae speciﬁc PCR assay was applied to the sample
set, DNA of the organism was not ampliﬁed from any of the
samples.
While B. koehlerae DNA was not ampliﬁed from this sample
set, the prevalence rates in other studies of C. felis was < 3%.
Thus, the negative ﬁndings could merely relate to the sample size.
However, the results suggest that B. henselae and B. clarridgeiae
are the most common Bartonella spp. of cats and C. felis in the
United States. If the 16S-23S intergenic region Bartonella spp.
PCR assay is used, amplicons consistent with B. henselae/B. koe-
hlerae should be sequenced.
ABSTRACT ID-31
A FLEA AND TICK COLLAR CONTAINING 10% IMIDA-
CLOPRID AND 4.5% FLUMETHRIN PREVENTS FLEA
TRANSMISSION OF BARTONELLA HENSELAE IN CATS
FOR 8 MONTHS. MR Lappin1, D Stanneck2. 1Colorado State
University, Department of Clinical Sciences, Fort Collins, CO,
Bayer Animal Health GmbH, Leverkusen, Germany.
Bartonella henselae is transmitted amongst cats by Ctenocepha-
lides felis and is associated with multiple clinical syndromes in
cats and people. In a previous study, monthly administration of
10% imidacloprid was shown to block transmission of B. hense-
lae amongst cats experimentally exposed to infected C. felis. The
purpose of this study was to determine whether application of a
ﬂea and tick collar containing 10% imidacloprid and 4.5% ﬂu-
methrin would lessen C. felis transmission of B. henselae amongst
cats over an 8 month study period.
Speciﬁc pathogen free cats (n = 19) were housed in three
adjoining enclosures that were separated by mesh to allow C. fel-
is to pass among groups yet prevent cats from contacting one
another. One group of 4 cats was inoculated intravenously with
B. henselae and after infection was conﬁrmed in all cats based on
positive polymerase chain reaction (PCR) assay results, the cats
were housed in the middle enclosure. The B. henselae infected cat
group was ﬂanked by a group of 8 cats that had the collar placed
and maintained for the duration of the study and a group of 7
cats that was not treated. Ctenocephalides felis (50 males and 50
females) raised in an insectary were placed on each of the 4 cats
in the B. henselae infected group monthly for 7 applications and
then every 2 weeks for 4 applications starting the day the collar
was applied. Blood was collected from all cats weekly for Barto-
nella spp. PCR, serology and culture.
While side-eﬀects associated with the collars were not noted,
persistent fever necessitating enroﬂoxacin therapy occurred in
one untreated cat. While B. henselae infection was ultimately con-
ﬁrmed in 4 of 7 of the untreated cats, none of the cats with col-
lars became infected (P = 0.026).
In this setting, use of a collar containing 10% imidacloprid
and 4.5% ﬂumethrin was well tolerated and prevented C. felis
transmission of B. henselae amongst cats.
ABSTRACT ID-32
CLASSIFICATION OF BORRELIA BURGDORFERI INFEC-
TION USING RESULTS OF 5 ANTIBODY TARGETS IN AN
AUTOMATED SYSTEM. S Moroﬀ1, I Sokolchik1,
T Woodring1, C Woodruﬀ, B Atkinson1, M Lappin2. 1Antech
Diagnostics, Lake Success, NY, 2Department of Clinical
Sciences, Colorado State University, Ft. Collins, Colorado
The purpose of this study was to validate a proprietary auto-
mated ﬂuorescence system (Accuplex4TM) that allows for simulta-
neous detection of 5 distinct serum antibodies against Bb in
canine serum and diﬀerentiation of natural infection from vacci-
nation and acute from chronic infection.
The Bb markers used in the Accuplex4TM included OspA,
OspC, OspF, P39 and SLP. Multiple titrations with sera from
naturally exposed or vaccinated dogs were performed to deter-
mine the optimal concentrations of the markers, buﬀers, serum
dilutions, and secondary antibody concentrations. After the assay
was optimized, sera from 36 mixed sex, young adult beagles that
were exposed to wild caught I. scapularis (average Bb PCR posi-
tive rate = 56%) before (18 dogs) or after vaccination (18 dogs;
6 dogs per vaccine group) with three vaccines (Merck Nobivac
Lyme; Pﬁzer LymeVax; Merial Recombitek Lyme) were assayed.
Sera was collected from vaccinated dogs on Weeks 0, 1, 2, 3, 4,
5, 6, 7, 8, 11, 17 and 24. Sera was collected weekly from all dogs
from weeks 24 through week 46. Results of Bb western blot im-
munoassays were also used in the development of proprietary
computer algorithms to classify Bb infections based on antibody
responses to the 5 targets.
Novibac Lyme induced positive Osp A, Osp C, and SLP
responses, LymeVax induced positive Osp A and SLP responses,
and Recombitek Lyme induced only Osp A responses. Vaccine
induced antibody responses could generally be detected 2 to 3
weeks after the ﬁrst vaccination. Of 18 dogs exposed to I. scapu-
laris prior to vaccination, 14 developed evidence of infection with
ﬁrst positive antibody assay results detected from 14 to 70 days
after tick attachment. Antibodies against Osp F were only
detected in unvaccinated dogs with chronic infections (> 7
weeks. When compared to western blot immunoassay, the Accu-
plex4TM detected antibodies for the ﬁrst time on the same sample
date (9 dogs), 1 week earlier (4 dogs) and 1 week later (1 dog).
Computer algorithm based evaluation of antibody response to
multiple targets provides classiﬁcations that can diﬀerentiate vac-
cinated dogs, those with acute infections, and those with chronic
infections and correlates closely with results of Western blot
immunoassay. However, antibody test results must be interpreted
in concert with clinical ﬁndings to diagnose clinical canine
borreliosis.
ABSTRACT ID-33
FELINE HISTOPLASMOSIS: FLUCONAZOLE THERAPY
AND IDENTIFICATION OF POTENTIAL RISK FACTORS.
JM Reinhart1, KS KuKanich1, T Jackson2, KR Harkin1.
1Kansas State University College of Veterinary Medicine,
Manhattan, KS, 2Pittsburgh Veterinary Specialty and Emergency
Center, Pittsburgh, PA
Feline histoplasmosis is a systemic fungal infection tradition-
ally treated with itraconazole, which can be cost prohibitive for
some clients. Additionally, although the clinical disease in cats
has been thoroughly documented, risk factors have yet to be
explored. The objectives of this study were to compare the out-
comes of cats with histoplasmosis treated with ﬂuconazole to
those treated with itraconazole and evaluate possible environ-
mental risk factors for aﬀected cats. Medical records from feline
patients with conﬁrmed histoplasmosis (n=32) at Kansas State
University were systematically reviewed, and follow-up was per-
formed by owner telephone interview.
One cat treated with ﬂuconazole (n=17) required a treatment
change as compared with ﬁve cats treated with itraconazole
(n=13). Two cats were not treated. Overall mortality rates of
cats treated with ﬂuconazole (29%) and itraconazole (38%) were
not signiﬁcantly diﬀerent (p=0.27). Rates of recrudescence were
also not signiﬁcantly diﬀerent (p=0.29) when comparing cats
treated with ﬂuconazole (24%) to those treated with itraconazole
(31%). At the authors’ institution, a one month supply of itraco-
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nazole for a 5-kg cat would cost $212.85 compared to $18.60 for
ﬂuconazole. Fluconazole is a viable, cost-eﬀective alternative
therapy for the treatment of feline histoplasmosis.
Forty-one percent of cats (12/29) represented in the follow-up
survey were housed strictly indoors. Commonly reported environ-
mental risk factors included exposure to indoor potted plants
(13/29) and unﬁnished basements (12/29). These ﬁndings diﬀer
from the traditionally held view that histoplasmosis is strictly a
disease of outdoor cats. Thus, other environmental risk factors
warrant critical investigation.
ABSTRACT ID-34
EVALUATION OF ENTEROCOCCUS FAECIUM SF68 SUP-
PLEMENTATION WITH METRONIDAZOLE FOR THE
TREATMENT OF NON-SPECIFIC DIARRHEA IN DOGS
HOUSED IN ANIMAL SHELTERS. A Fenimore, L Groshong,
V Scorza, MRLappin. Department of Clinical Sciences,
Colorado State University, Fort Collins, Colorado
Enterococcus faecium strain SF68 (FortiFlora, Nestle Purina
PetCare) supplementation was shown in a recent study of shelter
cats to lessen the incidence of non-speciﬁc diarrhea of > 2 days
duration when compared to placebo treated controls. SF68 is
known to be resistant to metronidazole which is commonly used
to treat shelter dogs with diarrhea. The purpose of this study was
to determine whether dogs with non-speciﬁc diarrhea adminis-
tered SF68 with metronidazole would have better clinical out-
comes than dogs administered metronidazole alone.
A physical examination and a standardized fecal score system
(7 = watery puddles; 6 = texture but no shape; 5 = moist
piles; 4 = moist log shape; 3 = normal) was applied to all
samples daily by a person masked to the treatment groups.
Stray dogs with diarrhea without vomiting, a fecal score of 
4, interest in food, and no clinical ﬁndings suggesting a foreign
body were included. All dogs were fed a standardized diet and
were administered metronidazole USP at 25 mg/kg, PO, twice
daily for 7 days. The treated dogs were randomized to be
administered SF68 (treatment) or a placebo mixed with their
food daily for 7 days. Feces collected prior to treatment were
analyzed by fecal ﬂotation as well as ﬂuorescent antibody assay
for Giardia cysts and Cryptosporidium spp. oocysts. Speed to
improvement was deﬁned as the ﬁrst day the score dropped 2
points from Day 0 or a fecal score of 4 was reached and sus-
tained for 2 days in a row.
A total of 48 dogs were entered into the study by the time of
abstract submission. Of these dogs, 33 dogs (16 treatment; 17
placebo) completed the study. Overall, 50% of the treatment
group and 29.4% of the placebo group had fecal scores < 3 by
day 7 (p > 0.05). However, speed to improvement was faster (p
= 0.036) for the treatment group (mean = 2.8 days) compared
to the placebo group (mean = 4.4 days). Both dogs with Giardia
in the treatment group had normal feces by Day 7 in contrast to
the controls where 3 of 7 dogs with Giardia had normal feces by
Day 7.
In these dogs, administration of SF68 resulted in a faster speed
to improvement than administration of metronidazole alone. A
larger number of Giardia infected dogs will be needed to deter-
mine if dual treatment is superior to metronidazole alone for the
treatment of this syndrome.
ABSTRACT ID-35
PREVALENCE OF AGENTS ASSOCIATED WITH CANINE
INFECTIOUS RESPIRATORY DISEASE SYNDROME IN
CLIENT-OWNED DOGS AND DOGS HOUSED IN SHEL-
TERS. C Karsten1, JR Hawley1, C Luttenegger2, MR Lappin1.
1Department of Clinical Sciences, Colorado State University, Ft.
Collins, Colorado; 2IDEXX Laboratories, Sacramento CA
Canine infectious respiratory disease syndrome (CIRDS) is a
common in dogs housed in high density housing such as board-
ing facilities, day care, and animal shelters. The primary agents
associated with this syndrome are Mycoplasma spp. (Myco),
Bordetella bronchiseptica (Bb), Streptococcus equi var. zooepi-
demicus (SZ), adenovirus 2 (A-2), canine distemper virus
(CDV), canine herpesvirus (CHV), parainﬂuenza (Para), canine
inﬂuenza virus (CIV), and respiratory coronavirus (RCV). The
purpose of this study was to use commercially available diag-
nostics to evaluate the prevalence of these agents in three
groups of dogs.
Community-sick dogs were animals presented to their veter-
inarians or boarding facility with clinical signs consistent with
CIRDS; shelter-sick dogs were animals that developed clinical
signs of CIRDS while in a large open admission animal shel-
ter; and shelter-healthy dogs were animals without clinical
signs in the same shelter. Nasal discharges or materials from
the caudal pharynx were collected onto 2 swabs with the
swab containing Amies media transported to Colorado State
University for Mycoplasma spp. culture and species determina-
tion. The other swab was transported to IDEXX Laboratories
for performance of a proprietary PCR panel that ampliﬁes
the DNA or RNA of the primary agents associated with
CIRDS.
CIV RNA (all dogs), SZ DNA (21 dogs), and H1N1 RNA
(human inﬂuenza; 42 dogs) were not ampliﬁed from any dog.
The distribution of results for other agents is listed in Table 1.
Shelter-sick dogs were more likely than community-sick dogs
to be positive for a Mycoplasma spp. (p = 0.002). Multiple
Mycoplasma spp. were grown but none were M. cynos. Coinfec-
tions with multiple agents were detected more frequently in shel-
ter-sick dogs than community-sick dogs (p = 0.03).
Currently available diagnostic assay results for dogs with sus-
pected CIRDS do not always correlate with clinical signs at the
time of testing. Mycoplasma spp. appear to be associated with
CIRDS in some dogs, but can be grown or ampliﬁed from
healthy and sick dogs and it is currently unclear which Myco-
plasma spp. are most likely to be pathogenic.
ABSTRACT ID-36
COMPARISON OF ELISA, CONVENTIONAL PCR, AND
QUANTITATIVE PCR FOR DETECTION OF CANINE PAR-
VOVIRUS. Y Nakayama, MR Lappin, JK Veir. Colorado State
University College of Veterinary Medicine and Biomedical
Sciences, Fort Collins, CO
A point-of-care antigen ELISA is currently the most com-
monly used diagnostic test for canine parvovirus (CPV-2). How-
ever, it has low sensitivity compared to PCR based assays. This
study compares the results of ELISA, conventional PCR (cPCR)
and quantitative real time PCR (qPCR) in detecting CPV-2 in
whole blood and feces of dogs suspected of being infected with
CPV-2.
A biased group of samples was obtained from 49 dogs exhibit-
ing clinical signs consistent with CPV-2 infection. DNA was
extracted from both fecal and EDTA blood samples for cPCR
and qPCR analyses. CPV-2 virus in the feces was also detected
by a commercially available antigen ELISA. For all samples, a
segment of the viral DNA was ampliﬁed and sequenced for geno-
typing.
Of the 49 fecal samples, 26 tested positive with ELISA. All of
these samples were determined by a previously published qPCR
assay to have a viral load of >105 viral particles/mg feces, the
limit of detection for this ELISA. Real time PCR of the match-
ing blood for these ELISA positive fecal samples showed that a
viral load of >105 virus/ul blood could be detected in most but
Table 1. Prevalence rates (%).
Myco Bb A-2 CDV CHV Para RCV
Community Sick (n
= 23)
43.5 13 4.3 0 0 0 4.3
Shelter Sick (n = 24) 87.5 25 25 8.3 4.2 4.2 25
Shelter Healthy (n =
10)
60 10 30 0 0 20 20
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not all cases (23/26). Conventional PCR detected CPV in the
blood and feces from all dogs with positive ELISA results.
Seventeen of the 23 fecal samples that tested negative with
ELISA were determined to have a viral load as determined by
qPCR less than the limit of detection of the ELISA assay. How-
ever, there were 6 ELISA negative fecal samples with viral loads
as determined by qPCR to be well above the limit of detection
for ELISA. When all samples were genotyped, and 2% of the
samples were CPV-2a, 50% CPV-2b, and 48% CPV-2c and dif-
ferences in genotypes did not account for the discrepancy
between qPCR and ELISA results seen above. Also, there were 6
samples that had positive results with both ELISA and cPCR,
that initially were not detected by qPCR. However, using diﬀer-
ent primers and probes targeting a more conserved region of the
CPV genome resulted in a high viral count as expected.
Overall, this study conﬁrms that qPCR and cPCR of fecal
samples are the most sensitive of the modalities presented. These
results also suggest that because CPV-2 is a rapidly evolving
virus, compatibility of existing diagnostic tests with current clini-
cal strains should be tested periodically.
ABSTRACT ID-37
PARVOVIRUS DNA COPY NUMBERS IN THE BLOOD OF
CATS WITH AND WITHOUT HISTOLOGICALLY CON-
FIRMED PANLEUKOPENIA. KP Polak, MR Lappin,
S Mcleland, JK Veir, JR Hawley. Department of Clinical
Sciences, Colorado State University, Fort Collins, CO
Use of real time polymerase chain reaction (qPCR) for quanti-
tative detection of FPV and CPV2 DNA in samples from cats
(qPCR-PV) has been shown to be both sensitive and speciﬁc over
a wide range of viral titers in cats with naturally occurring FPV.
Parvoviruses induce a viremia and so can be ampliﬁed from the
blood. The purpose of this study was to determine the range of
PV copies/µl blood in cats with suspected FPV infection with
and without histological evidence of infection.
Blood, jejunum and ileum samples were collected from 25 shel-
ter cats with clinical signs consistent with FPV after humane
euthanasia. The majority of cats were vaccinated with a paren-
teral modiﬁed live FPV, FHV-1, and FCV containing vaccine
upon intake to the shelter, prior to development of clinical signs.
Blood in EDTA was evaluated in a previously validated qPCR-
PV. Tissues were evaluated histopathologically after being stained
with hematoxylin and eosin. The tissues were examined by an
individual blinded to clinical history and qPCR-PV results. A
diagnosis of FPV was given if characteristic lesions were present
such as lymphoid depletion, intranuclear inclusions, villus blunt-
ing and fusion, or crypt necrosis, loss and abscessation.
In the 5 cats with histologically conﬁrmed FPV infection, 4
cats were positive in blood by qPCR-PV with the PV copies/µl
ranging from 0 – 89,333 (mean = 22,929; SD = 33,078). In the
20 cats with no histological evidence of FPV infection, PV cop-
ies/µl were < 3,000 in all cats with a range of 0 – 2,947 (mean
= 319; SD = 790). PV copies/µl were < 100 in 17 of 20 cats.
The use of qPCR-PV performed on blood of kittens suspected
to have FPV should be evaluated further for clinical utility by
comparing to other currently available assays.
ABSTRACT ID-38
TOXIN QUANTIFICATION OF CLOSTRIDIUM PERFRIN-
GENS IS A PREDICTOR FOR DIARRHEA IN DOGS AND
CATS. CM Leutenegger1, SL Marks2, J Robertson1. 1IDEXX
Laboratories, Inc., Sacramento CA, 2School of Veterinary
Medicine, University of California, Davis
Toxigenic Clostridium perfringens strains are believed to be
important contributors to gastrointestinal disease, and acute
hemorrhagic diarrhea has been well documented in association
with infection. Two toxins, the C. perfringens a-toxin and C. per-
fringens enterotoxin (CPE) are most frequently detected in dogs
and cats, although questions have been raised regarding their
toxigenic potential when detected in healthy animals. The objec-
tive of this work was to evaluate the relationship of toxin quanti-
ﬁcation with disease severity in diarrheic and apparently healthy
dogs.
A total of 181 healthy and diarrheic dogs and cats were
selected based on fecal scoring and analysis of clinical history.
Toxin DNA and RNA quantiﬁcation and toxin production were
measured with commercial real-time PCR tests (IDEXX Labora-
tories, Inc.) and a commercially available enterotoxin ELISA
(TechLab, Inc).
181 fecal specimens were evaluated, including, 48 from healthy
dogs, 39 from healthy cats and 46 from diarrheic and 48 from
diarrheic cats, respectively. When using a cutoﬀ value determined
by real-time PCR for toxin gene DNA quantiﬁcation, the a-toxin
gene was found to be signiﬁcantly associated with diarrhea: the
a-toxin gene was detected in 47.8% of diarrheic dogs vs. 4.2% of
healthy dogs (OR=25.2, p<0.0001), whereas the a-toxin gene
was detected in 37.5% of diarrheic cats vs. 12.8% of healthy cats
(OR 4.08, p=0.01). CPE was detected via ELISA in 19.6% of
diarrheic dogs vs 2.1% of healthy dogs (OR=11.43, p=0.007),
whereas CPE was detected in 8.3% of diarrheic cats vs. 0% of
healthy cats (OR=7.99, p=0.1). Quantiﬁcation of DNA from
both toxins in diarrheic and healthy animals was signiﬁcantly dif-
ferent in dogs and cats (Mann-Whitney test): a-toxin dogs:
p<0.001; a-toxin cats: p=0.0098; CPE dogs: p=0.02; CPE cats:
p<0.0001. All fecal specimens positive for toxin DNA were also
positive for toxin gene mRNA indicating active transcription of
the gene. This indicates that both the a-toxin gene and cpe are
actively transcribing and synthesizing toxin proteins in toxigenic
C. perfringens strains. The Pearson correlation between PCR and
ELISA indicated a weak positive r value of 0.59.
In conclusion, we found that quantitative toxin gene analysis
by real-time PCR for the a-toxin and CPE correlates with pres-
ence of diarrhea and has the potential to be used as a diagnostic
marker.
ABSTRACT ID-39
CANINE INFLUENZA VIRUS H3N8: A 4 YEAR REVIEW OF
SEASONAL PATTERNS, GEOGRAPHICAL FREQUENCY
DIFFERENCES AND AGE DISTRIBUTION. CM
Leutenegger1, M Estrada1, RD Armstrong2. 1IDEXX
Laboratories, Inc., Sacramento, CA, 2Merck Animal Health,
Summit, NJ
Canine inﬂuenza virus (CIV) H3N8 has been circulating in the
canine population of the United States since early 2000. Using
results from samples submitted by veterinarians, we analyzed epi-
demiological aspects of CIV occurrence between 2008 and 2011
including patterns in seasonal distribution, geographic occurrence
and age classes of positive dogs.
A total of 17,331 swab samples (conjunctival and pharyngeal)
submitted by veterinarians were analyzed over the 4 year period
using a panel of real-time PCR tests speciﬁc for nine respiratory
pathogens including CIV. A total of 311 CIV positive results
were recorded. The yearly CIV PCR test positive proportion was
2008 - 3.7%; 2009 - 1.2%; 2010 - 1.7%; 2011 - 1.4%. In general,
there was a seasonal distribution of positive results with peak
numbers during either the winter months (January through
March), or during summer to early fall (July - October). In 2008,
outbreaks occurred both during winter (14 cases from 1 state)
and summer (58 cases from 7 states). In 2009, a large outbreak
occurred between January and March (40 cases from 7 states)
and a second one between August and October (19 cases in 8
states). In 2010 two outbreaks were detected: one between April
and June (25 cases in 6 states) and September (6 cases in 1 state).
In 2011 three separate outbreaks were observed with a total of
28 cases in 6 states.
The main geographic locations with elevated case numbers
were : 2008 - Illinois and Colorado; 2009 - Colorado; 2010 -
North Eastern states; 2011- North Eastern states, Texas and Cal-
ifornia.. CIV positive cases were grouped into 4 age classes: < 6
months, 7-18 months, 19-84 months, and > 84 months. The
average age for H3N8 positive dogs was 40 months. Positive tests
were detected in all age classes, with the 19-84 month group
infected most frequently (36%). In contrast, canine distemper
virus PCR positive tests in our laboratory show an average age
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of 13 months with the youngest age class (< 6 months) most
likely to test positive.
These results highlight the dynamic situation of canine inﬂu-
enza virus H3N8 infections in the US dog population. Canine
inﬂuenza has a seasonal pattern, tends to occur as outbreaks
within a geographical area, and adult dogs (19 – 84 months) are
the main age class aﬀected.
ABSTRACT ID-40
THE EFFECTS OF MAROPITANT VERSUS ONDANSE-
TRON ON THE CLINICAL RECOVERY OF DOGS WITH
PARVOVIRAL GASTROENTERITIS. J Lenberg, L Sullivan,
P Boscan, T Hackett, D Twedt. Department of Clinical Sciences,
Colorado State University, Fort Collins, CO
Dogs aﬀected with parvoviral gastroenteritis often require par-
enteral antiemetic therapy to control vomiting, avoid dehydration
and enhance return of voluntary appetite. Maropitant acts cen-
trally at the neurokinin-1 receptor to inhibit vomiting and may
also provide visceral analgesia. The eﬃcacy of maropitant has
not been tested in dogs with parvovirus, but given its strong an-
tiemetic properties, maropitant may be superior in controlling
clinical signs when compared to traditional antiemetics. We
hypothesized that hospitalized dogs treated with maropitant
would demonstrate an improved clinical recovery and shorter
duration of hospitalization compared to dogs treated with ondan-
setron.
Twenty-two naturally infected dogs, not previously treated for
their disease, were included in the study following a positive snap
ELISA parvoviral test. All dogs were treated with intravenous
ﬂuids, cefoxitin, and enteral nutrition. Dogs were randomized to
receive either maropitant (1 mg/kg IV q24h, n=11) or ondanse-
tron (0.5 mg/kg IV q8h, n=11) as a primary antiemetic. Fre-
quency of vomiting and visceral pain/nausea scoring were
evaluated twice daily. Rescue analgesics and antiemetics were
administered as dictated by speciﬁc pain and nausea criteria.
Clinical severity scoring, body weight, and caloric intake were
monitored daily.
When comparing maropitant and ondansetron groups, there
was no statistical diﬀerence in: duration of hospitalization (3.36
+ 0.56 vs. 2.73 + 0.38 days, p=0.36), frequency of rescue antie-
metic use (3/11 vs. 5/11 dogs, p= 0.66), duration of vomiting (5
vs. 4 days, p=0.65), days to voluntary appetite (2 vs. 1.5 days,
p= 1.0), mean nausea score (27.9 + 6.3 vs. 22.7 + 5.9,
p=0.56), or mean CSU pain score (1.25 + 0.18 vs. 1.10 + 0.16,
p=0.87). Dogs treated with maropitant gained signiﬁcantly
(p=0.01) more weight during hospitalization (0.10 + 0.10 kg),
whereas dogs treated with ondansetron lost weight (-0.43 + 0.16
kg). Maropitant was administered intravenously in dogs > 9
weeks of age, consecutively for up to 6 days, without any noted
adverse eﬀects.
In dogs with parvoviral gastroenteritis, maropitant appears to
be equally as eﬀective in controlling clinical signs when compared
to ondansetron. Dogs treated with maropitant demonstrated
improved ability to maintain body weight during hospitalization.
ABSTRACT ID-42
IDENTIFICATION OF METHICILLIN-RESISTANT STAPH-
YLOCOCCUS AUREUS OF ANIMAL ORIGIN USING BAC-
TERIOPHAGE AMPLIFICATION AND A LATERAL-FLOW
IMMUNOASSAY. PS Morley1, D Bolte1, JD Rousseau2, D
Manna3, B Dreiling3, JS Weese2. 1Colorado State University,
Fort Collins, CO, 2University of Guelph, Guelph, ON,
3MicroPhage Inc., Longmont, CO
Methicillin-resistant S. aureus (MRSA) has emerged as an
important health hazard for animals. Rapid laboratory conﬁrma-
tion is essential for appropriate clinical management and to allow
appropriate control measures for minimizing nosocomial and
zoonotic transmission risks. Recently, bacteriophage ampliﬁca-
tion has been used as the basis for a commercial test designed to
rapidly identify MRSA in human clinical specimens. The purpose
of this study was to evaluate the ability of a similar prototype
test to identify animal-source MRSA and methicillin-susceptible
(MS) Staphylococcus aureus (SA) and to evaluate the test’s reac-
tivity with relevant non-SA staphylococcal isolates.
Bacteriophage speciﬁc for SA were included in 2 broth media
solutions, 1 that also contained cefoxitin to select for methicillin-
resistant (MR) bacterial strains. A variety of genetically charac-
terized staphylococcal isolates of animal origin were selected
from an archival bank, and standardized concentrations were
inoculated into the broth solutions. A lateral-ﬂow immunoassay
was used to detect phage that were ampliﬁed in overnight cul-
tures of broth solutions.
Thirty-six MRSA isolates belonging to 7 major genetic types
(USA 100, USA 200, USA 300, USA 500, USA 600, USA 700,
and CC398) were evaluated. Thirty-two MRSA were correctly
classiﬁed; 4/15 CC398 isolates were misclassiﬁed. Eleven of 15
MSSA isolates were correctly classiﬁed, as were 25 of 25 other
non-SA staphylococcal isolates (including MR S. pseudintermedi-
us, MS S. pseudintermedius, MR S. hyicus, MR S. schleiferi, and
coagulase-negative Staphylococcus spp).
This prototype rapid assay correctly classiﬁed a high propor-
tion of widely diverse MRSA, MSSA, and other non-SA staphy-
lococcal strains of animal-origin. However the failure to detect
some CC398 isolates might be problematic for some regions and
animal species. Modiﬁcation of the bacteriophage mixture may
help overcome this misidentiﬁcation and requires further study.
This inexpensive, rapid method has promise for practical applica-
tions requiring identiﬁcation of RSA colonization and infection
in animals.
ABSTRACT ID-43
PERFORMANCE OF THE NEW IN-CLINIC SNAP® 4DX®
PLUS TEST FOR THE DETECTION OF EHRLICHIA EWIN-
GII (GRANULOCYTIC EHRLICHIOSIS) AND ANAPLASMA
PLATYS (THROMBOCYTOTROPIC ANAPLASMOSIS)
ANTIBODIES IN DOGS. BA Stillman1, MJ Beall1, M Monn1, J
Liu1, B Thatcher1, P Shields1, B Andrews2,
SE Little3, M Eberts4, E Breitschwerdt5, R Chandrashekar1.
1IDEXX Laboratories, Westbrook, ME, 2Town and Country
Veterinary Clinic, Green Forest, AR, 3Oklahoma State
University, Stillwater, OK, 4Lakeland Veterinary Hospital,
Baxter, MN, 5College of Veterinary Medicine, North Carolina
State University, Raleigh, NC
The SNAP® 4Dx® Plus Test is an enzyme-linked immunosor-
bent assay (ELISA) for the simultaneous detection of canine
heartworm antigen and antibodies to Anaplasma phagocytophi-
lum, Anaplasma platys, Borrelia burgdorferi, Ehrlichia canis, and
Ehrlichia ewingii in canine serum, plasma or whole blood. The
heartworm antigen assay is a sandwich assay utilizing a monoclo-
nal and a polyclonal antibody as the capture and detection
reagents, respectively. The SNAP 4Dx Plus Test uses the same
reagents for E. canis, Anaplasma, and B. burgdorferi as in the
current SNAP® 4Dx® Test, but an E. ewingii synthetic peptide
derived from the major outer surface protein of E. ewingii has
been added. The Anaplasma analyte detects antibodies to both A.
phagocytophilum and A. platys. The SNAP 4Dx Plus Test was
evaluated using a total of 1,195 samples. Test results were com-
pared to conﬁrmatory tests performed on each of the samples, as
detailed in the Table below. To evaluate in-clinic performance, a
ﬁeld trial was conducted at four small animal veterinary practices
and two academic veterinary medical centers, located in geo-
graphic regions where the SNAP 4Dx Plus is expected to have
clinical utility. Results conﬁrmed that SNAP 4Dx Plus can iden-
tify dogs with exposure to as many as ﬁve diﬀerent tick-borne
rickettsial organisms.
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ABSTRACT ID-44
PREVALENCE OF SELECT VECTOR BORNE DISEASE
AGENTS IN OWNED DOGS OF GHANA. L Clarke1, LR
Ballweber1, K Allen2, S Little2, MRLappin1. 1Colorado State
University, Fort Collins, CO and, 2Oklahoma State University,
Stillwater, OK
While many dogs in West Africa are seen in clinics for evalua-
tion of clinical syndromes related to vector-borne diseases, such as
anemia, weakness, and lethargy, the resources for deﬁnitive diag-
nosis are not available. The purpose of this study was to evaluate
for evidence of vector borne infections in pet dogs in Ghana.
Ticks (n = 8), sera (n = 17), and blood samples in EDTA (n =
17) were collected from dogs evaluated in the Amakom Veterinary
Clinic in Kumasi, Ghana between Dec 2010 and Jan 2011. The
ticks were identiﬁed to the genus level by microscopy. Sera were
evaluated for Diroﬁlaria immitis antigen and antibodies against
Borrelia burgdorferi, Anaplasma phagocytophilum, and Ehrlichia
canis (SNAP®4DX, IDEXX Laboratories, Portland ME). Con-
ventional polymerase chain reaction assays designed to amplify the
DNA of Ehrlichia spp./Anaplasma spp./Neorickettsia spp./Wolba-
chia spp., Babesia spp., Rickettsia spp., Hepatozoon spp., Bartonel-
la spp. and the hemoplasmas were performed on DNA extracted
from EDTA blood. Positive amplicons were sequenced.
All of the ticks were Rhipicephalus spp. Overall, 8 of 17 dogs
(47%) were conﬁrmed by PCR and genetic sequencing to harbor
a vector borne agent (4 Hepatozoon canis; 2 E. canis; 1 A platys;
1 Wolbachia). In addition, 3 samples were positive for A. phago-
cytophilum antibodies, 2 samples were positive for E. canis anti-
bodies and 1 sample was positive for E. canis antibodies and D.
immitis antigen. Of the 3 dogs positive for E. canis antibodies, 2
were PCR positive and conﬁrmed by sequencing to be E. canis
and Wolbachia. One of the dogs that was PCR positive for E.
canis and the A. platys PCR positive dog were negative for anti-
bodies in the SNAP®4DX. The Wolbachia PCR positive dog was
also positive for D. immitis antigen in serum. Bartonella henselae
DNA was ampliﬁed from 2 ticks and Hepatozoon canis DNA
was ampliﬁed from 1 tick.
Vector borne diseases are common in this part of Ghana and
include H. canis, E. canis, D. immitis, and A. platys. Bartonella
henselae is generally considered to be vectored by Ctenocephalides
felis but has been ampliﬁed from both Ixodes and Rhipicephalus
ticks. Hepatozoon canis is known to be carried by Rhipicephalus
ticks and were the likely vectors in these dogs.
ABSTRACT ID-45
USE OF AN AUTOMATED SYSTEM FOR DETECTION OF
CANINE SERUM ANTIBODIES AGAINST GLYCOPRO-
TEIN GP36. S Moroﬀ1, I Sokolchik1, T Woodring1, C
Woodruﬀ1, B Atkinson1, M Lappin2. 1Antech Diagnostics, Lake
Success, NY, 2Department of Clinical Sciences, Colorado State
University, Ft. Collins, Colorado
Ehrlichia canis (EC) is the most common cause of monocyto-
tropic ehrlichiosis in dogs around the world. The purpose of this
study was to validate a new automated ﬂuorescence system (Ac-
cuplex4TM) to detect antibodies against the EC immunodominant
glycoprotein gp36.
Young adult, mixed sex beagles (n = 8) were inoculated with
culture derived EC IV. Serum and blood samples (EDTA) were
collected on Days 0, 3, 7, 10, 14, 17, 21, 28, 35, 42, 49, 63, 70, 77,
and 84. Doxycycline was administered daily at 10 mg/kg, PO on
Days 56 - 77. An assay to measure canine antibodies against gp36
in the Accuplex4TM was titrated with positive and negative control
sera to determine the optimal concentrations of gp36, buﬀers,
serum dilutions, and secondary antibody concentrations. After
optimization, the sample set from the EC inoculated dogs was
assayed. Sera were also assayed in an EC IFA (Prototek Reference
Laboratory, Chandler AZ) and a commercially available kit
(SNAP®4DX; IDEXX Laboratories, Portland ME). A complete
blood cell count and a proprietary EC PCR assay (Antech Diag-
nostics, Lake Success, NY) were performed on each blood sample.
Results from the EC inoculated dogs varied by the assay with
some statistical diﬀerences detected (Table 1). Onset of thrombo-
cytopenia (<170/cmm) occurred on Day 14 (4 dogs), Day 17 (1
dog) or Day 21 (3 dogs). On the day thrombocytopenia was ﬁrst
detected, PCR assay results (8 dogs) were positive more com-
monly than SNAP (1 dog) and IFA (2 dogs) but not more com-
monly than gp36 (4 dogs). Serum antibodies (all assays) but not
EC DNA were detected after starting doxycycline.
Abstract ID-43: Table
Comparison Test
Sample Size SNAP 4Dx Plus / Reference Test
Sample Type
Relative Sensitivity and Speciﬁcity
95% Conﬁdence limit+/+ -/+ +/- -/- Total
HTWM1,2 94 1 2 269 366 Serum/Plasma Sen., 98.9% (95% CL 94.3%-99.8%)
Spec., 99.3% (95% CL 97.3%-99.8%)
A.phagocytophlium3 123 13 15 235 386 Serum/Plasma Sen., 90.4% (95% CL 84.3%-94.3%)
Spec., 94.0% (95% CL 90.3%-96.3%)
A. platys3 102 21 15 235 373 Serum/Plasma Sen., 82.9% (95% CL 75.3%-88.6%)
Spec., 94.0% (95% CL 90.3%-96.3%)
B. burgdorferi4 112 7 10 246 375 Serum/Plasma Sen., 94.1% (95% CL 88.4%-97.1%)
Spec., 96.1% (95% CL 93.0%-97.9%)
E. canis5 131 3 18 217 369 Serum/Plasma Sen., 97.8% (95% CL 93.6%-99.2%)
Spec., 92.3% (95% CL 88.2%-95.1%)
E. ewingii6 109 4 10 154 277 Serum/Plasma Sen., 96.5% (95% CL 91.3%-98.6%)
Spec., 93.9% (95% CL 89.1%-96.7%)
Reference 1Necropsy and 2petchek 3A.phagocytophlium IFA 4B. burgdorferi IFA 5E. canis 6E. ewingii ELISA
Abstract ID-45:
Table 1. % positive results for 8 EC infected dogs.
Assay/
Day 0 3 7 10 14 17 21 28 35 42 49
PCR 0 0 0 0 75a 87.5a 100a 100a 100 87.5 87.5
Low plat. 0 0 0 0 50 62.5 100 100 87.5 87.5 87.5
gp 36 0 0 0 0 12.5b 87.5a 100a 100a 100 100 100
IFA 0 0 0 0 0b 50 75a 100a 100 100 100
SNAP 0 0 0 0 0b 12.5
b
12.5b 37.5b 87.5 100 100
ais statistically diﬀerent than b; plat = platelet.
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EC DNA was ampliﬁed before seroconversion in any assay and
correlated best with onset of thrombocytopenia. Antibodies
against gp36 were detected within 3 days of PCR positive test
results. Detection of EC antibodies in the Accuplex4TM assay
occurs 3 to 21 days sooner than by SNAP and 7 to 14 sooner than
IFA which likely reﬂects the cutoﬀ value chosen for each assay.
SMALL ANIMAL–NEPHROLOGY / UROL-
OGY
ABSTRACT NU-1
PROTEIN-LOSING NEPHROPATHY ASSOCIATED WITH
MUTATIONS IN NPHS1 (NEPHRIN) AND KIRREL2
(NEPH3/FILTRIN) IN SOFT-COATED WHEATEN TERRI-
ERS. MP Littman, CA Wiley, MG Raducha, PS Henthorn.
University of Pennsylvania School of Veterinary Medicine,
Philadelphia, PA
Soft-coated Wheaten Terriers are genetically predisposed to
adult onset protein-losing nephropathy (average onset, 6.3 ± 2.0
years). A genome-wide association study, using the Illumina Ca-
nineHD BeadChip with 177 000 validated SNPs for genotyping,
revealed a single statistically interesting region (p value 2.22 x 10-
7) when comparing DNA samples from aﬀected and geriatric
( 14 years) unaﬀected Wheatens. Criteria for phenotypic selec-
tion included blood, urine, and histopathologic ﬁndings. Gene
sequencing of candidate genes in the region revealed a single
nucleotide change in each of two closely linked genes, NPHS1
and KIRREL2, which encode the slit diaphragm proteins neph-
rin and Neph3/ﬁltrin, respectively. Mutations in nephrin and
decreased expression of ﬁltrin are associated with podocytopathy
and protein-losing nephropathy in humans. The polymorphisms
change a glycine to arginine in nephrin and a proline to arginine
in a conserved proline-rich region in ﬁltrin. These novel muta-
tions are not described in other species, nor found in 753 dogs of
114 other breeds, except in 3 dogs, including 2 Airedales, 1 of
which is doubly homozygous/aﬀected and 1 is doubly heterozy-
gous, and 1 Bloodhound, heterozygous for the ﬁltrin mutation
only. Risk for nephropathy is highest in dogs homozygous for
the mutations (n=186). Inheritance appears complex, with
incomplete penetrance, variable expression, possibly additional
genes and/or environmental triggers modifying the phenotype.
This is the ﬁrst canine inherited podocytopathy described.
ABSTRACT NU-2
PRE-OPERATIVE PREDICTORS OF OUTCOME FOR CATS
WITH SUCCESSFUL MANAGEMENT OF URETERAL
OBSTRUCTIONS VIA URETERAL STENTING OR A SUB-
CUTANEOUS URETERAL BYPASS DEVICE. C Horowitz,
A Berent, C Weisse, C Langston. Animal Medical Center, New
York, NY
Less-invasive alternatives to traditional surgical interventions
for feline ureteral obstruction include stents and subcutaneous
ureteral bypass (SUB). This study evaluated pre-operative param-
eters for prediction of hospitalization times, peri-operative sur-
vival, renal recovery, and long-term survival in cats with benign
ureteral obstructions treated with a ureteral stent or SUB.
Medical records of 40 cats treated for ureteral obstruction(s) at
the Animal Medical Center were reviewed. Pre-operative biochemi-
cal and imaging parameters were evaluated as predictors of length
of hospitalization, survival to discharge, creatinine and IRIS stage
at 3, 6 and 9 months post-procedure and overall survival.
There was a positive association between presenting creatinine
(rho=0.53, p<0.0008), BUN (rho=0.54, p<0.0006), and potas-
sium (rho=0.40, p<0.0152) with hospitalization time, while as
presenting sodium decreased, the length of hospitalization
increased (rho=-0.40, p<0.0217). Cats with IRIS stages 1 and 2
at 3 months (median survival not reached vs. 272 days respec-
tively, p<0.0014) and 6 months (median survival not reached vs.
322 days respectively, p<0.0024) post-procedure lived longer
than those with higher IRIS stages. For every unit increase in
presenting creatinine (HR=1.11, p<0.0251), BUN (HR=1.01,
p<0.0015) and potassium (HR=1.43, p<0.0476), there was a
higher hazard of dying.
Preoperative elevations in creatinine, BUN and potassium may
be prognostic for longer hospitalization and decreased overall
survival. Future studies should be performed to further assess
these ﬁndings.
ABSTRACT NU-3
EVALUATION OF WHITE COAT HYPERTENSION IN
DOGS AND CATS USING THE PETMAP OSCILLOMET-
RIC BLOOD PRESSURE MONITOR. SA Stewart, WW Muir,
CE Langston. Animal Medical Center, New York City, NY
White coat hypertension is hypertension in hospital that normal-
izes at home. It is believed to result from stress-associated pressor
release, and is documented in people, cats and dogs. If its magni-
tude is severe enough, patients may be erroneously diagnosed with
true hypertension. The purpose of this study was to use the indirect
oscillometric petMAP device to compare blood pressures in hospi-
tal with those measured at home by owners, to determine if we can
diﬀerentiate between white coat and true hypertension. We per-
formed a prospective observational study involving 55 client-
owned animals (39 dogs and 16 cats) presented over a 15 month
period. We collected a minimum of 6 systolic, diastolic and MAP
measurements from each patient in hospital and then at home,
and compared results using a paired 2-tailed t-test. We also com-
pared the eﬀect of temperament, age, gender, weight, disease sta-
tus, administration of antihypertensives and limb used on blood
pressure using non-paired 2-tailed t-tests and one-way ANOVA.
There was a statistically signiﬁcant diﬀerence between at home
and in hospital readings for all parameters (dog systolic: 27
mmHg diﬀerence, p<0.0001, diastolic: 14mmHg, p=0.0006,
MAP: 17mmHg, p=0.0005; cat systolic: 20mmHg, p= 0.015,
MAP: 14mmHg, p=0.03) except cat diastolic (10mmHg,
p=0.13). Statistically signiﬁcant diﬀerences were also found for
limb used in hospital (37mmHg systolic higher in hindlimbs ver-
sus forelimbs, p=0.0009, 16mmHg diastolic, p=0.02, 26mmHg
MAP, p=0.001) and dog age for diastolic (13mmHg, p=0.025)
and MAP (17mmHg, p =0.014) readings in hospital. We con-
cluded that white coat hypertension exists and can be success-
fully documented.
ABSTRACT NU-4
THE EFFECT OF BODY POSITION ON INDIRECT SYS-
TOLIC BLOOD PRESSURE MEASUREMENT IN DOGS.
DA Weinstein, ME Mackalonis, RS Hess. Department of
Clinical Studies-Philadelphia, School of Veterinary Medicine,
University of Pennsylvania, Philadelphia, PA
The eﬀect of body position on indirect systolic blood pres-
sure (BP) measurement in dogs is unknown. The objectives of
this study were to determine whether there is a diﬀerence in
systolic BP measurement by Doppler ultrasonography in sitting
compared to recumbent body position and to determine the
degree of BP measurement variability in each of these body
positions.
A prospective, randomized, crossover study was performed.
Systolic BP was measured in 51 healthy or sick dogs in sitting
and laterally recumbent positions using Doppler ultrasonogra-
phy. The position of the ﬁrst set of BP measurements was deter-
mined randomly for each dog by a coin-ﬂip. The ﬁrst of seven
consecutive measurements in each position was discarded from
the analysis.
Mean systolic BP was signiﬁcantly higher in the sitting (172.1
± 33.3 mm Hg) compared to the recumbent position (147.0 ±
24.6 mm Hg, P < 0.0001). Systolic BP was higher in the sitting
versus recumbent position in 86% of dogs (44/51). The mean dif-
ference in systolic BP measured in the two positions was 25.1 ±
28.5 mm Hg. Repeated BP measurements for each dog had a sig-
niﬁcantly (P < 0.00006) higher reproducibility in the recumbent
position than in the sitting position.
BP measurements in dogs are signiﬁcantly aﬀected by body
position and are higher in the sitting position than in a later-
ally recumbent position, for most dogs. The laterally recumbent
body position is preferred for BP measurements because mea-
surements in this position are less variable than in the sitting
position.
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ABSTRACT NU-5
FEEDING A RENAL DIET IS ASSOCIATED WITH A
REDUCTION IN PLASMA FIBROBLAST GROWTH FAC-
TOR 23 (FGF-23) IN CATS WITH STABLE CHRONIC KID-
NEY DISEASE (CKD). RF Geddes, J Elliott, HM Syme. Royal
Veterinary College, London, UK
FGF-23 is a phosphaturic hormone, which increases as renal
function declines and is further elevated in hyperphosphatemic
cats with azotemic CKD. FGF-23 concentrations decrease with
dietary phosphate restriction in humans and rodents. The aim of
this study was to investigate the eﬀect of dietary phosphate
restriction on plasma FGF-23 concentration in cats with stable
azotemic CKD.
Azotemic (plasma creatinine concentration >2.0 mg/dl and
USG <1.035) geriatric (> 9 years) cats seen at two London
ﬁrst opinion practices since August 2000 were identiﬁed. Cats
oﬀered a commercially available protein and phosphate
restricted diet (Royal Canin Renal or Renal Special) were
included in the study if they had blood samples taken on both
the day they started diet (baseline) and 28-56 days later (on
diet). Cats were excluded from the study if plasma creatinine
concentration changed >25% during the study period, if the
cat refused to eat the renal diet or if they had evidence of con-
current disease (with the exception of systemic hypertension
controlled with medication). Cats were classiﬁed as hyper- or
normophosphatemic based on the IRIS targets for plasma inor-
ganic phosphorus concentration (iP): stage 2 target iP  4.5
mg/dl, stage 3 target iP  5 mg/dl, stage 4 target iP  6 mg/dl.
Plasma FGF-23 concentrations were measured using a previ-
ously validated human intact FGF-23 ELISA. Comparisons
between visits were made using the Wilcoxon signed rank test,
with signiﬁcance determined at P<0.05. Results are reported as
median [25th, 75th percentiles].
In hyperphosphatemic cats (n=16) eating renal diet was asso-
ciated with a signiﬁcant decrease in plasma concentrations of iP
(from 5.9 [4.8, 7.4] to 4.1 [3.8, 4.5] mg/dl, P<0.001) and FGF-23
(from 1316.5 [491.9, 4227.6] to 537.7 [388.8, 1539.2] pg/ml,
P=0.008), but not plasma creatinine concentration (2.7 [2.3, 3.2]
vs. 2.7 [2.1, 2.9] mg/dl, P=0.255). In normophosphatemic cats
(n=18) eating renal diet was associated with a signiﬁcant
decrease in plasma FGF-23 concentration (from 682.9 [352.9,
1610.4] to 561.3 [259.7, 1006.1] pg/ml, P=0.006), but not plasma
concentrations of iP (3.5 [2.9, 4.0] vs. 3.3 [3.0, 3.7] mg/dl,
P=0.478) or creatinine (2.6 [2.3, 3.0] vs. 2.4 [2.1, 2.9] mg/dl,
P=0.102).
In conclusion, the feeding of a renal diet is associated with a
reduction in plasma FGF-23 concentration in hyper- and normo-
phosphatemic cats with stable azotemic CKD. This suggests that
dietary phosphate and protein restriction has eﬀects on phos-
phate homeostasis, even when plasma iP concentration does not
signiﬁcantly change.
ABSTRACT NU-6
ACUTE KIDNEY INJURY IN DOGS HOSPITALIZED IN
THE INTENSIVE CARE UNIT: A PROSPECTIVE STUDY
(INTERIM ANALYSIS). A Eatroﬀ, C Langston. The Animal
Medical Center, New York, NY
This report details an interim analysis of a study with the fol-
lowing objectives: determine the incidence of acute kidney injury
(AKI) in the canine intensive care unit (ICU); identify risk fac-
tors for AKI in the ICU; and determine if AKI is associated with
length of ICU and hospital stay, and hospital survival. Dogs
were eligible for inclusion if the ICU stay exceeded 24 hours.
Dogs were excluded if they weighed less than 2.5 kg or were
diagnosed with AKI on admission. Serum creatinine concentra-
tions were measured every 24 hours. Serial changes in creatinine
were evaluated by the Risk, Injury, Failure, Loss of function,
End-stage renal disease (RIFLE) and the Acute Kidney Injury
Network (AKIN) schemes, and a newly proposed scheme (Cowg-
ill). One hundred and nine dogs were included. All classiﬁcation
schemes reported similar incidences of AKI (9%, 10%, and 9%,
respectively). Those receiving ﬂuoroquinolones were more likely
to develop AKI (odds ratio [OR], 4.4; 95% conﬁdence interval
[CI], 1.2 to 15.8) by cumulative failure type (AKIN, RIFLE, or
Cowgill’s scheme) and more likely to develop AKI (OR, 4.4;
95% CI, 1.1 to 17.9) by RIFLE. Those receiving diuretics were
more likely to develop AKI (OR 4.6; 95% CI, 1.2 to 17.1) by
cumulative failure type, more likely to develop AKI (OR 5.6;
95% CI, 1.4 to 21.7) by AKIN, and more likely to develop AKI
(OR, 5.9; 95% CI, 1.4 to 22.9) by Cowgill’s scheme. There was
no association between AKI and lengths of ICU and hospital
stays, or survival.
ABSTRACT NU-7
LONG-TERM RENAL OUTCOME OF DOGS WITH ACUTE
KIDNEY INJURY. I Kis1,2, A Schweighauser1, T Francey1.
1Vetsuisse Faculty University of Berne, Switzerland, 2University
of Zagreb, Croatia
Most studies on acute kidney injury (AKI) state only short-
term survival data while long-term follow-up is very sparsely doc-
umented. All dogs diagnosed with AKI in 2007-2009 at the Uni-
versity of Berne were included in this study and grouped
according to the underlying etiology as leptospirosis (L) and AKI
from other causes (NL). Short- and long-term survival was deter-
mined 10d and >6m after discharge, respectively. Renal outcome
of the survivors was re-assessed prospectively, including clinical
and laboratory evaluation.
Of the 121 dogs diagnosed with AKI during the study period
(89L, 32NL), 69 dogs were treated with hemodialysis (49L,
20NL). Median peak creatinine during hospitalisation was 739
µmol/l (IQR 491-1053). 63 dogs survived short-term (48L (54%),
15NL (47%)) and 47 of them could be re-evaluated (38L, 9NL).
L-survivors were diagnosed with normal renal function (n=18,
47%), chronic kidney disease (CKD) IRIS stages 1 (n=13), 2
(n=3), 3 (n=3), and 4 (n=1). NL-survivors were diagnosed with
normal renal function (n=4, 44%), CKD stages 1 (n=1), 2
(n=2), and 3 (n=2). Development of CKD was neither associ-
ated with the etiology group (P=0.87) nor with the presenting or
the peak creatinine concentrations (P=0.42 and 0.29), but with
the requirement for hemodialysis (P=0.02) in a univariate logis-
tic regression analysis.
In conclusion, the high prevalence of CKD in dogs recovered
from AKI warrants close long-term monitoring of their kidney
function.
ABSTRACT NU-8
ACUTE AND CHRONIC EFFECTS OF TEPOXALIN ON
RENAL FUNCTION IN DOGS WITH CHRONIC KIDNEY
DISEASE AND OSTEOARTHRITIS. A Lomas1, S Lyon1, MW
Sanderson2, GF Grauer1. 1Departments of Clinical Sciences,
Kansas State University, Manhattan, KS, 2Diagnostic Medicine
and Pathobiology, Kansas State University, Manhattan, KS
Chronic kidney disease (CKD) and osteoarthritis (OA) are
common in older dogs. We assessed eﬀects of tepoxalin on renal
function in dogs with OA and Stage 2 or 3 CKD (serum creati-
nine [SrCr] 1.6-3.5 mg/dl). Inclusion criteria were OA and stable
CKD (assessed by SrCr, iohexol plasma clearance, urine protein/
creatinine ratio, enzymuria, and systolic blood pressure at -14
and -7 days). Dogs then received tepoxalin (10 mg/kg PO once
daily) for 28 days (acute phase, 16 dogs), and 6 months (chronic
phase, 10 dogs). Rechecks were performed weekly (acute phase)
and then at 1, 3, and 6 months (chronic phase). Three owners
elected not to continue beyond week 4.
Adverse events that resulted in withdrawal included: increased
SrCr in one dog (week 1), collapse in one dog (week 1), increased
liver enzymes in one dog (week 4), and vomiting, hematochezia,
and GI ulceration in three dogs (weeks 8, 24, and 26, respec-
tively). Renal function was not aﬀected in the latter 5 dogs.
Treatment discontinuation resulted in stabilized renal function in
the ﬁrst dog and resolution of 4 of the 5 adverse events. This rate
of adverse events is similar to those listed for dogs with normal
renal function.
Renal function parameters were analyzed using repeated mea-
sures ANOVA. There was no diﬀerence over time for any param-
eter in dogs that were not withdrawn for adverse events. Results
suggest that with close monitoring, tepoxalin may be used in
dogs with OA and stable Stage 2 or 3 CKD.
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ABSTRACT NU-9
ULTRASOUND-GUIDED PLACEMENT OF URETHRAL
STENTS IN DOGS. T Archer, E Brinkman-Ferguson, A
Dedeaux, B Geesaman, A Mackin. Mississippi State University
College of Veterinary Medicine, Mississippi State, MS
Neoplasia, particularly transitional cell carcinoma and pros-
tatic carcinoma, is a common cause of urethral obstruction in the
dog. Stranguria is a common clinical sign, with partial or com-
plete obstruction occurring in approximately 10% of these
patients. One method for relieving malignant obstruction in dogs
is the use of self-expanding metallic stents (SEMS). Placement of
a urethral stent is a fast and eﬀective means of rapidly achieving
urethral patency with a reduced risk of complications compared
to more aggressive surgical procedures. Stents are typically placed
under the guidance of ﬂuoroscopy, thereby limiting the availabil-
ity of this technique to academic institutions and large referral
practices.
The purpose of our study was to develop a technique for
placement of SEMS under ultrasound guidance without ﬂuoros-
copy. Five canine cadavers (2M, 3F; wt 12-15 kg) were used.
Positive contrast retrograde urethrocystography or vaginoure-
throcystography was performed prior to stent placement in males
and females respectively to establish landmarks for assessment of
stent location. Our goal was to place the cranial edge of the stent
2 cm cranial to the neck of the bladder. In males, a hydrophilic
guide wire was inserted in the penile urethra and fed into the
bladder, and the stent deployment device was passed over the
wire. In females, a modiﬁed polypropylene urinary catheter was
passed through the urethra into the bladder, and the deployment
device was passed through the catheter. The bladder was
expanded with a standardized ﬂuid volume to facilitate ultraso-
nography. The cranial tip of the deployment device was identiﬁed
on ultrasound and positioned 2 cm cranial to the bladder neck.
The stent was then slowly deployed while the position of the cra-
nial end of the stent was continuously monitored via ultrasound.
Repeat radiographs were performed to determine the ﬁnal posi-
tion of the stent. In all 5dogs, the urethral stent was successfully
placed within 0.5 cm of the target location.
Our study conﬁrms that urethral stents can be successfully
placed in normal dogs under ultrasound guidance without ﬂuo-
roscopy. Our technique can be utilized in practices that do not
have access to ﬂuoroscopic equipment. Further investigation in
tumor-bearing dogs is indicated.
ABSTRACT NU-10
URINARY NGAL: A BIOMARKER FOR EARLY IDENTIFI-
CATION OF ACUTE KIDNEY INJURY IN DOGS. CA Palm1,
JL Westropp1, B LeRoy2, G Segev3, LD Cowgill1. 1UC Davis
School of Veterinary Medicine, Davis, CA, 2Abbott Laboratories ,
3Koret University
Despite advances in the treatment of acute kidney injury
(AKI), the death rate among dogs remains high. A key factor
contributing to AKI-associated fatalities is lack of sensitive tests
allowing for early diagnosis. There is a growing interest in the
development of biomarkers, which are natural substances that
can be detected in urine or blood, and may allow for early AKI
diagnosis. Neutrophil gelatinase-associated lipocalin (NGAL) is
expressed in low concentrations in healthy dogs and humans,
however, expression is markedly increased by compromised renal
epithelium. Urinary NGAL (uNGAL) has been identiﬁed as one
of the earliest and most robustly induced proteins in animal mod-
els of AKI. A canine speciﬁc ELISA kit for uNGAL has been
developed for research purposes (BioPorto Diagnostics SA); pilot
data shows uNGAL increases 7- to 200-fold in dogs with docu-
mented renal disease. Therefore, the purpose of this study was to
evaluate the utility of uNGAL in a canine model of AKI.
Six dogs were administered gentamicin (10 mg/kg SC q
8hours) and uNGAL and serum creatinine were measured twice
daily. Data available for two dogs revealed that uNGAL concen-
trations increased 7-fold above baseline by day 5 and 9, respec-
tively, while serum creatinine remained within the reference range
until days 14 and 16, respectively. When serum creatinine values
increased by 50% in these two dogs, uNGAL had increased an
average of 789-fold.
uNGAL may be a useful diagnostic tool for early detection of
AKI in dogs and therefore may allow for improved patient out-
comes.
ABSTRACT NU-11
ACCURACY OF URICULT® VET PADDLES FOR THE
DIAGNOSIS AND IDENTIFICATION OF BACTERIAL CYS-
TITIS IN DOGS AND CATS. WL Ybarra, JE Sykes, YW
Zingale, BA Byrne, PH Kass, JL Westropp. UC Davis School of
Veterinary Medicine, Davis, CA
Quantitative urine culture is the gold standard for diagnosis of
bacterial urinary tract infections, but this can be costly. The pur-
pose of this study was to evaluate the accuracy of the Uricult®
Vet system, an in-practice urine culture kit marketed for compan-
ion animal use.
In this prospective blinded study, urine specimens submitted to
the UCD-VMTH microbiology laboratory for urinalysis and aer-
obic bacterial culture were selected by a veterinary technician for
parallel analysis using the Uricult® Vet system. Paddles were
inoculated by two investigators and incubated according to man-
ufacturer’s instructions. Each investigator’s results were com-
pared with each other and to those of the laboratory using
McNemar’s test.
A total of 207 urine specimens were analyzed, 64 of which
yielded growth in the laboratory. The two investigators’ results
agreed for 190/207 (91.8%) paddle results. The mean sensitivity
and speciﬁcity for identiﬁcation of bacterial growth, regardless of
the pathogen identiﬁed, was 92.4% and 98.9%, respectively.
Investigator 1 correctly identiﬁed 52/64 (81.3%) and investigator
2 46/64 (71.9%) uropathogens. The mean sensitivity and speciﬁc-
ity for identiﬁcation of Escherichia coli was 88.7% and 98.0%;
for Enterococcus spp. was 60.5% and 98.9%; and for Staphylo-
coccus spp. was 61.6% and 99.0%, respectively.
The Uricult® Vet paddles appear to be a useful screening tool
for identiﬁcation of bacterial growth. However, inaccuracies
occurred when paddles were used for organism identiﬁcation,
particularly when multiple uropathogens were present. When
growth occurs, paddles or urine should be submitted to a com-
mercial microbiology laboratory for identiﬁcation and antimicro-
bial susceptibility testing.
ABSTRACT NU-12
ASYMPTOMATIC BACTERIURIA ESCHERICHIA COLI
STRAIN 83972 IN COMPETITION WITH EMERGING,
HIGHLY VIRULENT MULTI-DRUG RESISTANT ESCHERI-
CHIA COLI STRAINS IN CANINE URINE. MF Thompson1,
JS Gibson1, PC Mills1, MA Schembri2, JL Platell1, DJ Trott3.
1The University of Queensland, Gatton, QLD, 2The University
of Queensland, St Lucia, QLD, 3The University of Adelaide,
Roseworthy, SA
Deliberate colonization of susceptible dogs with the human
asymptomatic bacteriuria Escherichia coli strain 83972 may repre-
Ultrasound image demonstrating a deployed urethral stent within the
bladder. The thick arrow indicates the cranial edge of stent, and the thin
arrow indicates the pubis.
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sent a viable alternative for management of recurrent urinary
tract infection (UTI). The strain outcompetes human uropatho-
genic E. coli (UPEC) in human urine in vitro, likely underpinning
its success in prevention of recurrent UTI. We examined the
growth of E. coli 83972 in competition with isolates representing
three successful emerging multi-drug resistant (MDR) E. coli clo-
nal groups in canine urine.
Mixed cultures were grown in pooled canine urine inoculated
1:1 with freshly grown pre-cultures of E. coli 83972 and one of
three previously published successful MDR UPEC isolates cul-
tured from canine UTIs (QUC07 [O75:ST1193]; QUC13 [ST131];
QUC18 [O15:K52:H1]). The cultures were grown aerobically at
37 oC for 17 hours and viable counts were obtained. All experi-
ments were performed in duplicate.
In two competition experiments (QUC07 vs. 83972 and
QUC13 vs. 83972), there was no signiﬁcant diﬀerence in mean
viable counts at 17 hours. In the remaining competition experi-
ment (QUC18 vs. 83972), E. coli 83972 was present in signiﬁ-
cantly lower numbers than the MDR E. coli strain after 17 hours
(P < 0.05).
Given that the starting ratio in dogs following prophylactic
bladder colonisation would favour E. coli 83972, it is feasible
that it will outcompete MDR UPEC strains. Investigation of
variables such as alternative bacterial concentrations, resistance,
colicin production and virulence characteristics will enhance our
understanding of the mechanisms by which E. coli 83972 grows
in urine and its suitability for use in prophylactic treatment.
ABSTRACT NU-13
GLOMERULAR FILTRATION RATE ESTIMATION ON
THE BASIS OF PLASMA CLEARANCE OF INULIN IN
DOGS. M Nishida, M Uechi. Nihon University, Kanagawa,
Japan
Accurate timed urine collections for the measurement of glo-
merular ﬁltration rate (GFR) may be impractical in animals. The
purpose of this study was to compare plasma clearance of inulin
(P-CL) without urine collection with urinary clearance of inulin
(U-Cin). The study included 23 healthy beagle dogs and 5 experi-
mental dogs with renal failure. GFR was estimated on the basis
of P-CL of inulin by using the trapezoidal method (P-CLTR)
and 1-compartment method (P-CL1c) and on the basis of U-Cin.
U-Cin was calculated following formula: U-Cin (ml·min-1) =
urinary output of inulin (mg·min-1) /serum inulin concentration
(mg·min-1). P-CL was calculated from the serum inulin concen-
tration versus time data by using the basic formula: P-CL
(ml·min-1) = dose of inulin (mg) /area under the curve (mg·ml-
1·min-1). P-CLTR was calculated for 9 blood samples, and P-
CL1c was calculated for 2 blood samples in each dog. Regression
analysis was performed to establish correction formulas for pre-
dicting the U-Cin from the P-CL1c values. The U-Cin could be
predicted from the P-CL1c values for 2 samples at 2 and 3 hours
after inulin injection (P-CL1c 2,3) by using the formula U-Cin =
-0.023 (P-CL1c 2,3)2 + 0.73 (P-CL1c 2,3) + 0.023 (R2 = 0.95).
In conclusion, GFR was estimated on the basis of plasma inulin
clearance with 2 blood samples at 2 and 3 hours after inulin
injection.
ABSTRACT NU-14
ESTIMATION OF GLOMERULAR FILTRATION RATE ON
THE BASIS OF INULIN INFUSTION CLEARANCE IN
DOGS WITH AND WITHOUT RENAL FAILURE. M Nishida,
M Uechi. Nihon University, Kanagawa, Japan
The gold standard method for measuring glomerular ﬁltration
rate (GFR) uses urinary inulin clearance (U-Cin). However, this
method is not generally used because determining the exact urine
volume in dogs is diﬃcult. The aim of this study was to evaluate
an inulin infusion-clearance (INF-Cin) method that does not
require urine sampling for pharmacokinetic measurement of
GFR during continuous inulin infusion in dogs. The study
included 64 dogs with suspected renal dysfunction. GFR was
simultaneously measured using U-Cin, urinary endogenous creat-
inine clearance (U-Ccr), and the INF-Cin method. U-Cin and U-
Ccr was calculated by formula: U-Cin or U-Ccr (ml·min-1) =
urinary output of inulin or creatinine (mg·min-1) /serum inulin or
creatinine concentration (mg·min-1). INF-Cin was calculated by
formula: INF-Cin (ml·min-1) = infusion rate of inulin (mg·min-1)
/serum inulin concentration (mg·min-1). The mean (standard devi-
ation) U-Cin, U-Ccr, and INF-Cin values were 2.6 (1.3), 2.8
(1.4), and 3.0 (1.1) ml·min-1·kg-1, respectively. A signiﬁcant corre-
lation was observed between U-Cin and INF-Cin (R2 = 0.91, P
< 0.001) and between U-Cin and U-Ccr (R2 = 0.82, P <
0.001). However, the INF-Cin method overestimated the U-Cin
in dogs with renal failure. In conclusion, these results indicate
that the INF-Cin method can be used to measure GFR without
urine collection in healthy dogs, whereas it may overestimate the
GFR in dogs with renal failure.
ABSTRACT NU-15
CLINICAL UTILITY OF PLASMA INULIN CLEARANCE AS
A MEASURE OF GLOMERULAR FILTRATION RATE IN
DOGS. CP Sturgess1, MD Dunning2. 1Vet Freedom Ltd,
Hampshire, UK, 2University Nottingham, School of Veterinary
Medicine and Science, Nottingham, UK
Glomerular ﬁltration rate (GFR) is acknowledged to give a
signiﬁcantly more accurate assessment of renal function than
standard biochemistry and urinalysis. Inulin clearance is well
established as a ‘gold standard’ measure of GFR in humans.
Further, inulin is commercially available, stable in plasma,
requires a small sample volume, is inexpensive to assay and a
canine reference range has been established.
A retrospective study of the clinical utility of using plasma
clearance of inulin to measure GFR in dogs was performed
investigating ease of use, quality of the clearance curve produced,
potential side eﬀects and clinical beneﬁt.
Inulin clearance was performed on 45 dogs with 4 dogs having
more than one test performed over time. A standard method was
used giving 3000mg inulin/m2 body surface area (Inutest 25%
solution Fresenius Kabi) as an intravenous bolus via a catheter.
Six timed blood samples were obtained over a 6 hour period
(approximately 5-10, 20, 40, 100, 180 and 360 minutes). The
exact time that the blood sample was acquired was recorded and
used for data analysis. High pressure liquid chromatography was
used to measure the inulin concentration in each sample by the
same external laboratory (Alomed). GFR was calculated using
commercial software (Inusoft - Laevosan).
Timed blood samples were obtained in all dogs (weight range
4-55kg, 17 breeds, 10-156 months of age). No side eﬀects were
observed following inulin injection, during the test period or over
subsequent hospitalisation. The results obtained produced a good
curve-ﬁt in the majority of cases. Occasional aberrant results
occurred that were unexplained and were discarded by the soft-
ware. Calculated inulin clearances were from 12 to 140ml/min/m2
[ref: 85-144].
The use of inulin to measure GFR was straightforward, repro-
ducible and without observed side eﬀects. It was felt to be of
value to diagnose or rule-out early renal disease (IRIS stage I
and II) in non-azotemic dogs with polyuria/polydipsia, to assess
the extent of long-term renal damage following acute renal fail-
ure in patient’s whose urea and creatinine had normalized and to
monitor progression of cases to help decide whether further inter-
vention e.g. biopsy was appropriate. The value in dogs with
established IRIS stage III-IV renal disease was unclear.
ABSTRACT NU-16
AST-120 ATTENUATES SERUM LEVELS OF THE UREMIC
TOXIN, INDOXYL SULFATE, IN CATS WITH DECREASED
RENAL MASS. BH Schmidt1, R Krebber2, M Murphy3, FJvan
derStaay4. 1Bayer Animal Health GmbH, Leverkusen, Germany,
2Bayer CropScience AG, Monheim, Germany, 3Charles River
Laboratories Preclinical Services Ireland Ltd., Ballina, Ireland,
4University of Utrecht, The Netherlands
Previous work has shown that there is an accumulation of the
putative uremic toxin, 3-Indoxyl sulfate (IS), in serum of cats
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with chronic kidney disease (CKD) similar to the situation in
human CKD patients. Since IS is derived from bacterial trypto-
phan metabolism to indole in the intestines, the present study
was undertaken to assess whether the potent activated carbon-
based adsorbent, AST-120 (also known as KremezinTM drug
substance or CovalzinTM, Kureha Corp., Tokyo, Japan) is able
to reduce the systemic burden of IS in cats with reduced renal
mass.
Two experiments were performed using the same colony of
laboratory cats that had undergone a unilateral nephrectomy and
ligation of branches of the renal artery supplying the remaining
kidney. Both were approved by the local ethical committee. At
the start of the ﬁrst study, 12 cats were switched to a suitable
moist diet in order to allow for mixing the test item into the feed.
The animals were sequentially treated with 0 (control phase), 50,
100 and 200 mg AST-120 per kg body weight daily. Each dose
was administered for a period of 14 days. This treatment series
was completed with a 2-week wash-out period. The second study
involved 11 of the cats which participated in the ﬁrst experiment
and consisted of three successive periods of 4 weeks each: no
treatment, AST-120 100 mg/kg daily, and a ﬁnal wash-out. In
both experiments, serum samples were taken at study start and
at the end of each dosing phase. The primary eﬃcacy variable
was serum IS. Secondary variables comprised serum levels of cre-
atinine, urea, and inorganic phosphate. The cats remained on the
same diet from the start of the ﬁrst experiment to the end of the
second one. The results were statistically analyzed by repeated
measures ANOVA, followed by t-test. The level of statistical sig-
niﬁcance was p<0.05.
Serum IS levels were signiﬁcantly lower than baseline follow-
ing administration of 100 and 200 mg AST-120 per kg body-
weight, but there was no diﬀerence between administration of
these two doses. No diﬀerence from baseline could be observed
for the dose of 50 mg/kg. All parameters except serum urea,
which was reduced compared to baseline, were unaﬀected at 100
mg/kg. The second study conﬁrmed the attenuation of serum IS
levels by the dose of 100 mg/kg, while the reduction in serum
urea levels was not conﬁrmed. In both studies, the AST-120
induced changes were not abolished and persisted beyond the
wash-out period. AST-120 was well tolerated by the study ani-
mals at all doses tested.
The results indicate that the dose of 100 mg AST per kg body
weight is necessary and suﬃcient to mediate a signiﬁcant and
clinically relevant reduction in serum IS levels. Further studies
are required to investigate the reason for the persistence of the
beneﬁcial eﬀects upon discontinuation of treatment.
ABSTRACT NU-17
EVALUATION OF 3 STRUVITE-OXALATE PREVENTA-
TIVE DIETS IN HEALTHY CATS. T Gluhek, JW Bartges, A
Callens, G Galyon, S Cox, CA Kirk. College of Veterinary
Medicine, The University of Tennessee, Knoxville, TN
There are 3 feline “oxalate-struvite” preventative diets avail-
able. We hypothesized that (a) these 3 diets would induce lower
urinary saturation estimated by relative supersaturation for stru-
vite (RSSstruvite) and calcium oxalate (RSScaox) than an adult
maintenance diet.
Six healthy shorthair cats, 2 FS aged 3 yr, 2 FS aged 6 yr, and
2 MC aged 3 yr, were randomly assigned to consume 1 of 3 dry
struvite-oxalate preventative diets (CD = Prescription Diet c/d
MultiCare, SO = Royal Canin s/o, and UR = Purina UR St/
Ox) or a maintenance adult food (M = Science Diet Mainte-
nance) in a Latin-square design. Diets fed for 3 weeks and a 24-
hour urine sample was collected. All cats consumed all 4 diets.
Data were analyzed using ANOVA with signiﬁcance of p <
0.05.
Diﬀerences were not found for body weight; 24-hour excre-
tions of magnesium, oxalate, citrate, or creatinine; or RSSstruvite
and RSScaox between diets. Diﬀerences between diet groups were
found for 24-hour urinary excretion of sodium, potassium, cal-
cium, ammonia, phosphorous, chloride, and 24-hour urine vol-
ume.
Despite diﬀerences, estimated RSS were not diﬀerent between
CD, SO, UR, and M, although RSScaox tended to be highest on
M and lowest on UR. Twenty-four hour urinary excretion of
sodium and chloride and urine volume was greatest with SO and
UR because these diets contain greater amount of sodium chlo-
ride than CD and M; 24-hour urinary excretion of calcium was
lowest with CD. The 3 oxalate-struvite preventative diets tend to
induce a lesser degree of urine saturation for calcium oxalate
than the maintenance diet by diﬀering dietary modiﬁcations.
ABSTRACT NU-18
EVALUATION OF CULTURE TECHNIQUES AND BACTE-
RIAL CULTURES FROM CANINE AND FELINE URO-
LITHS. L Perry, PH Kass, DL Johnson, R Shiraki, AL Ruby,
JL Westropp. University of California Davis School of
Veterinary Medicine, Davis, CA
Canine struvite uroliths can form due to an infection, while
others can act as a nidus. Published techniques for culturing uro-
liths are variable; washing the uroliths four times and culturing
the core has been reported. The objectives of this study was two-
fold:1) prospectively evaluate urolith culture protocols and 2)
report bacterial isolates from uroliths and their association with
signalment, stone type, and previous antimicrobial use.
For part 1, 50 urolith pairs were cultured by washing each
stone either 1or 4 times and then culturing the core. For part 2,
a retrospective search of isolates collected from uroliths submit-
ted to our laboratory was recorded; the signalment, stone type,
and previous antimicrobial use were reviewed. McNemar’s Tests
were performed on the prospective data. A multiple logistic
regressions were used to analyze the retrospective data.
Regarding stone culture techniques, no diﬀerences in bacterial
isolates from the urolith core were found. Washing the stone four
times does not appear warranted. In part 2, we evaluated culture
results from 520 canine and 168 feline uroliths. We found stru-
vite-containing uroliths had an increased risk for positive culture
Abstract NU-17:
Table. Twenty-four hour excretions of analytes, urine volume, and relative supersaturation from 6 cats consuming 4 diets. Results with diﬀerent superscript
letters diﬀer at p < 0.05.
Analyte Units CD SO UR M
Sodium mEq/kg 1.29 ± 0.32a 5.64 ± 1.23b 6.24 ± 1.96b 1,32 ± 0.30a
Potassium mEq/kg 2.10 ± 0.54ab 2.97 ± 0,57ac 3.08 ± 0.85c 1.69 ± 0.19b
Calcium mg/kg 0.18 ± 0.07a 0.43 ± 0.22b 0.34 ± 0.13ab 0.29 ± 0.10ab
Ammonia mM/kg 0.17 ± 0.15a 0.52 ± 0.16b 0.55 ± 0.28b 0.21 ± 0.37a
Phosphorous mg/kg 26.9 ± 4.9a 27.0 ± 5.6a 44.1 ± 11.9b 27.4 ± 3.5a
Chloride mEq/kg 2.14 ± 0.85a 6.13 ± 1.36b 7.69 ± 2.46b 1.85 ± 0.32 a
Volume ml/kg 10.4 ± 1.8a 17.5 ± 2.5ac 19.2 ± 6.5bc 11.7 ± 4.5a
RSScoax 1.48 ± 0.76
a 1.53 1.00 a 1.15 ± 0.79 a 2.53 ± 1.26 a
RSSstruvite 0.041 ± 0.059
a 0.034 ± 0.038 a 0.089 ± 0.089 a 0.017 ± 0.059 a
pH 6.09 ± 0.17 a 5.98 ± 0.12 a 6.14 ± 0.29 a 5.92 ± 0.18 a
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results compared to non-struvite (P<0.0001, OR 5.4, CI 3.5-8.4),
as did uroliths from female dogs (P<0.0001, OR 2.9, CI 41.9-
4.3). Dogs <7 years had a decreased risk for positive urolith cul-
ture (P<0.0001, OR 0.4, CI 0.3-0.6). There was no signiﬁcant
diﬀerence between culture results and previous antimicrobial
administration (P=0.4), suggesting stone cultures may be war-
ranted despite this. Analyzing urolith cultures may help guide
patient management and urolith prevention.
ABSTRACT NU-19
THE USE OF DARBEPOETIN ALFA IN CATS WITH
CHRONIC KIDNEY DISEASE. JE Markovich, MA Labato,
EH Fiocchi, EA Rozanski. Tufts University Cummings School of
Veterinary Medicine, North Grafton, MA
End stage chronic kidney disease (CKD) is often associated
with the development of non-regenerative anemia due to
decreased production of endogenous erythropoietin. Therapy
with recombinant human erythropoietin is eﬀective at raising the
hematocrit, but is associated with the possible development of
pure red cell aplasia (PRCA). Darbepoetin alfa is a newer syn-
thetic human recombinant erythropoietin analog and has been
suggested as less likely to cause the development of antibody-
associated PRCA.
The purpose of this study was to describe the use of darbepoe-
tin in cats with CKD in a prospective observational study. Cats
with CKD IRIS stage II-IV, with a non-regenerative anemia of
 23% were enrolled in the study. Darbepoetin at a dose of 1
mcg/kg/week was administered intravenously or subcutaneously
until the patient PCV = 30%. Blood pressure, PCV/TS, and cre-
atinine were monitored throughout the study. Descriptive statis-
tics were used.
Seven cats were enrolled. The length of time to achieve a PCV
 30% was a median of 47 days (range 7-52 days). No cats
developed new anemia during therapy or other evidence of
PRCA. Survival times from the initiation of darbepoetin therapy
to death ranged from 42-296 days (mean 133 days; median 78
days). All cats were IRIS Stage III or IV throughout the study.
At achievement of the target PCV of 30%, there was no signiﬁ-
cant increase in blood pressure in any cat from the start of the
study, and in one cat the blood pressure normalized.
In this pilot study, 1 mcg/kg/week was eﬀective in raising the
hematocrit of cats with CKD without evidence of pure red cell
aplasia. Further investigation of darbepoetin in cats is warranted.
ABSTRACT NU-20
INTRAVESICAL GLYCOSAMINOGLYCANS AS A NOVEL
THERAPY FOR FELINE IDIOPATHIC CYSTITIS – A
PILOT STUDY. A Bradley, MR Lappin. Department of Clinical
Sciences, Colorado State University, Fort Collins, CO
Feline idiopathic cystitis (FIC) is a common, frustrating condi-
tion with few proven therapeutic options. Its recurrence rate is
approximately 50% and FIC can result in urethral obstruction.
One of the proposed causes of FIC is a defective glycosaminogly-
can (GAG) layer lining the urinary bladder mucosa. Exogenous
GAGs adhere to damaged bladder uroepithelium, and promising
data exist for their use in human interstitial cystitis. The objec-
tives of this prospective study were to evaluate the safety of in-
travesical GAGs while gathering pilot data for a larger study.
At the time of abstract submission, 13 cats presenting for ure-
thral obstruction were enrolled. Previously treated cats, as well as
cats with severe azotemia or hyperkalemia, urolithiasis, and/or
uroabdomen were excluded. Cats were treated as similarly as pos-
sible (sedation or anesthesia for urinary catheter placement, ﬂuid
therapy, buprenorphine, phenoxybenzamine, canned urinary diet)
and randomized to receive either intravesical GAGs (hyaluronic
acid, chondroitin sulfate, glucosamine; A-CYST, Arthrodynamics
Laboratories, Lexington, KY) or intravesical saline placebo at
the time of catheter placement and again 12 and 24 hours later.
Outcomes included urinalysis at day 0, 3, and 7, urine culture at
day 0 and 7, standardized pain scoring, and incidence of repeat
urethral obstruction.
There was no signiﬁcant diﬀerence in presenting potassium or
creatinine levels or in pain score between the treatment group (n
= 6) and the placebo group (n = 7). The mean urine speciﬁc
gravity of the treatment group was 1.030 versus 1.043 for the pla-
cebo group (p = 0.05), and the mean protein content of the
treatment group was 2.8 versus 1.6 for the placebo group (p =
0.03). Three of the cats that received the placebo developed
repeated urethral obstruction within one week of initial presenta-
tion with 2 of 3 cats re-enrolled in the treatment group. When
these results were combined, 3 of 7 cats (42.9%) in the placebo
group and 0 of 8 cats in the treatment group developed a repeat
obstruction (p = 0.08). No adverse reactions to intravesical
GAGs were observed. Three of the 12 post-catheter urine cul-
tures were positive (one each of methicillin-resistant Staphylococ-
cus aureus, Streptococcus sp., and Escherichia coli). There was no
diﬀerence in incidence of urinary tract infection between the
treatment and placebo groups. Subjectively, urine sediment
became more benign in all cats over time.
This GAG was previously shown to be safe administered IM
and appears to be safe for instillation into the urinary bladders
of cats with urethral obstruction. A lower percentage of treated
cats developed a repeat urethral obstruction compared to the sal-
ine placebo, however, results were not signiﬁcantly diﬀerent, and
so larger studies are indicated to further evaluate the eﬃcacy of
this novel therapeutic option for FIC.
SMALL ANIMAL – NEUROLOGY
ABSTRACT N-1
CEREBELLAR ABIOTROPHY IN FOUR RELATED POM-
ERANIANS. C Levine1, J Evans1, RC Longshore2, SB
Plummer1, GC Johnson3. 1Veterinary Neurological Center,
Phoenix, AZ, 2Gulf Coast Veterinary Specialists, Department of
Neurology/Neurosurgery, Houston, TX, 3University of Missouri,
Veterinary Medical Diagnostic Laboratory, Columbia, MO
Cerebellar abiotrophy is the result of premature death or
degeneration of related groups of neurons, usually Purkinje cells,
in the cerebellar cortex, due to an inborn metabolic error result-
ing in their unexpected degeneration. This disease has been
described in a number of the domesticated species, primarily the
dog, but also in the cat, cattle, sheep, and horses. The disease
can manifest as neonatal, juvenile, or adult onset forms and an
autosomal recessive pattern of inheritance has been described in
several species. The symptoms of the disease are characteristic of
cerebellar dysfunction, such as ataxia, dysmetria, falling, inten-
tion or generalized tremors, and occasionally apparent blindness,
though not all clinical signs may be manifested. Four purebred
young adult Pomeranians with a history of slowly progressive
signs of cerebellar ataxia such as hypermetria, falling over back-
wards, and visual deﬁcits were examined. Diagnostic tests were
unremarkable and empirical treatment did not alter the progres-
sion of signs. Necropsy was performed on 3 of the dogs and
identiﬁed extensive loss of Purkinje neurons consistent with a
diagnosis of cerebellar abiotrophy. Analysis of the pedigrees
showed that these dogs were directly related and an autosomal
recessive mode of inheritance was likely. Cerebellar abiotrophy
has been best characterized in the dog, but has not been previ-
ously reported in the Pomeranian.
ABSTRACT N-2
DOES CEREBROSPINAL FLUID CYTOLOGY PREDICT
CENTRAL NERVOUS SYSTEM HISTOLOGY? U Jeﬀery, N
Jeﬀery. Iowa State University, Ames, IA
CSF analysis of cell count, cytology and total protein has been
shown to provide diagnostically useful, but non-speciﬁc, informa-
tion. However, CSF samples are often low volume, so tests must
be prioritized. This study determined how frequently CSF cytol-
ogy alone was able to predict: i) the precise histologic diagnosis;
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or ii) a category of histologic diagnosis with a single treatment
implication (e.g. immune mediated disease).
Medical record search identiﬁed 50 dogs and 7 cats that had a
CSF cytology report and CNS post mortem histology determined
within 14 days. Using standardized criteria, CSF cytology were
classiﬁed as: i) ‘non-diagnostic quality’; ii) ‘no abnormalities’; or
iii) ‘abnormal’. Cytologic diagnoses from abnormal CSF were
classiﬁed into categories as: a) a speciﬁc disease; b) multiple pos-
sible diagnoses requiring diﬀerent treatments; c) multiple possible
diagnoses all requiring a single type of therapeutic intervention.
CNS histology diagnoses were then grouped into the same cate-
gories using standardized criteria.
8 CSF samples were not of diagnostic quality. 13 CSF samples
had no cytologic abnormality; corresponding histology indicated:
no CNS lesion (n= 2); a CNS lesion with insuﬃcient informa-
tion for treatment (n=4); infectious disease (n=2); neoplasia
(n=2) and compression (n=3). For the 36 samples with cyto-
logic abnormalities, 1 CSF cytology indicated a deﬁnitive diagno-
sis of storage disease. Histologic diagnosis included storage
disease as one of multiple diﬀerentials. 1 CSF cytology suggested
only infectious diﬀerential diagnoses but GME was diagnosed on
histology. 34 CSF samples were compatible with multiple diﬀer-
ential diagnoses requiring diﬀerent treatments. Of these, histo-
logic diagnosis was neoplasia (n=8); immune mediated disease
(n=6); infectious (n=8) and myelomalacia (n=1) or did not pro-
vide suﬃcient information to treat (n=11). A comparison group
of patients that survived for more than 14 days after CSF analy-
sis showed no diﬀerence in the number of CSF samples providing
either a deﬁnitive diagnosis or a group of diagnoses all requiring
the same treatment.
Overall, diagnostic quality CSF samples had a sensitivity of
77% for detection of a lesion in CNS but only 2 (4%) CSF sam-
ples provided suﬃcient information to suggest a treatment
modality, and this would have lead to incorrect choice of therapy
in 1 of the 2 cases.
This study suggests that although CSF cytology may aid in
conﬁrming an inﬂammatory / infectious CNS process, it rarely
provides suﬃcient information to suggest therapy. Given the
increased interest in stereotactic brain biopsy, it is also interesting
to note that 30% of CNS post mortem histology results did not
give suﬃcient information for selection of therapy.
ABSTRACT N-3
THE PHARMACOKINETICS OF CYTARABINE IN DOGS
WHEN ADMINISTERED VIA SUBCUTANEOUS AND CON-
TINUOUS INTRAVENOUS INFUSION ROUTES. KI Crook,
PJ Early, KR Munana, R Gallagher, K Messenger, MG Papich,
JA Nettifee-Osborne. North Carolina State University College of
Veterinary Medicine, Raleigh, NC
The objective of this study was to compare the pharmacokinet-
ics of cytarabine (CA) in 6 healthy dogs following intravenous
constant rate infusion (CRI) and subcutaneous (SC) administra-
tions. The study was a two-period randomized cross-over design
in which each dog received a SC cytarabine injection of 50 mg/
m2 and a CRI of 25 mg/m2/hr over 8 hours, with a washout per-
iod of 7 days between treatments. Blood samples were collected
for 16 hours after initiation of the CRI and for 8 hours after SC
injection. Plasma cytarabine concentrations were measured by
HPLC. Pharmacokinetic parameters were determined with a
compartmental model with the input as either a zero-order CRI,
or ﬁrst-order absorption from the SC dose. The terminal half life
(T ½) of CA was 1.35 ±0.3h and 1.15 ± 0.13h after SC adminis-
tration and CRI, respectively. The mean peak concentration
(Cmax) after SC administration was 2.88µg/ml. For CRI admin-
istration the Cmax was 2.89µg/ml. Volume of distribution was
0.66 ± 0.07 L/kg. Mean concentrations were sustained above 1.5
µg/mL throughout the entire 8 hour CRI administration, whereas
they were sustained above this level for only 2 hours after SC
administration. Therefore, steady state achieved with the cytara-
bine CRI produces a more consistent and prolonged exposure of
this agent in the plasma, which is likely to produce an equilib-
rium between blood and the central nervous system, compared to
the poorly sustained concentrations after SC administration.
Therefore, IV administration via CRI may have an advantage for
treating CNS disease in dogs.
ABSTRACT N-4
CEREBROSPINAL FLUID CLUSTERIN IS A POTENTIAL
BIOMARKER OF CANINE NEURODEGENERATIVE DIS-
ORDERS. INF Shaﬁe1, M McLaughlin1, P Montague2, PEJ
Johnston1, J Penderis1, TJ Anderson1. 1School of Veterinary
Medicine, 2Institute of Infection, Immunity and Inﬂammation,
College of Medical, Veterinary and Life Sciences, University of
Glasgow, Glasgow, UK
The diagnosis of canine neurodegenerative disorders relies on
a combination of clinical evaluation, imaging modalities and, if
available, genetic assessment and often requires neuropathologi-
cal examination for conﬁrmation. Despite the continual improve-
ment in the range of diagnostic tests, conﬁrmation of speciﬁc
diagnosis for canine neurodegenerative disorders such as degener-
ative myelopathy (DM) can be elusive in the clinic, complicating
decision-making and therapeutic management. The purpose of
this study was to explore the potential of canine cerebrospinal
ﬂuid (CSF) as a source of biomarkers for supporting clinical
diagnosis of DM.
Clinical material for this study was derived from cases
undergoing routine neurological investigation at the University
of Glasgow Small Animal Hospital, with ethical approval. All
cases were diagnosed using routine techniques including hae-
matology, biochemistry, CSF analysis and advanced imaging.
Additionally, all cases were genotyped as to the presence of the
SOD1 mutation that is associated with DM; using an in house
protocol. CSF protein proﬁling by gel electrophoresis demon-
strated an abundant protein in DM that was subsequently iden-
tiﬁed by mass spectrometry as clusterin (also known as
apolipoprotein J). Initial semi-quantitative Western blot analy-
sis of canine CSF conﬁrmed that clusterin was signiﬁcantly ele-
vated in DM (n=5) compared to IE (n=7) (p<0.01). A
further comparison across a range of neurological conditions
found that clusterin was elevated in DM (n=4) and chronic
intervertebral disk disease (cIVDD) (n=4) compared to IE
(n=7) (DM vs. IE, p<0.001; cIVDD vs. IE, p<0.05) and men-
ingitis (n=8) (DM vs. meningitis, p<0.01; cIVDD vs. meningi-
tis, p>0.05). There was no signiﬁcant diﬀerence in CSF
clusterin between DM and cIVDD. An investigation of plasma
clusterin level in DM (n=5) and IE (n=7) found no signiﬁcant
diﬀerence in the protein level, although a proportion of DM
cases (3/5) demonstrated a gel shift which may indicate a post
translational modiﬁcation.
Clusterin mRNA level in the thoracic spinal cord of DM
and control cases (dogs unaﬀected by neurological diseases)
was compared by RT-PCR. For this comparison tissue was
derived from archival post mortem material and SOD1 geno-
typing was undertaken to support the histopathological diagno-
ses. CSF samples were not available for these cases. The mean
mRNA level was elevated by 42% in DM (n=4) compared to
control cases (n=4), a diﬀerence bordering on statistical signiﬁ-
cance (p=0.05).
These observations suggest CSF clusterin may be considered
as a potential biomarker for canine neurodegenerative conditions,
potentially those associated with neuronal dysfunction and death.
Clusterin may therefore represent one component in a panel of
emerging biomarkers that may combine to distinguish speciﬁc
neurodegenerative disorders such as DM in the clinic.
ABSTRACT N-5
L-2-HYDROXYGLUTARIC ACIDURIA IN YORKSHIRE
TERRIER DOGS: CHARACTERIZATION OF THE MOLEC-
ULAR DEFECT. D Sanchez1,2, J Mascort2, C Jakobs3, GS
Salomons3, R Artuch4, A Lujan Feliu-Pascual2. 1Animal Health
Trust, Newmarket, UK, 2Hospital ARS Veterinaria, Barcelona,
Spain, 3VU University Medical Center, De Boelelaan,
Amsterdam, The Netherlands. 4Hospital San Joan de De´u,
Barcelona, Spain
L-2-hydroxyglutaric aciduria (L-2-HGA) represents a recently
deﬁned inborn error of metabolism with a variety of clinical neu-
rological deﬁcits including seizures, head tremors and ataxia.
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Two female Yorkshire terrier dogs were evaluated because of
generalized tonic-clonic seizures. The dogs underwent a magnetic
resonance imaging study of the brain. T1-weighted, T2-weighted
and ﬂuid-attenuation inversion recovery sequences were obtained
in diﬀerent planes. These images revealed bilaterally symmetrical,
diﬀuse regions of grey matter hyperintensity on T2-weighted and
FLAIR images, which were most prominent in the parietal cere-
bral cortex, thalamus, mesencephalon and cerebellum. Postcon-
trast T1-weighted sequences showed no contrast enhancement.
Based on the imaging ﬁndings, diﬀerential diagnoses included
metabolic or toxic encephalopathies.
To investigate the possibility of an intrinsic metabolic disorder,
urinary organic acid and amino acid proﬁles were quantiﬁed by
gas chromatography-mass spectroscopy and were consistent with
diagnosis of L-2-HGA.
In both aﬀected dogs a homozygous pathogenic mutation at
the translation initiation codon of the L2HGDH gene was
detected (c.1A>G; p.Met1?) conﬁrming the diagnosis L-2-HGA
at the DNA level. To our knowledge these are the ﬁrst two cases
described of L-2-HGA in Yorkshire terriers, with a diﬀerent
mutation to the Staﬀordshire bull terriers.
ABSTRACT N-6
DIAGNOSTIC VALUE AND DISCRIMINATORY ABILITY
OF PROTON MAGNETIC RESONANCE SPECTROSCOPY
FOR INTRACRANIAL NEOPLASIA IN DOGS. KR
Mikoloski, PA March, D Faissler. Cummings School of
Veterinary Medicine at Tufts University, North Grafton, MA
Metabolic proﬁles have been developed using proton magnetic
resonance spectroscopy (1H-MRS) in humans to aid in distin-
guishing types of intracranial neoplasia. The goal of our study
was to determine whether 1H-MRS was useful in discriminating
diﬀerent types of intracranial neoplasia in dogs.
Ten dogs with intracranial neoplasia and 2 normal dogs
underwent single voxel 1H-MRS in addition to a standard MRI.
Spectra were obtained at echo times of 135 ms (long TE) and 30
ms (short TE). A manual, interactive shimming protocol was
used. Metabolites were quantiﬁed as areas beneath their respec-
tive peaks. Creatine (Cr), Choline (Cho), and N-acetyl aspartate
(NAA) were measured on long TE spectra. Cr, myoinositol/gly-
cine (mIG), and Cho were measured on short TE spectra. At
short TE, the NAA peak was partially obscured in many cases
by a broad overlapping glutamine/glutamate/macromolecule
complex (Glx/MM), making precise measurement diﬃcult. Lac-
tate (Lac), lipids, and alanine (Ala) were also subjectively evalu-
ated.
A histopathologic diagnosis with either necropsy or surgical
biopsy was obtained in seven dogs (3 meningiomas, 2 gliomas, 2
metastatic tumors). Presumptive diagnoses were made in the
remaining three dogs based on MRI and clinical ﬁndings (proba-
ble meningioma in 1 dog and probable glioma in 2 dogs).
mIG resonance on short TE spectra was over 4 times greater
in gliomas than meningiomas (1.98 versus 0.45) as compared to
0.86 in normal dogs. The Glx/MM/NAA complex on short TE
spectra was subjectively more prominent in meningiomas than in
gliomas. Ala was noted in one dog with a meningioma on short
TE spectra. On long TE spectra, both Cr and NAA were reduced
in all tumor groups compared to normal dogs. The mean Cr res-
onance at long TE was lower in meningiomas compared to glio-
mas (0.98 versus 1.21). Cho concentrations on long TE spectra
were greater in dogs with intracranial neoplasia compared to nor-
mal dogs (3.84 versus 2.83). Lac and lipid peaks were subjectively
higher in dogs with metastatic neoplasia than in dogs with pri-
mary neoplasia.
Based on the results of this study, meningiomas and gliomas
appear to have some important diﬀerences on 1H-MRS that may
help diﬀerentiate these tumors. The more prominent and consis-
tent diﬀerences were seen in mIG and Glx/MM metabolites on
short TE spectra. mIG was greater in dogs with gliomas than in
normal dogs and in dogs with meningiomas. The Glx/MM
metabolites were greater in dogs with meningiomas than in dogs
with gliomas. 1H-MRS spectra may be a valuable method to
non-invasively diﬀerentiate meningiomas from gliomas. More
cases will be needed to determine if these diﬀerences in their
metabolite proﬁles are statistically signiﬁcant.
ABSTRACT N-7
MAGNETIC RESONANCE IMAGING FEATURES OF
INTRACRANIAL GRANULAR CELL TUMORS IN SEVEN
DOGS. CC Anwer1, KM Vernau1, RJ Higgins1, PJ Dickinson1,
BK Sturges1, RA LeCouteur1, RT Bentley2, ER Wisner1.
1University of California – Davis, Davis, CA, 2Purdue
University, West Lafayette, IN
Intracranial granular cell tumors (GCTs) are rarely reported in
dogs. Histopathological descriptions exist, however magnetic res-
onance (MR) imaging features have been described in only two
dogs. The goal of this retrospective study is to describe the MR
characteristics of intracranial GCTs in a larger number of dogs.
Seven dogs with histologically conﬁrmed intracranial GCTs
and complete MR imaging were studied. MR images were evalu-
ated for tumor location, size, mass eﬀect, T1- and T2-weighted
signal intensity, contrast enhancement, and peritumoral edema.
In MR images of 6/7 patients, GCTs were well-deﬁned and
extra-axial, with a plaque-form, sessile distribution involving the
meninges. These six tumors were located along the convexity of
the cerebrum, the falx cerebri, or the ventral ﬂoor of the cranial
vault and were mildly hyperintense on T1-weighted images, and
iso- to hyperintense on T2-weighted images. A moderate to
marked degree of peritumoral edema and mass eﬀect was evident
in all six patients. Interestingly, 1/7 dogs had a small suprasellar
GCT that was isointense on T1- and T2-weighted images, and
did not have a plaque-form shape, peritumoral edema, or mass
eﬀect.
In summary, hyperintensity on T1-weighted MR images, pla-
que-form distribution, and marked peritumoral edema and mass
eﬀect were consistent cerebral GCT imaging features in 6/7 dogs.
However these ﬁndings are not unique to GCTs. In addition,
MR imaging features of the solitary suprasellar GCT diﬀered
from the other GCTs in the study.
ABSTRACT N-8
SIGNALMENT, CLINICAL FINDINGS, MAGNETIC RESO-
NANCE IMAGING FEATURES AND SURGICAL OUT-
COMES WITH HISTOPATHOLOGICALLY CONFIRMED
EPIDURAL AND SUBDURAL SPINAL CORD HEMATOMA
IN DOGS. DW Hague1, WW Bush1, EN Glass2, AC Durham3.
1Bush Veterinary Neurology Service, Leesburg, VA, 2Red Bank
Veterinary Hospital, Tinton Falls, NJ, 3University of
Pennsylvania School of Veterinary Medicine Department of
Pathobiology, Philadelphia, PA
Epidural spinal cord hematoma has been described in veteri-
nary medicine in association with neoplasia, intervertebral disc
disease, and snake envenomation. In human medicine there are
rare reports of spontaneous epidural or subdural spinal cord
hematoma where there was no known cause. Spontaneous spinal
cord hematoma has not been described in veterinary medicine.
The purpose of this study is to describe the signalment, clinical
ﬁndings, magnetic resonance imaging features and surgical out-
comes in histopathologically conﬁrmed epidural and subdural
spinal cord hematomas in dogs with no identiﬁed underlying eti-
ology.
Five dogs were included with a histopathologic diagnosis of
epidural or subdural spinal cord hematoma not associated with
an underlying cause. Magnetic resonance imaging and surgical
outcomes were evaluated. Large breed dogs (>25 kg) accounted
for 4/5 of the cases. There were 3 spayed females and 2 neutered
males. The mean age was 5.4 years. On presentation, most dogs
(4/5) were ambulatory with paresis and ataxia and only one
patient was non-ambulatory and paretic. In most dogs (4/5),
focal spinal pain was elicited on examination. All patients had an
acute onset and then progression of clinical signs. There was a
range of 1-13 days between the onset of clinical signs to magnetic
804 2012 ACVIM Forum Abstracts
resonance imaging. Hematoma was located at the vertebral col-
umn level C2, C4-5, C5, T13-L1 and L5.
Magnetic resonance imaging and surgery showed 3 patients
had epidural and 2 patients had subdural hematoma formation.
All ﬁve dogs had normal signal within the spinal cord and vari-
able spinal cord compression ranging from 20-50%. All hemato-
mas had mild to moderate T2W hyperintensity and mild to
strong contrast enhancement. They appeared isointense in 3 cases
and mildly hyperintense in 2 cases on the T1W pre-contrast
sequences. Prior to surgery and histopathology the primary dif-
ferential in most cases was neoplasia.
The underlying etiology of the hematomas was not identiﬁed
in all cases. All dogs had adequate platelet numbers. A coagula-
tion panel performed on one dog was normal. Two dogs had in-
traoperative cultures which were negative.
All dogs underwent surgical decompression with dorsal or
hemilaminectomy and all patients returned to normal or near
normal neurologic function following surgery. Follow-up on the
patients (ranging between 14-188 days) shows no progression of
neurologic symptoms or conditions associated with increased
bleeding. The prognosis with spontaneous spinal cord epidural
and subdural hematoma with surgical decompression appears to
be favorable.
ABSTRACT N-9
MRI ASSESSMENT OF DOGS WITH DESCENDING TRAN-
STENTORIAL AND/OR FORAMEN MAGNUM BRAIN
HERNIATIONS. JR Barker, D Faissler, O Taeymans.
Cummings School of Veterinary Medicine at Tufts University,
North Grafton, MA
The aim of this study was to develop a scoring system of MRI
images assessing backwards movement of the brain in the caudal
fossa caused by supratentorial space occupying lesions.
A semi-quantitative approach determining CSF ﬁlling in eight
regions, and a quantitative measurement of four diﬀerent param-
eters were designed. MRI images were examined for lesion loca-
tion and lateralization. Total brain and lesion volume,
surrounding edema, and relative volume of the mass were calcu-
lated. Clinical signs were grouped into seizure, abnormal cranial
nerve function, cranial nerve dysfunction combined with abnor-
mal gait and endocrine disease. Pairwise data analysis was per-
formed comparing aﬀected with unaﬀected dogs using the SPSS
19 software package.
81 aﬀected and 81 control dogs were analyzed. Sex and breed
distribution were similar in both groups. All semi-quantitative
and the quantitative parameters of tentorial angle, foramen mag-
num line and brainstem ratio showed a signiﬁcant diﬀerence
between study and control dogs. Tentorial angle, cerebellar
height, length, their ratio, spinal cord height and brainstem to
spinal cord ratio were signiﬁcantly correlated to the degree of
CSF ﬁlling. Lesions in the frontal or olfactory lobes caused sig-
niﬁcantly less herniation when compared to masses in other brain
areas. Total and relative lesion volumes were signiﬁcantly corre-
lated to all semi-quantitative measurements, tentorial angle and
cerebellar length.
In conclusion, our semi-quantitative measurements and tento-
rial angle best determine the magnitude of brain herniation. The
ratio of lesion and edema volume to brain volume can predict
degree of herniation best when used in conjunction with lesion
location.
ABSTRACT N-10
KINEMATIC GAIT ANALYSIS USING 3-D MOTION CAP-
TURE IN DOBERMAN PINSCHERS WITH AND WITHOUT
CERVICAL SPONDYLOMYELOPATHY. K Foss, RC da
Costa. Department of Veterinary Clinical Sciences, College of
Veterinary Medicine, The Ohio State University, Columbus, OH,
USA
The most widely used method for determining the response to
treatment in patients with cervical spondylomyelopathy (CSM) is
based oﬀ of the owner and clinician’s perception of the gait. This
form of evaluation is highly subjective and can suﬀer from obser-
ver bias. The purpose of this study was to utilize digital video
motion capture to compare multiple kinematic parameters
between Doberman Pinscher dogs with and without CSM.
Nineteen Doberman Pinschers were prospectively studied; 10
clinically normal dogs and 9 with CSM. Neurologic examinations
were performed in all dogs prior to enrollment. Clinically normal
dogs also underwent transcranial magnetic stimulation to further
exclude any underlying neurologic abnormalities. All CSM-
aﬀected dogs had their diagnosis conﬁrmed with a 3.0 T MRI.
All dogs were ﬁtted with a lycra bodysuit and 32 reﬂective mark-
ers representing speciﬁc anatomic landmarks from all four limbs,
head and trunk were applied. 3-D motion capture was performed
with 15 infrared cameras in a designated capture space using the
Vicon8i motion capture system.
Using Vicon iQ 2.0 software (Vicon, CA), the markers were
used to reconstruct a 3-D stick diagram representation of each
dog. This representation was then used to measure multiple
parameters of interest. Parameters evaluated included stride dura-
tion, stride length, stride height, maximal and minimal spinal
angles, elbow and stiﬂe ﬂexion and extension, and maximum and
minimum distances between the thoracic and pelvic limbs. At
least 45 seconds of high quality data capture were used for statis-
tical analyses. The means of all parameters were compared
between normal and CSM-aﬀected Dobermans using a random
eﬀects linear regression model.
Due to space constraints only portion of results will be pre-
sented and discussed. Minimum thoracic limb distance was signif-
icantly smaller (P=0.024) in CSM-aﬀected dogs (mean=116
mm) versus normal dogs (mean=146 mm), as was maximum
thoracic limb distance (P=0.001) with a mean of 184 mm in
CSM-aﬀected dogs and 222 mm in normal dogs. Additionally,
stride duration in the thoracic limbs was also signiﬁcantly smaller
(left thoracic: P=0.013; right thoracic P=0.016) in CSM-aﬀected
dogs (mean=0.7 sec) when compared to normal dogs (mean=0.8
sec).
In conclusion, the thoracic limb distances and thoracic limb
stride duration were found to be signiﬁcantly smaller in CSM-
aﬀected Doberman Pinschers when compared to normal Dober-
mans. Interestingly, these ﬁndings suggest that when using com-
puterized kinematic gait analysis to compare the gait between
normal and CSM-aﬀected Dobermans, the thoracic limbs appear
to reveal more consistent diﬀerences than the pelvic limbs.
ABSTRACT N-11
THE VACUUM PHENOMENON IN INTERVERTEBRAL
DISC DISEASE OF DOGS BASED ON COMPUTED
TOMOGRAPHY IMAGES. MK Mu¨ller1, E Ludewig1, G
Oechtering1, M Scholz2, T Flegel1. 1University of Leipzig,
Department of Small Animal Medicine, Leipzig, Germany;,
2University of Leipzig, Institute for Medical Informatics,
Statistics and Epidemiology, Leipzig, Germany
The term “vacuum phenomenon” is used to describe accumu-
lation of gas within tissues such as degenerated intervertebral
discs. Thus this phenomenon is sometimes used, to localise a her-
niated discs. The purpose of this study therefore was 1. to deter-
mine the frequency of the vacuum phenomenon in dogs
surgically treated for intervertebral disc diseases, 2. to evaluate
factors inﬂuencing the frequency of the vacuum phenomenon and
3. to determine the value of the vacuum phenomenon for localiz-
ing disc herniation.
Computed tomography scans of dogs with conﬁrmed interver-
tebral disc herniation were examined for a vacuum phenomenon.
Patients were included if a computed tomography with or with-
out subarachnoidal contrast was performed pre-surgically and
the site of radiologically diagnosed disc herniation could be con-
ﬁrmed by the surgical report, immediate postsurgical computed
tomography images or necropsy report. Inclusion criteria were
met by 187 dogs. Dogs were divided for statistical analysis into
the following subgroups: chondrodystrophic dogs (61%), non
chondrodystrophic dogs (15%) and such of unclear classiﬁcation
(24%).
The median number of scanned discs was 14 (range 4-26).
Vacuum phenomenon was found in 19.8 % of dogs. The preva-
lence in subgroups was 14.9% in chondrodystrophic dogs, 34.5%
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in non chondrodystrophic dogs, and 24.4% in dogs of unknown
classiﬁcation respectively. The frequency of vacuum phenomena
was signiﬁcantly higher in chondrodystrophic than in non chon-
drodystrophic dogs (P= 0.03). Age has a signiﬁcant inﬂuence on
the appearance of the vacuum phenomenon. With every addi-
tional year of age the relative risk to show a vacuum phenome-
non increases by 15 % (P=0.04).
The vacuum phenomenon appeared in the currently herniated
intervertebral disc in 64.1 %. The frequencies in the subgroups of
chondrodystrophic, non chondrodystrophic dogs and such of
unknown classiﬁcation were 67%, 40%, and 82% respectively.
The correspondence between vacuum phenomenon and herniated
disc in dachshunds only was 86%. Non chondrodystrophic dogs
were less likely to show a vacuum phenomenon in the currently
herniated disc (P=0.03). Age does not have a signiﬁcant inﬂu-
ence on the concurrence between the site of the phenomenon and
the actual herniated disc except in chondrodystrophic dogs,
where the relative probability increases by 22% every year
(P=0.04).
In conclusion, vacuum phenomenon is a frequent but inconsis-
tent ﬁnding in intervertebral disc disease in dogs. It does, how-
ever, not allow localizing the currently herniated disc.
ABSTRACT N-12
MUTATION ASSOCIATED WITH NEONATAL CEREBEL-
LAR CORTICAL DEGENERATION IN BEAGLE DOGS
IDENTIFIED BY GENOME-WIDE MRNA SEQUENCING. E
Beltran, O Forman, C Mellersh, J Stewart, L De Risio. Animal
Health Trust, Newmarket, UK
Neonatal cerebellar cortical degeneration is a neurodegenera-
tive disease described in several canine breeds including Beagle
dogs, for which autosomal recessive mode of inheritance has been
suggested. The aﬀected dogs are unable to ambulate normally
since the onset of walking and the main pathological ﬁnding
includes Purkinje neuron loss with swollen dendritic processes.
The aim of the study was to investigate whether a mutation in
one of the candidate genes was responsible for this disease.
A four-week old Beagle dog presented to the Animal Health
Trust with progressive signs of cerebellar ataxia. The neuroan-
atomic localization was to the cerebellum. Hematology and com-
prehensive biochemistry were normal. The owner elected
euthanasia. Histopathology was consistent with neonatal cerebel-
lar cortical degeneration. Genome-wide mRNA sequencing
(mRNA-seq) from post-mortem cerebellum tissue was used as a
method of candidate gene sequencing. After analysis of the
canine orthologues of spinocerebellar ataxia associated genes
from human studies, we identiﬁed a homozygous 8 bp deletion in
a candidate gene previously associated with spinocerebellar ataxia
in humans. Genotype analysis of the sire, dam and six clinically
unaﬀected siblings showed the mutation to fully segregate with
the disorder. Previous studies have demonstrated that this protein
is critical for Purkinje cell development, and its absence can lead
to cell damage through excitotoxicity, explaining the observed
Purkinje neuron loss, degeneration of dendritic processes and
associated neurological dysfunction. The mentioned mutation has
been found, at a low frequency, in the United Kingdom popula-
tion of Beagles and a DNA test is being developed.
ABSTRACT N-13
SURGICAL REMOVAL OF FELINE INTRACRANIAL MEN-
INGIOMAS: CLINICAL FEATURES AND OUTCOME IN
121 CASES (1994-2011). S Cameron, CW Dewey, M Rishniw.
Cornell University College of Veterinary Medicine, Ithaca, NY
Meningiomas are the most common brain tumor reported in
cats. The purpose of this study was to report clinical features
and outcome of a large group of cats with surgically removed
intracranial meningiomas.
Data were collected from 121 cats with intracranial meningi-
oma removed surgically and conﬁrmed histopathologically.
Breed, sex, age, clinical signs, duration of clinical signs, drugs
used before and after surgery, biopsy results, imaging reports,
and outcome were recorded for each case. 83 of the 121 cats were
domestic short-hairs with 76 neutered males and 43 spayed
females. Body weight ranged from 1.5 to 8.7kg (median 4.95kg).
Age ranged from 3.3 to 19.2 years (median age 12.2 years). 81
cats displayed behavior changes, 46 were ataxic, 32 had seizures,
31 had visual deﬁcits, 24 were circling, and 14 were paretic.
Duration of neurologic signs ranged from 0 to 23 months (med-
ian 1.25 months). The duration of non-neurologic signs ranged
from 0 to 18 months (median 2 months). At the time of data col-
lection, 41 cats were alive, 26 were dead or euthanized, and 54
were lost to follow-up. Of the 26 cats that died, 5 were due to
causes directly related to the meningioma and/or surgery. 8 cats
died due to causes that were thought to be related to the original
tumor, surgery, or regrowth of the tumor. The mean survival
time for cases, excluding those lost to follow-up 17.8 months
(range 0-71 months). Overall, cats with meningiomas treated with
surgery alone had a good prognosis.
ABSTRACT N-14
EFFECT OF CHLORIDE IN INFUSION FLUID ON SERUM
BROMIDE CONCENTRATION IN DOGS. K Orito1, K
Fukunaga1, H Matsumoto1, M Wate2, M Muto2, M Saito2.
1Department of Physiology II, 2Department of Veterinary
Surgery II, School of Veterinary Medicine, Azabu University,
Sagamihara, Kanagawa, Japan
Bromide is frequently used for the management of epilepsy in
canine medicine. Dogs with high dietary chloride content report-
edly show a reduction of serum bromide concentration. However,
it is unclear how chloride content in infusion ﬂuid aﬀects serum
bromide concentration in dogs. It is also unclear whether the
chloride lowers serum bromide concentration dependently on the
initial serum bromide concentration. In the present study, there-
fore, the eﬀects of saline transfusion on various serum concentra-
tion of bromide were examined in beagles.
Potassium bromide was administered to beagles with a loading
dose of 500 mg/kg, PO, and the serum bromide concentration
was maintained with a maintenance dose of 25 mg/kg, PO, BID.
After stabilization of the serum bromide concentration, saline
was infused intravenously at diﬀerent rates for 5 h. Serum and
urine were collected before and 1, 2, 3, 4, 5, 6, and 7 h after the
initiation of transfusion. Bromide concentrations of serum and
urine were measured using high-performance liquid chromatogra-
phy and an ion-selective electrode, respectively.
Serum bromide concentration decreased and urine bromide
concentration increased when saline was transfused for 5 h.
These eﬀects were marked when saline was infused at a higher
rate. The rate of reduction of serum bromide concentration was
higher when the initial serum bromide concentration was higher.
In conclusion, serum bromide concentration is aﬀected by
chloride content of infusion ﬂuid, and the concentration of serum
bromide is the determinant of the rate of reduction of serum bro-
mide.
ABSTRACT N-15
DOES BODY CONDITION SCORE INCREASE RECOVERY
TIME IN DOGS TREATED WITH HEMILAMINECTOMY
FOR ACUTE ONSET DISC RUPTURE? CC Williams, G
Barone. Veterinary Medical Center of Long Island, West Islip,
NY
Intervertebral disc disease (IVDD) was initially reported in the
1800’s, with surgical intervention ﬁrst being described in the
1950’s. One previous study conducted showed a correlation
between body dimensions and the risk of IVDD. However, there
have been no studies indicating a relationship with body condi-
tion and post-operative recovery rate. In this study, we hypothe-
sized that dogs with a higher body condition score (BCS) that
underwent hemilaminectomy to repair acute onset intervertebral
disc rupture would have a lengthier recovery time.
Medical records from ﬁfty-one dogs that had undergone hemil-
aminectomy to repair acute IVDD (surgically conﬁrmed) in the
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thoracolumbar spine were reviewed. Parameters evaluated
included signalment, length of clinical signs prior to presentation,
length of recovery time, and neurologic grades pre and post-op.
A BCS grading scheme of 1 through 9 was used for all ﬁfty-one
dogs. Finally, the BCS and time to recovery was compared statis-
tically in all dogs. Recovery was deﬁned as “ambulation without
assistance”.
Results of the study revealed that there was a signiﬁcant asso-
ciation between BCS and time to recovery. The dogs were 7.62
times more likely to have recovered at the initial 3 to 4 week fol-
low-up if they had a BCS of six or less.
In conclusion, this study showed that as weight increased, the
time to recovery post hemilaminectomy surgery, also increased.
ABSTRACT N-16
IMMUNOHISTOCHEMICAL QUANTIFICATION OF
INTERLEUKIN-6 AND INTERLEUKIN-8 EXPRESSION IN
CANINE INTRACRANIAL MENINGIOMAS. S Al-Nadaf1,
SR Platt2, M Kent2, N Northrup2, EW Howerth2. 1North
Carolina State University, College of Veterinary Medicine,
Raleigh, NC, 2University of Georgia, College of Veterinary
Medicine, Athens, GA
Meningiomas are the most common intracranial tumors of
dogs. Although surgical excision is the primary treatment avail-
able, recurrence remains prevalent. The expression of pro-inﬂam-
matory cytokines, interleukin-6 (IL-6) and interleukin-8 (IL-8),
has been detected in human intracranial meningiomas, and these
cytokines have been shown to both promote and inhibit growth
of the tumor; additionally, the over-expression of IL-6 has been
recorded as a marker of malignancy in human gliomas. However,
meningiomas in dogs have yet to be investigated for IL-6 and IL-
8 expression despite sharing similar histological appearance to
human meningiomas.
The purpose of this study was to evaluate IL-6 and IL-8
immunohistochemical expression in canine intracranial meningio-
mas.
Immunohistochemistry was performed on 19 formalin-ﬁxed,
paraﬃn-embedded canine intracranial meningioma samples using
mouse anti-canine IL-6 monoclonal antibody and mouse anti-
canine IL-8 monoclonal antibody. Normal canine tonsil lym-
phoid tissue, canine carcinoma tumor tissue and a canine malig-
nant histiocytic cell line (DH82 cells) challenged with
lipopolysaccharide served as controls. Each tumor was evaluated
for staining intensity and the percent area of positive staining
cells using a subjective scoring system. The percent area of posi-
tive staining was scored as follows: 0, 0% of cells stained; 1, 1-
30% of cells stained; 2, 31-60% of cells stained; 3, 61-100% of
cells stained. Intensity was scored as: 0, negative expression; 1,
weak expression; 2, moderate expression; 3, marked expression.
Of the 19 meningiomas, immunochemistry staining for IL-6
expression was positive in ﬁve (26%), and IL-8 expression was
positive in none (0%). In the ﬁve samples positive for IL-6
expression, the percent staining area was greater than 61% (score
of 3) with two (40%) having weak (score of 1) staining intensity
and three (60%) having moderate (score of 2) staining intensity.
In conclusion, IL-6 expression, but not IL-8, was demon-
strated in a subset of canine intracranial meningiomas. Further
studies are needed to determine the role of IL-6 in canine intra-
cranial meningioma tumorigenesis and whether IL-6 expression
in a subset of these tumors could be used as a potential cell mar-
ker and as targeted immunotherapy.
ABSTRACT N-17
A NOVEL ANTI-CANINE CD133 ANTIBODY COLOCALIZ-
ES WITH GFAP IN NORMAL AND NEOPLASTIC CANINE
BRAIN TISSUE. D York, RJ Higgins, RA LeCouteur, PJ
Dickinson. University of California Davis, Davis, CA
CD133 is a penta-transmembrane protein that has been pro-
posed as a potential marker for a variety of stem cells and also
brain tumor stem-like cells. However there is much controversy
over its speciﬁcity and value in relation to therapeutic targeting.
Expression based on a variety of CD133 antibodies has been con-
ﬂicting and is complicated by alternative transcription and vari-
able glycosylation patterns.
We developed a novel polyclonal antibody targeted against a
canine speciﬁc 16aa peptide in the intracellular C-terminal
domain of the canine CD133 protein. On western blotting, the
antibody recognizes an approximately 80kDa protein in canine
adult brain and kidney, neonatal brain, canine glioma cell lines.
Minimal signal was seen in murine tissues. We compared the
antibody to one previously reported in canine tissue (Clone
13A4) and found strong staining only in murine tissues with
13A4.
Immunohystochemistry revealed staining of astrocytic-like cells
in normal canine and murine brain and orthotopic canine glial
tumors. Neurospheres derived from neonatal dog brain also had
positive staining. Almost all cells in the normal canine brain
staining positive for CD133 co-stained for GFAP, as did neuro-
spheres and cells within orthotopic tumors. Costaining was also
seen in peritumoral tissue from human glioblastoma multiforme.
GFAP has been reported as a marker of adult neural stem cells,
however CD133/GFAP co-localization diﬀers from previous
studies where GFAP did not generally co-stain with CD133.
These ﬁndings have potential implications for the use of CD133
as a marker for stemness and therapeutic targeting in canine
brain tumors.
ABSTRACT N-18
CLINICOPATHOLOGIC AND MAGNETIC RESONANCE
IMAGING CHARACTERISTICS OF HYPERTENSIVE
ENCEPHALOPATHY IN TWO CATS AND TWO DOGS.
J O’Neill1, M Kent1, E Glass2, SR Platt1. 1College of Veterinary
Medicine, University of Georgia, Athens, GA, 30602, 2Red Bank
Veterinary Hospital, Tinton Falls, NJ 07724
Two dogs and two cats were evaluated for an acute onset of
neurologic dysfunction. Signs were referable to the prosencepha-
lon consisting of abnormal mentation, recumbency, and blind-
ness. All cases had consistent systemic hypertension ranging from
180mm/Hg to 260mm/Hg as measured using Doppler ultrasonog-
raphy. Magnetic resonance imaging (MRI) of the brain disclosed
non-contrast enhancing, ill-deﬁned T2-weighted hyperintensities
in the white matter of the cerebrum in the areas of the frontal,
parietal, temporal, and occipital lobes. Lesions were observed in
the caudate nuclei and thalamus in two animals, respectively.
There was scant contrast enhancement of the caudate nuclei in
one case. Retinal lesions consisting of retinal hemorrhages and or
detachment were observed in three animals. Hypertension was
presumed secondary to renal disease in three animals; a primary
underlying disorder was not identiﬁed in one animal. Normaliza-
tion of blood pressure was achieved within the ﬁrst 3-5 days with
amlodipine (0.1mg/kg Q12hr) alone or in combination with ena-
lapril (0.5mg/kg PO Q24hr). In one cat, hypertension spontane-
ously resolved. In three cases, neurological improvement
occurred within 24-48 hours of normalization of blood pressure.
The presumptive diagnosis of hypertensive encephalopathy is
supported by the MRI ﬁndings similar to humans and neurologi-
cal dysfunction coincident with systemic hypertension in which
the neurological dysfunction improves with treatment of hyper-
tension. All cases were alive and doing well at follow-up. Follow-
up times ranged from 8.5months to 18months. The prognosis
appears good for the resolution of neurological deﬁcits with nor-
malization of blood pressure in animals with hypertensive
encephalopathy.
ABSTRACT N-19
RELATIONSHIP BETWEEN SPINAL CORD SIGNAL
CHANGES AND CLINICAL AND MRI FINDINGS IN DOGS
WITH CERVICAL SPONDYLOMYELOPATHY – 102
CASES. RC da Costa. Dpt. of Vet Clinical Sciences, College
Vet. Medicine, The Ohio State University, Columbus, OH
Spinal cord signal changes (SCSC) are frequently seen in the
MR (magnetic resonance) images of dogs with cervical spondy-
lomyelopathy (CSM). However, little is known about the factors
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causing these changes and their relationship to clinical and MR
ﬁndings. This study aimed to evaluate these relationships in large
and giant breed dogs with CSM.
Medical and radiological records of dogs having CSM were
searched between 2003 and 2011. Inclusion criteria included a
deﬁnitive diagnosis of CSM achieved by MR (using high ﬁelds
units, either 1.5 or 3.0 T) in a large or giant breed dog. The fol-
lowing information was collected from the medical records:
breed, age, history (acute  5 days, chronic > 6 days), and
severity of neurological ﬁndings (1=neck pain, 2=mild ataxia,
3=moderate ataxia, 4=severe ataxia, 5=non-ambulatory). All
MRIs were reviewed and information regarding the presence or
absence of SCSC, as well as the location, direction and severity
(mild  25% cord diameter, moderate 25-50%, severe > 50%)
of compressive lesion were recorded. Statistical analyses were per-
formed with Fisher’s exact text for categorical variables and Wil-
coxon rank-sum test for continuous variables.
One hundred and two dogs met the inclusion criteria. Sixty
two were large breed dogs and 40 were giant breed dogs. Forty
of the 62 large dogs were Doberman pinschers and 21 of the
giant breed dogs were Great Danes. The remainder was com-
posed of several breeds. Overall 57 dogs (55.9%) showed SCSC;
36 (58.1%) of the large breed dogs and 21 (52.5%) of the giant
breed dogs. The age of dogs with and without SCSC was 3.2 ±
0.9 and 2.6 ± 1.0, respectively (p = 0.41). The mean score of neu-
rological deﬁcits in dogs with SCSC was 3.2 ± 0.9, whereas in
dogs without SCSC it was 2.6 ± 1.0 (p = 0.001). Dogs with
SCSC more commonly had a chronic history (80.7% vs. 62.2%
for those without SCSC) (p = 0.046). The location of the com-
pressive lesion was not signiﬁcant (p = 0.45) as the compression
was found at either C5-6 or C6-7 in 89.4% of dogs with, and
81.8% of dogs without SCSC. The severity of the compression
proved to be signiﬁcant (p = 0.001) as 89.5% dogs with SCSC
had severe (47.4%) or moderate (42.1%) compressions, whereas
only 48.9% of dogs without SCSC had severe (13.3%) or moder-
ate (35.6%) compressions. The direction of compression (ventral,
dorsal/dorsolateral, or lateral/bilateral) was not signiﬁcant.
The results indicate that SCSC are seen in both large and
breed dogs with CSM, with an overall incidence of 55.9%. SCSC
were signiﬁcantly more common in dogs with a chronic history,
more severe neurological deﬁcits, and with moderate or severe
spinal cord compressions. The location and direction of the com-
pressive lesions had no inﬂuence on the development of SCSC in
dogs with CSM.
ABSTRACT N-20
FORCE PLATE GAIT ANALYSIS IN DOBERMAN
PINSCHERS WITH AND WITHOUT CERVICAL SPONDY-
LOMYELOPATHY. K Foss1, RC da Costa1, M Allen1, PJ
Rajala-Shultz2. 1Department of Veterinary Clinical Sciences,
2Department of Veterinary Preventive Medicine, The Ohio State
University, Columbus, OH, USA
Currently, the most accepted means of evaluating the response
to treatment in a patient with cervical spondylomyelopathy
(CSM) has been a subjective measure based on the owner and cli-
nicians’ perception of the patient’s gait. The goal of this study
was to identify diﬀerences in force plate (FP) parameters between
Doberman Pinschers with and without CSM and then use this
information to subsequently develop a more reliable system for
detecting, quantifying, and diﬀerentiating gait abnormalities in
CSM.
Nineteen Doberman pinschers were prospectively studied; 10
clinically normal dogs and 9 with CSM. Neurologic examinations
were performed in all dogs. Clinically normal dogs underwent
transcranial magnetic stimulation to further exclude any underly-
ing neurologic abnormalities. CSM-aﬀected dogs had their diag-
nosis conﬁrmed with a 3.0 T MRI. Force plate analysis was
performed in all four limbs of all dogs using a stationary force
plate and computer system (Kistler Model 9687A). At least 4
runs of ipsilateral limbs were collected from each dog. Parame-
ters evaluated included the peak vertical force (PVF), peak verti-
cal impulse (PVI), peak braking force (PBF), peak braking
impulse (PBI), peak propulsive force (PPF), peak propulsive
impulse (PPI), peak mediolateral force (PMLF), and peak medio-
lateral impulse (PMLI). All force peaks were represented as a
percentage of body weight and the mean value of each parameter
was calculated. In addition, the coeﬃcient of variation (CV)
within each limb was also calculated for each individual parame-
ter. A repeated measures approach was used to analyze the data.
In regard to peak forces and impulses, there were no signiﬁ-
cant diﬀerences between PVF, PVI, PBF, PBI, PPF, PPI, or
PMLI in thoracic or pelvic limbs in aﬀected versus normal dogs.
PMLF of all limbs was signiﬁcantly higher in normal dogs com-
pared to CSM-aﬀected dogs (P=0.0062). By performing an anal-
ysis related to variability using the CV, there was signiﬁcantly
more variability of PVF in the CSM-aﬀected dogs compared to
normal dogs (P=0.0045). In addition, variability of PVF in the
thoracic limbs was signiﬁcantly higher in CSM-aﬀected Dober-
mans compared to the normal ones (P=0.0019).
In conclusion, the variability of PVF in all four limbs and in
particular the thoracic limbs, seems to consistently distinguish
clinically normal Dobermans from those with CSM. Even though
ataxia and weakness are manifested primarily in the pelvic limbs
of dogs with CSM, this data suggests that FP analysis should
evaluate all limbs, and the thoracic limbs may be more sensitive
to diﬀerences than the pelvic limbs.
ABSTRACT N-21
CHARACTERIZATION OF A NOVEL CANINE GBM-
DERIVED CELL LINE (G06A) AND ORTHOTOPIC
TUMORS IN MICE. D York, RJ Higgins, RA LeCouteur, PJ
Dickinson. University of California Davis, Davis, CA
Glioblastoma multiforme (GBM), grade IV astrocytoma, is the
most common primary brain tumor in humans, and carries a
poor prognosis with current therapies. Canine spontaneous brain
tumors bear striking similarities to their human tumor counter-
parts and may provide a valuable translational model system for
novel therapies. Veterinary preclinical assessment and develop-
ment of targeted therapies has been hampered by a lack of suit-
able canine glioma cell lines and murine xenograft models. We
have established a novel canine glioma cell line (G06A) derived
from a spontaneous canine GBM. The G06A cells grow adher-
ently in standard serum media, with an average doubling time of
22 hours. Cells express wild type p53 and overexpress
IL13R2 consistent with the original tumor.
Intracranial implantation of 1e6 G06A cells resulted in ortho-
topic tumors in 7/7 NOD scid gamma (NSG) mice and 3/3
NCr Nude mice 8-13 months following implantation. Routine
histopathology revealed extensive, invasive tumors consistent
with a high grade, mixed glial phenotype. Tumor invasion
occurred throughout the neuropil involving both white and grey
matter and was not limited to perivascular spaces. Both oligo-
dendroglial and astrocytic characteristics were present, reﬂective
of the original tumor. Based on immunohistochemistry, cells
within the tumor mass had positive staining for GFAP, Olig2,
Nestin, and CD133. Although the tumor latency period makes
in vivo therapeutic testing problematical, the cell line may be
valuable for in vitro screening and investigation of factors






COLOSTRUM FOR IMMUNE & GUT HEALTH IN DOGS.
E Satyaraj, A Reynolds. Nestle Purina Research, St. Louis, MO
While the need for colostrum in neonates is well established,
the immunomodulatory eﬀect of feeding bovine colostrums
[BC] to adult humans is gaining increased attention. However,
no such studies in dogs have been reported. The aim of this
study was to evaluate the immunomodulatory eﬀect of BC in
dogs.
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The trial was conducted in two phases: Pre-test [8 wks] and
Test [40 wks]. 24 dogs [mean age 2.5 yrs] were randomized into
two groups. In ‘Pre-test’ phase both groups were fed a nutrition-
ally complete diet. At the end of ‘Pre-test’ phase all dogs received
a Canine Distemper Vaccine [CDV], and dogs in ‘test group’
were switched to diet supplemented with spray dried BC.
Response to CDV vaccine was evaluated by measuring vaccine
speciﬁc plasma IgG. Gut Associated Lymphoid Tissue [GALT]
response was assessed by measuring fecal IgA. Gut microﬂora
was evaluated by Temporal Temperature Gel Electrophoresis
(TTGE) methodology. Repeated measures analysis of variance
was used to test for diﬀerences between groups and statistical sig-
niﬁcance considered to be p <0.05.
Dogs fed diets supplemented with BC demonstrated enhanced
immune status by showing signiﬁcantly higher vaccine response
and signiﬁcantly higher levels of fecal IgA as compared to the
control group. Supplementing diets with BC also resulted in sig-
niﬁcantly increased gut microﬂora diversity and stability [both
measures of enhanced gut health] in the test group. In conclu-
sion, diets supplemented with BC signiﬁcantly enhanced immune
health and gut health in dogs.
ABSTRACT NM-2
EFFECTS OF WEIGHT LOSS IN OBESE DOGS ON A
RANGE OF RENAL BIOMARKERS. A Tvarijonaviciute1, JJ
Ceron1, SL Holden2, PJ Morris3, V Biourge4, AJ German2.
1Department of Animal Medicine and Surgery, Veterinary
School, University of Murcia, Spain, 2Department of Obesity
and Endocrinology, University of Liverpool, UK, 3WALTHAM
Centre for Pet Nutrition, Waltham-on-the-Wolds, UK, 4Royal
Canin Research Centre, Aimargues, France
Human obesity is a risk factor for development and progres-
sion of CKD, and weight loss can reverse the associated manifes-
tations. To date, information is limited regarding the potential
for altered renal function in canine obesity. The aim of the cur-
rent study was to measure a range of renal biomarkers in obese
dogs, both before and after weight loss.
Thirty-seven overweight client-owned dogs undergoing weight
loss were studied, representing a range of breeds, ages and gen-
ders. Both before and after weight loss, body composition was
measured by dual-energy X-ray absorptiometry, and plasma con-
centrations of urea, creatinine, homocysteine, cystatin C, and
clusterin were measured using validated assays. Urinalysis was
also performed, which included measurement of speciﬁc gravity
(by refractometer) and protein:creatinine ratio (UPCR).
Urea (P=0.043) and urine speciﬁc gravity (P=0.012)
increased after weight loss, whilst creatinine decreased
(P=0.026). Homocysteine (P<0.001), cystatin (P<0.001) and
clusterin (P<0.001) also decreased with weight loss. UPCR was
more commonly abnormal pre-weight loss than post-weight loss
(8/27 vs. 1/27; P=0.015). On multivariable linear regression anal-
ysis, change in lean mass was associated with percentage weight
loss (greater weight loss, more lean tissue loss; R=-0.67,
R2=0.45, P<0.001) and pre-weight-loss plasma clusterin concen-
tration (greater clusterin, more lean tissue loss; R=0.48,
R2=0.23, P=0.003).
These results suggest possible subclinical alterations in renal
function in canine obesity, which improve with weight loss. Fur-
ther work is required to determine the nature of these alterations
and, most notably, the reason for the association between pre-
weight loss plasma clusterin and subsequent lean tissue loss dur-
ing weight management.
ABSTRACT NM-3
MRNA EXPRESSION RESPONSE OF ADIPOKINES TO
FELINE OBESITY DEPENDS ON ADIPOSE TISSUE LOCA-
TION. H Van deVeldea, GPJ Janssensa, H de Roostera, I Polisa,
K Pirona, I Petersb, A Verbrugghea, M Hestaa. aFaculty of
Veterinary Medicine, Ghent University, Merelbeke, Belgium,
bSchool of Veterinary Science, University of Bristol, Bristol,
United Kingdom
Obesity is an emerging problem in many species, including
companion animals. Concomitant disorders such as insulin resis-
tance, diabetes mellitus and dyslipidemia are directly or indirectly
linked with an increase of adipose tissue (AT). In humans and
rodents obesity is associated with enlarged adipocyte cell size,
subsequently creating hypoxia in AT. This altered perfusion can
result in necrosis whereby macrophages and lymphocytes are
attracted. In contrast to the situation in humans and rodents
where data on inﬂammation in AT -explaining the co-morbidities
in obesity- exist, this information is lacking in cats. Therefore,
AT mRNA expression of chemokines and adipokines was mea-
sured in chronically obese cats. The aim of the present study was
to increase the knowledge of the development of obesity and
related disorders in cats.
Ten chronically obese cats with a mean body weight (BW) of
6.2 ± 0.4 kg and a body condition score (BCS) of 8 ± 0.2 on a 9-
point scale were included in this study. Ten lean cats with a mean
BW of 3.9 ± 0.2 kg and BCS of 5 ± 0.1 were included as control
group. Under general anesthesia, samples were taken at ﬁve dif-
ferent fat depots, namely subcutaneous (SC) abdominal AT, SC
inguinal AT, bladder AT, renal AT and omental AT. mRNA
expression was determined in the AT using a two-step quantita-
tive real time RT-PCR for leptin, adiponectin, IL-6, IL-10, TNF-
a, IFN-c, IL-8, MCP-1 (a chemokine for monocytes) and RAN-
TES (a chemokine for T-lymphocytes). A relative copy number
value was calculated for each sample with the results normalised
to the three stably expressed housekeeper genes (HPRT1, YWAZ
and RPS7). Statistical analyses were performed using a one-way
ANOVA for which signiﬁcance was set at P<0.05.
Body weight and BCS was signiﬁcantly higher in obese cats
compared to lean cats (P<0.001). Obese cats showed higher lep-
tin mRNA expression in the ﬁve fat depots (P<0.01, SC inguinal
AT P=0.039), with lower adiponectin mRNA expression in blad-
der (P=0.017) and renal AT (P=0.047), compared to lean cats.
In SC inguinal AT, mRNA expression of obese cats was higher
for IFN-c (P=0.045), MCP-1 (P=0.03) and RANTES
(P=0.004) than in lean cats. At other AT locations, higher
expression of inﬂammatory cytokines was observed in obese cats
compared to lean cats, but they failed to reach the level of signiﬁ-
cance.
This study indicates that the response of feline AT to obesity
is present and diﬀers according to its location. Expression in SC
inguinal AT showed most changes, suggesting that this AT loca-
tion might best reﬂect the changes in inﬂammatory and immune
status of the obese cat. The increase of RANTES and MCP-1
illustrates the attraction of lymphocytes and monocytes into the
AT, which suggests a local inﬂammation of this latter tissue dur-
ing feline obesity.
ABSTRACT NM-4
COMPARISON OF TWO WEIGHT LOSS DIETS IN OVER-
WEIGHT CATS. I Jeusette1, A Tvarijonaviciute2, J Ceron2, A
Salas1, N Sanchez1, M Compagnucci1, S Fernandez3, Ll
Vilaseca1, C Torre1. 1Aﬃnity-Petcare, Barcelona, Spain,
2Veterinary Faculty, University of Murcia, Murcia, Spain,
3DOC’S veterinary clinic- Premia`, Barcelona, Spain
Inﬂammatory and oxidative pathways are involved in the
pathophysiology of feline obesity. Dietary supplementation with
olive oil or ﬂavanones induces lower oxidative stress and better
inﬂammatory status in overweight cats. High-protein low-starch
diets improve body composition and insulin sensitivity in obese
cats, however, they have been suggested to aﬀect negatively bone
or renal status. The purpose of this study was to compare 2 diets
for body weight loss (BWL) in cats. The hypothesis was that diet
A [as is, measured metabolisable energy (ME) 3290kcal/kg, pro-
tein 40%, fat 11%, starch 17%, total dietary ﬁber (TDF) 22%,
calcium (Ca) 1.5%, phosphorus (P) 0.9%, omega-3 fatty acids
2.3%, 1% ﬁsh oil, 0.5% olive oil, 0.06% ﬂavanoids] would
induce a safe BWL with improved body composition, glycemic
control, inﬂammatory status and oxidative stress, compared to
diet B [as is, ME 3310 kcal/kg, protein 36%, fat 8%, starch
28%, TDF 18%, Ca 1.9%, P 1.0%, omega-3 fatty acids 0.15%]
used as a regular obesity control diet.
Healthy colony cats (n=11) with body condition score >7/9
were fed a maintenance diet until T0. Then, 6 cats were fed diet
A and 5 cats diet B to induce a BWL between 1 and 2% of start-
ing BW per week. Fasting blood and urine were obtained at T0,
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after 3 weeks and after 3 months of energy restriction. Complete
blood count, serum biochemistry proﬁle, serum fructosamine,
amylase, haptoglobin, paraoxonase type 1 (PON-1, an antioxi-
dant and anti-inﬂammatory enzyme), IGF-1, butyrylcholinester-
ase activity, urine analysis (protein, creatinine, albumin,
fractional excretion of ions), body composition (deuterium dilu-
tion), markers of bone formation (serum bone alkaline phospha-
tase, BAP) and resorption [serum carboxy-terminal telopeptide
fragment (CTX), urinary total deoxypyridinoline (DPD)] and
ultrasound of the abdomen were assessed. To evaluate any diﬀer-
ence between diets, diﬀerences from baseline T0 were compared
(univariate ANOVA). To assess diet and BWL eﬀects, multivari-
ate ANOVA for repeated measurements was performed (diet,
time, diet*time eﬀects). Values are considered as statistically dif-
ferent for P value < 0.05.
No diﬀerence between diets was observed for energy intake
and BWL. Diet A resulted in signiﬁcantly better lean mass pres-
ervation, higher decrease in fructosamine and haptoglobin and in
higher increase in PON1 than diet B. Both diets signiﬁcantly
decreased basal insulin, amylase, butyrylcholinesterase, alkaline
phosphatase and BAP concentrations, and increased urinary Ca
excretion and serum Ca with time.
In conclusion, both diets resulted in a safe and similar BWL.
However, diet A showed additional beneﬁts for lean mass preser-
vation, glucose control (fructosamine), oxidative and inﬂamma-
tory status (haptoglobin, PON1), without side eﬀects for renal
health (BUN, creatinine, urinary albumin) and liver health (liver
enzymes, ultrasound). A decreased marker of bone formation
with both diets at T3, with a trend for increased resorption mar-
ker (DPD), requires further research.
ABSTRACT NM-5
COMPARISION OF HIGH FIBER AND LOW CARBOHY-
DRATE DIETS ON OWNER-PERCEIVED SATIETY OF
CATS DURING WEIGHT LOSS. AL Witzel1, TD Moyers1,
MG Cline1. 1University of Tennessee Department of Small
Animal Clinical Sciences, Knoxville, TN
Food seeking behaviors exhibited by cats during weight loss
programs are frustrating to owners. Two categories of prescrip-
tion weight loss diets are currently available for cats, high ﬁber
(HF) and low carbohydrate (LC). This study’s goal was to
determine if cat owners perceive a diﬀerence in satiety when cats
are fed either a HF or LC diet during weight loss. 28 client-
owned cats were randomly assigned to either a HF (protein
12.3g, carbohydrate 10.2g, ﬁber 5.0g/100kcal) or LC (protein
11.1g, carbohydrate 1.0g, ﬁber 0.6g/100kcal) canned diet and fed
to 80% of their ideal weight resting energy requirements. Cats
were rechecked at 2, 4, 6, and 8 weeks and food intake adjusted
to maintain weight loss between 0.5-2%/week. Owners com-
pleted behavior questionnaires at each visit and were blinded to
food assignments. A logistic regression model using a backward
selection procedure was used to examine the eﬀect of diet,
adjusted for covariables on the owner’ response to each ques-
tion. The two diet groups did not diﬀer by age, sex, body condi-
tion score, or rate of weight loss. LC cats consumed more
calories (210kcal/day) than HF cats (184kcal/day) on average
(p<.05). HF cats were less likely to pace (23% vs. 46%, p=.01)
or beg (42% vs. 62%, p=.02) at the food bowl. Cats fed the
LC diet were more likely to forage or steal food (61% vs. 43%,
p=.06). Owners feeding the HF diet were more satisﬁed with
their cats’ weight loss programs than those on the LC diet
(p=.006). In conclusion, HF diets may be superior to LC diets
for minimizing food-seeking behavior and improving owner sat-
isfaction during weight loss.
ABSTRACT NM-6
SEASON AND MONTH EFFECTS ON FOOD INTAKE IN
ADULT COLONY CATS. S Serisier1, A Feugier1, C Venet1, Y
Soulard1, V Biourge1, AJ German2. 1Royal Canin Research
Center, Aimargues, France, 2Department of Obesity and
Endocrinology, Institute of Aging and Chronic Disease,
University of Liverpool, Liverpool, United Kingdom
There are numerous reports about seasonal cycles on food
intake in animals but information is limited in dogs and cats.
During the course of a 6-year retrospective study (from 2004
to 2009), food intake was recorded in 38 ad-libitum-fed adult col-
ony cats. These cats were involved in palatability studies and,
therefore, the whole group was fed a diﬀerent dry diet each day.
Individual food intake was recorded on a daily basis, and the
mean daily intake for each calendar month was calculated.
Among these 38 cats, 17 were male (15 neutered) and 21 were
female (10 neutered), whilst, 32 were pure breeds and 6 were
mixed breeds. At study completion, median (range) age was 8.2
years (y) (7.4-9.6y); 22 cats were in ideal condition (BCS=5/9),
whilst 16 cats were overweight (BCS >5/9). Cats were housed in
closed indoor/outdoor runs with 30 having unlimited outdoor
access, and the remaining 8 housed indoor. Housing and man-
agement protocols adhered to European regulatory rules for ani-
mal welfare. The mixed procedure of SAS© was used. The
statistical model included either season and year or month and
year with their respective interactions as ﬁxed eﬀect and cat was
deﬁned as a random term.
Irrespective of year, a seasonal eﬀect was evident (p < 0.001),
with food intake during spring and summer being less than food
intake during autumn and winter. Further, again irrespective of
year, a monthly eﬀect was identiﬁed (p < 0.001) with food
intake being greatest in January, February, October, November
and December; intermediate in March, April, May and Septem-
ber; and least in June, July and August (Table 1).
In conclusion, whatever the year, average food intake in July
is 15% less than food intake in December. This variation of food
intake could be the result of variation of outside temperatures,
diﬀerences in daylight length, and/or haircoat changes. This sea-
sonal eﬀect in food intake should be properly considered when
estimating daily maintenance energy requirements in cats.
ABSTRACT NM-7
INFLUENCE OF DIFFERENT SOURCES OF CORN
STARCH ON STOOL CHARACTERISTICS IN DOGS OF
DIFFERING BODY SIZES. R Goudez1,2, M Weber2, V
Biourge2, JS Suchodolski3, L Martin1, V Leray1, JM Steiner3, H
Dumon1, P Nguyen1. 1LUNAM University, Oniris, National
College of Veterinary Medicine, Food and Science and
Engineering, Nutrition and Endocrinology Unit, Nantes, France,
2Royal Canin Research Center, Aimargues, France, 3GI
Laboratory, Texas A&M University, College Station, Texas
Previous works from our laboratory showed that large dogs
produce poorer quality stools compared to small dogs. This
diﬀerence could be related to a higher fermentative activity in
the hindgut of large dogs and could be modulated by dietary
protein and ﬁber sources. The aim of the present study was
to assess the eﬀect of diﬀerent corn starch sources on micro-
bial communities and fecal characteristics in large and small
breed dogs.
Five female miniature schnauzers (MS, 6.5-8.5 kg) and 5
female German shepherds (GS, 24.7-33.5 kg) were included in
the study. Three iso-formulated extruded diets (37.9±1.1%
starch, 25.2±0.4% protein, 14.8±0.3% fat, 7.9±1.9% TDF,
6.2±0.3% ash, 3834 kcal ME/Kg, as fed basis) were tested in
Abstract NM-6:
Table 1. Least square means of food intake per month of adult colony cats from 2004 to 2009.
Month Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec
Food intake (g) 57.2 56.3 54.8 52.8 53.2 52.0 50.4 51.5 54.5 57.5 58.0 57.9
SEM 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0 2.0
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a crossover design. Diets contained the same protein sources
but varied in the source of corn starch (ﬂour, puriﬁed, and
high-amylose). Fresh feces were collected and their consistency
was scored daily, from 1 (hard) to 5 (liquid). Fecal volume,
moisture, pH, lactate and short chain fatty acid [SFCA] con-
centrations were measured. Fecal microbial communities were
characterized by 454-pyrosequencing of the 16S rRNA gene.
Eﬀects of diet or breed on fecal parameters were statistically
tested using Friedman and Kruskal-Wallis tests. The Unifrac
metric followed by analysis of similarity (ANOSIM) was used
to assess diﬀerences in microbial communities among diets
and breeds.
Regardless of diet, a breed eﬀect was found for all fecal
parameters (p<0.017) and microbial communities (p<0.001).
Lactobacillaceae were signiﬁcantly higher in fecal samples of GS
compared to MS. Unifrac analysis revealed signiﬁcant diﬀerences
in microbial communities between both breeds. In GS, corn
starch sources had a signiﬁcant eﬀect on fecal consistency and
lactate concentrations (p<0.007), as well as on pH, fecal volume,
and SCFA concentrations (p<0.022). MS appeared more toler-
ant and only fecal volume (p<0.015) and lactate concentrations
(p<0.022) were aﬀected. Dogs on the high-amylose diet had the
lower fecal pH, and higher SCFA and lactate concentrations,
and increased fecal volume. In contrast, dogs on the puriﬁed
starch diet had stools with a harder consistency, a decreased fecal
volume and decreased concentrations of fermentation products.
The sources of corn starch had an impact on microbial communi-
ties in both breeds (p<0.035). Firmicutes were lower on the corn
ﬂour starch diet [64.30% (53/90)] compared to the puriﬁed and
high-amylose starch diets [93.78% (91/96) and 96.48% (87/98)].
This change was associated with a decrease in Fusobacteria and
Bacteroidetes.
These results suggest that the source of corn starch has an
impact on fecal consistency, fecal microbial communities, and
fermentation products. These eﬀects of the starch sources were
not consistent and may be due to diﬀerences in fermentative
activities as well as microbial communities between dog
breeds.
ABSTRACT NM-8
A 8.5-YEAR LONGITUDINAL STUDY TO IDENTIFY RISK
FACTORS OF OBESITY IN COLONY CATS. S Serisier1, A
Feugier1, C Venet1, Y Soulard1, V Biourge1, AJ German2.
1Royal Canin Research Center, Aimargues, France, 2Department
of Obesity and Endocrinology, Institute of Ageing and Chronic
Disease, University of Liverpool, Liverpool, United Kingdom
Several transverse studies have assessed factors predisposing
cats to becoming overweight. Generally, demographic factors (e.
g. breed, age, gender, sex status, housing), activity and diet have
been examined in adult cats, but early-life factors have not been
considered. In humans, studies have demonstrated that the risk
of being overweight in adulthood is largely determined early in
childhood. The aim of this retrospective cohort study was to
identify risk factors for the development of overweight in colony
cats fed dry diets ad libitum.
A total of 80 colony-cats were studied, representing 14 diﬀer-
ent breeds, with 36 males (34 neutered) and 44 females (24 neu-
tered). Of these cats, 36 were determined to be overweight (OW;
body condition score [BCS] >5/9), whilst the remaining 44 were
in ideal condition (I; BCS=5/9). The eﬀects of various factors
(including age, gender, neuter status, breed [pure vs. mixed],
mean daily food intake [measured over a 12-month period], hous-
ing status [indoor with outdoor access vs. exclusively indoor] and
body weight [BW] at 1year [y] of age [BW1y; BCS was 5/9 in all
cats at this age]) on weight status was assessed. Risk factors for
being overweight as an adult were examined using PLS-DA anal-
ysis (Tanagra©).
The main signiﬁcant descriptor variables that predicted the
likelihood of being overweight were food intake (median 46.3g
[range: 32.8-73.4g] vs. 62.7g [38.1-96.6g]) and BW1y (3.02 kg
[1.76-5.46kg] vs. 3.95 kg [2.22-6.50kg]). A statistical model was
then created (mixed procedure of SAS©; group [OW vs I]
included as a ﬁxed eﬀect and cat as a random term) to assess
changes in BW and food intake between 1y and 8.5y of age
where data were available (42/80 cats [25 I; 17 OW]). Diﬀer-
ences between groups (OW vs I) were noted for both BW
(p<0.001) and food intake (p=0.002). BW increased signiﬁ-
cantly with age only in the OW group (p<0.001), whilst food
intake did not change with age in either group. Interestingly,
when BW1y was included as a covariate in the model, no diﬀer-
ences in either BW (p = 0.17) or food intake (p=0.07) were
noted, suggesting that most eﬀects could be explained by
BW1y. Finally, given the importance of BW1y, changes in BW
from 3 months (mo) to 1y were assessed where data were avail-
able (16/80 cats [8I; 8OW]; SAS PROC MIXED analysis with
BW3mo included as a covariate). At 3 mo of age, no diﬀerence
in BW was observed between the 2 groups. However, BW
diverged in the two groups tending to become diﬀerent at 1y of
age (p=0.1).
In conclusion, BW at 1 year of age is suggested to be a major
risk factor for cats becoming overweight. Further investigations
are necessary to understand which factors (e.g. genetics, rate of
growth, food intake, physical activity) may be responsible for
BW diﬀerences at this age. Nonetheless, identifying at-risk cats at
12 months, even before the onset of obesity, could enable strate-
gies aimed at preventing feline obesity to be better targeted.
ABSTRACT NM-9
BALL FEEDING INCREASES PHYSICAL ACTIVITY AND
REDUCES BODY WEIGHT REGAIN AFTER A WEIGHT
LOSS DIET IN CATS. A Salas, I Jeusette, M Compagnucci, Ll
Vilaseca, C Torre. Aﬃnity Petcare, Barcelona, Spain
After a weight loss program, cats have diﬃculties to maintain
body weight (BW) and usually they regain their initial BW
quicker than desired. A lack of owner compliance and a decrease
in energy expenditure are the main causes for this quick regain.
Feeding enrichment with puzzle feeders, from which food has to
be obtained by rolling, have been proposed to help obese cats to
lose BW while improving physical welfare. The purpose of this
study was to evaluate if enrichment with a feeding ball would
increase objectively-measured physical activity, food intake and
its repercussion on BW after a weight loss diet.
Eleven healthy colony cats were used for this study. Cats had
been ﬁrstly energy-restricted for 3 months to induce a 15% BW
loss with 2 diﬀerent low-fat energy-restricted diets [diet A (n=6),
as is, measured metabolic energy (ME) 3290 kcal/kg, protein
40%, fat 11%, starch 17%, total dietary ﬁber (TDF) 22%; diet B
(n=5), as is, ME 3310 kcal/kg, protein 36%, fat 8%, starch
28%, TDF 18%]. Then, in a cross-over design, each group of
cats received during 3 months their low-fat diet ad libitum in 2
diﬀerent feeding conditions: in a conventional bowl (CB) or in a
feeding ball (FB). Daily physical activity was monitored by accel-
erometers that cats wore in the harness. Daily food intake and
weekly body weight were recorded. A general linear model
(GLM) with repeated measures was performed to assess feeding
condition, period and diet eﬀects on physical activity, BW regain
and food intake. Values were considered as statistically signiﬁ-
cant for P value < 0.05.
As there was no diﬀerence between diets, data from both diets
were pooled and only feeding condition and period eﬀects are
discussed. A signiﬁcant eﬀect of the cross-over period was
observed on food intake and BW regain independently of the
type of feeding, during the ﬁrst 3-months period, food intake was
higher (55±7 kcal/kg BW vs 46±7 kcal/kg BW; p=0.000) and
BW regain was faster (0.8%/week vs 0.09%/week; p=0.000) than
in the second period in both diet groups, probably due to a sea-
sonal eﬀect and/or a compensatory eﬀect after energy restriction.
Feeding ad libitum with a FB versus CB resulted in an increased
physical activity (+34%, p=0.000), in a reduced food intake (-
3.74 kcal/kg BW, p=0.000) and in a lower BW regain of the cats
(3.8±2.2% vs 7.6±2.5%, p=0.014).
In conclusion, feeding with FB could be an interesting strategy
to apply in overweight cats after weight loss programs to increase
physical activity, reduce food intake and consequently slow down
BW regain or simply to promote physical activity and conse-
quently improve the wellbeing of normal or overweight cats.
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ABSTRACT NM-10
PLASMA ADIPOKINE CONCENTRATIONS IN LEAN AND
OBESE DOGS. N Berghoﬀ1, R Stone2, JS Suchodolski1, JM
Steiner1, DL Zoran3. 1Gastrointestinal Laboratory, Texas A&M
University, College Station, TX, 2North Houston Veterinary
Specialists, Humble, TX, 3Department of Small Animal Clinical
Sciences, Texas A&M University, College Station, TX
White adipose tissue does not only provide energy storage, but
also produces inﬂammatory cytokines, as well as adipokines nec-
essary for normal metabolism. In humans, the release of these
mediators is believed to lead to a state of chronic low-grade
inﬂammation, which may play a role in the development of insu-
lin resistance and diabetes mellitus. Studies investigating plasma
cytokine and adipokine concentrations in dogs with naturally
occurring obesity are lacking. Thus, the aim of this study was to
measure plasma cytokine and adipokine concentrations in client-
owned lean and obese dogs, and to determine if a sub-inﬂamma-
tory state is present in obese dogs.
Blood samples were collected from 24 healthy lean dogs (body
condition score [BCS]: 4-5 out of 9) and 19 otherwise healthy
obese dogs (BCS: 7-9 out of 9). Plasma concentrations of cyto-
kines (GMCSF, IFN-c, IL-2, IL-4, IL-6, IL-7, IL-8, IL-10, IL-
15, IL-18, MCP-1, TNF-a), leptin, adiponectin, resistin, and
insulin were measured using a multiplex bead antibody assay sys-
tem (Millipore, MA). C-reactive protein (CRP) concentrations
were measured by ELISA (Tridelta, NJ). Complete blood count
(CBC) and plasma biochemical analyses were carried out using
routine automated analyzers. Test results were compared between
lean and obese dogs using an unpaired Student’s t-test or Mann-
Whitney U test, as appropriate. Statistical signiﬁcance was set at
p<0.05.
Plasma leptin and insulin concentrations were signiﬁcantly
higher in obese dogs than in lean dogs (p<0.0001 and
p=0.0324, respectively). No diﬀerences were found for adiponec-
tin, resistin, any of the cytokines, or CRP concentrations between
the two groups. White blood cell and absolute neutrophil counts
were signiﬁcantly higher in obese than in lean dogs (p=0.0379
and p=0.0073, respectively). Obese dogs had signiﬁcantly higher
plasma cholesterol (p=0.0192), total protein (p=0.0035), globu-
lin (p=0.0127), and triglyceride (p=0.0022) concentrations than
lean dogs, whereas the creatinine concentration was lower in
obese dogs than in lean dogs (p=0.0009).
Obese dogs in this study had high plasma leptin concentra-
tions, which is characteristic for obesity. Interestingly, the plasma
adiponectin concentration was not diﬀerent between lean and
obese dogs. Reduced plasma adiponectin concentrations have
been reported in obese humans and cats, while conﬂicting reports
exist for dogs. Low adiponectin concentrations were reported in
dogs with experimentally induced obesity, but not in dogs with
naturally occurring obesity, possibly suggesting metabolic diﬀer-
ences. The increase in WBC and neutrophil counts in obese dogs
suggests a possible low-grade inﬂammation in these dogs, even
though no diﬀerences in plasma cytokine and CRP concentra-
tions were found between the two groups. It is possible that the
cytokine markers used in this study were not able to reliably
detect diﬀerences in plasma concentrations, or that plasma cyto-
kine measurements are not optimal for assessing the overall
inﬂammatory state in dogs.
ABSTRACT NM-11
EFFECT OF LOW LEVEL FRUCTAN SUPPLEMENTATION
ON THE ABUNDANCE OF SPECIFIC BACTERIAL
GROUPS IN FECAL SAMPLES OF DOGS. Y Minamoto1,
KA Barry2, JF Garcia-Mazcorro1, ME Markel1, NM Gossett1,
GC Fahey Jr2, JM Steiner1, KS Swanson2, JS Suchodolski1.
1Gastrointestinal Laboratory, Texas A&M University, College
Station, TX, 2Department of Animal Sciences, University of
Illinois at Urbana-Champaign, Urbana, IL
Recent metagenomic studies in dogs with gastrointestinal dis-
ease have shown a decrease in speciﬁc bacterial groups such as
Ruminococcaceae, Faecalibacterium spp., Turicibacter spp., and
Bacteroidetes. Fructans are considered to have a prebiotic eﬀect
and have the potential to modulate the intestinal microbiota. The
aim of this study was to evaluate the eﬀect of low level fructan
supplementation on the abundance of those bacterial groups that
are frequently found to be decreased in dogs with gastrointestinal
disease.
Leftover frozen fecal samples from ﬁve research dogs utilized
in a previous low level fructan supplementation study were ana-
lyzed. Brieﬂy, ﬁve diets that contained either cellulose alone or
that were supplemented with either inulin or short-chain fructool-
igosaccharides (scFOS) each at 0.2% or 0.4% were evaluated in
a 5 9 5 Latin square design. Bacterial DNA was extracted from
each fecal sample and evaluated for the abundance of Rumino-
coccaceae, Faecalibacterium spp., Turicibacter spp., Biﬁdobacteri-
um spp., Lactobacillus spp., and Bacteroidetes using quantitative
PCR assays. For statistical analysis, a general linear mixed
model, adjusted for Tukey post-test comparisons, was used to
compare the abundance of bacterial groups in response to the
diﬀerent diets. Signiﬁcance was set at p<0.05.
No signiﬁcant diﬀerences in the abundance of the evaluated
bacterial groups were observed in response to inulin or scFOS
(Table 1). There was a trend for Faecalibacterium spp., to
increase with supplementation of 0.4% scFOS, but this increase
did not reach signiﬁcance (p=0.09).
In conclusion, in this study low level fructan supplementation
did not signiﬁcantly alter the abundance of selected bacterial
groups in healthy adult research dogs. Further studies are needed
to evaluate the eﬀect on the abundance of these bacterial groups
at higher levels of fructan supplementation.
ABSTRACT NM-12
SOY GERM ISOFLAVONES SUPPLEMENTATION
REDUCED BODY FAT ACCUMULATION AND
ENHANCED ENERGY METABOLISM IN DOGS. Y Pan.
Nestle´ Purina Research, Checkerboard Square, St. Louis, MO
Up to 40% dogs in developed countries are either overweight
or obese. Obesity increases the incidence of many chronic dis-
eases in dogs. One of the known risk factors for obesity in dogs
is spaying/neutering which results in signiﬁcant decline in energy
metabolism due to loss of sex hormones. So reversing the decline
in energy metabolism by natural estrogen analogs will be very
eﬀective in reducing the risk of obesity in spayed/neutered dogs
by maintaining healthy energy metabolism. Published research
shows that puriﬁed daidzein and glycitein were able to mimic
estrogen to prevent body fat accumulation.
Abstract NM-1:
Table 1. Mean abundance ± standard deviation (M ± SD) of bacterial DNA for each bacterial group at the various treatment levels.
Treatment
Control 0.2% inulin 0.4% inulin 0.2% scFOS 0.4% scFOS
M±SD M±SD p M±SD p M±SD p M±SD p
Ruminococcaceae 6.6±0.5 6.9±0.1 0.68 6.5±0.3 1.00 6.7±0.2 0.96 6.6±0.2 1.00
Faecalibacteriumspp. 4.1±0.8 5.0±0.2 0.22 4.6±0.9 0.42 4.8±0.5 0.16 4.9±0.4 0.09
Turicibacterspp. 6.6±0.6 7.1±0.4 0.77 6.6±0.7 1.00 6.9±0.3 0.85 7.0±0.6 0.75
Biﬁdobacteriumspp. 2.9±1.2 3.5±1.4 0.81 2.7±1.2 0.99 2.6±0.7 0.96 3.3±1.4 0.72
Lactobacillusspp. 3.9±1.3 4.0±1.4 1.00 4.2±1.0 0.99 4.7±1.5 0.72 4.6±1.9 0.81
Bacteroidetes 4.6±1.0 5.1±0.1 0.78 5.1±0.4 0.54 4.8±0.7 0.94 5.2±0.5 0.36
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Since the isoﬂavones in soygerm meal are mainly daidzein
and glycitein, we investigated the eﬀects of isoﬂavones from
soybean germ meal (SGM) on body fat accumulation, and
energy metabolism in spayed/neutered dogs with normal body
weight. Based on baseline maintenance energy requirement
(MER), body weight, and % body fat, spayed/neutered Labra-
dor Retrievers with normal body weight were randomized into
two groups: control, and isoﬂavones. Both the control and
isoﬂavone diets had comparable levels of metabolizable energy,
protein, fat, carbohydrates, and minerals. The dogs were
allowed to ingest 25% more than their baseline MERs for 9
months. Body composition using DEXA, thyroid function,
complete blood count, and blood clinical chemistry parameters
were measured at the baseline and every three months after
initiation of the feeding trial. Total energy expenditure was
measured using doubly-labeled water protocol at the end of
the study. The results show that the isoﬂavones from SGM
signiﬁcantly increased daily energy expenditure and reduced
body fat accumulation in dogs without reduction in food
intake.
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ABSTRACT O-1
CHARACTERIZATION OF BETA-CATENIN EXPRESSION
IN CANINE ORAL MELANOMA. E Chon, V Thompson, M
Huelsmeyer, T Stein. University of Wisconsin – Madison,
Madison, WI
Canine oral melanoma is a highly aggressive malignancy asso-
ciated with poor survival. Perturbation of the Wnt/beta-catenin
signaling pathway has been implicated in the progression of
human melanoma. However, there currently is no information
regarding this pathway’s role in canine oral melanoma. Our
objective was to characterize beta-catenin expression in canine
oral melanoma tumors and cell lines.
Initial characterization of beta-catenin expression was per-
formed with immunohistochemistry of twelve archived canine
oral melanoma tumors. For further characterization, we utilized
nine cell lines derived from spontaneously arising canine oral
melanomas. Cell lysates from each cell line was fractionated and
beta-catenin protein expression was semi-quantitatively deter-
mined with Western Blot analysis. A human melanoma cell line
having a known stabilizing mutation in beta-catenin served as a
positive control.
Among the twelve histologic samples, nine stained positive for
beta-catenin. Diﬀerential intracellular staining (cytoplasmic vs.
nuclear vs. membranous staining) was evident in positively
stained tumors. Similarly, subcellular fractionation of cell line ly-
sates revealed diﬀerential staining between cell lines and within
subcellular fractions.
Diﬀerential expression of beta-catenin suggests the Wnt/beta-
catenin signaling pathway may be active in a subset of canine
oral melanomas. (VCS Award Winner)
ABSTRACT O-2
AGREEMENT BETWEEN FLOW CYTOMETRY, PCR FOR
ANTIGEN RECEPTOR REARRANGEMENT, AND IMMU-
NOHISTOCHEMISTRY IN CANINE LYMPHOMA. LB
Thalheim, SE Suter, LB Borst, LE Williams. North Carolina
State University College of Veterinary Medicine, Raleigh, NC
Immunohistochemistry (IHC), ﬂow cytometry (FC), and PCR
for antigen receptor rearrangement (PARR) are utilized to help
diagnose ambiguous cases of canine lymphoma and to determine
immunophenotype. Objectives of this study were to calculate
level of agreement between IHC, FC, and PARR in canine lym-
phoma and to determine the ability of FC and PARR to cor-
rectly predict immunophenotype as deﬁned by IHC.
Medical records were searched to identify dogs with lym-
phoma that had concurrent FC, PARR and IHC performed.
Fifty-two cases were identiﬁed. Immunophenotype results were
categorized as T-cell, B-cell, dual T-/B-cell, and negative. The
percent agreement between tests was calculated. Sensitivity, speci-
ﬁcity, positive predictive value (PPV), and negative predictive
value (NPV) of FC and PARR in correctly determining immuno-
phenotype were also calculated.
The percent agreement between FC and IHC was 94.2%,
between PARR and IHC was 65.4%, and between all three tests
was 59.6%. For B-cell cases, the sensitivity, speciﬁcity, PPV, and
NPV for FC were 92%, 100%, 100%, and 81% respectively, and
for PARR were 62%, 100%, 100%, and 46% respectively. For
T-cell cases, the sensitivity, speciﬁcity, PPV, and NPV for FC
were 100%, 97%, 93%, and 100% respectively, and for PARR
were 77%, 97%, 91%, and 93% respectively.
The percent agreement between FC and IHC was signiﬁcantly
higher compared to PARR and IHC. While the PPVs are similar
between FC and PARR, the overall sensitivity of PARR in
detecting correct phenotype is lower compared to FC. Based on
these results, FC is superior to PARR in determining immuno-
phenotype. (VCS Award Winner)
ABSTRACT O-3
FIROCOXIB HAS ANTITUMOR ACTIVITY AS A SINGLE
AGENT AND ENHANCES THE ACTIVITY OF CISPLATIN
IN DOGS WITH TRANSITIONAL CELL CARCINOMA OF
THE URINARY BLADDER. DW Knapp1, CJ Henry2, WR
Widmer1, KM Tan1, GE Moore1, JA Ramos-Vara1, MD
Lucroy1, CB Greenberg1, SN Greene1, AH Abbo1, PD Hanson3,
R Alva3, PL Bonney1. 1From Purdue University, West Lafayette,
IN;, 2University of Missouri, Columbia, MO; and 3Merial
Limited, Duluth, GA
Cisplatin combined with a nonselective cyclooxygenase (cox)
inhibitor has potent antitumor activity against transitional cell
carcinoma (TCC) of the urinary bladder in dogs, but this
combination treatment is limited by renal toxicosis. Cox-2 is
expressed in TCC, but in limited sites within the kidney, sug-
gesting that a cox-2 inhibitor may be safely combined with
cisplatin. The hypothesis was that cisplatin combined with a
cox-2 inhibitor would have greater antitumor activity, but no
more renal toxicity, than cisplatin alone in dogs with TCC. A
randomized clinical trial was performed at Purdue University
and the University of Missouri. Entry requirements included
dogs with histopathologically-conﬁrmed TCC of the urinary
bladder, measurable lesions in the bladder, normal serum cre-
atinine, no prior cisplatin treatment, expected survival of at
least 6 weeks, and informed pet owner consent. Dogs were
excluded if they had received a cox inhibitor within the previ-
ous 14 days, or received one for more than a month in the
previous 3 months.
Dogs were randomized to receive cisplatin (60 mg/m2 IV q21d
with saline diuresis), ﬁrocoxib (Previcox®, Merial, 5 mg/kg PO
q24h), or the combination. Complete evaluation including tumor
staging and measurements was performed before, and at 6-week
intervals during therapy. Renal function was monitored by serum
creatinine concentration, iohexol clearance, and urine speciﬁc
gravity. Toxicoses were graded according to Veterinary Co-Oper-
ative Oncology Group criteria.
The primary endpoint was remission rate. It was expected that
34 dogs could be needed in each treatment group to detect a
35% diﬀerence in remission rate (power 0.90; two-sided test).
Interim analyses were scheduled to be done after entering 12 and
25 dogs per group. At the ﬁrst interim analysis, the remission
rate (all partial remissions) with cisplatin/ﬁrocoxib (8 of 14 dogs,
57%) was signiﬁcantly (P=0.021) greater than that with cisplatin
alone (2 of 15 dogs, 13%). The progression free interval was
longer (P= 0.026) with cisplatin/ﬁrocoxib (median 186 days)
than with cisplatin alone (median 87 days). Renal and gastroin-
testinal toxicoses were common in dogs receiving cisplatin, but
there were no signiﬁcant diﬀerences between dogs receiving cis-
platin or cisplatin/ﬁrocoxib. Firocoxib alone induced remission
or stable disease in 3 of 15 (20%) and 5 of 15 (33%) of dogs,
respectively. In conclusion, ﬁrocoxib signiﬁcantly enhanced the
antitumor activity of cisplatin resulting in a remission rate of
57%. Although ﬁrocoxib did not enhance the toxicity of cis-
platin, the toxicoses inherent to cisplatin (even as a single agent)
may aﬀect the decision as to whether to use this treatment or
not. Firocoxib had antitumor activity and minimal side eﬀects as
a single agent, and can be considered a palliative treatment for
dogs with TCC.
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ABSTRACT O-4
PHASE II CLINICAL TRIAL OF VINORELBINE AND PIR-
OXICAM FOR DOGS WITH TRANSITIONAL CELL CARCI-
NOMA OF THE URINARY BLADDER. ME Kaye1, JA
Lawrence1, K Weishaar2, DH Thamm2. 1University of Georgia
College of Veterinary Medicine, Athens, GA, 2The Animal
Cancer Center, Colorado State University, Fort Collins, CO
Transitional cell carcinoma (TCC) of the urinary bladder in
dogs is an invasive, locally aggressive disease with limited eﬀec-
tive therapies. Vinorelbine is a semisynthetic vinca alkaloid that
has demonstrated activity in advanced human TCC. The purpose
of this study was to evaluate the anti-tumor activity and toxico-
ses of vinorelbine and piroxicam in dogs with TCC.
Dogs were treated with vinorelbine (15 mg/m2 IV) once weekly
for four doses followed by every other week until tumor progres-
sion. Piroxicam (0.3 mg/kg PO) was administered daily. Tumor
response was determined according to Response Evaluation Cri-
teria in Solid Tumors (RECIST); toxicoses were graded accord-
ing to Veterinary Cooperative Oncology Group (VCOG) criteria.
Median time to progression (TTP) and median survival time
(MST) were calculated using Kaplan-Meier analysis.
Fourteen dogs were enrolled. A median of 6.5 doses of vino-
relbine (1-16) were administered. Two dogs (14%) had partial
responses; 8 experienced stable disease for a median of 100 days
(56-239d); 2 had progressive disease. Response could not be
assessed in 2 dogs. Subjective improvement in clinical signs was
noted in 11 dogs. Of 89 total doses of vinorelbine administered, 3
grade IV and 3 grade III neutropenias, 1 grade III thrombocyto-
penia, and 2 grade III gastrointestinal toxicities were docu-
mented. The median TTP was 93 days. The MST from the ﬁrst
vinorelbine treatment was 168 days; MST from initial diagnosis
was 432 days.
Vinorelbine and piroxicam appear to have antitumor activity
against canine TCC and may be a therapeutic option when man-
aging this disease.
ABSTRACT O-5
COMPUTED TOMOGRAPHIC APPEARANCE OF CANINE
THYROID TUMORS. K Deitz1, L Gilmour1, V Wilke2, E
Riedesel1. 1Iowa State University, College of Veterinary
Medicine, Ames, IA, 2University of Minnesota, College of
Veterinary Medicine, St. Paul, MN
Computed tomography is often used to help determine the
treatment approach to canine thyroid tumors. This study was
undertaken to describe the computed tomographic features of
canine thyroid tumors.
Nineteen dogs with computed tomographic images of a histo-
pathologically conﬁrmed thyroid tumor were identiﬁed. Each CT
scan was evaluated by 3 clinicians for various characteristics,
independently and then by consensus.
There were 17 carcinomas and 2 adenomas. Tumor consis-
tency was heterogeneous in 16/19 (84%). Most (12/19) had
internal mineralization, although in 2 there was extensive bone
destruction which made the presence of tumor mineralization
diﬃcult to determine. Sixteen tumors (84%) were unilateral. Of
these, 11/16 were left-sided, and 5/16 were right-sided. The
remaining 3 were considered bilateral or ventral. All tumors had
some degree of contrast enhancement. Eighteen had heteroge-
neous enhancement, with 7/19 having more contrast enhance-
ment peripherally than centrally. Most (16/19) had well-deﬁned
margins post-contrast. Location of tumors compared to bony
structures was variable, with most having their cranial margin
somewhere along the level of the second cervical vertebra (13/
19) or at the junction of the second and third cervical vertebra
(1/19). Some were much more cranially located, with the cranial
margin at the level of the temporomandibular joint (1/19) or
bulla (4/19). The caudal extent was variable, and was anywhere
from mid C1 to caudal C5.
Common CT features of canine thyroid tumors include unilat-
eral location in the neck anywhere from the temporomandibular
joint to C5, with heterogeneous consistency, internal mineraliza-
tion, and heterogeneous contrast enhancement with well-deﬁned
margins.
ABSTRACT O-6
MULTI-INSTITUTION RETROSPECTIVE STUDY OF 85
CASES OF CANINE THYMOMA (1999-2010). C Robat1, L
Cesario2, R Gaeta3, D Schrempp4, R Chun4. 1ONCOVET
(France), 2Michigan State University, 3University of
Pennsylvania, 4Purdue University, 5University of Wisconsin-
Madison
Thymomas are uncommon tumors of the thymic epithelium in
dogs. The objective of the study was to compile a large number
of cases and further characterize the disease in regards to presen-
tation and outcome.
Data was collected retrospectively from 85 cases from 4 insti-
tutions over an 11-year period (1999-2010). Signalment, clinical
presentation, diagnostic testing, treatment speciﬁcs, adverse
events, and survival were evaluated.
Eighty-ﬁve dogs were included in the study. Labrador Retriev-
ers and Golden Retrievers represented 38 % of the population.
The mean age was 9.4 years. The most common presenting signs
were cough, lethargy/weakness and tachypnea. Eleven dogs
(13%) had clinical signs compatible with myasthenia gravis (7
were conﬁrmed). Total calcium was high in 24/85 dogs (28%)
(high ionized calcium in 25/37 dogs). Three dogs had pulmonary
metastasis at the time of diagnosis. Surgery was performed in 56/
85 patients. Phrenic nerve section occurred in 20% of dogs. Thir-
teen percent had tumor recurrence (mean 682 days post surgery,
median 547d (32-2170)). Thirteen percent of dogs developed a
second tumor. For dogs receiving surgery the median survival
time was 758 days and without surgery was 103 days. There was
no diﬀerence in survival time between dogs with and without
hypercalcemia or myasthenia gravis at diagnosis.
This study conﬁrms that thymoma is a rare disease with a
good prognosis post surgery, even in dogs with a large tumor
burden or presenting a paraneoplastic syndrome. An interesting
ﬁnding is that 13% of dogs developed a second tumor.
ABSTRACT O-7
EVALUATION OF SECRETED FRIZZLED-RELATED PRO-
TEIN 2 EXPRESSION IN CANINE THYROID TUMORS
USING RT-PCR AND IMMUNOHISTOCHEMISTRY.
K Deitz1, K Metivier2, V Wilke2, M Ackermann1, C Wang1.
1Iowa State University, College of Veterinary Medicine, Ames,
IA, 2University of Minnesota, College of Veterinary Medicine,
St. Paul, MN
We have previously reported up-regulation of secreted frizzled-
related protein 2 (SFRP2) gene expression in canine thyroid
tumors using microarray and SFRP2 protein expression and cel-
lular localization were characterized with immunohistochemistry
(IHC). The purpose of this study was to validate the gene expres-
sion of SFRP2 using RT-PCR. Additional samples were also
evaluated via IHC and analyzed statistically with the samples
from the initial study to increase statistical power. Tissue samples
were obtained from dogs undergoing neck mass removal with
informed client consent. Only dogs with thyroid carcinomas con-
ﬁrmed by histopathology were included in the study. Control
samples of histologically normal thyroid were obtained from
dogs lacking thyroid disease that were euthanized for unrelated
reasons. Thyroid tumors from the dogs were categorized based
on the degree of invasion: tumor cells conﬁned to the capsule
were classiﬁed as non-invasive, and those with capsular or vascu-
lar invasion were classiﬁed as invasive. There were 9 samples in
each of the 3 groups (control, non-invasive, and invasive). For
RT-PCR, a 1-2cm3 section of tissue was placed in RNA later®
and samples were assessed for RNA quality by agarose gel elec-
trophoresis. Only samples with no evidence of degradation were
used for further analysis. Beta actin was used as the internal ref-
erence gene. The mean expression of SFRP2 mRNA in invasive
carcinoma was 288 times higher versus control samples. Mean
SFRP2 mRNA expression in non-invasive versus control samples
was 50 times higher.
Samples for IHC were placed in formalin and assessed for
SFRP2 antigen using goat anti-SFRP2 antibody. There were a
total of 35 tumor samples (including 20 from the previous study)
and 10 controls (including 4 from the previous study). In all sam-
ples, SFRP2 antigen was present in the cytoplasm of neoplastic
thyroid follicular epithelial cells. Tumor samples had signiﬁcantly
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higher distribution (p=0.000) and intensity scores (p=0.0021)
versus control tissues, which lacked immunoreactivity for SFRP2.
This study veriﬁes our previous microarray and IHC results using
RT-PCR to assess expression of SFRP2 in thyroid tumors.
SFRP-2 is up-regulated in these tumors at all levels and likely
plays a role in pathogenesis that requires further elucidation.
ABSTRACT O-8
INVESTIGATING IN VITRO ANTI-CANCER EFFECTS OF
BENZIMIDAZOLES IN CANINE OSTEOSARCOMA.
JM Schmit, JM Wypij, H Pondenis, TM Fan, LD Garrett.
College of Veterinary Medicine, University of Illinois, Urbana,
II. USA
Introduction: Benzimidazole (BZ) drugs have demonstrated
anti-cancer eﬀects in various tumor models and their direct
eﬀects on cell proliferation and apoptosis are hypothesized to be
due to microtubule inhibitory actions as well as indirect anti-
angiogenic eﬀects via vascular disruption and VEGF modulation.
Canine osteosarcoma is a common tumor with an aggressive clin-
ical course and angiogenic phenotype. Despite advances in veteri-
nary medicine, the overall survival has not dramatically
improved in recent years, warranting investigation of novel thera-
pies. The aims of this study were to assess eﬀects of the clini-
cally-used benzimidazoles [mebendazole(MBZ), fenbendazole
(FBZ), and albendazole (ABZ)] in canine OSA cell lines.
Materials and Methods: Canine osteosarcoma cell lines D17 and
HMPOS were incubated for 24-48 hr with varying doses of BZs
(ABZ, FBZ, and MBZ, Sigma-Aldrich) based on published phar-
macokinetic data and peak plasma concentrations of clinical dosing
regimens. Cell proliferation was assessed with a commercial MTS
assay (Cell Titer AqueousOne, Promega). Soluble canine VEGF
protein was assessed via commercial ELISA (R&D Systems).
Results: In D17 and HMPOS canine OSA cell lines BZs
induce a time and dose dependent decrease in cell proliferation
and modulate VEGF secretion.
Conclusions: Benzimidazole drugs (albendazole, mebendazole,
and febendazole) demonstrate In vitro anti-neoplastic eﬀects in
canine OSA cell lines. Further investigation is ongoing to evalu-
ate the molecular mechanisms of BZ anti-neoplastic function and
the potential for BZs as novel adjuvant treatment for veterinary
cancers. (VCS Award Winner)
ABSTRACT O-9
MULTIDRUG RESISTANCE GENE EXPRESSION BY REAL
TIME PCR IN CANINE OSTEOSARCOMA CELL LINES
FROM DOGS NORMAL AND INCREASED SERUM ALKA-
LINE PHOSPATASE CONCENTRATION. LCR Rodrigues1,
CM Piskun1, V Thompson1, TJ Stein1. 1Department of Medical
Science, School of Veterinary Medicine, University of Wisconsin-
Madison, Madison, WI, USA
Osteosarcoma (OSA) arises from malignant osteoblasts in dogs
and human and is highly metastatic and frequently develops che-
motherapy resistance resulting in short survival time even for trea-
ted patients. An increase in serum alkaline phosphatase (ALP)
concentration at diagnosis is a negative prognostic factor for OSA
patients. We have generated canine primary OSA cell lines from
OSA-bearing dogs with increased serum ALP concentration and
have found these lines to be more resistant to chemotherapy in vi-
tro than OSA cell lines from dogs with normal serum ALP. This
study evaluated the expression of multidrug resistance genes in
canine OSA cell lines generated from OSA-bearing dogs with nor-
mal and increased serum ALP concentration.
Six cell lines were used, 3 from OSA dogs with normal ALP, 3
from OSA dogs with increased ALP. Quantitative RT-PCR was
used to measure the mRNA expression level of ABCB1, ABCC1,
ABCG2, and ERCC1. The ribosomal 18S mRNA was used as an
endogenous reference and RNA from normal bone was used to
compare against.
OSA cell lines associated with increased serum ALP have an
increased relative expression of ABCB1, ABCC1, ABCG2 and
ERRC1. The most striking diﬀerence was a 17-fold increase in
relative expression of ABCG2 between cell lines associated with
increased and normal serum ALP (3.48 vs. 0.199, respectively).
In addition, the diﬀerence in relative expression was 10-fold for
ERCC1 (15.61 vs. 1.52) and 7-fold for ABCC1 (5.58 vs. 0.75).
Finally, relative expression of ABCB1 was increased nearly two-
fold (10.99 vs. 6.08) in cell lines associated with increased serum
ALP compared to normal serum ALP cell lines. Despite these
increases, the diﬀerences failed to meet statistical signiﬁcance
(p<0.05) using a two-tailed Mann-Whitney test.
An increased serum ALP concentration is a negative prognos-
tic factor in dogs with osteosarcoma. Similarly, cell lines from
OSA-bearing dogs with increased serum ALP are more resistant
to chemotherapy compared to cell lines from OSA-bearing dogs
with normal serum ALP. We evaluated the relative expression
level of multidrug resistance genes in OSA cell lines associated
with diﬀerent serum ALP concentration. We found increased rel-
ative expression of 4 multidrug resistance genes in OSA cell lines
associated with increased serum ALP, though the diﬀerences
failed to reach signiﬁcance. One potential reason for the poorer
prognosis in this population may be the diﬀerences in chemosen-
sitivity, possibly due to diﬀerences in the expression of multidrug
resistance genes. However, further studies are necessary to better
understand this relationship.
ABSTRACT O-10
CONTINUOUS LOW-DOSE (METRONOMIC) ORAL CHE-
MOTHERAPY OF CANINE APPENDICULAR OSTEOSAR-
COMA. JP Woods1, S Boston1, AJ Mutsaers1, DE Saam1, B
Coomber2. 1Clinical Studies, 2Biomedical Sciences, Ontario
Veterinary College, University of Guelph, Guelph, Ontario,
Canada
Osteosarcoma is the most common primary bone tumour in
dogs with most dogs dying of metastatic disease despite surgery
and maximum tolerated dose (MTD) adjuvant chemotherapy. In
veterinary oncology, continuous low-dose (metronomic) schedules
of chemotherapy have become more popular for patient manage-
ment. Therefore, the purpose of this study was to retrospectively
investigate the eﬀectiveness of the addition of low-dose metro-
nomic chemotherapy following curative-intent amputation and
adjuvant carboplatinum chemotherapy to dogs with appendicular
osteosarcoma.
Dogs presented to the Ontario Veterinary College with a diagno-
sis of appendicular osteosarcoma who underwent limb amputation
followed by adjuvant carboplatinum chemotherapy were eligible for
this study. Dogs completed the amputation and carboplatinum and
either received no further treatment (control); or continued with a
metronomic chemotherapy protocol (treated) consisting of cyclo-
phosphamide (10-25 mg/m2 q 24-48h); nonsteroidal anti-inﬂamma-
tory (NSAID); and doxycycline (5 mg/kg q24h).
Sixty-one dogs entered the study and 21 dogs were evaluable.
The control group had 13 dogs with a median metastasis-free
interval of 178 days and a median survival time of 504 days. The
treatment group had 8 dogs with a median metastasis-free inter-
val of 332 days (P=0.16) and a median survival time of 340 days
(P=0.55).
Low-dose metronomic chemotherapy had few adverse eﬀects;
however, eﬃcacy was diﬃcult to determine perhaps due to lack
of prospective randomization of the dogs into the groups. Future
studies are needed to determine selection of metronomic agents
(timing and dosing schedules); biomarkers for eﬃcacy and toxic-
ity; and combinations with standard drug dosing, newer targeted
drugs, or immunotherapy.
ABSTRACT O-11
SERUM C-REACTIVE PROTEIN CONCENTRATIONS IN
CATS WITH ALIMENTARY LYMPHOMA UNDERGOING
CHEMOTHERAPY. SRR Lucas, VM Winkel, TLR Pavan.
School of Veterinary Medicine and Animal Science – University
of Sa˜o Paulo, SP, Brazil
C-reactive protein (CRP) is an acute-phase protein that is used
as a marker of infection and inﬂammation. Recently, it has been
used as a predictor of survival in some neoplastic conditions in
dogs and human beings, but there are few studies about CRP in
cats. The goal of this study was to evaluate CRP during chemo-
therapy and its relation with remission in cats with alimentary
lymphoma. CRP was measured by the use of a commercial spe-
cies-speciﬁc immunoassay test (Elisa Kit Cat CRP- Icllab – USA)
2012 ACVIM Forum Abstracts 815
in thirteen healthy cats and eight cats with alimentary lymphoma,
conﬁrmed by histopathologic examination. The eight cats with
lymphoma did not receive any treatment prior the diagnosis. In
healthy cats only one sample was collected. The cats with alimen-
tary lymphoma were evaluated at 2-week intervals along 12
weeks, when they presented clinically stable. For both groups,
samples were collected, harvested and frozen at -70°C until
tested. Mann-Whitney test followed by multiple Tukey´s tests
were used to compare the groups and weeks of treatment. Mean
CRP concentration was signiﬁcantly higher (p = 0,0002) in cats
with alimentary lymphoma (270,8l±112,1µg/mL) at the diagnosis
than in healthy cats (88,76±23,72µg/mL). At all other times while
cats were in treatment, CRP concentrations decreased, specially
at 12th week (181,9±86,63µg/mL) but the diﬀerence was not sta-
tistically signiﬁcant (p = 0,113) in relation to the diagnosis. In
conclusion, CRP concentration was higher in cats with alimen-
tary lymphoma before chemotherapy and did not decrease to
normal values during chemotherapy.
ABSTRACT O-12
SERUM AMYLOID A CONCENTRATIONS IN CATS WITH
LYMPHOMA DURING CHEMOTHERAPY. VM Winkel,
SRR Lucas, VABF Wirthl. School of Veterinary Medicine and
Animal Science – University of Sa˜o Paulo, Sa˜o Paulo, SP, Brazil
Serum amyloid-A (SAA) is an acute-phase protein that has
been used as a biomarker of inﬂammation, infection, neoplastic
conditions and trauma, considered as a part of the innate host
defense system. Lymphoma is one of the most common neoplasia
in cats. The purpose of this study was to evaluate SAA concen-
trations at diagnosis and remission in cats with lymphoma. SAA
was measured by the use of a commercial immunoassay kit
(PHASETM Serum Amyloid A Assay (SAA) – Multispecies –
Tridelta ltd - Ireland) in two groups of cats: 13 healthy cats and
16 cats with lymphoma (alimentary, mediastinal, renal and multi-
centric) without previous treatment, including the use of predni-
sone or chemotherapy. From the cats with lymphoma, 11
animals were evaluated during chemotherapy, at 2- week inter-
vals along 12 weeks. For both groups, serum samples were col-
lected and frozen at -70ºC until assayed. ANOVA test followed
by multiple Tukey´s tests were used to compare the groups. The
mean of SAA concentration was signiﬁcantly higher (p<0,0001)
in cats with lymphoma (9,721±16,342µg/mL) at the diagnosis
than in healthy cats (0,053±0,138µg/mL). SAA levels decreased
when lymphoma remission was achieved, and was signiﬁcantly
diﬀerent from 6th (0,798±0,895µg/mL) until 12th week
(0,362±0,491µg/mL) of treatment (p=0,0076), when compared to
the moment of diagnosis. In conclusion, SAA concentrations
decreased at remission in cats with lymphoma undergoing chemo-
therapy but the levels didn´t return to the normal values.
SMALL ANIMAL – OTHER
ABSTRACT OT-2
HOSPITAL VERSUS COMMUNITY ACQUIRED INTRA-
ABDOMINAL INFECTION OF GASTROINTESTINAL ORI-
GIN IN DOGS. ANK Floras, CR Sharp. Tufts Cummings
School of Veterinary Medicine, North Grafton, MA
Intra-abdominal infections (IAI) are common and associated
with high mortality rates in dogs. In human medicine, hospital
acquired (HA)-IAI is more commonly associated with multidrug
resistant (MDR) bacteria, and thus higher mortality, than com-
munity acquired (CA)-IAI. The purpose of this study was to
determine whether signiﬁcant diﬀerences in bacterial culture and
susceptibility proﬁles and outcome exist between HA-IAI and
CA-IAI in dogs. Medical records of dogs with IAI of gastroin-
testinal origin were retrospectively reviewed. Age, sex, breed,
etiology of infection, culture & susceptibility, and outcome were
recorded. Fifty three dogs were identiﬁed; 24 had CA-IAI, 8
had HA-IAI from another hospital, 13 developed HA-IAI in
our hospital, 7 dogs had CA-IAI at the time of presentation
and later developed HA-IAI, and 1 dog presented with HA-IAI
and following source control developed another HA-IAI in our
hospital. E. coli and Enterococcus spp. were isolated most fre-
quently regardless of whether CA- or HA-IAI, however organisms
associated with HA-IAI were more likely to be MDR. Twenty
ﬁve dogs survived to discharge (47.2%), 20 (37.7%) were eutha-
nized and 8 (15.1%) died. Dogs with HA-IAI that developed in
our hospital were less likely to survive to discharge when com-
pared with dogs presenting with CA-IAI, however this did not
hold true for dogs that presented with HA-IAI from another hos-
pital. Results suggest that dogs with HA-IAI are more likely to
have infections with MDR bacteria and have a higher mortality
than CA-IAI. The results of this study have implications for anti-
biotic choice and prognosis for dogs with HA-IAI.
ABSTRACT OT-3
MULTI-CENTER EVALUATION OF THE ADMINISTRA-
TION OF CROTALID ANTIVENOM IN CATS. MB
Pashmakova1, MA Bishop1, DM Black1, SI Johnson2, JW Barr1.
1Texas A&M University, College Station, TX, 2Emergency
Animal Hospital of Northwest Austin, Austin, TX
Anecdotally cats are considered to be relatively resistant to
snake envenomation; therefore, the collective experience with an-
tivenom administration in cats is limited. The purpose of this
study was to describe administration criteria, complication fre-
quency, and overall survival following crotalid antivenom admin-
istration in cats.
Information about antivenom administration in cats from 2000
to 2011 was gathered from facilities that frequently manage crotalid
envenomations. Medical records were searched for patient data
including signalment, administration criteria, prophylactic medica-
tion, antivenom product, immediate reactions, and survival. A mul-
tiple-choice answer format was used to maximize response rate and
facilitate data analysis. Preliminary data were analyzed and odds
ratios were calculated using a Fishers exact test.
Sixty-eight of 203 (33.5%) envenomated cats received antiven-
om. The most frequently administered product was Antivenin
(Crotalidae) Polyvalent (ACP) in 57/68 (83.8%) cats, followed by
polyvalent F(ab’)2 in 9/68 (13.2%) cats and Crotalidae polyva-
lent immune Fab (Crofab) in 2/68 (2.9%) cats. The most frequent
indication was suspected rattlesnake envenomation in 66/68
(97.1%) cats, followed by hematologic abnormalities in 39/68
(57.4%) cats. Acute hypersensitivity reactions occurred in 15 cats
(22.1%), of which 14 cats received ACP. Three cats died acutely,
none of which received treatment with antihistamines or gluco-
corticoids before administration of antivenom (OR:19.4, 95%
CI:1.0-395.1, P=0.0227). Overall, 64/68 cats (94.1%) receiving
antivenom survived to discharge.
In conclusion, antivenom was well tolerated in cats and survival
following administration was excellent. Premedication may decrease
frequency of reactions and improve survival; however, severity of
illness rather than product administered may aﬀect outcome.
ABSTRACT OT-4
ENDOSCOPIC-GUIDED LASER ABLATION OF VESTIBUL-
OVAGINAL DEFECTS IN 36 DOGS. S Burdick, A Berent, C
Langston, C Weisse. The Animal Medical Center, New York, NY
The purpose of this report is to describe and retrospectively
evaluate short and long-term outcomes in female dogs after
endoscopic-guided laser ablation (ELA) of vestibulovaginal septal
defects.
36 female dogs with a persistent paramesonephric remnant
(PPMR) (n=19), vaginal septum (n=11), or dual vagina (n=6)
were included. All patients had complete cystourethrography.
Simultaneous diagnosis and treatment was performed via vagino-
scopic guidance. ELA was used to transect the vaginal membrane.
Patients with intramural ectopic ureters (EU) were concurrently
treated with cystoscopic-guided laser ablation. A repeat endoscopy
was performed in 18 dogs approximately 6 weeks post ELA and all
vaginal and ureteral defects were re-assessed.
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26 dogs presented for urinary incontinence, 2 for recurrent uri-
nary tract infections (UTI) and 8 for both incontinence and UTI.
Thirty dogs had concurrent EU. The diode laser (n=28) or Hol-
mium:YAG laser (n=8) were used. Five dogs had mild post-
operative dysuria, which resolved within 24 hours. One complica-
tion occurred (laser perforation of the vaginal wall). There were
no negative eﬀects from this event and at an 8 week re-scoping
the tissue was fully healed. There was signiﬁcant improvement in
continence scores in all dogs (p<0.001) and a decreased inci-
dence of UTIs after laser correction of the congenital malforma-
tion(s) in all dogs (p = 0.0287). The median follow-up time was
33 months (2-49 months).
ELA provided an eﬀective, safe and minimally invasive treat-
ment for various vestibulovaginal septal remnants, avoiding the
need for more invasive surgery for a disease that has an
unknown signiﬁcance.
ABSTRACT OT-5
18FLT-PET/CT FOR NON-INVASIVE FUNCTIONAL IMAG-
ING OF CANINE BONE MARROW. JA Rowe1, CJ LeBlanc1,
SA Kania1, SJ Newman1, M Akula2, GD Galyon1, MJ Long2,
SJ Kennel2, GW Kabalka2, AK LeBlanc1,2. University of
Tennessee College of Veterinary Medicine;
2University of Tennessee Graduate School of Medicine, Molec-
ular Imaging and Translational Research Program; Knoxville,
TN
Non-invasive techniques to evaluate bone marrow function are
needed to optimize care of dogs with suspected or conﬁrmed
hematopoietic disorders. Positron Emission Tomography/Com-
puted Tomography (PET/CT) using 18F-ﬂuoro-l-deoxythymidine
(18FLT), a PET tracer that physiologically concentrates in bone
marrow and acts as a marker of cellular proliferation, oﬀers a
non-invasive imaging technique for whole-body assessment of
marrow proliferation.
Three (3) clinically normal, purpose-bred dogs were imaged
using 18FLT for assessment of bone marrow proliferation at
baseline and at 7 and 14 days post administration of a single
dose of cyclophosphamide (225 mg/m2 PO) to nonselectively sup-
press hematopoiesis. PET/CT images were acquired with dogs
under light general anesthesia following a minimum 12 hour fast.
Regions of interest were drawn over sites of clinical relevance
and increased tracer uptake, including common marrow sampling
sites. Standardized uptake values were calculated utilizing dedi-
cated analysis software. Bone marrow aspirates from both the
proximal humerus and wing of the ilium were assessed within 24
hours of each imaging timepoint by cytology and ﬂow cytometric
cell cycle analysis for comparison with PET imaging ﬁndings.
Cytologic analysis included estimation of overall cellularity with
a 200-cell diﬀerential count discriminating cells as early erythroid,
late erythroid, early granulocytic, late granulocytic, monocyte/
macrophage, lymphocyte, plasma cell, or other. CBCs were
assessed daily after cyclophosphamide administration.
Despite development of profound circulating neutropenia
(median neutrophil nadir 580 cells/uL, 8 days post-cyclophospha-
mide administration), no signiﬁcant changes in overall marrow
cellularity were detected. Statistically signiﬁcant changes between
sampling timepoints were detected in the granulocytic index
(ratio of early to late granulocytic precursors) in the wing of the
ilium aspirates (p=0.007), and ﬂow cytometric cell cycle analysis
was indicative of DNA insult at all sites sampled. Strong physio-
logic 18FLT uptake remained present in axial and proximal
appendicular marrow sites. Changes over time in SUVmax were
signiﬁcant (p=0.003) in proximal humerus but not wing of ilium
sites.
Reports in humans with myeloproliferative diseases demon-
strate utility of 18FLT-PET in characterizing such diseases.
Changes observed in bone marrow samples in this study preclude
correlation between 18FLT signal and marrow function, likely
due to cyclophosphamide-induced cell cycle arrest rather than
cytotoxicity. Future studies using site-speciﬁc marrow ablative
techniques are planned to produce more conspicuous marrow
hypocellularity.
ABSTRACT OT-6
LIPOPOLYSACCHARIDE, TUMOR NECROSIS FACTOR,
AND INTERLEUKIN-1B INDUCE NT-PRO C-TYPE
NATRIUETIC PEPTIDE SECRETION FROM CANINE VAS-
CULAR ENDOTHELIAL CELLS. KA Osterbur, DH Yu, AE
DeClue. University of Missouri College of Veterinary Medicine,
Columbia, MO
The N-terminal portion of pro C-type natriuretic peptide (NT-
pCNP) has shown promise as a biomarker for sepsis in humans
and dogs. NT-pCNP is thought to be primarily secreted from the
vascular endothelium, however the mechanism of NT-pCNP
induction in dogs is unknown. We hypothesized that bacterial
pathogen associated molecular pattern motifs (PAMPs) would
induce NT-pCNP secretion from canine vascular endothelial cells
to a signiﬁcantly greater degree than inﬂammatory mediators. To
test our hypothesis, we stimulated canine vascular endothelial
cells with PAMPs (lipopolysaccharide, lipoteichoic acid, and pep-
tidoglycan), inﬂammatory mediators (TNF, IL-1b, IL-6, CXCL-
8, IL-10, IL-21, Interferon-c, and Vascular Endothelial Growth
Factor) or control (Phosphate Buﬀered Saline [PBS]). Statistics
were performed using the Mann Whitney Rank Sum Test or
Kruskal-Wallis One Way Analysis of Variance on Ranks with
post-hoc Dunn’s Method (P < 0.05 considered signiﬁcant).
NT-pCNP concentrations were signiﬁcantly greater after lipo-
polysaccharide (median, Q1, Q3; 11, 10, 11.5 pmol/L; P=0.024),
TNF (13.3, 12.1, 14.5 pmol/L; P=0.012) and IL-1b (24.1, 19.4,
28.1 pmol/L; <0.001) stimulation compared to PBS (1.7, 1.1, 2.1
pmol/L). The other stimulants did not result in NT-pCNP secre-
tion compared to PBS. Lipopolysaccharide, TNF and IL-1b
induction of NT-pCNP secretion were both dose and time depen-
dent in nature.
Of the compounds tested, IL-1b, TNF, and lipopolysaccharide
resulted in the greatest CNP secretion from canine vascular endo-
thelial cells. This study provides insight into why dogs with sepsis
have higher serum concentrations of NT-pCNP when compared
to dogs with other forms of critical illness.
ABSTRACT OT-7
PENTOSAN POLYSULFATE AND N-ACETYL GLUCOSA-
MINE COMBINATION ENHANCES INHIBITION OF
INTERLEUKIN-8 PRODUCTION BY MELOXICAM IN
CANINE CHONDROCYTES. KE Walker1, AN Johnson2, MW
Grzanna1, CG Frondoza1,2,4. 1Nutramax Laboratories, Inc.,
Edgewood, MD, 2Mississippi State University, Mississippi State,
MS, 3Johns Hopkins University, Baltimore, MD
The pathogenesis of osteoarthritis (OA) in humans and ani-
mals is characterized by excess production of pro-inﬂammatory
mediators including cytokines and chemokines. Chemokines such
as interleukin-8 (IL-8) are thought to play a role in OA by acting
as signaling molecules and pain inducers. Meloxicam, a non-ste-
roidal anti-inﬂammatory drug (NSAID), is commonly used to
treat OA in dogs. However, its eﬃcacy is hampered by life-
threatening side eﬀects raising the question whether dosing can
be reduced through combining with other agents. Non-pharma-
cologic compounds, such as pentosan polysulfate (PPS) and N-
acetyl glucosamine (NG), have been reported to promote chon-
drocyte anabolic activity and could be disease modifying. We
hypothesized that the combination of [PPS+NG] enhances the
eﬀect of low concentrations of meloxicam on IL-8 production in
canine chondrocytes.
Canine chondrocyte monolayer (5x105 cells/well) or microcar-
rier spinner cultures (4x106 cells/ﬂask) were activated with inter-
leukin-1 (IL-1 50ng/ml) for 24 hours and then incubated with:
(a) control media alone, (b) a clinically relevant concentration of
[PPS+NG] (AUPEN5000TM, PPS: 125lg/mL, NG: 200lg/mL),
(c) a sub-therapeutic concentration of meloxicam (11.7ng/ml), or
(d) a mixture of [PPS+NG]+ meloxicam (11.7ng/ml) for an
additional 24 hours. Cell culture supernatant was analyzed for
IL-8 production by ELISA. Statistical analysis was run using
one-way ANOVA and the Holm-Sidak method with signiﬁcance
set at P<0.05.
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Non-activated chondrocytes produced low levels of IL-8
(~5000pg/ml) in both monolayer and microcarrier cultures. IL-1b
activation increased IL-8 production (~3-5 fold P<0.001). The
sub-therapeutic concentration of meloxicam decreased IL-8 pro-
duction by ~20-30% (P<0.001). Treatment with [PPS+NG]
reduced cytokine-induced IL-8 production by ~20-50%
(P<0.001.) The combination of [PPS+NG] with meloxicam
showed a more profound decrease in IL-8 production by ~50-
70% (P<0.001) in both monolayer and microcarrier cultures.
Here we report that [PPS+NG], when combined with a sub-
therapeutic concentration of meloxicam, potentiates the inhibi-
tion of IL-8 production in canine chondrocytes. Our ﬁnding sug-
gests that this combination strategy may minimize adverse side
eﬀects while maintaining anti-inﬂammatory activity (Research
supported by Nutramax Laboratories, Inc.).
ABSTRACT OT-8
COMPARISON OF PCR- AND CULTURE-BASED METH-
ODS TO EVALUATE BLOOD FROM DOGS WITH SUS-
PECTED SEPSIS. RM Heilmann1, PG Xenoulis1, J Barr2, SE
Dowd3, JS Suchodolski1, JM Steiner1. 1Gastrointestinal
Laboratory and, 2Small Animal Veterinary Teaching Hospital,
Texas A&M University, College Station, TX, 3Molecular
Research DNA Lab, Shallowater, TX
Sepsis is associated with a poor outcome in critically ill dogs.
Conventional blood culture, the current gold standard method
for the detection of bacteremia in veterinary medicine, is associ-
ated with a long turnaround time, a low sensitivity for some
organisms, and often fails to grow bacteria after initiation of
antimicrobial treatment. Polymerase chain reaction (PCR)-based
diagnostics may have a high sensitivity for detecting bacterial
DNA in the bloodstream allowing early initiation of appropriate
antimicrobial therapy, which may improve patient outcome.
Molecular techniques have been considered as ancillary tools for
the detection of bacteremia and identiﬁcation of pathogens in
humans and also in dogs with bacterial endocarditis, but have
not been reported in dogs with suspected sepsis. The aim of this
study was to compare PCR analysis and culture of blood for the
detection of bacteremia in dogs with suspected sepsis.
Six dogs with suspected sepsis (median age [range]: 4 [1-10]
years; 4 males, 2 females), referred to the Emergency Service at
Texas A&M University, and 6 healthy control dogs (median age
[range]: 4 [0.8-10] years; 2 males, 4 females) were prospectively
enrolled. Sepsis was suspected in dogs that had  2 of the estab-
lished systemic inﬂammatory response syndrome [SIRS] criteria:
hypo- or hyperthermia, tachycardia, tachypnea, leukopenia or
leukocytosis, and/or an increased number of band neutrophils.
Patients included in the study were diagnosed with primary gas-
trointestinal (n=2), systemic (n=2), respiratory (n=1), or pleural
(n=1) disease; four (66.7%) of the 6 dogs with suspected sepsis
had received an antimicrobial drug within 1 week prior to sample
collection. Two serial samples were obtained from 1 patient.
Venous blood was collected aseptically for anaerobic and aerobic
blood culture. Also, an aliquot was placed into an EDTA-tube,
centrifuged, and blood cells were separated from plasma. DNA
was extracted using a commercial kit and included a negative
extraction control. Extracted blood cells and cell-free plasma
were analyzed separately by PCR using universal 16S rRNA gene
primers followed by 454-pyrosequencing of the PCR products.
One (14%) of the 7 blood cultures from patients with sus-
pected sepsis was positive for Enterococcus spp. and an unidenti-
ﬁed gram-negative bacterial strain, whereas none of the healthy
controls had a positive blood culture. PCR was negative for all
extracts from blood cells and cell-free plasma collected from
patients with suspected sepsis and from healthy controls.
This study does not support that PCR-based techniques used
directly on blood could serve as an alternative to conventional
blood culture for the diagnosis of bacteremia in patients with sus-
pected sepsis. However, further studies with larger numbers of
dogs are needed to conﬁrm these ﬁndings.
ABSTRACT OT-9
METAGENOMIC INVESTIGATION OF THE ORAL MI-
CROBIOME OF HEALTHY DOGS. JW Stull, A Sturgeon, M
Costa, AS Peregrine, J Sargeant, JS Weese. Ontario Veterinary
College, Guelph, Ontario, Canada
The body harbors complex and diverse bacterial populations
(microbiomes) that are important for health and disease but
which have been minimally investigated. Of particular interest is
the oral microbiome, as it has been implicated in several diseases
of varying anatomical locations including dental, respiratory, and
cardiovascular disease, as well as cancer. The development of
next generation sequencing platforms and advanced bioinformat-
ics tools has allowed for proper characterization of these vast
microbial populations. The objectives of this study were to deter-
mine the bacterial ﬂora and diversity of the canine oral cavity.
Six dogs from diﬀerent households were conveniently selected
and an oral sample was taken by brushing the inside mouth with
a sterile toothbrush. DNA was extracted and puriﬁed, 16S rRNA
gene PCR performed and PCR products sequenced using next
generation sequencing.
Over 10,000 sequences with mean lengths > 500 base pairs were
ampliﬁed from each sample. Relative abundance of bacterial phyla
in samples were similar among the dogs, with Bacteroidetes
accounting for over 70% of each dogs’ oral ﬂora, followed by Pro-
teobacteria (4-19%), Firmicutes (2-10%), and Fusobacteria (0.5-
9%). Unclassiﬁed phylum-level sequences were uncommon
(<0.02%). Dogs varied in the number of genera identiﬁed (range
39-81). Porphyromonas and Capnocytophaga were identiﬁed in all
dogs and were the most abundant genera in most dogs (45-84%
and 5-46%, respectively). Eleven diﬀerent Porphyromonas species
were identiﬁed from the dogs. Nine zoonotic species were identiﬁed
with  3 species present in each dog; Capnocytophaga canimorsus
and C. cynodegmi were the most common. Streptobacillus monili-
formis (causative agent of rat-bite fever) was identiﬁed in one dog.
Our methods ampliﬁed a large number of long sequences with
high organism identity, revealing the utility of this technique for
investigating the canine oral ﬂora. The high genera diversity iden-
tiﬁed far surpassed culture-based studies, demonstrating a diverse
and complex oral microﬂora. All dogs carried multiple zoonotic
bacterial species, highlighting the zoonotic potential of the oral
ﬂora of healthy dogs. These results are in contrast with culture-
based studies and indicate both a greater degree of complexity
than has been previously identiﬁed and the abundance of organ-
isms often reported as absent or rare. These data provide insight
into the oral microbiome of healthy dogs; a critical step in under-
standing the role of oral ﬂora in disease.
ABSTRACT OT-10
EFFECTS OF SPECIMEN TYPE (SERUM OR PLASMA) ON
BIOCHEMISTRY RESULTS IN HEALTHY CATS.
BS Reynolds, C Brosse, M Legras, HP Lefebvre. Clinical
Research Unit, National Veterinary School, Toulouse, France
Consecutive blood collection using diﬀerent tubes can be diﬃ-
cult in cats. Serum or heparinized plasma is usually recom-
mended for biochemistry but the potential eﬀect of other
anticoagulants is poorly documented in cats. The objective of this
study was therefore to compare the concentration of routine
chemical variables in serum or plasma obtained using various an-
ticoagulants.
Eleven healthy cats were used. Blood was drawn from a jugu-
lar vein into evacuated tubes without or with anticoagulants (Li-
heparin, EDTA and citrate). After centrifugation, serum/plasma
was assayed by use of dry slide technology analyzer for glucose,
urea, creatinine, sodium, potassium, chloride, total CO2, calcium,
phosphate, proteins, albumine, ALT and ALP. Eﬀects of speci-
men type on results were assessed by analysis of variance.
Results obtained from serum and heparinized plasma were sta-
tistically diﬀerent for 4/13 variables, but the observed diﬀerences
were clinically irrelevant. For EDTA plasma, potassium and cal-
cium could not be assayed. Other results were not statistically
diﬀerent or very close from those obtained from heparinized
plasma or serum. Results obtained from citrated plasma were
strongly divergent except for albumin, ALT and ALP.
In conclusion, EDTA plasma could be an appropriate alterna-
tive if needed for most biochemistry assays in cats.
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ABSTRACT OT-11
COMPULSIVE CAT ADOPTERS: EVALUATION OF OWN-
ERS´ MENTAL HEALTH STATUS AND ATTACHMENT TO
PETS IN A POPULATION OF BRAZILIAN OWNERS OF
MULTIPLE CATS. D Ramos1, A Reche-Junior1, NO Cruz1,
JAE Hernandez2. 1Department of Medical Clinics, Faculty of
Veterinary Medicine and Animal Science, University of Sa˜o
Paulo, Brazil, 2Department of Fundamentals of Psychology,
Institute of Psychology, State University of Rio de Janeiro,
Brazil
The acquisition of domestic cats as pets constitutes a world-
wide phenomenon. In highly populated areas such as Sa˜o Paulo
region of Brazil, keeping a less demanding pet such as a cat bet-
ter suits the busy daily routines people tend to have. For some
individuals, however, satisfaction seem to come from keeping
many cats at once, a condition frequently considered to be a
matter of animal hoarding, deleterious for both parts, the cats
and the owner. In order to explore the mental health status of
such individuals, a survey was conducted with 30 owners of mul-
tiple cats (i.e. 20 cats or more – group 1). Comparative groups 2
and 3 were composed by 30 owners of 1-2 cats and 30 partici-
pants who did not own any pet, respectively. A questionnaire
composed by the SI-R (Saving Inventory-Revised), HAD (The
Hospital Anxiety and Depression Scale) and the LAPS (Lexing-
ton Attachment to Pets Scale), all in Portuguese language, were
given to the participants to answer. Results indicated more cases
of anxiety among the non pet owners (i.e. 9 in 30 – versus 4 in
30 in both groups 1 and 2) and more depression cases among the
owners of multiple-cats (i.e. 4 in 30 – versus 1 in 30 in group
1and 2 in 30 in group 3). Owners of multiple cats showed higher
levels of attachment to pets, but their SI-R ﬁnal scores did not
diﬀer from the other groups. In several ways, owning many pets
seems to impair the social aspect of the owner´s life which can
lead to isolation – this maybe the reason why more depression
was seen in group 1. At least for the owners of this study, acquir-
ing many cats maybe analogous to the habit of collecting
“things”, but yet at a non-pathological degree as from the ques-
tionnaire there was no evidence of animal hoarding. Alterna-
tively, animal hoarding does not necessarily imply hoarding in
general (as evaluated in the SI-R).
SMALL ANIMAL - PHARMACOLOGY
ABSTRACT P-1
THE PHARMACOKINETICS OF SINGLE DOSE
EXTENDED RELEASE KEPPRA® WITH AND WITHOUT
FOOD IN HEALTHY ADULT DOGS. MJ Beasley1, DM
Boothe2. 1Mississippi State University College of Veterinary
Medicine, Mississippi State, MS, 2Auburn University College of
Veterinary Medicine, Auburn, AL
Levetiracetam appears to be a safe and potentially eﬀective
anticonvulsant for the control of epilepsy in dogs. However, its
eﬃcacy is challenged by a short half-life (often less than 2 hours).
This half-life often results in subtherapeutic concentrations dur-
ing an 8-hour dosing interval despite high oral doses. An
extended release oral preparation recently has been approved in
humans, which allows less frequent dosing intervals. The purpose
of this study was to evaluate the pharmacokinetics of extended
release levetiracetam (Keppra XR®) tablets in normal healthy
dogs after a single oral dose with the goal of establishing a dos-
ing regimen for the commercially available tablet that would
allow 12 to 24 hour dosing intervals. The eﬀect of food on drug
movement was also evaluated.
Twelve client-owned dogs weighing at least 15 kg were studied
using a crossover design. All dogs received intravenous levetirace-
tam, followed by a 24-hour washout period and then extended
release levetiracetam orally (6 each with food or following a 12
hour fast; selection was random). All doses averaged 32.67 mg/
kg. Blood samples were collected for 24 or 36 hours after intrave-
nous or oral administration, respectively. Serum levetiracetam
was quantitated using an ARK Diagnostic Levetiracetam Assay®.
Data was subjected to non-compartmental pharmacokinetic anal-
ysis.
Keppra XR® was well tolerated. Serum levetiracetam reached
the targeted therapeutic range (5 ng/mL) within 100 or 200 min-
utes and stayed within the range for an average of 19.8 hours
(range 15-24.2) or 20.7 hours (range 16.7-28.7), in fasted and fed
animals, respectively. Bioavailability and time to maximum con-
centration was signiﬁcantly higher in fed versus fasted dogs, how-
ever, half-life was not signiﬁcantly diﬀerent between groups. This
study supports 12 hour dosing intervals for levetiracetam when
administered as Keppra XR® at approximately 30 mg/kg in dogs;
24 hour intervals may be acceptable for some dogs, although
monitoring is recommended to conﬁrm.
ABSTRACT P-2
LOCAL AND SYSTEMIC EFFECTS OF A COMMERICAL
PREPARATION OF CHONDROTIN SULFATE, HYAL-
URONIC ACID AND N-ACETYL-D-GLUCOSAMINE WHEN
ADMINISTERED INTRA-ARTICULARLY OR INTRAMUS-
CULARLY TO HEALTHY DOGS. CM MacPhail, MM Brewer,
JR Hawley, JK Veir, MR Lappin. Department of Clinical
Sciences, Colorado State University, Fort Collins, Colorado
Products containing glycosaminoglycans (GAG) are frequently
administered by various routes to dogs to aid in the management
of osteoarthritis (OA). However, little information is available
concerning eﬀects of these products when administered to dogs,
particularly regarding biomarkers of OA. The purpose of this
study was to determine local and systemic eﬀects of a single
intra-articular (IA) administration or repeated intramuscular
(IM) administrations of a formulation of chondroitin sulfate,
hyaluronic acid, and N-acetyl-D glucosamine in healthy dogs.
Eight healthy, young adult, mixed sex beagles were used in this
study. Using procedures approved by the Institutional Animal
Care and Use Committee, blood, serum, and synovial ﬂuid (both
stiﬂe joints) were collected on Days -7, 0, 3, 7, 14, 35, 42, 49, 56,
and 63. After arthrocentesis on Day 0, 1.5 ml of Polyglycan®
(Arthrodynamic Technologies, Lexington, KY) was injected into
the right stiﬂe joint. Days 14 to 35 were designed as a washout
period. After sample collection on Day 35, Polyglycan® was
administered IM (0.1 ml/lb) to each beagle with repeated IM
injections on Days 42, 49, and 56. Complete blood cell counts
(CBC) and serum biochemical proﬁles were performed on Days -
7, 0, 35 and 63. Aggrecan synthesis (epitope CS846), GAG, and
prostaglandin E2 (PGE2) concentrations from serum and the
synovial ﬂuid of the treated stiﬂe collected at all time points were
determined using previously validated assays. The dogs were
observed daily for changes in appetite, attitude, ambulation, and
body temperature.
Other than evidence of transient lameness (< 24 hours) fol-
lowing synovial ﬂuid sampling, no other clinical side-eﬀects were
noted. There were no signiﬁcant changes in CBC or biochemical
results over time. There were no signiﬁcant changes in serum or
synovial ﬂuid concentrations of CS846 or GAG over time. While
there were no signiﬁcant changes in serum concentrations of
PGE2 over time, synovial ﬂuid concentrations of PGE2 were sig-
niﬁcantly lower on Day 56 (p = 0.03) and Day 63 (p = 0.02)
when compared to Day 35 concentrations.
The results indicate administration of Polyglycan® using these
routes of administration and dose schedule had no measurable
side-eﬀects. Repeated arthrocentesis in the presence of these Poly-
glycan® protocols had no measurable eﬀect on serum concentra-
tions of aggrecan synthesis, GAG, and or PGE2 or synovial ﬂuid
concentrations of aggrecan synthesis or GAG. However repeated
IM injection resulted in a signiﬁcant decrease in synovial ﬂuid
PGE2 concentrations, which may reﬂect a positive inﬂuence on
synovial inﬂammation.
ABSTRACT P-3
EFFECTS OF ORAL CYCLOSPORINE ON CANINE T-CELL
EXPRESSION OF IL-2 AND IFN-c ACROSS A 12-HOUR
DOSING INTERVAL. C Fellman, T Archer, J Stokes, K
Lunsford, A Mackin. Mississippi State University College of
Veterinary Medicine, Starkville, MS
Cyclosporine is a commonly used immunosuppressive drug in
dogs, but dosing is often empirical and based on clinical
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response. Pharmacokinetic monitoring of blood drug levels is
performed, but often does not reliably predict clinical response.
Pharmacodynamic assays measuring the eﬀects of the drug on
target cells more reliably predict immunosuppressive eﬀectiveness
in humans. Our laboratory has developed pharmacodynamic
assays for measuring the eﬀects of cyclosporine on canine T-cell
cytokine production. The current study evaluates the eﬀects of
cyclosporine on IL-2 and IFN-c expression across a 12-hour dos-
ing interval using ﬂow cytometry, and compares these values to
traditionally-measured drug levels at similar time points.
Oral cyclosporine was given to 6 healthy dogs at 10 mg/kg
every 12 hrs for 8 days. Blood was drawn before treatment (base-
line), and then on day 8 at 0, 2, 4, 6, 8, and 10 hrs. Cyclosporine
levels were measured post-treatment via immunoassay. For cyto-
kine assays, blood was incubated with PMA and ionomycin,
CD3 was used to label T-cells, and intracellular staining of IL-2
and IFN-c was performed. Samples were evaluated with a FAC-
SCalibur ﬂow cytometer, and the mean ﬂuorescence intensity of
5,000 lymphocytes was measured at baseline and day 8 (0, 2, 4 &
8 hrs).
Flow cytometry reﬂected consistent suppression of IL-2 and
IFN-c expression at all time points across the dosing interval
(Figures A&B). At trough drug levels, cytokine expression was
most variable, but was still markedly decreased from pre-treat-
ment levels. Blood cyclosporine levels were highly variable among
dogs, but still displayed a characteristic peak and trough (Figure
C).
Suppression of IL-2 and IFN-c was consistent among all dogs
tested, and the slightly more variable cytokine suppression at 0
hrs was reﬂective of decreased trough drug levels. Further testing
of pharmacodynamic cytokine assays to assess their utility in
clinic patients is indicated.
SMALL ANIMAL – RESPIRATORY
ABSTRACT R-1
COMPARISON OF BRONCHOALVEOLAR LAVAGE ASPI-
RATION TECHNIQUES IN HEALTHY DOGS: MANUAL
ASPIRATION AND SUCTION PUMP ASPIRATION. KS
Woods, AMN Defarges, ACG Abrams-Ogg, H Dobson, L Viel,
D Bienzle. Ontario Veterinary College University of Guelph,
Guelph, ON, Canada
The purpose of the study was to compare the diagnostic qual-
ity of bronchoalveolar lavage ﬂuid (BALF) cellular component
acquired by manual aspiration via polyethylene tubing (MAPT)
and suction pump aspiration (SPA) via suction trap connection
techniques in healthy dogs.
Bronchoalveolar lavage was performed under general anesthe-
sia using bronchoscopic guidance in twelve healthy beagles. Fol-
lowing passage of the endoscope, sterile polyethylene tubing was
inserted through the biopsy channel and MAPT performed with
a 35mL syringe attached to the tubing wedged in the bronchus.
Similarly, SPA was performed using 5kPa negative pressure
applied directly to the bronchoscope’s suction valve via dispos-
able aspiration tube. MAPT and SPA techniques were performed
in randomized order in opposite caudal lung lobes of each dog.
Two lavages boluses were infused at each site using a weight-
adjusted aliquot volume (1 mL/kg). The BALF samples were
submitted and prepared for total nucleated cell count and diﬀer-
ential cell count. A subjective scale for quality and percent of
retrieved ﬂuid were evaluated. Results were compared using a
paired Wilcoxon sign rank test.
The proportion of BALF retrieved was signiﬁcantly higher
(mean diﬀerence 19.02%, p = 0.001) for SPA than MAPT.
From the BAL cell diﬀerential analysis, a higher percentage of
epithelial cells was present when compared to SPA (mean diﬀer-
ence = 0.81, p = 0.05).
The results suggest that SPA provided BALF samples of
higher diagnostic quality than MAPT in healthy dogs. The SPA
technique may improve the diagnostic accuracy and signiﬁcance
of BAL in dogs.
Statement on prior publication: Abstract presented at the
Ontario Veterinary College Graduate Research Symposium, Uni-
versity of Guelph, Guelph, Ontario, Canada; November 16th, 2011.
ABSTRACT R-2
ENVIRONMENTAL AIR QUALITY, METEOROLOGICAL
FACTORS, AND FELINE RESPIRATORY DISEASE. RH
Stone1, M Mason2, JR Smith1. 1College of Veterinary Medicine
and, 2College of Public Health, University of Georgia, Athens,
GA
Poor air quality and temperature extremes increase overall
human mortality and hospitalization; the eﬀect on animal health
is undetermined. This study investigated if feline respiratory dis-
ease is associated with air quality or meteorological parameters.
Retrospective case review for adult, coughing cats. Monthly
meteorological and Environmental Protection Agency data were
gathered for 14 cities. Relationships between environmental vari-
ables were assessed with Pearson correlation coeﬃcients. Associa-
tion between environmental variables and respiratory visits was
evaluated with Poisson regression analysis. Demographic data
were compared using ANOVA and Chi square analysis.
Of 594,032 primary care visits, 10,483 involved coughing.
Respiratory diagnoses included asthma (1,352); bronchitis (853);
tracheitis (481); laryngitis (46) and pneumonia (12). Siamese cats
were overrepresented in coughing and asthma/bronchitis groups
(RR 1.6 [CI 1.3-1.8], p < 0.0001). A negative association existed
between ambient temperature and coughing (6.0% increase in
visits/ 10°F temperature drop, p < 0.0001). A positive associa-
tion was demonstrated for relative humidity and coughing (7.0%
increase in visits/ 10% rise in humidity, p < 0.0001). For cats
with asthma or bronchitis, only a negative association between
ambient temperature and cough was found (9.0 % increase in
visits/10°F temperature drop, p < 0.0001). No signiﬁcant associ-
ation was found for particulate or ozone concentrations. The city
of residence was signiﬁcant in all models (p< 0.0001).
In conclusion, relative frequencies of visits for coughing,
asthma or bronchitis were associated with seasonal variables. The
signiﬁcant variation in respiratory caseload between cities demon-
strates that other seasonal and regional air quality factors may
impact feline respiratory health.
ABSTRACT R-3
TRACHEAL MALFORMATIONS IN YORKSHIRE TERRI-
ERS. E Branter, C Weisse, A Berent. Animal Medical Center,
NY, NY
Tracheal collapse is a syndrome describing various forms of
functionally narrowed tracheal lumens. Focal tracheal cartilage
malformations in Yorkshire Terriers is a previously unclassiﬁed
manifestation of this syndrome.
The purpose of this study was to describe the clinical signs,
diagnostic ﬁndings, and short-term outcome following endolumi-
nal tracheal stenting for this unique population. Medical records
were reviewed of all dogs presenting to the Animal Medical Cen-
ter Interventional Radiology Service with a diagnosis of tracheal
malformation. Clinical signs including dyspnea, honking/raspy
breathing, and coughing were each serially classiﬁed by the owner
on a scale of 0-10 (absent to continuous). Outcomes and compli-
cations were reported.
Thirteen dogs, all Yorkshire Terriers, were identiﬁed to have
non-traditional cartilage malformations of the trachea. Thoracic
radiographs found focal collapse at the thoracic inlet in all dogs.






















Figures presented as mean +/- standard deviation.IL-2 Baseline MFI
54.2; IFN-c Baseline MFI 11.9.
Percentages superimposed below data points on Figures A&B represent
percentage reduction of mean MFI from these original baseline values.
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formed in 11/13 dogs and all of these had evidence of “W” shaped
tracheal rings. Median pre-stent coughing score was 2 (0-10), post-
stent was 2 (0-2), median pre-stent honking score was 6.5 (0-10)
and post-stent was 0 in all, median pre-stent dyspnea was 5 (2-10)
and post-stent was 0 (0-2). Complications occurred in 5/13; 2 stent
fractures not requiring intervention and 3 tissue ingrowth (1
resolved with prednisone, 2 required stent placement).
A subset of Yorkshire Terriers exists with a unique form of
the tracheal collapse syndrome that can be identiﬁed pre-opera-
tively and is treated in similar ways with expected outcomes and
complications similar to those reported with other forms tracheal
collapse.
ABSTRACT R-4
ORAL GLUCOCORTICOIDS MAY DIMINISH EFFICACY
OF ALLERGEN-SPECIFIC IMMUNOTHERAPY IN EXPERI-
MENTAL FELINE ASTHMA. CH Chang, AE DeClue, LA
Cohn, H Liu, CR Reinero. University of Missouri College of
Veterinary Medicine, Columbia, MO
Allergen-speciﬁc rush immunotherapy (RIT) shows promise to
treat asthma; however, pet cats would likely require concurrent
glucocorticoids (GC) to control serious clinical signs. How immu-
nosuppressive eﬀects of GC would impact RIT is unknown. We
hypothesized that oral but not inhaled GC will diminish eﬃcacy
of RIT in experimental feline asthma.
Cats (n=6/group) were sensitized using Bermuda grass aller-
gen (BGA) and randomized to receive BGA-speciﬁc RIT for 9
months with oral GC (prednisolone 10 mg SID), inhaled GC (bu-
desonide 600ug SID) or placebo for the ﬁrst 6 months. Bronc-
hoalveolar lavage ﬂuid (BALF) % eosinophils and other
immunologic assays were performed.
Eosinophilic airway inﬂammation was suppressed similarly in
all groups at month 6 (oral GC 5±2%; inhaled GC 13±4%; pla-
cebo 7±2%; p=0.176). At month 9, % BALF eosinophils did
not diﬀer signiﬁcantly between groups (oral GC 25±8%; inhaled
GC 13±4%; placebo 11±5%; p=0.084). However, 2 cats receiv-
ing oral GC/RIT at month 9 had markedly increased % BALF
eosinophils (46% and 54%); comparatively, the highest % BALF
eosinophils in the inhaled GC group was 23% and in the pla-
cebo/RIT group was 29%. No signiﬁcant diﬀerences were found
between groups at month 6 or 9 for lymphocyte blastogenesis, %
blood Tregs, numbers of IL-10 producing cells or serum BGA-
speciﬁc IgE.
While there was no statistically signiﬁcant eﬀect of oral or
inhaled GC concurrent with RIT on airway eosinophilia, a sub-
population of cats treated with oral GC had diminished eﬃcacy
of RIT. Thus, inhaled GC may be a better option for asthmatic
cats receiving RIT.
ABSTRACT R-5
FELINE T REGULATORY CELLS IN BRONCHOALVEO-
LAR LAVAGE FLUID AND WHOLE BLOOD IN HEALTHY
AND EXPERIMENTALLY ASTHMATIC CATS. CH Chang,
BD Eason, AE DeClue, CR Reinero. University of Missouri
College of Veterinary Medicine, Columbia, MO
Regulatory T cells (Tregs) dampen harmful immune responses
in allergic disease and are postulated to be deﬁcient in number
and/or function in allergic asthma. Evaluation of local Tregs in
the feline respiratory tract has not previously been described. The
purpose of this study was to develop a ﬂow cytometric assay to
measure Tregs in bronchoalveolar lavage ﬂuid (BALF) and whole
blood (WB), and to compare the %Tregs between healthy con-
trol (n=6) and experimentally asthmatic cats (n=8).
Asthma was experimentally induced using Bermuda grass aller-
gen and samples collected 24 h after allergen aerosol challenge.
Cells were stained with feline-speciﬁc and feline cross-reactive
antibodies against CD4, CD5, and foxP3. A CyAn ﬂow cytome-
ter was used. The gating strategy involved identifying CD5+
cells on a CD5 vs SSC plot; these cells were analyzed for double
staining with CD4 and foxP3 in a dot plot. The %Tregs was
compared between groups and between WB and BALF within
groups using a Mann-Whitney Rank Sum Test with P<0.05 con-
sidered signiﬁcant.
Results (median, range) showed detectable CD5+(CD4+foxP3
+) Tregs in WB (controls: 4.1%, 1.9-4.9%; asthmatics: 3.3%, 1.9-
5.8%) and BALF (controls: 4.1%, 1.6-8.9%; asthmatics: 6.7%, 3.3-
9.2%) with no signiﬁcant diﬀerences between groups (P=0.943).
The %Tregs was signiﬁcantly higher in BALF compared with WB
in asthmatic (P=0.015) but not healthy (P=0.931) cats.
In conclusion, ﬂow cytometry is useful to identify feline
Tregs. Experimentally asthmatic cats have signiﬁcantly more
local than peripheral Tregs, perhaps suggesting attempts to
increase this regulatory population to dampen aberrant airway
inﬂammation.
ABSTRACT R-6
LUNG PATHOLOGY ASSOCIATED WITH TOXOCARA
CATI INFECTION IN CATS IS INDEPENDENT OF DEVEL-
OPMENT OF ADULT INTESTIONAL PARASITES. AR
Dillon, DM Tillson, J Hathcock, B Brawner, R Cattley, A
Wooldridge, B Welles, S Barney, L Botzman, M Sermersheim.
Auburn University, College of Veterinary Medicine, Auburn, AL
Lung disease associated with migrating T cati larvae in the cat
has not been deﬁned as to the timing of the arrival of the larvae
in the lung, the nature of induced lung disease, or the correlation
of lung disease to relevant diagnostic techniques. The purpose of
this study was to describe the progression of T cati-induced lung
lesions in kittens and adult cats, and determine if medication pre-
scribed to prevent intestinal roundworm development alters the
early larval migration through the lung.
Cats in infected groups were administered 5 oral doses of L3
T cati larvae. Four month old Speciﬁc Pathogen Free (SPF) kit-
tens were randomly divided into three groups (6/group): an
infected untreated group, an uninfected untreated control group,
and an infected treated group (topical moxidectin and imidaclo-
prid at the label dose, Advantage Multi for Cats, Bayer Animal
Health). Six 2-3 year old adult multiparous female SPF cats were
used as an infected untreated adult group. Cats were evaluated
for the progressivity of the lung disease by serial CBCs, BALs,
fecal examinations, thoracic radiographs, and thoracic CTs. Cats
were euthanized 65 days after the initial infection and samples of
intestine, liver, and ﬁxed perfused lung were obtained. Lung sam-
ples were collected for bronchial ring reactivity via in vitro chal-
lenge. Adult worms in the intestine were collected for
determination of sex and length.
Adult T. cati, of all stages, were recovered in infected
untreated kittens (5/6) and infected untreated adults (5/6) in
numbers consistent with spontaneous natural infections; most but
not all cats with adult worms had eggs identiﬁed in the feces. No
adult worms were identiﬁed in the uninfected controls or the
infected treated group. All cats in the infected groups, including
treated cats and untreated cats which did not develop adult
worms, had lung pathology based on histopathology, radio-
graphs, and CT evaluation.
Evaluation of the serial data in the infected cats demonstrated
a peripheral eosinophilia (CBC) and eosinophilic cytology (BAL),
which usually preceded radiographically identiﬁable lung lesions.
Lung lesions were identiﬁed by CT on day 10 after infection and
were progressive in sequential CT evaluations. Disease was not
uniformly distributed among lobes or within lung lobes. Thoracic
radiographs showed a classic diﬀuse bronchial-interstitial pattern.
Pulmonary arterial, bronchial and interstitial disease were promi-
nent histological lesions. Based on statistical evaluation of the
histopathologic and CT lung scores, infected treated cats had a
subtle attenuation but not prevention of lung disease compared
to infected cats. Signiﬁcant lung disease in kittens and adult cats
is associated with the early arrival of T cati larvae in the lungs
and is independent of the development of adult worms in the
intestine.
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ABSTRACT R-7
CERVICAL LUNG LOBE HERNIATION IN DOGS WITH
COUGH AS IDENTIFIED BY FLUOROSCOPY. LA Nafe, ID
Robertson, EC Hawkins. North Carolina State University
College of Veterinary Medicine, Raleigh, NC
Dogs with cervical lung lobe herniation (CLLH) have been
described in few case reports. In our experience, CCLH is com-
mon in dogs with cough. The purpose of this study was to char-
acterize CLLH in dogs evaluated at a referral hospital. We
hypothesized that CLLH would be a frequent ﬁnding in coughing
dogs, and that herniation would be associated with a chronic
cough and with intra-thoracic large airway collapse. Study dogs
underwent ﬂuoroscopic evaluation of cough from 2008-2010.
CLLH was diagnosed by the transient displacement of lung cra-
nial to a line between the manubrium and the ﬁrst thoracic verte-
bra. Cases were eliminated if cough or forced expiration did not
occur during ﬂuoroscopy. Patient discharge summaries and
reports of thoracic radiographs and ﬂuoroscopy were reviewed
retrospectively. Findings were compared between dogs with
CLLH and without CLLH (controls) using routine statistical
methods, P < 0.05 considered signiﬁcant. Of 121 study dogs, 85
(70%) had CLLH. There was no signiﬁcant diﬀerence in median
duration of cough between dogs with and without CLLH (12
months and 10 months, respectively; P=0.792). Duration of
cough was < 1 month in 8 (9%) dogs with CLLH. No associa-
tions were found between signalment, body weight, presence of
heart murmur, or the radiographic ﬁndings of cardiomegaly or
left atrial enlargement, and CLLH. Collapse of the intra-thoracic
trachea, mainstem bronchi, or either during cough as identiﬁed
ﬂuoroscopically were associated with CLLH (P = 0.001, 0.004,
and 0.041, respectively). The extra-thoracic trachea was noted to
kink during herniation in 33 (39%) of dogs with CLLH. CLLH
was present in the majority of cases evaluated ﬂuoroscopically
for cough and was associated with intra-thoracic large airway
collapse, but not duration of cough. Kinking of the trachea dur-
ing herniation may contribute to progression of cough in some
patients.
ABSTRACT R-8
ASSESSMENT OF ARTERIALIZATION OF PERIPHERAL
VENOUS BLOOD IN WELL-PERFUSED DOGS.
Y Shiroshita1,2, Y Yamane1. 1Department of Veterinary Surgery,
Faculty of Agriculture, Tokyo University of Agriculture and
Technology, Tokyo, Japan, 2Sagamigaoka Animal Clinic,
Kanagawa, Japan
Multiple arterial blood gas samples are essential for monitor-
ing a patient during perioperative and critical care. In small ani-
mals, an indwelling arterial cannula is usually used for multiple
blood gas sampling, although it may cause massive hematoma
from rupture of the artery. In well-perfused humans, blood
obtained from a superﬁcial hand vein after heating the hands in
hot water for several minutes has been reported as an appropri-
ate substitute for arterial samples for the measurement of pH,
PCO2, and lactate. The heated-hand technique is referred to as
arterialization. Multiple blood gas samples can be obtained more
easily and safely with this technique than with an indwelling arte-
rial cannula. This study aimed to ascertain if arterialized venous
blood samples can replace arterial blood gas sampling in well-
perfused dogs.
Blood samples from the femoral artery (A), cephalic vein
(CV), and saphenous vein (SV) were simultaneously collected
from 8 lightly anesthetized dogs under conditions of experimen-
tally induced metabolic acidosis, metabolic alkalosis, respiratory
acidosis, and respiratory alkalosis in each dog. Samples were
analyzed for pH, PCO2, PO2, [HCO3], and base excess for
each acid–base status. Metabolic acidosis was induced by con-
tinuous infusion of 0.6 M NH4Cl in 5% dextrose, and meta-
bolic alkalosis was induced by administration of 1 M sodium
bicarbonate solution. Respiratory acid–base disturbances were
induced by mechanical ventilation. The forepaw and hindpaw
were continuously heated at 37°C to arterialize CV and SV.
Mean arterial pressure was maintained at more than 80 mm
Hg. Statistical analysis was performed using MANOVA and lin-
ear regression. Bland–Altman plots were used to assess the
degree of agreement between the blood gas values of A and ar-
terialized CV or SV. P < 0.05 was considered statistically sig-
niﬁcant.
pH, [HCO3], and base excess values in arterialized CV and
SV exhibited no signiﬁcant diﬀerences from those in A, high cor-
relations with those in A (coeﬃcient of determination, r2 = 0.93
–0.99), and a clinically approximate agreement with those in A,
respectively. PO2 values under all acid-base statuses in arterial-
ized CV and SV were signiﬁcantly lower than those in A (P <
0.01) and not correlated with those in A (r2 = 0.51–0.75), respec-
tively. PCO2 values under metabolic acidosis in arterialized CV
and SV were signiﬁcantly higher than those in A [CV, 38.7 ± 2.6;
SV, 37.5 ± 2.6; A, 33.2 ± 3.0 (mean ± SD) mm Hg; P < 0.01].
However, PCO2 in arterialized SV was closely correlated with
that in A under both metabolic and respiratory acid–base distur-
bances (r2 = 0.93 and 0.99, respectively). It also demonstrated
clinically acceptable agreement with that in A. In conclusion, ar-
terialized SV blood samples can replace arterial blood gas sam-
ples for the measurement of pH, PCO2, [HCO3], and base
excess in well-perfused dogs for clinical purposes.
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